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Wendy Vander Poel Russell
.;\ (1919-2006)
Wendy Vander Poel Russell, whose inherent cheerfulness, good taste, and devotion to the public good long
graced the North Shore of Long Island, died at age 86 on March 9, 2006. As a participant in one of our early
summer Nature Study courses, she waded in the waters, coming out of St. John's pond never having rea-
son to think that she would later assume a major role in helping chart the Lab's development into a major
worldwide center for biological research.
Born February 6, 1919, she was the daughter of Gretchen Billings and Halsted Vander Poel, a descen-
dent of one of New York's original Dutch settlers. After spending her grammar school years at the Nightingale
Bamford School in New York City, she prepared for her future as a thoughtful member of New York society
at The Ethel Walker School in Simsbury, Connecticut. In 1940, just before the United States entered World
War II, she married George Montagu Miller (Monty), and soon served as a Red Cross nurse's aide, first at
Presbyterian Hospital and then at Halloran General Hospital, Staten Island.
From their marriage, two daughters-Wendell Miller Steavenson of London, England, and Gretchen Miller
Elkus, of Ligonier, Pennsylvania, were born. Although her parents' main home was in New York City, it was
her family's Long Island estate on Mill River Road and Route 25A and membership in the Piping Rock Club
that provided Wendy her assemblage of lifelong friends, golf, and bridge partners who helped her pass
through years of domestic life that she wished might have gone differently. Equally important and stabilizing
to her long, productive life was her long role as President of Miller Richard, Inc. decorators. In 1977, after a
divorce from her first husband, she married Sinclair Hatch, a partner in the New York law firm Milbank, Tweed,
Hadley, and McCloy. Upon his death in 1989, she married William Francis Russell, who also predeceased her
on April 9, 1996.
In New York City, her main philanthropy was directed toward the Manhattan Eye and Ear Hospital of
which she was a vice president, serving for many years as President of the Eye Bank for Sight Restoration
(a parent foundation for 95 eye banks). On Long Island, she was already long associated with Hutton House,
the adult education outreach program of C.W. Post College, when she joined our Board of Trustees in
November 1984. At that time, the Laboratory had just purchased land at Uplands Farm from the Nature
Conservancy to create an agricultural research station for maize research. To raise funds for the station,
Wendy organized a visit from executives of the Ira W. DeCamp Foundation, which resulted in a $100,000
grant for plant genetics research. Soon after, she greatly assisted Ed Pulling with his task to raise monies
for the Lab's new Grace Auditorium.
During her three successive four-year terms on the Board, including two periods as secretary (1985-1987
and 1992-1997), she became a legendary fund-raiser for the Lab, describing herself as the best pickpocket
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the Lab ever had. Wendy's dinner parties, which introduced potential donors to visiting and resident Cold
Spring Harbor scientists, regularly attracted new Lab supporters. Already seasoned in the Lab's goals of con-
verting basic research into medical breakthroughs, she was key to the success of the Second Century
Campaign, serving as head of its "major gift" committee that raised from her vast circle of friends more than
$2 million for the construction of the Neuroscience Center. Upon its dedication in 1991, Wendy's main focus
turned the renovation of Cold Spring Harbor's 1926 brick school building into the highly functional DNA
Learning Center.
Toward its objective, she brought into existence a Corporate Advisory Committee, whose members came
from prominent Long Island industrial and commercial groups. By 1997, its ever-increasingly successful June
golf tournament at the Piping Rock Club raised $98,000 for the DNA Learning Center programs. Equally
important were her fund-raising efforts to bring into existence, in 1997, the Mary D. Lindsay Child Care
Center, which includes a playground that bears Wendy's name.
Upon retiring from our Board of Trustees in 1997, Wendy was elected an Honorary Trustee, taking much
pleasure in continuing to participate in virtually all of the Lab's public activities. The coming into existence of
the Lab's graduate program much excited her, with her happily participating in its first commencement exer-
cises that awarded an Honorary Degree to her close friend David Luke for his key role in bringing the Watson
School into existence.
Her inherent upbeat tone remained visible even after she was stricken with ovarian cancer that all too soon
was seen as incurable. As our final tribute to her, the lovely colonial-style superintendent's house on Uplands
Farm was completely remodeled into a residence for young scientists-the Wendy Vander Poel House. At its
dedication ceremony, on a warm September evening, Wendy was totally her long vibrant self, much enjoying
her daughter's retelling of 80 great things about Mummy on her 80th birthday.
In Wendy's passing, we take comfort in how long she was on our side.
James D. Watson
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Regina Clarkson Quick (1927-2006)
When Laboratory Trustee Tom Quick lovingly eulogized his mother at a memorial
service in St. Patrick's
Cathedral last April, he said, "Indeed, there was an elegant simplicity to her." How true.
And how fortunate
her Laurel Hollow neighbors and the Laboratory community were to have known
her for 25 years. Jean was
the rarest of people in that she seemed to embody all of the most admirable human qualities-kindness,
humility, selflessness, sense of humor, and generosity of spirit.
In many respects, her life story reflected the American ideal of her generation. Jean's grandparents sailed,
penniless, from Cork, Ireland, to Ellis Island in search of a better life. She grew up in Queens, New York, one
of five children of Thomas and Mary Clarkson. Thomas supported the family by laboring as an
iron worker,
contributing to the construction of New York City landmarks such as the Singer Building and the Queensboro
Bridge. Jean was an excellent student who, apparently, only strayed from the straight and narrow when pre-
sented with the opportunity to skip school and see the young Frank Sinatra perform at the Paramount
Theatre. She went on to work as a secretary at a local tool and die company.
It was during her childhood in Queens that Jean first met her eventual husband of 51 years-the late Leslie
C. Quick, Jr. The story goes that young Les, a paperboy for the Long Island Press, convinced a colleague to
switch delivery routes with him so that he could pass the Clarkson home each day in hope of catching a
glimpse of his childhood sweetheart. The rest is history. After wartime service in the U.S. Army Air Corps, Les
attended the Pennsylvania Military College, from which he graduated in 1950. Ten days later, he and Jean
were married.
Their life together was an adventure. They outgrew their first Long Island home in Levittown as the family
eventually expanded to seven children. As Jean dedicated herself tirelessly to child-rearing and community
activities, Les was pursuing his legendary business career culminating with the founding of the discount bro-
kerage Quick & Reilly, the firm for which all four of the Quick sons eventually worked. The business grew and
prospered over three decades and the Quick family along with it. Tom fondly remembers the days when,
despite the financial good fortune that the business brought to the family, Jean continued to clip grocery store
coupons out of the daily newspaper. "You can take the girl out of Queens, but you can't take Queens out of
the girl," says Tom. Indeed, Jean's charm stemmed from the fact that she forever maintained her humility.
There was no pretense as she always seemed comfortable with herself and with others, whether in Queens
or Palm Beach.
Fortunately for us, in 1978, Jean and Les moved from Woodbury to a beautiful house in Laurel Hollow
directly up the hill from the Laboratory campus. Equally fortuitous and totally by coincidence, my wife Sophie
and I bought the house directly next door to the Quicks in 1985. Jean and Les welcomed and befriended us
with an unexpected graciousness. In 1997, Laboratory Chairman David Luke and I approached Les about
serving on the Board and that began a wonderful relationship between the Laboratory and the entire Quick
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family. Les developed a love for the Laboratory and worked on its behalf with great energy and distinction
until his untimely death from cancer in 2001. After his death, I asked Jean whether she thought any of the
children would like to take Les' place on the board. Without hesitation, she replied "Les loved the Lab-it's
what he would have wanted." She suggested son Tom who immediately agreed and has served on the board
ever since. More recently, son Peter, a resident of Mill Neck, has joined the Lab's Capital Campaign
Committee.
The death of Les was a devastating blow to Jean. She had become physically frail as a result of her long
battle with progressive arthritis. Yet she remained tenaciously strong in mind and spirit, most likely due to her
strong faith in God and her love of family. She never complained. In 2004, Jim Watson and I visited Jean and
asked her to consider memorializing the Quick family legacy at Cold Spring Harbor Laboratory by naming one
of the two new cancer buildings to be built as part of the main campus expansion. When Jean invited us back
to the house to inform us of her decision to grant the request, I don't know who wore the broadest smile-
Jim or Jean. This spring, it will be wonderful for all of us to see the Leslie and Jean Quick Building for Cancer
Research begin to rise on the hillside overlooking the harbor that they both loved.
As Tom said at St. Patrick's, "she asked little, but gave so much." Certainly, in addition to Cold Spring
Harbor Laboratory, Jean gave a great deal of herself and her resources to many groups and institutions
including the Dana Farber Cancer Center, The Breast Cancer Research Foundation, The Arthritis Association,
St. Bonaventure University, Fairfield University, and St. Francis Hospital. Most of all though, I believe Jean
would have liked to be remembered for her love of family. She was unfailingly proud of her husband, her seven
children, and her twenty-six grandchildren. Whenever any of them were in the room, her eyes twinkled and
her laugh was ready.
Dill Ayres
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PRESIDENT'S REPORT
For much of its 116-year history, and particularly during the last thirty-five years, Cold
Spring Harbor Laboratory has provided an environment for science of the highest quality. As
we stand on the verge of the largest single expansion in the Laboratory's history, it is worth
reflecting on how this culture of achievement is fostered.
The value of science can be assessed subjectively by the benefits it brings to society, such
as advances in human health. There are more objective measures, such as the rate at which
a research group's publications are cited by other scientists. By this measure, the Laboratory
stands at or near the top of an elite group of international institutes and universities. But
important science can also be so visionary that it is overlooked or misunderstood. The pio-
neering genetics research done at Cold Spring Harbor in the 1940s and 1950s by Barbara
McClintock was not highly cited because it was so forward-looking, and in fact, two decades
had passed before the scientific community as a whole came to appreciate the work for
which Barbara eventually won a Nobel Prize in 1983. Even today, our plant biologists are still
discovering molecular intricacies of the phenomena Barbara described.
Outstanding science is produced when the most able investigators work in an intellectu-
al culture of the right kind. A successful research scientist needs talent but must also have a
passion for exploring by asking questions and doing experiments. And passion is truly
required, for the life of a scientist is demanding on time, intellectual effort, and family life. Thus
equipped, a successful scientist must work in an environment that promotes freedom of
exploration, because it is the imagination of an individual that generates new ideas and
testable hypotheses. The Laboratory's environment, aside from being one of the most sceni-
cally beautiful in science, contains many elements that promote excellence.
One is our very capable administration that nurtures science while minimizing obstacles.
Another is our internationally renowned meetings and courses program and the Banbury
Conference Center, which bring to our campus many of the world's leading investigators to
share new data and technologies. Many of our staff members take full advantage of the
opportunities to learn from our visitors, recruit new members of research teams, and initiate
collaborations. As a new Postdoctoral Fellow in 1979, I benefited enormously from the Cold
Spring Harbor meetings and gained knowledge that has helped my own research and my
ability to oversee a broad research program.
Another contribution to the Laboratory's research success has been the balance between
creating diversity in lines of pursued research and building a critical mass of investigators with
shared intellectual and technical interests. In maintaining such balance, it is important that
the appointment of new faculty complements the skills of existing faculty, adding strength
and depth to the research program as a whole. The combination of faculty turnover and
arrival of new staff keeps Cold Spring Harbor at the cutting edge of research.
The collaboration and interaction among our scientists is one of our strongest assets. We
actively foster such interactions through formal and informal discussion groups, joint labora-
tory meetings, and "in-house" seminars that encourage the exchange of ideas. In addition,
some of the best ideas emerge in informal locations, such as the cafeteria, coffee shop, or
bar. Postdoctoral Fellows and students gain valuable practical help and advance their
careers by getting to know our experienced and successful senior scientists.
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But even an institution such as ours, with so many elements conducive
to creative sci-
ence, needs the crucial addition of sufficient financial resources
to enable researchers to pur-
sue their ideas without constant worry about future funding.
Modern science is expensive,
time-consuming, and labor-intensive. Our scientists need the
money to take on bold chal-
lenges-the kind that get federal funding only after an initial
breakthrough. For this reason, a
large percentage of the highly innovative research at Cold
Spring Harbor is now funded by
philanthropy. Such funds are much appreciated, but unrestricted endowment
would provide
essential funds for research infrastructure, start-up costs for new
investigators, and support
for new projects.
Maintaining the financial resources necessary to sustain
outstanding science is our great-
est challenge. Because federal support for science has fallen
dramatically and competition
for grants has intensified, unrestricted funds are required
that can be directed to areas of
need. Being financially lean can force scientists to think
seriously about the most important
questions to be addressed, but one cannot be too lean for too long. To
maintain Cold Spring
Harbor Laboratory as a place of outstanding science, we
must be able to recruit the very
best young investigators and provide them with start-up
funds, and we must be able to sup-
port our successful senior scientists when they need it.
Perpetuation of our culture also requires contributions from our
senior staff, especially as
I devote more time in the future to raising funds to support our science and
education pro-
grams. Advice from a Board of Trustees subcommittee
(Robert Lindsay, Eduardo Mestre,
Titia de Lange, and Robert Tjian) has helped us to put in place a management structure that
will ensure that our culture of excellence will continue. A key
appointment has been the pro-
motion of Dr. David Spector to Director for Research. David is an internationally respected
leader in cell biology and continues to make notable contributions to the understanding of
the structure of the mammalian nucleus and its influence on gene expression. He has a deep
understanding of our culture and will be vital in maintaining it.
Challenging times are ahead for the sciences in the United States due to reductions in
research federal funding. With constant pressure from a public that wants its major diseases
cured, Congress should now act to reverse this trend. But at Cold Spring Harbor, we must
find a path that ensures that our way of doing science can be preserved independently of
national trends. As this Annual Report demonstrates, our science continues to produce sur-
prising and unexpected insights into the fundamentals of cancer, neurobiology, and the ways
in which genes work. Sustaining this productivity is our most important goal.
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HIGHLIGHTS OF THE YEAR
Research
Cancer
Liver cancer is the fifth most frequent neoplasm worldwide. However, owing to the lack of
effective treatment options, it is the third leading cause of cancer deaths. By generating
tumors in laboratory mice that mimic human liver cancer and by comparing the DNA of
mouse and human tumors, researchers at CSHL have identified two genes that are likely to
have a role in this form of cancer. The study also establishes an efficient and adaptable
method for exploring the biology of liver cancer, for validating potential therapeutic targets,
and for testing new treatments.
To gain a better understanding of the molecular causes of liver cancer, the researchers
(see below) devised a strategy for genetically engineering liver stem cells, harvested from
mouse embryos, and subsequently transplanting the cells into adult mice. Following trans-
plantation, the cells can become part of the recipient mouse's liver.
The scientists engineered the liver stem cells to mimic the genetic lesions that are known to
occur in human liver and other cancers (namely, deletion of the p53 gene and activation of the
myc gene). Transplanted cells lacking the p53 gene and bearing an activated version of the myc
gene rapidly gave rise to aggressive, invasive liver tumors. Scanning the DNA of these tumors
revealed that a specific segment of mouse chromosome 9 was amplified-or present in excess
copies-compared to the DNA of healthy mouse liver cells. Because this segment of mouse
DNA carried several genes, the researchers turned to the human genome to help them narrow
down which gene (or genes, as it turned out) was the culprit in liver cancer. In parallel with their
analysis of the mouse liver tumors, they scanned the DNA of human liver and other tumors.
Remarkably, they found that a region of human chromosome 11 that is evolutionarily related to
the segment of mouse chromosome 9 was amplified in several of the human tumors.
Additional experiments revealed that two genes-Yap and clAP1-were both consistent-
ly overexpressed in both mouse and human tumors. Thus, when produced at abnormally
high levels, proteins encoded by the Yap and clAP1 genes contribute significantly to human
liver and other cancers. Therefore, these proteins and others in the pathways they control are
attractive candidates for the development of novel cancer therapies.
The study involved scientists from five institutions in Europe, Asia, Australia, and the
United States and five research groups at CSHL led by Scott Lowe, Mike Wig ler, Greg
Hannon, Rob Lucito, and Scott Powers.
In some cases, the fusion of human cells is a normal process that leads,
for instance, to the formation of muscle and bone. Seemingly innocuous
infections by common viruses can also cause cells in our bodies to fuse. Such
fused or "hybrid" cells are widely considered to be harmless because they are
generally believed to die and be cleared from the body without consequences
to our health. This view of cells fused by viruses as being harmless may need
to be revised, and revised dramatically. According to a recent study led by Yuri
Lazebnik and postdoctoral fellow Dominik Duelli, cell fusion triggered by com-
mon viral infections may be a significant factor in the development of human
cancer.
The idea that aberrations in the number or structure of human chromo-
somes can spur tumor formation is more than a century old. Such aberra- Y. Lazebnik
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tions-known collectively as "aneuploidy"-arise in two
principal ways: as a consequence of
abnormal cell division or as a result of cell fusion. In both
cases, aneuploid cells have an
abnormal genetic makeup (e.g., too few or too many copies
of a particular chromosome or
chromosome segment) and they frequently die. But not always.
Researchers have long known that cancer cells-very
much alive--are often aneuploid.
Whether aneuploidy is a cause or a consequence of a
cancerous state is still being debated. But
in any case, given that cell fusion causes aneuploidy and that
aneuploidy may cause cancer, it
follows that cell fusion may cause cancer. This is where "innocuous"
viral infections come in.
Dominik and Yuri first observed that cultured human
cells are fused through the action of
a particular virus (Mason-Pfizer monkey virus [MPMV], one among
many "fusogenic" virus-
es). As expected, the resulting hybrid cells are aneuploid and fail
to grow. However, the
researchers next showed that if one of the cell fusion
partners is engineered to carry a par-
ticular mutation in an oncogene or a tumor suppressor gene, then a
significant number of
the resulting hybrid cells grow land are thus potentially
cancerous. Yuri's group is currently
exploring whether such proliferating fused cells are
produced by viral infections in animal
models. If they are, then the work of sorting out which of the many known
fusogenic virus-
es might contribute to human cancer will likely begin in many laboratories.
Genomics and Bioinformatics
Rice feeds more than half of the world's human population. Estimates indicate that the rice
crop yields will need to be increased by about 30% over the next two decades to meet a
projected increase in demand.
W. Richard McCombie, his CSHL colleagues, and other members of the 10-
nation International Rice Genome Sequencing Project have reported a highly
accurate, "finished" DNA sequence of the entire rice genome. The complete rice
genome sequence-which reveals some 38,000 genes on the 12 chromosomes
of rice-provides the raw material for many studies aimed at improving the agri-
cultural yield of the world's most important food source. Moreover, because the
rice genome is closely related to that of other major cereal grasses (including
corn, wheat, barley, rye, sorghum, and millet), the complete rice genome
sequence is an extraordinarily useful resource for identifying genes of interest in a
group of crop plants that collectively supply two thirds of humanity's food supply.
The study revealed thousands of genetic markers in the rice genome that are of
immediate use to plant breeders and others working to improve rice agriculture. It also gen-
erated the first finished genome sequence of any crop plant, making rice a powerful model for
how to use genome sequence information to improve many other aspects of agriculture. The
finished rice genome sequence builds upon draft sequences previously published by the pri-
vate companies Monsanto and Syngenta. As such, it is an excellent example of a successful
public-private partnership that saved the public consortium both time and money.
By enabling scientists to identify genes that underlie agriculturally important traits, a draft of
the rice genome sequence released by the public consortium in 2002 has already spurred
both biotechnological and conventional plant-breeding approaches to increasing rice yields.
The new, finished rice genome sequence has the potential to accelerate those efforts. The
availability of the sequence should greatly speed the hunt for genes that increase yield, pro-
tect against disease and pests, and improve other traits of rice and several other cereal crops.
W.R. McCombie
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Plant Molecular Genetics
Although most people probably do not give too much thought to leaves, they are in fact cru-
cial light-harvesting and gas-exchange organs, without which agriculture as we know it, not
to mention life on Earth itself, would be very different.
To the naked eye, the top and bottom surfaces of leaves look rather similar.
Closer inspection reveals that they are highly specialized regions that arise
through a complex series of molecular events. Marja Timmermans has recently
made a number of important discoveries concerning these events and how they
instruct unspecialized stem cells to form the specialized top (light-harvesting) and
bottom (gas-exchanging) surfaces of leaves.
One of Marja's projects explores the role of a gene called leafbladelessl in plant
development. Corn plants with a normal leafbladelessl gene develop broad, flat
leaves with distinct top and bottom surfaces, as usual. In contrast, mutant plants
lacking a functional leafbladelessl gene develop long, threadlike leaves that are
"all bottom, no top." This means that the leafbladelessl gene is somehow
required to specify the formation of top surfaces of leaves. To find out how, in par-
allel with other experiments (see below), Marja and her colleagues, including postdoctoral fel-
low Fabio Nogueira, isolated the leafbladelessl gene. They discovered that leafbladelessl is
similar to another gene with a known role in generating biologically powerful snippets of RNA
called "trans-acting small interfering RNAs" (ta-siRNAs). This is clue #1, i.e., leafbladelessl
specifies "top" by promoting to -siRNA formation. Clue #2 came from examining a different
sort of small regulatory RNA called "microRNA166" (miR166). Marja's group had previously
shown that in normal plants, miR166 is present in the cells that generate the bottom surfaces
of leaves but is absent from adjacent cells that generate the top surfaces of leaves. In short,
miR166 means "bottom."
If ta-siRNAs mean "top" and miR166 means "bottom," then what might ta-siRNAs and
miR166 mean to each other? Does one control the other? Marja and her colleagues
answered this question by determining whether the pattern of miR166 expression is altered
in plants (leafbladelessl mutants) that lack ta-siRNAs. The result (clue #3 and a major dis-
covery): In the absence of ta-siRNAs, miR166 is present both in its usual "bottom" cells and
in the cells that normally generate the top surfaces of leaves. This is consistent with the idea
that in normal plants, to -siRNA activity blocks miR166 expression in the "top" cells. It also
explains why the leaves of leafbladelessl mutants are "all bottom, no top." In such mutants,
the "bottom promoting" activity of miR166 is abnormally present in the "top" cells and trans-
forms the fate of those cells from top to bottom.
Through the work of other scientists, including some of CSHL's own (Greg Hannon,
Leemor Joshua-Tor, Rob Martienssen), small RNAs akin to miR166 and ta-siRNAs have
recently been shown to have important roles in the biology of many organisms, including
humans. Therefore, the discovery by Marja and her colleagues that the opposing activity of
two small RNAs can control major developmental events in plants establishes a paradigm
that is likely to have broad implications for the biological and biomedical sciences.
M. Timmermans
Neuroscience
CSHL neuroscientist Grigori (Grisha) Enikolopov and his colleagues have identified which cell
type among several different kinds of neural precursor cells in the brain is the sole target of
the widely prescribed antidepressant Prozac. This discovery might enable a new generation
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G. Enikolopov
of more specific treatments for
depression, with fewer
side effects, to be
developed. It also lays the foundation
for manyesnteurdaietesdoffrothme
fsatcetmorsoethllsatincothne-
trol how, when, and where new
neurons are g
brain. Such work could eventually
lead to celrlsrepinlaccluedminegnt therapies for
and
r neu-
rodegenerative and other brain
disorders
Parkinson's disease.
It has been known for some years
that Prozac (fluoxetine) is likely to relieve
the symptoms of depression by somehow
causing more neurons to be pre-
sent in a particular region of the
brain (the "dentate gyrus"). But the origins of
these neurons, and how Prozac
promotes their existence, have been a mys-
tery. Until now. By profiling the telltale
marker proteins produced by different
kinds of cells in the brains of adult
mice, Grisha's group-spearheaded by
postdoctoral fellow Juan Manuel Encinas-first
defined discrete steps in the
complex process, called neurogenesis, that converts
unspecialized stem cells into mature,
specialized neurons.
Next, knowing that Prozac treatment somehow
increases the number of neurons in the
brain, the researchers tested which step in the neurogenesis
pathway might be stimulated
by Prozac. They found that Prozac treatment
specifically stimulates the generation of a kind
of cells they dubbed "amplifying neural progenitors" or
ANPs-the second step in the neu-
rogenesis pathway from stem cells to mature neurons.
To address the controversy surrounding the use
of Prozac in children and in pregnant
women, Grisha's group is currently testing the effects of the
drug on brain neurogenesis in
juvenile and pregnant mice. The results of those experiments should
provide valuable infor-
mation for assessing the possible effects of Prozac
and related drugs on fetal and adoles-
cent brain development. The researchers are also using the tools
they have developed to
explore whether other treatments for depression,
including other drugs and deep brain stim-
ulation, act in the same way as Prozac or in different ways.
In addition, they are screening
for new drugs that stimulate ANP cells to multiply and
thus expand the production of brain
neurons for the treatment of neurodegenerative diseases.
It is a classic upper-middle-class dilemma: Should we buy a perfect second
home in an area that takes hours to get to or should we settle for something
closer but not as nice? In the rodent world, an equivalent decision-making sit-
uation might be, "Was the food I liked better down this alley or over there?"
By discovering that particular rat brain neurons combine or "integrate" dis-
similar pieces of information (e.g., location vs. reward), Zach Mainen and his
colleagues have begun to learn how the brain controls decision-making and
goal-oriented behaviors. Examples of these include foraging and navigation in
animals and in humans, whether to buy a particular second home or, in gen-
eral, whether to favor a long-term benefit over immediate gratification.
Zach's recent study represents the first time that brain neurons have been
shown to integrate spatial and reward information. Its results contrast with a
previous "pure economic" view that neurons in the orbitofrontal cortex (OFC) are involved sole-
ly in assessing value. Moreover, the study has implications for understanding pathological
states in humans that affect decision-making, motivation, and emotions such as addiction,
depression, obsessive-compulsive disorder, autism, and other disorders of thought or mood.
The research was spearheaded by graduate student Claudia Feierstein, who recorded the
activity of OFC neurons while rats performed an odor discrimination task that they had pre-
viously learned to accomplish. In the task, the animal receives a test odor ("A" or "B") by pok-
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ing its nose into a centrally located odor port. Next, the animal chooses odor A or odor B as
being the same as the test odor by poking its nose into a choice port located to its right (odor
A) or left (odor B). If the animal chooses correctly, it receives a reward (a drop of water). As
expected, many of the OFC neurons actively signaled "I'm getting a reward" when the ani-
mal moved right or left, i.e., toward odor A or odor B. Surprisingly, however, several of the
neurons signaled "I'm getting the reward to my right," whereas several others signaled "I'm
getting the reward to my left."
One of Zach's next steps will be to examine what happens in the brain while the animals
are first learning to recognize new odors. Through this work, the researchers hope to gain a
greater understanding of learning and memory as well as the neural basis of perception,
motivation, decision-making, and other aspects of behavior.
Cold Spring Harbor Laboratory Board of Trustees
The Board of Trustees was pleased this year to welcome four new members: John C.
Phelan, Managing Partner and cofounder of MSD Capital, L.P.; Jamie C. Nicholls, recently a
General Partner and currently a Limited Partner at Forstman Little & Co.; Donald Everett
Axinn, writer, respected investor and builder in the New York area, and committed public ser-
vant; and Landon Clay, Managing Member of East Hill Management Company.
Concluding their terms as Trustees this year were Arthur M. Spiro and Susan Lee
Lindquist. Mr. Spiro was first elected to the Board in November 1999 and was then reelect-
ed to a second term in 2002. He was active on several committees, including Audit,
Executive, and Woodbury Genome Research Center, and he served for 6 years as the
Chairman of the Dolan DNA Learning Center Committee. Dr. Lindquist was elected to the
Board in 2002 and brought her expertise to bear on the Tenure and Appointments
Committee throughout her term.
We said a sad goodbye to Wendy Vander Poel Russell, Honorary Trustee, who passed
away in March, 2006. Mrs. Russell was an active member of the Board of Trustees since
1984, serving as Secretary from 1985 to 1987 and from 1992 to 1997. A legendary fund-
raiser, her pet project at the Laboratory was the Dolan DNA Learning Center, and she was
instrumental in the establishment of its Corporate Advisory Board.
The Cold Spring Harbor Laboratory Association (CSHLA) raised a total of $1,155,000 this
year under the leadership of Association president Joe Donohue. We say thanks to Mr.
Donahue who served his second term as president in 2006, doing double duty while also
serving as a Trustee of the Board. New Directors in 2006 included Joe Amelia, Suzanne
Di Maio, Nancy Edsparr, Larry Gellman, M.D., and Scott J. Ratner, M.D.
Hillside Campus Dedication
The Hillside Campus Cornerstone Dedication Ceremony on October 15 marked the transi-
tion from constructing the infrastructure for new facilities to construction of the facilities them-
selves. Much of the work done this year has been groundwork for the construction of six
buildings dedicated to scientific disciplines that fulfill the core research mission:
The David H. Koch Building
The De Matteis Family Building
The William L. and Marjorie A. Matheson Building
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The Leslie and Jean Quick Building
The Donald Everett Axinn Building
The Wendt Family Building
The bright, crisp afternoon of the ceremony brought dozens of well-wishers, including
CSHL faculty, staff, dignitaries, and most importantly the donors
and their families whose
names will grace these facilities. Once complete, the Laboratory's
research space will
increase by nearly 40%.
The festive day included a solemn note with fond memories of Jean Quick who passed
away earlier this year after naming the Leslie and Jean Quick Building for Cancer Research
after her late husband and CSHL Trustee Leslie C. Quick, Jr.
Long-time residents of Laurel
Hollow and neighbors of the Laboratory, their legacy at CSHL lives on
through their gifts and
the continued involvement of the family.
In planning for the Hillside Campus, CSHL has worked to be environmentally and aes-
thetically sensitive to the unique environment of Cold Spring Harbor. The new facilities have
been designed to encourage efficiency and easy communication between buildings and sci-
entists. Together, they will function as an academic village at the southern end of the cam-
pus, stylistically within the broader village of science that now exists.
Much of the infrastructure work completed this year consisted of ensuring adequate storm
water drainage for the previously wooded site. Rather than employ the conventional
approach of installing an enormous quantity of dry wells to accommodate storm water, our
civil engineers adopted an ingenious approach: They designed water quality rain gardens
and bioretention ponds to collect and treat storm water runoff before it enters the harbor.
This approach not only provides an environmentally sound means of treating storm water,
but also creates additional naturalized water features on the campus, adding beauty and a
wildlife habitat.
Hillside Campus Dedication Ceremony
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Awards and Honors
Rob Martienssen was elected a Fellow of the Royal Society, distinguished for fundamental dis-
coveries on the epigenetic mechanisms that regulate transposon silencing, gene control, and
stem cell function in plants. He was also noted by the Royal Society as a major contributor to
sequencing the genome of Arabidopsis, the first plant genome sequence completed. This is
one of the highest honors that can be accorded a scientist, and CSHL now adds Martienssen
to its list of previously elected fellows: Jim Watson, Nick Tonks, and myself.
The Leukemia & Lymphoma Society selected Bill Tansey as one of five researchers to
receive its prestigious Stohllman Scholar Award, recognizing his outstanding
contributions to the advancement of blood cancer research. The focus of his
work is a protein, Myc, known to contribute to the growth of leukemia and
lymphoma cancer cells.
Sandra J. Kuhlman and Eleonore Real each received the National
Alliance for Research on Schizophrenia and Depression Young Investigator
Award. Sandra is studying in an animal model the role GABAergic synaps-
es in the prefrontal cortex have in memory impairment in people with
schizophrenia. Eleonore is working on glutamate receptor trafficking and
synaptic plasticity, since glutamate abnormalities have been implicated in
psychotic disorders.
CSHL Fellow Ira Hall received a 2006 Burroughs Wellcome Fund Career
Award in the Biomedical Sciences. This award provides early-career bio-
medical researchers with funding over a 5-year period to foster their development and help
them make the critical transition to independent investigators. Ira is using DNA microarray
technology to explore DNA copy-number fluctuations and epigenetic inheritance in the
mouse, an important model system for many diseases including cancer.
Thomson-ISI added the CSHL Press journal Genes & Development to its "Top 10
Scientific Journals in All Areas" list for the decade 1995-2005. Edited by Terri Grodzicker,
this journal presents research papers of broad general interest and biological signficance in
molecular biology, molecular genetics, and related fields. Thomson-ISI provides a service
that measures the impact of some 7 million papers published in 11,000+ journals in 22
major scientific fields.
Inside Cancer-a comprehensive, user-friendly Web guide to cancer biology created by
the BioMedia Group of CSHL's Dolan DNA Learning Center-was selected as an official
"Site of the Day" by Adobe Systems Incorporated, joining the ranks of other winners that
included Nike, Cartier, and Bentley Motors.
A publication by Leemor Joshua-Tor and her colleagues Niraj Tolia, Fabiola Rivas, and
Greg Hannon was selected as the "New Hot Paper" by Thomson Scientific's Essential
Science Indicators. "Purified Argonaute2 and an siRNA form recombinant human RISC"
won this distinction by virtue of it being cited more frequently than 99.9% of all other stud-
ies in numerous journals surveyed.
CSHL was selected to be part of a consortium that will benefit from a $100 million grant
from the Starr Foundation. CSHL, The Broad Institute of MIT and Harvard, Memorial Sloan-
Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medical College will
collaborate on research aimed at understanding cancer at its most fundamental levels and
at developing new approaches to the prevention, diagnosis, and treatment of many forms
of the disease.
R. Martienssen
9
Starr Cancer Consortium members (left to right) A.M. Grotto, Jr., E. Lander, M. Greenberg,
H. Varmus, B. Stillman, F. Davis
D. Spector
Development
David Spector will lead CSHL's involvement in the establishment of the
Nanomedicine Center for Nucleoprotein Machines. The National Institutes of
Health awarded a $10 million grant to CSHL, the California Institute of
Technology, Emory University, Georgia Institute of Technology, The German
Cancer Research Center, the Medical College of Georgia, Massachusetts
Institute of Technology, and the New York University Medical Center. The
focus of the center will be to understand the molecular machines that
enable cells to detect and repair damaged DNA. David was also the first
recipient of the Winship Herr Award for Excellence and Creativity in Teaching
in the Watson School of Biological Sciences.
CSHL President Bruce Stillman was honored by the Society of Surgical
Oncology, receiving the American Cancer Society Basic Science Award and
Lecture.
This year has proven to be another year of successful fund-raising at Cold Spring Harbor
Laboratory. Our most generous donors have provided much needed support to both capital
and research projects as well as our endowment.
Cold Spring Harbor Campaign
Capital
The following major donors have generously contributed new gifts and pledges of $100,000
or more to support the Laboratory's Hillside Campus expansion project: Mr. and Mrs. Donald
Everett Axinn, David H. Koch Charitable Trust, Mary D. Lindsay, and The Perkin Fund.
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Faculty Recruitment Support and Equipment
We gratefully acknowledge support of $100,000 or more from Mr. and Mrs. Landon T.
Clay, Mr. and Mrs. Norris Darrell, The Shelby Cullom Davis Foundation, The Coleman
Fung Foundation, Jeff Hawkins and Janet Strauss, Jamie Nicholls and Fran Biondi, The
Robertson Foundation, Dr. and Mrs. James Stone, and The Roy J. Zuckerberg Family
Foundation.
Watson School of Biological Sciences
Support of the Dean's Chair, fellowships, and lectureships enable the Watson School to
continue to grow and influence the field of biological sciences. We appreciate new gifts
and pledges of $100,000 or more this year by Mr. Michel David-Weill, Mr. Curt
Engelhorn, and Mr. and Mrs. Robert D. Lindsay and Family.
Dolan DNA Learning Center
New gifts and pledges to support the Dolan DNA Learning Center endowment were
gratefully received from The Lessing Family Foundation and the OSI Pharmaceuticals
Foundation.
Carnegie Library
The Genentech Center for Molecular Biology and Biotechnology was established with a
generous gift from Genentech. Other supporters of S100,000 or more include the New
York State Office of Parks and Historic Preservation and Dr. Norton Zinder (see the
Chancellor's Report).
Program Support
Private funding is essential to maintain the Laboratory's innovative research programs.
We appreciate new gifts and pledges of S100,000 or more from the following donors:
an anonymous donor, Mr. and Mrs. Donald Everett Axinn, Ms. Kathryn Wasserman
Davis, The De Matteis Family Foundation, Mr. and Mrs. Leo A. Guthart, The Thomas
Hartman Foundation for Parkinson's Research, Jo-Ellen and Ira Hazan, The Lita
Annenberg Hazen Foundation, Hope for Depression Foundation, The Keck Foundation,
The Miracle Foundation, The Don Monti Memorial Research Foundation, and Pam and
Pierre Omidyar.
Robertson Research Fund
The primary in-house support for our scientists for more than three decades, the
Robertson Research Fund in 2006 supported research in the labs of Alexei Koulakov,
Cordula Schulz, Leemor Joshua-Tor, Rui-Ming Xu, Wolfgang Lukowitz, Rob
Martienssen, Marja Timmermans, and David Jackson. Start-up research support was
also provided by the Fund to two new investigators: Glenn Turner and Hiroyasu
Furukawa. In addition, the Robertson Research Fund continues to support the annual
CSHL In-House Symposium and our programs for postdoctoral fellows, graduate stu-
dents, the laboratory seminar program, and faculty recruitment.
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Breast Cancer Research Support
The Laboratory greatly appreciates the many supporters
of our breast cancer research pro-
gram. This includes several local grassroots groups that provide
not only much needed
funds, but also public awareness and outreach. This year, we were
fortunate to receive sup-
port from Breast Cancer Awareness Day in memory of Elizabeth
McFarland, Breast Cancer
HELP, Glen Cove Cares, The Breast Cancer Research
Foundation, the Cold Spring Harbor
Main Street Association, Find A Cure Today (F.A.C.T.), Mr. and Mrs.
Richard Gordon, Long
Island 2-Day Walk, Long Islanders Against Breast Cancer
(L.I.A.B.C.), the Manhasset
Women's Coalition Against Breast Cancer, the Pierre and Pam
Omidyar Fund, the Judi
Shesh Memorial Foundation, the Waldbaum Foundation,
the West Islip Breast Cancer
Coalition for Long Island, the Women's Insurance
Network of Long Island, and the Clear
Channel/WALK for Women Breast Cancer Fund.
Building Projects
The year 2006 was a busy one for the Facilities Department, with
multiple simultaneous
construction projects being undertaken in addition to the work on the
Hillside Campus.
The James Laboratory renovation-a multiyear project in which nearly
the entire building has
been reconstructed to meet modern needs-continued
from 2005, with only one laboratory
and two offices remaining to be completed in 2007. The replacement
of the Grace Auditorium
bluestone patio, begun in the fall of the previous year, was
completed in time for the meeting
and course season, and the groundwater-cooled chiller
plant that was to service the Grace and
Harris Buildings was completed, meeting the increased
cooling demand with greater efficien-
cy. This also paved the way for the complete renovation of the Harris
Building mechanical sys-
tems, which, when completed in 2007, will increase the
building's capacity by more than 40%.
Additionally, the Demerec Building chiller, running above its design
capacity and beyond its use-
ful life, was replaced with a new unit of increased capacity and far greater efficiency.
2006 also saw a continuation of the Laboratory's program
to upgrade and improve its
residential properties. The final Hooper apartment, the remaining two Firehouse apart-
ments, and the Rose cottage were all renovated during this year. Additionally, the care-
taker quarters of the Robertson House-previously composed of two cramped rooms-
were expanded and renovated into a comfortable apartment for the live-in caretaker.
Other small projects include those in support of meetings, courses, and special events.
Restrooms in Grace were enlarged to accommodate the increased size of meetings.
Power and lighting were improved in the Bush Auditorium, and offices were constructed
in Blackford Hall to accommodate the increased size of the events planning staff.
Less visible, but equally as important, several key infrastructure projects were com-
pleted as well. Several sections of the Laboratory's underground high-voltage power
mains were replaced. Underground fiber optic network cables were extended to areas
not previously serviced. And the Laboratory's water main was extended both to accom-
modate future expansion into the Upper Campus and to connect to residential proper-
ties at the north end of the campus, which were previously fed by well water. Two high-
ly visible infrastructure projects are the curbing and stabilizing of the Davenport lawn
parking lot and a major drainage project intended to divert the stream running through
the campus around the foundations of the Demerec Laboratory during 100-year floods,
two of which occurred within a single month the previous year.
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Special Events
Symposium
The 71st Symposium-"Regulatory RNAs"-once again included the annual Dorcas
Cummings Lecture. Ron Pasterk's outstanding lecture on "The Emerging World of Small
RNAs" was presented to a mixed audience of scientists and lay friends and neighbors of the
Laboratory. Following the lecture, more than 20 of our neighbors graciously opened their
homes and hosted dinner parties for Symposium participants and Laboratory friends alike.
Gavin Borden Visiting Fellows
The 12th Annual Gavin Borden Visiting Fellow Lecture-in memory of the publisher of
Molecular Biology of the Cell-was held on Tuesday, May 9. Dr. Michael Levine, Professor of
Molecular and Cell Biology at the University of California, Berkeley, presented the lecture enti-
tled "Gene Networks for Fly Gastrulation and Heart Formation in Sea Squirts."
Delbriick 100th Birthday Celebration
On August 26 and 27, the Laboratory commemorated the centennial of the birth of Max
Delbruck (September 4, 1906). Delbruck, who frequently visited during the 1940s through
the 1960s, was a scientific leader who conducted breakthrough research and began Cold
Spring Harbor Laboratory's Phage Course. With Salvador Luria and Alfred Hershey, he
founded the "Phage Group" to research bacteriophage (viruses that attack bacteria) in
order to understand the nature of the gene, work for which the three shared the Nobel
Prize in 1969.
The meeting brought together several of DelbrOck's colleagues, students, friends, and
family members to share stories and discuss his contributions to 20th century science.
The 2-day conference included talks by Ernst Peter Fischer, DelbrOck's former student
and biographer; Matt Meselson, who conducted experiments that helped show how DNA
replicates; and DelbrOck's longtime collaborator, Gunther Stent; among others. The
meeting continued with a symposium on current research related to topics that had inter-
ested DelbrOck, concluding with a review of the burgeoning area of Systems Biology by
Lee Hood, a longtime colleague of Delbruck's.
The First Double Helix Medal
The Laboratory held its inaugural Double Helix Medal Dinner on November
9 at the Mandarin Oriental, New York. Medals were presented to
Muhammad Ali for his public campaign against Parkinson's disease;
to Suzanne and Bob Wright (NBC Universal) for their work in bring-
ing attention to autism through Autism Speaks; and to Nobel laure-
ate and former CSHL faculty member Phillip Sharp for his lifelong
contributions to biomedical research leading to a deeper under-
standing of cancer and other genetic diseases. This special event,
which raised nearly $2.5 million for the Laboratory, was cochaired by
CSHL Trustees Tom Quick, David Rubenstein, and Roy Zuckerberg and
NBC Universal President, Jeff Zucker. Double Helix Medal
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Public Lectures
The CSHL Cultural Series is a tradition in which an eclectic mix of artists, writers, and scien-
tists present lectures, concerts, and exhibits that provide compelling glimpses of how we
experience, discover, live in, and make sense of our world. Open to the public, the aim of the
Cultural Series is to stimulate, inspire, and entertain.
S. Lowe
M. Ridley
J. Friedman
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March 14
Simon Baron-Cohen, Professor of Developmental Psycho-
pathology at University of Cambridge and Director of the Austism
Research Centre in Cambridge: Seeking the Cause ofAutism.
April 25
Scott Lowe, HHMI Investigator/Professor, Cold Spring Harbor
Laboratory: Recent Progress in Cancer Research.
May 16
Irene Pepperberg, Adjunct Associate Professor, Brandeis
University; Research Associate, Harvard University; Leader, The
Alex Foundation: In Search of King Solomon's Ring: Cognitive
and Communicative Abilities of Grey Parrots.
June 13
Matt Ridley, F.R.S., Visiting Professor, Watson School of
Biological Sciences: Francis Crick: Discoverer of the Genetic
Code.
September 12
Jeffrey Friedman, HHMI Investigator/Professor, The Rockefeller
University: Leptin and the Biological Basis of Obesity.
September 26
Paul Liam Harrison, artist-in-residence, Human Genome
Organization: Pertaining to Origins: Organization of Form and
Function.
October 24
Tim Tully, St. Giles Professor of Neuroscience, Cold Spring
Harbor Laboratory: Recent Progress in Neuroscience
Research.
Public Concerts
March 18
Alexandre Pirojenko, piano
March 25
Rui Shi and Chris Gaudi, piano and oboe
April 29
Martin Kasik, piano
May 6
Asmira Woodward-Page, violin
May 20
Gleb lvanov, piano
August 26
Julie Albers, cello
September 2
Orion Weiss, piano
September 16
Efe Baltacigil, cello
September 30
Wonny Song, piano 0. Weiss
W. Song
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Jupiter String Quartet
October 14
Thomas Meglioranza, baritone
November 18
Daniel Phillips, violin
December 2
Jupiter String Quartet
Exhibits
The 2005 Photographer-in-Residence Ryan Brenizer exhibited his works in Bush Auditorium
throughout the month of July. The photographs of many CSHL researchers were captured
during his residency the previous summer.
Paul Liam Harrison, Artist and Printmaker, exhibited his work in a show entitled
"Pertaining to Origins," held in the Racker Room of Blackford Hall from September 26
through October 1.
Laboratory Employees
New Staff
Glenn Turner joined the faculty in the winter of 2006 to study the association between
smell and taste; for example, how the brain encodes the association between spoiled milk
and the memory of that awful taste. He is using the fruit fly's association between a given
odor and a bitter taste along with the electrophysiology techniques that he developed at
the California Institute of Technology (Cal Tech) and the powerful ability to manipulate genes
in the fruit fly using molecular genetics. Turner did postdoctoral research in Dr. Gilles
Laurent's laboratory at Cal Tech, where he collaborated on a method to measure electrical
activity and hence the activity of neurons in the fruit fly brain. Using this technology, he
found that olfactory information is represented in an area of the fruit fly brain called the
mushroom body that is essential for learning and memory.
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Hiro Furukawa, who joined the faculty of CSHL in December 2006, is interested in the
connection between the NMDA receptors and proteins involved in Alzheimer's disease. His
research both as a graduate student in Dr. Tatsuya Haga's laboratory at The University of
Tokyo and as a postdoctoral fellow in Dr. Eric Gouaux's laboratory at the Vollum Institute at
Columbia University focused on understanding how these neurotransmitter receptors work.
He is studying 7-secretase, which cuts amyloid precursor protein into a plaque-forming 7-
amyloid fragment found in Alzheimer's patients and may affect neuronal activity by associat-
ing with NMDA receptors. Understanding these interactions may aide in defining targets for
developing new drugs to treat Alzheimer's disease.
A new faculty member as of September, Raffaella Sordella is interested in exploring the
molecular mechanism of why particular mutations in the oncogene called epidermal
growth factor receptor (EGF-R) result in cancer cell addiction, and why other EGF-R
mutations are resistant to the drug lressa. Continuing the work that she did at
Massachusetts General Hospital Cancer Center as a postdoctoral fellow, she hopes to
identify other cellular components to which cancer cells become addicted that potential-
ly can be targeted by cancer therapies. Sordella received her Ph.D. from Turin University,
Italy, where she worked with Dr. Paolo Comoglio studying the role of growth factor recep-
tors in cancer development.
Dr. Walter Goldschmidts joined the laboratory as the Executive Director of Sponsored
Programs, bringing extensive federal and private sector management and research funding
experience to our campus. In this newly created role, his Department facilitates new and
continuing sponsored research initiatives to promote the research, education, and scholarly
mission of the Laboratory and its investigators.
Promotions
Congratulations to David Jackson and Linda Van Aelst who were both promoted to
Professor.
Departures
During the course of the year, several faculty took on new challenges at other institutions.
Associate Professor Carlos Brody moved to Princeton University, but we are pleased to have
him continue at CSHL as an Adjust Professor. Eli Hatchwell moved further east on Long
Island to Stony Brook University, and Andrew Neuwald began a faculty appointment at The
Instititute for Genomic Research (TIGR).
Jeff Picarello, the Director of Public Affairs for Cold Spring Harbor Laboratory and former
managing editor of the Annual Report, took a position with Edelman Public Relations.
Peter Sherwood, who was the Director of Research Communications and Editor-in-Chief
of the Harbor Transcript, moved on to Hofstra University.
We are saddened by the passing of Teresa Haire, a talented graduate student in Senthil
Muthuswamy's laboratory. Several events were held to celebrate Teresa's life, and a fund has
been established in her honor to support graduate student education at the Watson School
of Biological Sciences.
The CSHL community also mourned the death of Enrique (Henry) Cepero, a postdoctor-
al fellow in Scott Lowe's laboratory who had battled cancer for three years. He is survived by
his wife Jennifer and two newborn daughters, for whom college funds were established by
friends here.
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Hillside Campus expansion
Community Outreach
Cold Spring Harbor Laboratory participated in a number of community outreach events,
including the sixth annual Pancreatic Cancer Walk at Old Westbury Gardens; the Long Island
2-Day Walk to Fight Breast Cancer; the Long Island Prom Boutique; the Long Island Cares
Food Drive; and numerous activities to support the Ronald McDonald House at Schneider
Children's Hospital in New Hyde Park.
Looking Forward
The year 2006 was one that propelled Cold Spring Harbor Laboratory forward. The founda-
tions for the future were firmly set this year. Structurally, we moved mountains to set the cor-
nerstone for the Hillside Campus expansion whose buildings will proudly bear the names of
some of our most generous supporters. We celebrated the history and legacy of our Long
Island campus with yet another successful symposium and numerous other concerts and
lectures. The Double Helix Medal begins a new legacy that received national recognition for
CSHL's dedication to raising awareness about the importance of genetics research for
improving the health of people everywhere. The year 2006 should inspire us all to continue
to move forward and realize the full potential of this institution. Thanks to our Trustees, our
faculty and staff, and to our supporters for making this possible.
Bruce Stillman, Ph.D., F.R.S.
President
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CHANCELLOR'S REPORT
Several years ago, I began donating to the Cold Spring Harbor Laboratory Archives an
extensive collection of letters, manuscripts, and books related to my scientific career, includ-
ing academic and literary efforts from the 1950s to the present. Vital to our Archives receiv-
ing and digitizing many of these records was a much-needed series of gifts totaling $400,000
from Lewis Lehrman, who has already done so much to preserve key documents of our
nation's Civil War. In addition, instrumental in digitizing many photographs and other histori-
cal unpublished materials from mine and other unique scientific collections was a $500,000
grant from the Josiah Macy, Jr. Foundation.
Now magnifying my collection's importance is the recent decision of Sydney Brenner to donate
to our Archives virtually all the documentation from his eminent scientific career of the past 50
years. Toward this end, our ever-resourceful Director of Library and Archives, Mila Pollock, has
already made several trips to his East Anglian home in Ely, England to facilitate transfer of these
records cataloging his career at Cambridge. There for more than 20 years, his and Francis Crick's
desks faced each other in the same offices-first at the Cavendish Laboratory and then at the
Laboratory of Molecular Biology. Using funds from the sale of duplicate documents from my life,
many of Sydney's key letters and manuscripts have already been digitized.
Sydney's and my archives together comprise what we anticipate to be the beginning of a much
more extensive future collection of important letters and lab notebooks documenting key advances
in molecular biology and biotechnology that followed the discovery of the double helix. To proper-
ly house this collection, we have prepared architectural plans for a two-storied addition to our 1904
library building that was constructed to serve as the first laboratory for the Carnegie Institute of
Washington's Cold Spring Harbor Station for Experimental Evolution. Long the center of genetic
experiments, it became our library following the 1953 occupancy of Demerec Laboratory.
The need to expand our library was already obvious in 1994 when I ceased directing the
science here at the Laboratory to assume the new position of President. However, almost a
decade passed before a gift of $1 million from Waclaw Szybalski, who was on our staff in the
1950s, allowed us to begin planning this annex. The subsequent architectural plans gener-
ated by Bill Grover of Centerbrook, Essex, Connecticut, successfully preserved an early-
20th-century atmosphere-just what we wanted. With essentially all of the required building
and environmental permits now in place, we intend to start construction during late summer
2007, with occupancy expected in the spring of 2009.
We initially thought that some $3.5 million would cover the cost of our addition, but all too soon
we realized that we must renovate and restore the original 1904 building. Now we know that
approximately $6 million is needed to complete the project. To help raise this money, I traveled to
San Francisco last March to the pioneering biotech firm Genentech and returned with much more
assistance than I had requested. Genentech President Art Levinson authorized a $2.5 million
grant to create the Genentech Center for the History of Molecular Biology and Biotechnology.
Later, we also received a much-welcomed $287,500 contribution from New York State's Historic
Preservation Office to help preserve the long-admired ambience of our first year-round building for
science. To help the Center acquire unique historical material, an Archives Advisory Committee
has been formed. This Committee, comprised of leading scientists, including three Nobel laure-
ates as well as prominent historians and archivists, is working to collect and preserve materials on
specific research topics and make them available online. Last year, with endowed support from
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Philip Goelet and Sydney Brenner, the Sydney
Brenner Scholar Research
Program was begun,
for which the first annual scholarship was
awarded to Robert Olby to
assist in his research on a
biography of Francis Crick.
I have also been preoccupied with my
current desire to make our Laboratory a major play-
er in teaching and research on
schizophrenia and other major mental health diseases. Greatly
aided by Sydney Gary at the Banbury Center, during
the summer of 2006, as in 2005, we used
monies provided by my Oliver R. Grace
Professorship to support 2-week-long summer work-
shops on schizophrenia, with an aim to
entice more young neuroscientists to focus their
research on this devastating human disease.
Key to my belief that now is the time for us to
commit our resources to research on mental-
health disorders are the new advances in
genome technology that offer the prospect of
revealing the complete genetic underpin-
nings of mental disease. Fortunately, we
were able to induce David Porteous of
Edinburgh University to head this year's
teaching staff, bringing with him the latest
facts from his lab's study of balanced
mosomal exchanges that pinpointed several
Rendering of the expanded Carnegie Building, which will house the critical genes whose malfunctioning leads to
existing Library, Archives, and the new Genentech Center. psychiatric disorders. Grace funds also
allowed us to initiate a new course on social cognition taught by David Skuse of the Institute of
Neurology at University College London and by Ralph Adolphs from the California Institute of
Technology. Failure to have suitable social interaction leads to much human misery, and con-
siderable evidence demonstrates that misappropriate gene functioning is once again involved.
My goal is for Cold Spring Harbor Laboratory to be as effective in identifying genes behind
behavioral disorders as it has been in discovering key genes whose misfunctioning leads to
cancer. A most-welcomed late-2005 grant of $1 million from the Forrest and Frances Lattner
Foundation allowed Laboratory scientist Jonathan Sebat to move beyond finding copy-num-
ber variations involved in autism to also search for such genetic changes behind schizophre-
nia. Soon afterward, a noteworthy December 2005 visit to the Laboratory by Ted and Vada
Stanley inspired their donation of $5 million. This has allowed us to expand such efforts to
include bipolar disease and unipolar depression. Critical to the successful deployment of our
latest DNA genome technologies is to obtain DNA samples from properly documented psy-
chiatric patients. Toward this end, we are collaborating with Anil Malhotra of Hillside Hospital
here on Long Island, Francis McMahon of the National Institute of Mental Health, James
Potash of Johns Hopkins Hospital, and David Porteous of Edinburgh University.
Also at the center of our immediate efforts are the new high-throughput low-cost DNA sequenc-
ing technologies. The cost of resequencing a human genome has already fallen to $1 million, with
the sum during the next several years likely to fall by an additional factor of 5. When the dollars
needed to resequence a human genome become no more than the cost of a Chevrolet (by 2010?),
the long-argued controversies regarding the roles of nature versus nurture in human lives will no
longer be settled by rhetorical might. Then, happily, facts-not prejudices-will prevail.
I much anticipate the genomic zing at which we will move through the immediate future.
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James D. Watson
Chancellor
CHIEF OPERATING OFFICER'S REPORT
A literal and figurative "changing of the landscape" began at the Laboratory in 2006. Phase I of the
Hillside Campus expansion project was completed, laying the infrastructure and preparing the way for
the construction of six research buildings totaling 100,000 square feet of new laboratory and common
space. The buildings will provide much needed room for our programs in bioinformatics, cancer diag-
nosis and therapy, genomics, and neuroscience. A total of 180,000 cubic yards of soil were removed
and sold for reuse, and new gas, water, and electrical systems were installed. Construction sites are
not pretty and we are sensitive to the fact that the pristine vistas of our neighbors across the harbor
have been affected by this work. Consequently, 6 acres of cleared area have already been restored
and 300 trees have been planted to begin the reforestation process. As the buildings go up in the
coming months, we will continue to work diligently to restore the site. We are proud of the fact that
the Laboratory has been recognized for its environmentally friendly engineering of the project. An inno-
vative system for managing storm water runoff was engineered by creating a series of attractive plant-
ed retention ponds in which storm water is organically purified before dissipating into the surrounding
soil. The high-capacity "chiller building," containing the equipment needed to cool the water supply to
all of the new laboratories, has the look of an authentic antique barn. As has been our practice over
time, every effort is being made to preserve the character and natural beauty of our surroundings.
Fund-raising for the project has been a rigorous and rewarding process. Although the cost of infra-
structure and buildings is approximately $100 million, we must allocate substantial funds to start-up
expenses, recruitment of new investigators, and endowment. There is still much hard work to be
done, but we are pleased to be well past the halfway point toward our $200 million goal. We are
grateful for the generous support of our friends, donors, and Trustees who have made this possible,
as well as for the dedication and effort of Charlie Prizzi and the Development team.
In addition to fund-raising, the Laboratory reaffirmed its A+ credit rating and publicly issued $55
million in tax-exempt bonds to support the construction. The offering, underwritten by J.P. Morgan,
was well-received by investors and fully subscribed. The Investment Committee of the Board of
Trustees favored mitigation of the interest rate risk on the floating rate obligations, and so a "swap
contract" was executed to effectively fix the interest rate on all of the Laboratory's debt at 3.8% for
the 35-year life of the bonds.
During the course of the year, we also saw the research "landscape" change in some very posi-
tive and not so positive respects. The programs in bioinformatics, genomics, cancer, and neuro-
science have never been stronger, marked by important discoveries, distinguished publications, and
awards to our faculty. There is great excitement over the fact that much of the work here is evolving
from basic to more translational science, meaning that the results are contributing to advances in
diagnostics and therapeutics in addition to the understanding of the underlying mechanisms and
causes of problems like cancer. The challenging aspect of the current research environment is that
the federal government, through the National Institutes of Health, has cut back substantially on fund-
ing for biomedical research. Federal grants are fewer, smaller, and harder to come by. This causes
very real budgetary problems for institutions like ours, both by hindering the progress of innovative
programs and by restricting the amount of funds available to cover the indirect cost or administrative
and overhead expenses. The frustration level is high for dedicated professionals in a field where so
much is suddenly possible, due to available data, knowledge, and technology, yet resource-limited.
The Laboratory's educational programs continue their vibrancy and excellence. Attendance at
Cold Spring Harbor Meetings and Courses increased again this year, and the visiting scientists and
scholars clearly contribute to the intellectual dynamics of the campus. The same can be said for the
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ongoing success of the Dolan DNA Learning Center, the Banbury Center, and the Watson School of
Biological Sciences. The Cold Spring Harbor Laboratory Press has become a substantial enterprise
that is adapting creatively to the digital publishing environment by developing new distribution strate-
gies for its intellectual property.
For the fiscal year ended 12/31/06, the Laboratory budget reached $112 million-an 8% increase
over the prior year. We had anticipated and forecasted a difficult year on the bottom line as we began
to feel the effects of the federal funding reductions and increases in energy and insurance costs. As
is often the case, funding from grants and from endowment support were not going to be sufficient
to cover the direct cost of the research in 2006 and the institutional overhead expense. Despite rig-
orous and effective efforts to contain administrative expenses, it was necessary to access our reserve
of biotech stocks in an effort to balance the budget after depreciation and interest expense. These
measures, combined with the unrestricted proceeds from the wonderfully successful "Double Helix
Award" gala in New York City, allowed us to avoid what might have been a substantial operating cash
deficit for the year.
Fortunately, we saw another positive year in the financial markets and our endowment fund per-
formed accordingly, returning 13.6%. Since the initial endowment gift by the Robertson family in
1973, the total fund has grown in value from $8 million to $289 million at December 31, 2006. This
healthy appreciation is attributable to successful fund-raising, proactive commercialization of intel-
lectual property, above average investment performance, and prudent spending policy. Investment
strategy is determined by the Investment Committee of the Board of Trustees with the assistance of
a consultant. The strategy has remained consistent, with the objective of achieving capital apprecia-
tion within acceptable risk parameters. The above average returns, over the years, are the result of
good manager selection and diversity, as well as disciplined balancing of the portfolio. Historically, the
portfolio has been allocated primarily to equities and fixed-income investments in a mix ranging from
70%/30% to 60%/40%. In 2006, two new international equity managers and one domestic value
manager were added, all of whom achieved positive results. Also at year end, the Board and the
Investment Committee determined that it would be in the Laboratory's interest to increase its alloca-
tion to "alternative" asset investments in order to further diversify the portfolio, enhance returns, and
limit volatility. Execution of this strategy will be a priority in the coming year.
Looking ahead, the next several years are likely to be the most challenging in the modern era of
the Laboratory. The cost of doing cutting-edge research is escalating at a time when the pool of fed-
eral funds for research is shrinking. Operating costs that are difficult to control, such as utilities, insur-
ance, and healthcare, are increasing at double-digit rates. The expansion of our facilities is essential
and necessary in order for the Laboratory to continue as a worldwide leader in research and educa-
tion. However, the new buildings will add substantially to overhead expense and the recruitment of
new investigators is expensive. It is imperative that we operate as efficiently as possible and that we
redouble our efforts to attract research support from private foundations and individuals.
All of this requires the dedication of many. Our Board of Trustees, consisting of prominent scientists
and business/community leaders, provides leadership, oversight, and invaluable advice to the senior
management of the institution. This year, we thank two retiring trustees-Dr. Susan Lindquist and Arthur
Spiro-for their years of service. We also recognize Joe Donohue for his years of extraordinary service
in the dual role of Trustee and President of the Cold Spring Harbor Laboratory Association. Welcome
are four new trustees elected in 2006-John Phelan, Landon Clay, Jamie Nicholls, and Don Axinn.
Finally, we recognize an extraordinary staff-nearly 1000 strong-whose great effort and dedica-
tion cannot possibly be adequately rewarded in a nonprofit environment.
Dill Ayres
Chief Operating Officer
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LONG-TERM SERVICE
(Standing) Bruce Stillman, Michael Regulski, Pat
Wendel, John Maroney, Martha Daddario,
Delia King, Rodney Chisum, Adrian Krainer, Peter
Stahl, Bill Keen, Tim Mulligan, Phil Renna,
Peter Schwind, Chris Hubert, Frank Russo. (Seated)
Susan Lauter, Mary Cozza, Margaret
Wallace, Patricia McAdams, Mary Ann Miceli, Ingrid
Benirschke-Perkins.
The following employees celebrated milestone
anniversaries in 2006:
35 years Bill Keen, John Maroney
30 years Joseph Ellis, Peter Stahl, Margaret Wallace, Pat Wendel
25 years Rodney Chisum, Philip Renna
20 years Mary Cozza, Chris Hubert, Adrian Krainer, Susan Lauter, Vincent Meschan,
Tim Mulligan, Jacek Skowronski
15 years Ingrid Benirschke-Perkins, Kathy Cirone, Martha Daddario, Delia King, Patricia
McAdams, Mary Ann Miceli, Chris Oravitz, Michael Regulski, Frank Russo,
Claudia Schmid, Peter Schwind, Tim Tully, Linda Van Aelst, Michael Zhang
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See previous page for photos of the following scientific staff:
Row 1: R. Slotkin (Martienssen Lab); H. Oviedo (Zador Lab);
M. Galli (Lukowitz Lab); I. Hall (CSHL Fellow)
Row 2: L. Manche (Krainer Lab); J. Brennecke (Hannon Lab);
K. McJunkin (WSBS Student); J. Zuber (Lowe Lab)
Row 3: J. Hicks (Wig ler Lab); S. Hearn (Spector Lab), Y. Benitez Alfonso
(Jackson Lab); D.C. Gao (Mittal Lab); I. Bureau (Svoboda Lab)
Row 4: P. Kumar (Joshua-Tor Lab); C. Kopec (WSBS Student);
V. Aranda Calleja (Muthuswamy Lab); J. Boehm (Malinow Lab)
Row 5: A. Mazurek (Stillman Lab); R. Thakkar (Spector Lab); F. Rivas
(Hannon Lab); J. Li (Cline Lab)
CANCER: GENE EXPRESSION
Certain types of cancer and other diseases have been linked to defects in a cellular editing process
called premessenger RNA splicing. Adrian Krainer's lab continues to study the process of pre-mRNA
splicing in human cells, to understand its basic mechanism, regulation, and relevance to human genet-
ic disorders and cancer. Krainer and his colleagues are studying key RNA-binding proteins that are part
of the cellular RNA splicing machinery. They found that the gene coding for one of those splicing fac-
tors is an oncogene. Thus, elevated expression of this gene in a variety of tumors can cause the can-
cer in the first place and is necessary for continued tumor growth. The Krainer lab also studies spinal
muscular atrophy (SMA), a pediatric neurodegenerative disease that is the leading genetic cause of
infant mortality. Krainer and colleagues have identified the genetic defect that causes this disorder and
are developing a mouse model to test whether they can restore correct gene expression.
When DNA makes a copy of itself, two complementary DNA strands are separated and each
becomes a template for the construction of a new complementary strand. Strand separation is medi-
ated by a helicase enzyme, a molecular machine that uses the energy derived from a process called
ATP hydrolysis to separate DNA strands while moving along the DNA. Leemor Joshua-Tor determined
a crystal structure of a viral replicative helicase bound to single-stranded DNA and nucleotide mole-
cules at the ATP-binding sites. This structure demonstrates that a single strand of DNA passes through
a molecular structure called the hexamer channel and that the DNA-binding hairpins of each subunit
collectively form a spiral staircase that sequentially tracks the DNA backbone. It also demonstrates a
correlation between the height of each DNA-binding hairpin in the staircase and the ATP-binding con-
figuration, suggesting a straightforward mechanism for DNA translocation. This discovery has been
hailed as a dramatic insight into the mechanistic details of how a protein works.
The focus of research in William is known to contribute to
the growth of leukemia and lymphoma cancer cells. Tansey and his team have established that normal
cells control the levels of Myc by destroying it soon after synthesis, but that this process is abnormal
in lymphomas, leading to elevated levels of Myc in the tumor cells. The Tansey lab continues to study
the mechanisms that cells use to control Myc destruction and how this process goes awry in cancer.
In 2006, Professor Tansey was honored by the Leukemia & Lymphoma Society with its prestigious
Stohlman Scholar Award in recognition of his outstanding contributions to the advancement of blood
cancer research.
Michael Myers is using the accumulated knowledge of how proteins and protein complexes regu-
late cell physiology to create global network maps of all of the interacting proteins in a cell. These maps
display how protein-protein interactions contribute to normal cell physiology, and how the interactions
are disrupted in cancer. His global protein network map is beginning to reveal why cells can tolerate
certain kinds of errors, whereas other defects lead to cancer. Myers aims to understand how such net-
works generate robustness (error tolerance) and adaptability in cells.
Jacek Skowronski studies how the AIDS virus exerts control over protein sorting and signaling
machineries in human cells. He has recently identified several human proteins that associate with the
AIDS viral proteins Nef and Vpr/Vpx. Skowronski's group is now working to verify these interactions and
to determine their relevance to previously known roles of the Nef and Vpr/Vpx accessory factors in
AIDS pathogenesis.
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STRUCTURAL BIOLOGY OF NUCLEIC ACID REGULATORY
PROCESSES
L. Joshua-Tor C. Aksoy H. He
L. Barhak P.R. Kumar
D. Chitwood T. Schalch
E.J. Enemark S. Smith
C. Faehnle N. Tolia
We study the molecular basis of cell regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their interactions
with other molecules. Biochemistry and molecular
biology allow us to study properties that can be corre-
lated with protein structure and function. Our efforts
largely center on protein machines involved in nucleic
acid regulatory processes.
DNA Trans location
in a Replicative
Hexameric Helicase
E.J. Enemark
During DNA replication, two complementary DNA
strands are separated and each becomes a template for
the synthesis of a new complementary strand. Strand
separation is mediated by a helicase enzyme, a molec-
ular machine that uses the energy derived from ATP
hydrolysis to separate DNA strands while moving
along the DNA. This past year, we determined a crys-
tal structure of the replicative helicase El from papil-
lomavirus bound to single-stranded DNA and
nucleotide molecules at the ATP-binding sites.
Papillomaviruses are tumor viruses that cause
benign and cancerous lesions in their host. Replication
of papillomavirus DNA within a host cell requires the
viral El protein, a multifunctional protein. El initially
participates in recognizing a specific replication origin
DNA sequence as a dimer with E2, another viral pro-
tein. Subsequently, further El molecules are assem-
bled at the replication origin until two hexamers are
established. These hexamers are the active helicases
that operate bidirectionally in the replication of the
viral DNA. To unwind DNA, helicases must separate
the two strands while moving along, or translocating,
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on the DNA. On the basis of structures of the DNA-
binding domain of El bound to DNA that we deter-
mined a few years ago in collaboration with Arne
Stenlund's lab here at CSHL, we suggested a mecha-
nism for DNA strand separation. However, the mech-
anism that couples the ATP cycle to DNA transloca-
tion has been unclear. The El hexameric helicase
adopts a ring shape with a prominent central channel
that has been presumed to encircle substrate DNA dur-
ing the unwinding process, but the atomic details of
this binding have been uncertain, including whether
the ring encircles one or both strands of DNA during
unwinding.
Our crystal structure of the El hexameric helicase
bound to single-stranded DNA (Fig. 1) demonstrates
that only one strand of DNA passes through the cen-
tral channel and reveals the details of DNA binding
(Fig. 2). The 13 hairpins (DNA-binding hairpins) of
each subunit sequentially track the sugar-phosphate
backbone of the DNA in a one nucleotide per subunit
increment. This configuration resembles a spiral stair-
case (Fig. 2).
ATP-binding (and hydrolysis) sites are located at
the subunit interfaces, and multiple configurations are
observed within the hexamer. These have been
assigned as ATP-type, ADP-type, and apo-type. The
configuration of the site for a given subunit correlates
with the relative height of its DNA-binding hairpin in
the staircase arrangement. The subunits that adopt an
ATP-type configuration place their hairpins at the top
of the staircase, whereas the hairpins of apo-type sub-
units occupy the bottom positions of the staircase. The
hairpins of the ADP-type subunits are placed at inter-
mediate positions.
A straightforward "coordinated escort" DNA-
translocation mechanism is inferred from the stair-
cased DNA binding and its correlation with the con-
figuration at the ATP-binding sites. Each DNA-bind-
ing hairpin maintains continuous contact with one
unique nucleotide of single-stranded DNA and
migrates downward via ATP hydrolysis and subse-
FIGURE 1 Views of the El hexamer parallel and perpendicular to the central channel with individual subunits. Single-stranded DNA
is bound discretely within the channel, and nucleotides are present at the subunit interfaces.
quent ADP release at the subunit interfaces. ATP
hydrolysis occurs between subunits located toward
the top of the staircase, whereas ADP release occurs
between subunits located toward the bottom of the
staircase. The hairpin at the bottom of the staircase
releases its associated single-stranded DNA phos-
phate to conclude its voyage through the hexameric
channel. Upon binding a new ATP molecule, this sub-
unit moves to the top of the staircase to pick up the
next available single-stranded DNA phosphate, initi-
ating its escorted journey through the channel and
repeating the process. For one full cycle of the hexa-
mer, each subunit hydrolyzes one ATP molecule,
releases one ADP molecule, and translocates one
nucleotide of DNA through the interior channel. A
full cycle therefore translocates six nucleotides with
associated hydrolysis of six ATPs and release of six
ADPs.
Mechanisms of RNAi
N. Tolia, T. Schalch, C. Faehnle, C. Aksoy, D. Chitwood,
S. Smith [in collaboration with G.J. Hannon and
R.A. Martienssen, Cold Spring Harbor Laboratory;
C. Mello, University of Massachusetts]
RNA interference (RNAi) has made an enormous
impact on biology in a very short period of time. Not
only are new cellular pathways for the regulation of
gene expression that use these pathways still being dis-
covered, but RNAi became an extraordinary useful and
simple tool for gene silencing. Almost from its begin-
nings, researchers have used genetics, biochemistry,
molecular biology, and bioinformatics to study the
mechanism of RNAi and related pathways. We argued,
however, that to get a true mechanistic understanding
of these pathways required understanding how the
components of the RNAi machinery work at a molec-
ular level. Therefore, we embarked on structural and
biochemical studies of key proteins in the RNAi path-
way.
During RNAi, long double-stranded RNA is
processed to yield short (-19-31 nucleotides) double-
stranded RNAs that trigger the RNAi response. These
short RNAs get incorporated into effector complexes
called the RNA-induced silencing complex (RISC),
where in the mature complexes, a single-stranded
RNA, the antisense strand of the original double-
stranded RNA, is retained in the complex. This short
RNA (small interfering RNA or microRNA) then acts
to guide the RISC complex to its target through base
complementarity. The best-characterized pathway, and
the one that is predominantly used for gene knock-
down technology, is a posttranscriptional gene silenc-
ing (PTGS) pathway called "slicing." Here, the RISC
complex is targeted to the mRNA and produces an
endonucleolytic cut in the mRNA, thus preventing
gene expression from proceeding. Other RNAi silenc-
ing pathways such as translational inhibition and tran-
scriptional gene silencing (TGS) are also mediated
through RISC complexes. In all cases, these complex-
es contain a small single-stranded RNA and an
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FIGURE 2 Details of DNA coordination viewed parallel (top left) and perpendicular (top right) to the hexamer channel and a cartoon
(bottom) depicting the "coordinated escort" mechanism for DNA translocation.
Argonaute protein, features that serve to define the
RISC complex.
In solving the structure of a full-length Argonaute
protein a couple of years ago, we showed that a char-
acteristic domain of these proteins, called the PIWI
domain, belongs to the RNase H family of proteins.
This finding was consistent with what was known
about the biochemistry of the "slicing" reaction (the
endonucleolytic cleavage of the mRNA by the RISC
complex guided by the siRNA). Mutating the key
aspartates identified at the active site to alanine in
human Argonaute 2 abolished slicing. We could also
show that a large positively charged groove along the
protein could accommodate the siRNA and target
(mRNA) binding, with the scissile phosphate at the
active site. This was done by placing the 3 end of the
siRNA in a cleft of another characteristic domain,
called the PAZ domain, in accordance to our previous
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results about 3 '-end recognition by the PAZ domain,
as well as results from other laboratories.
Since then, we were able to produce recombinant
human Argonaute 2, the only Argonaute in human
cells able to carry out slicing, in an organism that lacks
RNAi, namely, Escherichia coli. Together with Greg
Hannon's laboratory here at CSHL, we showed that all
that is needed to carry out slicing is an active
Argonaute protein and an siRNA. This also enabled us
to specifically examine what features of this effector
step of RNAi resides in Argonaute in combination
with the siRNA and what features must come from
other components of RISC or perhaps other steps in
the pathway.
We have been examining several Argonaute fami-
ly members and found that the sole Argonaute protein
in Schizosaccaromyces pombe is an active slicer.
Importantly, together with Rob Martienssen's group,
we showed that slicing is required for TGS in S.
pombe.
We were also able to better define the active site of
the Argonautes, as there are some unique aspects that
are different from other RNase H enzymes. We have
identified a third Glade of the Argonaute family that is
different from the Argonaute Argonautes and the Piwi
Argonautes, which we named the group-3 Argonautes.
These appear to be specific to worms-C. elegans and
C. briggsae-and consist predominantly of nonslicing
Argonautes, meaning they do not have an intact cat-
alytic motif Together with Craig Mello, we have
shown that a group of secondary Argonaute proteins in
C. elegans that act in a separate downstream silencing
step belong to these nonslicing Argonautes of this
third Glade. These act following the initial trigger that
does require slicing, carried out by the well-character-
ized primary Argonaute, RDE-1, in the exo RNAi
pathway, or following the primary Argonaute, ERGO-
1, in the endo RNAi pathway in worms.
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RNA SPLICING
A.R. Krainer E. Allemand
P. Guzzardo
M. Hastings
Y. Hua
M. Jensen
R. Karni
B. Khoo
Y. Liu
L. Manche
MECHANISMS OF CONSTITUTIVE AND
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RNA splicing is an essential step in the expression of
most eukaryotic protein-coding genes. The spliceosome
selects and pairs authentic splice sites with extremely
high fidelity, which requires precise interpretation of
limited and dispersed sequence information present
throughout introns and exons. In humans, about 75% of
genes are expressed via alternative splicing, giving rise
to multiple protein isoforms. The choice ofalternative
splice sites is commonly regulated to alter gene expres-
sion, either tissue-specifically or in response to a devel-
opmental program or to signaling pathways. The fact
that multiple protein isoforms can be expressed from
individual genes demonstrates that the classical "one
gene-one enzyme" paradigm is no longer valid and pro-
vides an explanation for the unexpectedly small number
of genes uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well as
RNA components that are part of small nuclear ribonu-
cleoprotein (snRNP) particles. The work in our lab
focuses on the identification and molecular characteri-
zation of protein factors and sequence elements that are
necessary for the catalysis and fidelity of splicing
and/or for the regulation of alternative splice site selec-
tion. We are interested in how the spliceosome correct-
ly identifies the exons on pre -mRNA, and how certain
point mutations in either exon or intron sequences cause
aberrant splicing, leading to various human genetic dis-
eases. Related areas of interest include the remodeling
of mRNP architecture as a consequence of splicing,
which influences downstream events such as nonsense-
mediated mRNA decay, and the role of alternative splic-
ing misregulation in cancer. A brief summary of some
of our recently published studies is given below.
MECHANISMS OF EXON RECOGNITION IN THE SPINAL
MUSCULAR ATROPHY GENES SMN1 AND SMN2
Spinal muscular atrophy (SMA) is a neurodegenerative
genetic disorder caused by the deletion or mutation of
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the survival-of-motor-neuron gene, SMN1. An SMN1
paralog, SMN2, differs by a C to T transition in exon 7
that causes substantial skipping of this exon, such that
SMN2 expresses only low levels of functional protein.
A better understanding of SMN splicing mechanisms
should facilitate the development of drugs that increase
SMN protein levels by improving SMN2 exon 7 inclu-
sion. In addition, exonic mutations that cause defective
splicing give rise to many genetic diseases, and the
SMN1/2 system is a useful paradigm for understanding
exon identity determinants and alternative splicing
mechanisms. Skipping of SMN2 exon 7 was previous-
ly attributed either to the loss of an SF2/ASF-depen-
dent exonic splicing enhancer (ESE) or to the creation
of an hnRNP A/B-dependent exonic splicing silencer
(ESS), as a result of the C to T transition. We extensive-
ly tested the and silencer-gain models by
mutagenesis, RNA interference, overexpression, RNA
splicing, and RNA-protein interaction experiments.
Our results supported the enhancer-loss model but also
demonstrate that hnRNP A/B proteins antagonize
SF2/ASF-dependent ESE activity and promote exon 7
skipping by a mechanism that is independent of the C
to T transition and is therefore common to both SMN1
and SMN2. These findings explain the basis of defec-
tive SMN2 splicing, illustrate the fine balance between
positive and negative determinants of exon identity and
alternative splicing, and underscore the importance of
antagonistic splicing factors and exonic elements in a
disease context.
We also collaborated with Dr. Brage Andresen
(Aarhus University Hospital) to help characterize
defective splicing due to a "missense" mutation in
exon 5 of the MCAD gene, leading to medium-chain
acyl-CoA dehydrogenase deficiency. The relevant
region of this exon is remarkably similar to the
above-mentioned region of SMN2 exon 7. The
MCAD missense mutation likewise inactivates a pre-
sumptive SF2/ASF-dependent ESE, resulting in exon
skipping. However, there is also a juxtaposed ESS in
exon 5 that is inactivated by a synonymous A to C
single-nucleotide polymorphism (SNP). The C SNP
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has no effect on splicing by itself, but because of the
antagonism between the ESE and the ESS, it sup-
presses the splicing defect due to the ESE-inactivat-
ing mutation. This study demonstrated that SNPs can
have strong context-dependent effects on posttran-
scriptional gene expression, and thus the effects of
clinically relevant mutations that potentially affect
splicing should be evaluated in the context of the rel-
evant haplotype.
ANTISENSE-CORRECTION OF DISEASE-ASSOCIATED
SPLICING DEFECTS
We are exploring strategies to increase the extent of
exon 7 inclusion during splicing of SMN2 transcripts
for eventual therapeutic use in SMA, a genetic neuro-
muscular disease. Antisense oligonucleotides (ASOs)
that target an exon or its flanking splice sites typically
promote exon skipping. However, when we systemati-
cally tested a large number of ASOs with a 2' -0-
methoxyethyl ribose (MOE) backbone that hybridize
to different positions of SMN2 exon 7, we identified
several that promote greater exon inclusion, others
that promote exon skipping, and still others that were
neutral. This approach provides positional information
about presumptive exonic elements or secondary
structures with positive or negative effects on exon
inclusion. The ASOs are effective not only in cell-free
splicing assays, but also when transfected into cul-
tured cells, where they affect splicing of endogenous
SMN transcripts. The ASOs that promote exon 7
inclusion increase full-length SMN protein levels,
demonstrating that they do not interfere with mRNA
export or translation, despite hybridizing to an exon.
Some of the ASOs we identified are sufficiently active
for us to proceed now with experiments in available
SMA mouse models. This work was done in collabo-
ration with Isis Pharmaceuticals.
We also pursued antisense modulation of splicing
in the context of apolipoprotein B (APOB) expression.
The APOB gene comprises 29 constitutively spliced
exons. APOB protein, which is an integral part of var-
ious lipoprotein particles, exists as two natural iso-
forms: the full-length APOB100, secreted by the liver,
and the carboxy-terminally truncated APOB48, secret-
ed by the intestine. APOB48 is generated by cytidine-
to-uridine mRNA editing, which introduces a stop
codon in exon 26. Down-regulation of APOB100 is a
potential therapy to lower circulating low-density
lipoprotein (LDL) and cholesterol levels, whereas
down-regulation of APOB48 gives unwanted side
effects. We investigated the ability of 2'-O- methylri-
bose ASOs to induce the skipping of exon 27 in
endogenous APOB mRNA in HepG2 cells. These
ASOs were complementary to the 5' and 3' splice sites
of exon 27, the branchpoint sequence (BPS) of intron
26, or several predicted splicing enhancers within exon
27. ASOs targeting either the 5' or 3' splice site, in
combination with the BPS, were the most effective.
The mRNA skipping exon 27 was translated into a
truncated isoform, dubbed APOB87SKIP27. The
induction of APOB87SKIP27 expression in vivo is
expected to reduce LDL and cholesterol levels, by
analogy to patients with hypobetalipoproteinemia. As
intestinal APOB mRNA editing and APOB48 expres-
sion rely on sequences within exon 26, exon 27 skip-
ping should not affect APOB48 expression, in contrast
to other methods of down-regulating APOB100
expression, which also down-regulate APOB48.
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EXONIC AND INTRONIC SPLICING SIGNALS
Numerous disease-associated point mutations exert
their effects by disrupting the activity of ESEs. We
previously derived position weight matrices to predict
putative ESEs specific for four human SR proteins.
The score matrices are part of ESEfinder, an online
resource to identify ESEs in query sequences. In col-
laboration with Michael Zhang here at CSHL, we car-
ried out a refined functional SELEX screen for motifs
that can act as ESEs in response to the human SR pro-
tein SF2/ASF. We derived an increased specificity
score matrix that incorporates information from both
of our SF2/ASF-specific matrices and that accurately
predicts the exon-skipping phenotypes of deleterious
point mutations.
We also collaborated with Ravi Sachidanandam
here at CSHL to collect and classify more than 500,000
pairs of splice sites from five different species. We used
these large genomic data sets to examine the phyloge-
netic conservation of U2-dependent and U12-depen-
dent splice sites and associated sequence features and
to draw mechanistic and evolutionary inferences. The
data sets and analysis tools are also very useful for
examining dependencies between individual positions
of the splice sites and the frequencies of occurrence of
actual wild-type or mutant splice sites in the genome,
both of which help us to study the mechanisms and
fidelity of splice site selection.
These ESE and splice site informatics tools have
been very valuable for our collaborative studies with
clinical geneticists. For example, we collaborated with
Katharina Wimmer (Universitat Wien) to help analyze
36 NFI splicing mutations from neurofibromatosis
type 1 patients. One goal of this study was to derive
predictive rules for the precise outcome of mutations
that disrupt 5' splice sites. In another collaboration
with Dr. Brage Andresen (Aarhus University Hospital)
involving a 5' splice site mutation in the SBCAD gene
resulting in short/branched-chain acyl-CoA dehydro-
genase deficiency, we addressed why a change from A
to G at position +3 of a 5' splice site can lead to aber-
rant splicing, even though both nucleotides match the
degenerate 5' splice site consensus.
A SPLICING-FACTOR ONCOGENE
Alternative splicing has an important role in cancer,
partly by modulating the expression of many onco-
genes and tumor suppressors, and also because inacti-
vating mutations that affect alternative splicing of var-
ious tumor suppressor genes account for some of the
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inherited and sporadic susceptibility to cancer. We
have tested the hypothesis that some of the principal
factors that regulate alternative splicing events are
causally involved in cancer; this work was done in col-
laboration with David Mu and Scott Lowe here at
CSHL. We found that the splicing factor SF2/ASF and
its antagonist hnRNP Al are up-regulated in different
sets of human tumors. In the case of SF2/ASF, this is
sometimes due to increased copy number of its gene,
SFRS1. SFRS1 resides on chromosome 17q23, a
region frequently amplified in breast cancer. Using
retroviral transduction, we found that slight overex-
pression of SF2/ASF is sufficient to transform immor-
tal rodent fibroblasts, which form sarcomas in nude
mice. The increased expression of SF2/ASF modulates
the sensitivity to apoptotic stimuli and increases cell
proliferation. In addition, SF2/ASF overexpression
results in activation of downstream components of the
PI3K/Akt/mTOR and Ras/MAPK signaling pathways,
i.e., phosphorylation of S6K1 and eIF4E, respectively,
bypassing upstream signaling. As expected from its
biochemical activities, SF2/ASF overexpression
affects alternative splicing of transcripts from many
endogenous genes, including several tumor suppres-
sors and oncogenes. One of the key targets is S6K1
pre-mRNA, resulting in increased expression of an
unusual isoform of this kinase with oncogenic activity.
Short hairpin RNA (shRNA)-mediated downregula-
tion of either SF2/ASF or the novel S6K1 isoform is
sufficient to reverse the transformed phenotype caused
by SF2/ASF overexpression in vitro and in vivo, indi-
cating that SF2/ASF has a role in tumor maintenance.
These findings demonstrate that an alternative splicing
factor, SF2/ASF, can act as an oncoprotein by modu-
lating alternative splicing of critical target genes and is
a potential target for cancer therapy.
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PROTEOMICS
M. Myers R. Bish L.L. Schmidt
0. Fregoso C. van der Meijden
D. Perkowski
The completion of the human genome has ushered in
a new age of biological discovery. This accomplish-
ment has essentially identified all of the players gov-
erning human biology. The important work of assign-
ing functions to this myriad of proteins has become
one of the principal tasks of modern biology. Although
many functions will be assigned using genetics or
bioinformatics, the majority of this functional charac-
terization will be performed by proteomics.
The goal of our laboratory is to understand how
proteins and protein complexes regulate cellular
behavior. In the environment of a cell, almost all of the
proteins can be found in a highly interactive network.
Our laboratory is focused on understanding the global
architecture of this network and how this network gen-
erates robustness (error tolerance) and adaptability to
the system and how this network is altered to produce
and survive complex diseases, such as cancer.
Optimization of Protein Identification
D. Perkowski, L.L. Schmidt
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially
its sensitivity. However, the improved sensitivity
comes at a price, as the sample preparation becomes
increasingly important to ensure success. We have
been optimizing a number of parameters to increase
this success rate.
As part of the optimization, we have found that
nanoscale chromatography gives the best sensitivity.
Using conventional reversed-phase chromatography
media (packed beds of functionalized beads), we have
been fabricating our own nanoscale (75-gm internal
diameter) columns that operate at flow rates of
200-500 nl/min. We have switched over from large-
bead media (>3 gm) to 1.811m media. The 1.8 -gm
media significantly increases the resolution of the
chromatography and results in an approximately
twofold increase in the number of proteins identified
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per run. A further increase in the number of identified
proteins can be obtained by performing two rounds of
chromatography. Traditionally, a prefractionation is
performed using strong cation exchange (SCX) chro-
matography, which is then coupled to a reversed-phase
separation; this multidimensional approach is frequent-
ly referred to as multidimensional protein identifica-
tion technology (MudPIT). Although extremely power-
ful, this approach has several drawbacks for proteomic
samples including the degradation of the reversed-
phase separation by the salts required for the SCX
chromatography and the trypsinization of the sample
tends to produce peptides with identical behavior on
SCX columns. Therefore, we have explored the cou-
pling of two rounds of reversed-phase chromatography.
Importantly, we have found that altering the pH of the
separation dramatically alters the behavior of peptides
on reversed-phase columns. This allows us to couple a
reversed-phase column developed at pH 10 with a
reversed-phase column developed at pH 2.5.
Interestingly, extremely acidic peptides, such as phos-
phorylated peptides, are enriched in the early fractions
of the high-pH separation, allowing for a simple, robust
enrichment of phosphorylated peptides.
"Small World" Proteomics
R. Bish, C. van der Meijden [in collaboration with
R. Sachidanandam, Cold Spring Harbor Laboratory]
We have modeled the data from several high-through-
put protein interaction screens as a network. We have
chosen to model these data as a network because it is
one of the only ways to make sense of these large and
complicated data sets. In this model, each protein is
treated as a node and the interactions are treated as
links between the nodes. In this way, the yeast protein
network ends up looking very similar to the network of
computers that make up the World Wide Web or the
network of human social interactions that make this a
"small world." On the basis of the network properties
of the yeast protein network, we have been able to
classify the yeast network as a scale-free network, in
which only a fraction of the proteins are responsible
for making the lion's share of the connections. One
prediction from the network model is that these highly
connected proteins are essential for yeast viability. In
fact, we find that this is the case, as essential proteins
are highly enriched in the pool of highly connected
proteins. Importantly, not all highly connected genes
are essential, and we are focusing on trying to under-
stand the differences between these proteins and those
that are essential.
The overall goal of this study is to understand how
these protein networks provide adaptability to genetic
alterations, such as loss of a node (gene) that occurs
during tumorigenesis. The large number of essential
genes, 15-20% depending on the organism, suggests
that the network is very intolerant of gene loss.
Interestingly, we have found that the yeast nonessential
and essential genes differ in their chromosomal distri-
butions, indicative of a selective pressure excluding
essential genes from some areas and enriching them in
others. In contrast to normal proteome networks, the
cancer network is expected to be robust to gene loss,
largely because genomic instability is one of the hall-
marks of human cancer.
We were hoping that our analysis of the yeast pro-
teome network would reveal properties of mammalian
networks and perhaps even how these networks become
reprogrammed during tumorigenesis. One of the
lessons from our work on yeast was that even this rela-
tively small-scale network (6000 genes) was incredibly
complex, suggesting that global approaches would
result in few inroads. Therefore, we have focused on
studying the DNA-damage response, partially due to
our finding on the distribution of essential genes in
yeast and partially because most tumors are initially
sensitive to therapies based on DNA-damaging agents.
DNA damage elicits a signaling cascade that results
in cell cycle arrest and recruitment of the DNA repair
machinery to sites of DNA damage. Importantly,
polyubiquitin chains have an important role in this
recruitment. In fact, BRCA1, a gene identified from
hereditary forms of breast cancer, is a critical factor for
DNA repair and it functions as an ubiquitin ligase.
Interestingly, BRCA1 elaborates a specific form of
polyubiquitin, K6-linked chains. However, the sub-
strates and effectors of this chain are unclear, and we
have attempted to identify potential BRCA1 effectors
by identifying proteins that are associated with K6-
linked polyubiquitin chains. This resulted in the identi-
fication of a WHIP (Werner's helicase interacting pro-
tein). Importantly, WHIP binds to polyubiquitin via a
previously uncharacterized polyubiquitin-binding
domain The yeast homolog of WHIP, MGS1, has pre-
viously been implicated in DNA repair, and we have
found WHIP to be in a larger network of DNA-repair
proteins, including Werner's helicase, ERCC1,
ERCC4, and a human RuvB homolog. In addition, we
also find WHIP to be associated with proteins involved
in the unfolded protein response. These findings sug-
gest that WHIP may function in both DNA-damage
repair and an ubiquitin-dependent chaperone.
Interestingly, RAD23 also has a dual role in DNA-
damage repair and as an ubiquitin chaperone.
Small world protein networks are typically built by
mapping protein::protein interactions using either the
yeast two-hybrid system or by immunoprecipitation
coupled to mass spectrometry (IP-MS). This has
proven to be very powerful in determining protein net-
works in yeast, but it has not been truly transferred to
mammalian systems. Typically, mammalian systems
require the overexpression of an epitope-tagged target
(bait) protein. The overexpression can be a source of
artifacts. Using adeno-associated virus (AAV), we
have been developing a strategy to epitope-tag pro-
teins in the genome. AAV directs the site-specific inte-
gration of the epitope tag into the genome and requires
about 1 kb of homologous sequence. In addition, we
have developed a novel selectable marker that couples
the marker to the translation of the targeted protein,
which results in at least a sixfold enrichment of target-
ed alleles over transcription-coupled (IRES)-based
strategies.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska M. Kwofie
K. Hrecka S. Srivastava
Our interest lies in understanding the molecular
mechanisms that underlie the pathogenesis of AIDS
and, in particular, understanding the functional con-
sequences of interactions between viral proteins and
the regulatory machineries in the infected cells. The
main focus of our research is to understand the func-
tions of accessory proteins Nef and Vpr of human
and simian immunodeficiency viruses (HIV and
SIV). These proteins are important determinants of
virulence. We directed a major effort toward the iden-
tification of mechanisms and downstream effectors
that mediate the effects of Nef and Vpr in the infect-
ed cells, and our experiments have been concentrated
in two main areas. First, we have focused heavily on
the isolation and identification of cellular proteins
that mediate the effects of Nef on signal transduction
and endocytic machineries. This has led to the purifi-
cation and microsequencing of several cellular fac-
tors that associate with Nef in T lymphocytes.
Importantly, we found that Nef targets a critical mol-
ecular switch that regulates Rac GTPases down-
stream from chemokine- and antigen-initiated signal-
ing pathways. This interaction enables Nef to influ-
ence multiple aspects of T-cell function and thus pro-
vides an important mechanism by which Nef impacts
pathogenesis by primate lentiviruses. During the last
year, we continued our studies of Nef interaction
with various elements of the Rac-signaling pathways.
We also continued to study novel interactions of Nef
with other host-cell proteins identified by mass spec-
troscopic analyses and to evaluate their potential
roles as downstream effectors of Nef. Second, we
continued experiments aimed at purifying and identi-
fying downstream effectors of lentiviral Vpr/Vpx
accessory proteins. These experiments have led to the
identification of several novel cellular proteins that
tightly associate with Vpr in monocytes. Among
them are E3 ubiquitin ligase complexes that regulate
cell cycle progression and the repair of damaged
DNA. The observation that Vpr tightly associates
with E3 ubiquitin ligase components is interesting
because HIV replication has been known to be
restricted by protein ubiquitination. Current studies
aim to verify these novel interactions and to address
38
their involvement in the lentiviral life cycle and rele-
vance to Vpr function. Here, we describe in more
detail our studies of lentival Vpr.
PURIFICATION AND IDENTIFICATION BY
MASS SPECTROSCOPY OF NOVEL
EFFECTORS OF LENTIVIRAL VPR PROTEINS
Vpr and Vpx are multifunctional accessory proteins
of HIV and SIV. One function of HIV-1 Vpr is to
mediate translocation of viral reverse transcription
complexes into the nucleus in nondividing cells, such
as terminally differentiated macrophages. The other
effect is to perturb the cell cycle progression of the
infected cell. Both functions are thought to facilitate
the HIV-1 life cycle in the infected host. Unlike HIV-
1, which possesses only the vpr gene, HIV-2 and
SIVmac viruses specify both the vpr gene and a close-
ly related vpx gene. Notably, the Vpr proteins encod-
ed by SIV and HIV-2 block cell cycle progression in
the G2/M phase similar to Vpr proteins from HIV-1
strains, but they do not have the ability to promote
nuclear transport of the preintegration complexes in
nondividing cells. In contrast, the Vpx proteins medi-
ate import of the viral reverse transcription complex
into the nucleus of the infected cells, but they do not
affect cell cycle progression. Thus, two separable
functions of the HIV-1 Vpr protein are encoded by
distinct polypeptides in HIV-2/SIV. We thought that
comparative studies of host-cell proteins that associ-
ate with Vpr/Vpx would provide a interesting system
in which to analyze the molecular mechanisms medi-
ating the cell cycle and nuclear transport effects of
these accessory proteins.
To facilitate purification of the associated proteins,
HIV-1 and SIVmac Vpr proteins were tagged at their
amino termini with FLAG and hemagglutinin (HA)
epitopes in tandem and expressed stably in U937
monocytes by retroviral transduction, or transiently in
human embryonic kidney 293 (HEK 293) cells by cal-
cium phosphate coprecipitation. Next, Vpr and their
associated proteins were purified from detergent
extracts by sequential immunoprecipitations with anti-
HA and then anti-FLAG epitope antibodies, followed
each time by elution with the respective peptide epi-
tope. The immunoprecipitates were analyzed by multi-
dimensional protein identification technology
(MudPIT), which is a combination of chromatograph-
ic and mass spectrometric procedures that allows unbi-
ased and sensitive identification of proteins in com-
plex mixtures. The MudPIT experiments were carried
out in collaboration with Drs. Michael Washburn and
Laurence Florens of Stowers Institute for Medical
Research (Kansas City, Missouri). This led to the iden-
tification of several common polypeptides associated
with Vpr proteins.
HIV-1 AND SIV VPR PROTEINS BIND A
COMMON SET OF POLYPEPTIDES
Significantly, three relatively abundant polypeptides,
DDB1, DDA1, and VprBP, that were specifically asso-
ciated with both HIV-1 and SIVmac Vpr proteins in
both U937 and HEK 293T cells, and absent in purifi-
cations from negative control cells, were thus identi-
fied. Besides these proteins, several additional
polypeptides, including those involved in chromatin
remodeling, such as histone acetyltransferases, in
transport across the nuclear membrane, such as karyo-
pherins, or in repair of damaged DNA, were found
associated preferentially and abundantly with HIV-1
Vpr, but only in HEK 293T cells. Some of such
polypeptides, for example, adenine nucleotide translo-
cator and karyopherins, have been implicated as
important for Vpr function by previous studies.
Others, such as histone acetyltransferases, are poten-
tially relevant to known transcriptional effects of HIV-
1 Vpr. Of particular interest was that among all of the
polypeptides we identified, only DDB1, DDA1, and
VprBP were found in complexes with Vpr proteins
from both HIV-1 and SIVmac, which are two distantly
related primate lentiviruses. Based on normalized
spectral counts in HEK 293T cells, DDB1, DDA1, and
VprBP were recovered from the affinity purifications
at relative abundances similar to the epitope-tagged
Vpr levels, suggesting the formation of a stochiomet-
ric quaternary complex. The conservation of these
interactions suggested that they are important media-
tors of a common Vpr function. Therefore, we focused
our studies on these proteins.
VPR TARGETS A NOVEL CUL4 E3 UBIQUITIN
LIGASE-LINKED COMPLEX
The finding that Vpr binds DDB1, VprBP, and DDA1
linked Vpr to Cullin-4 RING E3 (Cul4 E3) ubiquitin
ligase complexes, as DDB1 is an obligatory subunit of
Cu14 E3 ligases. These enzymes regulate DNA repair
and replication through ubiquitination of key sub-
strates in these processes. VprBP, a known HIV-1 Vpr-
binding protein, and DDA1 have been found recently
to bind DDB; however, their normal functions remain
unknown. Therefore, to gain further insights into Vpr
interactions with these polypeptides and their relation
to Cu14 E3 ligases, we initiated a biochemical charac-
terization of Vpr association with VprBP, DDB1, and
DDA1 . The observations that VprBP and DDA1, as
well as DDB1, all copurified with Vpr and that VprBP
and DDA1 can bind DDB1 suggested that they form a
ternary complex, which is then targeted by Vpr. To
address this possibility, protein complexes were
immunopurified from HEK 293T cells expressing
individual FLAG epitope-tagged VprBP, DDA1,
DDB1, or HIV-1 Vpr. Immunoblot analysis confirmed
that each protein was capable of associating with each
other. Furthermore, analysis of the protein complexes
purified via their VprBP or HIV-1 Vpr subunits by
sedimentation in glycerol density gradients revealed
that DDB1, DDA1, and VprBP form a ternary com-
plex, which Vpr then binds.
The notion that Vpr proteins target a Cul4-based E3
ubiquitin ligase is interesting since previous evidence
indicated that replication of primate lentiviruses is
restricted to some extent by protein ubiquitination.
Current studies address how the interaction between Vpr
and Cu14 E3 ligase modulates the HIV life cycle and the
consequences of this interaction on the infected cell.
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The maintenance of normal cellular homeostasis
requires that cells synthesize proteins when they are
needed and destroy them when their function is no
longer appropriate. These two "bookends" that define
the life of any protein are, respectively, transcriptional
regulation and ubiquitin (Ub)-mediated proteolysis.
Despite the apparent dissimilarity of these processes, a
growing body of evidence suggests that components
of the Ub-proteasome system are intimately involved
in regulating gene activity. Work in our laboratory
takes advantage of the unexpected connection between
the transcription and Ub-proteasome systems to
achieve two objectives: To gain new insight into the
actions of the oncoprotein transcription factor Myc
and to probe with which the factors normal-
ly associated with protein destruction are involved in
regulating gene activity.
REGULATION OF MYC BY UBIQUITIN-MEDIATED
PROTEOLYSIS
The c-myc oncogene encodes a basic helix-loop-helix
leucine-zipper transcription factor that can act as both
a transcriptional activator and a repressor. First identi-
fied as a cellular counterpart of the transforming gene
from the avian myelocytomatosis virus MC29, Myc
has been shown to have an extensive role in cancer: It
can collaborate with other oncogenes to induce cellu-
lar transformation, and aberrant Myc expression is
observed in many human malignancies, including ade-
nocarcinoma, colon, breast, and lung cancer, as well as
a variety of leukemias and lymphomas. Indeed, it has
been estimated that one third of all human cancers dis-
play deregulated Myc activity.
The majority of evidence indicates that Myc exerts
is biological effects by controlling transcription.
Activation of Myc target genes depends on the associ-
ation of Myc with its partner protein, Max, and is
mediated via the actions of an amino-terminal tran-
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scriptional activation domain (TAD) that interacts with
components of the transcriptional machinery. A large
number (-1700) of Myc target genes have been iden-
tified, which include an impressive assortment of cell
cycle regulators, metabolic enzymes, and components
of the translational machinery. The ability of Myc to
regulate so many genes important for cell proliferation
and growth undoubtedly underlies its ability to pro-
mote ectopic S-phase entry, apoptosis, and cellular
transformation.
Because of its potent growth-promoting proper-
ties, cells have evolved a number of mechanisms to
limit Myc accumulation and activity. One of the most
prominent of these mechanisms is Ub-mediated prote-
olysis, which typically destroys Myc within minutes of
its synthesis. The rapid and controlled destruction of
Myc keeps Myc levels low and has a major role in
restraining Myc's function, a notion supported by the
fact that tumor-derived mutations within Myc block its
rapid destruction and are aggressively oncogenic. Our
lab is interested in the mechanisms and consequences
of Myc destruction by the Ub-proteasome system. We
have defined the elements in Myc that control its sta-
bility, identified molecules that regulate Myc destruc-
tion, and investigated the consequences of aberrant
Myc destruction to cellular growth control.
These studies have revealed that Myc destruction
is important to the normal control of Myc function
and, in fact, is intimately connected to Myc's activity
as a transcriptional regulator: Not only is the tran-
scriptional activation domain of Myc the primary ele-
ment that signals Myc ubiquitylation, but a Ub-ligase
that signals Myc destruction (SCFskP2) is also a potent
stimulator of Myc's transcriptional activity. The inti-
mate relationship between Myc destruction and func-
tion is typical of many transcriptional regulators (see
below) and provides us with a unique opportunity to
learn more about how Myc protein functions. Our the-
sis is that if activity and destruction are linked, then
we should be able to use one of these activities to
learn about the other. This point is particularly rele-
vant to Myc, which is a challenging protein to study
in terms of transcriptional regulation (Myc typically
activates or represses genes only a fewfold), but is
robustly destroyed by the Ub-proteasome system in
most settings.
Our current research on Myc is focused on
exploiting the connection between activity and
turnover to learn more about how Myc regulates gene
expression programs relevant to oncogenic transfor-
mation. Much of our work is focused on the highly
conserved elements within Myc known as "Myc
boxes" (Mb). The first two Myc boxes-MbI and
MbII-are within the transcriptional activation
domain of Myc and have important roles in regulating
Myc stability: MbI is the hot spot for tumor-derived
mutations that stabilize Myc, whereas MbII is a major
site of interaction of Myc with SCFSkP2. MbI has also
received considerable attention because other groups
have found that it is the site of interaction of Myc with
the SCFFbw7 Ub-ligase. The ubiquitylation of Myc by
SCFFbW7, in particular, appears to be a highly regulat-
ed process that is controlled by growth-factor-depen-
dent phosphorylation within MbI. Specifically, phos-
phorylation at serine 62 (S62), which is signaled via
the Ras/Raf/ERK pathway, protects Myc from prote-
olysis, but at the same time is required for phosphory-
lation of Myc at threonine 58 (T58) by GSK3[3. Once
T58 is phosphorylated, dephosphorylation at S62
occurs, creating a phosphodegron that is recognized
by SCFFbW7. Thus, interdependent phosphorylation
events at T58 and S62 are proposed to function, via
SCFFbW7, as a "rheostat" that controls the metabolic
stability of the Myc protein.
Despite the intensive work on Myc regulation by
SCFFbW7, we have failed to find any evidence that this
Ub-ligase complex is responsible for the turnover of
the majority of Myc protein. Interestingly, the regula-
tion of MbI by these phosphorylation events raises
the distinct possibility that destruction of Myc by the
SCFFbW7 ligase may be under cell cycle control. If this
were the case, then we might expect that subtle
SCFFbw7-dependent changes in Myc turnover that
occur during the cell cycle may not be obvious from
analysis of asynchronous cultures. For this reason,
we sought to develop a protocol that would allow us
to take a comprehensive look at the influence of the
cell cycle on Myc synthesis, location, and stability.
The recent development of laser-scanning cytom-
etry (LSC) allows such cell cycle analyses to be per-
formed in unperturbed, asynchronous, culture sys-
tems. The LSC, which is a technical merger between
fluorescence microscopy and flow cytometry, allows
for whole-cell quantification of fluorophores target-
ed to DNA, RNA, or protein. In this way, levels (and
localization) of a particular RNA or protein can be
measured in individual cells and expressed relative to
the particular cell cycle stage, as determined by
simultaneous analysis of DNA content. By compiling
data from thousands of cells in this way, highly quan-
titative cell cycle analysis can be performed without
any disruption to normal cellular physiology.
We have used LSC, together with protein synthe-
sis inhibition and small interfering RNA (siRNA)-
mediated gene knockdown of Fbw7, to ask whether
Myc synthesis, localization, and stability are influ-
enced by the cell cycle and to examine the contribu-
tion of SCFFbW7 to Myc levels and stability. This
analysis has found that Myc is predominantly
nuclear at all phases of the cell cycle and that
steady-state levels of Myc transcripts and protein are
not appreciably different at different stages of the
cell cycle. Importantly, we have also found that
unlike for another SCFFbW7 target, cyclin E, Fbw7 is
not required to regulate Myc levels at any particular
cell cycle stage (Fig. 1). These data support the
notion that Myc synthesis and stability are constitu-
tively regulated and reveal that SCFFbW7 is not
responsible for targeting a significant pool of the
Myc protein for Ub-mediated destruction. We are
currently investigating whether mechanisms are in
place to actively protect Myc from Fbw7-dependent
destruction or whether there is a smaller subpopula-
tion of Myc (e.g., in a discrete subcellular compart-
ment) that is subject to Fbw7-dependent turnover.
In addition to MbI, we are also interested in events
that are occurring at the highly conserved MbIII
region of Myc. We have recently found that MbIII is
important for Myc function and destruction. MbIII
was originally identified about 20 years ago but has
not been studied extensively, leaving a considerable
gap in our knowledge about Myc function. We have
found that MbIII is important for Myc's ability to drive
cellular transformation both in vitro and in vivo and
that it has a crucial role in transcriptional repression by
the Myc protein. Our current efforts on MbIII are cen-
tered on understanding how this element functions in
transcriptional repression, identifying the cellular pro-
teins that bind to this element to mediate its activity,
and learning whether tumor-derived mutations within
this element alter Myc stability and activity.
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FIGURE 1 Differential regulation of Myc and cyclin E by Fbw7 during the
cell cycle. (A) Effects of siRNA-mediated knockdown of
Fbw7 on Myc and cyclin E. U2OS cells were transfected with the indicated siRNAs
(control [= luciferase]; Fbw7, and Myc), and Myc
and cyclin E levels were determined in each cell cycle subpopulation of cells.
Protein expression histograms show that Fbw7 knock-
down substantially increases cyclin E levels in S and G2 phases (rightward shift), whereas it has no significant effect on
Myc profiles.
(B) Analysis of total steady-state levels of Myc and cyclin E following Fbw7 knockdown. Western blot analysis
of cells analyzed in A.
(C and D) Quantification of relative protein levels. Fluorescence intensities for Myc
(C) and cyclin E (D) were quantified by LSC in cells
binned into G1, S, or G2/M populations, normalized to the signal for DNA content
in those cells, and expressed relative to the signal
from G1 phase.
CONTROL OF TRANSCRIPTION BY THE
UBIQUITIN-PROTEASOME SYSTEM
Although transcriptional activation and Ub-mediated
proteolysis are two processes that have apparently
very little in common, research from a number of lab-
oratories, including our own, has revealed that these
two processes come together to control gene activity.
Our efforts in this area began with the observation
that within Myc, the element that signals Myc ubiqui-
tylation overlaps precisely with the domain that acti-
vates transcription. Subsequent studies have revealed
that the overlap of TADs and degrons occurs in most
unstable transcription factors, that the relationship
between these elements is intimate, and that in some
cases the ability of an activator to engage the Ub-pro-
teasome system is essential for transcriptional activa-
tion. Together with other findings demonstrating that
Ub-ligases can function as transcriptional coactiva-
tors, that some general transcription factors have Ub-
ligase activity, and that components of the proteasome
have a nonproteolytic role in transcriptional elonga-
tion and chromatin modifications, these observations
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suggest a deep and mechanistic connection between
the transcription and ubiquitin systems that we are
anxious to explore.
Our research in this area is divided into four key
areas, each of which uses the yeast Saccharomyces
cerevisiae as a model organism. First, we are interest-
ed in how ubiquitylation and destruction control the
activity of transcriptional regulators such as Myc. For
these studies, we focus on the yeast transcriptional
activator Ga14. We have found that Gal4 is unstable
when it activates transcription, that it is destroyed by
the Dsg 1 Ub-ligase, and that ubiquitylation and/or
destruction of Gal4 is important for its ability to pro-
ductively activate transcription. We are currently
investigating whether ubiquitylation and destruction
are both involved in Gal4 activity or whether Ub is the
activating event that is terminated by Gal4 proteoly-
sis. Second, we are studying the ubiquitylation of his-
tones and its role in chromatin localization and activ-
ity. Third, we are studying the effects of ubiquitylation
of RNA polymerase II on the regulation of gene
expression in normal and stressed states. Finally, we
are working on understanding how the proteasome
interacts with chromatin and the various functions it
performs during the transcriptional process.
By combining these four approaches, we hope to
not only understand the scope with which Ub and the
Ub-proteasome system controls gene regulation, but
also reveal the underlying mechanisms. The general
"rules" that we learn from studies in this streamlined
eukaryote will also hopefully help guide our studies
of Myc.
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CANCER: GENETICS
The discovery approximately 9 years ago of RNA interference (RNAi), a fundamental
molecular process
that controls gene expression in many organisms, has prompted a revolution
in the biological sciences.
This fundamental process has allowed the activity of nearly any gene
to be manipulated at will in many
biological systems including mice and humans. However, gaining
these abilities has required the acqui-
sition of a more detailed understanding of the way RNAi operates.
Greg Hannon's group continues to make many key discoveries that not only
increase knowledge
about RNAi as a basic and important biological process but also enable the
use of RNAi ever more
effectively as a tool to probe gene function. In this regard, the Hannon
lab has created a genome-wide
collection of RNAi-inducing tools that are being used both at the
Laboratory and around the world to
study a panoply of biological problems. At CSHL, the use of this library is
mainly being harnessed to
identify new targets for cancer therapy, an activity in which the
Hannon lab is an active participant.
The mouse RNAi library is now being used by CSH Fellow Patrick
Paddison to map the roles of genes
in the earliest stages of mammalian development. By blocking the
production of individual gene products
in mouse embryonic stem cells via RNAi, Paddison aims to create a
biological time line in which he can
place when and in which tissues certain genes are turned on as a mouse
embryo develops from its ear-
liest stages. This research promises to reveal new insights into stem cell
biology and mammalian devel-
opment and should eventually provide a basis for testing stem cells in
human cell replacement therapies.
Vivek Mittal studies the mechanism of blood vessel formation that is critical for tumor
progression
and metastasis. This year, he has shown that cells known as "blood vessel progenitors"
contribute to
vessel formation during the progression of small metastases into large
metastases that are known to
kill cancer patients. Using a type of RNAi, his group has targeted these
progenitors and successfully
blocked the formation of large metastases. Given the clinical importance
of these progenitor cells in
cancer development, the insights gained through these approaches may quickly translate
applications that should ultimately lead to improved treatments for human cancer.
Scott Lowe's laboratory studies cancer gene networks and determines how genetic lesions affect-
ing these networks contribute to tumor development and resistance to cancer therapy. This past year,
Lowe and colleagues continued efforts to understand how mutations in cancer genes affect resistance
to cancer therapy, and they have found a number of genetic factors that produce resistance. Lowe and
his group also continued to study the process of cellular senescence, a potentially powerful mecha-
nism for suppressing tumors. In related work, Lowe has developed an integrative approach to cancer
gene discovery that combines the use of genomic information and mouse modeling to rapidly identify
and characterize new cancer genes and potential therapeutic targets. These studies hold the promise
to produce new insights into the genetic basis of tumor diversity between patients that can ultimately
be exploited to tailor treatment strategies to individual cancer patients.
Cancer can be thought of as a disease of genetic changes-whether mutations or so-called "epi-
genetic" changes in gene function-and these changes are responsible for a cell developing into a
tumor. To identify and characterize genes affected by mutation, Michael Wig ler and Robert Lucito pio-
neered a technique to look to the genome of the cancer cell itself. The technique is known as repre-
sentational oligonucleotide microarray analysis, or ROMA, and is based on the fact that often mutations
in the genome of cancer cells can result in increased or decreased gene copy number, namely ampli-
fications or deletions, and these changes can be used as markers for the location of oncogenes or
tumor suppressor genes, respectively. Robert Lucito is using these and other leading-edge techniques
to detect copy-number changes in a large set of ovarian and pancreatic cancer specimens. He and his
colleagues have identified the genetic patterns of deletion and amplification in these tumor types and
are currently using these alterations to identify genes involved in tumor formation.
Michael Wigler's lab uses ROMA to identify the most frequent genes mutated in breast cancer and
to determine whether these genes distinguish subtypes of breast cancer. Furthermore, Wig ler seeks to
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understand what distinguishes breast cancer from other epithelial cancers and, in general, whether the
profiles of cancers can be used to predict outcome of the disease and response to therapy. A similar
program is focused on CLL (chronic lymphocytic leukemia), the most common form of adult leukemia.
The Wig ler lab also uses a related technology to examine the genomes of children with autism and con-
genital heart disease for clues into the origins of these devastating disorders of childhood.
To find more cancer genes, it is important to detect as many genomic alterations in tumor cells as
possible. To this end, Scott Powers's lab continues their work on DNA copy-number analysis and
forged new collaborations in 2006 with CSHL scientists Robert Martienssen and Robert Lucito to apply
their methods for detecting promoter methylation, another type of genomic alteration, to the problem
of cancer gene identification. The Powers lab also works with Scott Lowe's laboratory on hepatocellu-
lar carcinoma and is investigating the application of a highly effective, flexible mouse model for testing
cancer genes that are operative in the liver.
Genomes are by no means fixed, immutable entities. Through genetic recombination, sections of
chromosomal DNA can be lost, amplified, or rearranged, resulting in a wide variety of genomic differ-
ences among species, among individuals of a species, and within the cells and tissues of an individual
organism. CSH Fellow Ira Hall is using ROMA to explore the dynamics of genome rearrangement that
may underlie a variety of normal and pathological processes in biology. He is currently using mouse
models to determine the genomic changes that gave rise to different strains of inbred mice, an
approach that among other factors may reveal unstable or hypervariable regions of the mouse genome.
As a basis for future research, Hall will also examine genome stability during normal biological process-
es such as tissue development ("mitotic" genome stability), reproduction ("meiotic" genome stability),
and aging.
In some cases, the fusion of human cells is a normal process that leads, for instance, to the forma-
tion of muscle and bone. Seemingly innocuous infections by common viruses can also cause the cells
in our bodies to fuse. Such fused cells are widely considered to be harmless because they are gener-
ally believed to die and be cleared from the body without consequences for our health. This view of
cells fused by viruses as being harmless may need to be revised. A recent study of cultured cells by
Yuri Lazebnik and his colleagues has revealed that cell fusion triggered by common viral infections may
be a significant factor in the development of human cancer. Lazebnik's group is currently testing this
possibility in animal models. Non-CSHL scientists are developing fusogenic viruses as gene-delivery
tools for human gene therapy. Lazebnik's research indicates that because these viruses might cause
cancer, their use for therapeutic purposes should be carefully evaluated.
Alea Mills is using a variety of mouse models that enable her to investigate the link between cancer
and aging. One project involves p63, a protein similar to the well-known tumor suppressor protein p53.
Work from the Mills lab has demonstrated that loss of the p63 gene accelerates aging in mice. A sec-
ond project in the Mills lab that links aging and cancer involves the 1p36 region. The Mills group is using
functional approaches to try to identify the long sought after tumor suppressor that maps to this region.
They have identified a genomic segment that harbors a gene regulating senescence, a process that
occurs during normal aging. Remarkably, loss of this region causes cancer. Mills is now using these
models to understand the delicate balance between aging and cancer, work that may lead to better
anticancer therapies.
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The Hannon laboratory probes the biology of small
RNAs in numerous contexts. Small RNAs represent a
new gene regulatory phenomenon that has gained
prominence in biology both because of its extensive
impacts and because of the promise that small RNAs
may provide new routes to disease therapy. Overall,
work in the laboratory divides among three general
topics: (1) The underlying mechanisms through which
small RNAs act to regulate gene expression, (2) the
biological impacts of small-RNA-based regulatory
systems, and (3) the use of small RNAs to devise new
cancer therapies. Descriptions of selected work from
the past year appear below.
This year we were joined by Kata Fejes-Toth,
Alexei Aravin, and Julius Brennecke, all most recently
from The Rockefeller University. Jidong Liu left to
accept a position as an Assistant Professor at Memorial
Sloan-Kettering Cancer Center, and Faby Rivas became
an editor at the journal Cell. Michelle Carmell left for a
postdoctoral position in David Page's lab at the
Massachusetts Institute of Technology. Oliver Tam and
Fred Rollins joined our lab as graduate students from
the Watson School. Ahmet Denli left for a postdoctoral
position in Rusty Gage's lab at the Salk Institute, and we
were joined by Emily Hodges from Karolinska.
One of the special highlights of this last year was
provided by our Partners for the Future student,
Catherine Schlinghyde, who placed fourth in the
National Intel Science Competition. In addition, Lin
He and Jose Silva received K99 Awards from the
National institutes of Health, highly competitive grants
designed to bridge their transition to independent fac-
ulty positions. Lab alumnus Scott Hammond received
the Gertrude Elion Award from the American
Association for Cancer Research, and Despina Siolas
was recognized as a Brigid G. Leventhal Scholar by the
Women in Cancer Research. Finally, Tom Gingeras has
returned to CSHL as a visiting scientist in the lab.
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piRNAs: A New Class of Small
RNAs in Mammals
A. Aravin, M. Carmell, A. Girard
Small RNAs associate with Argonaute proteins and
serve as sequence-specific guides for regulation of
mRNA stability, productive translation, chromatin
organization, and genome structure. In animals, the
Argonaute superfamily segregates into two clades.
The Argonaute Glade acts in RNA interference
(RNAi) and in microRNA (miRNA)-mediated gene
regulation in partnership with 21-22-nucleotide
RNAs. Members of a distinct Glade of the Argonaute
family, the PIWI proteins, are usually expressed
specifically in germ cells and animals, with muta-
tions in these genes showing severe defects in game-
togenesis. This year, we identified the small RNA
partners of PIWI proteins, the PIWI-interacting RNA
or piRNAs.
piRNAs arise from discrete locations in the
genome. Although PIWI proteins and their piRNA
partners have yet to be assigned definitive functions,
in mice, two PIWI family members have been demon-
strated to have essential roles in spermatogenesis.
Recently, we examined the effects of disrupting the
gene encoding the third family member, MIWI2.
Miwi2-deficient mice display a meiotic progression
defect in early prophase of meiosis I and a marked and
progressive loss of germ cells with age.
In Drosophila, several studies point to a role of the
PIWI subfamily in transposon silencing. We have
shown that several classes of mobile elements are
demethylated and reactivated in mutants for two mem-
bers of the PIWI subfamily, Miwi2 and Mili, suggest-
ing a conserved role for the PIWI subfamily in trans-
poson silencing across metazoan clades.
piRNAs Dance Flamenco:
A Small-RNA-based Immune
System Protects the
Drosophila Genome
J. Brennecke, A. Aravin, M. Dus, C. Malone, C. Schlinghyde
The genomes of essentially all living organisms are
loaded to different degrees with selfish genetic ele-
ments, many of which are still active and have evolved
ways to multiply in their host genome. Although sev-
eral reports have demonstrated or suggested that
immobile remnants of these elements are beneficial to
the host genome (i.e., as essential components of het-
erochromatin domains), the negative effects of trans-
posing elements have led to the development of host
defense mechanisms, which prevent uncontrolled
propagation of transposable elements.
Studies in Drosophila indicate that this mechanism
is active in the female and male germ line and strong-
ly suggest that a novel small RNA pathway constitutes
the heart of the host defense system. In fact, loss of
this pathway has no adverse effects on host develop-
ment, except fatal consequences in germ-line develop-
ment, ultimately leading to sterility.
A small RNA pathway specific for silencing selfish
genetic elements elegantly offers a way to silence all
highly variable types of transposons with a common
strategy, but a major question is how does the host cell
manage to program this defense system specifically
with antisense transposon small RNAs and not small
RNAs derived from other cellular transcripts?
We are studying this fascinating pathway in the fruit
fly Drosophila melanogaster using molecular biology,
biochemistry, and genetics. We initiated our research by
systematically describing and identifying the core com-
ponents of this pathway, which are three members of the
Argonaute protein family (PIWI, Aubergine, and
Argonaute3) and their thousands of different associated
small RNAs that we have termed piRNAs. Our results
confirm specific expression of the relevant proteins in
the germ line and indicate that the three proteins are
loaded with distinct sets of small RNAs, providing a
molecular explanation for their genetic nonredundancy.
Our data also show that intricate correlations exist
between the three ribonucleoprotein (RNP) complex-
es, suggesting that all three RNP complexes are inter-
dependent of each other and are directly involved in
the production on small RNAs. Interestingly, the small
RNAs that we identify appear to arise from discrete
genomic loci, all of which are located in the hete-
rochromatic, pericentromeric, and telomeric regions
of the four chromosomes. Two of these loci have been
shown genetically to act as master control loci in the
control of certain types of transposable elements. This
led us to propose an "immune-system"-like defense
mechanism acting in the Drosophila germ line, which
uses distinct genomic loci loaded with remnants of
transposable elements as "memory" and a linked small
RNA pathway, which can respond to active transpos-
able elements analogous to "clonal expansion."
We will continue to analyze this pathway by identi-
fying the piRNA populations in ovaries from flies
mutant in key pathway components with the aim to elu-
cidate additional details of how this pathway processes
only certain types of transcripts and not others.
Furthermore, we are interested in the evolution of this
system and will identify piRNA populations and their
genomic origins in ten different Drosophila species,
whose genomes have recently been sequenced.
Testing the Cancer Stem
Cell Hypothesis
I. I barra
Recent studies have identified tumor-initiating cells in
both breast and brain tumors. These findings are of ther-
apeutic significance since drugs that fail to eliminate
these rare populations of cells may permit regeneration
of the tumor (relapse), although the tumor mass may
initially diminish. It has been hypothesized that tumor-
initiating cells are stem cells that harbor mutations in
their self-renewal program. Thus, we are currently using
RNAi technology in combination with mammary fat
pad transplantation to screen for genes that expand or
deplete the mammary epithelial stem/progenitor com-
partment. We are also interested in cloning small RNA
molecules from mammary epithelial stem cells to deter-
mine their role in stem cell identity and cell fate.
The Role of Small dsRBD
Proteins in RNAi
M. Dus
I am currently investigating the role of a novel double-
stranded RNA-binding protein in viral immunity.
Recent studies have highlighted the importance of the
RNAi pathway in mounting an immune response
against RNA viruses. In particular, when Drosophila
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Ago2, Dcr2, and R2D2 mutants are challenged with
RNA viruses such as canine parvovirus and flock
house virus, they die because they are unable to
respond efficiently to viral infection. I am now testing
whether mutants of this protein have reduced life
spans when infected with RNA viruses.
Characterization of
Promoter-associated Small RNAs
K. Fejes-Toth, T. Gingeras
Small RNAs participate in the regulation of several bio-
logical processes. In yeast and plants, they have been
shown to regulate chromatin structure and transcription
by specifically targeting heterochromatization of homol-
ogous sequences. To date, dataaddressing the direct con-
nection between small RNAs and transcription in ani-
mals are still awaited. Recently, Tom Gingeras and his
group at Affymetrix have described promoter-associated
small RNAs in human cell lines. They have mapped
small RNAs (<200 nucleotides) to the genome using
high-resolution tiling arrays and have found strong sig-
nals around the promoter region of a large proportion of
the genes. We have characterized these small RNAs bio-
chemically. Using northern blotting, we detected small
RNAs of discrete sizes that mapped to several promoter
regions. Specific signal was observed at around 25, 35,
and 55 nucleotides with multiple probes.
Nuclear/cytoplasmic fractionation showed an
enhancement of the signal in the nuclear fraction as
expected for a potential transcriptional regulatory func-
tion. Subsequently, the 5' and 3' ends were determined
using terminator and 13-elimination assays, respective-
ly. Terminator is an exonuclease that needs 5' phos-
phate. The northern blot signal of the small RNAs only
vanished if it was kinased prior to terminator treatment,
indicating a 5 '-OH end. 0-elimination, on the other
hand, needs free 3 "-hydroxyl groups and leads to a sin-
gle nucleotide shift. A shift could only be observed if
the sample was dephosphorylated prior to treatment,
indicating a 3 "-phosphate end.
The small RNAs of the determined characteristic
sizes were isolated from nuclei of HepG2 cells and
cloned according to the cloning protocols established
in the Hannon lab but modified to account for the end
structures that we had determined. The small RNA
libraries that we obtained were subsequently
sequenced using high-throughput sequencing with
Solexa. At the present time, the sequences are being
annotated and analyzed in collaboration with Ravi
Sachidanandam here at CSHL.
48
microRNAs and Cancer
L. He, X. He
We are interested in looking at
the role of miRNA in
tumorigenesis. To date, more than 200 miRNAs have
been described in humans.
Although there is circum-
stantial evidence suggesting that these
regulatory non-
coding RNAs have a role in tumor
development, it still
remains largely obscure whether an miRNA can func-
tion as an oncogene. A comparison of B-cell lymphoma
samples and cell lines with normal tissues reveals that
substantially increased levels of the mature miRNAs
from the miR17-92 locus are often found in these can-
cers. Notably, the gene encoding this miRNA poly..
cistron is present in a region of DNA amplification
found in human B-cell lymphomas. Enforced expres-
sion of the miR17-92 cluster cooperates with c-myc,
accelerating tumor development in a mouse B-cell lym-
phoma model. Tumors derived from hematopoietic
stem cells (HSCs) expressing mir 1 7-92 and c-myc are
distinguished by an absence of the apoptosis that is oth-
erwise prevalent in c-myc-induced lymphomas. Our
studies indicate that noncoding RNAs, specifically
miRNAs, can modulate tumor formation and implicate
the miR17-92 cluster as a potential human oncogene.
Critical Roles for Dicer in the
Female Germ Line
E. Murchison, 0. Tam
To further understand the roles of RNAi in the germ
line, we have embarked on a systematic study of the
roles of RNase III enzymes Dicer and Drosha in the
male and female germ lines of the mouse. Toward this
end, we have created Cre-loxP conditional alleles of
Dicer and Drosha in mice. These are crossed to germ-
line-specific Cre lines to generate mice lacking these
enzymes specifically in developing germ cells.
We have found that Dicer is required for comple-
tion of meiosis in oocytes. Female mice in which Dicer
has been ablated specifically in oocytes shortly after
birth are sterile, and they exhibit severe defects in mei-
otic maturation. Although Dicer-b- oocytes progress to
the fully grown stage, they fail to mature and develop
disorganized spindles and severe chromosome con-
gression defects. Many transcripts are misregulated in
Dicer % oocytes, suggesting a role for miRNAs in reg-
ulating maternal transcripts. Our results reveal a previ-
ously unknown role for Dicer in regulating meiosis.
Future studies will focus on understanding the
identity and biogenesis of small RNAs in the germ
line, particularly in the female. We are developing sen-
sitive cloning protocols for the discovery and charac-
terization of the small RNA population in oocytes.
Precise knowledge of the identity of small RNAs in
the female germ line will complement studies of
RNase III mutant oocytes, and we hope to identify the
precise small RNA pathways that control spindle for-
mation and chromosome segregation in oocytes.
Enhancing the Response to
Targeted Cancer Therapies
through RNAi
F. Rollins
I am currently using RNAi to investigate cancer biolo-
gy. I am specifically interested in chemotherapeutics,
the drugs that are used to treat cancer. Many of the cur-
rent generation of cancer drugs have very broad activ-
ity; they cause much harm to the patient, resulting in
numerous side effects. Because the side effects are so
severe, the scientific community is hard at work trying
to develop new drugs that target specific molecules.
These targets are often chosen based on previous
research that identified specific genes as important to
various cancer types or to processes required for can-
cer development and maintenance.
One of these drugs is called Tarceva, which targets
a specific cellular receptor present on cells. Tarceva is
already FDA-approved for the treatment of lung cancer
and for pancreatic cancer. A new drug for lung cancer
is extremely important, as it is the leading cause of can-
cer-related deaths, and very few people who develop
lung cancer survive. The only problem with Tarceva is
that only about 15% of patients respond to it. So
although we know that the target is expressed in
patients, it does not seem to be as effective as expected
in some patients. The goal of my project is to under-
stand what makes Tarceva work and to identify the
genes that cause Tarceva to be ineffective. If we could
scan the entire human genome, we might be able to
identify genes that make Tarceva work better. My goal
is to identify these genes, which will allow us to
increase the effectiveness of Tarceva in the near future.
Another important aspect of the above project is that
even if I were to identify a gene that interacts with
Tarceva, more work would be required to develop a drug
against that gene. There is also the problem that a drug to
this second gene could have the same problem as Tarceva
and that only a small portion of the patients would
respond. To circumvent this problem, I am developing a
new drug based on RNAi. In theory, any gene could be
disrupted using RNAi. My goal is to develop a drug that
could be tailored to disrupt any gene in the human body.
This would be a great tool for both researchers and could
have tremendous clinical implications.
High-throughput RNAi Bar Code
Screens as a Tool for
Discovering Gene Function
D. Siolas
Recent advances in the field of RNAi have enabled
researchers to conduct in-depth investigations of gene
function. High-throughput screens in cultured mam-
malian cells can now be performed using RNAi libraries
such as our own Hannon-Elledge library. Our second-
generation libraries consist of more than 200,000 short
hairpin RNA (shRNA) constructs targeting more than
45,000 human and mouse genes with RNAi triggers
modeled after primary miRNA transcripts. Each hairpin
is linked to a unique 60-nucleotide identification
sequence, which serves as a bar code and allows us to
virtually count the number of cells that contain a specif-
ic hairpin in a cell population. Small changes in bar code
copy number can be monitored through the use of
microarray technology. The bar code can be amplified
from a cell's genomic DNA and fluorescently labeled to
produce a probe that is hybridized to a microarray.
We have optimized our probe-labeling methods,
probe size, and hybridization conditions using a plas-
mid DNA library in a Nimblegen platform. This opti-
mized protocol allows us to detect 78.6% of probes
within 1 standard deviation above the mean back-
ground from a complex mixture of approximately
1500 hairpins. In addition, by using two-color
hybridization (Cy3 and Cy5), we can detect control
subsets of hairpins known to be depleted from a sam-
ple population. We applied this RNAi bar code screen-
ing method in an in vivo screen using a complex mix-
ture of 7500 library hairpins in HCT 116 colon cancer
cells to identify genes that modify sensitivity to a com-
mon chemotherapeutic, paclitaxel. Hairpin-infected
cells were treated with paclitaxel at an ineffectual dose
(IC20) where 80% of the cells survive. This low dose
exposes genes that will increase the sensitivity of HCT
116 cells to the drug by causing an increase in cell
death. Genes that synergize with a suboptimal drug
treatment should make the drug more potent at a lower
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dose. Cells that have increased susceptibility to pacli-
taxel are reflected as a loss of bar code representation
on the microarray as compared to dimethylsulfoxide
(DMSO)- treated control populations. This screen has
resulted in a number of viable candidate genes that are
currently being validated.
Genome-wide RNAi Libraries
as an Engine for Gene Discovery
K. Chang
During the past year, we have expanded the availabili-
ty of the shRNA libraries (human, mouse, and rat) to a
lentiviral vector (pGIPz) format and continued our
efforts to complete the construction of the retroviral
(pSM2) libraries. For the current status of each of
these libraries, see the RNAi Codex database/Web
page (http: / /codex.cshl.edu /scripts /newmain.pl).
We have also made significant progress in building
tools to harness RNAi for large-scale loss-of-function
screens in mammalian cells. This has been our goal
since the beginning of the RNAi library project. In the
past, we have successfully carried out large-scale
transfection-based screens in multiwell format, and
this year, we have built a tractable screening platform
that would permit us to perform screens in pools of up
to 20,000 shRNAs as a complex population. Our new
screening platform has several advantages over the
conventional 96-well screening technology and is a
significant step toward being able to perform genome-
wide loss-of-function analysis in human cells without
adopting robotics. The pool-based format permits
monitoring of long-term effects of RNAi, as the task
of creating and passaging stable cell lines in individual
wells would be physically daunting. Our new method
is highly parallel, and a screen can be easily carried
out by one person. This is important as we have initi-
ated a large-scale effort to screen a collection of breast
cancer cell lines to identify genes that are important
for breast cancer cell survival and to search for under-
lying targets responsible for drug resistance/sensitivi-
ty. Our goals for the breast cancer project are to find
genes that when inactivated will cause cancer cells to
die ("straight-lethal" analysis) and also to find ways to
improve cancer therapy by discovering new drug com-
binations ("synthetic-lethal" analysis). In addition to
the potential of improving breast cancer treatment, the
cataloging of synthetic-lethal interactions can provide
insight into the robustness of cancer cells to perturba-
tions, a perspective crucial to the understanding of vul-
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nerabilities in cancer genomes, and to overcome the
"buffering" against lethal genetic interactions.
The Cytoskeleton in Tumor
Suppression and Metastasis
J. Silva
I have completed an RNAi screen focused on the iden-
tification of new tumor suppressors in epithelial can-
cers. This screen was inspired by the extensive study
of copy-number variations in cancer carried out by the
Wigler, Powers, and Lucito labs here at CSHL.
Beginning with a set of genes that were deleted in can-
cers, I found that loss of expression ofkey components
that regulate cytoskeleton dynamics behave as putative
tumor suppressors in epithelial cells. Inhibition of
these genes compromises the ability of epithelial cells
to establish strong interactions with neighbor cells and
with their environment (extracellular matrix). In vivo,
knock down of these genes cooperates with the onco-
gene, ras, to promote invasion of the stromal compart-
ment in a mouse model of skin carcinogenesis. Finally,
I have identified the presence of genetic alterations
(deletions, reduced expression, and loss of heterozy-
gosity) in a wide variety of epithelial cancers, includ-
ing breast, colon and lung, the most prevalent ones. At
this time, I am focusing on characterizing their
involvement in metastasis and in EMT (epithelial mes-
enchymal transition).
Applications of Single-molecule
Sequencing to Small RNA Biology
E. Hodges
Following a paradigm of Sanger sequencing, in which
many high-quality whole-genome sequences have
been produced, radical advances in technology have
emerged that achieve DNA sequencing at a speed and
ultra-high depth for a fraction of the cost. These new
methods prove timely as we enter a new age in which
the demand for genome resequencing is high, but
funds for such projects are low. We are employing
Solexa sequencing for a number of applications rele-
vant to our work. This technology permits the sequenc-
ing of millions of single DNA molecules by in situ
synthesis on arrays. Applying this method, we are
interested in resequencing genomic samples selected
and enriched for chromosomal regions of interest rel-
evant to diseases including cancer and neurological
disorders such as autism and schizophrenia.
In addition, our work focuses primarily on the biol-
ogy of RNAi mechanisms and their role in gene and
transposon silencing. We have cloned populations of
small RNAs from various model organisms including
the fly and mouse for the purpose of deep sequencing.
Deep sequencing enables us to thoroughly study small
RNA content leading not only to the identification of
potentially millions of new small RNAs, but also to
addressing key questions regarding, for instance,
changes in small RNA populations from wild-type and
knockout models. It also allows us to study fluctuations
over time in miRNA content between various tissues
and, likewise, piRNAs during stages of germ cell
development or to correlate sequence representation
with expression levels providing an understanding for
the tissue/disease specificity of gene targets.
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THE ORIGIN OF GENOMIC INSTABILITY IN CANCER CELLS
Y. Lazebnik C. Cormier
D. Duelli
A. Gottesman
S.-C. Lin
A. Matapurkar
A Darwinian model that can explain many features of
solid cancers, especially their heterogeneity, diversity,
and ability to evolve argues that these cancers are
caused by genomic instability (GIN), which is defined
as an abnormal and persistent change of a genome
over time. According to this model, GIN generates a
diverse population of abnormal cells by causing
numerous genome-wide aberrations that trigger mas-
sive deregulation of gene expression. The vast majori-
ty of the cells die or fail to proliferate because of the
genomic abnormalities or because they are killed or
arrested by tumor suppressor mechanisms. However,
some by pure chance have a combination of properties
that is sufficient to bypass these mechanisms and pro-
liferate to form cancers. Considering that the inci-
dence of cancer relative to the number of cells in a
human body is astronomically small, the probability of
producing cancerous cells by GIN does not need to be
high to be clinically significant.
In most solid cancers, GIN is manifested by chro-
mosomal instability (CIN), a condition in which the
structure of chromosomes or their assortment changes
over time, making the affected cells aneuploid.
Although cells of some benign tumors are also aneu-
ploid, their number of chromosomes is usually near
normal and is uniform within a tumor, indicating that
the chromosomal abnormalities are CIN. In many
solid cancers, however, the number of chromosomes
varies among and within tumors widely, from near
haploid to polyploid, indicating the presence of CIN.
The incidence of CIN in solid cancers suggests that
this condition either is a consequence of processes that
are intrinsic to carcinogenesis or is a cause of cancer.
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It is well documented that the maintenance of CIN
is enabled by deficiencies in proteins that police
genome integrity, such as the tumor suppressor p53,
but the cause(s) of CIN in sporadic cancers remains
uncertain. The primary suspects are mutations that
deregulate telomere maintenance, or mitosis, yet such
mutations have not been identified in the majority of
sporadic cancers. Alternatively, CIN could be caused
by a transient event that destabilizes the genome with-
out permanently affecting mechanisms of mitosis or
proliferation.
We previously proposed a hypothesis that several
features of cancer cells, including their genomic insta-
bility, are a result of cell fusion induced by viruses.
During the last year, we found that an otherwise harm-
less virus rapidly causes massive chromosomal insta-
bility by fusing cells whose cell cycle is deregulated
by oncogenes. This synergy between fusion and onco-
genes "randomizes" normal diploid human fibroblasts
so extensively that each analyzed cell has a unique
karyotype and some produce aggressive, highly aneu-
ploid, heterogeneous, and transplantable epithelial
cancers in mice. Because many viruses are fusogenic,
our study suggested that viruses, including those that
have not been linked to carcinogenesis, can cause
chromosomal instability and, consequently, cancer by
fusing cells.
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REGULATION OF APOPTOSIS AND SENESCENCE
BY CANCER GENES
S. Lowe A. Bric
D. Burgess
C. Chang
A. Chicas
R. Dickins
K. Diggins
Y. Hippo
V. Krizhanovsky
B. Ma
M. McCurrach
K. McJunkin
C. Miething
S. Nunez W. Xue
T. Pardee M. Yang
P. Premsrirut L. Zender
J. Simon Z. Zhao
M. Spector J. Zuber
H. Wendel
Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence produces "genetic death" in
that the senescent cell is incapable of further propaga-
tion. Both processes are frequently disrupted in cancer
cells, implying that each can limit tumor development.
Moreover, radiation and many chemotherapeutic
agents can induce either apoptosis or senescence, rais-
ing the possibility that the integrity of these pro-
grammed responses influences the outcome of cancer
therapy in patients. The goal of our research is to
understand how cancer genes control apoptosis and
senescence in normal cells, and how mutations that dis-
rupt these processes impact tumor development and
therapy. Our approach emphasizes genetics, and we
have increasingly relied on new types of animal mod-
els and gene manipulation technologies to study tumor
development and cancer therapy in vivo.
Control of Apoptosis by Oncogenes
and Tumor Suppressor Genes
A. Bric, D. Burgess, C. Chang, K. Diggins, M. McCurrach,
W. Xue, L. Zender [in collaboration with former laboratory
members C. Scott and J. Gil; D. Beach, Institute of Cell
and Molecular Science, London; J. Teruya-Feldstein,
E. Hernando, R. Benezra, and C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center]
Normal cells possess intrinsic tumor suppressor mech-
anisms that limit the consequences of aberrant prolif-
eration. For example, deregulated expression of the c-
Myc or disruption of the Rb (retinoblastoma) pathway
in normal cells can force aberrant S-phase entry and
predispose cells to apoptotic cell death. This increased
sensitivity to apoptosis acts through both p53-depen-
dent and -independent pathways and potently limits
tumor development. We have previously shown that
oncogenes can engage the ARF-p53 pathway to pro-
mote apoptosis and that disruption of this pathway
cooperates with oncogenes to transform normal cells
in vitro and promote tumorigenesis in vivo. We are
currently interested in identifying additional compo-
nents of these programs and understanding how they
function in a "tumor suppressor network."
Cbx7 is a chromobox family protein and a compo-
nent of polycomb repressive complex 1 (PRC1) that
extends the life span of cultured epithelial cells and can
act independently of Bmi-1 (another PRC1 component)
to repress the Ink4a /Arf tumor suppressor locus. To
determine whether Cbx7 might be oncogenic, we exam-
ined its expression pattern in a range of normal human
tissues and tumor samples. Cbx7 was expressed at high
levels in germinal center lymphocytes and in germinal
center-derived follicular lymphomas, where elevated
expression correlated with high c-Myc expression and a
more advanced tumor grade. By targeting Cbx7 expres-
sion to the lymphoid compartment in mice, we showed
that Cbx7 can initiate T-cell lymphomagenesis and
cooperate with c-Myc to produce highly aggressive B-
cell lymphomas. These data identify Cbx7 as the first
chromobox protein causally linked to cancer develop-
ment, and may explain, at least in part, the low frequen-
cy of INK4a/ARF mutations observed in human follic-
ular lymphoma (C.L. Scott et al., in press).
Using a murine model of hepatocellular carcinoma
(liver cancer) and representational oligonucleotide
microarray analysis (ROMA) of murine and human
tumors, we identified two new oncogenes that are ampli-
fied in murine and human cancers and cooperate to pro-
mote tumorigenesis (Zender et al. 2006). One encodes
the yes-associated protein (Yap) and the other is the cel-
lular inhibitor of apoptosis protein cIAP1. Interestingly,
previous work from other investigators indicates that Yap
can promote apoptosis, although the Drosophila
ortholog (Yorkie) can promote proliferation. We also see
that Yap can promote proliferation, whereas cIAP1 can
block cell death. We are currently studying Yap function
to determine how it acts as an oncogene and whether,
like Myc, it can drive both proliferation and cell death.
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In studying how proliferation is coupled to apopto-
sis, we previously showed that deregulation of the Rb-
E2F pathway could also compromise mitosis by pro-
ducing aberrant expression of the mitosis regulator,
Mad2. These results suggested that mutations compro-
mising Rb function could drive proliferation but also
produce genomic instability, which itself could be
oncogenic. Working with Robert Benezra, we exam-
ined the impact of enforced Mad2 expression, either
alone or in combination with other oncogenes, on
oncogenesis. Indeed, we see that deregulated Mad2
can promote tumorigenesis but, consistent with its role
in promoting genomic instability, was not required for
tumor maintenance (R. Sotillo et al., in press). These
results support our initial suggestions that deregulated
Mad2 expression is one consequence of Rb loss that
can contribute to tumorigenesis.
Control of Cellular Senescence
A. Chicas, M.V. Krizhanovsky, S. Nunez, W. Xue, L. Zender,
K. Diggins [in collaboration with former laboratory members M.
Narita and M. Narita; E. Hernando and C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center]
Cellular senescence was originally described as the
process that accompanies in
cultured human fibroblasts and is characterized by a
series of poorly understood markers. Senescent cells
remain metabolically active, but they are unable to
proliferate and display changes in gene expression
that could alter tissue physiology. As such, they are
genetically "dead" and cannot contribute to tumor
development. Although "replicative" senescence is
triggered by telomere attrition and can be prevented
by telomerase, an identical endpoint can be produced
acutely in response to activated oncogenes, DNA
damage, oxidative stress, and suboptimal cell culture
conditions. These observations have led us to propose
that senescence acts in parallel to apoptosis as a cel-
lular response to stress and acts in a similar way to
suppress tumorigenesis and mediate responses to
chemotherapy. Indeed, based on this analogy, much of
our work on senescence is guided by our past experi-
ence on apoptosis.
We previously showed that senescent cells can
accumulate senescence-associated heterochromatic
foci (SAHFs), which may provide a chromatin buffer
that prevents activation of proliferation-associated
genes by mitogenic transcription factors. This year, we
showed that the high-mobility-group A (HMGA) pro-
teins, which can promote tumorigenesis, accumulate
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on the chromatin of senescent fibroblasts and are
essential structural components of SAHFs. HMGA
proteins cooperate with the pl 6INK4a tumor suppressor
to promote SAHF formation
and proliferative arrest
and to stabilize senescence by contributing to the
repression of proliferation-associated genes (Narita et
al. 2006). These antiproliferative activities are can-
celed by coexpression of the HDM2 and CDK4 onco-
genes, which are often coamplified with HMGA2 in
human cancers. Our results identify a component of
the senescence machinery that contributes to hete-
rochromatin formation and imply that HMGA proteins
also act in tumor suppressor networks.
Our laboratory was the first to demonstrate that
deregulated mitogenic oncogenes can drive cells into a
senescent state thereby preventing transformation and
that senescence contributes to the outcome of chemo-
therapy in vivo. This year, we conducted a series of
experiments (discussed in more detail below) where we
showed that p53-deficient liver carcinoma cells under-
go senescence following p53 reactivation in vivo.
Remarkably, although senescence is a cytostatic pro-
gram, the tumors underwent massive regressions as a
result of an attack of the immune system on the senes-
cent cells. Thus, despite the cytostatic nature of the
senescence program, senescent cells can turn over in
vivo. Although it is established that chronic inflamma-
tion triggered by senescent stromal cells or other fac-
tors can promote tumorigenesis, our study illustrates
how innate immune cells-when targeted against
senescent tumor cells-can have antitumor effects as
well. We suggest that strategies that specifically har-
ness these processes may represent a promising thera-
peutic approach.
Cancer Gene Discovery and
Comparative Oncogenomics
M. Spector, W. Xue, L. Zender [in collaboration with
R. Lucito, D. Mu, M. Wilger, and S. Powers,
Cold Spring Harbor Laboratory; C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center; J. Luk,
Hong Kong University]
Hepatocellular carcinoma (HCC) represents the fifth
most frequent neoplasm worldwide. However, due to the
lack of treatment options, it constitutes the third leading
cause of cancer death (>500,000 deaths per year). The
only curative treatment options for HCC are surgical
resection or liver transplantation. Unfortunately, at the
time of diagnosis, the majority of HCC patients have an
advanced tumor and are not candidates for surgical ther-
apy. Systemic chemotherapeutic treatment is ineffective
against HCC, and thus, there is a great need for new
therapies to treat this disease. To better understand this
disease, we generated a new mouse model of hepatocel-
lular carcinoma that is based on the ex vivo manipula-
tion of liver progenitor cells, followed by the seeding of
these cells into normal recipients. These methods
allowed us to rapidly produce in situ liver cancers of
defined genetic origin.
In an attempt to gain insights into the lesions that
give rise to HCC, we used representational oligonu-
cleotide microarray analysis (ROMA) to conduct a
genome-wide analyses of tumors in this mouse model
and in human hepatocellular carcinomas. Our results
revealed a recurrent amplification at mouse chromo-
some 9qA1 and the syntenic region of human chromo-
some 11q22. Gene expression analyses delineated
cIAP 1 , a known inhibitor of apoptosis, and Yap, a tran-
scription factor as candidate oncogenes in the ampli-
con. In the genetic context of their amplification, both
clAP 1 and Yap accelerated tumorigenesis and were
required to sustain rapid growth of amplicon-contain-
ing tumors. Furthermore, cIAP 1 and Yap cooperated to
promote tumorigenesis.
Our study also suggests an integrative strategy to
complement the human cancer genome project, whose
goal is to catalog all of the mutations that contribute to
human cancer. By integrating data from human cancer
genomics with corresponding data from appropriate
mouse models, it should be possible to expeditiously
focus on the cancer lesions most likely to have transla-
tional potential.
First, cross-species comparisons can prioritize
lesions for further study by increasing the probability
that they are important, a particularly relevant issue
when studying relatively low-frequency events. Second,
by incorporating murine tumors into the analysis, it is
possible to increase the sample size and exploit synteny
to exclude candidates outside the region of overlap.
Third, genetically engineered mice, by definition, devel-
op more defined cancers than humans. Thus, the identi-
fication of a particular lesion in murine cancers immedi-
ately provides information concerning the evolutionary
context in which it arose and identifies a relevant setting
in which to study its oncogenic potential. Finally, mouse
models provide excellent settings to test the suitability of
a cancer lesion as a therapeutic target, and at the same
time, they provide ideal preclinical models for subse-
quent drug testing. We believe that such integrative
approaches will speed up the pace of discovery and help
translate the promise of cancer genetics into improve-
ments of cancer diagnosis, prognosis, and therapy.
Modulation of Gene Expression In Vivo
Using RNA Interference
A. Bric, R. Dickins, B. Ma, K. McJunkin, C. Miething,
P. Premsrirut, J. Simon, W. Xue, L. Zender [in collaboration
with G. Hannon and L. He, Cold Spring Harbor Laboratory]
RNA interference (RNAi) is a powerful method for
suppressing gene expression in mammalian cells.
Stable knockdown of gene expression can be achieved
by continuous expression of synthetic short hairpin
RNAs (shRNAs), typically from RNA polymerase III
promoters. However, primary microRNA transcripts
(pri-miRNAs), which are endogenous triggers of
RNAi, are normally synthesized by RNA polymerase
II (pol II). In collaboration with Gregory Hannon, we
previously showed that pol II promoters expressing
rationally designed pri-miRNA-based shRNAs
(shRNAmir) produce potent, stable, and regulatable
gene knockdown in cultured cells and in animals, even
when present at a single copy in the genome. In prac-
tice, this shRNAm'r vector system is remarkably similar
to cDNA overexpression systems and should be a pow-
erful tool for studying gene function in cells and ani-
mals. We are taking advantage of these tools to explore
various aspects of tumor suppressor gene networks in
vitro and in vivo (Ramiro et al. 2006; Yin et al. 2006;
E.E. Bosco et al., in press).
As one example, we recently used our tet-regulat-
ed RNAi system to explore the role of p53 in tumor
maintenance. As indicated above, p53 acts to restrict
proliferation in response to DNA damage or deregula-
tion of mitogenic oncogenes, and thus p53 mutations
increase proliferation and survival and, in some set-
tings, promote genomic instability and resistance to
certain chemotherapies. In principle, the instability
associated with p53 loss could allow the tumor to
evolve beyond its dependence on p53 mutations. To
determine the consequences of reactivating the p53
pathway in p53-deficient tumors, we used RNAi to
conditionally regulate endogenous p53 expression in a
mosaic mouse model of liver carcinoma (W. Xue et al.,
in press). We showed that even brief reactivation of
endogenous p53 in p53-deficient tumors can produce
complete tumor regressions. The primary response to
p53 was not apoptosis but instead involved the induc-
tion of a cellular senescence program that was associ-
ated with differentiation and the up-regulation of
inflammatory cytokines. This program, although pro-
ducing only cell cycle arrest in vitro, also triggered an
innate immune response that targeted the tumor cells
in vivo, thereby contributing to tumor clearance.
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The above results indicate that p53 loss can be
required for the maintenance of aggressive carcinomas
and illustrates how the cellular senescence program
can act together with the innate immune system to
potently limit tumor growth. However, they also estab-
lish the utility of conditional shRNA technology to
study tumor phenotypes in live mice. Current work is
attempting to generalize this strategy with the goal of
eventually enabling the spatial and temporal control of
the expression of any endogenous gene.
Molecular Genetics of Drug
Sensitivity and Resistance
D. Burgess, B. Ma, M. McCurrach, K. McJunkin,
C. Miething, J. Simon, H. Wendel, M. Yang, L. Zender,
Z. Zhao, J. Zuber [in collaboration with C. Cordon-Cardo,
Memorial Sloan-Kettering Cancer Center; S. Kogan,
University of California, San Francisco]
Our laboratory has a long-standing interest in under-
standing genetic determinants that influence the cellular
response to conventional chemotherapy, with the goal of
identifying mechanisms of drug resistance and develop-
ing new drug targets. During the last several years, we
have also expanded our efforts toward understanding the
action of targeted therapeutics. As one example, we stud-
ied the action of imatinib (STI-571, Gleevec) against
murine cells and leukemias expressing BCR-ABL, an
imatinib target and the initiating oncogene for human
chronic myelogenous leukemia (CML). We showed that
the tumor suppressorp53 is selectively activated by ima-
tinib in BCR-ABL expressing cells as a result of BCR-
ABL kinase inhibition (Wendel et al. 2006). Inactivation
of p.53, which can accompany disease progression in
human CML, impedes the response to imatinib in vitro
and in vivo without preventing BCR-ABL kinase inhibi-
tion. Concordantly, p.53 mutations are associated with
progression to imatinib resistance in some human
CMLs. Our results identify p.53 as a determinant of the
response to oncogene inhibition, and suggest one way in
which resistance to targeted therapy can emerge during
the course of tumor evolution.
We have also characterized factors that influence the
sensitivity and resistance to rapamycin, a drug that tar-
gets mTOR (mammalian target of rapamycin) and is in
clinical trials to treat a variety of cancers. We previously
showed that rapamycin can suppress mTOR activity and
synergize with chemotherapy in Akt-expressing lym-
phomas, leading to potent antitumor responses.
Interestingly, eIF4E (eukaryotic initiation factor 4E), a
translational regulator acting downstream from mTOR,
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accelerated lymphomagenesis and promoted drug resis-
tance in a manner comparable to that of Akt, suggesting
that a substantial portion of the Akt survival signal is
transmitted through deregulated translation. This year,
we showed that reduced dosage of PTEN, a negative reg-
ulator of phosphoinositide 3-kinase (PI3K) signaling, is
sufficient to activate Akt, but has only a modest effect on
lymphomagenesis in the same model (Wendel et al.
2006). Nonetheless, loss of even one PTEN allele result-
ed in lymphomas that were resistant to conventional
chemotherapy yet sensitive to rapamycin/chemotherapy
combinations. Finally, the introduction of lesions that act
downstream from mTOR (eIF4E) or disable apoptosis
(Bcl -2 and loss of p53) into PTEN±t- lymphomas pro-
moted resistance to rapamycin/chemotherapy combina-
tions. Thus, whether activation of the PI3K pathway con-
fers sensitivity or resistance to therapy depends on the
therapy used as well as secondary genetic events. We
believe that a better understanding of these genotype-
response relationships in human tumors will be impor-
tant for the effective use of rapamycin or other com-
pounds targeting the PI3K pathway in the clinic.
Finally, we are continuing a multi-institutional
effort to use mouse models of acute myelogenous
leukemia to identify molecular determinants of both
conventional and targeted therapies, with the goal of
translating this information to human patients. We are
excited about the potential of the program, as it pro-
vides all of the elements necessary to validate the use
of new mouse models as preclinical test systems and
to translate this information into clinical trials. We are
also integrating experiments using mouse models,
genomics, and RNAi methods in an attempt to
increase the rate of discovery of genes that influence
the sensitivity and resistance of tumor cells to various
therapies in vivo. These efforts involved collaborations
with several CSHL investigators who will be an
important part of future efforts.
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GENOMIC MICROARRAY ANALYSIS OF CANCER
R. Lucito T. Auletta
S. Chen
0. Dovirak
S. El-ftesi E. Lum
S. Khan C. Tang
K. Kuntz
Mutation of the genome is central to the development
and progression of cancer. Mutations occur in the
genome of precancerous cells and accumulate, altering
gene function until the growth of these cells goes
unchecked. The genes responsible for cancer must be
identified if we are to understand the cellular pathways
that become subverted to allow the cell to become can-
cerous. We have developed a genomic microarray
technique, representational oligonucleotide microar-
ray analysis (ROMA), to identify copy-number fluctu-
ations, which borrows the methodology of complexity
reducing representations developed for RDA (repre-
sentational difference analysis) to increase hybridiza-
tion efficiency and increase signal to noise. A repre-
sentation is a reproducible sampling of the genome,
produced by first cleaving the genome with a restric-
tion enzyme such as BglII, ligation of adaptors, and
PCR (polymerase chain reaction) amplification. BglII
representations of tumor and normal that are differen-
tially labeled are compared on such an array to identi-
fy copy-number fluctuations. The array is composed of
oligonucleotides based on the sequence of the human
genome. We are using microarrays photochemically
synthesized by Nimblegen Systems Inc. Currently, we
are using arrays with 85,000 probes distributed
throughout the genome and soon will be moving to an
array of 390,000 probes.
We have continued surveying the genome of sever-
al cancer types to identify regions that have undergone
increased or decreased gene copy number, namely,
amplifications or deletions, since these changes can be
used as markers for the location of oncogenes or tumor
suppressor genes, respectively. Regions are being
informatically searched for gene candidates, and func-
tional analysis of these candidates is being carried out
to determine which genes have oncogenic potential.
Once identified, these genes functions can be investi-
gated to understand their role in the path to tumorige-
nesis. In addition, by analyzing the regions alongside
clinical data, we will determine if there are any regions
or combination of regions that correlate to clinical out-
come. The application of this type of an array spans
many areas of biology, from cancer to genetic dis-
eases. We will be using this microarray method to cat-
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egorize the mutations that occur in primarily two
tumor types initially, pancreatic
and ovarian cancer.
PANCREATIC CANCER
There will be an estimated 30,000 cases of pancreatic
cancer this year. Of those, 29,700 patients will suc-
cumb to the disease. Although the number of cases is
low, in comparison to several other cancers such as
colon, lung, or breast cancer, the survival rate for pan-
creatic cancer is one of the lowest. Treatments can
extend survival or alleviate pain but seldom cure the
patient. In fact, the mean survival time is approximate-
ly 6 months. Because the life span after diagnosis is
very short, the number of patients that receive tumor
resections is very low. This translates to few samples
available for analysis. Because of this, we are collabo-
rating with many clinicians to put together a useful
tumor bank of pancreatic tissue for analysis by ROMA.
Currently, we are collaborating with Dr. Ralph
Hruban of Johns Hopkins University, Dr. Daniel Von
Hoff of the Arizona Cancer Center, and Dr. Vijay Yajnic
of Massachusetts General Hospital, who will be pro-
viding pancreatic specimens and invaluable clinical
information and expertise. To date, we have analyzed
82 samples composed of 27 primary tumors, 23 cell
lines, and 32 xenografts. In addition, we have compiled
published data for an additional 16 primary tumor sam-
ples into our data set to increase information content.
We have confirmed that many of the known mutated
regions are altered in this set, including genes such as
the INK4a-ARF locus, SMAD4, p53, and c-myc to
name a few. In addition, there are other less-character-
ized regions deleted 2p23, 3p, 4q23, 5p15, 10p15, and
12p and amplified 1q42-43, 3q26, 6p21, 7p21, 14821,
18q11, and 19q12 frequently in this cancer, and we are
continuing to study these regions to identify possible
gene candidate tumor suppressors and oncogenes.
Although we are working on several regions at this
time, we will summarize one region amplified on
19q12 in specifics. There are a number of tumors and
cell lines that have this region amplified, but with two
tumors that have the most informative amplicons, the
epicenter or common region of mutation was delimit-
ed to approximately 2 million bases. This region con-
tains 20 gene candidates. In the samples that have
gene amplification, it is highly likely that the target
gene is overexpressed at the RNA level, and the non-
target genes will not be overexpressed, although they
may be overexpressed as a consequence of being
gene-amplified. To decrease the number of viable
gene candidates, gene expression analysis was per-
formed on the cell lines and one of the primary
tumors that have the amplicon.
After this analysis was completed, the number of
candidates was decreased to only two. Immunohisto-
chemistry on one of the tumors that had gene amplifi-
cation clearly demonstrated that one candidate was
expressed highly in the normal as well as the tumor.
The other candidate, a gene called p21 -activated kinase
or PAK4, was nearly absent in the normal but was
found at extremely high levels in the tumor sample tis-
sue. To determine if the encoded protein is active, we
performed an in vitro kinase assay on extracts from cell
lines that have the amplicon. In comparison to a cell
line that did not have amplification of this gene, the
cell lines had 10-15 more protein and 8- to 10-fold
more kinase activity. Mutated or activated forms of
PAK4 have been shown to increase tumorigenicity.
We are presently sequencing the PAK4 gene in these
samples to determine if the gene present encodes a
constitutively active protein. However, another way of
activating PAK4 is to activate RAS, an extremely com-
mon event in pancreatic cancer. Codon 12 (the most
commonly mutated codon) of RAS was sequenced for
these samples and four of five have an oncogenic form
of the RAS protein. It is possible that PAK4 itself is
activated in this fifth sample, and we will dermine this
shortly. In the future, we plan to use short hairpin RNA
(shRNA) constructs to knock down the level of PAK4
in cells with the amplicon to determine the effect on
tumorigenicity. We will also be moving this gene into
an animal model for pancreatic cancer.
OVARIAN CANCER
We are also focusing on the analysis of ovarian cancer
using ROMA. Ovarian cancer has a relatively high
incidence and approximately 50% survival rate. In
many patients, the cancer is diagnosed late, often hav-
ing metastasized, the first symptoms being an accumu-
lation of fluid in the abdominal cavity. There have
been few genes discovered that are involved in the pro-
gression of ovarian cancer. We will be collaborating
with Dr. Michael Pearl of SUNY Stony Brook for
access to tissue and clinical information. We will also
be performing ROMA on a tumor set of approximate-
ly 200 ovarian cancer samples to identify gene copy-
number fluctuations to identify candidate tumor sup-
pressor and oncogenes.
At present, we have analyzed 121 tumors and have
compiled the data to identify regions commonly ampli-
fied or deleted. We have identified uncharacterized
regions commonly amplified (1q21, 3q26, 6p, 11q13,
12p, and 20p13) and regions that are deleted frequent-
ly (1p35, 3p26, 4p15, 4q34, 5q14, 5q34, 6q22, 9q22,
12q, 13q13, 16q, 19p, and 22q13). We have character-
ized these regions for gene content and have chosen
several to move further for gene characterization.
One such region we are further characterizing is a
deletion on chromosome 5q14. This region is relative-
ly small and contains only seven gene candidates.
Since there were so few candidates in this region, we
performed quantitative PCR (Q-PCR) on the mRNA
of a large panel of cell lines and primary ovarian
tumors. Presently, we have removed all candidates
from analysis based on the expression data (similarly
to what we have done for the pancreatic region dis-
cussed above) and have three candidates to further
characterize. One gene, Centrin 3 (CETN3), in this
region is of particular interest. CETN3 is a component
of the centrosome and takes part in the cellular dupli-
cation process. In lower organisms, there is only one
centrin and experimental deletion of this gene resulted
in centrosome amplification and aneuploidy, a com-
mon phenotype of cancer cells. We are presently
studying whether the removal of this gene contributes
to aneuploidy in cancer cells.
Methylation-specific Oligonucleotide
Microarray Analysis
T. Auletta, 0. Dovirak, S. Khan, K. Kuntz, C. Tang
In addition to genetic mutation such as amplification
and deletion, there are epigenetic mechanisms used to
influence the transcriptional activity of a gene. One
such mechanism is methylation of the cytosines pre-
sent in the DNA of the transcriptional control region,
which often suppresses the expression of the gene. It
has been known that methylation of DNA has been
involved in the silencing of gene expression in
imprinting and in cancer. Recent advances including
technical and also the sequencing of the genome have
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made detection of methylation at loci more reliable
and accurate. However, there are few methods that can
identify methylation changes over the entire genome.
We have adapted ROMA to methylation detection
oligonucleotide microarray analysis (MOMA). We are
currently utilizing this to survey the methylation
changes that occur in CpG islands in cancer, but in
principle, this method would have applications for
identifying methylation differences involved in
imprinting or other syndromes that do not involve
genetic mutation.
At the heart of this method is the use of a represen-
tation. If we wish to capture the CpG islands within a
representation, we must reshape the representation to
do so. We therefore set out to find which representa-
tions faithfully capture the majority of CpG islands.
We determined that a restriction enzyme with a four-
base recognition sequence would be required and
determined that the best endonuclease would be one
with a cleavage site rich in CG dinucleotides. Since an
overhang is required for ligation of adaptors for subse-
quent PCR, the endonuclease MspI was chosen. This
restriction endonuclease cleaves at both unmethylated
and methylated CpGs. Therefore, we will lose some
information content from the genome, but we felt that
the few CpGs lost would on average not be detrimental
to the data available. The ligated material is split in
half, one half digested with a second endonuclease
McrBC, which cleaves at (G/A)mC (N40-3000)
(G/A)mC, and the other half mock-digested. The PCR
amplification product of these two templates is then
compared on a CpG island microarray.
We have tested the array with several samples and
have demonstrated that it can discriminate when a CpG
island is methylated or not methylated. We can also
see, as others have reported, that when a cell becomes
cancerous, there is a paradoxical decrease in global
methylation and an increase in CpG island methyla-
tion. We have analyzed several cell lines and can iden-
tify methylation at common sites of several tumor sup-
pressors such as p16, and Rassfl a. By analyzing those
regions of the genome that are differentially methylat-
ed and combining the data for copy number and
expression, we will obtain a more complete picture of
the cancer cell. Currently, we are doing this for a set of
16 ovarian samples and another set of 83 breast sam-
ples. We expect that this information will help to iden-
tify tumor suppressors within regions where one allele
has been deleted and the remaining allele has been
silenced by methylation.
We have also identified a pattern of demethylation
of non-gene-associated CpG islands that may be useful
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to identify the stage or
grade of the tumor. Although
grading/staging cancers is a measurement
determined
by a well-trained pathologist, it is
still somewhat sub-
jective since of course pathologists differ. In addition,
tumor classification based on qualitative
analysis of
morphology, in some cases, is not necessarily predic-
tive of clinical outcome. It has long been understood
that within the genome, the CpG islands not associated
with genes often proximal or contiguous with repeti-
tive sequences become hypomethylated in cancer. This
hypomethylation is thought to make the repetitive
regions unstable contributing to genomic instability,
with a likely consequence of the cancer becoming
more aggressive. Therefore, we have surmised that the
methylation content of these non-gene-associated
islands could be used to judge the grade/stage of the
cancer. If this hypothesis is correct, genome-wide mea-
surements of the methylation content could be obtained
and calculated, resulting in a score that could serve as
a parameter utilized by pathologists to grade/stage
tumors. By developing a quantitative measurement, we
hope to remove some error in determining the
grade/stage of tumors. If positive results are obtained,
we expect to move to a larger study, hopefully in a clin-
ical setting. The outcome will be better patient man-
agement and we hope the more accurate prescription of
treatment strategies.
Mutational Analysis of Phosphatases
E. Lurn, T. Auletta [in collaboration with N. Tonks, Cold Spring
Harbor Laboratory]
The goal of this collaborative study is to integrate gene
discovery technology with experimental strategies
developed in Dr. Tonks's lab here at CSHL for the char-
acterization of the protein tyrosine phosphatase (PTP)
family of enzymes, to investigate how tyrosine-phos-
phorylation-dependent signaling pathways are disrupt-
ed in cancer.
Dr. Tonks's lab conducted a bioinformatic analysis of
the human genome sequence to compile a list of all
human PTPs. This list was used to identify the genomic
coordinates for all PTP genes, which was then matched
to the genomic copy-number data generated. This
allowed us to identify those PTPs that were amplified or
deleted within the tumor genomes analyzed. We identi-
fied two receptor-like PTPs, LAR and PTPsigma, that
are encoded by genes amplified in these ovarian tumor
specimens. These receptor-like PTPs display features of
cell adhesion molecules and have been implicated in
regulating the function of adhesion complexes that con-
trol cell-cell interactions and may be disrupted in cancer.
Disruption of mitogen-activated protein kinase
(MAPK)-dependent signals is known to contribute to
cancer in humans. Two of the members of the PTP fam-
ily that we identified as being amplified in ovarian can-
cer specimens are regulators of MAPK-dependent sig-
naling modules. VHY is a dual specificity phosphatase
that the Tonks lab has implicated in the activation of a
signaling pathway (the JNK pathway) that has a critical
role in the control of cell survival. MKP5 is another
dual specificity phosphatase that functions in the inac-
tivation of the p38 and JI\TK MAPKs.
Oncogenes and tumor suppressor genes are fre-
quently altered in their expression between normal and
tumor specimens. Therefore, in addition to our analysis
of gene copy number, we conducted transcriptional
expression analysis of tumor samples to identify any
PTPs that are misexpressed. We have grown 11 ovari-
an and 9 pancreatic cell lines and have performed
genome-wide expression analysis. Of the 76 PTPs
queried in the expression data, we found that 13 dis-
played statistically significant altered expression in the
cell lines. We have also used quantitative reverse tran-
scriptase (RT)-Q-PCR as a complementary approach to
validate these data on changes in expression.
Interestingly, in an independent project, we have
identified the gene encoding Liprin as being highly
amplified and displaying altered gene expression.
Liprin is a binding partner for the receptor PTP LAR,
which, as described above, we have also identified as
being amplified in ovarian cancer. LAR has been been
shown to be targeted to focal adhesions and to regulate
cytoskeletal function and interactions with extracellu-
lar matrix. Liprin was shown originally to be important
for targeting LAR to focal adhesions and for clustering
the PTP at these sites. This observation not only high-
lights the potential significance of LAR in ovarian can-
cer, but also, and more generally, introduces an inter-
esting extension of the primary project, i.e., an analy-
sis of the proteins that interact with the PTPs.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills A. Bagchi W. Keyes
E. Garcia C. Papazoglu
X. Guo Y. Wu
The Mills lab (see Fig. 2) designs and utilizes novel
models for elucidating the genetic and molecular basis
of human disease. Research areas include (1) the func-
tional identification of novel tumor suppressor genes
at Human 1p36 and (2) investigation of the role of the
p53-related protein p63 in development, cancer, and
aging.
THE QUEST FOR THE 1P36 TUMOR
SUPPRESSOR
Deletions encompassing 1p36, a portion of the
genome residing on human chromosome 1, were first
reported in 1977. Since that time, a number of studies
of late-stage tumors have indicated that 1p36 is fre-
quently deleted in a variety of human cancers, includ-
ing those of the brain and blood, as well as epithelial
malignancies such as those of the breast, colon, and
prostate. Although these observations suggest that an
important cancer-preventing gene resides at 1p36, this
tumor suppressive gene has not been identified. We
have been taking a functional genomics approach to
try to identify a tumor-suppressor mapping to 1p36.
We have been using chromosome engineering to gen-
erate models with gains and losses of the region of the
genome corresponding to human 1p36. Briefly, chro-
mosome engineering combines the power of gene tar-
geting with Cre /loxp technology and allows the gener-
ation of mouse strains that harbor precise rearrange-
ments such as deletions and duplications; these mod-
els have loss and gain of specific regions of the
genome, respectively. Using this approach, we identi-
fied a 4.3-Mb region of the mouse genome with potent
tumor-suppressive activity. Whereas loss of this region
rendered mice tumor prone, gain of this interval trig-
gered excessive tumor suppression (Fig. 1). Now that
we have pinpointed the region containing the tumor
suppressor, these models will be used to identify the
gene(s) within the region that functions as a tumor
suppressor. Identification of this gene is likely to have
a significant impact on our understanding of the
tumorigenic process.
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FIGURE 1 Engineerting chromosomes. We altered normal cells
so that they had one extra (left) or one fewer (right) copies of a
chromosome segment (representing human 1p36) than normal
cells. This caused added tumor suppression and increased
cancer, respectively.
FUNCTION OF THE p53 HOMOLOG p63
p63 Deficiency Is Tumor Protective. The discovery
that the p53 tumor suppressor is a member of a multi-
gene family that also includes p63 and p73 has
brought the p53 field into a new era. p63 is a tran-
scription factor structurally and functionally similar
to p53; in contrast to p53, however, p63 is rarely
inactivated in human cancers. In fact, the 3q27
region to which p63 maps is frequently amplified, or
p63 is overexpressed in the majority of epithelial
tumors, suggesting that p63 has oncogenic potential.
Several years ago, we identified p6.3 and generated
several p63-deficient mouse models. What was clear
from the phenotype was that despite the striking sim-
ilarities between p63 and p5.3, they perform very dif-
ferent functional roles in vivo: p63 is essential for
development of stratified epithelia, whereas p.53 is
dispensable during embryogenesis but functions as a
potent tumor suppressor in the adult. More recently,
we found that in contrast to the high incidence of
spontaneous tumors in p53+1- mice, p63 +1- mice were
not predisposed to cancer. In fact, p6.3 heterozygosi-
ty decreased the high tumor incidence of p53 +% mice,
indicating that haploid levels of p63 may even be
tumor protective. Loss of the wild-type p63 allele did
not occur and p63 expression was maintained in the
rare tumors that did develop in the p63 ±1- cohort.
p63 +/- mice were not even susceptible to chemical
carcinogens. This indicated that p63 does not per-
form a role equivalent to that of p.53 in tumor sup-
pression and that reduced p63 may provide a novel
tumor-suppressive mechanism, suggesting that mod-
ulation of p63-mediated pathways could offer an
effective strategy for anticancer therapy. We are cur-
rently working on how the six different p63 proteins
modulate cancer.
p63 Links Cellular Senescence and Aging. During
the course of the tumor study outlined above, we dis-
covered that p63+1- mice had a significant reduction in
life span and developed age-related pathology. Using a
conditional system to shut down p63 function specifi-
cally in proliferating cells of stratified epithelia such
as the skin, we discovered an unanticipated link
between p63, cellular senescence, and aging.
Remarkably, p63 deficiency activates a program of
cellular senescence and leads to accelerated aging.
This finding suggests a mechanism for the low tumor
incidence of p63+1.- mice: Cellular senescence effec-
tively removes aberrantly proliferating cells from the
proliferative pool, thus providing a tumor-suppressive
mechanism. A further understanding of how p63-
mediated pathways modulate the senescent process
and which of the different p63 isoforms modulates this
process is currently under way. This work will provide
a clearer understanding of cellular senescence that will
likely impact our ability to design more effective anti-
cancer regimens in the future.
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ESIS-MEDIATED TUMOR GROWTH
AND METASTASIS
ANGIOGEN
V. Mittal K. Amodeo K. McDonnell
K. Bambino A. Mel lick
D. Gao D.J. Nolan
J. Marku R. Stephan
In addition to malignant cancer cells, the tumor
microenvironment comprises nonmalignant cells that
regulate tumor progression, invasion, and metastasis.
Of the nonmalignant cells, the bone marrow (BM)-
derived hematopoietic and endothelial progenitor cells
(EPCs) offer significant proangiogenic activity.
Although the hematopoietic cells promote tumor
angiogenesis through the release of proangiogenic fac-
tors or by creating permissive conditions in the tumor
microenvironment that favor the growth of locally
derived blood vessels, the EPCs are believed to pro-
vide an alternative source of endothelial cells that
directly incorporate into nascent blood vessels as bona
fide endothelial cells. Despite the general importance
of these cells, the precise composition of specific indi-
vidual lineages and their relative contribution to tumor
angiogenesis remain poorly understood. However, the
existence of a BM reservoir of EPCs, and their
tive involvement in tumor neovascularization, has
attracted considerable interest because these cells rep-
resent novel targets for therapeutic intervention.
Our lab is using a multidisciplinary approach to
investigate the cellular and molecular mechanisms
governing blood vessel formation in tumors by de
novo recruitment of BM-derived EPCs. Our results
demonstrate that EPC-mediated neovascularization is
critical for the progression of both primary tumors and
metastatic lesions and suggest that EPC targeting may
offer a promising approach for cancer therapy. In the
last 3 years, we have systematically addressed these
issues by using a powerful combination of mouse
genetic models, functional genomics, and BM trans-
plantation (BMT) approaches. Using this strategy, we
have demonstrated the precise spatial and temporal
contribution of EPCs to the neovascularization of
growing transplanted and spontaneous tumors in vivo.
We have demonstrated that early tumors recruit BM-
derived EPCs that differentiate into mature BM-
derived endothelial cells and luminally incorporate
into a subset of sprouting tumor neovessels. Notably,
in later tumors, these BM-derived vessels are diluted
by an increase in non-BM-derived vessels from the
periphery, which accounts for purported differences in
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previously published reports. Importantly, specific and
selective ablation of EPCs in vivo by an a-emitting
radioimmunoconjugate, which targets an EPC-specif-
ic receptor, significantly reduced tumor growth as a
consequence of reduced EPC contribution and
decreased vessel density. These results not only have
demonstrated the biological role of EPCs in angiogen-
esis-mediated tumor growth, but have also suggested
an approach for preventing tumor growth by ablation
of one critical and specific component of the tumor
microenvironment. We have extended our analysis of
primary tumors toward elucidating the progression of
metastatic lesions. Although metastasis remains the
main cause of death in cancer patients, little is known
about the progression of micrometastases to
macrometastases in secondary organs. We have
demonstrated that a second angiogenic switch under-
lies the progression of avascular lung micrometastases
to vascular macrometastases. De novo contribution of
EPCs was observed in the neovascularization of these
progressing lesions. Importantly, ablation of EPCs did
not affect initial colonization by metastatic cells but
markedly impaired their progression into macroscopic
lesions as a consequence of reduced neovasculariza-
tion. Our progress in the last year is elucidated below.
Investigating the EPC Lineages
and Vascular Niche in the
BM Compartment
D.J. Nolan, K. Bambino
In last year's Annual Report, we described our
progress in understanding the spatial and temporal
contribution and the functional role of EPCs in the
neovascularization of a variety of tumors including
xenografts (B6RV2 lymphomas and Lewis lung carci-
noma) and an orthotopic tumor (B 16F0 melanoma).
More recently, this analysis has been extended to spon-
taneous breast tumor mouse models. Detection of BM-
derived EPCs in these models highlights their general
relevance in the process of tumor angiogenesis. The
biological function of EPC was discerned by ablating
them with an anti-VE-cadherin antibody that specifi-
cally recognized the monomeric VE-cadherin present
on EPCs, but not the homodimerized form present on
mature ECs. Cytotoxicity was enhanced by coupling
this antibody with radioisotope actinium (225Ac).
Ablation of EPCs reduced tumor mass, associated
with decreased vascular density, underscoring the crit-
ical role of EPCs in angiogenesis-mediated tumor pro-
gression.
In the last year, we have put our efforts in unravel-
ing hierarchies of the endothelial lineage in the BM
compartment. Elucidation of the endothelial lineages is
likely to provide insights into EPC biogenesis and fate
determination and may also lead to the identification of
endothelial "stem" cells capable of preferentially
repopulating the vascular compartment. We have begun
to identify endothelial lineages within the BM com-
partment by analyzing the Lin- c-Kit+ Seal+ (LKS)
population. Since the LKS population is known to con-
tain both the long-term and short-term hematopoietic
progenitors, we believe that it may also contain EPCs
with similar potential to reconstitute the endothelial
lineage. Further investigation of the LKS population
with respect to EPC markers (VEGFR2, VE-cadherin)
and progenitor markers (c-Kit, Seal) has revealed three
distinct populations in resting animals. Kinetic analy-
ses of these populations posttumor challenge have
begun to define hierarchical lineages and have unrav-
eled VEGFR2- VE- cadherin ScaI- Kitl+ cells as the
mobilizing population. The observation that the mobi-
lizing cells are VEGFR2- is paradoxical because cell
surface VEGFR2 has been demonstrated to have a role
in mobilization in reports by other investigators.
Further investigation of the recycling endosome path-
way determined that the VEGFR2 receptor was inter-
nalized in the mobilizing EPCs.
We have also determined that the VE-cadherin+
cells in the BM compartment give rise to mature
endothelial cells. Flow-sorted VE-cadherin+ Lin cells
(which also include -80% of VEGFR2+ cells) were
cocultured with mature endothelial cells in vitro. VE-
cadherin+ cells rapidly differentiated into endothelial
cells and incorporated into endothelial networks, con-
firming that they are part of a BM-derived endothelial
lineage. We are currently using flow sorted green fluo-
rescent protein (GFP+) EPC populations to determine
whether any of these EPC lineages can repopulate the
vascular niche and give rise to endothelial lineages.
Our future plans are to determine the long-term
reconstitution potential of these individual lineages
through serial transplantation experiments. We will
also investigate the EPC niche in the context of the
hematopoietic and osteoblastic niches within the BM
compartment and determine how the niche microenvi-
ronment regulates the balance between cellular self-
renewal and differentiation and, importantly, how
tumors influence migration of EPCs out of the niche.
BM-derived EPCs Regulate the
Progression of Micrometastases
to Macrometastases
D. Gao
In cancer patients, malignant tumor cells disseminate
from their site of origin, metastasize, and colonize dis-
tant organs. Following initial colonization, these
metastatic colonies usually remain microscopic or dor-
mant and may eventually progress into macrometas-
tases, leading to organ dysfunction and resulting in
death of the cancer patient. However, despite the clini-
cal importance of metastasis, the cellular and molecu-
lar mechanisms that govern macrometastases forma-
tion remain poorly understood. We have demonstrated
that the progression of micrometastaes to macrometas-
tases is mediated by an angiogenic switch, associated
with the de novo contribution of BM-derived EPCs.
EPCs are recruited to the sites of active neovasculariza-
tion via stromal-derived factor 1 (SDF1)-chemo-kine
receptor 4 (CXCR4) and VLA (integrin a4131)-VCAM
interactions. Generation of a loss of function in EPCs
with inducible RNA interference (RNAi)-mediated
suppression of Idl transcription factor did not effect
formation of pulmonary micrometastases but impaired
their progression into macrometastases and increased
overall survival of animals (Fig. 1). Our results demon-
strate that EPC-mediated neovascularization is critical
for metastasis progression, and suggest that therapeutic
targeting of EPCs may be promising in situations
where metastatic colonization has already occurred.
To Determine Transcriptional
and Posttranscriptional Events
Regulating Mobilization of EPCs
A. Mellick
Last year, we began to delineate molecular pathways
with respect to differentially regulated genes and
microRNAs (miRNAs) that are responsible for tumor-
induced EPC mobilization/differentiation. Candidate
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FIGURE 1 Inducible RNAi-mediated suppression of Idl in the BM progenitors impaired
macrometastases formation in the lungs. (A)
A representative fluorescent stereomicroscopic image depicting pulmonary metastases
(day 28) in a nonspecific shRNA (short hairpin
RNA) BMT mice (upper panel) and Id-I -shRNA BMT mice (lower panel) in the absence of Dox (-Dox) and presence
of Dox (+Dox). Bar,
20 givi. (B) Quantitation of the total number of micrometastases in the lungs of inducible
control nonspecific shRNA and Id-I shRNA
BMT mice at day 28 in the absence of Dox (-Dox) and presence of Dox (+Dox). (C) Quantitation
of macrometastases in the lungs of
inducible control nonspecific shRNA and Idl shRNA BMT mice at day 28 in the absence
of Dox (-Dox) and presence of Dox (+Dox).
genes such as helix-loop-helix transcription factor
Idl, chemokine receptor CXCR4, stromal-derived
factor SDF1, VE-cadherin, flk1NEGFR2, GATA2,
and Brn3a were identified. The expression of some of
these candidate genes was localized to the Lin- VE-
cadherin+ EPCs. To carry out functional analysis of
EPCs in vivo, we have begun to investigate the pro-
moters of these genes (Idl, VEGFR2, and VE-cad-
herin) for their ability to mark EPCs in vivo. The
proximal promoters were cloned and used to drive
two fluorescent markers (red fluorescent protein and
GFP). Of these, the Idl promoter was found to specif-
ically mark EPCs in the early BM, peripheral blood,
and the tumor.
We next investigated whether the exquisite property
of the Idl promoter to mark EPCs can be exploited for
cell-specific ablation or generating loss of EPC func-
tion. The Idl promoter was used to drive a suicide gene,
herpes simplex virus-thymidine kinase (HSV-TK).
Administration of ganciclovir specifically ablated EPCs
in TK BMT mice. EPC ablation impaired tumor growth
associated with reduced vessel density.
In another powerful approach, we have used RNAi
for suppressing the expression of EPC-specific genes
(e.g., Idl and VEGFR2) in vivo. Suppression of Idl or
VEGFR2 in EPCs resulted in mobilization defects and
impaired angiogenesis-mediated growth of tumors.
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Collectively, our results suggest that these promoters are
useful reagents for investigating EPC function in vivo.
In last year's Annual Report, we also described our
efforts in determining microRNA changes that may reg-
ulate EPC mobilization. We identified 53 microRNAs
as differentially regulated (at least twofold) in the Lin-
BM following tumor challenge. Detailed analysis of
these candidate microRNAs is being conducted in con-
junction with Exiqon, to localize microRNAs to EPCs
in the BM, blood, and tumor. We believe that the EPC-
specific promoter we have recently identified will allow
us to more closely understand which microRNAs might
be critical in EPC biology.
To Determine the Contribution
of Individual Oncogenes and Tumor
Suppressor Genes in the
Angiogenesis-mediated Progression
of Hepatocellular Carcinoma
K. McDonnell [in collaboration with S. Lowe, Cold Spring
Harbor Laboratory]
Oncogenes and tumor suppressors have been implicat-
ed in angiogenesis-mediated expansion of tumor mass.
For example, loss of certain tumor suppressors,
including p53, or oncogene activation, such as Myc, is
associated with robust angiogenesis resulting from
down-regulation of a negative angiogenesis regulator
thrombospondin 1 (TSP1), possibly via microRNA
17-92. Some activated oncogenes like EGFR or Ras
stimulate signaling pathways in cancer cells that cause
increased expression of the angiogenic factor VEGF
(vascular endothelial growth factor).
This project seeks to determine how oncogenes
and tumor suppressor genes impact tumor angiogene-
sis, particularly via recruitment of BM-derived prog-
enitor cells. As a mouse model of cancer, we are using
the hepatocellular carcinoma (HCC) model developed
in the Lowe laboratory. This model has allowed us to
rapidly develop spontaneous liver tumors driven by an
oncogene of choice, including Ras, Myc, Akt, or 13-
catenin. We are determining the windows of the
"angiogenic switch" in each of these tumors in order
to assess the spatial and temporal contribution of BM-
derived EPCs. The mechanisms by which these onco-
genes recruit BM-derived EPCs will be explored fur-
ther. The expansion and activation of BM cellular ele-
ments occur within BM stem cell niches. Presently,
the biology of these niches remains incompletely
characterized. We are anticipating that delineation of
the oncogene and tumor suppressor genes associated
with BM cellular mobilization will define molecular
pathways through which to further investigate the
physiology of these niches.
The elucidation of the oncogene and tumor sup-
pressor pathways associated with mobilization and
recruitment of BM cellular elements and the unveiling
of the biology of BM stem cells niches may identify
novel molecular and cellular targets for the develop-
ment of effective therapeutic strategies directed
against tumor angiogenesis.
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CANCER GENES
S. Powers A. Bak leh K. Nguyen
R. Kohnz J. Zhang
D. Mu
Cancer is caused by the accumulation ofgenomic dam-
age that affects a subset of human genes casually
involved in the cancer process. Genomic damage is ran-
dom, but the cancer process is not. Starting with a
slightly altered premalignant cell, fully malignant
tumors will evolve only if additional genomic alter-
ations provide distinct proliferative or survival advan-
tages. This Darwinian process, which mixes random
genomic alterations with selection for increasingly
malignant cells, results in tumors that contain different
configurations of genomically altered cancer genes.
Although this genomic heterogeneity is responsible for
the wide variation in cancer outcomes and therapeutic
responses, some of the cancer genes are commonly
altered in a significant percentage of tumors. A select
few of these commonly altered cancer genes-EGFR,
BCR-ABL, HER2-have provided the starting point for
several new highly effective cancer therapies.
can we find of these select cancer
genes? Clearly, it is important to detect as many
genomic alterations in tumor cells as possible. Toward
this end, our laboratory has in the past successfully
exploited the genome-wide DNA copy-number alter-
ation techniques developed by Mike Wig ler and Rob
Lucito here at CSHL to detect new cancer genes. This
year, in addition to continuing DNA copy-number
analysis, we have forged new collaborations with
CSHL scientists Rob Martiensen and Rob Lucito to
apply their methods for detecting promoter methyla-
tion, another type of genomic alteration, to the prob-
lem of cancer gene identification.
Is comprehensive detection of genomic alterations
enough to find these select cancer genes?
Unfortunately, no. Genomic damage frequently extends
over regions containing several genes, making it impos-
sible to pinpoint the true culprit by detection methods
alone. Fortunately, experiments that address the func-
tional importance of candidates can identify bona fide
cancer genes. Here, the rate-limiting factor is the exper-
imental approach itself, and we are very fortunate to
collaborate with Scott Lowe's laboratory on hepatocel-
lular carcinoma, as they have developed a highly effec-
tive, flexible mouse model for testing cancer genes that
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are operative in the liver. We are also fortunate that Greg
Hannon's laboratory has developed an extraordinarily
useful resource in the genome-wide RNA interference
(RNAi) libraries that contain ready-made RNAi mole-
cules to virtually every candidate cancer gene.
Currently, these systems are being used in a large-scale
systematic evaluation of hundreds of candidate cancer
genes culled from the list of genes that are deleted or
amplified in human liver cancer. We are extending this
type of systematic analysis to other tumor types as well.
Previously, we had used ROMA (representational
oligonucleotide microarray analysis) to discover a new
type of genomic instability in colon cancer (the dele-
tion syndrome). We continued our study of the gene
that is most frequently deleted in colon cancer and
determined that its deletion was a by-product of the
deletion syndrome and that it did not have any cancer-
related effect on the properties of the cell. Other genes
that are deleted are already known to be functionally
and clinically important, but this gene is very fre-
quently deleted without phenotypic consequence. It is
possible that this deletion may be useful diagnostical-
ly. We have drafted our manuscript on our findings on
this deletion syndrome, and this coming year, we will
publish our findings.
This year, we concluded a preliminary effort with
Dr. Sandy Markowitz at the Cleveland Clinic to use
ROMA to find genomic DNA copy-number alter-
ations which could distinguish primary colon cancer
that would not metastasize from colon cancer with
clear metastatic potential. Although we did find DNA
copy-number alterations that were more significantly
prevalent in metastatic colon cancers, they coincided
exactly with what had previously been discovered
using lower-resolution techniques (e.g., 8p loss and 8q
gain). We may go back to revisit this important diag-
nostic issue with newer genomic methodologies, but
our current primary focus is on functional studies of
genomically altered genes of high-interest. These
include a group of secreted proteins operative in liver
cancer and a set of what appear to be lineage-specific
oncogenes in lung cancer. Our goals in the next year
are to determine the degree to which these factors are
involved in their respective tumor types and whether
they do or do not provide a good starting point for
developing new cancer therapies.
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COPY-NUMBER ANALYSIS AND HUMAN DISEASE
M. Wig ler M. Chi L. Hufnagel
D. Esposito J. Kendall
V. Grubor A. Krasnitz
J. Hicks Y-H. Lee
J. Hicks E. Leibu
MAMMALIAN GENETICS
A. Leotta
J. Meth
L. Muthuswamy
N. Navin
D. Pai
We study variations in the human genome that arise
when a large segment of the genome is duplicated or
deleted. Such copy-number variations, or CNVs, can
arise somatically or in the germ line. The former are
often seen in cancer and distinguish cancers from the
normal cells of the body, in which case, they provide
clues for the origin and behavior of the cancers. The
latter, germ-line CNVs, distinguish individuals from
each other and may be inherited, in which case, they are
known as copy-number polymorphisms, or CNPs, or
they may arise spontaneously, in which case, they serve
as engines of creation ofhuman diversity and also can
cause devastating genetic disorders, such as autism.
Our studies are based on a high-throughput high-
resolution microarray technology developed at CSHL
called ROMA (representational oligonucleotide
microarray analysis), which itself was based on an ear-
lier technology developed at CSHL called RDA that
was used for genomic subtraction. ROMA is a form of
a more general technology called CGH, or compara-
tive genome hybridization. CGH is evolving, and part
of our laboratory works on technical improvements
and extensions, such as the use of ROMA to study
DNA methylation, and on more powerful statistical
methods for data interpretation. Part of the lab uses the
copy-number data and methylation status to study
solid cancers, especially breast cancer, and leukemias,
especially B-cell chronic leukemia (B-CLL). We seek
to identify the genes most frequently mutated in can-
cers and leukemias, to distinguish solid cancers from
each other, and in general to determine whether the
genomic data that we generate can be used to predict
the outcome of the disease and its response to therapy.
Finally, part of the lab studies CNV that may underlie
autism, congenital heart defects, and other profound
disorders of normal human development.
CANCER
Our studies of breast cancer have largely drawn upon
samples from two Scandinavian collaborations:
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M. Riggs
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J. Troge
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S. Yoon
Anders Zetterberg at the Karolinska Institute, Sweden,
and Anne-Lisa Borresen-Dale at the Radium Hospital,
Norway, and with Larry Norton at the Memorial
Sloan-Kettering Cancer Center (MSKCC), New York.
These studies have elucidated a set of loci, called epi-
centers, which are the recurrent sites for genome
amplification and deletion in breast cancer. The set of
breast cancer epicenters overlap with epicenters from
lung cancer (data from Scott Powers and David MU,
CSHL) but are clearly a distinct set. In fact, we can
distinguish breast cancers from lung cancers largely by
the loci involved in amplification and deletion, a
method that may be useful in a clinical setting. The
epicenters are locations where reside many of the
genes that will make good tumor markers or therapeu-
tic targets. Work in progress suggests that by dissect-
ing tumors, we may be able to determine the time
sequence of the amplifications and deletions, enabling
us to determine the earliest genomic events. In a col-
laboration with the laboratories of Scott Lowe, Scott
Powers, and Rob Lucito (all of CSHL), we have found
that animal models will be a further source of informa-
tion about these epicenters (Zender et al. 2006)
We documented a new form of genomic instability
that is very common in breast cancer. There is a good
correlation between the number of genomic events,
and the type of genomic instability, with survival
(Hicks et al. 2006). In working with Dr Zetterberg and
pathologist Kiki Tan at MSKCC, we have shown an
excellent correlation between CGH and fluorescent in
situ hybridization (FISH), a mainstay of clinical
pathology (see also Navin et al. 2006). CGH is in
many ways more reliable than FISH, and we anticipate
that FISH will be replaced by CGH, particularly for
tests that oncologists use to decide on treatment.
In collaboration with David Botstein and Robert
Pelham of Princeton Univesity, New Jersey, we have
used mouse ROMA (Lakshmi et al. 2006) to deter-
mine how many of the stromal cells of human tumors
transplanted in mice are likely to be both mutant and
clonal (Pelham et al. 2006). We do not know whether
these mutant stroma are selected by the tumor from
circulating cells or whether they become mutated dur-
ing stromal growth. But the results open up a new win-
dow on host-cancer interactions.
Our studies of B-CLL are a collaborative effort
with Nick Chiorazzi of North Shore University
Hospital, Manhasset, New York. In these studies, we
have used ROMA to identify essentially all the known
recurrent lesions that have been observed in that dis-
ease, as well as several new epicenters. We are in the
process of designing B-CLL "tiling" arrays that will
allow us to examine the leukemic epicenters at greater
resolution, so that we will be able to narrow the gene
candidates in each region and assess their recurrence
with greater accuracy. Such a B-CLL chip may enable
oncologists to rapidly assess the progression of the dis-
ease and guide decisions about therapy.
Utilizing a new microarray designed by Robert
Lucito here at CSHL, we have begun to assess the
methylation status of CpG islands in the genomes of
cancer and leukemia cells. These islands are rich in
sites for DNA methylation, and the status of methyla-
tion at these sites may be clues to cell lineage and can-
cer progression. Although still preliminary, the results
suggest that the vast majority of CpG islands in all cells
are partially methylated, and we can readily distinguish
cell-specific patterns by the small number of recurrent
sites that have become hypo- or hypermethylated. Only
a few of the islands change status as the tumors
progress. The clinical significance of these changes
remains to be evaluated. Nevertheless, we expect that
determination of methylation state in the DNA from a
biopsy can be used to determine the origins of a tumor,
as well as determine the cellular composition of a biop-
sy, both useful objectives in a clinical setting.
GENETIC DISORDERS
Since the seminal discovery that CNV is common in
the human gene pool (Sebat et al., Science 305: 525
[2004]; Iafrate et al., Nat. Genet. 36: 949 [2004]), in
collaboration with the laboratory of Jonathan Sebat
here at CSHL we have focused on the role of CNVs in
human disease and, in particular, on the role of sponta-
neous or de novo CNVs (see, e.g., Jobanputra et al.,
Genet. Med. 7: 111 [2005]). We tested the hypothesis
that de novo CNV is associated with autism spectrum
disorders (ASD). We performed CGH on the genomic
DNA of patients and unaffected subjects to detect
copy-number variants not present in their respective
parents. Candidate genomic regions were validated by
higher-resolution CGH, paternity testing, cytogenetics,
FISH, and microsatellite genotyping. Confirmed de
novo CNVs were significantly associated with autism
(P = 0.0005). Such CNVs were identified in 12/118
(10%) of patients with sporadic autism, in 2/77 (2%) of
patients with an affected first-degree relative, and in
2/196 (1.0%) of controls. Most de novo CNVs were
smaller than microscopic resolution. Affected genomic
regions were highly heterogeneous and included muta-
tions of single genes. These findings establish de novo
germ-line mutation as a more significant risk factor for
ASD than previously recognized and clearly point to a
new and potentially rich avenue of approach for the fur-
ther study of the genetic basis of the disorder (for
details, see Sebat's report in this volume).
Consonant with the finding of spontaneous CNVs
in humans, studies in mice (a collaboration with Ira
Hall at CSHL) have demonstrated that de novo CNVs
occur frequently in mice lineages (for details, see
Hall's report in this volume).
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CANCER: CELL BIOLOGY
Before a cell divides, it must first make an exact copy of its DNA. Bruce
Stillman's group studies the
process of DNA replication, focusing on how it is
regulated and how it is coordinated with other events
such as chromosome segregation during mitosis. First, the
cell must "know" where to begin copying.
DNA contains start sites called origins that direct the initiation of DNA replication.
Binding to these ori-
gins are large complexes of proteins that have a role in the process.
Recent work in the Stillman lab
has revealed that one such protein-Orcl -is involved in preparing
the mass of condensed DNA and
proteins known as chromatin for DNA replication.
Tatsuya Hirano studies how cells assemble and organize their
chromosomes in preparation for cell
division. His research focuses on two protein complexes, known as
cohesin and condensin, that are
structurally related to each other but have different functions in this process. During the
past year,
Hirano identified a new cohesin-binding protein, termed Wapl, and
studied how it regulates the dynam-
ic behavior of cohesin during cell division. His group showed that
Wapl helps remove cohesin from
chromosomes, thereby allowing two copies of each chromosome to split properly before
they are
transported into daughter cells.
David Spector and his colleagues have identified a messenger RNA that lingers uncharacteristical-
ly in the cell nucleus but can be rapidly released into the cytoplasm in response
to cellular stress (or
other signals) such as viral infection. The "cut-and-run" mechanism revealed by this study is a new par-
adigm of gene regulation that is likely to be broadly relevant to biology and biomedical research. It
establishes a role for the cell nucleus in harboring mRNA molecules that are not immediately needed
to produce proteins, but that are ready at a moment's notice to produce protein in response to stress
or other cellular signals. Ongoing studies are focused on identifying and characterizing additional nucle-
us-retained RNAs and elucidating their roles in regulating gene expression.
Cells register external signals and react with an internal response. Understanding this process of
"signal transduction" is key to understanding such fundamental cellular processes as growth, prolifer-
ation, differentiation, migration, and metabolism. Nicholas Tonks studies the coordinating and compet-
ing actions of proteins called protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs)
that are crucial for the regulation of signal transduction pathways. Furthermore, disturbance of this del-
icate balance between the activity of PTKs and PTPs has been shown to be a cause of human dis-
eases including cancer, diabetes, and inflammation. With this in mind, the focus of the Tonks lab is to
characterize the structure, modes of regulation, and physiological function of members of the PTP fam-
ily of enzymes. Tonks and his team are making progress in defining the functional links between par-
ticular PTPs and specific signaling pathways, with a view to establishing whether disruption of such
functions underlies disease and whether individual PTPs show potential as therapeutic targets.
Some clusters of abnormal or precancerous cells in the breast progress to malignancy, while others
remain benign. Senthil Muthuswamy studies why some precancerous lesions develop the loss of tis-
sue organization and increased rate of cell division that are the hallmarks of cancer. The goal of
Muthuswamy's lab is to identify new molecules and signaling pathways that are crucial for genetic
changes in breast tissue organization during the initiation and progression of cancer. He has developed
a three-dimensional tissue culture system that mimics the basic glandular structure of the breast. Using
this system, his group has identified a direct relationship between ErbB2, a gene known to be misreg-
ulated in nearly half of all breast cancers, and molecules that regulate cell architecture. ErbB2 appears
to inactivate proteins that help establish normal breast tissue structure. This ability of ErbB2 to disrupt
breast tissue organization may contribute to the observed disruption of normal tissue organization in
breast cancer.
Linda Van Aelst's research is focused on signal transduction pathways involving members of the
family of proteins known as Ras and Rho GTPases and the physiological processes they regulate.
These proteins have key roles in cellular activities controlling cell growth control, differentiation, and
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morphogenesis. Alterations that affect normal Ras and Rho function result in the development of sev-
eral diseases including cancer and neuropathologies. Van Aelst and her team made progress in 2006
in defining the role and mechanisms by which Ras and Rho family members exert their effects on
tumorigenesis and on neuronal development.
Arne Stenlund is using the papillomavirus replication system to gain a better understanding of the
crucial first steps of how DNA is copied in human cells. He has managed to recapitulate the assembly
of the viral "helicase," providing the first description of how such a protein-DNA complex is formed. The
helicase is the enzyme that unwinds DNA in preparation for DNA replication. Until now, little has been
known about precisely how this complex forms in human cells. Stenlund's efforts to dissect the heli-
case assembly process provide an opportunity to achieve a detailed understanding of the initiation of
DNA replication in mammalian systems.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano N. Aono I. Onn
R. Gandhi K. Shintomi
M. Hirano
The long-term goal of our research program is to
understand the molecular basis of chromosome segre-
gation during mitosis and meiosis. Central to this
process are two multiprotein complexes, known as
condensin and cohesin, that regulate chromosome
condensation and cohesion, respectively. The two
complexes are structurally related to each other and
contain members of a large family of chromosomal
ATPases, known as structural maintenance of chromo-
somes (SMC) proteins. Mutations in the subunits of
condensin and cohesin lead to genome instability in
many model organisms, and recent lines of evidence
implicate that subtle perturbation of condensin and
cohesin functions might be linked to developmental
diseases in humans. Our laboratory takes multidisci-
plinary approaches to understand how condensin,
cohesin and SMC proteins might work at a mechanis-
tic level both in vivo and in vitro.
Assembly and Subunit
Geometry of Human
Condensin Complexes
I. Onn, N. Aono, M. Hirano, T. Hirano
Vertebrate cells possess two types of condensin com-
plexes, termed condensin I and condensin II, that
have essential yet distinct roles in chromosome con-
densation and segregation. Both complexes share the
same pair of SMC2 and SMC4 subunits as their core
subunits, but they have different sets of three non-
SMC regulatory subunits (i.e., two HEAT-repeat sub-
units and a kleisin subunit). To better understand their
molecular architecture and mechanism of action, we
have reconstituted human condensin complexes from
their recombinant subunits. A reconstituted human
condensin I fraction functionally complements a
Xenopus egg extract that has been depleted of
endogenous condensin I. Subunit-subunit interaction
assays reveal that both condensin I and condensin II
have a pseudo-symmetrical structure, in which the
amino-terminal half of kleisin links the first HEAT
subunit to SMC2, whereas its carboxy-terminal half
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links the second HEAT subunit to SMC4. No direct
interactions are detectable between the SMC dimer
and the HEAT subunits, indicating that the kleisin
subunit acts as the linchpin in holocomplex assembly.
Construction and characterization of a panel of SMC
mutant proteins allow us to conclude that the assem-
bly and integrity of the complexes are ATP-indepen-
dent. Furthermore, a limited proteolysis assay sug-
gests that SMC2 may undergo large conformational
changes upon its binding to ATP. This study repre-
sents the first step in our long-time effort to dissect
the detailed mechanism of action of the chromosome
condensation machinery.
Specialized Functions of
Condensin II in DNA
Replication
N. Aono, T. Hirano
A previous genetic study in fission yeast suggested
that condensin I (the sole condensin complex in this
organism) may have a role in replication checkpoint
responses. In vertebrate cells, condensin I is
sequestered in the cytoplasm, whereas condensin II is
located within the nucleus during interphase. We
therefore hypothesize that it is condensin II, not con-
densin I, that may have an interphase function, if any,
in vertebrate cells. To test this hypothesis, we have
investigated the possible contribution of condensin II
to DNA replication in Xenopus egg-cell-free extracts.
We show that condensin II is not required for replica-
tion under unperturbed conditions but becomes
essential under stressed conditions. For instance,
DNA replication in the extracts is blocked in the pres-
ence of aphidicolin, but such a block is suppressed by
addition of caffeine, an inhibitor of checkpoint kinas-
es. It is thought that the so-called "dormant" origins
become activated under this stressed condition to
complete DNA replication. When condensin II, but
not condensin I, is depleted from the extracts, the
replication from the dormant origins becomes incom-
plete. This requirement for condensin II in dormant
origin replication is bypassed when the checkpoint
kinase (chkl) is depleted from the extracts. This is the
first indication that condensin II may have a special-
ized role in DNA replication in vertebrate cells.
Further studies will help unravel how condensin II
might regulate replication from dormant origins and
how the two condensin complexes might contribute to
maintaining the genome stability in distinct manners.
Role of Microcephalin in
Condensin Regulation
N. Aono, R. Gandhi, T. Hirano
Primary autosomal recessive microcephaly is a neu-
rodevelopmental disorder characterized by marked
reduction in brain size and mental retardation. The
MCPH1 gene, one of the genes responsible for
microcephaly, encodes microcephalin, a protein con-
taining multiple BRCT (BRCA1 carboxy-terminal)
domains. Cells from MCPH1 patient cells display a
unique cellular phenotype with premature chromo-
some condensation in early G2 phase and delayed
decondensation postmitosis. Our previous study
showed that this phenotype is caused by misregula-
tion of condensin II, but not of condensin I. To fur-
ther understand how microcephalin might regulate
condensin II, we have raised antibodies specific to
human microcephalin. We show that microcephalin
coimmunoprecipitates with condensin II from a
He La cell lysate. Less efficient coprecipitation is
observed in a mitotically arrested cell lysate, indicat-
ing that the interaction between condensin II and
microcephalin is cell-cycle dependent. We are now in
the process of expressing recombinant microcephalin
to test whether the interaction between the two com-
ponents is direct or indirect.
We also show that small interfering RNA
(siRNA)-mediated depletion of micocephalin in HeLa
cells causes premature chromosome condensation, a
phenotype reminiscent of that observed in the
MCPH1 patient cells. Although the cells depleted of
microcephalin undergo apparently normal mitosis,
the morphology of metaphase chromosomes prepared
from these cells is highly abnormal: They display
curly chromatid axes (reminiscent of condensing-II-
depleted chromosomes) and loosened centromeric
cohesion (reminiscent of condensing-I-depleted chro-
mosomes). These observations support the idea that
an intricate balance of the actions of condensin I and
condensin II determines the final architecture of
metaphase chromosomes. We anticipate that further
studies of microcephalin will help dissect the differ-
ential regulation of condensin I and condensin II dur-
ing the cell cycle.
Molecular Basis of
Sister-chromatid Cohesion
K. Shintomi, T. Hirano
The cohesin complex is composed of two SMC core
subunits (SMC1 and SMC3) and two non-SMC regu-
latory subunits (Sccl and SA1 /SA2). Although it has
been demonstrated that this complex has a central role
in sister-chromatid cohesion from yeast to humans,
very little is known about how it might work at a
mechanistic level. To fully understand the molecular
basis of sister-chromatid cohesion, we have reconsti-
tuted sub- and holocomplexes of cohesin from its
recombinant subunits. A panel of SMC mutant pro-
teins defective in their ATPase cycle has also been
constructed. Limited proteolysis assays using the
wild-type and mutant forms of the SMC1-SMC3
dimer suggests that the core subunits of cohesin
undergo large conformational changes upon binding
to ATP or DNA. We will extend this assay to the holo-
complex and address how the non-SMC subunits
might modulate the ATP- and DNA-dependent confor-
mational changes of the SMC dimer. To test the func-
tional relevance of the conformational changes, we
also plan to examine the behavior of the wild-type and
mutant forms of cohesin in Xenopus egg extracts,
which recapitulate the whole process of sister-chro-
matid cohesion in vitro.
Another yet related aim of this project is to
understand how the establishment of cohesion might
be coupled to DNA replication. Our effort is now
focused on Eco 1 , a class of replication-coupled reg-
ulator of cohesion that was originally identified in
yeast. Vertebrate cells have two different Eco 1 pro-
teins, known as EcolA/ESCO2 and EcolB/ESC01,
and mutations in the human ESCO2 gene cause
Roberts syndrome, a disorder characterized by
growth retardation and craniofacial anomalies.
Preliminary results show that Eco 1 A is the predom-
inant form in Xenopus egg extracts and that its asso-
ciation with chromatin is regulated during the cell
cycle. We are now exploring the functional contribu-
tion of Eco 1 A to sister-chromatid cohesion in this
system by immunological and biochemical
approaches.
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Wapl Regulates Sister-chromatid
Cohesion
R. Gandhi, T Hirano
In vertebrate cells, most of the cohesin complex is
removed from chromosome arms during mitotic
prophase in a manner dependent on two mitotic kinas-
es: Polo-like kinase 1 (P1k1)- and Aurora B. A small
amount of cohesin, which is concentrated at cen-
tromeres, escapes this removal and holds sister cen-
tromeres together until it is proteolytically cleaved at
the onset of anaphase by a specialized protease known
as separase. During the past year, we have focused on
the human ortholog of wings apart-like (Wapl), a gene
product originally identified as a potential regulator of
heterochromatin organization in Drosophila
melanogaster, and we have found that human Wapl is
a new cohesin-binding protein that promotes cohesin
removal during prophase. siRNA-mediated depletion
of Wapl in HeLa cells causes transient accumulation
of prometaphase cells. Chromosomes in these
prometaphase cells retain a high level of cohesin on
their arms, and their sister chromatids are poorly
resolved. This phenotype is relieved when the level of
cohesin is reduced in the Wapl-depleted cells.
Conversely, overexpression of Wapl causes premature
separation of sister chromatids. The Wapl protein
coimmunoprecipitates with cohesin from HeLa cell
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nuclear extracts. As judged by in vitro reconstitution
experiments, Wapl directly interacts with the regulato-
ry subunits of cohesin in a stoichiometric manner,
implicating its direct and noncatalytic contribution to
cohesin removal. Because premature separation of sis-
ter chromatids is a potential cause for aneuploidy, a
hallmark of many types of cancer and human genetic
diseases, future studies on this class of cohesin regula-
tors will enhance our understanding of how genomes
are stably maintained throughout the cell cycle and
transmitted across generations.
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EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy V. Aranda
K. Bergami
S. Chatterjee
A. Lucs
M. Nolan
A. Rosenberg
L. Zhan
Breast cancer is a leading cause of cancer death among
women. Current therapeutic strategies are mostly
aimed at controlling malignant breast cancers.
Although this strategy is helping patients by extending
their life span, in the end, the patients succumb to the
disease. I believe that there are alternative strategies
that can be exploited. If we can treat or control precan-
cerous lesions so that they never progress to form
malignant cancers, the patients can be maintained
tumor-free. The bottleneck in accomplishing this goal
is the almost complete lack of understanding of the
molecular mechanisms that regulate development and
progression of precancerous lesions. Our long-term
goal is to understand the molecular mechanisms that
are important for development of precancer and its
progression to cancer.
Increased rates of cell proliferation and disruption
of normal organization of epithelial cells are among
the principal changes observed in precancerous
lesions. Although changes in proliferation rates can
occur under normal physiological states such as preg-
nancy, disruption of epithelial organization is unique
to disease states. Thus, epithelial cells must possess
mechanisms that actively maintain normal tissue orga-
nization under normal physiological conditions, and
oncogenes must have gained ways to disrupt them.
Although significant inroads have been made toward
understanding how oncogenes increase cell prolifera-
tion, we do not understand how they disrupt epithelial
organization/architecture. I believe that a detailed
understanding of the mechanism by which oncogenes
disrupt cell organization/architecture will provide new
insights into understanding precancerous lesions.
Human-breast-derived epithelial cells grown as
monolayer cultures on plastic culture dishes are poor
models for investigating changes in epithelial organi-
zation, because they do not recreate the three-dimen-
sional organization observed in vivo. To overcome
this, we use a three-dimensional organotypic cell cul-
ture model using the nontumorigenic immortalized
human mammary epithelial cell line, MCF-10A.
MCF-10A cells cultured on a bed of basement-mem-
brane matrix resemble breast acini in vivo. Thus, the
cultured three-dimensional structures can serve as an
excellent platform to interrogate the molecular mech-
anisms by which oncogenes induce disruption of
epithelial organization.
Among the oncogenes implicated in breast cancer,
amplification of ErbB2/HER2, a receptor tyrosine
kinase, is observed in 25-30% of breast cancer and
correlates with poor clinical outcome. Expression of
ErbB2 in mouse models results in development of inva-
sive mammary tumors. Thus, ErbB2 serves as a model
for an oncogene, which can induce initiation and pro-
gression of tumors that end as an aggressive disease.
Since there is no known ligand for ErbB2, we use a
chimeric receptor that can be inducibly activated using
a small-molecule FKBP-dimerizing ligand (AP1510,
Ariad Pharmaceuticals). Activation of ErbB2 homod-
imers in MCF-10A three-dimensional structures
induced uncontrolled proliferation, prevented apopto-
sis, and disrupted epithelial organization, resulting in
formation of large multiple acini-like (multiacinar),
noninvasive structures that resemble early lesions with
atypia. This phenotype contrasts with other oncogenes
such as cyclin D1 that induce uncontrolled prolifera-
tion but fail to induce multiacinar outgrowths, suggest-
ing that ErbB2 must engage mechanisms to disrupt
epithelial organization/architecture.
RESEARCH PROGRESS
During the past year, we have made significant
progress. We discovered a new pathway used by ErbB2
to disrupt epithelial organization. In doing so, we have
defined a role for proteins that regulate apical-basal
polarity during transformation of epithelial cells orga-
nized as three-dimensional acini (Fig. 1). The polarity
proteins have now occupied a central place in our
research program because, as outlined below, they not
only regulate changes in epithelial organization, but
also regulate apoptosis and metastatic progression.
Thus, it is likely that either polarity proteins them-
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FIGURE 1 Par6-aPKC is required for ErbB2-induced disruption
of apical-basal axis of polarity in MCF10A three-dimensional
acini. Day-20 acinar structures stimulated with dimerizer for 4
days were immunostained for a cis-Golgi matrix protein, GM130
(Golgi). Nuclei costained with DAPI (nuclei). Arrows show mislo-
calization of GM130 to the lateral or basal (*) surfaces. Bar, 50
Rm. The images demonstrate that whereas activation of ErbB2
in the presence of active Par6-aPKC interaction disrupted api-
cal-basal localization of GM130 (A), absence of active ErbB2-
Par6-aPKC interaction blocked ErbB2-induced mislocalization
of GM130 (8).
selves, or pathways that regulate polarity proteins,
have a critical role during development and progres-
sion of precancerous lesions.
Polarity proteins and disruption of epithelial organi-
zation: We reported that ErbB2 interacts with compo-
nents of the Par epithelial cell polarity protein com-
plex during disruption of epithelial organization.
Interfering with the ErbB2-Par complex interaction
blocked the ability of ErbB2 to induce formation of
multiacinar structures but did not affect ErbB2-
induced cell proliferation. Thus, we identified polari-
ty proteins as mediators required for oncogene-
induced disruption of epithelial organization but was
dispensable for oncogene-induced proliferation.
Polarity proteins and apoptosis: During the course of
the above study, we made a surprising observation-
the ErbB2-Par pathway was not only required for dis-
ruption of three-dimensional epithelial organization,
but also required for ErbB2 to protect cells from apop-
tosis. Thus, regulators of cell polarity may provide a
survival advantage during cancer initiation. We fol-
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lowed up on this observation using Myc, an oncogene
that can induce proliferation but has the ability neither
to disrupt epithelial cell polarity nor to block apopto-
sis. Forced disruption of polarity by RNA interference
(RNAi)-mediated down-regulation of a polarity gene,
Scribble, protected cells from Myc-induced apoptosis.
To determine the in vivo relevance of this observation,
we used a mammary- fat -pad transplantation model
system to rapidly study genetic interactions during
mammary tumorigenesis. Loss of scribble protected
cells from Myc-induced apoptosis in vivo, demon-
strating that polarity genes have important roles dur-
ing tumorigenesis. The mosaic mouse model allows us
to establish the importance of the observations we
make using three-dimensional culture for mammary
tumorigenesis in vivo.
Polarity proteins and invasive progression:
Increasing loss of cell architecture is thought to be
associated with progression of precancerous lesions to
invasive cancers. It is possible that progression of pre-
cancerous lesions can be triggered by inducing
changes in cell architecture. To test this possibility, we
performed a genetic screen using a library of RNAi
vectors targeting expression of polarity genes to iden-
tify genes that can confer an invasive property to the
noninvasive ErbB2-induced multiacinar structures.
Loss of AF-6 was sufficient to promote invasion of
ErbB2-induced multiacinar structures. We are pursu-
ing this observation to understand the mechanistic
basis of this cooperation. Thus, pathways that regulate
polarity may have a critical role during both initiation
and progression of precancerous lesions.
Pathways and interactions specific to three-dimen-
sional organized epithelia: None of the above-men-
tioned relationships between ErbB2 and polarity genes
were observed in cells cultured as two-dimensional
monolayers. This prompted us to identify pathways
and interactions that are unique to cells within a three-
dimensional context, because such analysis can aid in
identification of novel targets that were not realized by
experiments in two dimensions. Microarray analysis
of changes in gene expression led to identification of
several gene expression changes unique to three-
dimensional culture. Our initial studies have identified
two novel interactions, one involving a protein tyro-
sine phosphatase, PTPRO, and another involving a
receptor tyrosine kinase, EphA2. How these mole-
cules, and their targets, regulate ErbB2-induced dis-
ruption of three-dimensional structures is currently
being pursued.
Thus, using a unique set of approaches we have
identified novel molecular pathways that critically reg-
ulate development and progression of precancerous
lesions. I believe that developing ways to treat and
control precancerous lesions will be an excellent com-
plement or an alternative to the current approaches to
control late-stage cancer.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector M. Camiolo M. HObner H. Sunwoo
Y.-C.M. Chen N. HObner R. Thakar
L. Denis I. Kumaran J. Wilusz
Y. Fang T. Nakamura M. Yuan
S. Hearn K.V. Prasanth R. Zhao
Most cellular processes can trace their beginnings to
the nucleus where a gene is activated, resulting in the
production of an RNA molecule that must get
processed and transported to the cytoplasm. Although
much biochemical information is available regarding
many of the factors involved in gene expression, the
spatial and temporal aspects of gene expression and
the dynamics of the nuclear domains that the gene
expression machinery occupies are less well under-
stood. During the past year, we have focused a signif-
icant amount of our efforts on two main areas: (1)
examining the mechanism by which epigenetic marks
are transmitted to daughter cells through the cell cycle
and (2) characterizing the dynamics of nuclear bodies
in mammalian cells and in living Arabidopsis plants.
In addition, we have continued our studies focused on
characterizing the role of noncoding RNAs in regulat-
ing gene expression.
Polycomb Bodies and Gene
Regulation
M. HObner, N. Hubner
The expression of the approximately 25,000 different
protein coding genes in the human genome needs to be
tightly regulated in a spatial and temporal manner that
is also cell-type specific. This regulation must be both
flexible in order to allow for plasticity during develop-
ment and differentiation and stable in order to maintain
cell identity during the lifetime of an organism. Genes
encoding proteins that are not required in a certain cell
type become inactivated through epigenetic mecha-
nisms. These mechanisms comprise chromatin modifi-
cations such as histone methylation, ubiquitylation, and
acetylation, as well as DNA methylation. Polycomb
group (PcG) proteins are essential components of the
epigenetic silencing mechanism. PcG proteins are
found in at least two complexes called polycomb repres-
sive complexes PRC-1 and PRC-2. The PRC-2 complex
is thought to be involved in the establishment of silenc-
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ing, whereas the PRC-1 complex is thought to be
involved in the maintenance of silencing. Members of
the PRC-1 complex localize in nuclear structures called
polycomb bodies. To date, little is known about the
dynamics and function of these bodies and how they
contribute to the inherited epigenetic state of a gene.
Using a human cancer cell line stably expressing the
yellow fluorescent protein (YFP)-tagged PRC-1 mem-
ber Bmi 1, we have shown that PcG bodies are remark-
ably static structures that show little movement and
remain inside very confined spaces in interphase nuclei.
Interestingly, PcG bodies remain associated with chro-
matin throughout mitosis (Fig. 1). Starting in prophase,
PcG bodies appear as doublets, presumably occupying
corresponding positions on sister chromatids. The dou-
blets align on the metaphase plate and during anaphase
move with the chromatids to the spindle poles.
Consequently, PcG bodies occupy the same genes in the
daughter cells, thereby providing a means for the mitot-
ically stable inheritance of the silenced state of genes.
We demonstrate that throughout mitosis, PcG bodies
colocalize with histone H3K27 dimethylation and
trimethylation but not K27 monomethylation or K9
trimethylation. In S phase, PcG bodies colocalize with
dimethylated and trimethylated H3K27 and occupy
mid-to-late replicating chromatin. We sought to induce
the formation of a new PcG body at a defined genetic
locus using our previously established cell line (Janicki
et al., Cell 116: 683-698 [2004]). Recruitment to that
locus of a Lad fusion of the PRC-2 histone methyl-
transferase EZH2, but not a catalytically inactive
mutant, leads to H3K27 di- and trimethylation of the
locus. Importantly, H3K27 trimethylation leads to the
colocalization of the PcG body component Bmi 1 with
the locus. We are currently investigating the functional
consequences that PcG body formation has on gene
expression and the epigenetically inheritable nature of
gene silencing by PcG proteins.
Our goal is to understand the mechanisms leading
to the induction and maintenance of the epigenetic
regulation of gene expression. A loss of regulation
results in the aberrant expression of genes and is often
raw data, single focus 3D image stack
projection of deconvolved 3D image stack over time
projection of
3D image stack
t=1 Omki 53sec 12mln 12sec t=14mIn 47sec
FIGURE 1 Live-cell imaging of a mitotic human U2OS osteosarcoma cell expressing YFP-tagged polycomb protein Bmi1 (dots).
Chromatin is visualized by mRFPcherry-H2B. A three-dimensional image stack (five images, 1 gm spacing) was acquired every 5
seconds and images from each time point are shown as projections. (From Michael HObner.)
the cause of uncontrollable cell proliferation. In fact, a
number of mutations in polycomb group proteins have
been associated with human cancers. Therefore, our
work will help to elucidate the basic underlying prin-
ciples of gene expression with the ultimate goal of
developing approaches to regulate genes whose
expression has been altered in disease.
Dynamics of PML Nuclear Bodies
during the Cell Cycle
Y.-C.M. Chen [in collaboration with C. Kappel and R. Ells,
DKFZ, Heidelberg, Germany]
Although the cell nucleus was once thought of as an
amorphous milieu containing little organization or
functional compartmentalization, more contemporary
studies have identified an increasing number of spe-
cialized domains or subnuclear organelles. In some
cases, these domains are dynamic structures, exhibit-
ing rapid protein exchange between the domain and
the nucleoplasm. To date, more than 12 different
nuclear domains have been identified. Ongoing stud-
ies in the laboratory are focusing on two of these
nuclear domains, promelocytic leukemia (PML)
nuclear bodies (PML NBs) and a newly identified
nuclear body in plant cells (see next section).
PML NBs have received much attention because
they display a more dispersed intranuclear pattern in
blast cells from individuals with acute PML carrying a
t(15,17) translocation involving a fusion of the PML
protein and the retinoic acid receptor-a. Retinoic acid
or arsenic trioxide treatment can induce complete
remission of the disease and results in reformation of
the PML bodies. In addition, PML NBs are modulated
by interferon or heat shock treatments, and they are
associated with the sites of initial DNA tumor virus
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transcription/replication in infected cells and are sub-
sequently disrupted at later stages in the infectious
cycle. A clear function for these bodies has as yet not
been established; however, roles in transcriptional reg-
ulation, as storage sites regulating the levels of active
proteins within the nucleus or as sites of active prote-
olysis, have been pursued.
To reveal the function of these NBs, we have been
particularly interested in their dynamics and how they
are segregated to daughter cells during the process of
cell division. We developed a U2OS cell line stably
expressing two different proteins that localize to PML
NBs: ECFP-PML1 (PML-V) and EYFP-Sp100. Live-
cell imaging (4D) revealed that 40% of PML NBs
exhibit rapid directed movement in prophase cells as
compared to only 12% in interphase nuclei. During
this period of time, and prior to nuclear envelope
breakdown, the dynamic PML NBs move freely with-
in the interchromatin space and Sp100 is still present
within the PML NBs. At later time points, PML NBs
fuse to form mitotic PML NBs, which contain signifi-
cant amounts of PML protein and low levels of Sp100.
From prometaphase to early G1, rapid directed move-
ments are significantly reduced and 90% of the PML
NBs move by diffusion. After cytokinesis, Sp100,
Daxx, and Hp 1 -a enter the daughter nuclei, prior to
the entry of PML protein; however, the formation of
PML NBs is initiated only after entry and multimer-
ization of the PML protein. Newly assembled PML
NBs appear only after a functional nuclear membrane
has been reformed. These studies suggest that chro-
matin condensation, upon entry into prophase of mito-
sis, results in a loss of tethering between regions of
chromatin and PML NBs, thereby resulting in their
increased dynamics. Upon chromatin decondensation
at the end of mitosis, PML NB formation initiates in
association with HP1-a. Future studies will examine
the molecular interactions necessary for the formation
of PML NBs.
NBs Involved in Pri-microRNA
Processing in Arabidopsis thaliana
Y. Fang
microRNAs (miRNAs) are important for regulating
gene expression in muticellular organisms. miRNA
processing is a two-step process; in animal cells, the
first step is nuclear and the second step is cytoplasmic,
whereas in plant cells both steps occur in the nucleus
via the enzyme Dicer-likel (DCL1). The miRNA pro-
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cessing pathway in Arabidopsis involves several pro-
teins including a zinc finger domain protein Serrate
(SE), DCL1, a double-stranded RNA (dsRNA)-bind-
ing domain protein Hyponastic Leaves 1 (HYL1), a
methyltransferase and dsRNA- binding domain protein
Hua Enhancer (HEN1), and the slicer Agronate 1
(AGO1). However, little is known about the cellular
basis of miRNA biogenesis. To determine the subnu-
clear organization of proteins involved in miRNA bio-
genesis, we generated transgenic Arabidopsis plants
expressing YFP- or cyan fluorescent protein (CFP)-
tagged SE, DCL1, and HYL1, each under the control
of their endogenous promoters. The functionality of
each fusion protein was determined by complementa-
tion of mutant phenotypes. Using live-cell imaging,
we found that DCL1 and HYL1 colocalize in discrete
nuclear bodies measuring 0.2-0.8 gm in diameter, as
well as being diffusely distributed throughout the
nucleoplasm. The number of bodies per nucleus
ranged from one to four. A population of DCL1 bod-
ies (-60%) localizes in close proximity to, but not
within, nucleoli. These bodies, which we refer to as
nuclear dicing bodies (D-bodies), differ from Cajal
bodies which contain components involved in small
interfering RNA (siRNA)-directed cytosine methyla-
tion at endogenous DNA repeats. Importantly, mutated
DCL1 (DCL1-9), in which the carboxy-terminal 73
amino acids of DCL1 (second dsRNA-binding
domain) were truncated, resulting in impaired function
in miRNA processing, failed to target to D-bodies. If
the D-bodies represent sites of miRNA biogenesis, pri-
mary (pri)-miRNAs should be recruited to these sites.
To directly track a pri-miRNA in the nucleus, an
amplified 245-bp genomic DNA fragment flanking
mi173 was fused upstream to 24 tandem MS2 transla-
tional operators (MS2 repeats) and introduced into
tobacco cells by coinfiltration with MS2 coat pro-
tein-YFP (MS2-YFP) and DCL1-CFP fusion proteins.
Upon induced expression of MS2-YFP, its binding
with the MS2 repeats allows the pri-miRNA to be
localized in the cells, whereas DCL1-CFP under the
control of its endogenous promoter was used as a
marker for D-bodies. pri-mi 173 was observed to be
enriched in D-bodies, indicating that pri-miRNAs are
recruited to D-bodies where the machinery for their
processing is enriched. If D-bodies are the nuclear
sites for the dicing reaction of DCL1, protein-protein
interaction of the respective proteins (DCL1 and
HYL1) should occur within D-bodies. We used bimol-
ecular fluorescence complementation (BiFC) to deter-
mine the locations in the cell nucleus where these pro-
teins interact. BiFC signals between DCL1, HYL1,
and SE were observed in D-bodies, while the signal in
the nucleoplasm was very low, suggesting that these
proteins predominantly interact in the nuclear D-bod-
ies. In contrast, mutant DCL1-9 showed no interaction
with SE, HYL1, or DCL1. On the basis of these data,
we propose that D-bodies are crucial for orchestrating
pri-miRNA processing in the nuclei of plant cells. Our
results provide significant insight into the function of
this nuclear body and to our understanding of how the
pri-miRNA processing machinery is organized in the
cell nucleus of living plants.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund X. Liu
S. Schuck
The papillomaviruses are a group of viruses that
infect and transform the basal epithelium inducing
proliferation of the cells at the site of infection. The
resulting tumors (warts) are in most cases benign and
will usually regress after some time, but certain types
of human papillomaviruses (HPVs) give rise to
tumors that are prone to progress toward malignancy,
especially frequently cervical carcinoma. Indeed,
HPV infection appears to be a necessary cause of
invasive cervical carcinoma and thus represents the
few firmly established links between viral infections
and the development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell
culture systems for analysis of the viral life cycle.
These viruses normally require specialized differen-
tiating cells that only with difficulty can be generat-
ed in cell culture. However, for bovine papillo-
mavirus type 1 (BPV-1), a convenient cell culture
exists where viral gene expression, oncogenic
transformation, and viral DNA replication can be
studied. Thus, BPV has become a useful model for
these aspects of the viral life cycle. The DNA repli-
cation properties of the papillomaviruses show some
unique and interesting characteristics. As part of their
normal life cycle, these viruses can exist in a state of
latency, which is characterized by maintenance of the
viral DNA as a multicopy plasmid in infected cells.
The copy number of the viral DNA is tightly con-
trolled, and the viral DNA is stably inherited under
these conditions. Papillomaviruses therefore provide
a unique opportunity to study plasmid replication in
mammalian cells. In addition, the viral DNA replica-
tion machinery represents one of the most promising
targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identi-
fication of the viral components that are required for
viral DNA replication. In recent years, we have
directed our attention toward the biochemical events
that are associated with initiation of DNA replica-
tion. We are studying the biochemical properties of
the viral El and E2 proteins and how these two pro-
teins interact with the viral origin of DNA replication
and with the cellular replication machinery to gener-
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ate initiation complexes. Our studies demonstrate
that the E 1 protein has all of the characteristics of an
initiator protein, including on recognition, DNA-
dependent ATPase activity, and DNA helicase activi-
ty. The transcription factor E2, whose precise func-
tion has remained more elusive, appears to serve
largely as a loading factor for El . Through direct
physical interactions with both El and the ori, E2
provides sequence specificity for the formation of the
initiation complex.
We are currently attempting to elucidate how the
El and E2 proteins orchestrate the precise biochemi-
cal events that precede initiation of DNA replication
at the viral ori. These events include binding of the
initiator to the ori, the initial opening of the DNA
duplex (melting), and the assembly and loading of
the El replicative helicase at the replication fork. Our
studies so far indicate that these activities are gener-
ated in an ordered process that involves the sequen-
tial assembly of El molecules on the ori. This
sequential assembly generates different complexes
with different properties that in turn recognize ori,
destabilize the double helix, and function as the
replicative DNA helicase.
MUTATIONAL ANALYSIS OF THE El DBD SURFACE
The DNA-binding domain (DBD) of the El protein
clearly is responsible for the site-specific DNA bind-
ing of the El protein. This site-specific DNA binding
is responsible for recognition of the origin of DNA
replication in the viral genome. Furthermore, on the
basis of both structural and biochemical studies of the
El DBD, the DBD also provides the dimerization sur-
face for the El protein and also contains an interaction
surface for the DBD from the E2 protein. In addition,
imaging analysis of, for example, SV40 T antigen indi-
cates that the El DBD likely takes an active part in for-
mation of large complexes such as the double hexam-
er, which appear to be the entity that unwinds the ori-
gin of DNA replication.
To identify additional functions in the DBD we
have performed a complete surface mutagenesis of the
El DBD. On the basis of the high-resolution structure
of the El DBD, we have substituted 63 surface
residues for alanine, avoiding areas known from the
structural analysis to be involved in DNA binding and
dimerization. After screening these El mutants for
expression and for in vivo DNA replication activity,
we were able to identify 16 mutants with defects in
DNA replication. Four of these mutants were defective
for expression in vivo, whereas the remaining 12 gave
rise to wild-type levels of full-length protein.
To determine which biochemical functions might be
defective in these mutants, we expressed the 12 mutant
El proteins in Escherichia coli and purified them. We
tested these mutants in different in vitro assays related
to DNA replication. From the behavior of the mutants in
these assays, we could group these mutants into four
categories depending on which aspect of DNA replica-
tion was affected by the mutation. The results from in
vitro DNA replication were particularly informative. Of
the 12 mutants, 8 had severe defects for in vitro DNA
replication. These mutants clearly had biochemical
defects for replication-related processes. The remaining
four mutants (Group I) still had activity for replication
in vitro. These mutants are therefore likely to affect
processes that are only required for DNA replication in
vivo, such as regulation of viral DNA replication, for
example, by cell cycle mechanisms.
Despite our efforts to avoid residues involved in
DNA binding, four substitutions (Group II) had slight
defects for DNA binding, most likely because these
mutants affected the structure of the El DBD.
Although these four mutants may also affect other
activities, such effects would be obscured by the defect
for DNA binding. A third group (III) consists of two
mutants that have wild-type activity for all of the bio-
chemical activities that we can measure, with the
exception of in vitro DNA replication. These two
mutants are likely to affect a function required only for
DNA synthesis, such as the interaction with cellular
DNA replication factors. The final and fourth group
consists of two mutants that have specific defects in
the formation of the double trimer and double hexam-
er. These mutants also show the expected defects for
unwinding activity.
It is apparent that there are many ways to disable
the DNA replication activity of the El protein, which
is a testimony to the multitude of diverse functions that
this class of protein encodes. It is surprising, however,
that so many of these activities appear to depend to
some extent on the El DBD. This provides good evi-
dence that the El DBD takes part in many biochemi-
cal activities that previously have been considered to
reside in other domains.
ADJACENT RESIDUES IN THE CONSERVED
El INITIATOR 0-HAIRPIN DEFINE DIFFERENT
ROLES OF THE 0-HAIRPIN IN LOCAL ORI MELTING,
HELICASE LOADING, AND DNA HELICASE ACTIVITY
The mechanism through which local on melting is
achieved is not understood for any replicon. As report-
ed last year, we have recently identified a specific
form of the papillomavirus El initiator protein that is
associated with local on melting. This form, a double
trimer (DT), is a required precursor for the double
hexameric (DH) helicase and forms in the presence of
ATP. On the basis of mutational analysis of the heli-
case domain of the El protein, a specific structural
element, a [3-hairpin, is specifically required both for
the formation of the DT and for template melting.
Mutation of H507 at the tip of the 0-hairpin to alanine
results in loss of both DT formation and on melting.
To determine the specific role of this residue, we
substituted the histidine with a wide range of residues,
including A, V, L, R, N, M, F, and Y, and tested these
mutant El proteins for DNA replication in vivo and in
vitro. In vivo DNA replication assays demonstrated
that only H507F had significant replication activity.
DNA replication assays in vitro, however, showed that
both H507F and H507Y had activity similar to that of
the wild-type protein, whereas the rest of the substitu-
tions lacked activity. To determine at which step in ini-
tiation of DNA replication the H507 has an essential
role, we tested the H507 substitutions in a variety of
assays that we have developed. By using EMSA (elec-
trophoretic mobility-shift assay) we determined that
the wild-type El, H507F, and H507Y all could form
the DT complex. However, only the wild-type El and
H507F could form the DH helicase. Because of the
location of the 0-hairpin on the inside surface of the
hexameric ring, we also tested all of the mutants for
DNA helicase activity.
Although we could observe slight (less than
twofold) differences in helicase activity of some H507
substitutions compared to wild-type El, a helicase
defect is not responsible for the replication defect of
these substitutions, since H507F, which is the only
mutant with wild-type replication activity, had among
the lowest activities. In contrast, mutation of the
neighboring residue, K506, resulted in complete loss
of DNA helicase activity, demonstrating that this par-
ticular residue is required for the helicase.
These results provide a clear demonstration that
the 0-hairpin is directly involved in both local on
melting and helicase activity of El and that mutation
of neighboring residues distinguishes between these
two activities. H507 is required specifically for local
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on melting, whereas the adjacent residue, K506, is
required for both local melting and DNA helicase
activity. Consistent with these results, an alignment of
known SF3 helicases demonstrates that K506 is well
conserved in both papovaviruses and parvoviruses, in
agreement with the importance of this residue for the
helicase activity of these proteins (Fig. 1A). In con-
trast, H507 is only conserved in the papovavirus
group. This distinction between the papovavirus and
parvovirus groups is consistent with the fact that
papovaviruses have double-stranded DNA genomes,
whereas the parvoviruses have single-stranded DNA
genomes and therefore do not require a local on melt-
ing activity.
These results now provide an explanation for how
the local melting activity and the helicase activity are
linked (Fig. 1B). In the DT, which initially melts the
double-stranded DNA, the [3-hairpin, and specifically
H507, is involved in melting the double-stranded
DNA, most likely through a direct interaction with the
DNA. As the DNA is melted, additional E 1 molecules
are recruited to the complex and as the helicase is
formed, K506 in the 13-hairpin now contacts the single-
stranded DNA in the helicase. This scheme provides
an explanation for the transition between the local on
melting activity and the helicase activity and provides
a novel mode of helicase loading in that the E 1 heli-
case, in essence, loads itself through the DT precursor,
which melts the DNA template.
MECHANISM OF LOCAL ORI MELTING IN
PREPARATION FOR INITIATION OF DNA
REPLICATION
Although local on melting is an essential process in all
organisms, surprisingly little information is available
about the process and the types of activities that per-
form the melting. For many years, it has been known
that in prokaryotes, the protein DnaA is responsible
for on melting, although the mechanism is not under-
stood. In eukaryotes, no activity has been identified
that melts the on in preparation for DNA replication.
Viral initiator proteins such as the El protein from
papillomaviruses have long been known to be respon-
sible for local on melting, as detected by oxidation of
unbase-paired T residues in the ori, although the
mechanism is not known.
To define the local ori melting process, we have
examined this process in detail, including the
sequence dependence for local melting. We have
determined that local melting is not a single event but
consists of several events that happen in sequence.
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FIGURE 1 (A) The [3- hairpin generates the substrate for helicase
loading. Sequence alignment of the B' and C motifs of represen-
tative members of the SF3 helicase family. Shown above the
alignment is the relative location of SF3 signature motifs in BPV
E1. The number above each motif corresponds to the starting
and end residue number of each motif in BPV E1. The residue at
the tip of the [3- hairpin (H507) is marked with an asterisk.
Included in the comparison are BPV-1 El (bovine papillomavirus
type-1 El protein), HPV-18 El (human papillomavirus type-18 El
protein), SV40 TAg (simian virus 40 large T antigen), AAV-2 Rep
(adeno-associated virus type-2 Rep 40 protein), ADVG NS1
(Aleutian mink disease parvovirus [strain G] NS1 protein), FPV
NS1 (feline panleukopenia virus NS1 protein), PAVBO NS1
(bovine parvovirus NS1 protein), and PAHVB NS1 (human par-
vovirus B19 NS1 protein). (B) Model for the transition between
the El DT complex, which melts DNA, and the El DH, which
unwinds DNA:El forms a DT and H507 at the tip of the I3-hair-
pin intercalates into the DNA in the minor groove. The DT-DNA
complex is the substrate for formation of the DH, which forms on
one of the melted strands, and K506 at the tip of the hairpin inter-
acts with single-stranded DNA. For simplicity, only one trimer and
one hexamer is shown.
The earliest event is carried out by a DT of E 1. The
helicase domain in the E 1 protein specifically recog-
nizes a stretch of six T-A base pairs that flank the E 1 -
binding site.
Surprisingly, this recognition occurs in the minor
groove and results in local melting of the six T-A base
pairs. As expected from this result, the six T-A base
pairs are also essential for formation of the DH, for
unwinding of the ori, and for DNA replication in vivo.
In addition to melting of the six T-A base pairs, which
likely results from a direct interaction between the El
13-hairpin and the six T-A base pairs, the six T-A base
pairs also direct melting 5-6 by away from the T-A
base pairs, toward the El binding site (BS). This melt-
ing is likely generated by interaction of the oligomer-
ization domain in El and the DNA. These events
account for melting of about 15 by on each side of the
El BS. The El BS is clearly melted by a different
mechanism, most likely by untwisting of the DNA by
the two trimers.
Together, these data suggest a simple model for
how El may be able to melt large regions of DNA
using simple means. One consequence of the dual
interactions of each El molecule with DNA is that
each interaction need only be responsible for melt-
ing of a few base pairs since a total of six El mole-
cules and 12 interactions are involved in melting in
the El DT.
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DNA REPLICATION AND CHROMATIN INHERITANCE
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Chromosomal DNA replication in eukaryotes is a
highly regulated process that involves the licensing of
chromosomes prior to S phase for subsequent initia-
tion of DNA replication at origins. The licensing
occurs at specific sites on DNA by the formation of
prereplicative complexes (pre-RCs). A central compo-
nent of the pre-RC is the origin recognition complex
(ORC) that recruits Cdc6, Cdt 1 , and MCM proteins to
form a stable pre-RC at each origin. This assembly
occurs in telophase of mitosis in rapidly proliferating
cells or in G1 phase in cells stimulated to replicate
from a period of quiescence. Later in G1 phase, upon
commitment to cell division, cyclin-dependent kinase
(CDK) and Cdc7-Dbf4 protein kinase (DDK) are acti-
vated and stimulate assembly of preinitiation complex-
es that then recruit the DNA polymerases and their
accessory factors to replicate the DNA from each ori-
gin. Origin activation, or firing, occurs in a predeter-
mined temporal order that is specific to each cell type.
Moreover, DNA replication is spatially regulated in
the S-phase nucleus.
Previous genetic studies have shown that the Cdc7-
Dbf4 protein kinase (called DDK for Dbf4-dependent
protein kinase) is required for the initiation of DNA
replication at each origin that is licensed by a pre-RC.
The action of DDK is triggered by the synthesis of the
Dbf4 subunit in late G1 phase of the cell division cycle.
From our previous research, and that of other investiga-
tors, it was known that DDK can phosphorylate the
MCM (minichromosome maintenance) proteins in
vitro. The six different, but sequence-related, MCM
subunits form a hexamer structure that is similar to the
virus-encoded DNA helicases such as SV40 T antigen
or the papillomavirus El (see reports by A. Stenlund
and L. Joshua-Tor). Genetic studies by other investiga-
tors had demonstrated weak suppression of a cdc7 null
allele by a mutation in the MCM5 gene (mcm5b0b/),
suggesting that activation of the MCM hexameric com-
plex is a downstream consequence of activation of
DDK. The problem was that we had demonstrated that
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of the six MCM subunits, Mcm5 was not a substrate
for DDK in vitro, whereas Mcm2, Mcm4, Mcm6, and
Mcm7 were good substrates in vitro. Prior attempts to
map the DDK phosphorylation sites and demonstrate
that they were important DDK phosphorylation sites in
vivo had not resulted in conclusive evidence that MCM
subunits were the key DDK targets. Our experiments
during the past year have addressed this issue and have
elucidated a mechanism for how DDK recognizes
some of its key substrates.
One of the proteins that binds the MCM hexamer
is Cdc45, a protein that we had previously shown to be
loaded onto origins of DNA replication only after acti-
vation of both CDK and DDK kinases in late G1 phase
of the cell cycle. Immunoprecipitation experiments
showed that Cdc45 associated tightly with the MCM
hexamer in S phase and only on chromatin. Soluble
Cdc45 did not associate with the MCM complex.
More interestingly, the Mcm4 subunit in the Cdc45 -
MCM complex was hypophosphorylated. The appear-
ance of the phosphorylated form of Mcm4 was depen-
dent on DDK activity in vivo. The Mcm4 subunit of
MCM was a substrate for DDK phosphorylation in
vitro, and we mapped the phosphoacceptor sites to the
amino-terminal 174 amino acids of the Mcm4 subunit.
This region is predicted to be unstructured and is rich
in serine (S) and threonine (T) residues (S/T constitute
29% of the first 174 amino acids in Mcm4 in
Saccharomyces cerevisiae) and is also rich in acidic
amino acid residues. This 174-amino-terminal frag-
ment was sufficient as a substrate for DDK, but the
phosphorylation was very weak compared to the full-
length Mcm4 protein, and multiple phosphorylation
sites were not observed. A small region of the Mcm4
protein, lying immediately colinear to the amino-ter-
minal region, was found to be a binding site for the
DDK, and when this binding site was combined with
the S/T-rich region, the phosphorylation by DDK was
as efficient as the full-length Mcm4 protein.
Moreover, phosphorylation on multiple sites was
shown to be processive, with the DDK enzyme
remaining bound to the substrate while phosphorylat-
ing multiple sites in the adjacent amino-terminal 174
amino acids. Thus, phosphorylation of Mcm4 requires
the binding of DDK to a region of Mcm4 that is itself
not a phosphorylation target, but which promoted
phosphorylation of an adjacent S/T-rich sequence.
Foreign S/T-rich amino acid sequences could substi-
tute in vitro and in vivo for the S/T-rich domain of
Mcm4, as long as the DDK-binding site was intact.
Mutations in the Mcm4 amino terminus were
defective for loading Cdc45 onto chromatin, and this
phenotype could be complemented by expression of
Mcm4 derivatives containing artificial phosphoaccep-
tor sites or by conversion of S/T residues to aspartic
(D) residues, thereby mimicking phosphorylation.
These results demonstrated that Mcm4 (and possibly
Mcm2 and Mcm6) phosphorylation is a functional tar-
get of DDK in vivo and that this phosphorylation was
key to recruitment of Cdc45 to the MCM complex.
Activation of MCM protein as a DNA helicase has
recently been shown by other investigators to require
Cdc45 and the GINS protein complex, and thus, we
have suggested that activation of MCM helicase
requires DDK. These studies have uncovered a key tar-
get of DDK, but there are almost certainly other sub-
strates that are important for cell cycle progression.
We have used the biochemical information gained by
studying the Mcm4 target to search for other DDK tar-
gets in a biochemical screen. To date, a number of
interesting candidates have emerged.
In addition to regulation at the G1 /S -phase transi-
tion of the proteins that are involved in DNA replica-
tion, the production of the building block precursors
for DNA synthesis is also highly regulated. These
deoxyribonucleoside triphosphates (dNTPs) that are
used by DNA polymerases are synthesized from
ribonucleoside diphosphates (NDPs) by the enzyme
riboncleotide reductase (RNR) to produce dNDPs that
are rapidly phosphorylated to dNTP. RNR in eukary-
otes is one of the most highly regulated enzymes
known. Production of the RNR1 subunit is controlled
by transcription of the RNR1 gene only in G1 phase,
and the protein itself is proteolytically degraded after
S phase is completed. Furthermore, a protein inhibitor
of RNR called Sml 1 blocks any RNR activity present
in G1 phase. Finally, the RNR enzyme is controlled by
feedback inhibition by one of the end products of the
reaction, dATP. Thus, cells go to extraordinary lengths
to make sure that dNTPs are only produced in S phase
when the synthesis of chromosomal DNA occurs. This
raised the obvious question of why was all of this reg-
ulation necessary?
We investigated the consequences of deregulation
of RNR so that it could produce high levels of dNTP
throughout the cell division cycle in the yeast S. cere-
visiae. This was achieved by the controlled overex-
pression of an Rnr 1 subunit that had a mutation in the
dATP feedback control site (rnrD57R). When this pro-
tein was induced, the high levels overcame the Sml 1
inhibition and sufficient enzyme was active to produce
30-fold higher dNTPs than present in normal cells.
This high dNTP level dramatically slowed entry into S
phase and inactivated the checkpoint regulation in
response to DNA damage. Checkpoint control ensures
that cells do not progress through S phase when DNA
damage is present in cells. If this regulatory pathway
is blocked, DNA damage is copied, thereby promoting
genome instability.
Moderately high, constitutive dNTP levels in yeast
cells were lethal when the number of active origins of
DNA replication was reduced by a mutation in one of
the origin recognition complex (ORC) subunits. The
particular ORC subunit mutants used reduce the num-
ber of origins that are active in any given cell, but nor-
mally, cells survive because of the redundancy of ori-
gins of DNA replication in chromosomes. When, how-
ever, dNTP levels were moderately overexpressed,
these cells died.
These results suggest that dNTP levels regulate the
initiation of DNA replication and progression through
S phase. DNA-damage checkpoint pathways normally
monitor the progression of chromosome replication
through S phase. Therefore, one possibility is that
dNTP directly regulates the activity of these checkpoint
pathways. Alternatively, dNTP levels could directly
regulate pre-RC proteins to control the process of initi-
ation of DNA replication. We have shown that both
ORC and Cdc6 are ATPases required for assembly of
pre-RCs and for the subsequent steps of initiation of
DNA replication. dNTP activity could control the
ATPase activity of one or more of the pre-RC proteins,
thereby linking DNA synthesis to production of the
building blocks used by DNA polymerases. A final
possibility is that the dNTP may control one of the reg-
ulators of progression into or though S phase, such as
DDK. Since DDK regulates the initiation of DNA
replication at each origin of DNA replication and also
monitors progression through S phase by its associa-
tion with the checkpoint protein Rad53, it is possible
that the activity of DDK may be controlled by dNTP
levels. Such possibilities are under investigation.
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In addition to studying the biochemistry and control
of DNA replication in yeast, we have continued our
studies on the role of ORC and other pre-RC proteins in
human cells. We have shown that unlike the yeast ORC,
the human complex is dynamically regulated through-
out the cell division cycle. Of particular interest is the
role of human Orc 1 in the process of assembly and con-
trol of ORC localization during the cell cycle. In human
cells, ORC subunits also participate in DNA replication,
centrosome duplication, and the function of cen-
tromeres and kinetochores during mitosis and during
cytokinesis. The human cell ORC is a dynamic complex
during the cell division cycle. For example, the Orc 1
subunit is degraded by a Skp2-dependent, ubiquitin-
mediated process at the G1 /S -phase transition.
Interestingly, Ore 1 localization in the nucleus of G1-
phase cells varies as cells progress toward commitment
to cell division and S phase. The spatial and temporal
patterns of Orc 1 localization in the nucleus anticipate
the pattern of MCM localization and DNA replication
in S phase after activation of the CDK and DDK. These
studies show that ORC participates in spatial-temporal
patterning of the nucleus in newly born cells.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
N .K. To n ks J.N. Andersen N. Gorovits L. Li
B. Boivin A. Hague G. Lin
D.A. Buckley S. Hinton A. Piccini
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects the activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
family of protein tyrosine phosphatases (PTPs),
which, like the kinases, comprise both transmembrane
receptor-linked forms and nontransmembrane cyto-
plasmic species and represent a major family of sig-
naling enzymes. We are integrating a variety of exper-
imental strategies to characterize the physiological
function of members of the PTP family. Disruption of
normal patterns of tyrosine phosphorylation has been
implicated in several human diseases. Therefore,
insights into the mechanisms involved in modulating
PTP function may ultimately yield important informa-
tion to help counter such diseases.
During the last year, Jannik Andersen left the lab
to take up a Project Leader/Senior Scientist position at
Merck Research Labs, and Zhong Yao joined the
University of British Columbia as a Research
Associate. Li Li joined the lab as a postdoctoral fellow
from Albert Einstein School of Medicine.
DEFINING THE "PTPOME"
Unlike the protein kinases, which are derived from a
common ancestor, the protein phosphatases have
evolved in separate families that are structurally and
mechanistically distinct. During the past couple of
years, we defined the composition of the PTP family in
humans and other organisms. The PTPs, which are char-
acterized by the active-site signature motif HC(X)5R,
are divided into the classical pTyr-specific phosphatases
and the dual specificity phosphatases (DSPs). There are
38 classical ptp genes encoding receptor-like proteins,
which have the potential to regulate signaling directly
through ligand-controlled protein dephosphorylation, as
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well as nontransmembrane cytoplasmic enzymes. There
are approximately 65 genes encoding a heterogeneous
group that are broadly described as DSPs. In general,
they share the same catalytic mechanism as the classical
PTPs, but the construction of the DSP active site allows
them to accommodate pSer/pThr residues as well as
pTyr residues in proteins. Nonetheless, in terms of phys-
iological function, the "DSPs" may actually show pref-
erence for either Tyr or Ser/Thr residues. Some even tar-
get nonprotein substrates such as inositol phospholipids
and RNA.
Overall, there are about 100 human ptp genes,
compared to 90 human protein tyrosine kinase (PTK)
genes, suggesting similar levels of complexity between
the two families. However, the number of genes only
illustrates the minimal level of complexity in the fam-
ily, with additional diversity introduced through use of
alternative promoters, alternative mRNA splicing, and
posttranslational modification. This structural diversi-
ty is indicative of the functional importance of the
PTPs in the control of cell signaling. It is now appar-
ent that the PTPs have the capacity to function both
positively and negatively in the regulation of signal
transduction. Furthermore, the PTPs have the potential
to display exquisite substrate, and functional, speci-
ficity in vivo. Therefore, the definition of the
"PTPome" provides a foundation for detailed analyses
of the structure, regulation, and physiological function
of the members of the PTP superfamily as critical
modulators of signal transduction.
RNA interference is a powerful approach for con-
ducting loss-of-function analyses as a method for
examining the physiological function of particular pro-
teins in mammalian cells. Having defined the compo-
sition of the PTP superfamily in humans during the
past year, we have now designed and constructed a
library of short hairpin RNA (shRNA) constructs that
will allow us to examine systematically the function of
individual PTPs in a variety of cell systems. We are
using the pMLP retroviral expression vector produced
in Scott Lowe's lab here at CSHL. The construct uti-
lizes a murine stem cell virus (MSCV) backbone. The
hairpin is incorporated into the sequence of the human
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microRNA-30 (miR30), which facilitates processing of
the expressed hairpins. A puromycin resistance marker
and green fluorescent protein (GFP) are also expressed
from an internal ribosome entry site (IRES), to enrich
small interfering RNA (siRNA) expressing cells and
generate stable lines. The construct we will use, in
which the modified miR30 is expressed from the viral
long terminal repeat (LTR), has been shown to work
effectively for both transient and stable expression. In
future follow-up studies, we may also use a construct
from which the shRNA is expressed conditionally.
We are working in collaboration with Senthil
Muthuswamy, also here at CSHL, in our first applica-
tion of this library. We are using his three-dimensional
culture system to explore the effect of attenuating PTP
expression on MCF10A mammary epithelial cell dif-
ferentiation. This cell culture system recapitulates sev-
eral aspects of mammary gland architecture in vivo and
has been used to model the biological activities of can-
cer genes. Our preliminary results reveal that attenua-
tion of expression of receptor PTPs LAR and PTPRO
leads to abnormal development of acini. In the latter
case, the effects of disruption of PTPRO were accentu-
ated in MCF10A cells that overexpress the oncoprotein
tyrosine kinase ErbB2 (HER2), which is overexpressed
in approximately 25% of breast tumors. Thus, PTPRO
may have an as yet undefined role in down-regulating
signaling pathways triggered by ErbB2. Currently, we
are completing a screen in which we are testing the
effects of attenuating expression of each of the PTPs on
acinar development in the three-dimensional (3D) cul-
ture of MCF10A cells. I anticipate that this approach
will serve as a first step to shed new light on potential
roles of PTPs in the etiology of breast cancer.
REGULATION OF PTP FUNCTION BY
REVERSIBLE OXIDATION
As might be anticipated for a family of enzymes that
have such critical roles in the regulation of cell signaling,
the activity of PTPs is tightly controlled in vivo.
Recently, the production of reactive oxygen species
(ROS), such as hydrogen peroxide, and the resulting
posttranslational modification of PTPs by reversible oxi-
dation has been implicated in the regulation of tyrosine-
phosphorylation-dependent signaling pathways initiated
by a wide array of stimuli, including growth factors, hor-
mones, cytokines, and cellular stresses. The signature
motif of the PTP family, [IMHCxxGxxR[S/T], contains
an invariant Cys residue, which, due to the unique envi-
ronment of the active site, is characterized by an
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extremely low pKa. The low pKa promotes the function
of this Cys residue as a nucleophile in catalysis but ren-
ders it highly susceptible to oxidation
with concomitant
abrogation of nucleophilic function and inhibition of
PTP activity. Work from several labs has now established
that multiple PTPs are transiently oxidized in response to
various cellular stimuli. This represents a novel tier of
control of tyrosine-phosphorylation-dependent signaling
and is a major empasis of the research efforts in our lab.
In our initial investigations of PTP oxidation in
response to cell stimulation by growth factors and hor-
mones, we had applied a modified in-gel PTP assay
that we had developed to measure reversible PTP oxi-
dation in a cellular context. Although this has proven to
be a powerful approach and has allowed us to charac-
terize the oxidation of several different PTPs in a vari-
ety of signaling contexts, there are certain technical
challenges that limit its application. In particular, this
assay does not detect the oxidation of receptor PTPs.
Recent efforts have focused on developing new
assays that allow us to measure oxidation of all mem-
bers of the PTP family in cells. We have been optimiz-
ing a protocol that uses a chemical label to tag the oxi-
dized PTPs. Cells are lysed under anaerobic conditions
in the presence of an alkylating agent, which irre-
versibly inactivates any PTPs that are present in the
reduced, active state. Those PTPs that are in an oxi-
dized state are protected from alkylation. Lysates were
then subjected to buffer exchange on a size-exclusion
chromatography column. In this key step, the alkylat-
ing agent was removed and a reducing buffer allowed
the oxidized PTPs to be reduced back to the active
state, in which they may then react with biotinylated
active-site-directed compounds. The two biotinylated
compounds used were a bromobenzylphosphonate
(BBP) activity-based probe (in collaboration with
Zhong-Yin Zhang, Department of Biochemistry and
Molecular Biology, Indiana University) or a sulfydryl-
reactive polyethylene oxide (PEO)-iodoacetyl probe.
Subsequent purification by streptavidin pull-down and
immunoblotting allowed us to identify those PTPs that
were susceptible to oxidation. Initially, we have applied
the method to measurement of PTP oxidation in
angiomyolipoma cells, which are transformed by
expression of platelet-derived growth factor, PDGF-
BB. We have identified several PTPs as targets of
PDGF-receptor-induced oxidation. Oxidation of these
PTPs was shown to be elevated in PDGF-BB-trans-
formed cells and to be dependent on NADPH oxidase
activity. Interestingly, a similar pattern of immunoreac-
tive bands was observed with both BBP- and PEO-
labeled probes, suggesting that both probes are labeling
a similar pool of oxidized PTPs. Finally, in addition to
detecting nontransmembrane PTPs, this method also
revealed receptor PTP oxidation. This improved
method for detecting reversible oxidation of the entire
PTP superfamily is now being applied to other cell sys-
tems and should help delineate new signaling cascades
and identify potential therapeutic targets.
In collaboration with T.C. Meng, Kay-Hooi Khoo,
and their colleagues at the Academia Sinica in Taiwan,
we have been developing mass-spectrometry-based
approaches to characterize the various oxidative modi-
fications of Cys residues in PTPs. In HepG2 and A431
human cancer cells, which produce high levels of ROS
constitutively, we detected the reversible oxidation of
three PTPs, TC-PTP, PTP-PEST, and PTP1B. We have
focused our attention on PTP and have used mass
spectrometry to determine the oxidation status of each
Cys residue in the protein as isolated by immunoprecip-
itation from these cancer cells. Oxidation was only
detected on the active-site Cys residue, whereas the
other Cys residues in the PTP were unaffected, consis-
tent with the unique properties of this residue conferred
by the architecture of the active site. We observed that
up to 50% of PTP was reversibly oxidized in HepG2
and A431 cells. Furthermore, due to the presence of the
high ROS levels produced in these cells, we observed
that up to 40% of PTP was irreversibly oxidized.
Inhibition of NADPH oxidases by treatment with
diphenyleneiodonium attenuated ROS production and
inhibited PTP oxidation, concomitant with a decrease in
tyrosine phosphorylation of cellular proteins and inhibi-
tion of anchorage-independent cell growth. These data
suggest that the high level of ROS produced by HepG2
and A431 cells may promote the transformed phenotype
by inactivation of cellular PTPs. Furthermore, it may
now be possible to apply this approach to determining
the stoichiometry of oxidation of specific PTPs in vari-
ous signaling contexts.
JSP1
Multiple DSPs have been identified that have the abil-
ity to dephosphorylate and inactivate various mitogen-
activated protein kinases (MAPKs), constituting a
complex response network for attenuation of MAPK-
dependent signals. We identified a novel DSP and
observed, contrary to expectation, that it had the capac-
ity to activate JNK specifically, exerting its effects
upstream of MKK-4 in the JNK signaling cascade,
hence the name JSP1 (JNK stimulatory phosphatase 1).
This study illustrates a new potential tier of control of
the JNK signaling pathway and a novel aspect of the
role of protein phosphatases in the control of MAPK
signaling. This raised the possibility that JSP1 may
offer a new perspective to the study of various disor-
ders associated with aberrant JNK signaling.
We have been characterizing JSP1 knockout mice,
which contain a targeted deletion at exon 3 resulting in
the production of a truncated, inactive protein of
approximately 20 amino acids. These mice reproduce
at normal Mendelian ratios, display no obvious physi-
cal abnormalities, and have a life expectancy similar to
that of their wild-type controls. We are characterizing
two aspects of their phenotype, one indicating that
JSP1 may have a role in the neurodegenerative
processes that lead to Parkinson's disease and the other
implicating JSP1 in the regulation of innate and adap-
tive immunity.
Regulation of JNK Signaling by JSP1 in a Mouse Model of
Parkinson's Disease. Parkinson's disease (PD), one of
the most prevalent neurodegenerative diseases affecting
aging individuals, is characterized by disabling motor
defects arising from a progressive loss of dopaminergic
neurons in the substantia nigra pars compacta (SNpc).
Less than 10% of PD cases have been linked to genetic
factors and therefore the disease is thought to be primar-
ily sporadic in nature with unknown etiology. Animal
models of PD primarily involve the use of neurotoxins,
the most common being MPTP (1- methyl -4- phenyl-
1,2,4,6-tetrahydropyridine), administration of which
leads to dopaminergic neuronal cell death and a
Parkinsonian phenotype. Apoptosis is the key cell death
mechanism in both PD and in MPTP-induced lesions,
with the JNK signal transduction pathway having a
major role in this process. There is significant interest in
targeting the JNK pathway for PD therapeutics; howev-
er, global inhibition of JNK activity would be likely to
have detrimental systemic affects, and therefore it is
important to identify key regulators of JNK signaling in
the context of neuronal cell death in PD.
Considering the ability of JSP1 to regulate JNK
activity in cell transfection systems, we investigated
JNK signaling in the JSP1 knockout mice. On the
basis of previous studies that have shown that basal
JNK activity is high in brain tissue, we examined JNK
phosphorylation in the cortex, cerebellum, and hip-
pocampus of wild-type and Jspl-/- mice and found no
alterations in JNK activity due to JSP1 ablation. In
addition these mice do not display any outwardly
apparent neuronal phenotype. To investigate the possi-
bility that JSP1 may regulate JNK signaling in the con-
text of neuronal stress, we injected wild-type and
jspl-l- mice with MPTP and examined c-JUN phos-
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phorylation in the SNpc following MPTP treatment.
These studies are being performed with Serge
Przedborski and his colleagues at Columbia
University. Using confocal fluorescence microscopy,
we observed significant phosphorylation of c-JUN in
the dopaminergic neurons of wild-type mice at 6 hours
post-MPTP treatment. Interestingly, the level of
MPTP-induced c-JUN phosphorylation injsp1-1- mice
was dramatically lower than in their wild-type counter-
parts. This indicates that JSP1 may act to regulate
MPTP-mediated JNK signaling in dopaminergic neu-
rons. We are currently using laser-scanning cytometry
(iCys ®) to quantitate the effects of ablation of JSP1 on
both MPTP-induced JNK signaling and degeneration
of dopaminergic neurons and are focusing on identify-
ing the substrates of the phosphatase that underlie
these effects.
Modulation of Innate and Adaptive Immunity by JSP1.
Preliminary analysis of JSP1 knockout mice has
revealed interesting immunological phenotypes. We
have observed that ablation of JSP1 leads to attenua-
tion of the inflammatory response to Gram-negative
bacterial endotoxin. Production of tumor necrosis fac-
tor-a (TNF-a) in response to sublethal lipopolysac-
charide (LPS) administration is significantly
decreased in JSP1 knockout mice compared to their
wild-type counterparts; this appears to be dose-depen-
dent for JSP1, as the heterozygous animals produce an
intermediate TNF-a response. Interestingly, inter-
leukin-6 (IL-6) production is unaffected, indicating
that JSP1 acts at a point downstream from Toll recep-
tors, where the signals mediating TNF-a and IL-6 pro-
duction diverge. To pursue the mechanistic basis for
this effect, we have been trying to identify a suitable
cell type from the mouse which, in culture, would
recapitulate the in vivo response (decreased LPS-
induced production of TNF-a) and which could be
cultured in sufficient numbers for biochemical analy-
sis of signaling downstream from TLR4, the Toll
receptor that mediates the effects of LPS. Splenocytes
isolated from JSP1 knockout mice display decreased
TNF-a secretion in response to LPS compared to wild
type; however, the low numbers and short life span of
these cells make it difficult to perform biochemical
analysis of the signaling pathways responsible for this
difference. Similar results were also obtained with
bone-marrow-derived dendritic cells, but again, this
system does not yield sufficient cells for a comprehen-
sive biochemical characterization. We did not observe
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a difference in LPS-induced TNF-a production
between resident macrophages from the JSP I wild_
type and KO mice; however, we observed a reduction
of approximately 50% in TNF-a levels produced by
bone-marrow-derived macrophages from knockout
compared to wild-type animals. At this time, we have
not observed a difference in LPS-induced activation of
iMAPK signaling pathways, or n I xl3a degradation,
between wild-type and JSP1 KO bone-marrow-derived
macrophages.
Analysis of aged JSP1 knockout animals (>1 year)
revealed that these mice develop moderate
splenomegaly and that this is associated with lymphoid
hyperplasia and an expansion of memory T cells. No
differences were observed in the proliferative capacity
of memory T cells isolated from wild-type and JSP1 KO
mice; however, analysis of naive CD4+ T-cell prolifera-
tion has revealed an interesting phenotype. At an early
age (1-month-old mice), JSP1 KO naive CD4+ T cells
display a reduced proliferative capacity compared to
wild type, as measured by thymidine incorporation and
IL-2 production. However, at 4 months, JSP KO naïve
CD4+ T cells display a moderately increased prolifera-
tive capacity compared to wild type. This apparent dis-
parity can be explained by the observation that wild-
type CD4f T cells undergo a dramatic decline in prolif-
erative capacity as they age from 1 to 4 months. In con-
trast, although JSP1 KO CD4+ T cells from young mice
do not display as robust a response to T-cell activation
as their wild-type counterparts, they display no signifi-
cant age-dependent decline in proliferation. These data,
and the observation that aged JSP1 KO mice possess an
increased memory T-cell pool, indicate that JSP1 may
have important roles in aging of the adaptive immune
system. Current efforts are focused on defining the
effects of ablating JSP1 on signaling in these cells.
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RAS AND RHO GTPASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner N. Nadif Kasri
J. Janas R. Packer
K. John Y.-T. Yang
Research in my laboratory focuses on signal transduc-
tion pathways involving Ras and Rho GTPases. Ras
and Rho family members have key roles in cellular
activities controlling cell growth control, differentia-
tion, and morphogenesis. Alterations that affect nor-
mal Ras and Rho function have been found to result in
the development of several disease processes includ-
ing cancer and inflammatory and neurological disor-
ders. Our ultimate goal is to understand how aberra-
tions in Ras and Rho signaling components contribute
to the development of these disease processes. Toward
this end, my lab has continued to define the functions
of selected GTPases, their regulators and effectors, in
models of cancer and neurological disorders. Below
are highlighted the main projects that have been car-
ried out during the past year.
ROLE OF RAP1 SIGNALING IN MORPHOGENETIC
PROCESSES
The Rap 1 protein, a member of the Ras family, was
initially identified as an antagonist of oncogenic Ras
proteins; however, more recent studies indicate that
the function of Rap 1 is largely Ras-independent.
Increasing evidence points to a critical role for Rap 1
in the control of epithelial morphogenesis, and recent
studies suggest a dysregulation of Rap 1 signaling in
malignant processes. How Rap 1 proteins exert their
effects in vivo has remained largely elusive. We previ-
ously described the identification of the mammalian
junctional protein AF-6 as a Rap 1- interacting protein.
To demonstrate the physiological relevance of this
interaction, we decided to carry out functional analy-
ses of their orthologs (dRap 1 and Canoe) in the more
genetically tractable Drosophila system. We found
that both dRap 1 and Canoe are required for epithelial
migration events in the embryo and that Canoe acts as
a downstream effector of dRap 1 in these processes.
More recently, we identified a Drosophila Rapl-
specific exchange factor, dPDZGef, that is responsible
for Rap 1 activation in migrating embryonic epithelia.
Canoe acts downstream from dRap 1 and dPDZGef in
this event. Interestingly, we found a striking loss in cell
tension in the proximity of junctional complexes in
dPDZGef mutant cells generated in a mosaic analysis.
Surrounding wild-type cells often compensate this
loss by increasing tension and display ectopic concen-
trations of myosin II (zip). In addition, overexpression
of dPDZGef in a defined epithelial compartment
results in a striking decline of cell and tissue tension
that is partially compensated for by wild-type cells in
the adjacent compartment. Thus, changes in tissue ten-
sion can be signaled and integrated across clone and
compartment boundaries. Furthermore, we established
that dPDZGef activity is genetically linked to myosin
II/zip and thereby provide first insight into the molec-
ular machinery targeted by Rap signaling to modulate
cell plasticity. We propose that dPDZGef-dependent
signaling functions as a rheostat that links Rap 1 activ-
ity to the regulation of cell tension in epithelial mor-
phogenesis and homeostasis at different stages of
development.
ROLE OF DOK PROTEINS IN MITOGENIC AND
ONCOGENIC SIGNALING
Dok-1 (also called p62d°19 was initially identified as a
tyrosine-phosporylated 62-1(D protein associated with
Ras-GAP in Ph+ chronic myeloid leukemia (CML)
blasts and in v-Abl-transformed B cells. This protein
was termed Dok (downstream of kinases), since it was
also found to be a common substrate of many receptor
and cytoplasmic tyrosine kinases. Subsequently, four
additional Dok family members have been identified.
Among them, Dok-1 and Dok-2 share the ability to
bind to a negative regulator of Ras, Ras-GAP. We
described previously that Dok-1 acts as a negative reg-
ulator of growth-factor-induced cell proliferation and
that Dok-1 inactivation in mice causes a significant
shortening of the latency of the fatal myeloprolifera-
tive disease induced by p210bcr-abi. Strikingly, in collab-
oration with Dr. Pandolfi's group (Memorial Sloan-
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Kettering Cancer Center), we also found that mice
lacking both Dok-1 and Dok-2 spontaneously develop
a CML-like myeloproliferative disease, likely result-
ing from increased cellular proliferation and reduced
apoptosis. Thus, Dok proteins function as negative
regulators of mitogenic and oncogenic signaling.
More recently, we obtained insight into the mole-
cular mechanism by which Dok-1 exerts its negative
effect on mitogenesis and oncogenic transformation.
Using Dok-1 knockout cells and Dok-1 mutants defi-
cient in binding to specific Dok- 1 -interacting pro-
teins, we found that Dok-1 interferes with platelet-
derived growth factor (PDGF)-stimulated c-myc
induction and Ras/MAPK (mitogen-activated protein
kinase) activation by tethering different signaling
components to the cell membrane. Specifically, Dok-
1 attenuates PDGF-elicited c-myc induction by
recruiting Csk to active Src kinases, whereupon their
activities and consequent c-myc induction are dimin-
ished. On the other hand, Dok-1 negatively regulates
PDGF-induced MAPK activation by acting on Ras-
GAP and at least one other Dok-l-interacting protein.
Most importantly, we demonstrated that the actions of
Dok-1 on both of these signaling pathways contribute
to its inhibitory effect on mitogenesis. Our data sug-
gest a mechanistic basis for the inhibitory effect of
Dok-1 on growth-factor-induced mitogenesis and its
role as a tumor suppressor.
ROLE OF RHO REGULATORS IN NEURONAL
DEVELOPMENT
Accumulating data indicate that the Rho family of
GTPases (including Rac, RhoA, and Cdc42) and their
regulatory molecules have critical roles in many
aspects of neuronal development and function. Their
importance in these processes is further emphasized
by the findings that mutations in Rho-linked genes,
such as oligophrenin-1, are associated with neurolog-
ical disorders and defects in neuronal development.
The cellular and molecular mechanisms by which
aberrations in Rho signaling lead to such deficits
remain largely elusive.
We obtained insight into the function of
oligophrenin-1 (OPHN1), a gene located on chromo-
some Xq12 that codes for a negative regulator of Rho
GTPases. Mutations in OPHN1 (which result in
OPHN1 loss of function) have been reported in a fam-ily with nonsyndromic X-linked mental retardation
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(MR) and in families with MR associated with epilep-
sy and/or cerebellar hypopla sia. We demonstrated that
OPHN1 is present in major regions of the brain,
including the hippocampus, cerebellum, and cortex,
and provided evidence for the requirement of OPHN1
in dendritic spine morphogenesis of hippocampal neu-
rons. Using RNA interference and antisense approach-
es, we showed that knockdown of OPHN1 levels in
CAl pyramidal neurons in hippocampal slices results
in a significant decrease in dendrite spine length and
that this spine length phenotype is mediated by the
Rho/Rho-kinase pathway. In addition, we recently
demonstrated a biochemical interaction between
OPHN1 and Homer, a postsynaptic adaptor molecule
involved in spine morphogenesis and synaptic trans-
mission. The interaction between OPHN1 and Homer
raises the intriguing possibility that OPHN1 acts
downstream from glutamatergic receptors to regulate
RhoA activity in spines, and thus spine morphogene-
sis. Our future experiments are geared toward address-
ing these interactions and their functional roles in den-
dritic spine morphology, calcium signaling, and
synaptic plasticity.
More recently, we identified a novel activator of
the Rac GTPases, termed DOCK7, and demonstrated
a critical role for this protein in axon development and
axon-dendrite polarization. DOCK7 belongs to the
DOCK180-related superfamily of proteins, which has
recently emerged as a group of distinct regulators of
the Rho proteins. We found that DOCK7 is highly
expressed in major regions of the brain during early
stages of development and, importantly, that the pro-
tein is asymmetrically distributed in unpolarized hip-
pocampal neurons and becomes selectively expressed
in the axon. We obtained evidence that DOCK7 has a
critical role in the early steps of axon formation.
Knockdown of DOCK7 expression prevents axon for-
mation, whereas overexpression induces the formation
of multiple axons. We further demonstrated that
DOCK7 and Rac activation lead to phosphorylation
and inactivation of the microtubule-destabilizing pro-
tein stathmin/Op 18 in the nascent axon and that this
event is important for axon development. Our findings
unveil a novel pathway linking the Rac activator
DOCK7 to a microtubule regulatory protein and high-
light the contribution of microtubule dynamics to
axon development. Together, our studies contribute to
defining the molecular mechanisms by which neurons
acquire their polarity and may also shed light on axon
regenerating processes.
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NEUROSCIENCE
Neuroscientists at CSHL are continuing to make tremendous strides in understanding many aspects
of normal brain structure and function, as well as what goes wrong in several major diseases including
Alzheimer's, Parkinson's, schizophrenia, and autism.
Understanding brain function seems impossible without a comprehensive description of its structure
on the level of individual synapses. To this end, Dmitri Chklovskii's lab is developing technologies for high-
throughput reconstructions of brain circuits using serial section electron microscopy. His group was able
to reconstruct a 1000-m3 neuropil volume entirely, including every synapse, axon, and dendrite. Such
reconstructions already provide invaluable information, necessary to construct a theoretical description of
brain design based on engineering principles. Full reconstruction of "interesting" circuits requires scaling
up reconstruction capabilities at least hundredfold, thus posing interesting computational challenges.
New neurons are constantly produced in the adult brain. The birth of new neurons is a dynamic
process and it changes in response to a wide range of stimuli. The role of this constant supply of new
neurons is still unclear; however, there is increasing evidence that adult neurogenesis may be impor-
tant for learning, memory, and mood. Grigori Enikolopov's lab studies signals that regulate distinct
steps in the cascade converting stem cells into neurons. Enikolopov also studies whether similar sig-
nals regulate stem cells in other tissues, and he is particularly interested in how neurogenesis may be
linked to mood regulation and may underlie the action of antidepressant therapies. He and his team
have developed a new approach for identifying and quantifying cellular targets of neurogenic stimuli
and have used it to determine cell populations targeted by antidepressants in the adult brain. They are
now using this approach to examine whether different types of treatments that regulate mood have a
similar effect on the neuronal differentiation cascade and to identify signaling molecules that translate
the treatment into an increased number of new neurons.
Karel Svoboda explores how information gathered from our senses is converted first into electrical
activity and then transferred into memories through changes in synapses, neurons, and neural circuits.
He combines a variety of powerful imaging techniques with rodent models to probe the brain's circuit-
ry and how it changes over time. Many synaptic connections in the brain persist for months or years.
When synaptic connections break down, memory is destroyed. Svoboda's group has discovered that
the protein components that form synapses are remarkably short-lived. They recently helped resolve
the paradox posed by persistent synapses and labile proteins by discovering intricate mechanisms that
control the comings and goings of proteins at synapses.
Holly Cline studies how specific patterns of connections among brain neurons arise and how these
patterns can change over time. By using time-lapse imaging of developing tadpoles, Cline's group is
revealing the fundamental molecular and cellular mechanisms that are likely to underlie brain plasticity
across species, including in humans.
Even fruit flies need to learn and remember in order to survive. Moreover, by comparing the mech-
anisms of learning and memory in flies, humans, and other organisms, Tim Tully has discovered
ancient, fundamental molecular pathways of memory that are shared from flies to man. Tully and his
colleagues have uncovered some 170 candidate memory genes (CMGs) in fruit flies and are in the
process of elucidating the roles of these genes in learning and memory.
Josh Dubnau is using a combination of approaches to identify the molecular and anatomical path-
ways that underlie learning and memory in flies. His group has identified several genes that the
researchers believe are involved in a mechanism that stores memories in response to external experi-
ences. They are also using a genetic technique to map the neuroanatomical circuitry involved in mem-
ory processing in flies. Finally, Dubnau is pioneering an "artificial evolution" strategy with the goal of
uncovering the network of gene interactions that govern learning and memory.
Partha Mitra is one of a number of CSHL neuroscientists that combine theoretical, computational,
and experimental approaches to exploring brain function. His group is continuing to develop mathe-
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matical algorithms and powerful software necessary for making sense of large volumes of neurobiolog-
ical data. He participates in a number of experimental collaborations, on and off campus. With Tim Tully
and Josh Dubnau, he is performing integrative analysis of memory formation in the fruit fly, combining
genetic, neurobiological, and behavioral approaches. Collaborative efforts include the study of song-
birds, with Ofer Tchernichovski of City College of New York, and studies of cognition and conscious-
ness with Niko Schiff and Keith Purpura at the Weill Medical School of Cornell University.
Within the Neuroscience department, the Center for the Neural Mechanisms of Cognition (CNMC)
continued its success in 2006. The CNMC consists of the research groups of Carlos Brody, Zach
Mainen, and Anthony Zador. The goal of the Center is to develop rodent models that combine behav-
ioral training with electrophysiological recordings to understand the neurological basis of several com-
plex brain functions including learning, memory, time perception, motivation, and decision-making.
Carlos Brody is interested in how neurons interact with one another to form the neural networks that
underlie rapid decision-making and short-term or "working" memory. His group is also exploring how
time and temporal patterns are sensed and represented in the brain.
Zach Mainen studies how odors are detected, represented in the brain, and transformed into deci-
sion-making and other behaviors. A few years ago, his group discovered that rats (and probably som-
meliers and other humans) can respond quickly and accurately to odors in a single sniff. Mainen and
his colleagues continue to study the implications of this finding. From a "neuroeconomic" perspective,
Mainen is studying how the brain deals with the biological "costs" of decision-making (e.g., uncertain-
ty, effort, and delay). His group is also investigating the effects of psychoactive drugs in rodents to
uncover neural circuits that might be targets of improved therapies for schizophrenia, Parkinson's dis-
ease, and other disorders.
The brain is able to solve hard computations that remain far beyond the reach of the fastest com-
puters. Anthony Zador uses a combination of theoretical and experimental approaches to study how
the brain computes, particularly in the realm of processing auditory input. Most of what is known about
the auditory cortex comes from studies of the anaesthetized cortex. But in order to understand the way
the brain can direct attention to a single sound among many ("selective attention"), it is necessary to
study the cortex of unanaesthetized animals. Zador and colleagues have therefore focused on devel-
oping experimental techniques for studying the activity of neurons in the auditory cortex of awake ani-
mals. The techniques they use reveal that the diversity in neural responses seen in awake animals is
much greater than those in anesthetized animals, and they are currently trying to elucidate the causes
of this diversity.
Writers and poets know that memory is suffused with pain, ecstasy, fear, and desire. Science now
supports the notion that intense emotions drive the changes in our brains that encode learning and
memory. As part of his groundbreaking studies of the molecular basis of learning and memory, Roberto
Malinow (in collaboration with Anthony Zador) recently discovered that fear conditioning-a form of
learning and memory-is encoded by the movement of proteins called AMPA (a-amino-3-hydroxy-5-
methyl-3-isoazole) receptors into synapses in a portion of the brain known to be responsible for basic
instinctual learned responses.
Jonathan Sebat is using representational oligonucleotide microarray analysis (ROMA) to identify
genetic changes that cause neuropsychiatric disorders. His initial study of 200 families with sporadic
autism has found a very high frequency of deletions that occur spontaneously in affected children.
These findings suggest that specific genes are involved in the pathology of autism, including a hormone
known as oxytocin and a regulator of splicing called ataxin-2-binding protein 1. Sebat's group has
taken a similar approach to studying psychosis. ROMA analysis of 400 patients with schizophrenia has
identified genomic imbalances at several interesting loci. The most frequent mutations found in schiz-
ophrenia involve genomic regions that are similar between the X and Y chromosomes.
One of the central questions of biology is how changes in gene activity transform one type of cell
into other types. Cold Spring Harbor Fellow Lee Henry studies this process, called cellular differentia-
tion, by using taste bud development as a model system. Taste buds comprise unspecialized "prog-
enitor stem cells" at their periphery. These cells become specialized taste receptor cells within the cen-
ter of the bud. Different taste receptor cells respond to different tastes (sweet, sour, salty, and bitter).
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Henry is working to define taste at the level of individual genes. To do this, he and his colleagues
have
developed a method that allows the gene products of individual cells to be attached
to magnetic
beads, which are then "read" using a series of chemical modifications. By comparing
specialized taste
receptors to unspecialized stem cells, these researchers aim to understand how individual
taste recep-
tor cells tell our brains, for example, "this is sweet."
Josh Huang is deciphering how the brain develops neural networks that respond to
GABA, the pri-
mary inhibitory neurotransmitter in the brain. Huang's group discovered that a cell adhesion protein
called CHL1 has a major role in directing how neurons controlled by GABA connect to other neurons.
These findings may have significant implications for understanding schizophrenia and other common
neurodevelopmental and psychiatric disorders.
Alexei Koulakov uses mathematical methods to explore how real-world neurons form
functional net-
works in the brain. Some of his work has generated robust theoretical models of visual and
olfactory
neural circuits-models that match experimental observations and, importantly, make testable
predic-
tions that are likely to reveal new clues to brain structure and function.
Memories can be destroyed when synaptic connections in the brain break down. Yi Zhong stud-
ies this breakdown, which underlies neurodegenerative disorders such as Alzheimer's disease. In his
lab, researchers use the fruit fly brain as a model system for studying corresponding human genes
that affect brain function in Alzheimer's patients. This analysis is revealing new clues about the dis-
ease and is providing insight into the general molecularmechanisms of learning and memory. Zhong's
recent work has focused on neurofibromatosis 1 (NF1) and other genes implicated in Alzheimer's. His
group has uncovered the pathways by which NF1 controls learning and memory and continues to
explore the mechanisms that underlie f3- amyloid- induced neurodegeneration and memory loss in
Alzheimer's disease.
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COMPUTATIONAL SYSTEMS
C. Brody S. Chakraborty C. Machens
S. Chow M. Nikichenko
E. Glushenkova S. Pai
S. Lima
Our lab is interested in how neurons interact with each
other to form networks that underlie flexible cognitive
acts, such as decision-making and short-term memory.
We are also interested in how time and temporal pat-
terns are sensed and represented in the brain. Our
approach to these questions is both experimental and
computational. During 2006, several projects either
came to fruition or began to produce final results.
Shraddha Pai successfully completed the develop-
ment of training protocols to teach rats to discriminate
sound durations or discriminate sound frequencies.
Using the latter task as a control for the former, she has
begun lesioning brain structures in order to identify
structures uniquely necessary for duration discrimina-
tion. Christian Machens published an elegant mathe-
matical analysis of a large family of computational
models that support continuous attractors for short-term
memory. Stephanie Chow showed, first, that contextual
modulation of neural responses exists in secondary
somatosensory cortex and, second, that this is sufficient
to radically change readout of such responses.
Finally, after a nearly two-year-long effort fre-
quently marked by both signs of success and subse-
quent dashing of hopes, Carlos Brody succeeded in
reliably training rats to perform a two-stimulus-inter-
val discrimination task. This task had previously been
performed only by monkeys and had formed the
behavioral basis for much of the laboratory's data
analysis and modeling efforts. In December 2006, the
laboratory moved to Princeton University and Brody
became an Adjunct Professor at Cold Spring Harbor
Laboratory.
Determining the Neuroanatomical
Loci of Sound Duration
Discrimination in the Rat
S. Pai
Interval timing (IT) is the ability to estimate time, and
it is used in decision-making in tasks where timing is
important; e.g., in foraging, the renewability of food
sources must be timed to maximize food intake.
Identifying the sources and electrophysiological corre-
lates of IT have been challenging due to the lack of a
controlled behavioral paradigm in a model organism
amenable to lesion studies and electrophysiology.
Discrimination of pure-tone durations using the
two-alternative forced-choice (2AFC) paradigm in rats
is a powerful yet simple model to study relative IT. We
have developed a behavioural paradigm in which rats
discriminate pure-tone durations that are longer than a
standard interval from those that are shorter (temporal
bisection). We have also trained the rats to discriminate
sound frequencies (higher than a standard vs. lower
than the standard). The 2AFC paradigm is extremely
well-controlled, allowing us to precisely measure the
accuracy and extent of discrimination in both tasks
using psychophysical analysis. The same stimuli and
the same responses are involved in the two tasks: What
differs is what aspect of the sound stimulus the rat uses
to make its discrimination. We are lesioning different
auditory structures-specifically, the medial geniculate
body of the thalamus, the auditory cortex, and audito-
ry striatum-using a combination of reversible and
permanent lesioning techniques to determine the brain
regions that lead to the ability to time auditory stimuli.
We specifically seek areas that, when lesioned, cause
an impairment in one discrimination task but not the
other. The unimpaired task will then provide a control
showing that the impairment is neither sensory (rat can
still hear) nor motor (rat can still move to report result)
nor general cognitive (rat can still make a discrimina-
tion) but is instead specific to either duration or fre-
quency discrimination.
Two-stimulus-interval Discrimination
Tasks in Rodents
C. Brody
Much work in the Brody group has been based on data
collected by R. Romo's group in Mexico, recording
from monkeys trained in a two-stimulus-interval dis-
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crimination task. In such tasks, a first stimulus (fl) is
delivered and then there is a delay, typically lasting
several seconds. A second stimulus (f2) is then deliv-
ered, and the subject must compare the two stimuli and
make a two-alternative forced choice as to which of
the two is the larger (fl > f2? Yes or No). The task
therefore requires short-term memory to remember fl
in the delay between fl and f2, a comparison compu-
tation, and decision-making.
Together with Zachary Mainen's and Anthony
Zador's labs here at CSHL, one of our goals is to bring
such high-level tasks, whose neurophysiology is often
explored with monkeys, into the rodent domain. This
would provide a far more tractable model system for
data collection and manipulation of brain activity. Initial
training attempts, although at first apparently success-
ful, proved unstable, and for unknown reasons, the rats
did not maintain high performance. Thanks to the
numerous training rigs that the Center for the Neural
Mechanisms of Cognition obtained, we were able to
explore a very large set of approaches and were able to
find an approach that produced the desired results. On
Friday October 28, 2006, we obtained our first rat to
successfully complete training and then maintain subse-
quent stable performance. Other rats have since suc-
cessfully completed this training procedure.
Design of Continuous Attractors
with Monotonic Tuning Using
a Symmetry Principle
C. Machens
Neurons that sustain elevated firing in the absence of
stimuli have been found in many neural systems. In
"graded persistent activity," neurons can sustain firing
at many levels, suggesting a widely found type of net-
work dynamics in which networks can relax to any one
of a continuum of stationary states. The reproduction of
these findings in model networks of nonlinear neurons
has turned out to be nontrivial. A particularly insightful
model has been the "bump attractor" in which a contin-
uous attractor emerges through an underlying symmetry
in the network connectivity matrix. This model, howev-
er, cannot account for data in which the persistent firing
of neurons is a monotonic-rather than a bell-shaped-
function of a stored variable. Here, we show that the
symmetry used in the bump attractor network can be
employed to create a whole family of continuous attrac-
tor networks, including those with monotonic tuning.
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Our design is based on tuning
the external inputs to net-
works that have a connectivity matrix
with Toeplitz
symmetry. In particular, we
provide a complete analyti-
cal solution of a line attractor
network with monotonic
tuning and show that for many other networks, the
numerical tuning of synaptic weights reduces to the
computation of a single parameter.
Context -dependent Modulation of
Functional Connectivity: S2 to PFC
Connections in Two-stimulus-interval
Discrimination Tasks
S. Chow
Processing of signals from the environment must be
flexible: A sensory cue may prompt different actions in
different contexts. Our goal is to use context-dependent
modulations of firing rates in the secondary somatosen-
sory cortex (S2) as a basis for a biologically plausible
model that achieves a context-dependent inversion of
the inputs to the prefrontal cortex (PFC) without requir-
ing changes in connectivity. The sign change is required
by our laboratory's recently proposed network model of
processing in the PFC (see Machens et al., Science 307:
1121 [2005]). Many neurons in PFC and S2 exhibit fir-
ing rates that are functions of stimulus frequency and
can be classified into two groups by their firing-rate
response to the first stimulus "fl." "Plus" neurons have
firing rates that increase with increasing stimulus fre-
quency, whereas "minus" neurons have firing rates that
decrease with stimulus frequency. PFC neurons may
switch the sign of their frequency dependence in
response to the second stimulus "f2," whereas S2 neu-
rons do not. Salinas showed that a simple two-layer net-
work model is sufficient to implement drastic changes
in functional connectivity, enabling context switching
without rewiring. We combined the insights of Salinas'
model with the extensive neurophysiological data from
Ranulfo Romo's laboratory to develop a biologically
plausible model of context switching in the signal trans-
formation from S2 to PFC. The resulting static network
solves the sign-change problem and is robust to varia-
tions in model parameters.
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FROM NEURONAL CIRCUIT RECONSTRUCTIONS TO PRINCIPLES
OF BRAIN DESIGN
D. Chklovskii B. Chen Y. Mishchenko
A. Genkin Q. Wen
How does electrical activity in neuronal circuits give
rise to intelligent behavior? We believe that this ques-
tion is impossible to answer without a comprehensive
description of the connectivity in neuronal networks.
Such a description may be a wiring diagram, which
catalogs all neurons and synaptic connections between
them. In collaboration with several laboratories, we
are reconstructing vertebrate and invertebrate wiring
diagrams from electrophysiological, light, and elec-
tron microscopical data. To gain insight into brain
function from the wiring diagrams, we formulate engi-
neering principles of brain design and test them exper-
imentally. By focusing initially on explaining the func-
tion of simpler organisms, we are assembling a theo-
retical framework and accumulating experience neces-
sary to understand more complex systems, such as the
mammalian neocortex.
STATISTICAL CIRCUIT RECONSTRUCTIONS FROM
LIGHT MICROSCOPY AND ELECTROPHYSIOLOGY
We have developed the necessary theoretical frame-
work to estimate, or reconstruct statistically, wiring
diagrams from the shapes of axonal and dendritic
arbors visualized with light microscopy. Such recon-
structions are based on the principle that physical
proximity between the axons of one neuron and the
dendrites of another predicts probabilistically synaptic
connections between the two. This principle is not
new. However, only with recent developments in cell
labeling, imaging, and computing infrastructure has
the comprehensive geometric description of neuronal
connectivity become an attainable goal. As a demon-
stration, we have statistically reconstructed the corti-
cal column from three-dimensional shapes of dozens
of neurons labeled in vivo.
To determine how well geometric connectivity
maps correspond to functional connectivity, we com-
pared maps calculated from neuronal shapes with
those obtained electrophysiologically in collaboration
with Karel Svoboda's lab here at CSHL. In many
cases, our maps accurately predicted connectivity on
the level of populations of neurons, i.e., projections
between cortical layers.
A geometric connectivity map is a particularly
appropriate description of cortical circuits in the face
of ongoing changes in connectivity. Previously, we
proposed that the growth and retraction of dendritic
spines could alter connectivity, and Svoboda's lab has
observed such experience-dependent plasticity in
adult animals. As geometric connectivity maps rely on
the mostly stable layout of axons and dendrites, rather
than on the more volatile spines, they provide an
invariant description of cortical circuits.
Geometric maps have their limitations: They yield
the probability of connections but cannot predict for
certain whether a given pair of neurons is connected.
The maps also do not capture the strong correlations
we found in synaptic connections in pairs and triplets
of neurons when we analyzed electrophysiological
recordings by collaborators.
COMPLETE CIRCUIT RECONSTRUCTIONS FROM
ELECTRON MICROSCOPY
Electron microscopy is currently the only technique
capable of reconstructing wiring diagrams in their
entirety. By detecting synapses on electron micro-
graphs of serial sections and tracing axons and den-
drites to their somas, one can identify synaptically
connected neurons. The largest such reconstruction,
the Caenorhabditis elegans nervous system, was car-
ried out manually at the Medical Research Council
(MRC), Cambridge, England, and finalized by us.
Complete electron microscopic circuit reconstruc-
tion is a painstakingly slow process because of the sheer
amount of data involved. Axons and dendrites spanning
millimeters must be traced with a resolution of a few
nanometers. The reconstruction of the C. elegans ner-
vous system, containing only 279 neurons, took the
equivalent of several decades of work to complete!
To reconstruct more complex circuits, we are
using techniques from image processing and machine
learning to develop automated tracing algorithms. So
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far, we have reconstructed a neuropil volume of 1000
cubic microns. We intend to scale up our automated
algorithms to fully reconstruct circuits of wide inter-
est among neurobiologists, such as the fly brain, the
vertebrate retina, and the cortical column.
FROM WIRING DIAGRAMS TO BEHAVIOR
Armed with wiring diagrams, we are starting to under-
stand how electrical activity in neuronal circuits gener-
ates behavior. Our initial strategy is to focus on rela-
tively simple circuits and behaviors. Once those are
well understood, our experience will serve as a founda-
tion for reverse engineering more complex systems.
One such simple system is the neuronal control of
undulatory locomotion in C. elegans. Many species
rely on a central pattern generator for undulatory loco-
motion. The C. elegans wiring diagram by itself does
not support required oscillations. This implies that
undulatory locomotion likely relies on propriosensory
feedback. To understand how locomotion arises, we
combine measurements of body muscle activity using
a calcium indicator and a simple model based on the
known wiring diagram.
This simple system demonstrates that even the
complete wiring diagram is not sufficient to understand
how a circuit works. Modeling circuit function requires
knowing certain dynamic parameters of neurons and
synapses-most of which are missing from the wiring
diagrams. The problem goes even deeper: Not only are
most of the parameters missing, but we do not even
know which of them are essential and which are not.
DESIGN PRINCIPLES BASED ON
OPTIMIZATION THEORY
For models of brain function to have predictive power,
an appropriate level of abstraction must be chosen and
the essential parameters must be identified and mea-
sured. When we look to disciplines where modeling is
well established, such as physics or engineering, we
find that model building must be based on fundamen-
tal principles, or physical laws, such as the laws of
conservation. Identifying similar fundamental princi-
ples in biology would help constrain the choice of
possible models and focus our efforts.
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As biological systems have evolved over
hundreds
of millions of years, their design has been optimized
under various physical constraints. It is thus natural
that a theoretical approach to biology
must incorporate
aspects of constrained optimization. We quantitatively
formulate principles of brain design and rely on opti-
mization theory to answer why questions.
A particularly successful example of optimization
in biology is the wiring economy principle proposed
by Ramon y Cajal more than 100 years ago. By quan-
titatively formulating and applying this principle, we
were able to make unexpected, experimentally testable
predictions and explain many aspects of brain design,
such as the existence and structure of cortical maps,
the spatial arrangement of neurons, the existence of
dendritic spines, the dimensions of axons and den-
drites, and the segregation of the neocortex into the
gray and white matter. In addition to the many suc-
cesses of our theoretical predictions, experiments have
revealed several discrepancies. These discrepancies
led to the discovery of another important principle of
brain design: maximization of entropy (or information
capacity). This principle in turn explains several key
properties of synapses and the shapes of neurons.
Our research continues to focus on mapping the
brain's structure and establishing its relationship with
function. We have reconstructed both statistical and
deterministic wiring diagrams and explained many
structural observations as outcomes of constrained
optimization. We plan to reconstruct wiring diagrams
of more complex circuits and understand their func-
tion by combining anatomical, physiological, and the-
oretical approaches.
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BRAIN DEVELOPMENT AND PLASTICITY
H. Cline J. Bestman
K. Bronson
K. Burgos
M. Chen
S.-L. Chiu
J. Demas
R. Ewald
M. Hiramoto
S.-Y. Lee
J. Lee-Osbourne
H. Li
J. Li
E. Rial Verde
J. Santos da Silva
P. Sharma
Our research is focused on understanding the mecha-
nisms by which experience controls the development of
the brain. We address this fundamental question by
examining the development of the visual system in
albino Xenopus tadpoles and the development of the
spinal cord in zebra fish. The visual system ofXenopus
is well known for its experience-dependent plasticity.
We have established this preparation as an excellent
experimental system in which to conduct in vivo time-
lapse imaging studies of neuronal development and
synaptogenesis, combined with both gene transfer and
electrophysiological studies of visual system function.
During the past 15 years, we have demonstrated a
role for afferent coactivity, postsynaptic N-methyl-D-
aspartate receptor (NMDAR) activity, and downstream
activation of calcium-dependent enzymes including
calcium/calmodulin-dependent protein kinase II
(CaMKII) in controlling retinotectal synaptic matura-
tion, optic tectal cell structural plasticity, and topo-
graphic map formation (Wu et al., Science 274: 972
[1996]; Zou and Cline, Neuron 16: 529 [1996]; Wu and
Cline, Science 279: 222 [1998]; Zou and Cline, J
Neurosci. 19: 8909 [1999]; Ruthazer et al., Science
301: 66 [2003]; Haas et al. 2006; Ruthizer et al. 2006).
More recently, we have demonstrated that visual expe-
rience has multiple effects on visual system develop-
ment. A relatively brief period, 4 hours, of visual expe-
rience enhances the growth rate of tectal cell dendritic
arbors through a mechanism that requires glutamater-
gic transmission and the RhoA GTPases (Li et al.,
Nature Neurosci. 3: 217 [2000]; Li et al., Neuron 33:
741 [2002]; Sin et al., Nature 419: 475 [2002]). This
same brief period of visual experience increases the
excitability of tectal neurons and their sensitivity to
visual stimuli, through a mechanism that requires intra-
cellular polyamines, the modulation of ix-amino-3-
hydroxy-5-methy1-3-isoazole receptor (AMPAR) func-
tion, and compensatory changes in sodium channel
activity (Aizenman et al., Neuron 34: 623 [2002];
Aizenman et al., Neuron 39: 831 [2003]).
The finding that we can use visual stimulation to
modify the development and properties of the retinotec-
W. Shen
V Thirumalai
R.-Y. Tzeng
K. Van Keuren-Jensen
tal system has spurred our interest in determining the
function of activity-induced genes on visual system
plasticity. For instance, our studies of Homer, Arc, and
cpg15 (candidate plasticity gene 15) demonstrate that
each has distinct roles in controlling neuronal plasticity.
Homer is a widely expressed scaffold protein, which
affects calcium signaling and metabotropic glutamate
receptor (mGluR) signaling. In addition to finding a
role in axon guidance (Foa et al., Nature Neurosci. 4:
499 [2001]; Foa et al., J. Comp. Neurol. 487: 42
[2005]), our more recent work indicates that experi-
ence-dependent changes in postsynaptic Homer expres-
sion regulates mGluR-mediated plasticity of retinotec-
tal transmission (Van Keuren-Jensen and Cline 2006).
This is particularly interesting in light of recent
work suggesting that mGluR-mediated potentiation
and depression of synaptic transmission may have a
role in developmental neurological disorders such as
Fragile X. CPG15, another activity-induced protein, is
noteworthy because it is a GPI-linked signaling mole-
cule whose expression results in a large increase in
dendritic arbor development, coupled with an increase
in glutamatergic retinotectal synaptic maturation and a
coordinated elaboration of presynaptic retinal axon
arbors (Nedivi et al., Science 281: 1863 [1998];
Cantallops et al., Nat. Neurosci. 3: 1004 [2000]; Nedivi
et al., J Comp. Neurol. 435: 464 [2001]). We have
recently shown that CPG15 mediates these changes by
promoting synapse formation, which in turn enhances
axonal arbor growth (Javaherian and Cline, Neuron 45:
505 [2005]). These data suggest that CPG15 is akin to
an activity-induced targeted growth factor.
It now appears that many activity-induced genes
function in a homeostatic manner to maintain synaptic
strength within a functional operating range, despite
experience-dependent increases or decreases in synap-
tic strength. This is the case for Arc (Rial Verde et al.
2006) and Homer (Van Keuren-Jensen and Cline
2006), as well as ornithine decarboxylase, which gen-
erates polyamines and thereby regulates neuronal
excitability and the strength of glutamatergic synaptic
transmission.
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The goal of this body of work is to generate a
comprehensive understanding of the role of experi-
ence in shaping brain development. We have taken a
multidisciplinary approach to this question which has
successfully revealed the complexity of brain devel-
opment. Our experiments use a combination of mol-
ecular/ genetic manipulation and quantitative obser-
vations of structural and functional plasticity in
response to visual stimulation. Our experiments have
demonstrated a diverse range of effects of visual
activity on the development and plasticity of the
visual system and have the potential to reveal both
direct and homeostatic mechanisms of circuit devel-
opment. We are now poised to move beyond analysis
of individual neurons within the retinotectal system
and to address questions more related to circuit
development and function.
Activity-induced Genes Homerla
and Arc Mediate Homeostatic
Changes in the Strength of
Neuronal Connections
K. Van Keuren-Jensen, E. Rial Verde
A fundamental adaptive feature of neurons within a
functional network is their ability to respond to affer-
ent activity by changing the strength of synaptic con-
nections. At most excitatory synapses, changes in
ionotropic AMPAR transmission underlie changes in
synaptic strength, whereas the ligand and voltage-
dependent NMDARs and mGluRs are thought to
modulate AMPAR synaptic plasticity and down-
stream signaling events. In two independent sets of
experiments, we find that activity-induced neuronal
genes, Homerla and Arc, function to regulate synap-
tic strength in a homeostatic manner.
These data suggest that activity-induced genes
have two distinct types of functions with respect to
circuit plasticity: One function is to more or less
directly affect synaptic strength, for instance, as we
have shown that CPG15 enhances synaptic strength
and increases dendritic and axonal arbor elaboration
(Nedivi et al., Science 281: 1863 [1998]; Cantallops
et al., Nat. Neurosci. 3: 1004 [2000]; Javaherian and
Cline, Neuron 45: 505 [2005]). The second function
of activity-induced genes is to control the magnitude
of the changes in synaptic strength through homeo-
static mechanisms, so that plasticity can occur
despite stimuli that drive synaptic strength toward
extreme high or low values.
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FIGURE 1 Model of Homerla/Homerlb regulation of mGluR-
mediated changes in AMPAR synaptic transmission. After
12-15 hr dark, Homerla/Homerlb is low and mGluR activation
enhances AMPA-mediated transmission. With visual stimulation
Homerla/Homerlb increases, reducing the mGluR-mediated
increase in AMPAR synaptic transmission.
Homer proteins are integral components of postsy-
naptic density and are thought to function in synapto-
genesis and plasticity, possibly through their interac-
tion with mGluRs. Brief mGluR activation leads to
plasticity of AMPAR synaptic transmission. To test
whether mGluR-mediated plasticity of AMPAR trans-
mission is influenced by recent neuronal activity, we
manipulated visual activity in Xenopus laevis tadpoles
in vivo. We compared mGluR-mediated plasticity of
AMPAR transmission in optic tectal cells of tadpoles
with low levels of previous synaptic activity (overnight
in the dark) to transmission in neurons from animals
following 4 hours of constant visual stimulation.
mGluR-mediated plasticity of AMPA transmission
was significantly decreased in neurons with recent
activity. By changing the ratios of Homerla to
Homerlb in vivo, either by induction of endogenous
Homerla by visual activity, or by ectopic expression
of Homerla or Homerlb, we could change the direc-
tion of mGluR-mediated plasticity (Fig. 1). This is the
first evidence that mGluR-mediated changes in AMPA
transmission can be regulated by Homer proteins in
response to physiologically relevant stimuli.
Arc is an immediate-early gene whose expression
levels are increased by strong synaptic activation,
including synapse-strengthening activity patterns. Arc
mRNA is transported to activated dendritic regions,
conferring the distribution of ARC protein both tempo-
ral correlation with the inducing stimulus and spatial
specificity. We found that increased ARC levels unex-
pectedly reduce the amplitude of synaptic currents
mediated by AMPARs. This effect is prevented by
RNA interference (RNAi) knockdown of ARC, by
deleting a region of ARC known to interact with
endophilin 3 or by blocking clathrin-coated endocyto-
sis of AMPARs. Our results demonstrate that ARC
reduces the number of synaptic AMPARs leading to a
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FIGURE 2 Arc mediates homeostatic control of glutamatergic
transmission. The schematic illustrates the scenario in which a
region of the dendrite receives a synapse-strengthening stimulus
that causes different amounts of potentiation in three neighbor-
ing synapses and induces Arc mRNA expression and localiza-
tion to that region. Synapse 1 is 100% potentiated, synapse 2 is
not potentiated, and synapse 3 is 50% potentiated. ARC-
induced depression preferentially affects synapses with relative-
ly more GIuR2 /3 content. Consequently, the potentiated-to-non-
potentiated synaptic strength ratio is increased by ARC-induced
GIuR2 /3 removal, e.g., synapse 1-to-synapse 2 ratio, initially 1,
becomes 2 after long-term potentiation (LTP) and increases to 3
after ARC has acted. In addition, total synaptic strength for that
dendritic region is homeostatically regulated (initially 6, becomes
9 after LTP, returning to 6 after ARC's action).
decrease in synaptic currents, consistent with a role in
the homeostatic regulation of synaptic strength (Fig. 2).
Regulation of Retinal Axon Arbor
Elaboration and Branch Dynamics
by Synaptic Contacts
E. Ruthazer, J. Li
Patterned neural activity and synaptic transmission
guide the remodeling of axonal arbors in the develop-
ing central nervous system by regulating the addition,
stabilization, and elimination of branches as arbors
grow. In the retinotectal projection of frogs and fish,
the dynamic rearrangement of axonal branches active-
ly refines and maintains the retinotopic map. Previous
work in our lab had demonstrated a critical role for
Ohr
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FIGURE 3 Branch retractions halted by mature SYP puncta. (a)
Schematic of axon branch retractions relative to the positions of
synapses. (b,c) Examples of branch retractions over 4 hr that
stop at mature SYP puncta (closed arrow). Faint puncta do not
prevent branch retraction (open arrow). For a detailed explana-
tion, see Ruthazer et al. (2006).
activity-dependent Hebbian mechanisms in control-
ling axon branch retraction. We showed that the cellu-
lar mechanisms involved retrograde signaling down-
stream from activation of postsynaptic tectal NMDA-
Rs, which effectively function as correlation detectors.
These and other studies, including our studies on
motor neuron axon development (Javaherian and
Cline, Neuron 45: 505 [2005]), suggest a central role
for synaptic connections in axon arbor remodeling and
raise the intriguing possibility that as synapses mature
and strengthen, they may serve double duty as struc-
tural sites for axon branch stabilization.
To examine the role of synaptogenesis and synaptic
maturation in the structural development of axonal pro-
jections during the formation of the topographic retino-
tectal projection, we coexpressed cytosolic fluorescent
protein (FP) and FP-tagged synaptophysin (SYP) in
small numbers of retinal ganglion cells in living albino
X laevis tadpoles to reveal the distribution and dynam-
ics of presynaptic sites within labeled retinotectal
axons. Two-photon time-lapse observations followed
by quantitative analysis of tagged SYP levels at indi-
vidual synapses demonstrated the time course of synap-
togenesis: Increases in presynaptic punctum intensity
are detectible within minutes of punctum emergence
and continue over many hours.
Puncta lifetimes correlate with their intensities.
Furthermore, we found that axon arbor dynamics are
affected by synaptic contacts. Axon branches retract
past faintly labeled puncta but are locally stabilized by
mature synapses with intensely labeled SYP puncta
(Fig. 3). Visual stimulation for 4 hours enhanced the
stability of the arbor at intense presynaptic puncta
while concurrently inducing the retraction of
exploratory branches with only faintly labeled or no
synaptic sites.
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Depolarizing GABAergic Conductances
Regulate the Balance of Excitation to
Inhibition in the Developing Retinotectal
Circuit in Vivo
C. Akerman
Neurotransmission during development regulates
synaptic maturation in neural circuits, but the contri-
bution of different neurotransmitter systems is unclear.
We investigated the role of GABAA receptor-mediated
Cl- conductances in the development of synaptic
responses in the Xenopus visual system. Intracellular
Cl concentration ([C1-]1) was found to be high in
immature tectal neurons and then falls over a period of
several weeks. GABAergic synapses are present at
early stages of tectal development and, when activated
by optic nerve stimulation or visual stimuli, induce
sustained depolarizing Cl- conductances that facilitate
retinotectal transmission by NMDARs.
To test whether depolarizing GABAergic inputs
cooperate with NMDARs during activity-dependent
maturation of glutamatergic synapses, we prematurely
reduced [C11 in tectal neurons in vivo, by expressing
the Cl- transporter KCC2. This blocked the normal
developmental increase in AMPAR-mediated retino-
tectal transmission and increased GABAergic synaptic
input to tectal neurons. Therefore, depolarizing
GABAergic transmission has a pivotal role in the mat-
uration of excitatory transmission and controls the bal-
ance of excitation and inhibition in the developing
retinotectal circuit. Control cells, expressing GFP or a
mutant form of the transporter Y1087D are compara-
ble to untransfected cells (Fig. 4). For details, see
Akerman and Cline 2006.
AMPARs Regulate Experience-depen-
dent Dendritic Arbor Growth In Vivo
K. Haas, J. Li
The size and shape of neuronal dendritic arbors affect
the number and type of synaptic inputs, as well as the
complexity and function of brain circuits. In the intact
brain, dendritic arbor growth and the development of
excitatory glutamatergic synapse are concurrent.
Consequently, it has been difficult to resolve whether
synaptic inputs drive dendritic arbor development.
Here, we test the role of AMPAR-mediated gluta-
matergic transmission in dendrite growth by express-
ing peptides corresponding to the intracellular car-
boxy-terminal domains of AMPAR subunits GluRl
(GluR1C0 and G1uR2 (GluR2Ct) in optic tectal neu-
4dpf 16dpf KCC2 GFP Y1087D
fGABAergic
'17\001°.
Ct.GABAergic
Ct.
-MO
FIGURE 4. Low [C11, impairs the developmental balance of glutamatergic and GABAergic synaptic inputs in the retinotectal circuit in
vivo. (a) The ratio of AMPA input to GABA input increases with development but was significantly reduced by premature expression
of KCC2, the Ch transporter. Control cells, expressing green fluorescent protein (GFP) or a mutant form of the transporter,Y1087D,
are comparable to untransfected cells. For details, see Akerman and Cline (2006).
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FIGURE 5 Maturation of glutamatergic synapses is required for normal dendritic arbor growth and experience-dependent dendrite
arbor plasticity. (A) Schematic of the effect of expressing the carboxy-terminal peptides of AMPARs on dendritic arbor development.
(B) Retinal input activity to the optic tectum was increased by exposure of freely swimming tadpoles to moving-bar visual stimulation
for 4 hr following 4 hr in the absence of visual stimulation. (C) Relative changes in tectal neuron total dendritic arbor length and (D)
branch tip number over each 4-hr period for control neurons and neurons expressing GIuR1 or GIuR2 carboxy-terminal peptides.
GluR1Ct and GluR2Ct neurons retracted branches in response to visual experience, whereas control neurons increase arbor growth
with experience. (*) Significant difference compared to controls within same time period, p < 0.05; (+) significant difference within
same group between dark and visual stimulation periods, p < 0.05.
rons of the Xenopus retinotectal system. These pep-
tides significantly reduce AMPAR synaptic transmis-
sion in transfected neurons while leaving visual sys-
tem circuitry intact. Daily in vivo imaging over 5 days
revealed that G1uR1Ct or G1uR2Ct expression dramat-
ically impaired dendrite growth, resulting in less com-
plex arbors than controls. Time-lapse images collected
at 2-hour intervals over 6 hours show that both
G1uR1Ct and G1uR2Ct decrease branch lifetimes.
Ultrastructural analysis indicates that synapses formed
onto neurons expressing the G1uRCt are less mature
than synapses onto control neurons.
These data suggest that the failure to form complex
arbors is due to reduced stabilization of new synapses
and dendritic branches. Although visual stimulation
increases dendritic arbor growth rates in control tectal
neurons, a weak postsynaptic response to visual expe-
rience in G1uRCt- expressing cells leads to retraction of
branches (Fig. 5). These results indicate that AMPA-R-
mediated transmission underlies experience-dependent
dendritic arbor growth by stabilizing branches and sup-
port a competition-based model for dendrite growth.
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GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Blum
M. Cressy
C. Jurgensen
E. Kockenmeister
W. Li
H. Qin
The long-term goal of our research is to understand
memory. Dissection of complex behaviors such as
memory and learning will require a multidisciplinary
approach that will include discovery and manipulation
of the relevant genetic, cellular, and anatomical path-
ways, as well as computational modeling of how infor-
mation is processed in the brain. Work in genetic model
systems such as Drosophila can contribute to our under-
standing in two main ways. First, by enabling discovery
of genes and genetic pathways underlying behavior,
genetic model systems provide entry points for subse-
quent interventionist experiments. Second, systematic
manipulation of gene function in relevant anatomical
loci of the brain allows a conceptual integration of find-
ings from cellular and behavioral neuroscience.
The Drosophila model system also offers an econ-
omy of scale to discover and develop hypotheses in a
relatively cost-effective and rapid manner. Given the
remarkable evolutionary conservation of genetic, cel-
lular, and behavioral mechanisms, the findings from
Drosophila can ultimately be informative to work in
mammalian model systems.
Discovery of Genes Involved
in Memory
J. Dubnau [in collaboration with T. Tully and N. Sinha,
Cold Spring Harbor Laboratory]
In collaboration with the Tully lab, we have used a
combination of behaviorally specific training proto-
cols and expression profiling with DNA chips to iden-
tify transcriptional responses during memory consol-
idation (Dubnau et al., Curr Biol. 13: 286 [2003]).
We have used this approach to compare gene expres-
sion profiles after spaced training, which induces
both short-term and protein-synthesis-dependent
long-term memory, and massed training, which only
induces short-lived memory. We have identified a
large number of candidate memory genes (CMGs)
differentially expressed at three different retention
intervals after spaced versus massed training. Using
real-time polymerase chain reaction (PCR) follow-up
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assays, we have confirmed differential expression for
60 of these transcripts.
This effort has identified CMGs that serve as entry
points for molecular genetic investigation of gene
function in memory. These CMGs have become fodder
for in vivo genetic manipulations to forge mechanistic
connections between individual gene pathways and
memory formation at the behavioral level. With that
aim in mind, we are focusing on local translational
control, one of several pathways suggested from the
array experiments. Our genetic studies already support
a role in memory for several components of this path-
way. These include staufen and oskar, which are
known components of a cellular mRNA localization
machinery in oocytes, and pumilio, which is a transla-
tional repressor protein. A large number of the known
components of the mRNA localization machinery, as
well as of the apparatus for regulating cytoplasmic
polyadenylation-stimulated translational control, also
are differentially expressed. Genetic reagents to
manipulate these pathways are extant in Drosophila.
In addition to this obvious point of convergence
between the microarray and behavioral screen, many
additional hypotheses are suggested by the above two
gene discovery efforts. Several projects in the lab now
focus on testing hypotheses derived from this data set.
Identification of Synaptic Targets of
Drosophila Pumilio
J. Dubnau, W. Li [in collaboration with G. Chen,
Q.S. Zhang, M. Regulski, N. Sinha, T. Tully, A. Krainer,
M. Zhang, Cold Spring Harbor Laboratory]
Drosophila melanogaster Pumilio (Pum) protein is
one of the founding members of the PUF RNA-bind-
ing protein family. Its function in the posterior body
patterning of Drosophila embryos is relatively well
studied. The 3 '-untranslated region (3 'UTR) of mater-
nal hunchback (hb) mRNA contains two copies of
sequence elements named Nanos response elements
(NREs), which are essential for normal abdominal
segmentation. It was later shown that Pum binds these
elements, recruits Nanos (Nos) and Brain Tumor
(Brat), and represses the translation of maternal hb
mRNA. More recently, we identified Pum as having a
key role in long-term memory (Dubnau et al., Carr.
Biol. 13: 286 [2003]), and Pum was also recently
shown to regulate excitability at the neuromuscular
junction via translational regulation of sodium chan-
nels. Despite these genetic observations, few neuronal
targets of Pum have been identified.
To screen for potentially relevant neuronal (and in
particular synaptic) targets of Pum, we (in collabora-
tion with G. Chen and M. Zhang) have used a combi-
nation of informatics and experimental approaches.
Our first step to identifying new Pum targets was to
characterize and model the Pum-binding sites. We
then used our models to predict the presence of NREs
in the 3 'UTRs of mRNAs coding for synaptic pro-
teins. Several of these were validated by in vitro bind-
ing assays (Q.S. Zhang and A. Krainer). Finally, we
used an established in vivo functional assay to vali-
date pumilio-dependent regulation of several of the
predicted targets.
To generate in vivo support for the target prediction
method, we chose to use the Pum response assay origi-
nally described for the hb gene. This assay relies upon
the requirement that maternally supplied hb mRNA is
repressed by Pum/Nos in posterior regions of the early
embryo. We started with the canonical genomic hb-res-
cuing transgene in which the endogenous NRE motifs
have been deleted. In the absence of functional NRE ele-
ments, this construct causes a dominant sterility in trans-
genic females due to ectopic hb translation in the poste-
rior half of the embryos produced. Such embryos are
unable to form abdominal segments. Insertion into this
canonical construct of a functional NRE motif restores
Pum-mediated repression in the posterior, allowing pro-
duction of viable progeny. Using this strategy, we tested
the functional capacity of the predicted NRE motifs
from Ace and dlgl. We chose these two putative targets
because they showed robust in vitro binding and also
because both transcripts are induced by spaced training
(not shown).
We generated a series of hb-transgene constructs
(Fig. 1) in which the two endogenous hb NREs had
been deleted entirely (hbA), had been replaced with a
single hb NRE, NRE2 (hb2), had both hb NRE ele-
ments reinserted (hb1,2), had been replaced with puta-
tive NRE elements from Ace or dlgl genes (Ace or
dlg1), or had been replaced with an antisense version
of the predicted dlgl NRE (dig-anti). We found that
the predicted NRE from dlgl is sufficient to partially
restore abdominal patterning when compared with
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FIGURE 1 Predicted Pum-binding site in dig is able to restore
normal Pum-dependent regulation to the hb gene in the embryo.
hb1,2 (Fig. 1), which provided full rescue as expected.
It is worth noting that the rescue observed with the sin-
gle dlgl NRE is superior to that observed with a sin-
gle copy of the hb NRE. A single hb NRE (hb2) yields
partial rescue. In contrast, control transgenic lines in
which no functional NRE was provided or in which the
dlgl NRE was inserted in opposite orientation (dig-
anti) generate progeny nearly devoid of abdominal
segments.
Together, these findings indicate that dlg may be a
synaptic target of Pum. Dlg is the sole Drosophila
member of a family of membrane-associated guany-
late kinases (MAGUKs) that in mammals have been
shown to have a key role in assembling the postsynap-
tic density in glutamatergic synapses. In Drosophila,
Dlg expression is both pre- and postsynaptic at type I
boutons at the neuromuscular junction (NMJ), and
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mutants exhibit postsynaptic structural
defects as well
as increased transmitter release. Dlg
is thought to have
a key role in clustering GluRIIB receptors
at the NMJ
as well as Shaker 1(± channels throughout the central
nervous system (CNS).
Like Dlg, Pum also appears to have both pre- and
postsynaptic effects at the NMJ and is colocalized
with Dlg at type I boutons. In addition to morpholog-
ical effects on synapse structure, Pum appears to reg-
ulate excitability via an effect on expression of para
Na + channels. The regulation of para may be direct, or
it may depend on Pum's proposed role in regulating
translation of eIF-4E. Pum expression itself is
induced by behavioral training that results in long-
term memory (Dubnau et al., Curr Biol. 13: 286
[2003]). Thus, one hypothesis that seems reasonable
is that activity-dependent increases in Pum expression
have a homeostatic role by reducing excitability via
repression of para.
Our findings indicate an additional role of Pum is
directly regulating dlgl expression, suggesting that Pum
antagonizes the effects of Dlg on neuronal structure
and/or function. We cannot distinguish whether this
interaction is pre- or postsynaptic (or both). Current
efforts focus on testing the role in memory of Pum-
dependent regulation of several of the predicted targets.
Functional Anatomy of
Memory Consolidation
A. Blum, M. Cressy, H. Qin, J. Dubnau [in collaboration
with A.S. Chiang, Taiwan]
In both vertebrate and invertebrate animals, anesthetic
agents cause retrograde amnesia for recently experi-
enced events. In contrast, older memories are resistant
to the same treatments. In Drosophila, anesthesia-
resistant memory (ARM) and long-term memory
(LTM) are genetically distinct forms of long-lived
memory that exist in parallel for at least a day after
training. Genetic and pharmacological experiments
indicate the presence of at least five mechanistically
distinct temporal phases of memory (short-term, mid-
dle-term, ARM, and LTM). Although a neural struc-
ture called the mushroom bodies (MBs) has a demon-
strated role in early memory and in memory retrieval
at several time points, very little else is known about
the anatomical circuitry underlying each of the above
memory phases.
To map the neural circuits required for memory
formation, storage, and retrieval, we take advantage of
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a large panel of Gal4 "driver" lines that express in
small, reproducible sets of neurons. These can be used
to drive expression of florescent reporters to generate
high-resolution images of the neuronal connectivity, or
they can be used to drive expression of any other gene
of interest to investigate functional requirements for
behavior of each circuit component. We are using two
main strategies to dissect the functional role of these
identified neuronal circuits. First, we use the Gal4 lines
to map the temporal and spatial requirements for genes
involved with memory formation. Second, we are using
a temperature-sensitive dynamin transgene, which dis-
rupts synaptic transmission reversibly and on a time
scale of minutes. With the former approach, we are able
to determine the anatomical circuits in which each
genetic/cellular pathway functions. With the latter
approach, we are able to reversibly silence reproducibly
specific groups of neurons in vivo to directly probe the
functional role of each identified neuron type.
We already have demonstrated a role for synaptic
transmission in MB neurons during memory retrieval
but, surprisingly, not during acquisition of early mem-
ory (Dubnau et al., Nature 411: 476 [2001]). These
data suggest that the synaptic plasticity underlying
olfactory associative learning initially resides in MB
dendrites and/or upstream of the MB and that the
resulting alterations in synaptic strength modulate MB
output during memory retrieval. But virtually nothing
is known about the neural circuitry involved in the
subsequent consolidation of short-term, middle-term,
anesthesia-resistant, or CREB-dependent LTM phases.
And nothing is known about the downstream circuitry
of memory retrieval.
To select Gal4 lines for functional anatomy inves-
tigations, we have used two approaches. First, Ga14
insertion mutations in genes involved in memory per-
mit a first-pass evaluation of the green fluorescent
protein (GFP) reporter expression pattern of biologi-
cally relevant genes. These are then used in combina-
tion with the dynamin mutant to reversibly silence
synaptic transmission. A second approach that we are
using to select relevant Gal4 driver lines is based sole-
ly on their expression pattern, rather than on their
insertion in a "memory gene." In collaboration with
A.S. Chiang (Taiwan), we have access to a growing
panel of Ga14 enhancer lines that yield remarkably
specific expression in neurons that send projections
into different substructures of the MB. These identi-
fied MB "extrinsic" neurons constitute a significant
fraction of the inputs, outputs, and modulation of MB.
With the dynamin method, we can functionally manip-
ulate these neuronal populations.
FIGURE 2 VAM neurons are output neurons of MB alpha lobes.
The ventral anterior medial (VAM) neuron driver,
for example, yields expression in four neurons whose
dendrites project to the axon outputs of the MB alpha
lobe (Fig. 2). Axon outputs of the VAM neurons termi-
nate in the posterior superior protocerabrum (PSP).
With the dynamin approach, we have established a role
for these neurons in an intermediate-term memory
(Fig. 3). We used transient disruption of transmission
in VAM neurons at different time points after training
to examine the temporal requirements for these MB
output neurons. When VAM neurons are blocked dur-
ing the first 30 minutes after training, memory (mea-
sured 3 hours after training) is partially disrupted. In
contrast, transient inhibition of VAM neuron function
at later time points appears to have little or no effect.
These VAM neurons appear to be dispensable for
learning (not shown), suggesting that these MB output
neurons are specifically required to maintain a memo-
ry trace or to consolidate memory. Ongoing efforts are
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FIGURE 3 Transient inhibition of dynamin-mediated neurotrans-
mission in VAM neurons reveals a temporal window where VAM
mediates memory storage. Inhibition times are 0-30 min (2), 30-60
min (3), or 60-90 min (4) after training.
focused on filling in the rest of the circuitry for these
"early" memory phases, as well as for LTM and for
memory retrieval.
Selective Breeding of rutabaga
Suppression
M. Cressy, E. Kockenmeister, J. Dubnau [in collaboration
with P. Mitra, Cold Spring Harbor Laboratory]
Genetic investigation of memory has revealed that
underlying mechanisms are highly conserved across
phyla. The cAMP cascade, for example, has been
implicated in memory in both invertebrate and verte-
brate animals, including humans. The informative
power of genetics derives in part from identification of
genes that influence phenotype but also from analysis
of gene interaction. Saturation mutagenesis for embry-
onic patterning, for instance, identified most of the
relevant genes. Equally important, however, were sec-
ond-site suppressing and enhancing screens. This
approach allowed cell-signaling pathways and mecha-
nistic insights to be distilled from what otherwise
would be unconnected gene lists.
In the case of complex behavioral phenotypes such
as memory, forward mutagenesis has identified a num-
ber of relevant genes (Margulies et al., Curr Biol. 15:
R700 [2005]). Here too, the most informative
instances are where mechanistic interactions among
genes are understood. cAMP signaling is the most
notable example. Assembly of genes into functional
networks, such as the cAMP cascade, is the most chal-
lenging aspect of genetics. Although sup-
pressor/enhancer screens have yielded some success,
this approach is often not feasible for complex quanti-
tative traits such as memory. Moreover, modifier
screens are only designed to detect interactions
between pairs of genes, but they generally do not iden-
tify more complex gene networks. We are using exper-
imental evolution with identified memory mutants
(Dubnau et al., Curr. Biol. 13: 286 [2003]) in
Drosophila as a strategy to screen for networks of gene
interaction capable of suppressing or enhancing the
role of cAMP signaling.
Our approach relies on artificial selection over the
course of multiple generations to "evolve" combina-
tions of known and molecularly tagged gene variants
that interact to suppress the learning defect of rutaba-
ga mutants. We are able to follow the "evolution" of
allele combinations by using a high-throughput geno-
typing strategy. The initial stage of this project involved
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a series of Mendelian crosses to establish founding
populations that are homozygous mutant for rutabaga
and heterogeneous for a large collection
of autosomal
recessive alleles of memory-related genes
(Dubnau et
al., Cum Biol. 13: 286 [2003]). We now are conducting
the selective breeding strategy in parallel
with high-
throughput genotyping of each population.
Poly-ADP-Ribosylation in
Memory
J. Dubnau, C. Jurgensen [in collaboration with Ladurner
Lab, EMBL]
In all species that have been studied, long-term mem-
ory involves a cascade of CREB-dependent DNA tran-
scription, a process that is fundamentally regulated at
the level of chromatin structure.
One of the most dynamic ways to manipulate
chromatin is through chemical changes on the his-
tone proteins themselves. Among these, poly-ADP-
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ribosylation is one of the first characterized and
least understood posttranslational changes of pro-
teins. Recent in vitro and in vivo evidence suggests
that this modification alters the transcriptional
activity of genes. Crucially, this modification has a
known role in long-term memory in Aplysia, as
well as in neurodegeneration in Drosophila and
mammals.
The overall aim of this project is to understand
the function of the poly-ADP-ribose pathway in
memory. We are capitalizing on existing mutant
strains and transgenic lines for the single fly PARP
and PARG genes. To complement existing mutant
Drosophila strains, we will use a structure-guided
biophysical approach to design novel protein variants
with altered enzymatic activity and with changed
poly-ADP-ribose-binding function. We will then
exploit Drosophila molecular genetic approaches to
determine how these rationally designed as well as
existing mutant PAR pathway components regulate
the formation of memory.
STEM CELLS, SIGNAL TRANSDUCTION, AND DIFFERENTIATION
G. Enikolopov J. Encinas
J. Hemish
T. Michurina
J.-H. Park
N. Peunova
K. Ravi
New neurons are continuously produced in the adult
brain. The birth of new neurons is a dynamic process
and it changes in response to a wide range of stimuli.
The role of this constant supply of new neurons is still
unclear; however, there is increasing evidence that
adult neurogenesis may be important for learning,
memory, and mood.
We study signals that regulate distinct steps in the
cascade converting stem cells into neurons. We also
study whether similar signals regulate stem cells in
other tissues. We are particularly interested in how neu-
rogenesis may be linked to mood regulation and may
underlie the action of antidepressant therapies. We
have developed a new approach for identifying and
quantifying cellular targets of neurogenic stimuli and
have used it to determine cell populations targeted by
antidepressants in the adult brain. We are now using
this approach to examine whether different types of
treatments that regulate mood have a similar effect on
the neuronal differentiation cascade and to identify sig-
naling molecules that translate these treatments into an
increased number of new neurons. Much of our effort
is related to a versatile signaling molecule, nitric oxide,
which is involved in controlling cell division and dif-
ferentiation. Furthermore, we continue to generate new
animal models to study stem cells and neurogenesis.
NEURAL STEM AND PROGENITOR CELLS IN THE
ADULT BRAIN
New neurons of the adult brain are generated from
neural stem and progenitor cells and become fully
functional several weeks after they are born; during
this time, cells undergo symmetric and asymmetric
divisions, exit the cell cycle, express a range of mark-
ers, change their morphology, establish connections
with other cells, and become integrated into the exist-
ing neuronal circuitry.
The transition from stem cells to fully differentia-
tion neurons, the neuronal differentiation cascade,
occurs through defined steps, and different classes of
neuronal precursors can be distinguished by their mor-
phology, expressed markers, and mitotic activity. We
developed a transgenic approach that allows identifi-
cation, in vivo visualization, isolation, and accurate
enumeration of various classes of stem and progenitor
cells in the adult brain. For that, we generated a series
of reporter mouse lines in which neural stem and prog-
enitor cells express various fluorescent proteins (GFP,
CFPnuc, H2B-GFP, DsRedTimer, mCherry) under the
control of the regulatory elements of the nestin gene.
In particular, nuclear localization of the fluorescent
signal in nestin-CFPnuc and nestin-H2B-GFP mice
greatly simplifies the distribution pattern of neural
stem and progenitor cells and allows accurate quanti-
tation of changes induced by neurogenic agents in dis-
tinct classes of neuronal precursors. Using the reporter
lines, we were able to dissect the neuronal differentia-
tion cascade into several discrete steps (Fig. 1) and to
evaluate the changes induced by various neurogenic
and antineurogenic stimuli.
NEUROGENIC TARGETS OF ANTIDEPRESSANTS
Emerging evidence indicates a close link between the
action of a diverse range of antidepressant therapies
and augmented generation of new neurons in the adult
hippocampus. Moreover, recent findings suggest that
adult hippocampal neurogenesis not only accompa-
nies, but is also required for the behavioral effects of
antidepressants (e.g., fluoxetine/Prozac). This discov-
ery may clarify several observations regarding the
clinical course of action of antidepressant drugs. For
instance, it may explain why an appreciable clinical
effect of antidepressants usually takes at least 3-4
weeks: This period may reflect the time required for
neural stem cells to proceed through the differentia-
tion cascade and become fully differentiated and inte-
grated neurons.
Using our transgenic reporter lines and the scheme
of the neuronal differentiation cascade in the adult
brain, we decided to determine the cell population tar-
geted by fluoxetine. We found that the drug does not
affect division of stem-like cells, but it increases sym-
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FIGURE 1 Neuronal differentiation cascade in the hippocampus.
metric divisions of an early progenitor cell class. We
further demonstrated that this is the sole class of neu-
ronal progenitors targeted by fluoxetine in the adult
brain and that the subsequent fluoxetine-induced
increase in new neurons arises as a result of the expan-
sion of this class of cells.
Importantly, these studies suggested a general
strategy to explore the changes induced by other anti-
depressant treatments. We are now using
approach to determine the neurogenic targets of anti-
depressant drugs of different families and of the other
types of antidepressant treatments, such as electrocon-
vulsive shock and deep brain stimulation, trying to
determine whether they converge on the same neuro-
genic targets. We also study whether these therapies
may target other types of progenitor cells in the devel-
oping brain. Furthermore, we study whether neuroge-
nesis and the action of antidepressants in the adult
nervous system may differ under normal conditions
and when affected by a disease (e.g., Parkinson's).
Finally, we are using the reporter lines and the infor-
mation that we gained about distinct steps of neuronal
maturation to identify the signals that control the qui-
escence and self-renewal of stem cells and that direct
the differentiation cascade in the adult brain.
STEM CELLS IN NONNEURAL TISSUES
Tissue maintenance requires a constant supply of new
cells. These new cells replace cells lost to stress and
damage or destroyed as part of the normal cell death
program; moreover, in response to physiological and
pathological stimuli, they may convey new properties
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GRANULE
CELLS
to the tissue. The replacement of old cells by new ones
is made possible either by self renewal of differentiat-
ed cells or through the activity of adult tissue-specific
stem cells. Adult stem cells are usually morphological-
ly unspecialized, can undergo long-term self-renewal,
and are located in specialized niches that restrict their
division and support their undifferentiated status.
We found that in our nestin-GFP and nestin-
CFPnuc reporter mouse lines, expression of the
reporter transgene marks stem and progenitor cells in
several nonneural tissues. We have demonstrated that
such GFP/CFPnuc-expressing cells can be found in
the bulge region of the hair follicle, where they repre-
sent a population of cells with stem properties and a
capacity to generate neuronal cells in vivo and in vitro;
in testis, where they persist as precursors to the
steroidogenic Leydig cells; and in the skeletal muscle,
where they correspond to the satellite cells, the quies-
cent myogenic stem cells. They are also seen in the
liver, where they reside as oval cells that can serve as
stem cells after exposure to carcinogens or when the
usual mode of liver regeneration through division of
hepatocytes is suppressed. Furthermore, they are
found in the anterior pituitary, where they serve as
adult stem cells, able to generate all six endocrine lin-
eages of the adult gland.
These findings suggest a close relationship
between the expression of nestin and stem-like proper-
ties of cells in the adult tissues. Furthermore, they pro-
vide a means to isolate stem cells from various adult
tissues and examine the requirements for such cells for
tissue maintenance, response to injury, repair, or trans-
plantation.
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CONSTRUCTION AND PLASTICITY OF THE GABAERGic CIRCUITS
IN NEOCORTEX AND CEREBELLUM
Z.J. Huang G. diCristo S. Kulhman
Y. Fu C.A. Paul
M. He H. Taniguchi
P. Wu
X. Wu
H. Yang
A major challenge in modern neuroscience is to under-
stand how neuronal functions emerge from the under-
lying neural networks and their cellular constituents. In
many areas of the vertebrate brain, GABAergic
interneurons are crucial in establishing the functional
balance, complexity, and computational architecture of
neural networks. For example, GABAergic inhibition
regulates synaptic integration, probability, and timing
of action potential generation in glutamatergic princi-
pal neurons. Furthermore, interneurons generate and
maintain network oscillations, which provide the tem-
poral structures for orchestrating the activities of neu-
ronal populations. Therefore, the specific spiking pat-
terns in dynamic ensembles of principal neurons, the
neural code underlying their functional output, are
largely determined by the spatial and temporal distrib-
ution of inhibition in the network.
The rich variety and fine details of inhibition are
achieved by stunningly diverse types of GABAergic
interneurons, which display distinct morphology, physio-
logical properties, connectivity patterns, and biochemical
constituents. Decades of studies suggest that the biophys-
ical properties of different classes of interneurons are
optimized for generating a rich array of distinct firing
patterns, which constitute the "physiological vocabulary"
of interneurons to control electrical activity in neurons
and networks. Furthermore, each class of interneurons
displays highly characteristic axon arbors and innervation
patterns, which distribute their temporal firing patterns to
discrete spatial locations, cell types, and subcellular com-
partments within the network. In addition, like the gluta-
matergic connections, GABAergic synapses can also be
modified by usage, leading to reconfiguration of the
inhibitory circuits by prior experience.
Understanding the design, operation, and plastici-
ty of GABAergic circuits is therefore key to decipher-
ing the precise organization and functional architec-
ture of neural networks. My laboratory combines
genetic, imaging, and physiological approaches to
study the construction, plasticity, and function of
GABAergic circuits, using cerebral and cerebellar cor-
tex as complementary experimental systems.
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SUBCELLULAR ORGANIZATION OF GABAERGic
SYNAPSES: L1CAMs AND ANKYRIN MEMBRANE
SKELETONS
A striking feature of GABAergic innervation is the tar-
geting of different classes of inhibitory synapses to sub-
cellular compartments of principal neurons (spines,
dendrites, soma, and axon initial segment [AIS]).
Subcellular organization of inhibitory synapses is
superimposed upon the intrinsic biophysical compart-
mental architecture of principal neurons and is essential
in regulating input integration, spike probability, timing,
and back propagation, but the underlying mechanism is
poorly understood. Combining mouse genetics and
high-resolution imaging, we have established in vivo
and in vitro systems to visualize and manipulate defined
classes of GABAergic interneurons.
Our study is beginning to outline the mechanisms
underlying subcellular synapses organization. First, we
demonstrated that subcellular targeting of GABAergic
synapses is largely guided by genetically determined
mechanisms and does not involve experience-dependent
neural activity. Second, we discovered that the subcellular
distribution of neurofascin, a member of the L 1 family
immunoglobulin cell adhesion molecules (L1CAMs),
recruited by the ankyrinG membrane cytoskeleton, is a
key molecular mechanism, which directs GABAergic
innervation to MS of Purkinje neurons. Third, we discov-
ered that GABAergic innervation of the Purkinje dendrite
is guided by an intermediate scaffold of Bergmann glial
fibers. Interestingly, this glial scaffold appears to direct
both the geometric and subcellular organization of
GABAergic axons and involves another member of
L1CAMs, CHL 1 (close homolog of L1) as a major mol-
ecular signal (F. Ango et al., submitted).
Our general hypothesis is that members of
L1CAMs recruited to subcellular domains by different
ankyrins contribute to subcellular organization of
GABAergic synapses. These studies raise many ques-
tions: What are the mechanisms for GABAergic
synapse targeting in other brain circuit such as neocor-
tex? What are the receptors in different classes of
GABAergic neurons for L1CAMs?
ACTIVITY-DEPENDENT MATURATION AND
PLASTICITY OF INHIBITORY SYNAPSES
AND INNERVATION PATTERNS: A NOVEL
FUNCTION OF GABA
The development of inhibitory circuits is shaped by
neural activity, but the underlying mechanisms are
unclear. We have established organotypic culture and in
vivo systems to visualize and genetically manipulate
defined classes of GABA interneurons in neocortex.
We demonstrate that the maturation of perisomatic
innervation by basket interneurons in the visual cortex
is regulated by neural activity and visual experience.
Most recently, we made a fundamental discovery
that GABA acts beyond its classic role as an inhibito-
ry transmitter to sculpt the maturation, and likely plas-
ticity, of inhibitory synapses and innervation patterns
(Fig. 1) (Chattopadhyaya et al. 2007). We found that
different aspects of GABAergic development are dif-
ferentially sensitive to GABA synthesis by its rate-lim-
iting synthetic enzyme GAD67. Although many earli-
er steps, such as cell migration and differentiation,
proceed normally with reduced GAD67 expression,
the maturation of perisomatic synapses from the bas-
ket interneuron in the adolescent neocortex is signifi-
cantly deficient even with the loss of one GAD67
allele (-30% reduction of neocortical GABA content).
These results suggest a surprisingly stringent
requirement for GAD67 and GABA signaling in shap-
ing the fine architecture of inhibitory circuits. Because
GAD67 level is strongly coupled to neuronal inputs,
activity-dependent GABA synthesis and signaling
may provide a cell-wide as well as synaptic mecha-
nism to sculpt GABAergic connectivity patterns. Our
findings suggest an unexpected parallel between the
role of glutamate in regulating the morphogenesis of
excitatory synapses and that of GABA for inhibitory
synapses; yet, they also imply fundamental differences
between these two systems: Activity-dependent cell-
wide regulation of "GABA resource" implies a novel
logic for the plasticity of synaptic innervation patterns.
Our discovery begs a revision in the current concept of
GABA function in vertebrate brains and also raises a
whole series of questions for future studies.
MATURATION OF GABAERGic TRANSMISSION AND
CRITICAL PERIOD PLASTICITY IN VISUAL CORTEX
Functional maturation of GABAergic circuits in the
developing visual cortex is regulated by neural activi-
ty and sensory inputs and, in turn, influences the criti-
cal period of ocular dominance (OD) plasticity. We
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FIGURE 1 GAD67 promotes the maturation of inhibitory presy-
naptic terminals. (Top) Basket interneuron axons are labeled
with red fluorescent protein (tdtomato) and synapto-
physin-green fluorescent protein (GFP). The dynamics and sta-
bility of inhibitory terminals are imaged using two-photon
microscopy in wild-type, GAD67-1-, and GAD67 overexpressing
basket cells. (Bottom) GAD67 promotes the accumulation of
synaptophysin-GFP in presynaptic boutons.
recently discovered a role for polysialic acid (PSA),
presented by the neural cell adhesion molecule
(NCAM), in the maturation of GABAergic innerva-
tion and OD plasticity. Our results suggest that devel-
opmental and activity-dependent removal of PSA is a
permissive mechanism that regulates the timing of the
maturation of GABAergic inhibition and onset of OD
plasticity.
Maturation of GABAergic inhibition promotes the
onset of the critical period for OD plasticity, but the
underlying cellular mechanism remains elusive.
Combining simple modeling and brain slice physiolo-
gy, we found that a sufficient level of synaptic inhibi-
tion was critical to ensure that temporal correlation of
inputs, rather than their initial synaptic strength, con-
trolled postsynaptic spike timing. These results sug-
gest that maturation of inhibition in the visual cortex
ensures that the temporally coherent, open eye inputs
control postsynaptic spike times of binocular neurons,
a prerequisite for Hebbian mechanisms to induce OD
plasticity (S. Kuhlman et al., submitted).
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VISUALIZATION AND MANIPULATION OF GABAERGic
NEURONS AND CIRCUITS IN VIVO
For decades, the heterogeneity and complexity of the
GABAergic network has hampered progress in under-
standing their development and function. Genetically
engineered mice provide an ideal strategy to study the
GABAergic system, but useful tools thus far are very
limited. What is particularly needed are lines of mice
in which genetic manipulations can be performed in
specific classes of GABAergic neurons in restricted
brain regions during a defined developmental window.
We have received major funding from the NIH
Neuroscience Blueprint Project to achieve this goal
using the Cre-loxP-based binary genetic system
(U01-MH078844-01). We are systematically generat-
ing more than 20 "driver lines" expressing Cre or
inducible Cre recombinase in different classes of
GABAergic neurons and their progenitors. In addition,
we are constructing a new generation of Cre-activated
"reporter" mice at the Rosa26 locus to achieve high-
level GFP (or other gene of interest) expression by
incorporating a variety of amplification strategies.
In collaboration of Sacha Nelson at Brandeis
University (subcontractor), we will characterize these
driver and reporter lines and establish a Web-based
platform for disseminating the mice, reagents, and
expression data to other investigators. These
GABAergic driver and reporter lines will significantly
accelerate progress in understanding all aspects of the
development and function of the GABAergic system.
GENE EXPRESSION PROFILE AND PROGRAMS
IN DIFFERENT CLASSES OF GABAERGic
INTERNEURONS
The stunning heterogeneity and complexity of
GABAergic interneurons in their intrinsic and synaptic
physiology, morphology, and connectivity are likely
conferred by differential gene expression. A systemat-
ic characterization of gene expression profiles among
GABAergic cell types may provide the most compre-
hensive and quantitative description of their molecular
make-up and yield fundamental insight in their classi-
fication, biophysical repertoire, and the genetic pro-
gram directing their development. We have generated
an array of bacterial artificial chromosome (BAC)
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transgenic mice expressing GFP in different classes of
GABAergic neurons.
In collaboration with my lab, Sacha Nelson at
Brandeis University has developed a method to manu-
ally purify GABA neurons for microarray analysis
(Sugino et al. 2006). We are applying this method to the
development of neural circuit in cerebellar cortex. The
cerebellum is appealing since various transgenic mice
label every major class of GABAergic neurons and glia
cells throughout development. These studies may reveal
novel biophysical properties, signaling pathways, and
transcription programs among interneurons and also
yield better tools (such as genes that define novel cell
types) for more refined genetic manipulations.
Such a non-hypothesis-driven approach is essential
to elucidate the genetic design of the GABAergic sys-
tem, its function, and capacity for plasticity. Using
genetic strategies including MADM (mosaic analysis
with double markers), we recently succeeded to reli-
ably label individual basket and stellate interneurons to
their entirety throughout their development in vivo.
The lattice-like circuit architecture in the cerebellar
cortex, centered on Purkinje neurons, allows high-res-
olution imaging and quantitative morphometry of bas-
ket and stellate interneurons with their synaptic targets.
Together, the combined genetic, imaging, and genomic
approaches promise to reveal new insights into the
genetic logic of the development of GABAergic cir-
cuits in the cerebellum.
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BIOPHYSICAL BASIS FOR NEURAL COMPUTATION
A. Koulakov D. Tsigankov
We continued to focus on the theoretical model for
development of connectivity in the visual system. Our
model combines the effects of binding and activation
of chemical labels, such as Eph receptors and their lig-
ands, ephrins, and Hebbian plasticity. This year, we
also included the effects of growth factors, such as
BDNF, in our model. We studied both the final con-
nectivity configurations and the dynamics of axons
and dendrites when this connectivity is formed. Our
model allows us to study the role of various factors on
neural development and to make experimentally
testable predictions. Thus, we showed that in some
cases, Hebbian mechanisms can contribute to the for-
mation of neural connectivity with a single-neuron
precision.
General methods advanced by us this year allow us
to represent formation of a more abstract neural net-
work as a result of interplay between genetic factors
represented by molecular labels and environmental
information given by the neuronal electric activity.
Our theoretical methods will allow us to address a
broad range of questions pertaining to the dynamics
and configurations of biologically realistic neural net-
works in the future.
A Unifying Model for
Activity-Dependent and
Activity-independent Mechanisms
of Topographic Map Development
D. Tsigankov, A. Koulakov
In the developing brain, axons are capable of finding
and recognizing their targets based on specific chemi-
cal cues, which are emitted into intercellular space or
localized on the cellular membranes. Further refine-
ment of neural connectivity is dependent on correlated
neural activity. In some cases, neuronal connectivity is
known to be assembled with a single-cell precision. To
understand the relationship between the effects of
chemical labels and activity-dependent refinement, we
investigated a quantitative model that is capable of
including both of these factors.
Our model generalizes Sperry's chemoaffinity
principle. We postulate that the system of axons fol-
lows a gradient and optimizes the binding affinity of
axons to their targets. The affinity includes both con-
tributions from binding and activation of chemical
labels and activity-dependent contributions. Our
model takes as inputs the distribution of chemical cues
expressed by axons and dendrites, the affinity matrix
between these cues, and the correlation function of
electric activity between connecting cells. As a result
of this model, we obtained the complete connectivity
matrix between cells.
To test our model we investigated the formation of
topographic connectivity between the retina and supe-
rior colliculus or optic tectum that depends on binding
and activation of the Eph family of receptor tyrosine
kinases by their ligands, ephrins. Using our model, we
obtained the following results: (1) Combined effects of
chemoaffinity and correlated activity can help orga-
nize connectivity with a single-neuron precision. (2) In
FIGURE 1 Coordinated dynamics of axon, dendrite, and
synapses of this axon (black circles) in our model. The arbors are
shown for four numbered time points. This dendrite and axon
end up having 80% of their synaptic connections with each
other, which implies a single-neuron innervation. The single-neu-
ron innervation is possible because the arbors of axon and den-
drite are highly correlated in geometric space. The soma location
determines the level of ephrin expression. The simulation includ-
ed 900 axons and 900 dendrites (only one pair is shown).
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Is12/EphA3 knockin mice described recently, the
requirements imposed by molecular cues may contra-
dict the activity-dependent Hebbian factors. In these
animals, the winning factor depends on the relative
strength of these contributions. (3) The axonal and
dendritic branch dynamics observed in the optic tec-
turn ofXenopus tadpoles is reproduced in detail by our
model. (4) Geometric connectivity inferred from the
overlap of dendritic and axonal arbors does not neces-
sarily reflect functional connectivity. Our model there-
fore suggests a general method to combine disparate
contributions affecting neural circuitry.
Speed Accuracy Trade-off
in Olfaction
A. Koulakov [in collaboration with A. Gelperin and D. Rinberg,
Monell Chemical Senses Center, Philadelphia, Pennsylvania]
We report the first direct observation of speed accura-
cy tradeoff (SAT) in olfaction. We developed a behav-
ioral paradigm in which both the time of odor expo-
sure and the difficulty of the odor discrimination task
were controlled by the experimenter. The accuracy of
odor discrimination performance increases with the
duration of odor exposure, and the rate of this
increase is slower for harder tasks. We also present a
unifying picture of two previous, seemingly disparate,
experiments studying the timing of rodent odor dis-
crimination (Uchida and Mainers, Nat. Neurosci. 6.
1224 [2003]; Abraham et al. Neuron 44: 865 [2004]).
The presence of SAT in olfaction provides evidence
for temporal integration in olfaction and constrains
the applicability of different models of olfactory
information processing.
Combinatorial On/Off Model for
Olfactory Coding
A. Koulakov [in collaboration with A. Gelperin and D. Rinberg,
Monell Chemical Senses Center, Philadelphia, Pennsylvania]
We study a model for olfactory coding based on spa-
tial representation of glomerular responses. In this
model, distinct odorants activate specific subsets of
glomeruli, dependent on the odorant's concentration.
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The glomerular response specificities are understood
statistically, based on experimentally measured dis-
tributions of detection thresholds. A simple version
of the model, in which glomerular responses are
binary (the on/off model), allows us to quantitatively
account for the following results of human/rodent
psychophysics: (1) Just-noticeable differences in the
perceived concentration of a single odor (Weber
ratios) are dC/C - 0.1; (2) the number of simultane-
ously perceived odors can be as high as 12; and (3)
extensive lesions of the olfactory bulb do not lead to
significant changes in detection/discrimination
thresholds. We conclude that a combinatorial code
based on a binary glomerular response is sufficient to
account for the discrimination capacity of the mam-
malian olfactory system.
Saha Formula in Olfaction
A. Koulakov [in collaboration with A. Gelperin and D. Rinberg,
Monell Chemical Senses Center, Philadelphia, Pennsylvania]
Olfactory perception is based on interactions between
odor molecules and olfactory receptor proteins. The
molecular specificity of binding and activation of the
receptors by odorants forms the basis for discrimina-
tion of smells of different qualities and quantities. In
this study, we considered the reaction of binding
between odor molecules and receptor protein and
derived the general relationship for the degree of
receptor binding. We show that this relationship has a
form of the Saha equation. We argue that the olfactory
Weber law may be a consequence of the Saha equation
for general assumptions about specificities of odorant-
olfactory receptor-binding affinities.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen C.E. Feierstein M. Murakami
G. Felsen S. Ranade
A. Kepecs M. Smear
N. Uchida
N. Xu
H.A. Zariwala
Our lab is studying the neural mechanisms of goal-
directed behavior. We work with a simple but flexible
psychophysical paradigm in which rats use odors to
guide spatial choices to obtain rewards. We are partic-
ularly interested in how olfactory information is encod-
ed and transformed into adaptive decisions. We discov-
ered several years ago that rats can respond accurately
to sensory information extremely quickly-in a single
sniff-and we are continuing to study the temporal
limits and mechanisms of rapid olfactory discrimina-
tion, as well as more complex computational problems
such as concentration- and background-invariant odor
recognition and odor-guided navigation. To get at the
underlying neural mechanisms, we are using chronic
multielectrode recording to monitor single-neuron
activity and neural circuit interactions.
We recently found that the orbitofrontal cortex
(OFC) integrates spatial and reward information to
construct maps of behavioral goals. Ongoing record-
ings focus on temporal coding in the olfactory cortex
and the dynamics of representations during learning.
From a broader neuroeconomic perspective, we are
also studying how the brain deals with the costs of
decisions (effort, delay, uncertainty).
Finally, we are investigating how psychoactive
drugs alter behavior, beginning with ketamine, a drug
thought to mimic aspects of psychosis. We hypothesize
that drug states can be understood as specific perturba-
tions of neural circuit dynamics. An understanding of
neuropharmacology at the circuit level may lead to
more effective treatments for disorders such as
Parkinson's disease and schizophrenia.
Olfactory Target-Background
Segmentation
N. Xu
Figure-ground segmentation is a fundamental issue
faced by most sensory systems. Rats, which rely heav-
ily on olfaction for getting around the world, may fre-
quently have to identify important odors in the pres-
ence of various background odors. In some circum-
stances, the concentrations of the background odors
are likely to be much higher than the significant odors.
How do rats segment the target odors from the back-
ground, instead of perceiving the target-background
mixture as an inseparable object? What are the neural
mechanisms that can solve such a problem?
A bottom-up mechanism for odor segmentation
has been proposed based on odor-specific adaptation
of the neural response in the anterior olfactory cortex.
This mechanism requires the background odor to be
present prior to the target odor, so that the cortical neu-
rons adapt to the background while keeping the
responsiveness to the target odors. However, if
encountering the target and background odors at the
same time, could rats still solve the problem? If so,
what could be the neural mechanism? Could the mem-
ory of the target odor have any role in this processing?
Could active top-town (feedback) processing partici-
pate in target odor identification?
To explore these questions, we designed a behav-
ioral paradigm in which rats learn to identify one of
two chosen target odorants delivered simultaneously
with one of many different background odorants. A
custom-made 64-channel olfactometer is used to deliv-
er various odors with precise timing. Currently, we
have trained and tested rats with one pair of target
odors versus more than 60 background odors. The
behavioral data show a clear trend of improvement of
performance. We are now testing rats' performance
with randomly rewarded novel background odors inter-
leaved with learned background odors. Data acquired
so far suggest that rats can segment target odors from
simultaneously encountered background odors, even
when backgrounds have a much higher concentration.
Our future work will focus on the neural mecha-
nisms underlying behavioral performance. We will use
chronic multielectrode recordings in the olfactory cor-
tex while rats perform the segmentation task. We wish
to test whether olfactory cortex neurons contain back-
ground-invariant representations of the target odors.
Also of particular interest is to test the hypothesis that
the olfactory cortex generates a predictive representa-
tion of the target odors that might serve as a "search
image" of the target odor.
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Motivating Rats to Trade
Speed for Accuracy
Zariwala, N. Uchida, A. Kepecs
Time can have an important role in the process of
deciding between competing options. It is commonly
observed that human subjects can sacrifice speed for
accuracy in many types of decisions, and a large class
of formal decision models are based on the integration
of information over time. However, the time scale of
integration may vary depending on the nature of the
task and the neural systems underlying it.
In a reaction time two-alternative choice odor mix-
ture discrimination task, we found that rats performed
the most difficult discriminations with a very small
increase in reaction time (-10%) compared to the easi-
est discriminations (Uchida and Mainen, Nat. Neurosci.
6: 1224 [2003]). As a follow up to these observations,
one goal was to motivate rats to use longer odor-sam-
pling times in order to increase accuracy.
In a first set of experiments, we manipulated task
parameters to discourage speed and/or encourage accu-
racy. We introduced a variety of manipulations includ-
ing (1) air puff for incorrect choices to increase the cost
of errors, (2) minimum delays to reward delivery and
between trials to eliminate incentives for rapid respond-
ing, and (3) carefully controlled restriction of water
intake to increase the reward value of a successful dis-
crimination. Although each of these manipulations
slowed the reaction times of the rats, none produced the
expected increase in accuracy, suggesting intrinsic lim-
its on temporal integration in mixture discrimination.
In a second set of experiments we used a forced
sampling duration task, training rats to withhold
responding until an auditory "go" signal. This allowed
us to enforce a minimum odor-sampling duration more
strictly. Using this paradigm, odor-sampling durations
increased from about 250 msec in the reaction time
task to more than 1000 msec. Again, despite large
increases in time for integration of information, the
accuracy on the delay task was not greater than in the
reaction time version of the task across all difficulties.
These results show that rapid olfactory reaction times
are not simply a question of motivation but rather reveal
fundamental underlying neural constraints. Important
factors that may favor rapid processing of olfactory infor-
mation are decreasing information rates due to sensory
adaptation and chunking of information by the sniff
cycle. Coding of elementary olfactory m. formation into
discrete snapshots may facilitate higher-order olfactory
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computations such as associating olfactory cues with
spatial landmarks or navigating toward odor sources.
Active Sensation and Olfactory
Behavior: Rapid and Precise
Control of Sniffing
A. Kepecs, N. Uchida
Sensory organs are not passive receivers, rather they
are active instruments controlled by the brain. A famil-
iar example of active sensation is saccadic eye move-
ment control known to be critical to vision. Olfactory
perception also relies on an active sampling process
-
sniffing-to rapidly deliver odorants from the environ-
ment to the olfactory receptors. The respiration cycle
strongly patterns the flow of information into the
olfactory systems, but the behavioral significance of
particular sniffing patterns is not well understood.
We used a nasal thermocouple (small temperature-
sensing probe) that allowed us to monitor respiration in
freely behaving animals. This method monitored the fre-
quency and timing of nasal respiration in rats perform-
ing an odor mixture discrimination task. We found that
respiration frequencies varied widely from 2 to12 Hz,
but odor discrimination was dependent on 6-9-Hz sniff-
ing: Rats almost always entered and maintained this fre-
quency band during odor sampling, and their accuracy
on difficult discrimination dropped when they did not.
Moreover, the switch from baseline respiration to sniff-
ing occurred not in response to odor delivery, but in
anticipation of odor sampling and was executed rapidly,
almost always within a single cycle. Interestingly, rats
also switched from respiration to rapid sniffing in antic-
ipation of reward delivery but in a distinct frequency
band, 9-12 Hz. These results demonstrate the speed and
precision of control over respiration and its significance
for acquisition of olfactory information.
Chemotaxis by Rats:
The Where Problem
in Olfaction
M. Smear
Animals use spatiotemporal patterns of odor concentra-
tion to locate what they smell, a form of navigation
known as chemotaxis. Chemotaxis is essential for ani-
mals to find mates and food or to avoid predators and
toxins. To understand how the brain uses spatiotemporal
patterns of odor concentration to locate odor sources,
we are studying chemotaxis in rats. We know that rats
excel at odor-guided navigation, but we do not know
what behavioral strategies and neural circuits they use.
In species in which chemotaxis has been studied in
more detail, a common feature is that the behavior
seems to take two states: one for when olfactory sig-
nals indicate that the animal is taking the correct tra-
jectory and one for when the animal's trajectory is
incorrect. Thus, microorganisms such as Escherichia
colt and Caenorhabditis elegans navigate in straight
runs in an increasing concentration gradient and turn
more frequently in a decreasing concentration gradi-
ent. Moths navigate in odor plumes dispersed by wind.
Their chemotaxis behavior also seems to have two
states: They fly upwind as they encounter filaments of
an odor plume, and in the absence of filaments, they
fly perpendicular to the course of the wind.
To test whether rats use a similar two-state chemo-
taxis strategy, we built an olfactorium in which rats
would have to experience both correct and incorrect tra-
jectories as they navigate to odor sources. In prelimi-
nary studies, we have shown that rats can correctly nav-
igate to odor sources >90% of the time, but not without
first initiating and correcting an incorrect trajectory on
50% of correct trials. We will next study how rats
behave when they experience correct and incorrect tra-
jectories to an odor source and how they behave when
we make the chemotaxis problem more difficult. In this
way, we hope to understand what features of the spa-
tiotemporal pattern of odor concentration can serve as
the rat's cue for chemotaxis. In the future, we will com-
bine this task with neural recordings as we seek to
uncover the brain's olfactory "where" pathway.
Activity of Orbitofrontal
Neurons during Initial
Task Learning
G. Felsen
Numerous behavioral studies have demonstrated that
animals are capable of learning complex sequences of
actions in order to obtain rewards. Models based on
reinforcement learning theory provide predictions
about the processes that underlie task learning: For
example, that there exist representations of the task
states and values that can be used by the animal to
determine the optimal action corresponding to each
state. However, how the nervous system mediates such
learning remains unclear, especially since relatively
few studies have examined neuronal activity in animals
that are learning, as opposed to those already well-
trained in complex tasks.
To address these issues, we simultaneously recorded
from multiple neurons in rats as they progressed through
a series of tasks, culminating in a two-alternative choice
odor discrimination. In the first task, the rats learned to
"nose poke" into one of two goal ports (on the left and
right sides of the environment) in order to receive a water
reward. Next, the rat was required to first nose poke into
a centrally located port before obtaining the reward at the
goal port. Finally, the rat learned to sample an odor at the
center port, the identity of which would determine at
which of the two goal ports it would be rewarded.
We focused our recordings on the orbitofrontal
cortex (OFC), an area known to represent reward value
and that has more recently been shown to be spatially
selective in rats well-trained on the two-alternative
choice task. Such spatial activity can be thought of as
a "state map," in which the location of the rat (which
in our tasks corresponds to a state) is represented by
the firing rates of OFC neurons.
We addressed two questions: First, does spatial
selectivity develop immediately after exposure to the
behavioral task or is extensive training on the task
required? Second, do the dynamics of OFC responses
reflect task learning? We found that from the earliest
behavioral sessions, populations of neurons were selec-
tive for all relevant spatial locations (left and right goal
ports and center odor port) and for movement toward
these locations. This selectivity could provide real-time
information about the current task state, which would be
useful for exploring and evaluating actions during early
training stages. In addition, a subset of neurons showed
different response timings in later trials than in earlier
trials within the same session. Specifically, we found
that the peak response of movement-selective cells
occurred earlier during later trials. This peak shift was
not due to a change in movement speed but was correlat-
ed with improvement in behavioral performance over the
course of the session. These results suggest that OFC
responses may have a role in guiding task learning.
Activity of Orbitofrontal
Neurons during Acquisition
of Novel Odor Discriminations
C.E. Feierstein
Adaptive, flexible behavior relies on the ability to
learn from the consequences of ones actions and to use
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that knowledge to guide our decisions. This form of
decision-making is known as "goal-directed" behav-
ior. We are interested in understanding the neural basis
of decision-making and goal-directed behavior, and
the OFC is a brain area thought to be central to these
functions. To sustain such behavior, the brain should
represent two aspects that are essential to this process:
the desired outcomes (or goals) and the actions lead-
ing to those outcomes. We previously recorded the
activity of OFC neurons in rats performing a two-
alternative choice discrimination task and found that
OFC neurons represented the behaviorally relevant
spatial locations, the "goals" in the context of the task
(Feierstein et al. 2006). Moreover, OFC neurons
encoded the outcomes of each trial (rewarded or not
rewarded, i.e., the success or failure of the rat's
choice). These results indicate that the OFC neurons
encode a signal that reflects the performance of the rat;
such a signal could be used to update behavior when
outcomes are not favorable or could be used to learn
the consequences of actions by trial and error.
To test the possibility that OFC neurons encode
error signals and to explore the role of OFC during
learning, we trained rats in a novel-odor discrimination
paradigm. In this task, rats started each session with a
well-learned two-odor discrimination (A/B). After
approximately 100 trials, a new odor pair (C/D) was
introduced and the rats had to learn the contingencies
associated with that novel pair while continuing to dis-
criminate the original A/B pair. In each recording ses-
sion, a different novel pair was introduced. Rats
learned new odor associations fairly rapidly. Usually, a
performance accuracy of 80% for the novel pair was
achieved in 1 to 60 trials, while maintaining intact per-
formance for the original pair (>90%).
We next recorded the activity of OFC neurons dur-
ing the acquisition of novel odors. Preliminary data
suggest that OFC neurons fire selectively to novel
odors, whereas our previous recordings using a well-
learned pair showed that there is relatively little odor
selectivity in OFC. The selectivity for novel odors
developed extremely rapidly (one or a few trials) after
these stimuli were introduced. Although many neurons
responded to novel odors during the odor-sampling
period, as might be expected, the introduction of novel
stimuli was also associated with a more widespread
change in response properties, including both increas-
es and decreases in firing outside the odor presentation
period (e.g., during movement or reward).
These data suggest that OFC circuits are engaged
by novel olfactory stimuli. By integrating representa-
tions of novel stimuli with representations of actions
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leading to reward, OFC may participate in the learning
of new stimulus response outcome contingencies.
Further analyses will address how outcome represen-
tations evolve with learning.
Neural Representation and
Behavioral Impact of Uncertainty
in Decision-making
A. Kepecs, N. Uchida, H.A. Zariwala
Uncertainty has long been studied in economics, psy-
chology, and behavioral ecology as a decision variable
critical for understanding behavior. More recently,
several computational schemes have been proposed
for how populations of neurons might be able to repre-
sent not only a value of interest, but also the uncertain-
ty associated with it. However, despite the recognition
of uncertainty as a pivotal variable for decision-mak-
ing and neural coding, little is known about how and
where it is represented in the brain.
We therefore explored the neural representation of
uncertainty and its behavioral impact in an odor-mix-
ture categorization task. Rats were trained to report the
category (dominant component) of binary mixtures of
two odors and were rewarded at either the left or the
right choice port for correct decisions. Discrimination
accuracy for pure odors was close to 100%, but for the
most difficult mixtures, performance dropped to almost
60%. Since reward was always provided for correct
choices, the outcome was uncertain only because rats
sometimes were not able to discern and/or remember
the correct category of the odor mixture. We hypothe-
sized that the OFC-a region of the prefrontal cortex
known to be activated during choice behaviors involv-
ing uncertainty in humans-represents the degree of
uncertainty or confidence associated with choices.
What would a representation of uncertainty look
like? First, uncertainty will vary with the difficulty of
stimulus. Second, for a fixed stimulus, on average, a
good estimate of uncertainty will predict the accuracy
of a decision (correct/error). We formalized and
checked these predictions using two different models of
decision-making. Both models agreed in their qualita-
tive predictions: For correct choices, uncertainty
increases with stimulus difficulty, whereas for incorrect
choices, on average uncertainty is always larger but
decreases with stimulus difficulty (Fig. 1A). We record-
ed the activity of OFC neurons during this decision task
and focused our analysis on the reward anticipation
period after the choice was made but before reward
feedback was provided. We found that about 30% neu-
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FIGURE 1 Comparison of uncertainty model (4), neural recordings from OFC (B), and behavioral data (C). See text for description.
rons predicted trial outcome (reward/no reward), and
their firing rates varied consistent with the model (Fig.
1B). This suggests that orbitofrontal neurons provide an
estimate of uncertainty during decision-making.
Next, we tested whether the rats could use uncer-
tainty to guide their behavior. We modified the deci-
sion task by delaying reward and allowing rats to abort
and restart trials during the delay. This behavior could
be compared to a human's when looking for a particu-
lar exit on an unfamiliar road based on a fuzzy road
sign: The decisions of whether and when to turn
around depends on the uncertainty about whether the
exit was already passed. Similarly, rats preferentially
aborted uncertain trials: Those with stimuli closer to
the category boundary and when they made erroneous
decisions (Fig. 1C). Thus, rats, like humans, are able to
estimate the uncertainty associated with their deci-
sions and use it to guide their behavior. Our results
emphasize that uncertainty is a fundamental quantity
for decision-making-one that is easily and most like-
ly automatically computed during the decision process
to support adaptive behavior-similar to other previ-
ously studied decision variables such as choice proba-
bility and reward value.
Should I Stay or Should I Go:
Neural Mechanisms of Patience
M. Murakami
Consider the situation in which you wait for a bus but
it is delayed. You have no idea when it will arrive.
There is another option, taking a cab, which costs
much more but is available immediately. How long do
you wait for the bus? When do you give up waiting for
the bus and decide to take a cab? In such circum-
stances, your brain must compute the costs and bene-
fits of the choices and use that information for choos-
ing an action-waiting or giving up.
The medial prefrontal cortex (mPFC) is recipro-
cally connected to the OFC, which is suggested to be
involved in value representation of stimuli. Previous
studies show that inactivation of the mPFC impairs the
ability for an animal to wait. A recent electrophysio-
logical study also suggested the involvement of the
mPFC in waiting. The mPFC neurons send output to
the striatum, which is thought to be involved in action
generation. Thus, the neuronal circuit centering on the
mPFC is well-situated to use value information to
choose between waiting and giving up. In this study,
we address the question of how this circuit decides to
wait or not to wait.
We developed a task in which a rat is faced with a
waiting problem similar to the "bus or cab" dilemma.
There are two nose poke ports, one is for waiting and
the other is for delivering water reward. A short delay
(400 msec) after a rat pokes in the waiting port, a first
tone is played, and this signals the availability of a
small reward at the reward port. If the rat goes to a
reward port after the first tone, it receives a small
amount of water reward. If the rat waits longer in the
waiting port, instead of going to the reward port, a sec-
ond tone is played after a random delay period or up to
several seconds. If the rat goes to the reward port after
this second tone, it receives a larger amount of water
reward. In this task, after the first tone is played, the rat
is confronted with a choice of either going to the
reward port to get small reward or waiting for a second
tone to get large reward.
We first plan to record neuronal activity from the
mPFC and other areas connected with the mPFC and
then examine whether neuronal activities from these
areas can predict the choice of waiting time and other
aspects of the behavior. Preliminary results showed that
the time a rat is willing to wait for a given set of reward
amounts and delays varies randomly from trial to trial.
On some trials, the rat will respond immediately after
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the first tone, but on others, it will withhold responding
until after the second tone, and on others, it will wait
well past the first tone, but give up before the second.
Brain areas responsible for the choice of either to wait
or to give up waiting should be able to predict how long
a rat will wait and when it will give up waiting.
Diversity and Precision of Neural
Activity in Serotonergic
Brain Stem Nuclei
S. Ranade
Serotonin is a neurotransmitter implicated in a diverse
range of physiological functions and behaviors, as
well psychiatric disorders including depression and
anxiety. Serotonin is released by neurons in a set of
brain stem nuclei called the raphe nuclei. The raphe
system is by far the most complex, divergent neuro-
modulatory system in the brain. Our current under-
standing of serotonin function has been gained most-
ly from pharmacology and lesion studies. Neuronal
recordings from animals performing well-controlled
behavioral tasks have greatly increased our knowl-
edge of dopamine and norepinephrine function, but
there have been few recordings from raphe neurons
during behavioral tasks. We hypothesize that such
studies will yield novel insights about raphe function,
particularly at fast time scales.
In this project, we recorded from raphe nuclei in
rats performing a two-alternative choice odor discrim-
ination task. Rats were trained to associate individual
odors with water reward at one of two choice ports.
Correct responses were rewarded probabilistically after
a variable delay. This paradigm allowed us to study sen-
sory, motor, and reward-related responses with high
temporal precision by aligning to nose poke events.
After training, rats were chronically implanted
with a six-tetrode recording drive. Tetrodes were tar-
geted to the raphe using a guide cannula. Recordings
were obtained from 54 neurons in seven rats over an
average of four to eight sessions per rat. Recording
locations were verified histologically following termi-
nation of experiment. Raphe neurons showed diverse
firing properties with respect to waveform characteris-
tics, firing rate, and sleep state modulation. By con-
ventional criteria, 10% of neurons were wide-spiking
putative serotonin neurons.
Neuronal responses were analyzed with respect to
four epochs: odor sampling, movement, reward antici-
128
pation, and reward consumption. Firing rates of >70%
neurons were modulated during at least one behavioral
epoch, with a large fraction tuned to multiple events.
Many neurons responded to behavioral events within
100 msec, whereas some were even more precisely
time-locked (order 20 msec), showing a very strong
(>40 sp/sec) phasic response, apparently to the click
produced by water valve opening.
A wide range of event tuning characteristics
were observed in the recorded population. During
odor sampling, approximately one third of units
showed a decrease in firing rate. A subset of neurons
also showed odor-induced activation, which, in rare
cases, was stimulus-selective. During the movement
epoch, an equal proportion of neurons showed
enhancement and suppression of firing. There were
few instances of direction-selective tuning. A large
proportion of neurons (-40%) were inhibited during
reward anticipation. A small subset of neurons
(10%) showed changes in firing rate around the time
of the expected reward. Putative serotonin neurons
showed no obvious association with a specific
response profile.
These recordings demonstrate that raphe neurons
are rapidly and precisely modulated by diverse behav-
ioral events. This is in accord with the known diversi-
ty of serotonin function and the difficulty in account-
ing for it with a simple unified theory. Functional
diversity of raphe responses likely reflects in part the
diversity of intrinsic properties and synaptic connec-
tivity of neurons within the nucleus. Classification of
units into putative serotonin and nonserotonin neurons
did not yield any obvious simplification of response
diversity, highlighting the need for methods relating
firing patterns to precise identification of neuronal
cell types. Finally, the observed functional diversity of
raphe neurons is consistent with the possibility that
significant information processing may occur within
the raphe itself. Future studies will focus on develop-
ing novel molecular genetic approaches to selectively
label and record activity of populations of raphe neu-
rons that are biochemically homogeneous and/or share
similar connectivity patterns.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow W. Benjamin I. Ehrlich H. Kessels
J. Boehm H. Hsieh C. Kopec
N. Dawkins-Pisani H. Hu B. Li
My laboratory is directed toward understanding synap-
tic function, synaptic plasticity, and synaptic dysfunc-
tion. Through such an understanding, we hope to eluci-
date how learning and memory are achieved and how
diseases corrupt them. This year, we continued to exam-
ine the regulation of a-amino-3-hydroxy-5-methylisox-
azole-4-propionic acid (AMPA) and N-methyl-D-
asparate (NMDA) receptors at synapses that may under-
lie plasticity and the malfunction that could lead to dis-
ease. Some of our studies are summarized below.
AMPA-R Removal Underlies
AO-induced Synaptic Depression
and Dendritic Spine Loss
H. Hsieh, R. Malinow [in collaboration with S. Sisodia,
University of Chicago]
Beta amyloid (A(3), a peptide generated by neurons, is
widely believed to underlie the pathophysiology of
Alzheimer's disease when overproduced. Recent stud-
ies indicate that this peptide can drive endocytosis of
AMPA- and NMDA-type glutamate receptors. We now
show that Af3 uses signaling pathways of long-term
depression (LTD) to drive endocytosis of synaptic
AMPA receptors (AMPA-R). Synaptic removal of
AMPA-R is key, because it is necessary and sufficient
to drive loss of dendritic spines and synaptic NMDA
responses. Our results indicate that increased levels of
AP tap into endogenous physiological processes to
depress synaptic structure and function.
PSD-95 Is Required for Activity-driven
Synaptic Development
I. Ehrlich, R. Malinow
The activity-dependent regulation of AMPA-type gluta-
mate receptors and the stabilization of synapses are crit-
ical to synaptic development and plasticity. One candi-
date molecule implicated in maturation, synaptic
strengthening, and plasticity is PSD-95. Here, we find
that acute knockdown of PSD-95 in brain slice cultures
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T. Takahashi
W. Wei
by RNA interference arrested activity-driven develop-
ment of synaptic structure and function, manifested by
reduced synaptic strength and altered spine morphology.
Surprisingly, PSD-95 was not necessary for the induc-
tion and early phase of long-term potentiation (LTP)
expression. However, following PSD-95 knockdown,
chemically induced LTP produced smaller changes in
the size of stable spines, and we observed a larger frac-
tion of transient spines that turned over more readily.
Taken together, our data support a model in which PSD-
95 is required for activity-dependent synapse stabiliza-
tion following initial phases of synaptic potentiation.
Signaling by Neuregulin/ErbB4,
Genes Implicated in Schizophrenia,
Is Critical to Proper Maturation of
Excitatory Synapses
B. Li, R. Malinow [in collaboration with L. Mei,
College of Georgia]
Neuregulin 1 (NRG1) and its receptor ErbB4 activate
signaling cascades that are essential for the develop-
ment and function of many organ systems including the
neural system. However, the function and mechanism of
NRG1 and its receptors in the central glutamatergic
synapse are poorly understood. Here, we show that
NRG1 signals via erbB4 to control spine growth, synap-
tic maturation, and synaptic plasticity at the Schaffer
collateral-CA1 synapse. Our data suggest that the
defect in glutamatergic synapse development caused by
a perturbation in the NRG1/erbB4 signaling pathway
may contribute to the etiology of schizophrenia.
Postsynaptic Receptor Trafficking
Underlying a Form of Associative Learning
S. Rumpel, A. Zador, R. Malinow [in collaboration with
J. LeDoux, New York University]
To elucidate molecular, cellular, and circuit changes
that occur in the brain during learning, we investigat-
ed the role of a glutamate receptor subtype in fear
conditioning. In this form of learning, rodents associ-
ate two stimuli, such as a tone and a shock. In this
study, we found that fear conditioning drives AMPA-
type glutamate receptors into the postsynapse of a
large fraction of neurons in the lateral amygdala, a
brain structure essential to this learning process.
Furthermore, memory was reduced if AMPA-R
synaptic incorporation was blocked in as few as
10-20% of lateral amygdala neurons. Thus, the
encoding of memories in the lateral amygdala is
mediated by AMPA-R trafficking, is widely distrib-
uted, and displays little redundancy. We have contin-
ued these studies by examining dendritic spines in
vivo before and after fear conditioning.
Spine Enlargement Precedes
AMPA-R Exocytosis during LTP
C. Kopec, B. Li, W. Wei, J. Boehm, R. Malinow
The changes in synaptic morphology and receptor
content that underlie neural plasticity are poorly
understood. In this study, we used a pH-sensitive
green fluorescent protein (GFP) to tag recombinant
glutamate receptors and showed that chemically
induced LTP drives robust exocytosis of AMPA-R
onto dendritic spines. In contrast, the same stimulus
produced a small reduction of NMDA-R from spines.
LTP produced similar modification of small and large
spines. Interestingly, during LTP induction, spines
increased in volume before surface incorporation of
AMPA receptors, indicating that distinct mechanisms
underlie changes in morphology and receptor content.
We are continuing these studies by establishing opti-
cal methods to detect synapses that have undergone
plasticity.
Differential Subcellular Overexpression
of AMPA-R Subunits in CA1 Neurons
H. Kessels, M. Klein, R. Malinow
The role of AMPA-type glutamate receptors in synap-
tic plasticity can be studied by the introduction of
recombinant AMPA subunits in glutamatergic neu-
rons. Here, we show that whereas transient expression
of AMPA subunits leads to considerable overproduc-
tion in neuronal somata of organotypic hippocampal
slices, at dendrites, they remain close to endogenous
levels. These results provide evidence for a tightly
controlled transport mechanism of AMPA-R com-
plexes traveling from soma to dendritic compart-
ments. We have now evidence that the AMPA-R-asso-
ciated protein, stargazin, is a rate-limiting protein in
the transport of AMPA-Rs from cell bodies to den-
drites. This transport system is selective for certain
AMPA-R subunits.
Direct Phosphorylation by PKC
at a Novel Site on AMPA-R
Subunit Glur1 Controls Synaptic
Incorporation during LTP
J. Boehm, R. Malinow [in collaboration with R. Huganir,
Johns Hopkins University]
Incorporation of G1uR1- containing AMPA-Rs into
synapses has an important role in several forms of
neural plasticity. A number of signaling pathways
have been identified, but the direct modifications of
GIuR1 that control its synaptic incorporation have
not yet been found. Previous studies indicate that
activation of protein kinase C (PKC) is required to
generate LTP, a leading model of synaptic plasticity.
However, the targets of PKC responsible for LTP
have not been determined. We find that G1uR1 Ser-
818, which is highly conserved evolutionarily, is
phosphorylated by PKC in vitro and by LTP in hip-
pocampal slices. Acute phosphorylation by PKC at
G1uR1 Ser-818 as well as molecular mimicking
phosphorylation at this site drives GluR1 into
synapses. Preventing GIuR1 Ser-818 phosphoryla-
tion blocks LTP and PKC-driven synaptic incorpora-
tion of GIuR1. Thus, G1uR1 Ser-818 is rapidly phos-
phorylated by PKC during LTP induction and is
required for its incorporation into synapses.
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INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra C. Alen H. Bokil J. Serkhane H. Wang
P. Andrews H. Maniar D. Valente
Our basic research philosophy is to combine theoretical,
computational, and experimental approaches for the study
of complex biological systems, with a particular focus on
neurobiological questions. Efforts in our group fall into
three main areas: Neuroinformatics, Theoretical Engin-
eering, and Quantitative Behavior and Electrophysiology.
Neuroinformatics research in our lab involves the
application of statistical and signal-processing tools to
large volumes of neurobiological data, as well as the
development of informatics infrastructure for large-
scale data integration. In the area of theoretical engi-
neering, we apply theories developed alongside human-
engineered systems to study design principles in biolog-
ical systems. The third area of our research is experi-
mental and consists of behavioral and electrophysiolog-
ical studies in multiple species including Drosophila,
zebra finch, macaque monkey, and human infants.
Continuing in our lab in 2006 are Hiren Maniar, (sci-
entific informatics analyst), Hemant Bokil (postdoctoral
fellow), and Peter Andrews (scientific informatics man-
ager). Joining us in 2006 are Haibin Wang, Dan Valente,
and Jihene Serkhane (postdoctoral fellows) and Cara
Allen (scientific informatics manager). We also have
close collaborative ties with multiple research groups at
CSHL and other institutions, which currently include a
collaboration with Nicholas D. Schiff and Keith Purpura
at the Weill Medical School of Cornell University, where
Dr. Mitra is an adjunct associate professor; a consortium
of zebra finch researchers at four different universities,
including a long-standing collaboration with Ofer
Tchernichovski at City College of New York (CCNY);
an integrative analysis of memory formation in
Drosophila, as part of the Dart Neuro-genomics Alliance
at CSHL; and the Brain Architecture Project, begun in
2006 with coinvestigators at Harvard/Massachusetts
General Hospital, California Institute of Technology, and
the University of Southern California.
Chronux: Open Source Software for
Neural Signal Processing
H. Bokil, P. Andrews
Nervous system activity can be measured at many spa-
tial and temporal scales, from electrophysiological
recordings of single neurons to monitoring large net-
works of neurons or brain areas with various imaging
technologies. For the last several years, our group has
been developing algorithmic and computational tools
for the statistical analysis of such neural time series
data, and we are encoding these tools into an open
source software package entitled Chronux (www.
chronux.org). This continuing project includes the
development of a high-quality numerical analysis
library, data input-output and management utilities,
and a user interface that gives experimental neurosci-
entists access to advanced analysis tools. We expect
tools like these to be critical to advancing our under-
standing of systems-level neuroscience.
We made improvements to the Chronux software
package in 2006, largely to increase its usage in the field.
We created several new tutorials that discuss signal-pro-
cessing theory and provide step-by-step instructions for
how to handle common data analysis scenarios. We have
also added several new GUIs for specific analysis tasks,
including spike sorting and audio segmentation. Since
2001, we have used Chronux in the annual MBL
Neuroinformatics summer course, and this year, we pre-
sented a one-day tutorial at the Dynamical
Neurosciences Workshop preceding the 2006 Society for
Neuroscience Annual Meeting in Atlanta, Georgia. Use
of Chronux in the neuroscience community is increas-
ing, and the package has been downloaded more than
2000 times (1300 in 2006), with more than 240 users
registering for support and updates (170 in 2006).
LBEX: A Technique for EEG/MEG
Source Localization
H. Maniar
Electroencephalography (EEG) and magnetoen-
cephalography (MEG) provide noninvasive images of
electrical and magnetic fields resulting from internal
neural activity. Localizing the spatial origins of this
neural activity from EEG/MEG images is a challeng-
ing problem requiring both an understanding of human
brain function and sophisticated mathematical and sig-
nal-processing expertise. Our objective is to provide
the research community with a tool kit for reliable and
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FIGURE 1 Localization of brain activity in a working memory task, where EEG and MEG were simultaneously measured. Localization
based on EEG (left) and MEG (right) show overlapping regions of activation. Since these areindependent measurements, this increas-
es our confidence in the source localization technique.
accurate source localization of neural activity, and
during the past few years, we have developed a
promising new localization technique: local basis
expansions for linear inverse problems (LBEX). With
theoretical aspects of LBEX now well-characterized,
we initiated a collaborative study with Dr. Richard
Coppola at the National Institute of Mental Health to
apply the technique to real EEG-MEG data. Figure 1
compares unimodal localization of neural activity in
the 8-12-Hz frequency range (alpha band) using EEG
(left) and MEG (right) recordings. Since information
captured by EEG and MEG is complementary, we
expect that bimodal localization using simultaneous
EEG and MEG recordings will be more robust and
accurate than unimodal localization using EEG or
MEG images separately.
Arena Control and
Data Acquisition
Integrative Analysis of Memory
Formation in Drosophila
D. Valente
This is the second project year of the Mitra lab's partic-
ipation in the Dart NeuroGenomics Alliance at CSHL.
Our group represents the alliance's principal theoretical
modeling component and has a broad goal of integra-
tive data analysis and modeling of memory formation in
the fruit fly Drosophila melanogaster, spanning genet-
ic, cellular, neural, and behavioral levels.
We are developing several experimental setups to
probe memory formation at the neural network and
behavioral levels. The first is a flight simulator (Fig. 2)
for tethered flight conditioning assays. A fly is tethered
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FIGURE 2 Flight simulator for Drosophila melanogaster. A fly is tethered in the apparatus and is presented with a visual panorama
that rotates in response to the flight behavior.
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in the center of a cylindrical arena, where visual stimuli
are presented. The simulator can be run in an open-loop
mode, in which the visual stimuli are independent of the
fly's behavior, or in a closed-loop mode, in which the
fly's wing-beat pattern is used as feedback to control the
visual panorama.
Another important step in creating an integrative
model of memory is the phenotypic characterization of
memory mutants and wild-type flies. The majority of
memory mutants have no obvious phenotype besides
memory deficiency, but pleiotropic effects on other
behaviors cannot be ruled out, and their characterization
may further elucidate the function of particular genes in
memory processes. As one approach to this characteri-
zation, we will quantify locomotor behavior with an
automated system allowing for high-throughput experi-
ments. For this purpose, we are developing an open-
field arena for observing exploratory walking behavior,
along with trajectory tracking software. Our tracking
software is in use by our group and Tim Tully's group
here at CSHL and by our collaborator in this work, Dr.
Ilan Golani of Tel Aviv University.
Song Learning in the Zebra Finch
Our research on zebra finch song learning is part of a
consortium of researchers at four different institutions.
This collaborative approach toward understanding the
neural mechanisms of vocal learning seeks to provide
a quantitative description of the relationship between
physiological variables and vocal performance in the
zebra finch over the course of song development. The
goals of the Mitra lab component of this collaboration
are to provide an informatics infrastructure, to build an
integrative theoretical framework, and to develop sig-
nal-processing algorithms for data integration and
hypothesis discovery and testing.
We have set up an external portal for the consor-
tium at zebrafinch.org and are currently in the process
of building an internal portal that will feature collabo-
rative tools such as a bulletin board, a file archive, and
a database for experimental data. Since the data sets
generated by the consortium are very large, we have
had to devote significant effort to the hardware and
software aspects of terabyte-scale databases, but
expect this to have significant payoffs in terms of the
ability to perform analysis of the song system at an
unprecedented scale. Semantic Web methods, which
we have chosen to employ in our work, may facilitate
the integration of neurobiological data across modali-
ties and scales, an aspect of data analysis currently
under intense investigation and therefore of potential-
ly far-reaching significance for neuroscience.
Quantitative Analysis of Speech
Development in Human Infants
J. Serkhane
Brain-imaging techniques are revolutionizing research
in human psychology and neuroscience, but their appli-
cation to the infant human brain will remain limited due
to ethical and technical reasons. An alternative and
complementary approach can be found in quantitative
human ethology, with noninvasive high-resolution
recording and fine analysis of natural behavior.
The purpose of this project is to study the develop-
ment of speech in human infants through quantification
of vocalizations in ecological conditions. Previous stud-
ies of early language acquisition have largely consisted
of linguists transcribing infant sounds by hand or of rel-
atively short acoustic recordings (a few hours per week
or month), although infant vocalizations can change
significantly from day to day. Instead, we will use more
continuous, dense recordings of vocalizations (audio
and video) and will also develop associated analysis and
data management tools. Before collecting data from a
larger target population, we are conducting preliminary
analyses of smaller data sets to guide the development
of analysis and classification software. One data set,
from Dr. April Benasich (Rutgers University), consists
of analog audiovideo recordings of infants at 6, 12, 24,
and 36 months of age. A second data set, consisting of
a several-month-long audio recording, has been
acquired from the Max-Planck Institute in Nijemegen in
The Netherlands.
Engineering Principles in Biological
Systems
P. Mitra
We have begun a series of workshops and conferences
intended to foster an emerging approach to theoretical
biology with a formal emphasis on design or engineer-
ing principles. Through the process of evolution, living
systems retain accidentally found solutions to prob-
lems they must solve in order to survive. Although
such solutions or designs are not engineered but
instead evolve incrementally, the premise of this theo-
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retical approach is that they may nevertheless be stud-
ied in their existing forms in the framework of theo-
ries developed alongside human-engineered systems.
Our goal is to determine whether major existing engi-
neering theories (controls, communication, computa-
tion) can be applied to biological systems and, if not,
what modifications are in order.
The first workshop, entitled "Design Principles in
Biological Systems," was held at CSHL's Banbury
Center in May 2006. Each session included a tutorial
overview of an engineering theory, followed by partic-
ipant presentations about corresponding examples
from biological systems, chosen to span organization-
al levels, from populations to molecular pathways.
The small workshop format provided an opportunity
for biological researchers to learn about engineering
theories relevant to their work and for engineering the-
orists and computer scientists to learn about biological
questions they might help answer. A larger meeting,
"Engineering Principles in Biological Systems," held
at CSHL in December 2006, allowed for presentation
of a broader range of relevant research. A second
Banbury workshop is planned for 2007 and another
CSHL meeting for 2008.
The Brain Architecture Project
P. Mitra, C. Allen
Although the human genome has been sequenced, the
architecture of the human brain, in terms of its con-
nectivity patterns and functional subsystems, remains
incompletely characterized, despite the classical ori-
gins of human neuroanatomy research. The Brain
Architecture Project is a new collaborative effort
based in the Mitra lab with a long-term goal to pro-
duce a comprehensive draft of the connectivity matrix
of the human brain, along with analytical and visual-
ization tools. A main focus will be collation and inte-
gration of existing but fragmented information about
human neuroanatomy into a comprehensive database.
Data from a large-scale functional brain-imaging
study will be analyzed with respect to project goals,
and we will also consider the architecture of rodent
and non-human primate brains to exploit homologies
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across species. The results of the project will be made
readily accessible to researchers for scientific and
clinical applications.
The Brain Architecture Project is supported by the
W.M. Keck Foundation and draws on the expertise of
coinvestigators in neuroanatomy (Larry Swanson,
University of Southern California), human brain
imaging (Hans Breiter, Massachusetts General
Hospital), and analysis of connectivity graphs (John
Doyle, California Institute of Technology). The project
begins 2007 with a newly recruited full staff, several
additional collaborators, and a board of prominent
external advisors.
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GENE COPY-NUMBER VARIATION AND
ITS ROLE IN HUMAN DISEASE
J. Sebat W. Choi
R. Kim
M. Kusenda
P. Lin
J. Lloyd K. Pavon
D. Malhotra P. Roccanova
S. McCarthy S. Yoon
Large-scale differences in gene copy number called
copy number variants (CNVs) are a significant source
of human genetic variation. In contrast to DNA
sequence variants such as single-nucleotide polymor-
phisms (SNPs) and microsattelite repeats, CNVs have
not been well characterized. We seek to understand
more about the genomic locations, frequency, and sta-
bility of these structural variants and their role in
human disease.
Determining the Genetic
Basis of Autism
J. Sebat, S. Yoon, M. Kusenda, P. Lin, D. Malhotra [in collabo-
ration with M. Wig ler, K. Ye, B. Lakshmi, M. Ronemus, and A.
Krasnitz, Cold Spring Harbor Laboratory]
Our work on the genomic analysis of autism has made
distinct contributions to our understanding of the genet-
ic basis of cognitive disorders. We have shown that
microarray-based CNV analysis can detect copy-num-
ber mutations at a much higher resolution than cytoge-
netic methods, and we have used these methods to iden-
tify a strong association of de novo copy-number muta-
tions with autism (Sebat et al., in press). In the latter
study, we showed that spontaneous CNVs are frequent
in sporadic autism (10%), a rate much higher than in
healthy individuals, suggesting that the majority of
mutations that we detected contribute to the disorder. In
contrast, spontaneous mutations were not significantly
associated with disease in families with more than one
affected child, indicating that in terms of the genetic
mechanism involved, there is a distinction between the
familial and sporadic cases.
The mutations that we detected occurred at many
loci throughout the genome, and few were detected
more than once. These results are consistent with the
findings of linkage studies and cytogenetics and sup-
port the hypothesis that there are many genes in the
genome that potentially contribute to autistic spectrum
disorder (ASD), with each gene contributing to only a
small fraction of cases. Our findings implicate specif-
ic genes in autism including genes involved in sterol
metabolism, hormonal signaling, and synaptic trans-
mission; however, further studies are needed to deter-
mine the contribution of each gene to the disorder in
the broader population of patients.
To this end, we have begun candidate gene studies,
including sequencing and fine-scale CNV analysis in
a large sample of patients and controls. Preliminary
results suggest that more complete ascertainment of
variation within candidate regions may reveal the
greater extent of an individual gene's contribution to
ASD. For instance, our recent work done in collabora-
tion with Dan Geschwind (University of California,
Los Angeles) has found a convergence of evidence
from analysis of SNPs and CNVs implicating the gene
CNTNAP2 in ASD.
A Genomic Analysis of Schizophrenia
and Bipolar Disorder
J. Sebat, S. McCarthy, S. Yoon, P. Lin [in collaboration with S.
Gary, J. Watson, and T. Leotta, Cold Spring Harbor Laboratory]
A high spontaneous rate of structural mutation is a
property of the human genome and exists independent-
ly of the phenotypes that emerge from it. Thus, our find-
ings in ASD may serve as a model for other disorders.
We hypothesize that rare highly penetrant mutations,
including a significant proportion that are CNVs, may
also have a role in the etiology of schizophrenia (Scz)
and bipolar disorder (BD). We have therefore recently
initiated genetic studies of Scz and BD, with a focus on
families with sporadic and young-onset cases. In addi-
tion, a small collection of families have been obtained
that each have more than three individuals diagnosed
with Scz. To date, we have scanned the genomes of 350
Scz patients and more than 500 controls.
Spontaneous copy-number mutations have been
identified in our studies, suggesting that the
approach described above will be effective in these
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disorders as well. However, because twin studies of
both Scz and BD suggest that the penetrance of the
mutations involved are lower on average compared
to risk factors for ASD, we may expect that the pro-
portion of variants that are familial (as opposed to
spontaneous) will be higher. Therefore, our studies
will likely require a larger sample size, and we will
also rely to a greater extent on detecting the associ-
ation of rare variants by observing recurrent non-
identical mutations at individual loci in the genome.
A Case Control Study of
Parkinson's Disease
J. Sebat, D. Malhotra, S. Yoon
Parkinson's disease (PD) is the most common neu-
rodegenerative movement disorder characterized by
age-dependent increases in bradykinesia, muscular
rigidity, gait abnormalities, and a rest tremor. PD can
arise from multiple etiologies, including genetic muta-
tions that for the most part are uncommon. Evidence
has been lacking for the existence of common genetic
variants with large effect, but it does exist for multiple
genes including common alleles with small effect and
rare highly penetrant alleles. Such complex etiology is
inherently difficult to study using traditional genetic
approaches. Analysis of genome copy-number poly-
morphisms holds great promise in identifying struc-
tural variants predisposing to PD pathology.
We used an 85K probe representational oligonu-
cleotide microarray analysis (ROMA) to screen 300
late-onset sporadic PD cases and an equal number of
matched controls from Caucasian and Chinese
cohorts. Findings include the detection of deletions in
both familial and sporadic cases involving two genes,
Z/C/ and ZIC4, which are related to cerebellar devel-
opment. Also detected were deletions of Parkin, a gene
previously implicated in recessive early-onset PD.
These findings suggest that heterozygous deletions of
Parkin also may have a role in late-onset PD. More
comprehensive studies of candidate genes identified in
this study will help us to determine the contribution of
these genes to the disease.
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Analysis of Large-scale Copy-number
Variation in the HapMaP
J. Sebat, S. Yoon, J. Lloyd, D. Malhotra
[in collaboration with K. Ye and B. Lakshmi, Cold Spring
Harbor Laboratory]
Much remains to be learned about the extent of "nor-
mal" structural variation in the human genome and its
implications for genetic studies of populations. We
have initiated a CNV-discovery effort that will focus on
DNA samples from the International HapMap Project.
The key advantage of using the HapMap samples for
this study is the availability of high-density SNP geno-
types on the same individuals. CNV data can be com-
bined with SNP data to determine, for example,
whether a polymorphic duplication or deletion is asso-
ciated with a unique SNP haplotype (indicating that the
variant results from an ancestral event that was inherit-
ed by descent) or with many different haplotypes (sug-
gesting recurrent structural mutation at that site). In
addition, direct analysis of copy-number variation is
helpful for resolving aberrant patterns in the HapMap
data that result from CNVs, such as apparent non-
Mendelian patterns of inheritance. Here, we analyzed
copy-number variation in 30 CEPH trios using ROMA.
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EXPERIENCE-DEPENDENT PLASTICITY OF SYNAPSES AND
SYNAPTIC CIRCUITS
K. Svoboda I. Bureau T. O'Connor
V. De Paola G. Tervo
C. Harvey L. Wilbrecht
A. Holtmaat C. Zhang
A. Karpova
The functional properties of the brain change in
response to salient sensory experiences. The nature of
these changes, at the level of synapses, neurons, and
their networks, also known as the engram, is unknown.
We are dissecting the mechanisms of experience-depen-
dent plasticity in the developing and adult neocortex.
Neocortical tissue is dauntingly complex: 1 mm3
contains nearly a million neurons, each of which con-
nects to thousands of other neurons. To probe neurons
and synapses within the intact network, we build and
use sensitive tools. Two-photon laser-scanning
microscopy (2PLSM) allows us to image single
synapses in intact tissues and to track changes in intra-
cellular calcium and signal transduction events.
Excitation of neuronal elements by focal uncaging of
neurotransmitters allows us to probe the connectivity
of neural networks with high efficiency. We combine
these optical methods with electrophysiological mea-
surements of synaptic currents and potentials and mol-
ecular manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. As a model system, we use the
rodent barrel cortex, where whiskers are represented
in a topographic manner, with information from each
whisker represented by a small cortical region (barrel).
Whisker maps are shaped by experience during devel-
opment and reshaped in the adult. The cellular mech-
anisms underlying sensory map plasticity are likely to
share mechanisms with those underlying learning and
memory in other brain regions and other species.
[Ca21-dependent Signaling in Single
Dendritic Spines
C. Harvey
Postsynaptic Ca2+ activates diverse Ca2±-dependent
signal transduction mechanisms. We have designed
high-sensitivity fluorescence resonance energy trans-
fer (FRET) sensors for Ras, mitogen-activated protein
kinase (MAPK), and protein kinase A (PKA) activa-
tion and cAMP levels. Fluorescence lifetime imaging
microscopy (FLIM) allows us to image the Ca2+-
dependent signal transduction cascades activated by
synaptic transmission in dendrites and even individual
spines. We can thus study the biochemical dynamics
of Ca2±-dependent Ras signaling in neuronal micro-
compartments. For example, we find that Ras acts as a
Ca2+-dependent switch in neurons. Activation of single
synapses leads to local activation of Ras, but activated
Ras escapes from spines and invades the dendrite and
neighboring spines. The spread of Ras activation like-
ly underlies subtle coupling between the properties of
neighboring synapses.
Experience-dependent Plasticity in the
Adult Cortex In Vivo
V. DePaola, A. Holtmaat, L. Wilbrecht [in collaboration
with G. Knott, Lausanne]
Sensory representations in the adult brain are stable,
yet we are able to learn. To understand the underpin-
nings of stability and plasticity, we image structural
dynamics in vivo. We find that the large-scale
arborization of axons and dendrites is stable but that
neurons display a rich repertoire of micrometer-level
structural plasticity of dendritic spines, axonal termi-
nals, and axonal branch tips. Experience-dependent
changes in spines and boutons are cell-type specific.
By combining in vivo imaging with retrospective ser-
ial section electron microscopy we have found that
new spines grow to make synapes and that they pref-
erentially grow toward existing boutons in the neu-
ropil. We find that mutant mice that are defective in
experience-dependent plasticity and learning also
show profound defects in structural plasticity.
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Circuit Mechanisms of Cortical
Plasticity and Dysfunction
I. Bureau, A. Karpova
The wiring diagram is fundamental to understanding
cortical function and plasticity. However, little quanti-
tative information about functional circuits is avail-
able. What are the sources of input to a neuronal sub-
type in a particular layer and column and what are
their relative strengths? Which connections change
with novel sensory experience?
We developed laser-scanning photostimulation
(LSPS) into a quantitative and rapid tool for circuit
analysis in brain slices. Using LSPS, we performed an
unbiased search for circuit phenotypes in animal mod-
els of fragile-X mental retardation. We found specific
defects in the function and plasticity of excitatory
L4--->L2/3 synapses.
Molecular Methods to Reversibly
Inactivate Synapses In Vivo
G. Tervo, A. Karpova
Inducible and reversible silencing of selected neurons
in vivo is critical to understanding the structure and
dynamics of brain circuits. We have developed mole-
cules for inactivation of synaptic transmission
(MISTs) that can be genetically targeted to allow the
reversible inactivation of neurotransmitter release.
MISTs consist of modified presynaptic proteins that
interfere with the synaptic vesicle cycle when cross-
linked by small-molecule "dimerizers." MISTs based
on the vesicle proteins VAMP2/Synaptobrevin and
Synaptophysin induced rapid (-10 min) and reversible
block of synaptic transmission in cultured neurons
and brain slices. In transgenic mice expressing MISTs
in Purkinje neurons, administration of dimerizer
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reduced learning and performance of the rotarod
behavior. MISTs allow for specific, inducible, and
reversible lesions in neuronal circuits and may provide
treatment of disorders associated with neuronal hyper-
activity. We are currently investigating the mecha-
nisms underlying MIST-dependent silencing. We are
also constructing knock-in mice expressing MISTs in
specific neuronal populations.
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NEUROGENETICS OF MEMORY IN DROSOPHILA
T. Tully J. Barditch H. Cox
K. Bell Y. Hua
F Bolduc J. Kui
Y. Chen
W. Lin
M. Regulski
N. Sinha
H. Wang
Y. Wang
S. Xia
Studies on Pavlovian learning in many animals have
revealed remarkably similar behavioral properties of
associative learning. Surprisingly, Pavlovian learning
in fruit flies also displays these behavioral properties,
suggesting a common underlying mechanism. The
neural architecture of the Drosophila brain bears no
resemblance to that of mammalian brains, of course,
which suggests that the behavioral "homology of func-
tion" must result from conserved cellular/molecular
mechanisms.
Consistent with this view, several genes and genetic
pathways have been identified to function in both verte-
brate and invertebrate associative learning, including N-
methyl-n-aspartate (NMDA) receptors (NMDA-Rs),
cAMP signaling, cAMP response element binding
(CREB)-dependent gene transcription, and staufen- and
fragile-X mental retardation protein (FMRP)-mediated
local regulation of protein translation. This systematic
rationale approach now is beginning to connect the bio-
chemistry of memory formation with the molecular
bases of heritable forms of mental retardation.
MUTANTS AND MICROARRAYS
We continue work derived from earlier experiments on
regulated gene expression induced during memory for-
mation. To date, we have confirmed 53 of 170 candi-
date memory genes (CMGs) using quantitative poly-
merase chain reaction (Q-PCR). Although perfectly
adequate to identify a few genes for further in vivo
analyses, this approach is too slow to provide a
genome-wide confirmation of CMGs. Thus, this year,
we designed and hybridized (with independent RNA
extracts) a custom microarray from Nimblegene, with
isothermal oligo probes corresponding to each of our
CMGs from the original Affymetrix experiments. We
currently are using "concordance" between the two
platforms to (1) determine the optimal analytic method
for these data and (2) provide simultaneous confirma-
tion of all CMGs from our original experiments.
We also are beginning to "connect the dots"
among the memory mutants we have identified either
from a past behavioral screen at CSHL (supported by
the Hartford Foundation) or from a more recent behav-
ioral screen at Tsinghua University in Beijing (done in
collaboration with Dr. Yi Zhong here at CSHL). A few
years ago, X. Ge and coworkers at Tsinghua
University showed that overexpression of Notch could
enhance long-term memory (LTM) formation, provid-
ing some of the first evidence that this canonical
developmental gene is involved in adult behavioral
plasticity. In this past year, Q. Meng at Tsinghua iden-
tified the X-linked chi mutant from a behavioral
screen for memory defects 1 day after spaced training.
In collaboration with Meng, Y. Zhong, and others, we
have shown that chi disrupts PTP10D, a protein tyro-
sine phosphatase, the mouse homolog of which is
PTPN5 (see Publications). Preliminary genetic exper-
iments in flies have confirmed claims in the literature
that PTP1OD interacts with gp150, which itself inter-
acts with Notch. In collaboration with M. Matsuno and
M. Saitoe at Tokyo Metropolitan Institute for
Neuroscience, we have more recently shown that the
memory-enhancing effects of Notch overexpression
can be blocked in the ruslan mutant, which was iden-
tified from our CSHL behavioral screen and which
disrupts the cell adhesion molecule Klingon (Fig. 1).
25
-hs
20 +hs
c
+1+ hs-N+ hs-N+:rus rus
FIGURE 1 One-day memory after one training session is
enhanced in transgenic fliesw (hs-N1 after heat-shock-induced
overexpression of Notch compared to wild-type flies (+1+) or
ruslan (rus) mutants. When Notch is overexpressed in a rus
mutant background (hs-N+;rus), however, the enhancement of
1-day memory is blocked. This observatoin suggests that klin-
gon function downstream from Notch during LTM formation (in
collaboration with M. Matsuno and M. Saitoe, Tokyo
Metropolitan Institute for Neuorscience).
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CIRCUITS AND PHASES
We continue to perform spatiotemporal experiments,
which reveal where in the adult brain LTM formation
occurs. This year, we have shown that modulations of
the NMDA-R subunit genes, NR1 and NR2, restricted
to adult mushroom bodies do not affect 1-day memory
after spaced training. In regions outside the mushroom
bodies, however, these same modulations can either
disrupt or enhance LTM. Thus, we are beginning to
believe that NMDA-R-dependent memory formation
requires anatomical structures in the adult fly brain
outside of, or in addition to, the mushroom bodies.
We have established a reliable new method to cell-
sort green fluorescent protein (GFP)-expressing neu-
rons from dissociated adult brains. This approach, in
principle, will allow us to extract proteins and RNA
from specific types of neurons involved with memory
formation. The amount of material collected is too
small for most subsequent biochemical assays, howev-
er. To address this issue, we are collaborating with Dr.
Lee Henry here at CSHL to develop a novel solid-
phase method of RNA amplification. Preliminary
results to date suggest that this method can reliably
amplify relatively small starting amounts of RNA.
GENETIC MODELS OF
We have succeeded to demonstrate an acute (biochem-
ical) requirement for FMR1 during LTM formation in
142
flies. Pharmacological study of fmrl mutants also has
begun to establish the molecular mechanism by which
FMRP functions during behavioral (and presumably
synaptic) plasticity.
We also have begun studies on a fly model of
Parkinson's disease (transgenic overexpression of
human a-synuclein). We want to challenge these flies
with various stressors and then to look genome-wide
for early changes in gene expression in response to
these conditions. We are particularly interested in gene
expression changes that may occur in both Parkinson's
disease and memory formation-ultimately as a
means to identify contributing factors to the cognitive
decline detected in early-stage Parkinson's patients.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION IN
THE CORTEX
A. Zador H. Asari
D. DeWeese
T. Hromadka
S. Jaramillo
S. Lima-Mainen
G. Otazu
H. Oviedo
L.-H. Tai
Y. Yang
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party, and tune out the others-a
task that remains beyond the capacity of modern com-
puters-we are engaging in a form of selective audito-
ry attention. Our ability to attend selectively is not lim-
ited to the auditory domain: Analogous tasks demand
selective attention in the visual and even somatosenso-
ry domains. In monkeys, visual attention selectively
enhances neural activity even in the earliest stages of
visual cortical processing. This enhancement is sur-
prising because the areas associated with these first
stages of visual processing have traditionally been
thought of as representing the sensory world faithful-
ly, in a way that depends only on the properties of the
sensory input itself The discovery of attentional mod-
ulation overturns the notion that the peripheral senso-
ry cortex is a passive "TV screen" available for view-
ing by a "homunculus" buried deep within the cortex.
The specific projects in the laboratory fall into
two main categories. First, we are interested in how
neurons represent auditory stimuli, and how these
representations are computed from the cochlear
inputs half a dozen synapses away. To address these
questions, we are using electrophysiological and
imaging approaches in anesthetized rats, as well as
computational approaches, to characterize the
properties of natural sounds. Second, we are inter-
ested in how these representations are modified
dynamically-within seconds to hours or longer-
in awake behaving rats by attention and other forms
of learning.
Sparse Representations for
the Cocktail Party Problem
H. Asari [in collaboration with B. Pearlmutter, Cold Spring
Harbor Laboratory]
To extract the behaviorally relevant information imbed-
ded in natural acoustic environments, animals must be
able to separate the auditory streams that originate
from distinct acoustic sources (the cocktail party prob-
lem). The auditory cortex has several orders of magni-
tude more neurons than does the cochlea, so that many
different patterns of cortical activity may faithfully rep-
resent any given pattern of cochlear activity. We have
been exploring the hypothesis that the cortex exploits
this excess "representational bandwidth" by selecting
the sparsest representation within an overcomplete set
of features. We have constructed a model showing how
sparseness can be used to separate sources perceived
monaurally. The model makes testable predictions
about the dynamic nature of representations in the
auditory cortex. Our results support the idea that sparse
representations may underlie efficient computations in
the auditory cortex (Asari et al. 2006).
Context Dependence and Response
Predictability in Rat Auditory Cortex
H. Asari
Sensory signal processing in the brain depends on
stimulus history and contexts. Classical linear encod-
ing models with rather shorter time scales (typically,
hundreds of milliseconds), however, have failed to
fully capture neural dynamics in the auditory cortex.
Here, we used whole-cell recordings in vivo to assess
the relevant time scales and how neural responses
depend on the stimulus context. We found that the
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changes in lower-order sound properties (e.g., intensi-
ty) had larger and longer effects than the changes in
higher-order properties (e.g., amplitude modulation);
and the context dependence sometimes lasted as long
as 4 seconds in some neurons. We also showed that the
predictive power for the best nonlinear model, but not
for the linear models even with static nonlinearities,
asymptotically approached the predictable response
power on the time scale of seconds. These results sug-
gest that complex modulations on longer time scales
should be considered as well for fully understanding
the auditory cortical activities and functions.
Sparse Synchronous
Inputs Drive Neurons in the
Auditory Cortex In Vivo
M. DeWeese, T. Hromadka
Cortical neurons receive most of their synaptic drive
from other cortical neurons. This fact imposes a strong
constraint on models of cortical activity: The dynamics
of one neuron's spiking output must be consistent with
the ensemble activity of the population of neurons that
synapse onto it. The usual solution to this self-consis-
tency constraint posits that both excitatory and
inhibitory neurons fire asynchronously, varying their
rates only slowly. According to this model, subthresh-
old fluctuations in membrane potential should be well-
described by a random walk. However, based on our
experiments using the in vivo whole-cell patch-clamp
technique, we have developed an alternate model in
which inputs are organized into synchronous volleys.
According to this model, subthreshold fluctuations
should be small most of the time, punctuated by large
excursions corresponding to the arrival of volleys. Our
results show that activity is organized into synchronous
volleys superimposed on a relatively quiet background.
This observation has implications for coding and com-
putation. In particular, the correlations we have found
among the synaptic population are precisely what is
required for sparsely encoded signals to successfully
propagate from one stage of cortical processing to the
next (Deweese and Zador 2006).
Identifying Neurons with ChR2
during In Vivo Recording
S. Lima-Mainen, T. Hromadka
Neural circuits consist of a heterogeneous mixture of
neurons with different neuroanatomical projections
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and patterns of molecular expression. Recordings of
neural activity in behaving animals reveal tremendous
functional heterogeneity as well: nearby neurons often
respond very differently to the same stimulus or action.
However, little is known about how this structural cir-
cuit-level heterogeneity contributes to function, in part
because of the technical difficulty of identifying neu-
rons during in vivo recordings in behaving animals.
To overcome this difficulty, we have developed a
technique that allows us to "tag" subpopulations of
neurons for identification during in vivo electrophysio-
logical recordings. The tag is a light-gated ion chan-
nel-the algal protein channelrhodopsin-2 (ChR2)____
whose expression can be genetically restricted to a sub-
population of neurons. In the subpopulation of neurons
expressing ChR2, a brief flash of blue light triggers a
single action potential with millisecond precision.
We are using this approach to test the hypothesis
that neuroanatomical connectivity represents one
important structural correlate of the functional diversi-
ty in the rodent cortex. To do this, we restrict ChR2
expression to subsets of neurons in the rat auditory cor-
tex (ACx). ACx pyramidal neurons project to multiple
brain regions, including the amygdala, the posterior
parietal cortex, or the contralateral ACx, and presum-
ably carry different information about auditory stimuli
to these centers. To target ACx neurons specifically
based on their projection pattern, we inserted the
ChR2-coding region into a herpes simplex virus
(HSV). HSV travels in a retrograde fashion through the
axons of infected neurons. ChR2-tagged neurons, i.e.,
neurons projecting to the infected area, can be identi-
fied by their low latency and reliable spiking response
to a brief light flash. Thus, for example, we have used
this approach to identify the subpopulation of layer-5
ACx neurons that project to the contralateral cortex.
This approach is general, in that any population to
which expression of ChR2 can be genetically restricted
can be tagged. Promising future applications include
tagging of different subpopulations of neurons based on
promoters (e.g., for subclasses of inhibitory interneu-
rons) and tagging of neurons in different cortical layers.
Separation of Sound Sources
by Awake Behaving Animals
G. Otazu, L.-H. Tai
Sounds in the natural world rarely occur in isolation,
but rather as part of a mixture. To survive, the auditory
system must be able to attend selectively to one sound
source and ignore others, and it does so more effective-
ly than any artificial system yet devised. To understand
how this is performed, we are using multielectrode
recording (tetrode) technology to monitor the activity
of many neurons simultaneously in awake, behaving
rodents performing an auditory discrimination task.
Mapping of Auditory Cortex
Circuitry Using Laser-scanning
Photostimulation
H. Oviedo [in collaboration with I. Bureau and K. Svoboda,
Cold Spring Harbor Laboratory]
It is widely assumed that the organization of the sen-
sory cortex can be described by a "canonical" circuit.
According to this view, sensory input from the thala-
mus arrives at cortical layer 4, propagates to layer 2/3,
and then descends to layer 5 before exiting a brain
region. However, until recently, it has been technically
difficult to test this hypothesis directly. We are apply-
ing a new approach, laser-scanning photostimulation,
to map the circuitry within the rodent auditory cortex.
Using this approach, we can directly compare the cir-
cuitry within the auditory cortex with that of other
sensory cortices, such as the better-studied barrel cor-
tex. Preliminary results indicate that although the
auditory cortex is organized according to many of the
same general principles, the detailed structure appears
to be quite different.
Using Cortical Timing
Information to Guide Behavior
Y. Yang, G. Otazu, M. DeWeese
It is well established that animals can exploit the fine
temporal structure of some stimuli; for example, inter-
aural time differences of less than 1 msec are used for
spatial localization of sound. It is also clear that corti-
cal neurons can lock with millisecond precision to the
fine temporal structure of some stimuli. However, it
has been difficult to establish whether the fine tempo-
ral structure of cortical responses can be used in a
behavioral context to guide decisions. Indeed, in the
case of spatial localization of sound, the relevant inter-
aural time difference cues are processed below the
level of the cortex by means of specialized circuitry.
We have therefore adopted a direct approach to
probe the precision with which cortical timing infor-
mation can be used to guide behavior in the rat. To
bypass subcortical auditory pathways, we stimulate the
primary auditory cortex directly, using transient bipha-
sic current trains delivered via chronically implanted
intracortical microelectrodes. The behavioral para-
digm we use is a two-alternative choice task in which
stimulus 1 consists of the simultaneous stimulation of
two intracortical sites (A and B), and stimulus 2 con-
sists of sequential stimulation of the two sites separat-
ed by a brief interval dt (A - dT - B). After the sub-
jects are trained to perform to criterion (1-2 weeks)
with the initial long interstimulus interval (dT > 50
msec) for stimulus 2, we probe the subjects' psy-
chophysical threshold by reducing dT, until the sub-
jects can no longer distinguish between the two stim-
uli. Our initial experiments indicate that the cortex can
make use of information on a time scale as short as 10
msec and possibly much less.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong H.-C. Chiang
I. Hakker
I.S. Ho
K. Lijima
A. Mamiya
M. Pagani
Y. Wang
We are investigating the neural basis of learning and
memory by using Drosophila to combine functional
analyses with genetic manipulation. Currently, we are
pursuing two major projects. First, we are establishing
Drosophila models for studying genes involved in
human neurodisorders that impair learning and mem-
ory. In particular, we are interested in genes known to
contribute to neurofibromatosis 1 (Nfl), Alzheimer's
disease, and Noonan syndrome. For Nfl, we have
shown that different fragments of NF1 are involved in
the regulation of different signal transduction path-
ways and have distinct roles in mediating formation of
short-term memory (STM) versus long-term memory
(LTM). For Alzheimer's disease, we have shown that
although aggregation proneness is critical for the tox-
icity of A1342, increasing or decreasing the aggrega-
tion propensity of AP42 does not simply change the
level of toxicity, but it can also result in qualitative
shifts in the pathologies they induce in vivo. For
Noonan syndrome, our preliminary data suggest that
gain-of-function mutations associated with the disease
may cause learning and memory defects. In the second
major project, we are investigating learning-associated
changes in the activity of neurons. For this project, we
have found that a specific group of neurons in the
mushroom body, a brain structure critical for insect
learning and memory, responds greater to an odor after
that odor has been associated with aversive stimulus.
The specific projects are described below.
Two Functional Domains of NF1
Independently Control Learning
and Memory Formation
I.S. Ho, I. Hakkar, M. Pagani
Neurofibromatosis type 1 (NFI) is an autosomal dom-
inant genetic disorder characterized by benign tumors
of the peripheral nervous system called neurofibro-
mas, café au lait spots, and extreme freckling. In addi-
tion, at least 40% of afflicted children have learning
difficulties. The NF1 protein contains a highly con-
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served GTPase-activating protein (GAP) domain that
inhibits Ras activity, and the carboxy-terminal region
regulates G-protein-dependent activation of adenylyl
cyclase (AC). Behavioral analysis has indicated that
learning and memory are also disrupted in Drosophila
and mouse NF1 models; however, the learning defect
in flies is attributed to altered activation of the cAMP
pathway, whereas the mouse learning deficit results
from increased Ras activity. Because of the enormous
difference in the timescale involved in training para-
digms for mice (water maze) and flies (odor-foot
shock association), we suspected that different compo-
nents of memory were being affected. We found for
the first time that not only STM, but also LTM was
defective in Drosophila Nfl mutants. Analysis of clin-
ically relevant human NF1 mutations and deletions
expressed in Drosophila Nfl mutants allowed us to
dissect the molecular basis for the role of NF1 in
mediating both STM and LTM. We found that the
GAP-related domain with its GAP activity and bind-
ing with Ras was necessary and sufficient for LTM,
whereas the carboxy-terminal domain of NF1 that is
required for G-protein-dependent activation of AC was
critical for STM. Thus, this study shows that two func-
tional domains of the same protein participate inde-
pendently in formation of two memory components.
Mutant Ap42 with Different Aggregation
Propensities Induce Distinct
Pathological Phenotypes in Drosophila
K. lijima, H.-C. Chiang, I. Hakker, Y. Zhong
The amyloid-P-42 (A342) protein has been suggested
to have a central role in the pathogenesis of
Alzheimer's disease (AD). The neurotoxicities of
AP42 have been well established in various experi-
mental models and often correlated with its aggrega-
tion-prone nature, leading to the hypothesis that
reducing aggregation proneness of AP42 decreases its
toxicity. To revisit this hypothesis in vivo, we exam-
ined the effects of expression of mutant A1342 with
altered aggregation propensities in the Drosophila
brain. We found that some aspects of A1342 toxicity do
not positively correlate with aggregation proneness.
Rather, A1342 with different aggregation properties
can induce distinct pathological phenotypes. A1342
with the Arctic mutation (AI342Arc), which causes
early-onset familial AD, is more aggregation-prone,
whereas AP42 with an artificial mutation (A1342art) is
known to suppress aggregation. Consistent with in
vitro observations, A1342Arc expressed in the
Drosophila brain formed more oligomers and A13
deposits than wild-type Ar342, whereas A1342art flies
showed less formation of both oligomers and
deposits. Age-dependent locomotor dysfunction and
premature death correlated well with aggregation
proneness, with A1342Arc showing the strongest phe-
notypes and A1342art the weakest. However, A1342art
induced a more severe memory defect than did Af342.
Strikingly, these flies developed different pathologies.
A1342Arc caused extensive neuron loss, whereas
A1342art flies showed the strongest neuropil degener-
ation. This may be partly explained by the different
distribution patterns of these A13 peptides. A[342Arc
accumulates primarily in the cell body as large
deposits, and A1342art preferentially accumulates in
neurites, and A1342 showed both properties. Thus,
although aggregation proneness is critical for the tox-
icity of A1342, our results demonstrate that increasing
or decreasing the aggregation propensity of A1342
does not simply change the level of toxicity but can
also result in qualitative shifts in the pathologies they
induce in vivo.
Experience-dependent Behavioral
Alteration in a Drosophila Model
of Noonan Syndrome
M. Pagani
Noonan syndrome is a pleiomorphic dominant genet-
ic disorder showing developmental defects, high inci-
dence of leukemia, mental retardation, and behavioral
disorders. Recently, it has been identified that mis-
sense mutations in the PTPN11 gene, which encodes
the protein tyrosine phosphatase nonreceptor 11, SHP-
2, are associated with Noonan syndrome, as well as
with several types of leukemia. It is thought that gain-
of-function mutations are associated with both
Noonan syndrome and leukemia. The SHP-2 protein is
highly conserved among human, vertebrates, and
invertebrates and has an essential role in growth factor
and integrin signaling. However, the genetic and mol-
ecular mechanisms that mediate behavioral alterations
in Noonan syndrome have not been explored.
To examine the role of SHP-2 in behavior and the
mechanisms underlying its effect on behavior, we
started studying transgenic Drosophila flies carrying
mutations associated with Noonan syndrome,
leukemia, or both disorders in the Drosophila ortholo-
gous gene, csw.
We have found that gain-of-function mutations
associated with Noonan syndrome, leukemia, or both
disorders may cause learning and memory defects.
Preliminary studies showed that learning defects are
not dependent on developmental alterations of the ner-
vous system. In addition, although normal learning,
STM and LTM were dependent on csw function, the
mechanisms involved for each stage seem to be differ-
ent. For example, learning was affected by an increase
in the dosage of the csw gene but not by missense
mutations, whereas LTM seems to be sensitive to both
mutation and the dosage of csw.
Further genetics, behavioral, and physiological
studies will help us to identify the molecular mecha-
nisms involved in experience-dependent behavioral
alteration mediated by SHP-2 in Noonan syndrome as
well as in normal individuals.
Imaging of Memory Traces in the
Drosophila Mushroom Body
Y. Wang, A. Mamiya
The Drosophila mushroom body (MB) is a higher-
order brain center that is crucial for olfactory associa-
tive learning and memory formation. Depending on
their birth orders, the MB neurons can be divided into
three subtypes, the y, a' /f3', and a/13 neurons, which
give rise to separate axonal branches. Axons of the y
neurons form the horizontal y lobe. Axons of 013'
neurons bifurcate to form vertical a' lobes and hori-
zontal 13' lobes, whereas axons of a'/I3 neurons bifur-
cate to form vertical a lobes and horizontal 13 lobes. As
an initial step in understanding the neural mechanisms
underlying learning and memory formation, we are
investigating how an odor-evoked response of differ-
ent types of MB neurons changes after the odor has
been associated with electric shock. To do this, we
express GCaMP, a genetically encoded Ca" sensor, in
MB neurons and monitor the neuronal-activity-
induced increase in the Ca" at different regions of MB
using a two-photon microscope.
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We took three different in vivo and in vitro
approaches. In the first approach, we used an isolated
fly brain and stimulated the antennal nerve (AN) to
mimic olfactory input and the ventral nerve cord
(VNC) to mimic electric shock. Pairing of AN and
VNC stimulation was used to mimic odor-aversion
conditioning, and the response to AN stimulation
before and after pairing was compared. In the second
approach, flies were trained in a traditional T-maze
where they were presented with an odor with electric
shock, followed by a different odor without electric
shock. In this approach, responses to shocked odor and
nonshocked odor were compared. In the third
approach, flies were fixed and conditioned under the
microscope by presenting an odor together with elec-
tric shock to its body. The response to an odor before
and after odor-electric shock pairing was compared.
In all three approaches, we observed enhanced
odor-evoked Ca" influx after conditioning in the
148
axonal branches of the a' /J3' MB neurons, but not in
the other types of MB neurons nor the dendritic
region. The enhancement lasted for more than an hour
and was abolished by disrupting the G protein signal-
ing that impairs olfactory learning. Furthermore,
immediate memory was impaired by disrupting G pro-
tein signaling in the a'/13' neurons or blocking their
synaptic output. Therefore, the observed enhanced
Ca" influx after learning in the a' /13' neurons may rep-
resent a memory trace in the MB.
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PLANT GENETICS
From orchids to dandelions, the dazzling diversity of plants' shapes, colors, and forms are an endless
source of wonder. But all of these traits, including those of tremendous agricultural significance, have
been shaped by evolution or by human selection. Uncovering the molecular processes that govern how
plants grow and develop is thus of fundamental biological interest and importance.
David Jackson's lab aims to identify the genes and signals that regulate plant signaling and morpho-
genesis. In the last year, they have isolated a gene that controls how plant cells communicate through
small channels, called plasmodesmata. This gene is expressed in the growing regions of the plant and
may control the allocation of nutrients and developmental signals during plant growth. Jackson's lab
also continues to use positional cloning to identify maize genes with defined roles in development. In
the past year, candidate genes that control branching, stem cell proliferation, and inflorescence organ
identity have been identified. One of these, RAMOSA3, appears to function through modulation of a
hypothetical sugar signal, highlighting a novel mechanism by which plants regulate their growth. Finally,
Jackson and colleagues have also begun to compile a collection of fluorescent-protein-tagged maize
lines that will be used for studies in cell and developmental biology. This is the first collection of its kind,
and it promises to enhance maize genetics research through characterization of developmental gene
pathways and identification of maize promoters.
The specialized shapes of leaves have a vital role throughout plant biology. Moreover, within each
leaf, the functions of the upper and lower surfaces are very different. Marja Timmermans's work is
focused in part on understanding how unspecialized stem cells create this dorsoventral (upper/lower)
axis of leaves. Her group has identified two genes-Leafbladeless1 (Lb 11) and Rolled leafl (Rid 1)-
that are essential for controlling this process. Timmermans discovered that these genes are in turn
controlled by the opposing action of two particular microRNAs. One significant aspect of these find-
ings is that like classical protein "morphogen gradients," microRNAs can act as diffusible develop-
mental signals that move through tissues and thereby control stem cell specialization. Timmerman's
findings suggest that small RNAs may be mobile, and this offers the intriguing possibility that they can
function as signals in development. Moreover, these results reveal a novel patterning mechanism,
whether in plants or animals, in which opposing fates along a developmental axis are established by
two distinct small RNAs.
Unlike most developing animal embryos, plant embryos begin to differentiate from the very first cell
division. An unequal division of the fertilized egg cell creates daughters with radically different fates-
embryonic and extraembryonic. Wolfgang Lukowitz studies the molecular steps that regulate this fate
decision and its impact on the subsequent tissue specializations. His group has identified a number of
proteins that are likely forming a signaling pathway controlling this earliest step in plant embryonic
development. One of these proteins appears to act through the sperm cell and to link the onset of sig-
naling to fertilization.
Gene expression can depend on many factors, not only on a gene's DNA sequence, but on its posi-
tion. A major aspect of work in Robert Martienssen's lab involves shedding light on the mystery of gene
expression by studying the process of "position effect variegation." First described in the 1930s, posi-
tion effect variegation refers to plant color diversity caused by the inactivation of a gene in some cells
due to its position near a condensed clump of chromosomal material called heterochromatin.
Martienssen and colleagues are investigating the role of RNA interference in heterochromatin, epige-
netics and plant development. This work holds the promise of yielding fundamental insights into plant
biology and has implications for an understanding of human disease as well.
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PLANT SIGNALING AND DEVELOPMENT
D. Jackson J. Anker
Y. Benitez
P. Bommert
D. Bouyer
0. Dmytrenko
A. Gallavotti
K. Lau N. Satoh-Nagasawa
B.H. Lee J. Wang
J. Linder C. Whipple
A. Maizel Y. Yan
A. Mohanty R Yin
Research in our lab focuses on the molecular mecha-
nisms of cell-to-cell communication and development
in plants. We use genetics to identify developmental
regulators, genomic tools to isolate the corresponding
genes, and various biochemical and cell biology tech-
niques to investigate the underlying mechanisms. In
the last year, we have made very significant advances
in several areas, notably in the ability to isolate maize
mutant genes by positional cloning and in the identifi-
cation of a gene that regulates cell-to-cell transport, as
discussed below.
Maize is the premier model system for the cereal
crops and probably the best genetic plant model. In
the past, isolation of genes identified by mutations
has been slow; however, with the emerging rice and
maize genome sequences, we have been among the
first to report the use of positional cloning in maize.
This last year we reported the isolation of RAMOSA3,
a gene involved in inflorescence branching.
Remarkably, we found that RA3 encodes a trehalose
phosphate phosphatase, giving the first inkling that
certain sugars may act as very specific developmental
signals (Satoh-Nagasawa et al. 2006). We have also
isolated genes regulating vegetative branching, inflo-
rescence organ identity, and stem cell proliferation
and are in the process of characterizing their gene
products.
Several years ago, we identified a novel mecha-
nism of cell-cell communication in plants that
involves the specific transport of regulatory proteins
between cells. In the last year, we have begun to iden-
tify the plant genes that regulate this process. We have
also started to compile a collection of fluorescent-pro-
tein-tagged maize lines that will be used for studies in
cell and developmental biology. This is the first collec-
tion of its kind, and it promises to enhance maize
genetics research through characterization of develop-
mental gene pathways and identification of maize pro-
moters.
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Characterization of the Function of the
RAMOSA3 Gene in Maize
N. Satoh-Nagasawa, A. Mohanty, A. Gallavotti, Y. Yang,
J. Linder [in collaboration with H. Sakai and N. Nagasawa,
Dupont; S. Malcomber, California State University,
Long Beach; S. Swaminathan, Brookhaven National
Laboratories, New York]
To elucidate the genetic and molecular mechanisms of
inflorescence branching, a major yield trait in crops,
we have been working with the ramosa3 (ra3) mutant
of maize. By observation of the mutant phenotype and
double-mutant analyses, we found that RA3 functions
upstream of another RA gene (RAJ) to establish the
correct identity and determinacy of axillary meristems
in the maize inflorescence. The RA3 gene was cloned,
and we found that it encodes a trehalose-6-phosphate
phosphatase (TPP). TPPs are considered to be meta-
bolic enzymes that catalyze the conversion of tre-
halose-6-phosphate (T6P) to trehalose, a disaccharide.
Interestingly, RA3 is expressed outside of the cells
whose fate it regulates, at the base of axillary meris-
tems, and this novel expression pattern is conserved
throughout the grasses.
From these studies, we developed two hypotheses
for the molecular mechanism of RA3 function. First,
T6P or trehalose may act as a mobile signal during
axillary meristem development. Second, the RA3 pro-
tein itself may directly control the expression of other
genes, like RAl. To test these hypotheses, we investi-
gated RA3 protein localization, and preliminary
results show that a RA3 yellow fluorescent protein
(YFP) fusion is localized in the cytosol and nucleus.
This leads us to speculate that RA3 protein could act
as a regulator of gene expression in the nucleus, a role
distinct from its proposed metabolic activity. To deter-
mine whether this is the case, we made catalytically
inactive RA3 mutants, after three-dimensional struc-
ture modeling of the TPP domain. The mutant RA3
proteins expressed in bacteria did not have enzymatic
activity. We are currently testing whether this mutant
protein can complement the ra3 phenotype. We are
also attempting to measure the concentration of tre-
halose and T6P in young inflorescences of wild type
and ra3 mutants and have started to purify RA3 antis-
era. To further investigate the mechanism of RA3
action, we used microarray experiments to search for
RA3-regulated genes, which may also provide direc-
tion for further genetic analysis.
While we are examining RA3 function in maize, we
are also interested in the function of RA3-like genes in
other plants and genetic interaction of RA3 with other
genes in maize. We analyzed the expression of RA3 and
its closest homolog, sister of RA3 (SRA) and are char-
acterizing mutants in other grasses and in Arabidopsis
in order to define the function of those genes. With
these experiments, we aim to more fully understand the
function of RA3 and fit it into an emerging network of
regulators of inflorescence development in maize.
Regulation of Phyllotaxy
in Maize
B.H. Lee, Y. Yan [in collaboration with J. Traas, Lyon,
France; H. Sakakibara, RIKEN, Yokohama, Japan;
C.-X. Xie, Chinese Academy of Agricultural Sciences,
Beijing, China]
One of the most fascinating aspects of plant morphol-
ogy is the regular geometrical arrangement of leaves
and flowers, called phyllotaxy. The shoot apical meris-
tem (SAM) determines these phyllotactic patterns,
which vary depending on species and developmental
stage. For example, maize develops leaves in alternat-
ing patterns, and Arabidopsis rosette leaves display a
spiral arrangement. Unlike normal maize, abphl
(aberrant phyllotaxyl) mutants show decussate leaf
phyllotaxy, where two leaves develop at the same
node, paring at 180°. ABPH1 encodes a cytokinin-
inducible type-A response regulator and is believed to
function in cytokinin hormone signaling. Since auxin
and polar auxin transport have also been implicated in
phyllotaxy, we focused our studies on the interactions
of cytokinin and auxin signaling in phyllotaxy.
We observed reduced ABPH1 expression in polar
auxin transport-inhibited SAMs, suggesting that the
ABPH1 expression is dependent on auxin. Using anti-
bodies for the Arabidopsis PINFORMED1 (PIN1) pro-
tein, which functions as a polar auxin efflux carrier, we
found that the maize SAM has a PIN1 protein expres-
sion domain similar to that in Arabidopsis. Quantitative
reverse transcriptase-polymerase chain reaction (RT-
PCR) for a maize PIN1 homolog showed reduced
expression level in the abphl SAM. These results are
consistent with our observations of delayed expression
of the maize PINT protein at the incipient leaf initiation
sites in abphl, as found by three-dimensional recon-
structions of sections probed with a PIN1 antisera.
Consistent with these observations, auxin levels were
lower in abphl mutants than in the wild type.
Together, these results suggest a positive feedback
loop involving ABPH1, auxin, PIN1, and polar auxin
transport. In the past, we proposed that ABPH1 acts as
a negative regulator in cytokinin signaling.
Consequently, we now propose that ABPH1 operates
at a junction point that modulates a negative feedback
in cytokinin signaling and a positive feedback in auxin
signaling in the maize SAM. To further characterize
this proposed network, we used microarrays to com-
pare gene expression in normal and abphl embryos.
We selected 22 putative ABPH/ -regulated genes and
have independently confirmed 11 of these as having
altered expression in abphl. Interestingly, several of
these encode predicted hormonal or developmental
regulators, and their functions will be examined using
a reverse genetics approach.
We also generated transgenic maize containing a
YFP-tagged ABPH1 construct (ABPH1-YFP) under the
control of the endogenous ABPH1 promoter, and it
showed the native expression pattern. We also found that
the transgene complements the abphl mutant phenotype,
suggesting the YFP fusion is functional. Thus, these lines
will be very useful for in vivo studies of ABPH1.
A second maize abnormal phyllotaxy mutant has
been identified. This one is dominant and we have called
it Abph2. We mapped this gene at the top of chromo-
some 7 in a region that shows synteny to the top of rice
chromosome 7. There are about 200 rice genes in the
syntenic region defined by two maize markers that flank
ABPH2. We are in the progress of refining this mapping
information, with a goal of identifying the ABPH2 gene.
Role of the Phytohormone
Auxin in Maize Branching
A. Gallavotti, Y. Yan [in collaboration with M.J. Zanis, Purdue
University; R.J. Schmidt, University of California, San Diego]
One of the most striking features of plants is their abil-
ity to constantly adapt their development in response
151
FIGURE 1 Fluorescent protein markers for hormonal regulators in maize. (A) Maize developing flower meristems (m) showing spikes
of ZmPIN1a-YFP expression at sites of organ initiation (arrow), indicative of auxin maxima. (B) ZmPIN1a-YFP expression in the maize
embryo. YFP expression is detected in the shoot apical meristem (m), epidermal layer of the scutellum, and vascular bundles (v). (C)
HP1-RFP expression in callus. This protein is localized to the nuclei (n) and also present throughout the cytoplasm. All images cap-
tured using the confocal microscope.
to environmental changes. This plasticity is made pos-
sible thanks to few groups of cells, called meristems,
that are responsible for postembryonic development
of organs such as leaves, branches, and flowers. In the
past few years, it has become clear that the formation
of new meristem and organ primordia is triggered by
a universal mechanism involving the creation of
dynamic gradients of the plant hormone auxin. These
gradients are the result of the subcellular localization
and activities of auxin efflux and influx carriers. We
are studying the role of auxin transport throughout
maize development. Maize has unique features that
make it an attractive system to study the formation of
new meristems and new organs. Most noticeably,
maize inflorescences are formed by a progression of
different meristem types, each characterized by dis-
tinct identity and fate.
The maize PINFORMED1 auxin transporter gene,
ZrnPIN1a, is expressed throughout vegetative and
reproductive development and acts as an auxin efflux
carrier in a heterologous system. To monitor the
dynamics of auxin transport during the formation of
branches and organs, we made transgenic lines
expressing a fusion of ZmPINIa with YFP. We are also
generating maize transgenic lines carrying a synthetic
auxin responsive promoter, "DR5rev," fused to red flu-
orescent protein (RFP), to monitor auxin maxima dur-
ing development. With the goal of describing a unified
model for branching in maize, from the formation of
vegetative axillary meristems to the formation of flo-
ral organs, we are characterizing the localization of
ZmPIN 1 a (Fig. 1) and the direction of auxin flow
using these marker lines. Taking advantage of the
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existing large collections of maize mutants, we are
also crossing several branching mutants with our fluo-
rescent protein reporters to understand how they inter-
act with the auxin pathway. For several of these
mutants, the underlying genes have been recently iso-
lated. This analysis will help to gain a comprehensive
view of the molecular mechanisms behind meristem
formation and activity in maize.
Using Trichomes as a Tool
to Study Intercellular
Protein Transport
D. Bouyer, J. Wang
Cell-to-cell communication is a prerequisite to ensure
the coordinated development of multicellular organ-
isms. The development of leaf hairs, so-called tri-
chomes, in Arabidopsis involves cell-to-cell communi-
cation in order to establish a regular pattern on the leaf
epidermis. The TRANSPARENT TESTA GLABRA 1
(TTG1) gene is necessary for seed pigmentation and
trichome initiation and acts in a non-cell-autonomous
matter. Moreover, this protein is able to move between
cells. Interestingly, this protein mobility is a character-
istic that is absent in some TTG1 homologs. In contrast
to TTG1, the petunia homolog AN11 is not able to res-
cue the Arabidopsis ttgl mutant when expressed from
the subepidermis, a tissue that does not make tri-
chomes, but can complement the mutant when
expressed using the ubiquitous CaMV35S promoter.
This attribute of mobility can be localized to a small
domain within the TTG1 protein. In summary, where-
as the role in anthocyanin pigment regulation is high-
ly conserved between AN11 and TTG1, the
Arabidopsis homolog is additionally involved in sev-
eral patterning processes, which require intercellular
communication.
In plants, protein transport between cells is
enabled by small channels, plasmodesmata, that con-
nect cells and allow the exchange of signals. Although
these structures have been known for quite some time,
their composition and regulation are poorly under-
stood. To gain more insight into the function of plas-
modesmata, we are performing a genetic screen based
on the ability of TTG1 to be transported from the
subepidermis to the epidermis. In this screen, mutants
that are defective in protein transport should lack tri-
chomes. In a second screen, the inability of AN11 to
move from the subepidermis to the epidermal layer
will be used as a tool to screen for mutants that have
"dilated" plasmodesmata, leading to the restoration of
trichomes. Taken together, the analysis of TTG1
mobility may serve as an excellent way to investigate
the mechanism and evolution of mobile protein sig-
nals in plants.
We also performed a screen using the KNOT-
TED1 homeodomain protein, this was the first plant
transcription factor found to move cell-to-cell. A
fusion of the homeodomain of KN1 with the
GLABROUS1 (GL1) protein was able to comple-
ment trichome formation when expressed in the non-
trichome producing subepidermal cells of a gll
mutant line. We showed that this rescue was depen-
dent on the ability of the KN1-GL1 fusion protein to
move into the epidermal cells. Four mutants have
been identified in this screen, and we have mapped
each to a small region in preparation for positional
cloning of the corresponding genes. Analysis of
these genes should be informative as to the mecha-
nism of intercellular transport of KN1 and other
mobile plant signals.
Molecular and Genetic Characterization
of Plant Intercellular Channels
Y. Benitez, 0. Dmytrenko
We are interested in mechanisms regulating transport
through plant intercellular channels, plasmodesmata.
We previously reported the isolation of mutants by
screening of approximately 1000 M2 EMS (ethyl-
methane sulfonate) lines in a pSUC2-GFP (green flu-
orescent protein) background. These mutants were
affected in GFP unloading from the phloem vascula-
ture and in cell-to-cell transport to the meristematic
cells of the root tip. We focused our efforts on two
mutants, called "gfp aberrant trafficking" or gat for
short. These mutants are recessive and show a
seedling-lethal phenotype.
We have performed experiments to further charac-
terize these mutants and identify the genes responsible
for the mutant phenotype. We analyzed the targeted
trafficking of developmental proteins, such as
SHORTROOT (SHR) and SHOOTMERISTEMLESS
(STM), in the mutant meristems. SHR::GFP,
expressed under the SHR promoter, normally traffics
from the stele to the endodermis, and we found that the
transport is unaffected in gat mutants, suggesting they
may affect general PD permeability rather than trans-
port of specific targeted proteins.
We have isolated gatl by positional cloning. By
allelism tests with insertional mutants in genes in the
candidate region, we found that the CSHL gene-trap
transposon line GT12462 failed to complement gatl,
suggesting that GAT1 is encoded by the gene tagged
by the gene trap. Furthermore, we found that a con-
struct expressing this gene can complement the gatl
mutant phenotype; therefore, GAT1 has been cloned.
Interestingly, we were not able to find any mutation in
the coding or promoter sequence in gatl homozygous
mutants, suggesting that this might be an epiallele.
Preliminary experiments to check the methylation sta-
tus of this gene in gatl mutants indicate that the pro-
moter is methylated, consistent with the idea that it is
indeed an epiallele. Polymerase chain reaction (PCR)
analysis of genomic DNA digested with methylation-
sensitive enzymes and analysis of double mutants with
genes in DNA methylation pathways are being per-
formed. We hope to show that a reduction of methyla-
tion in the gatl EMS allele is able to rescue the gatl
phenotype.
The GT12462 gene-trap line carries a P-glu-
curonidase (GUS) reporter gene, and by using GUS
staining, we have detected expression in shoot and root
meristems. We also found strong expression in the leaf
and root vasculature and leaf primordia. In embryos,
staining appeared at the transition from heart to torpe-
do stage and was also localized in root and shoot apical
meristems. This staining is greatly reduced in homozy-
gous mutants, suggesting that the transposon insertion
in the intron of this gene affects its expression. To fur-
ther explore the expression and subcellular localization
of GAT1, we made a YFP-tagged construct of the gene
under the control of its own promoter. Expression of
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this construct together with the results of in situ local-
ization experiments will be critical in understanding
the role of this gene in plant development and cell-to-
cell transport. At the same time, we are planning exper-
iments to study the effect of misexpression of the gene.
We have made several constructs carrying the wild-
type gene under the control of tissue-specific promot-
ers for vascular, meristematic, and mature tissues.
These experiments will help dissect the potential
developmental and physiological functions of GAT]
and will elucidate its importance in meristem develop-
ment and in intercellular trafficking.
Hormonal Signaling in Maize
A. Mohanty, Y. Yang [in collaboration with A. Chan, The
Institute of Genomic Research; A. Sylvester, University of
Wyoming]
Plant hormones have critical roles in growth and devel-
opment. Among them, cytokinins are especially inter-
esting as they regulate a variety of agronomic process-
es including crop yield and nodulation. Cytokinins are
perceived by histidine kinase receptors (HKs), which
upon binding of cytokinins initiate a phosphorelay sig-
nal transduction pathway. The phosphorylation is
transferred to B-type response regulators (RRs) via
histidine phosphotransfer (HP) proteins, which translo-
cate from the cytoplasm to nucleus. In turn, the B-type
response regulators act as transcription factors to acti-
vate A-type response regulators.
We have taken a localization-based approach to
decipher cytokinin signaling pathways in maize. We
have generated fusions of fluorescent proteins to the
HPs, HKs, and RRs, as well as to cytokinin oxidase
(CKO) genes that degrade cytokinins, and have
obtained transgenic maize plants harboring these con-
tructs. Some of the questions that we are interested in
addressing include Is the subcellular localization of
these proteins regulated in tissue-specific manner?
Does the nucleocytoplasmic shuttling of HPs
observed in transient assays in Arabidopsis hold true
for these maize genes? Preliminary analysis of trans-
genic maize calli expressing HP1-RFP shows local-
ization in the cytosol as well as nucleus (see Fig. 1).
Another area of interest is the interplay between cell
cycle control and cytokinin signaling in the meristem.
Cyclin D (CYCD) has been proposed to be a sensor
for cytokinins, and we have made a maize CYCD-
YFP fusion construct. We are currently generating
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FIGURE 2 Pink maize kernels expressing a fusion of a seed
storage protein with the red fluorescent protein.
transgenic plants harboring this gene. It will be inter-
esting to determine the expression pattern and regula-
tion of this gene in the meristem, and analysis of these
lines should greatly aid our understanding of
cytokinin biology.
Since the tools for subcellular localization in
maize are very limited, we have also generated a series
of marker lines for nuclei, microtubules, tonoplast
membrane, plastids, peroxisomes, protein storage
bodies, and other structures. We are evaluating expres-
sion patterns of these markers in multiple organs and
cell types so as to develop an atlas of expression pat-
terns in maize. In addition, our use of native promot-
ers will allow us to generate useful promoters for tis-
sue- and developmental-stage-specific regulated
expression. The expression of fluorescent proteins in
maize appears to be robust and stable. In one particu-
lar example, to develop an endosperm and protein-
storage-body-specific marker, we used RFP to tag an
endosperm-specific gene, FLOURY2 (FL2), encoding
a zein class storage protein. Confocal image analysis
of transgenic maize showed the endosperm-specific
expression of FL2-RFP driven by its native promoter
and localization in protein bodies, consistent with pre-
vious studies on this gene. Furthermore, the FL2-RFP
kernels have a distinct pink color to the naked eye, due
to accumulation of high levels of the FL2-RFP fusion
protein (Fig. 2). This feature could be exploited for use
as a reporter for selection of transgenic seeds.
Regulation of Inflorescence
Meristem Size in Maize
P. Bommert, K. Lau, J. Anker, J. Wang [in collaboration with
W. Bruce, Pioneer Hi-Bred Intl.]
The development of the maize tassel and ear is depen-
dent on the activity of the inflorescence meristems.
Our interest is in the analysis of mechanisms that con-
trol the size of the inflorescence meristem using genet-
ic and biochemical approaches. Our previous analysis
of the fasciated earl (fea2) and thick tassel dwarf]
(tdl) mutants in maize suggested that the CLAVATA
(CLV) signaling pathway, which regulates meristem
size in Arabidopsis, is conserved in maize, since FEA2
encodes an LRR receptor protein orthologous to
CLV2, and TD1, an LRR receptor-like kinase, ortholo-
gous to CLV1.
Currently, we are continuing to isolate the FEA2 -
containing receptor complex by using GFP and cTAPi
(a modified, plant-specific version of the yeast TAP-
tag) as epitope tags. Initial gel-filtration experiments
found that the FEA2 protein is a member of a 450-kD
complex, and subsequent analysis of both epitope-
tagged FEA2 proteins revealed that they are also
incorporated in high-molecular-weight complexes of a
similar size. We were also able to show that both
tagged complexes are located at the plasma mem-
brane, indicating that adding of the epitope tags does
not interfere with the correct intracellular localization.
Our eventual aim is to perform a mass spectrometric
analysis of the purified complexes. Identified proteins
and their encoding genes will then be analyzed by
expression profiles, mutant phenotypes, and genetic
interactions with feat and td1 .
We are also following a genetic approach to isolate
other fasciated mutants, such as fasciated ear3 (fea3)
and compact plant2 (ct2). Both mutants develop
abnormally enlarged inflorescence meristems, indicat-
ing that they also regulate meristem size. Using a map-
based cloning strategy, we have identified the ct2
gene. A combination of molecular markers used on a
population of 450 ct2 mutants was sufficient to narrow
down the chromosomal location of ct2 to an interval of
0.5 cM on chromosome 1. As this region is highly syn-
tenic to rice, we were able to follow a candidate gene
approach, which allowed us to identify ct2 as a pre-
dicted kinase. Preliminary in situ hybridization exper-
iments show that ct2 is expressed within the inflores-
cence meristem, which, together with the phenotypic
analysis, suggests that CT2 might be a newly identi-
fied factor in the CLAVATA signaling pathway. Map-
based cloning of the fea3 gene is also in progress.
Tassel sheath Mutants and the Regulation
of Bract Suppression in Grasses
C. Whipple
Shoot development can be interpreted as a reiteration
of three basic units: the leaf, stem, and an axillary
meristem that will itself grow out and continue this
pattern. Together, these units constitute a "phytomer,"
that is repeated throughout plant growth and develop-
ment. It is by modification of this phytomer that
changes in morphology occur. Distinct phytomer
morphologies characterize transitions in the plant life
phase (e.g., vegetative to reproductive), as well as
interspecies differences. Although there is a lot
known about the development of individual phytomer
components, little attention has been given to how
phytomer growth is modified throughout either the
life cycle of a single plant or through evolution. One
interesting phytomer modification that occurs in
many plant species is the suppression of leaf develop-
ment after the transition to reproductive development.
For example, in most grass species, inflorescence
leaves (called bracts) fail to grow, although a rudi-
mentary bract primordium does form. Interestingly, in
a few grass taxa, as well as in close relatives of the
grass family, bracts are not suppressed and grow out
normally. It thus appears that a mechanism for bract
suppression evolved in the common ancestor of all
grasses and was subsequently lost in a few species.
Understanding the mechanism by which bract sup-
pression occurs will shed light on an interesting mod-
ification important both in the development of a sin-
gle species and in evolution.
To understand the regulation of this process in
grasses, we have begun an investigation of maize
mutants that fail to suppress bract development. These
mutants are known as tassel sheath (tsh). The mutants
often have well-developed bracts in the inflorescence.
We have collected several mutants with a tassel sheath
phenotype and are beginning genetic characterization.
Initial complementation and mapping studies suggest
that at least three distinct loci (tshl, tsh2, and tsh3)
exist. A tshl tsh2 double mutant has a synergistic phe-
notype indicating that they interact in a common path-
way of bract suppression (Fig. 3). We have used a map-
based cloning approach to isolate the tshl gene, which
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FIGURE 3 A tshl tsh2 double mutant has a synergistic pheno-
type, indicating that they interact in a common pathway of bract
suppression.
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encodes a predicted transcriptional regulator contain-
ing a putative GATA zinc finger domain. Currently,
we are performing an expression analysis of TSH1 as
well as other genes known to be important for leaf ini-
tiation and growth in order to understand the mecha-
nism by which this gene regulates bract suppression.
Ultimately, we hope to investigate TSH genes from
other grass species and outgroups to see if this path-
way is involved in the evolution bract suppression in
the grass family.
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CELL-FATE DECISIONS IN THE EARLY PLANT EMBRYO
W. Lukowitz T. Awoyomi T. Nawy
M. Bayer J. Nemiroff
R. Devenyi S. Peters
M. Galli J. Williams
In most plants, the early stages of embryogenesis fol-
low a predictable sequence of cell divisions and cell-
shape changes reflecting the coordinated fate deci-
sions that lay down the reference points of the body
plan. Our goal is to identify and understand the genet-
ic network regulating this process. We are working
with the small weed Arabidopsis, an inexpensive
experimental model with very good comparability to
economically important species.
Paternal Control of
Embryonic Patterning
W. Lukowitz, M. Bayer, M. Galli
Plant development begins with an asymmetric division
of the zygote. This division entails a fundamental fate
decision that sets the stage for all subsequent pattern-
ing events: The small apical daughter cell will produce
the proembryo, whereas the large basal daughter cell
will mainly form the extraembryonic suspensor. The
mitogen-activated protein kinase kinase (MAPKK)
kinase gene YDA promotes suspensor fate in the basal
cells. Loss of YDA activity essentially eliminates for-
mation of the extraembryonic suspensor, whereas
hyperactive variants of YDA suppress formation of the
embryo often to the extent that all daughters of the
zygote appear suspensor-like. On the basis of these
findings, we have proposed that the YDA MAP kinase
cascade acts a molecular switch that promotes
extraembryonic or suspensor fate.
A mechanistic understanding of the YDA pathway
will require an inventory of its component. Using var-
ious approaches, five other genes with a likely func-
tion in YDA-dependent signaling have been identified.
A reverse genetic analysis of Arabidopsis MAP kinase
genes performed in the lab of S. Zhang (University of
Columbia, Missouri) has revealed that MPK3 and
MPK6 act redundantly downstream from YDA in
postembryonic development. In collaboration, we
have confirmed that the same two MAP kinases also
function in the embryo. An ongoing, systematic sur-
vey of Arabidopsis MAPKK genes in our lab has, so
far, implicated MKK9: Expression of hyperactive vari-
ants in the embryo has an effect similar to expression
of hyperactive YDA variants. Thus, the YDA MAP
kinase cascade appears to consist of YDA, MKK9 (and
possibly other MKK genes with overlapping function),
and MPK3/6. This MAP kinase cascade is required
throughout the life cycle, regulating, among other
processes, the size of the stem-cell population in the
shoot apical meristem and the formation of guard cells
in the leaf epidermis.
In contrast, two components of the YDA pathway
that we originally identified by virtue of their yda-like
mutant phenotypes in the embryo are not required
after germination. The GRD gene likely executes sus-
pensor-specific gene transcription in response to the
YDA MAP kinase cascade. GRD encodes a protein of
the RWP-RK family, a small group of predicted tran-
scription factors that have only been found in green
algae and higher plants. The only members of this
family with an assigned function both affect develop-
mental fate decisions: minus dominance (mid) from
the unicellular alga Chlamydomonas dominantly
determines the mating type of gametes, and nodule
inception (nin) from the legume Lotus japonicus pro-
motes the colonization of roots with nitrogen-fixing
symbiontic bacteria in response to Nod-factor signal-
ing. The GRD gene product contains two possible
MAP kinase phosphorylation sites, one of which has a
high score with different prediction algorithms and is
conserved in the rice homolog of GRD. We have con-
structed variants of GRD in which one or both of these
sites have been mutated such that they cannot be phos-
phorylated any more or such that they are mimicking
the effects of constitutive phosphorylation. These vari-
ants are being tested in mutant plants. If GRD is a sub-
strate of the YDA MAP kinase cascade, phosphoryla-
tion of GRD should be essential for normal function.
Activation of the YDA MAP kinase cascade
appears to require the SSP gene. SSP encodes a mem-
ber of the receptor-like protein kinase family. In ani-
mals, these proteins operate in association with cell sur-
face receptors, such as the interferon-1 receptor corn-
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plex. We have found that SSP protein is myristoylated
at its amino terminus and that this modification effec-
tively anchors the protein in the plasma membrane.
Myristoylation of SSP is essential for normal function:
Mutation of the modified glycine residue causes mislo-
calization of the SSP protein to the cytoplasm where it
remains inactive. Although SSP has been classified as
a protein kinase, key positions of the catalytic domain
are not conserved, and SSP variants that harbor transi-
tion-state mutations in the ATP-binding pocket fully
complement the phenotype of mutant embryos. This
would suggest that SSP is a "dead" kinase. On the other
hand, a small carboxy-terminal TRP domain of SSP
that likely mediates protein-protein interactions is
absolutely essential: Even deletions of a few amino
acids create completely inactive variants. Taken togeth-
er, our findings suggest that SSP functions as an
adapter protein at the plasma membrane.
What is the role of SSP in the YDA-dependent sig-
naling event? Unexpectedly, we found that SSP links
activation of the YDA MAP kinase cascade to fertiliza-
tion. Expression of SSP mRNA is restricted to pollen,
and ssp mutations show a rather unusual paternal
effect: The phenotype of the zygote and embryo is
completely determined by the genotype of the pollen,
i.e., wild-type egg cells fertilized with mutant pollen
develop as mutants, whereas mutant egg cells fertilized
with wild-type pollen develop as wild type. Forced
expression of SSP in leaves is sufficient to trigger
YDA-dependent signaling, implying that SSP can act as
a signal (Fig. 1). This truly unique mechanism imme-
diately raises a number of questions surrounding the
signaling event: Is SSP mRNA or SSP protein deliv-
ered to the zygote? How is SSP mechanistically con-
nected to activation of the YDA MAP kinase cascade?
When after fertilization does the YDA pathway because
active and for how long does it stay active? Our current
research focuses on addressing these issues.
A GATA Factor Organizing
Initiation of the Embryonic Root
W. Lukowitz, T. Nawy
The embryonic root of Arabidopsis develops at the
border between the two cell types established with the
asymmetric division of the zygote: the suspensor and
proembryo. Root initiation is triggered by an inductive
signal from the lower-tier cells of the proembryo to
the uppermost suspensor cell. This signaling event is
dependent on the plant hormone auxin and results in
158
FIGURE 1 Forced expression of SSP protein in leaves elimi-
nates stomata. (A) Stomata-the pores on the surface of leaves
that allow for gas exchange-are formed by two specialized,
kidney-shaped guard cells (an example is circled). Activity of the
YDA MAP kinase cascade represses the differentiation of guard
cells, limiting the numbers of stomata on the leaf. Expression of
an inactive variant of SSP that is defective in N-myristoylation
has no effect on formation or spacing of stomata. (B) In con-
trast, no stomata are found on leaves expressing an active SSP
variant, implying that SSP protein is sufficient to hyperactivate
the YDA MAP kinase cascade in leaves. Images were taken
with a confocal laser-scanning microscope, and both SSP vari-
ants were tagged with a fluorescent protein moiety to visualize
their distribution in the cell. Bar, 50
the formation of a characteristic lens-shaped cell,
which functions as the quiescent center of the incipi-
ent root meristem and organizes the establishment of
the various tissue initials.
Mutations in the GATA-type transcription factor
HAN eliminate all anatomical hallmarks associated
with root formation in the early embryo. Despite this,
about 20% of all han mutants eventually recover and,
after a lag period, form relatively normal, viable
seedlings. This feature of han mutants is in striking
contrast to mutants in the auxin signaling pathway,
which typically result in rootless seedlings and affect
root formation throughout the life cycle. Thus, we
have proposed that HAN is not required for root for-
mation in general but specifically for initiating a root
in the early embryo.
Surprisingly, an analysis of han mutants with a
panel of molecular cell fate markers revealed that the
expression of root-specific genes is not absent in the
mutants but rather shifted toward the center of the
proembryo. For example, a WOX5 reporter gene, nor-
mally expressed in the uppermost suspensor cells and,
later, the lens-shaped cell is found in a broad stripe
across the center of the proembryo (Fig. 2). In summa-
ry, our analysis of cell fate markers suggests that han
mutations change the coordinates of the fate map,
shifting it toward the apex.
How can this global effect on the fate map be ratio-
nalized? The only known pathway with a global effect
FIGURE 2 Mutations in the GATA-type transcription factor
result in an apical shift of the embryonic fate map. (A) The
homeodomain gene WOX5 is normally transcribed in the upper-
most suspensor cells, which will form the distal part of the root
primordium. (B) In han mutants, WOX5 is expressed in a broad
stripe in the center of the globular proembryo. WOX5 expres-
sion was visualized using a fluorescent reporter gene and
imaged with a confocal laser-scanning microscope. Nuclei of
the embryo and the surrounding endosperm are seen as weak
dots in the background. The star marks the border between the
embry and the suspensor. Bar, 20 gm.
on embryonic development is auxin signaling. We have
found that mutations in han can dominantly suppress
the rootless embryo phenotype caused by loss of the
auxin response factor gene MP: mp han/+ embryos
often develop a rudimentary root meristem and clearly
show expression of auxin-dependent transcripts that
are absent in mp embryos. These observations indicate
that the auxin signaling network is highly sensitive to
changes in HAN activity. Perhaps the simplest explana-
tion is that HAN functions to inhibit select auxin
responses. According to this view, han embryos should
show overactive or inappropriate auxin responses.
Indeed, the expression of auxin-responsive markers is
expanded in han embryos, although not to the extent
that they become ubiquitous.
In the early embryo, HAN mRNA is expressed in a
pattern very similar to that of the BDL and IAA13
genes, two redundant negative regulators of auxin
response factors. This observation has led us to inves-
tigate whether HAN might function by promoting the
expression of BDL/IAA13, which in turn would nega-
tively regulate auxin response factors. Preliminary
results suggest that this is not the case: Expression of
BDL from a HAN promoter has no effect on the phe-
notype of han embryos, and the expression of BDL
reporter genes appears to be relatively normal in a han
mutant background. We are now investigating whether
han mutations affect auxin signaling at the level of
hormone transport.
The biochemical function of HAN is to regulate
gene expression. To identify the set of target genes
subject to regulation by HAN, we have initiated a glob-
al comparison of the transcriptional profiles of wild-
type embryos with han mutant and HAN-overexpress-
ing embryos. This approach will provide an unbiased
whole-genome snapshot of transcription that can then
be mined to define a mechanistic context for HAN
function in the embryo.
Role of the YDA MAPKK Kinase
Gene in Maintaining the Stem
Cell Population of the Shoot
Apical Meristem
W. Lukowitz, J. Williams [in collaboration with G.V. Reddy,
University of California, Riverside]
Plant growth is dependent on the continuous produc-
tion of new organs, such as leaves, flowers, or lateral
shoots. All of these organs are initiated by the apical
meristems, a group of cells at the tip of the shoots. The
apical meristems contain a small population of stem
cells that are the ultimate progenitors of all organs.
The shoot meristem of seedlings is located between
the petioles of the two embryonic leaves or cotyledons.
An analysis with the scanning electron microscope
revealed that hyperactive variants of YDA frequently
cause fusion of the cotyledons and eliminate the shoot
meristem. On a molecular level, expression of the
CLV3 gene, which marks the stem cells of the meris-
tem, is undetectable in a large portion of embryos har-
boring hyperactive YDA variants.
The small, secreted ligand CLV3 is part of a feed-
back loop between the stem cells of the shoot meris-
tem and the cells directly below them, called the orga-
nizing center. The stem cells secrete CLV3, which is
perceived by a cell surface receptor complex including
CLV1 and CLV2 and represses transcription of the
homeodomain gene WUS. As a consequence, WUS
mRNA is absent in the stem cells and only found in the
cells of the organizing center (negative branch of the
loop). The organizing center, in turn, provides an
inductive signal required to maintain the stem cells in
an undifferentiated state (positive branch of the loop).
This feedback loop is thought to maintain the size of
the stem cell population. Since it has been proposed
that a MAP kinase cascade mediates transduction of
the CLV3 signal from the cell surface to the nucleus,
we have investigated whether YDA acts in the CLV
pathway. So far, our results seem to indicate that this is
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not the case. For example, expression of hyperactive
YDA variants in the stem cell population does not have
any effect on the phenotyope of clv mutants.
Alternatively, YDA might act on antagonistic tran-
scription factors that regulate the formation of organ
primordia. The knotted-type homeodomain gene STM
is expressed in the center of the meristem to prevent
premature differentiation of the stem cells, whereas
the myb domain gene AS1 is expressed at the periph-
ery, in the primordia, to promote differentiation.
Misexpression of AS7 in the center of the meristem
represses STM and results in a loss of the stem cells.
We are now investigating the possibility that hyperac-
tive YDA eliminates the meristem by causing ectopic
expression of AS/. Furthermore, in collaboration with
Venu Reddy at the University of California, Riverside,
we are developing the tools to forcibly induce YDA
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activity in subsets of cells within the shoot apical
meristem. The effect of these manipulations will be
followed by imaging cell division and marker gene
expression in live meristems and will allow us to
directly test the assumption that hyperactive YDA vari-
ants interfere with primordia formation.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen P. Ferreira A. Kloc
D. Garcia S. Locke
J. Horn U. Ramu
D. Irvine D. Roh
M. Ronemus
R. Shen
J. Simorowski
R. Schwab
Research in our laboratory concerns transposon
silencing, gene control, and stem cell function in
plants, as well as heterochromatic silencing in yeast,
which provide useful models for higher organisms.
Stem cell function and axis formation in Arabidopsis
depends on asymmetric leaves] and on RNA inter-
ference (RNAi) via spatially restricted microRNA
(miRNA) and trans-acting small interfering RNA
(siRNA). In fission yeast, RNAi of centromeric tran-
scripts regulates histone modification by endonucle-
olytic cleavage, and we have found similar tran-
scripts in Arabidopsis, where small RNA, DNA
methylation, and chromatin remodeling regulate het-
erochromatin through transposons and repeats. We
continue to develop novel tools that use transposons
to probe genomic function.
During the last year, Damien Garcia left for a
position in Strasbourg, and Mike Ronemus took a
position at Cold Spring Harbor Press. We were
joined by postdoc Rebecca Schwab from Germany
and graduate student Sarahjane Locke.
Specification of Leaf
Polarity in Arabidopsis
via trans-acting siRNA
D. Garcia, R. Schwab [in collaboration with M. Byrne,
John Innes Center]
In plants, leaves initiate on the flanks of the shoot api-
cal meristem and subsequently develop distinct proxi-
modistal, dorsoventral (adaxial-abaxial), and medio-
lateral patterns. The SANT (myb) domain gene
PHANTASTICA (PHAN) is required for adaxial fate in
the snapdragon Antirrhinum and in other plants, but
the Arabidopsis ortholog AS] has milder effects on
leaf shape, suggesting the existence of alternate or
redundant regulatory functions. We performed a
screen for enhancers of as] with more elongate and
dissected leaves. These enhancers disrupt an RNA-
R.K. Slotkin
M. Tanurdzic
M.W. Vaughn
M. Zaratiegui-Biurrun
dependent RNA polymerase (RDR6), ARGONAUTE7
(AG07)IZIPPY, SUPPRESSOR OF GENE SILENC-
ING3 (SGS3), and DICER-LIKE4(DCL4) which all
regulate trans-acting siRNA (ta-siRNA). Microarray
analysis revealed that the AUXIN RESPONSE FAC-
TOR genes ETTIN (ETT)/ARF3 and ARF4 were up-
regulated in ago7, whereas FILAMENTOUS FLOWER
(FIL) was up-regulated only in as1 ago 7double
mutants. RDR6 and SGS3 likewise repress ARF3 and
ARF4, which specify abaxial fate. We found that the
ta-siRNA gene TAS3, which targets ARF3 and ARF4,
is expressed in the adaxial domain (Fig. 1) and that ett
as] ago7 triple mutants resemble asl. Thus, FIL is
down-regulated redundantly by AS] and by TAS3, act-
ing through ETT, revealing a role for ta-siRNA in leaf
polarity. RDR6 and DCL4 are also required for sys-
temic silencing, implicating ta-siRNA as a potentially
mobile signal. Interestingly, TAS3 also matches one of
six precursor genes for miR165/166, which we have
previously shown was abaxially expressed.
Misexpression of miR166 in TAS3 mutants could con-
tribute to the phenotype in some cells, although
miR166 target genes were still expressed in as] ago7
double mutants.
miRNA-targeted and siRNA-mediated
mRNA Degradation Regulated by
Argonaute, Dicer, and RdRP
M. Ronemus, M.W. Vaughn
ARGONAUTE] of Arabidopsis mediates the cleavage
of miRNA-targeted mRNAs, and it has also been
implicated in the posttranscriptional silencing of
transgenes and maintenance of chromatin structure.
Mutations in AGO] severely disrupt plant develop-
ment, indicating that miRNA function and possibly
other aspects of RNAi are essential for maintaining
normal patterns of gene expression. Using microar-
rays, we have found that 1-6% of genes display sig-
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FIGURE 1 Epigenetic variation: DNA methylation profiles of Arabidopsis chromosome 4. McrBC digestion-based, and two antibody-
based methylation detection profiles are compared along 125 kb of euchromatin 9 Mb from the end of Arabidopsis chromosome 4,
ORFs (open reading frames) from genes (light) and retrotransposons (dark) are indicated, along with repeats predicted by RepBase
and TandemRepeatFinder. Small RNA matches from massively parallel signature sequencing (MPSS) data are indicated by arrow-
heads. Tiles that detect significant differences in copy number are highlighted (CGH), whereas tiles that detect significant DNA methy-
lation by means of McrBC-based detection are highlighted for the two strains Columbia and Landsberg erecta (5mC, Col and 5mC,
Ler). For comparison, the posterior probability of methylation at 35-bp microarray probes as determined by mCIP-based detection
on Affymetrix arrays (Zhang et al. 2006) and significant uncorrected log 2 ratios of mCIP antibody-enriched DNA to input DNA for
220-bp Nimblegen probes (Zilberman et al. 2006) are shown for wild-type Columbia. The three detection protocols show significant
agreement, especially for more heavily methylated features such as repetitive elements. McrBC-based profiling is more sensitive and
detects significant variation between strains.
nificant expression changes in several alleles of agol
at multiple time points, with the majority showing
higher levels. Several classes of known miRNA tar-
gets increased markedly in agol, whereas others
showed little or no change. Cleavage of mRNAs with-
in miRNA-homologous sites was reduced but not
abolished in an agol null background, indicating that
redundant slicer activity exists in Arabidopsis; 21-22
-
nucleotide siRNA, as well as larger (30-65
nucleotides) RNA fragments, corresponding to highly
up-regulated miRNA target genes accumulated in
wild-type plants, but not in agol, nor in the RNA-
dependent RNA polymerase mutants rdr2 and rdr6,
nor in the Dicer-like mutants dell and dcl3. Both
sense and antisense RNAs corresponding to these
miRNA targets accumulated in the agol and dell
backgrounds. These results indicate that a subset of
endogenous mRNA targets of RNAi may be regulated
through a mechanism of second-strand RNA synthe-
sis and degradation initiated by or in addition to
miRNA-mediated cleavage. The 21-nucleotide siRNA
corresponding to some targets (TIR1-like genes) were
cleaved in register with the miRNA target site, resem-
bling ta-siRNA.
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The Slicer Function of Argonaute
Is Required for Heterochromatic
Silencing and Spreading
D. Irvine, M. Zaratiegui, A. Kloc, S. Locke [in collaboration
with D. Goto, Hokkaido University, Japan, and
L. Joshua-Tor, Cold Spring Harbor Laboratory]
In the fission yeast Schizosaccharomyces pombe, the
RNAi machinery converts transcripts from pericen-
tromeric repeats into siRNAs, which are required for
the assembly of pericentromeric heterochromatin.
siRNA guides chromatin silencing via the Argonaute
and RNA-dependent RNA polymerase complexes,
and this silencing presumably depends on base pair-
ing with either RNA or DNA. We have shown that
Argonaute requires the conserved DDH amino acid
motif for heterochromatic silencing and histone H3
lysine-9 dimethylation (H3K9me2). Argonaute pro-
teins require this motif for RNase H activity, which
cleaves (or slices) target messages complementary to
siRNA. H3K9me2 spreads into silent reporter genes
when they are embedded within heterochromatic
transcripts. Silencing of these reporter genes requires
readthrough transcription by RNA polymerase II (pol
II) and processing of these transcripts via Argonaute.
Thus, siRNA appears to impact histone modification
by cleaving heterochromatic RNA, whereas spread-
ing of the silencing effect depends, ironically, on
transcription of this "aberrant RNA" by pol II.
Heterochromatic silencing occurs in most eukaryotes
and shares some common properties. For example,
silencing due to position effect is inherited from one
cell to another but is unstable (variegated) in
Drosophila; similarly, patterns of transposable ele-
ment control are unstable (cycling) in maize, and
centromeric silencing is unstable in S. pombe. We are
exploring these patterns of variegation and their rela-
tionship to histone modification and RNAi.
Maize-targeted Mutagenesis:
A Knockout Resource in Maize
P. Ferreira, D. Roh, M. Vaughn [in collaboration with W.R.
McCombie and L. Stein, Cold Spring Harbor Laboratory]
Maize-targeted mutagenesis (MTM) population com-
prises seed and tissue from 44,000 maize plants in
which Mutator transposons have been mobilized and
then stabilized genetically. We estimate this resource
has approximately 0.5 to 1 million independent new
insertions of Mutator elements in the gene-rich portion
of the genome, or more than one insertion per kilobase.
Tissue was harvested in 18 two-dimensional "grids" of
48 x 48 plants each, and genomic DNA was prepared
from row and column pools that permit cross-referenc-
ing of any individual sample. These pools have been
extensively used to select insertions in target genes
using polymerase chain reaction (PCR), as a service to
the maize community. Target sites flanking each
Mutator insertion can also be amplified en masse from
these pools by a variety of PCR methods. We have opti-
mized the use of GWALK (genome walker) PCR to
amplify a representation of flanking sequences from
row and column pools. Sequencing using massively
parallel 454 technology followed by mapping back to
the maize genome resulted in identification of a high
proportion of the flanking sites, including control
insertions previously recovered by conventional means.
By first comparing nonintersecting row pools, and then
row and column pools, it is possible to distinguish pre-
existing (parental) insertions from new germinal inser-
tions at row-column intersections. We are currently
exploring the use of Solexa sequencing technology to
further reduce costs, and we estimate that it should be
possible to saturate the maize genome, to the extent
possible with Mutator insertions, with only a few hun-
dred sequencing reactions.
Polyploidy, Transposable Elements,
and Epigenetic Control
M. Tanurdzic, K. Slotkin, J. Simorowski, M. Vaughn
[in collaboration with L. Comai, University of Washington;
W. Thompson, N. Carolina State University; and
R.W. Doerge, Purdue University]
Heterochromatin is composed of transposable elements
(TEs) and related repeats. Like TEs, heterochromatin
silences genes located nearby and has a major role in
epigenetic regulation of the genome. siRNA corre-
sponding to heterochromatic sequences can be detect-
ed in plants, animals, and fission yeast, indicating that
these sequences are transcribed. In plants, siRNA cor-
responding to different classes of TEs depends on the
DNA methyltransferase MET1, the SWI/SNF ATPase,
DDM1, or both, but not on the histone deacetylase
SIL 1 . All three genes are required for silencing trans-
posons in the absence of RNAi, but they depend on
siRNA for resilencing in backcrosses. DNA methyla-
tion is concentrated in TEs and heterochromatin, but
many genes have low levels of methylation in their cod-
ing region. Genic methylation is not associated with
H3K9me2, is highly polymorphic, does not require
DDM1, and is inherited in recombinant inbred lines,
but it has little effect on gene expression. Transgene
reporters, integrated around the genome by gene-trap
mutagenesis, are silenced by position-effect variegation
when they are located a few kilobases from the NOR,
and depend on SIL1 and MET1 for silencing, but not
DDM1. Similar insertions in centromeric satellite
repeats are also silenced.
Polyploidy in plants results in a variety of genet-
ic and epigenetic changes in gene expression from
generation to generation following the establishment
of allopolyploids. The mechanisms that underlie
these changes are important in the short term (hybrid
vigor) as well as in the long term, as polyploids are
stabilized during evolution. We are using microarrays
and Solexa sequencing to profile chromatin modifi-
cations in synthetic allopolyploids from crosses
between tetraploid A. thaliana and tetraploid A.
arenosa. Although changes in heterochromatin are
relatively modest, some transposons are activated in
the allotetraploids. We are also comparing diploid
chromatin modification profiles to the pattern of
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replication of chromosomal DNA using BrdU incor-
poration in synchronized cultured cells.
Epigenetic Natural Variation
in A. thaliana
M.Vaughn, M. Tanurdzic [in collaboration with W.R.
McCombie, Cold Spring Harbor Labratory; Z. Lippman,
Hebrew University of Jerusalem, R.W. Doerge, Purdue
University, and V Co lot, URGV, France]
Cytosine methylation of repetitive sequences is wide-
spread in plant genomes, occurring in both symmetric
(CpG and CpNpG) and asymmetric sequence con-
texts. We have used the methylation-dependent
restriction enzyme McrBC to profile methylated
DNA using tiling microarrays of Arabidopsis chromo-
some 4 in two distinct ecotypes, Columbia and
Landsberg erecta. We have also used comparative
genome hybridization (CGH) to profile copy-number
polymorphisms (Fig.1). Repeated sequences and TEs,
especially LTR (long terminal repeat) retrotrans-
posons, are densely methylated, but one third of genes
also have detectable methylation in one or more exons
and introns. siRNA are preferentially associated with
methylated TEs, but not with methylated genes, indi-
cating that most genic methylation is not guided by
siRNA. Whereas TEs are almost always methylated,
genic methylation is highly polymorphic, with half of
all methylated genes being methylated in only one of
the two ecotypes. A survey of loci in 96 Arabidopsis
accessions revealed a similar degree of methylation
polymorphism. Within-gene methylation is heritable
but is lost at a high frequency in segregating F2 fami-
lies. Promoter methylation is rare, and gene expres-
sion is not generally affected by differences in DNA
methylation, although highly expressed genes are
more likely to have methylated exons.
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PLANT DEVELOPMENTAL GENETICS
M. Timmermans D. Chitwood F. Nogueira
M. Guo T. Phelps-Durr
S. Madi A. Sarkar
Development in higher plants is a continuous process as
organs emerge throughout the entire plant life cycle,
which for some plants extends over hundreds of years.
The growing tip of a plant, referred to as shoot apical
meristem (SAM), contains a population of stem cells
that divide to maintain the SAM and to generate daugh-
ter cells from which lateral organs, such as leaves and
flowers, arise. The research in our lab aims to under-
stand the molecular mechanisms that distinguish inde-
terminate stem cells from their differentiating deriva-
tives. In addition, we are studying the role of stem-cell-
derived signals in the patterning of lateral organs.
Observations from our lab indicate that microRNAs
(miRNAs) are among these meristem-derived signals.
Moreover, stem cells produce signals required for the
establishment of determinacy. This process involves an
epigenetic silencing mechanism, indicating that the
switch from stem cell to differentiated cell is not simply
encoded in DNA but by proteins associated with DNA.
Adaxial/Abaxial Patterning of Lateral
Organs in Maize
F. Nogueira, S. Madi, D. Chitwood
Outgrowth and patterning of lateral organs in plants
depend on the specification of adaxial-abaxial
(dorsoventral) polarity. This asymmetry is generated in
part through the polarized expression of class III home-
odomain leucine zipper (HD-ZIPIII) transcription fac-
tors that specify adaxial/upper fate. We have reported
that in maize, the adaxial-specific expression of the hd-
zipIll genes is established by a 21-nucleotide microRNA,
miR166. miRNAs are endogenous, small noncoding
RNAs that mediate the cleavage or translational repres-
sion of target transcripts containing complementary
sequences, thus controlling gene expression at the post-
transcriptional level. We have shown that miR166 accu-
mulates in a gradient on the abaxial side of young leaf
primorida and thereby sets up leaf polarity (Fig. 1).
Specification of adaxial fate in maize also requires
leafbladelessl (1b11), recessive mutations of which
lead to formation of radial abaxialized leaves. Double-
mutant and expression analyses indicate that lbll is
required for the accumulation of hd-ziplII transcripts
in the developing leaf Using in situ hybridization
analysis, we have shown that loss of lbll leads to mis-
expression of mature miR166 throughout the initiating
and developing leaves. Reverse transcriptase-poly-
merase chain reaction (RT-PCR) analysis showed that
transcript levels for three of the nine maize mir166
genes are increased in lbll apices compared to wild
type. These findings indicate that lbll contributes to
leaf polarity by spatially restricting expression of
selected mir166 family members. We have cloned lbll
and found that it encodes a homolog of SUPPRES-
SOR-OF-GENE SILENCING3 (SGS3), a key compo-
nent of the biogenesis pathway of a second family of
small regulatory RNAs termed trans-acting small
interfering RNAs (ta-siRNAs). Using small RNA
blots, we have shown that ta-siRNAs accumulate at
detectable levels in wild-type but not in lbll apices,
suggesting a functional conservation between LBL1
and SGS3. More importantly our data indicate a role
for ta-siRNAs in specification of leaf polarity through
repression of abaxial factors such as miR166.
ta-siRNAs are generated in 21-nucleotide phasing
as defined by a miRNA cleavage site from noncoding
transcripts (referred to as tas). Therefore, the ta-
siRNAs generated from each tas locus can be predict-
ed, enabling the identification of potential target genes
using computational approaches. Previous work in
Arabidopsis had identified a ta-siRNA, tasiR-ARF,
that regulates the expression of AUXIN RESPONSE
FACTOR3 (ARF3) and ARF4. We have identified four
tas loci harboring tasiR-ARFs in maize, and using in
situ hybridization, we have shown that tasi-ARF accu-
mulates on the adaxial side of the incipient and devel-
oping leaf primordia, consistent with a possible role in
setting up the adaxial side of the leaf (Fig. 1). 5'
RACE (rapid amplification of cDNA ends) analysis
showed that maize arf3a is a direct target for tasiR-
ARF, and expression studies showed that arf3a is
expressed abaxially in normal developing leaves but is
ectopically expressed in the SAM of lbll mutants. As
mir166 precursors are not direct targets for tasiR-
ARFs, it is likely that their misexpression in lbll
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FIGURE 1 The small regulatory RNAs, miR166 and tasiR-ARF, establish opposing domains along the adaxial-abaxial axis of the leaf.
(A) miR166 is expressed on the abaxial/lower surface of newly initiated (arrow) and developing leaf primordia (arrowheads). (B) tasiR:
ARF is expressed on the adaxial/upper surface of leaf primordia. (C) A model for adaxial-abaxial patterning via tasiR-ARF and miR166
LBL1, along with miR390, is required for the biogenesis of ta-siRNAs from tas3 precursor transcripts. tasiR-ARF acts on the adaxial
side of the incipient leaf and sets up organ polarity by spatially restricting the expression domain of arf3. ARF3, perhaps via addition-
al abaxial determinants, regulates expression of specific mir166 family members. This leads to the accumulation of miR166 on the
abaxial side of the initiating leaf, where it guides the cleavage ofhd-zipIlltranscripts and represses adaxial fate. tasiR-ARF and miR166
thus establish opposing fates along the adaxial-abaxial axis in developing leaves. Direct interactions (solid lines) are distinguished from
putative interactions (dashed lines).
mutants results from the misregulation of ARF3 tran-
scription factors. This possibility is being investigated
using genetic approaches in maize and by analyzing
mir166 promoter reporter constructs in Arabidopsis
arf3 and arf4 mutants.
Our observations indicate that lbll /SGS3 is essen-
tial for adaxial/abaxial patterning in maize and present
the intriguing possibility that dorsoventrality is speci-
fied through the opposing action of two small regula-
tory RNAs, tasi-ARF and miR166; tasiR-ARF defines
the adaxial domain by spatially restricting expression
of abaxial determinants, whereas miR166 delineates
the abaxial domain by restricting expression of the
adaxializing hd-ztplII genes (Fig. 1). These findings
thus reveal a novel patterning mechanism in develop-
ment. By studying the genetic pathway involving lbll
and the maize hd-ziplII genes, we hope to further
improve our understanding of the role of small regula-
tory RNAs as developmental signals.
The Spatiotemporal Regulation
of miR166 Expression in
Developing Leaves
F. Nogueira, D. Chitwood, S. Madi [with contributions
from K. Marran and W. Kruesi, Undergraduate Research
Program, CS H L]
The dynamic expression pattern and gradient of
miR166 accumulation is reminiscent of a movable sig-
166
nal and suggests that expression of the mirl 66 genes is
under such control or alternatively that miR166 can
move between cells. Testing the latter possibility is of
key importance, as the knowledge that miRNAs can act
as mobile signals will have major implications regard-
ing their role in developmental biology. A number of
experiments suggest that miRNAs, unlike siRNAs, do
not spread systemically throughout the plant, but we
are taking a variety of approaches in maize and
Arabidopsis to test whether mobility of small RNAs
over ranges of just a few cells or within particular
developmental contexts does occur.
The maize genome contains at least nine mir166
loci, suggesting that the dynamic miR166 accumula-
tion pattern may result in part from the differential reg-
ulation of individual mir166 family members.
Detection of miRNA precursors by in situ hybridiza-
tion has been unsuccessful. We therefore employed
laser capture microdissection (LCM) in combination
with RT-PCR to analyze the expression profiles of
mir166 genes in specific domains of the SAM and
young leaves. Although some mir166 family members
displayed overlapping expression profiles, most
mir166 genes exhibit unique tissue and cell-type-spe-
cific expression patterns. One of the tissue samples
tested included cells from the incipient leaf. Four
mirl 66 family members are expressed in that domain
and are thus important candidates for establishing
adaxial/abaxial leaf polarity. Interestingly, the mir166a
precursor was found to be expressed at the tip of the
SAM. This result was surprising, because these cells
do not accumulate mature miR166 and in fact express
the miR166-targets rldl and rd12 at high levels. This
suggests that miR166 accumulation may be regulated
in part at the posttranscriptional level. LCM/RT-PCR
analysis on more precisely defined developmental
domains in leaf primordia is being used to establish
whether miR166 is mobile.
As mentioned above, maize contains another leaf-
polarity-related class of small regulatory RNAs, the ta-
siRNAs. tas transcripts are direct targets for miR390
cleavage, which is required to process tas transcripts into
mature ta-siRNAs. LCM separating cells from the epi-
dermal (L1) and sub-epidermal layers (L2) of the SAM
shows that tas transcripts accumulate in both Ll and L2
layers. In contrast, the precursor of miR390 is detected
only in the Ll layer of the SAM. Using in situ hybridiza-
tion, we have detected the accumulation of mature
miR390 in the adaxial domain of the incipient leaf. More
importantly, we found that miR390 accumulates in both
the L 1 and L2 layers of the incipient leaf Our observa-
tions are consistent with a scenario in which miR390 is
produced exclusively in the Ll layer and moves into the
underlying cell layers. Thus, it is plausible that specific
miRNAs could move over extremely short distances of
one or only a few cell lengths from specific cell types,
such as the epidermal layer, to act as developmental sig-
nals during pattern formation. We are currently testing
this possibility in Arabidopsis as well.
In Arabidopsis, we are using GUS-reporter lines to
determine the expression patterns of miR166 precur-
sors in developing leaves. Five MIR166 family mem-
bers are expressed during early stages of vegetative
development, including MIR166a. We established that
a full-length promoter of MIR166a drives expression
on the abaxial side of young leaves, reminiscent of the
accumulation of mature miR166. Most prominently,
its abaxialized expression is restricted to the L 1 layer.
Last year, we reported our initial results from
MIR166a promoter deletion analyses. More detailed
characterizations of these deletion constructs identi-
fied a DNA fragment required for Ll-specific expres-
sion; however, we were unable to detect any known
Ll-specific cis-elements in the promoter of MIR166a.
Similar expression studies are under way to determine
the precursor expression patterns for other small
RNAs with roles in leaf polarity, such as miR390 and
tasi-ARF, and, as in maize, precursor expression data
will be compared to the expression pattern of the
mature small RNA to test for movement.
These precursor reporter lines are also being used to
identify genes involved in the spatiotemporal regulation
of the polarizing small RNAs. Several lines of evidence
indicate that ASYMMETRIC LEAVES1 (AS1) and
ASYMMETRIC LEAVES2 (AS2) act together to regu-
late leaf morphology as well as adaxial/abaxial leaf
polarity. We have tested whether the AS1-AS2 pathway
affects miR166 expression. Using the MIR166a::GUS,
we have shown that MIR166a is adaxially misexpressed
in an as2 mutant background, and we are currently ana-
lyzing whether the AS1-AS2 pathway affects expres-
sion of MIR166a and other family members directly or
indirectly. Similarly, we have generated arf3 mutants
expressing the MIR166a: :GUS reporter to determine
the contribution of the ta-siRNA pathway in regulating
miR166 expression in Arabidopsis and to begin to ana-
lyze the role of the plant hormone auxin in
adaxial/abaxial patterning, specifically its contribution
to the dynamic expression pattern of miR166.
Establishment of Determinacy during
Organ Development
M. Guo, T. Phelps-Durr [with contributions from E. Jusseaux,
Denis Diderot University, Paris, France]
Indeterminacy within the SAM is specified in part by
the KNOX homeobox genes. Down-regulation of
KNOX expression is a key factor that distinguishes
stem cells and their immediate derivatives in the SAM
from lateral organ founder cells. Moreover, establish-
ment of determinacy in developing organs requires the
continued silencing of the KNOX genes. We have pre-
viously shown that this process involves the highly
conserved MYB domain proteins ROUGH SHEATH2
(RS2) and ASYMMETRIC LEAVES1 (AS1) from
maize and Arabidopsis, respectively. On the basis of
expression and genetic analyses, we proposed that
these proteins function as epigenetic regulators, which
in response to a stem cell signal keep KNOX genes in
an "off" state during organogenesis, thus preventing
differentiating cells from reverting into indeterminate
stem cells. In the past few years, we have gained
important new insights into the mechanism of KNOX
gene silencing by RS2/AS1 that confirm this hypoth-
esis. We have shown that RS2 and AS1 form highly
conserved repressor complexes that include the zinc
finger transcription factor ASYMMETRIC LEAVES2
(AS2), an RNA-binding protein named RIK, and the
histone chaperone HIRA.
Using chromatin immunoprecipitation (ChIP), we
identified two sites in the promoter of BP, one of the
KNOX genes, that mediate AS1 complex binding. The
significance of these AS1 complex binding sites for
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stable BP silencing in leaves was demonstrated in vivo
using various BP promoter :: GUS reporter constructs.
Deletion of either AS1-binding site resulted in misex-
pression of BP in wild-type leaves. This year, we have
used gel-shift assays to more precisely characterize the
cis sequences and proteins required for binding of the
AS1 complex to BP. Consistent with earlier genetic
data, we found that AS1 requires AS2 for binding to
the BP promoter. We also found that AS1-AS2 bind to
each of the approximately 200-bp promoter fragments
identified by ChIP. Considering that both binding sites
are required for stable repression of BP in leaves, this
result suggests that AS1-AS2 binding creates a loop in
the BP promoter. These gel-shift assays further identi-
fied 6-bp and 8-bp consensus sequences that mediate
binding of AS1 and AS2, respectively. We are current-
ly using this information to identify additional genes
that are potentially regulated by an AS1-AS2 complex.
As mentioned above, we are particularly interested in
the contribution of AS1-AS2 to the spatiotemporal
regulation of leaf polarity genes.
We have previously reported that AS1-AS2 interact
with the chromatin remodeling protein HIRA, which is
involved both in heterochromatic gene silencing and in
the spatiotemporal regulation of euchromatic genes.
We are therefore studying the role of HIRA in KNOX
repression during leaf development using genetic and
biochemical approaches. As a first step, we are testing
whether KNOX gene silencing is associated with
changes in chromatin organization and/or DNA methy-
lation. Preliminary data suggest that the promoter
region of BP between the two AS1-AS2-binding sites
may become methylated in differentiating leaves, but
whether this methylation is AS1-AS2- or HIRA-depen-
dent remains to be tested. These data will eventually
clarify the assembly of the AS1 complex at the KNOX
loci as well as the molecular mechanism with which
these genes are stably repressed to establish determina-
cy in differentiating lateral organs.
Global Expression Analysis of Meristem
Function and Leaf Initiation
A. Sarkar, S. Madi [in collaboration with M. Scanlon, Cornell
University, Ithaca, New York; P. Schnable, Iowa State
University, Ames; B. Buckner and D. Janick-Buckner,
Truman State University, Kirksvile, Missouri]
Plant meristems comprise distinct histological and
functional domains. For instance, the stem cells are
located at the most apical tip in the so-called central
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zone, whereas lateral organ founder cells are located
on the flanks of the SAM. Traditional genetic analyses
have demonstrated the importance of this meristemat-
ic organization for normal plant development and have
led to the identification of some genes required for
meristem function and lateral organ development. To
identify novel and potentially redundant or essential
genes that function in discrete domains of the SAM or
developing leaf primordia, we are using a technique
called laser-capture microdissection (LCM), which
allows the isolation of specific cells within a tissue or
organ, in combination with microarray analyses to
compare global gene expression patterns between dif-
ferent cell populations. Expression profiles between
the following cell types have been compared: (1) inde-
terminate stem cells in the SAM and determinate cells
of newly initiated leaf primordia; (2) the epidermal
(L1) and subepidermal (L2) layers of the SAM; and
(3) SAMs and/or leaf primordia from developmental
mutants and wild-type plants.
This year, we have used this approach to compare
the gene expression profiles in the SAM and first leaf
primordia from wild-type and lbll mutant plants. We
identified nearly 300 genes whose expression levels
are significantly altered in 1b11. The L 1 layer of the
SAM had been shown to be crucial for adaxial-abaxi-
al patterning of leaves. Interestingly, 22 genes that are
differentially expressed between wild-type and lbll are
also differentially expressed between the L 1 and L2
meristem layers. We are currently in the process of val-
idating these differentially expressed genes by real-
time quantitative RT-PCR, followed by in situ mRNA
localization, and the function of genes of particular
interest will be determined using functional genomics
resources available in maize and Arabidopsis. We are
also taking a bioinformatics approach to identify
potential targets of ta-siRNAs among those genes that
are up-regulated in lbll apices. Even though this pro-
ject is still in its infancy, it will soon provide novel
insight into gene networks controlled by ta-siRNAs
and involved in leaf polarity.
PUBLICATIONS
Kidner C. and Timmermans M.C.P. 2006. In situ hybridisation
as a tool to study the role of miRNAs in plant development.
Methods Mol. Biol. 342: 159-179.
In Press
Chitwood D.H., Guo M., Nogueira F.T.S., and Timmermans
M.C.P. 2007. Establishing leaf polarity: The role of small
RNAs and positional signals in the shoot apex.
Development 134: 813-823.
Kidner C. and Timmermans M.C.P. 2007. Mixing and matching
pathways in leaf polarity. Curr. Opin. Plant Sci. 10: 13-20.
Nogueira F.T.S, Sarkar A., Chitwood D.H., and Timmermans
M.C.P. 2007. Distinct small regulatory RNAs interact to
specify organ polarity in plants. Cold Spring Harbor
Symp. Quant. Biol. 71: 157-164.
Nogueira F.T.S., Madi S., Chitwood D.H., Juarez M.T., and
Timmermans M.C.P. 2007. Two small regulatory RNAs
establish opposing fates of a developmental axis. Genes
Dev. (in press).
Mengjuan Guo
169
BIOINFORMATICS AND GENOMICS
With the full genome sequences of many organisms completed, scientists are
increasingly turning their
attention to the important task of putting this gene sequence information to work to explore biology,
improve agriculture, and advance biomedical research. Much of this will focus on resequencing all or
large parts of selected genomes to understand the relationship between sequence
variation and phe-
notypic variation, including disease.
This year, W. Richard McCombie joined a team that has begun sequencing the genome of maize, the
most important crop in the United States. McCombie has also continued testing the first of a new gen-
eration of DNA-sequencing instruments. As part of this, they have been developing methods to selec-
tively isolate large, targeted genomic regions. The goal of this project is to develop new, more rapid, and
cost-effective methods to determine the variation that occurs in these regions among large numbers of
individuals. This will be important in understanding the role of sequence variation in disease.
For plant breeders and others interested in the major crop plants-rice, corn, wheat, oats, sorghum,
and barley-the availability of a publicly accessible comparative genome database has the potential to
speed the development of improved varieties to meet the world's increasing food demands. Lincoln
Stein and his colleagues have created just such a database, dubbed Gramene. A major milestone in
2006 was the integration of genome-mapping information on 11 wild rice species to the Gramene
database, which could provide information that will allow plant breeders to create new robust varieties
of domestic rice. Stein's group is also part of the International Human Hap Map Project, an internation-
al project to map out regions of common genetic variability in the human genome by genotyping three
major world populations across a large number of naturally variable sites. The resulting "haplotype
map" will greatly reduce the cost of genetic association studies to find cancer susceptibility genes and
other disorders with genetic components. The work is already bearing fruit: During the
Hap Map data have been used to identify a gene responsible for age-related macular degeneration (the
major cause of acquired blindness in the United States) and to identify several genes that appear to
contribute to type-2 diabetes.
Certain proteins have persisted over a billion years or more of evolution, and it is likely that these
proteins form critical interactions subject to specific geometric and/or chemical constraints. Conserved
sequence patterns reflect these functional constraints and thus contain implicit information regarding
underlying structural mechanisms. Andy Neuwald uses comparative methods to study protein mech-
anisms through statistical analysis of the constraints imposed on protein sequences during evolution.
With these methods, Neuwald and his colleagues compared a family of key enzymes called eukaryot-
ic protein kinases (EPKs) with a set of protein kinases called "atypical protein kinases," proteins that do
not appear to fit into any known protein kinase family. The result of this analysis indicates that EPK reg-
ulatory mechanisms evolved through modification of an ancestral structure. In 2006, the Neuwald lab
began extending their statistical models to include detailed three-dimentional structural features and
thus to come closer to more directly modeling aspects of protein mechanisms by using structural data
in addition to sequence data. Neuwald and colleagues' findings provide clues to the functions of EPKs
and EPK-like kinases, many of which are implicated in cancer, diabetes, and other diseases.
The DNA in cells is coated with proteins and chemical modifications that change how and when the
DNA code is read. To make sense of one such modification, DNA methylation, Michael Zhang and his
colleagues have identified large-scale DNA methylation patterns in the structure of the human brain and
developed a new computer algorithm (Human DNA Methylation Finder) that predicts DNA methylation
profiles in the human genome. This work has implications for understanding cancer and other diseases.
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GENOME SEQUENCE ANALYSIS
W.R. McCombie V. Balija M. Kramer S. Muller
L. Cohen L. Nascimento T. Rancanelli
F Katzenberger B. Miller L. Spiegel
We have begun a project to sequence the corn
genome.. The project, headed by the Washington
University Genome Sequencing Center, is designed
to sequence the "genespace" of the B73 strain of
maize by the end of 2008. The maize genome will be
the largest plant genome sequenced to date, with a
size of about 2.5 billion bases. Maize is an extreme-
ly important agricultural commodity in the United
States. It has been for many years the largest crop in
the United States. The very recent concerns over
energy security have significantly heightened its
importance within the United States. Major increases
in the use of corn to make ethanol are increasing the
demand for corn, and this is expected to continue for
the foreseeable future.
The strategy we are employing is to focus on
regions of the genome that are non-repetitive. This is
what we refer to as the "genespace." Entire bacterial
artificial chromosomes are shotgun-sequenced and
assembled at Washington University. Software devel-
oped by Doreen Ware's lab here at CSHL is then used
to identify the regions of the assemblies that are non-
repetitive. Following this analysis, the data are trans-
ferred to groups carrying out the finishing:
Washington University, Arizona Genomics Institute,
and our lab. These groups then carry out the finishing
steps of the sequencing process to produce the final
sequence of the nonrepetitive portion of the genome.
In 2006, our lab finished clones comprising about 100
million bases of the maize genome. This amount was
completed mostly in the second half of the year and we
are still ramping up our output.
DEVELOPMENT OF TOOLS AND STRATEGIES TO
MAXIMIZE THE UTILIZATION OF NEXT-GENERATION
SEQUENCING INSTRUMENTS
S. Powers, G. Hannon
It became clear to us that rapid, possible revolutionary
changes are taking place in DNA sequencing technol-
ogy. Although the new sequencing instruments have
great potential, they also have certain limitations. We
began aggressively preparing ways to most efficiently
use the instruments and to as great an extent as possi-
ble avoid their limitations
HYBRIDIZATION-BASED SELECTION OF A DEFINED
SUBSET OF THE HUMAN GENOME
Oligo Design for Hybrid Selection Arrays. The process of
selecting and isolating specific regions of a genome
can be accomplished by very time-consuming and
expensive traditional techniques such as polymerase
chain reaction (PCR) amplification. Whereas tradi-
tional processes may be feasible for small sets of tar-
geted regions, when extremely large numbers of
genetic loci are targeted, an alternate approach must
be considered. An oligonucleotide-array-based selec-
tion scheme was designed to address the issue of
ultra-large-scale targeting and selection as well as to
offer a rapid technique using significantly smaller
amounts of genomic DNA.
To test the recovery of target regions of the genome
of interest, we have designed an oligonucleotide array
of probe sequences to be synthesized on microarray
chips. As a first step in designing the oligonucleotide
probes, the pseudomolecules for all chromosomes of
the human genome (assembly hg17; May 2004 refer-
ence sequence) were downloaded from the genome
browser (http://genome.ucsc.edu) at the University of
Southern California. Repeat sequences (as noted by
RepeatMasker) were masked to lowercase bases
before download. The bgl2fragmentor script (written
by Scott Powers [CSHL]) was used to create in silico
BglII digestion fragments for each chromosome. The
bgl2fragmentor script was modified to select BglII
fragments between 300 and 800 by in length. The
resulting fragment sequences were then screened, and
any fragment that contained repetitive sequence (indi-
cated by sequence in lowercase) was ignored.
To design the oligonucleotide probes for the selec-
tion array, the BglII fragments (minus one 50 mer
kept out for later selection if necessary) were then
chopped into sequential, adjacent (but nonoverlap-
ping) 90 mers. Obviously, these fragments were not
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5Q-PCR Amplification of Selected Fragment from Hybridization Recovered Material Compared
to Bgl II Fragment Dilutions
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FIGURE 1 Q-PCR analysis of hybridization-selected material. Q-PCRs were performed using serially diluted amounts of Bglll- digested
human genomic DNA. The hybridization-selected material was also diluted and amplified for a selected fragment alongside the serially
diluted Bglll fragments.
all equally divisible by 90 bp, so any end sequences
smaller than 90 by were removed. An 18-bp 5' adapter
sequence [TGCTGTTGACAGTGAGCG] and a 16-
bp 3' adapter sequence [TGCCTACTGCCTCGGA]
(Cleary et al. Nat. Methods 3: 241 [2004]) were then
added to each 90 mer from each BglII fragment to
create 124-mer probes. These adapters will serve to
make the 124-mer probes cleavable and amplifiable.
A set of 20,000 124 mers from 4181 randomly select-
ed BglII fragments has been selected to be loaded
onto an Agilent array. This will serve as the selection
chip. The selection probes were then cleaved from the
array using alkaline treatment and collected. Due to
the small amount of probes that are collected by this
method, amplification of the probes was carried out
using primers specific to the adapter sequences pre-
sent at the terminal ends of the probes. A second
round of amplification was then carried out using
biotinylated adapter-specific primers to generate
labeled probes. Human genomic DNA was then
digested with BglII endonuclease and served as the
target DNA for the probes.
Hybridization-based Selection. Both the probes and tar-
get DNA were denatured, and hybridization was carried
out for 24 hours at 65°C. Approximately 1 pg of target
DNA was used in the hybridization. After hybridization,
the biotinylated probes bound to their target were cap-
tured by streptavidin-coated magnetic beads. The cap-
tured material was washed stringently, and the bound
material was then eluted from the beads under mild
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alkaline conditions that strip the bound target while
leaving the probe attached to the magnetic beads. The
stripped material was then collected and purified.
The collected material was then assayed by quanti-
tative PCR (Q-PCR) using primers designed to ampli-
fy (1) a fragment that was selected for by the probes
(selected fragment) and (2) a fragment that were not
selected for by the probes (nonselected fragment). In
parallel, these primers were also used on the serial
dilutions of the initial BglII-digested target DNA.
Figure 1 shows the results of the Q-PCR amplification
of a selected fragment. The serial dilutions of the tar-
get DNA ranged from 60 ng (estimated fragment copy
number of 1.71 x 104) to 6 pg (copy number of 1.71).
The hybridization-recovered material was also diluted
by a factor of 10 and 100 prior to amplification. Figure
2 shows the results of the Q-PCR amplification of
nonselected materials.
Analysis of the CT values of the BglII target DNA
dilutions (Table 1) indicated that the ratio of the
selected fragment to the nonselected fragment was
almost exactly the expected 1:1 ratio, whereas in the
hybridization-selected material, the ratio was nearly
25:1 (Table 2).
AMPLIFICATION OF BAR-CODED SAMPLES
Amplification of p53 exons. The ability to screen a large
number of tumors for a distinct set of genomic loci at
the resolution level of the nucleotide sequence is
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FIGURE 2 Q-PCR analysis of hybridization-nonselected material.
Q-PCRs were performed using serially diluted amounts of Bglll-
digested human genomic DNA. The hybridization-nonselected
material was also diluted and amplified for a selected fragment
alongside the serially diluted Bglll fragments.
invaluable in identifying novel and recurring muta-
tions within these regions that can ultimately be linked
to cancer. Although this task can be performed using
currently utilized amplification and sequencing tech-
niques, the time, labor, and cost associated with this
task are considerable. A major innovation would be to
perform this task on a massively parallel scale. The
amplification of a distinct set of loci from a large num-
ber of patient samples in parallel is a relatively easy
task; however, the ability to distinguish and link each
amplified fragment to the tumor sample from which it
was amplified requires consideration. The use of
nucleotide "bar codes" seemed to be the ideal choice
for this application. Each bar code consists of a short,
unique nucleotide sequence that would be assigned to
each tumor sample. The size of the bar code can vary,
but, practically, a 6-base sequence would allow a
unique bar code to be assigned to 4097 different tumor
samples. This bar-code sequence would then be
appended to the ends of an amplified fragment to iden-
tify the sample origin of the fragment. There are sev-
eral ways in which amplified fragments can be bar-
coded. The method chosen to test this application
would entail synthesizing PCR primers specific to the
loci of interest with the bar-code sequence present as a
5' overhang region. A separate set of these pre-bar-
coded primers would have to be generated for each
tumor sample to be tested as part of a single group
being sequenced. For instance, if we were to test 1000
tumor samples at a time, we would need 1000 sets of
oligos. The same bar code could be used on multiple
regions of the same tumor genome since the sequences
of the target regions themselves would be different and
hence easily discernible from one another. So two
exons from p53, as an example, could be amplified
from the same patient sample using one bar code,
since we really only need the bar codes to distinguish
between the same exon from multiple patients.
This method was tested on a small scale using ten
human genomic samples from the Coriell collection.
Two 100-bp regions located in exon 2 and exon 3 of the
p.53 gene were used as the amplification targets. Ten
pre-bar-coded primer sets were chosen for each region
consisting of a 20-base complementary region and a 6-
base bar-code overhang at the 5' end. A total of 5 ng of
genomic DNA from each of the ten samples was used
in each amplification. The amount of amplified prod-
uct was virtually equivalent in the PCRs (-10 ng/p.1)
without equalizing. Equimolar amounts of each prod-
uct from both exon 2 and 3 were pooled together. At
this stage, the pooled material was either cloned for
sequence comparison on the ABI 3730x1 or input
directly into the 454 sample preparation work flow. For
TABLE 1 CT Values of the Bglll Target DNA Dilutions
Dilution of 1st Rnd Hyb
Recovered Material
Specific
Fragment Copy
No.
logcm, number
CT of Selected
Fragment
CT of Non-Selected
Fragment
1:10 83.10 1.919436943 27.728756
1:10 3.13 0.495748086 31.830537
Ratio of Selected to Unselected
Fragment 26.5: 1
TABLE 2 Extrapolated Fragment Number of Hybridization-selected Material
Amt of Bgl II
Fragments
Specific Fragment
Copy No. loci copy number.
CT of Selected
Fragment
CT of Non-Selected
Fragment
60 ng 1.71E+04 4.233782715 21.106998 21.312162
6 n_g 1.71E+03 3.233782715 23.183012 23.945086
600 pg 1.71E+02 2.233782715 26.569784 27.339945
60 pg 1.71E+01 1.233782715 30.393559 30.417076
6 pg 1.71E+00 0.233782715 32.597576 31.849861
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TABLE 3 Comparison of Recovery and Identification of Primer Bar-coded
p53 Fragments
Barcode Bar code Identifier
ABI 3730 Sequencing of
cloned products"
454 Sequencing Data' '
Frequency of
p53 axon 2
Frequency of
p53 exon 3
Frequency of
p53 exon 2
Frequency of
p53 axon 3
/ A4:TGAti:
6% 8%
2 ATTACA 7%
19% 12%
3 CCGGCT 2%
0.20% 7%
4 CTGAGG 2% 5''
11% 6%
5 GCCGTC 0% 0' -
3% 5%
6 GTCCAA 7% - 6%
7%
7 TCATAT 7% 14'0 4%
8%
8 TTACCG 49% 30% 6.80% 9%
9 AATTGC 7% 14% 17%
12%
/0 AGTCAG 9% 13% 10% 11%
Ambiguous 3% 5% - 17% 15%
*-400 Sequences in Analysis
**-3500 Sequences in Analysis
the cloned material, transformants were plated, and 192
clones were sampled for sequencing and separation on
the ABI 3730x1. The sequences were assembled and
aligned to the p.53 exon 2 and exon 3 reference
sequence using the Consed software. The bar-code
sequence for each sample was clearly distinguishable
in each trace. The assembly was then analyzed to deter-
mine the distribution of reads from each sample. In
parallel, the pooled exon products were also sequenced
on a 1/4 plate on the 454 instrument. More than 20,000
sequences were generated. A sampling of 3500 fasta
sequences was then examined to determine the pres-
ence of each bar code. The results are summarized in
Table 3. It was apparent that sequencing of the pooled
products on the 454 instrument had a much more uni-
form distribution of bar-code recovery when compared
to the cloned products sequenced on the ABI 3730xl.
In any case, this analysis served two purposes: (1)
as an exercise to determine if efficient identification
of the bar-code sequence in the amplified fragments
was feasible and (2) with and without cloning to deter-
mine if direct sequencing was more representative of
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the sample. Again, this makes it seem likely that the
bias was introduced during cloning. In addition to test-
ing bar-code distribution, we also showed that we
could test the assembled fragments for polymorphisms
by comparison with the human p.53 reference
sequence. The results are presented in Table 4.
BAC Sequencing Utilizing Bar-code Identifiers. Two
methods were designed and tested to append bar-code
identifiers to randomly sheared bacterial artificial
chromosome (BAC) fragments. These methods were
designed to ultimately allow simultaneous sequencing
of several pooled BACs on the 454 instrument and the
Solexa platform as well as for testing and evaluation of
the methods using the ABI 3730x1. Three Oryza sativa
cv. Nipponbare BACs (OSJNBa0050A24, -0046G16,
and -0078F08) that were previously finished at CSHL
were chosen for the tests. BAC DNA from each of
these clones were isolated and sheared by high-psi neb-
ulization with a target fragment size of 300 bp.
The first bar-coding method utilized a fairly
straightforward PCR-based strategy adapted from a
TABLE 4 SNPs and Deletions Detected in Samples
Coriel Sample
ethinic origin
Russian
6 by barcode
exon 2
Base Position in Assembly
exon 3
Base Position in Assembly
13 18 45 52 53 56 61 13 14 17 18 20 28 29 46 61 66ACTGAC APT C/TAmerican Indian ATTACA
Melanesian CCGGCT
Pygmy CTGAGG
Chinese GCCGTC DEL NG Aft NG* DEL NT NGCambodian GTCCAA T/G* NG NG T/CFrench TCATAT
Druze TTACCG T/C NO NC DELVenezuelan AATTGC
Japanese
Base position in 2SArnhly
AGTCAG
ic rolatiwo tr, +kr, ,v....-.,..4.....-1 ....,...., .-,
..
procedure frequently employed in CHIP-Chip experi-
ments where small amounts of immunoprecipitated
genomic representations are randomly amplified. The
strategy relies on a single 26-base tagging primer,
which has been named the terminal tag bar code
primer, containing an 11-base "platform" region, fol-
lowed by a 6-base unique bar-code identifier and a 9-
base degenerate stretch at the 3' end.
This amplification-based bar-coding procedure
involves two phases. In the first phase, the degenerate
region of the primer anneals to the terminal ends of the
target DNA fragments, and nucleotide incorporation is
initiated with two rounds of isothermal extension. In
the second phase, this amplified material is used in a
standard PCR utilizing a second amplification primer
complementary to the "platform" region of the termi-
nal tag bar-code primer. The extension time in this sec-
ond phase was stringently controlled to amplify only
smaller fragments. Agarose gel analysis of the ampli-
fication products confirmed that the product sizes
were between 150 and 400 bp. The fragments were
then cloned into a TA-cloning vector (pCR2.1,
Invitrogen) and sequenced.
The second bar-coding method utilized a more
standard ligation-based approach to append bar-code
adapters to the BAC fragments. The 50-bp bar-code
adapters were designed using
sequence utilized by the 454 company, followed by a
6-base bar-code sequence at the 3' end. The same
sheared BAC material that was used in the first bar-
coding method described above was also used to ligate
the bar-code adapters. These fragments were cloned
and then sequenced.
As stated previously, these methods were designed
to generate bar-coded BAC fragments that would
allow pooled sequencing of a large number of BACs
on the 454 instrument or Solexa platform with the
ability to link the resulting sequences back to the BAC
of origin via the unique bar-code sequence at the ends
of the reads. However, to test the effectiveness of these
methodologies, we cloned the bar-coded material to
sequence them using traditional methods. After
cloning, approximately 600-700 reads were generated
for each BAC. The expected coverage for each of these
BACs with 600-700 reads was approximately 1 x
assuming an average insert size of 250 bp. The reads
generated were aligned to the finished BAC sequence
using Consed. A manual inspection of each read was
performed to determine if the correct bar code
assigned to each BAC was present at the terminal ends
of each read. Table 5 summarizes the criteria used for
the analysis as well as the results.
TABLE 5 Comparison of BAC Bar-coding Techniques
(a) Amplification-based Bar Coding
BAC name 50A24 46G16 78F08
BAC size (Kbp) 143 160 166
Number of reads 698 596 554
Avg. insert size (bp) 278 249 330
Actual coverage* 1.4x 0.9x 0.9x
*Expected Coverage = 1x
(b) Ligation-based Bar Coding
BAC name 50A24 46G16 78F08
BAC size (Kbp) 143 160 166
Number of reads 356 346 325
Avg. insert size (bp) 321 289 302
Actual coverage* 0.8x 0.62x 0.6x
On the basis of these results, the amplification-
based bar-coding method was a more efficient
approach. Analysis of the ligation-based bar-coding
method revealed that 40-50% of the fragments gen-
erated were not inserted into the assembly due to
very small insert sizes (10-40 bp). Since this method
did not rely on a traditional agarose-based size selec-
tion of fragments prior to processing, adding this
size selection step in the ligation-based bar-coding
procedure would readily solve this problem.
Of the fragments that were inserted into the
assemblies from both methods, the insert size was in
the size range expected (-300 bp). Another consid-
eration was the distribution of reads across the
assembly and the possible overrepresentation of cer-
tain sequences or regions in the reads. For both
methods, the reads distributed evenly across the
assembly and no apparent read "stacking" was dis-
cernible.
PCR OF DNA FROM PARAFFIN-EMBEDDED SAMPLES
Six different DNA samples were extracted from
paraffin-embedded tumors using the Puregene DNA
purification Kit (Gentra Systems). The samples were
subsequently amplified using PCR with HotStarTaq
(QIAGEN) for exons 5-8 of the p53 gene. (Ribeiro
et al., Cancer 83: 7 [1998]) After an initial denatura-
tion step for 15 minutes at 95°C, samples underwent
35 cycles of PCR (30 sec 94°C; 30 sec 60°C; 1 min
72°C). This was followed by a 10-minute extension
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TABLE 6 Summary of Amplification of Exons 5-8 of the p53 Gene
in Six Tumor Samples
Tumor Exon 5 (202 bp) Exon 6 (162 bp) Exon / (164 Dp)
rxon 0 oy op)
Liver3 amplification + amplification +
amplification + amplification +
Liver6 (low
concentration)
no
amplification -
no
amplification - amplification +
no
amplification -
Liver9 amplification + amplification +
amplification + amplification +
Liver10 amplification + amplification +
amplification + amplification +
3881A2 (melanoma) amplification + amplification + amplification +
amplification +
9341A2 (lungs) no
amplification -
no
amplification -
no
amplification -
no
amplification -
at 72°C. Of the six samples, five showed amplifica-
tion (Table 6). Of those five samples, four amplified
very well and were sequenced with the ABI Big Dye
terminator chemistry on the ABI 3730 sequencer.
The sequence quality varied with the samples; how-
ever, in general, the sequences were all legible and
provided usable data. Although no SNPs were found
in the samples that we examined, we showed that the
DNA in the paraffin-embedded samples was able to
be recovered, amplified, and sequenced.
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OBTAINING MECHANISTIC CLUES FROM THE EVOLUTIONARY
CONSTRAINTS IMPOSED ON PROTEINS
A.F. Neuwald N. Kannan
We continue to study aspects of protein mechanisms
through Bayesian statistical analysis of the functional
constraints imposed during evolution. This year, our
focus has been on bacterial clamp loader AAA+
ATPases and on AGC protein kinases. Clamp loaders
have critical cellular roles inasmuch as a clamp must
be loaded onto DNA and attached to DNA polymerase
in order to keep polymerase from disassociating dur-
ing DNA replication and repair. My analysis of bacte-
rial clamp loader subunits strongly suggests that these
subunits utilize a mechanism strikingly different from
that of the corresponding eukaryotic clamp loader
subunits. In particular, bacterial clamp loader ATPases
appear to be activated through DNA-dependent repo-
sitioning of the catalytic base and of a putative trans-
acting threonine directly involved in ATP hydrolysis.
Both of these mechanisms seem to be entirely absent
from eukaryotic clamp loaders. Our analysis of AGC
kinases likewise suggests key aspects of their mecha-
nisms. AGC kinases control critical cellular processes,
such as cell growth, differentiation, and cell survival
and thus are subject to tight spatial and temporal reg-
ulation. Our analysis suggests that features distin-
guishing the AGC catalytic domain from other eukary-
otic protein kinases (EPKs) have coevolved with a
characteristic carboxy-terminal tail to create an
extended allosteric network that links the C tail to the
active site. Finally, this year we have begun extending
our Bayesian statistical models to include detailed
three-dimensional structural features and thus to come
closer to more directly modeling aspects of protein
mechanisms by using structural data in addition to
sequence data.
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GENOME-SCALE DATABASES OF PATHWAYS, GENETIC
VARIATION, AND EVOLUTION
L. Stein S. Avraham
S. Cain
R Canaran
P. D'Eustachio
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C. Liang
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THE HUMAN HAPLOTYPE MAP
L. Matthews
S. McKay
S. Michaelsen
L. Ren
C. Schmidt
W. Spooner
The International Human Hap Map Project (www.
hapmap.org) is an international project to map out
regions of common genetic variability in the human
genome by genotyping three major world populations
across a large number of naturally variable sites. The
resulting "haplotype map" will greatly reduce the costof
genetic association studies to find cancer susceptibility
genes and other disorders with genetic components.
Our lab is a central participant in this project in our
role as the Data Coordinating Center (DCC). We man-
age the central database for the project; allocate sin-
gle-nucleotide polymorphisms (SNPs) to the 11 geno-
typing centers; coordinate data submission, quality
checks, and quality control; and manage the public
release of project data. The Hap Map Web site, which
was developed in our lab, describes the project in the
four languages of the project participants (English,
French, Chinese, Japanese, Yoruba) and provides
access to the data both for bulk download and for
interactive querying and browsing.
During 2006, we extended our phase I work on the
project (published in October 2005 in Nature) to geno-
type an additional 3 million SNPs. This brings the total
number of genotyped SNPs to almost 4 million, for
one typed polymorphism every 750 by of sequence-
a map of unprecedented detail and resolution. The
work is already bearing fruit: During the past year, the
Hap Map data have been used to identify a gene
responsible for age-related macular degeneration (the
major cause of acquired blindness in the United
States) and to identify several genes that appear to
contribute to type 2 diabetes.
We are also extending the features available on the
Hap Map Web site to bring in summary data from
whole-genome association studies, as well as to allow
researchers to view the locations and nature of the
large number of copy-number polymorphisms that
have come to light in recent months.
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GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic
and physical maps of the major monocot crops, name-
ly, maize, barley, oats, sorghum, and wheat, to the
emerging rice genomic sequence. This allows
researchers to identify candidate genes in the rice
genome that correspond to genetically mapped
mutants and quantitative traits in the nonrice crop they
are studying. Hence, the resource allows researchers
studying traits in maize, barley, and so forth the bene-
fit of genomic sequencing without waiting for the
sequencing of these much larger genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 1 million monocot expressed
sequence tags (ESTs) to the rice genome, allowing
gene predictions to be further refined based on cross-
species comparisons.
A major milestone this year was the integration of
genome mapping information on 11 wild rice species
to the Gramene database. These species are adapted to
a wide range of conditions, including semidesert and
high-altitude sites. Our comparative maps provide a
detailed view of how these genomes evolved and
diversified from domestic life over a period of rough-
ly 10 million years. By elucidating which regions were
selected for during the divergence and adaptation of
these species, we hope to provide information that will
allow plant breeders to create new robust varieties of
domestic rice.
We also used the information in the Gramene data-
base to identify previously unknown microRNAs
(miRNAs) in the rice, maize, and sorghum genomes.
miRNAs are thought to be responsible for regulating
key events during development and maturation. Our
work provides the first window into how these genes
evolve and diversify in plants.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
Our lab continues to be a major developer and main-
tainer of the Worm Base database (www.wormbase.
org), an online information resource for the small free-
living nematode, Caenorhabditis elegans. This organ-
ism is favored as a simple model animal because of its
small genome size, experimental malleability, and
well-understood cellular anatomy. Worm Base is a
curated model organism database developed as part of
an international collaboration that includes the
California Institute of Technology, Washington
University at St. Louis, and the Sanger Centre. Our lab
is responsible for the Web site, user interface, and soft-
ware architecture for the project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted
genes, alternative splicing patterns, oligonucleotide
probes, and evolutionarily conserved segments. It also
contains many other types of biological information,
including the C. elegans cell pedigree, the organism's
neuroanatomy, its genetic map, and the physical map
from which the genomic sequence was derived.
During 2006, we added gene interaction and
orthology data to Worm Base. Gene interactions form a
network of positive and negative regulatory reactions
and are the basis for forming models of how cells reg-
ulate themselves and each other. Orthology data
describe how gene families evolve and acquire new
functionality. Both sets add considerable value to
researchers seeking to understand the basis of life
processes. We also added a new resource, called
WormBook (www.wormbook.org), an open-access
journal of C. elegans review articles. This resource,
which already contains over 100 substantial chapters,
is extensively cross-referenced with WormBase,
allowing researchers to move seamlessly between
highly structured database pages and human-friendly
narrative text.
In 2006, we used the resources of WormBase to
perform a genome-wide investigation of the function-
al relationship of genes that neighbor each other in the
C. elegans genome. We found a high degree of coex-
pression among neighboring genes that are oriented in
the same direction and among those that are tran-
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FIGURE 1 Correlation in gene expression among neighboring
genes in C. elegans. (A) A heat map that shows the correlation
in gene expression for genes within the region 1-2 Mb on chro-
mosome I. Each small box represents a pairwise Pearson cor-
relation coefficient value that indicates the level of gene expres-
sion. (B) Distribution of Pearson correlation coefficient values
calculated based on tissue-specific SAGE tags. (Parallel)
Parallel gene pairs with distance between closest coding exons
<1000 bp; (Divergent) divergent neighboring gene pairs with
distance between closest coding exons <1000 bp;
(Convergent) convergent neighboring gene pairs between clos-
est coding exons <1000 bp; (Operon) gene pairs within oper-
ons; (Random cis) random gene pairs within same chromo-
somes; (Random trans) random gene pairs in which two genes
are from different chromosomes.
scribed in divergent directions, but no correlation of
neighboring genes that are transcribed in convergent
directions. This finding suggests that some neighbor-
ing genes share the same transcriptional regulatory
elements and represents a novel mechanism of tran-
scriptional coregulation.
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REACTOME
Reactome (www.reactome.org) is a collaboration with
the European Bioinformatics Institute (EBI) and the
Gene Ontology Consortium to develop a Web-accessi-
ble resource for curated information about biological
processes.
Reactome is organized like a review journal.
Bench biologists are invited to create modules that
summarize a particular aspect of their field. Currently,
summations include DNA replication, transcription,
translation, intermediary metabolism, the cell cycle,
RNA splicing, and hemostasis. Many more modules
are under way. Modules are similar to minireviews,
except that each paragraph of text is reduced to a series
of logical assertions that is entered into a database of
processes and macromolecules. The database is then
used to drive a Web site that can be browsed like a text-
book or searched with queries to discover pathways
and connections.
During 2006, we brought the number of genes
curated in Reactome to 1576 proteins, covering
approximately 11% of the annotated portion of the
human genome. We also added a new interface that
allows users to interpret microarray data sets based on
where affected genes are placed in the reaction map. A
paper describing Reactome was recently accepted for
publication in Genome Biology.
GENERIC MODEL ORGANISM DATABASE PROJECT
In collaboration with the model organism system data-
bases FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a
set of database schemas, applications, and interfaces
suitable for creating a model organism system data-
base. These tools significantly reduce the time and
expense required to create new databases to curate
genomic information coming out of various model
organism system sequencing projects. 2006 saw the
establishment of GMOD-based model databases for
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cow, honeybee, planaria, and tribolium beetle. In addi-
tion, GMOD tools were used for the analysis and pub-
lication of the largest survey of human copy-number
polymorphisms to date (Redon et al., Nature 444:
444-454 [2006]).
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COMPUTATIONAL GENOMICS
M.Q. Zhang G. Chen
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P. Sumazin
In the last year, more members have left the lab and
moved on to their new careers: S Kamalakaran became
a staff scientist at Philip Research; G. Chen became a
staff scientist at Invitrogen; and D. Schones has gradu-
ated and started a postdoc at the National Institutes of
Health. Dr. F. Li, a visiting scientist, joined our DART
project for 7 months, and Mr. Jeff Rosenfeld, a new
New York University Ph.D. student, joined our lab.
Our main achievements last year were to (1) study
large-scale structure of human brain DNA methylation
patterns (Rollins et al. 2006) and develop two SVM-
based prediction algorithms: one for methylation pre-
diction in the general genomic region (Das, Dmitrova et
al. 2006) [in collaboration with Columbia University
groups]) and the other for methylation prediction of a
CpG island (Fang et al. 2006) [in collaboration with
Tsinghua University groups]); (2) demonstrate that
when using the proximal promoter (-1 kb) alone, one
can predict the tissue specificity of target gene expres-
sion (Smith et al. 2006). Conversely, using tissue-spe-
cific expression profiles, we are able to catalog major
tissue-specific cis-regulatory binding-site motifs in
each different tissue type (Smith et al. 2007 for heart,
kidney, liver, pancreas, skeletal muscle, testis, and T
cells; Martinez et al. 2006 for lung); (3) successfully
develop the new algorithm MARS Motif M for mam-
malian promoter motif discovery using multivariate
adaptive regression splines technology (Das, Nahle et
al. 2006); and (4) map insulator sites in the human
genome and derive the primary CTCF-binding motif for
the first time (Kim et al. 2006 [in collaboration with
University of California, San Diego and National
Institutes of Health groups]).
Adaptively Inferring Human Transcriptional
Subnetworks with MARSMotif-M
D. Das, M.Q. Zhang [in collaboration with Z. Nahle
at Washington University]
Although the human genome has been sequenced,
progress in understanding gene regulation in humans
Z. Xuan
C. Zhang
X. Zhao
has been particularly slow. Many computational
approaches developed for lower eukaryotes to identify
cis-regulatory elements and their associated target
genes often do not generalize to mammals, largely due
to the degenerate and interactive nature of such ele-
ments. Motivated by the switch-like behavior of tran-
scriptional responses, we present a systematic
approach that allows adaptive determination of active
transcriptional subnetworks (cis-motif combinations,
the direct target genes, and physiological processes
regulated by the corresponding transcription factors)
from microarray data in mammals, with an accuracy
similar to that achieved in lower eukaryotes. By
extending our MARSMotif technology for mam-
malian transcription-factor-binding site (TFBS)
motifs, our analysis uncovered several new subnet-
works active in human liver and in cell cycle regula-
tion, with functional characteristics similar to those of
the known ones. We present biochemical evidence for
our predictions and show that the recently discovered
G2/M-specific E2F pathway is wider than previously
thought; in particular, E2F directly activates certain
mitotic genes involved in hepatocellular carcinomas.
Additionally, we demonstrate that this method can pre-
dict subnetworks in a condition-specific manner, as
well as regulatory cross-talk across multiple tissues.
Our approach allows systematic understanding of how
phenotypic complexity is regulated at the transcription
level in mammals and offers a marked advantage in
systems where little or no prior knowledge of tran-
scriptional regulation is available.
Understanding Tissue-specific
Transcriptional Regulations
in Mammals
A.D. Smith, R Sumazin, Z. Xuan, M.Q. Zhang
For a better understanding of tissue-specific tran-
scriptional regulation, we have further developed
our classification-based cis-regulatory motif dis-
covery algorithms (DME-b, and more tools, such as
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STORM, in CREAD Open Source package). Using
tissue-specific microarray expression data, we first
showed that DNA motifs within human and mouse
proximal (1-kb) promoter regions can predict tissue
specificity of target gene expression with high con-
fidence (Smith et al. 2006). Subsequently, we car-
ried out a computational intensive characterization
of specific TFBS motifs for many tissues (Smith et
al. 2007). In particular, we reported on a systematic
analysis of promoters controlling tissue-specific
expression in heart, kidney, liver, pancreas, skeletal
muscle, testis, and CD4 T cells, for both human and
mouse. We integrated multiple sources of expres-
sion data to compile sets of transcripts with strong
evidence for tissue-specific regulation. The analysis
of the promoters corresponding to these sets pro-
duced a catalog (http://rulai.cshl.edu/tcat2/) of pre-
dicted tissue-specific motifs and modules, and cis-
regulatory elements. Predicted regulatory interac-
tions are supported by statistical evidence and pro-
vide a foundation for targeted experiments that will
improve our understanding of tissue-specific regu-
latory networks. In a broader context, methods used
to construct the catalog provide a model for the
analysis of genomic regions that regulate differen-
tially expressed genes.
A New Core Promoter Prediction
Program Core Boost: Boosting
with Stumps for Predicting
Transcriptional Start Sites
X. Zhao, Z. Xuan, M.Q. Zhang
Promoter prediction is a difficult but important prob-
lem in gene finding, and it is also critical for under-
standing the regulation of gene expression. Taking
advantage of new sequences of full-length cDNAs and
5'-untranslated regions (5 'UTRs), we developed a new
core promoter prediction program called CoreBoost,
which applies a boosting technique with stumps to
select important small-scale features as well as large-
scale features. CoreBoost greatly improves locating
transcription start sites. We also demonstrate that by
further utilizing some tissue-specific information, bet-
ter accuracy can be achieved. This can also be used for
correcting systematic bias in recent ChIP-chip map-
ping of human active core promoters/transcriptional
start sites.
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Analysis of the Vertebrate Insulator
Protein CTCF-binding Sites in the Human
Genome
A. Smith, M.O. Zhang [in collaboration with the B. Ren
Lab, University of California, San Diego, and
the Lobanenkov Lab at NIH/NIAID]
Insulator elements affect gene expression by preventing
the spread of heterochromatin and restricting transcrip-
tional enhancers from activation of unrelated promoters.
In vertebrates, insulator's function requires association
with the CCCTC-binding factor (CTCF), a protein that
recognizes long and diverse nucleotide sequences.
Insulators are critical in gene regulation, but only a few
have been reported. Here, we describe 13,804 CTCF-
binding sites in potential insulators of the human
genome, discovered experimentally in primary human
fibroblasts. Most of these sequences are located far
from the transcriptional start sites, with their distribu-
tion strongly correlated with genes. The majority of
them fit to a consensus motif highly conserved and suit-
able for predicting possible insulators driven by CTCF
in other vertebrate genomes. In addition, CTCF local-
ization is largely invariant across different cell types.
Our results provide resources for investigating insulator
function and possible other general and evolutionarily
conserved activities of CTCF sites.
A Clustering Property of Highly
Degenerate TFBSs in the Mammalian
Genome
C. Zhang, Z. Xuan, M.Q. Zhang [in collaboration with G.
Mandel, SUNY Stony Brook]
Due to the relatively short length of TFBSs, it is
important to understand how the specificity of protein-
DNA interaction is achieved. We have performed a
genome-wide analysis of nearby TFBS-like sequences
for the transcriptional repressor, RE1 silencing tran-
scription (REST) factor, as well as for several other
representative mammalian transcription factors (c-
myc, p53, HNF-1, and CREB). We find a nonrandom
distribution of inexact sites for these transcription fac-
tors, referred to as highly degenerate TFBSs, that are
enriched around the cognate binding sites.
Comparisons among human, mouse, and rat ortholo-
gous promoters reveal that these highly degenerate
sites are conserved significantly more than expected
by random chance, suggesting their positive selection
during evolution. We propose that this arrangement
provides a favorable genomic landscape for functional
target site selection.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage
independent research by
outstanding young scientists who, during theirgraduate studies, displayed
exceptional promise of becoming
leading scientists of the future. The purpose of this program is to provide an
opportunity for these young sci-
entists to work independently at the Laboratory for a period of 3 years on projects of their own choosing.
Fellows are provided with a salary, research support, and technical assistance so that
they can accomplish
their goals free of distraction. The interactions among research groups at the Laboratory
and the program of
courses and meetings on diverse topics in biology contribute to a research
environment that is ideal for inno-
vative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1986), Scott Lowe (1995), and Marja
Timmermans (1998) are currently members of the faculty at the Laboratory. After 9 years at the Laboratory,
Carol Greider (1988) left to join Johns Hopkins University School of Medicine, where she is now the Daniel
Nathans Professor and Director of Molecular Biology and Genetics. Eric Richards (1989) is now a Professor
in the Department of Biology at Washington University in St. Louis. After finishing his fellowship, David Barford
(1991) returned to the Laboratory of Molecular Biophysics at Oxford University and is now a Professor of
Molecular Biology at the Institute of Cancer Research in London. Ueli Grossniklaus (1994) was a member of
our faculty before leaving to become a Professor at the Institute of Plant Biology, Universitat ZOrich,
Switzerland. Terence Strick (2000) left at the end of his Fellowship to become a Group Leader at the Institut
Jacques Monod at the Centre National de la Recherche Scientifique and University de Paris.
The Laboratory currently has three CSHL Fellows, Gilbert (Lee) Henry, who joined the Laboratory in 2000,
and Patrick Paddison and Ira Hall, both of whom joined the Laboratory in 2004. Their reports are listed below.
Lee joined us from Doug Melton's laboratory at Harvard University, where he earned his Ph.D. for studies on
Xenopus development. Lee is studying the molecular biology of taste-receptor-cell differentiation. Patrick was
a graduate student at the Watson School of Biological Sciences here at CSHL, where he worked in Greg
Hannon's lab on the development of RNA interference (RNAi) libraries. Patrick has been using RNAi technol-
ogy to establish the genetic requirements for embryonic stem (ES) cell self-renewal and differentiation. Ira was
also a graduate student at the Watson School of Biological Sciences, where he worked in Shiv Grewal's lab
on the relationship between RNA interference and chromosome dynamics. He is currently studying mam-
malian genomic instability and plasticity and characterizing the contribution of DNA copy-number polymor-
phisms to genetic variation.
I. Hall
L. Henry
P.J. Paddison
Investigation of DNA Copy-number
Fluctuation Using Genomic
Microarrays
I. Hall, C. Egan
We are interested in pursuing a genome-wide examina-
tion of genetic instability and plasticity and in character-
izing the contribution of DNA copy-number differences
to natural variation. The arrangement and copy number
of chromosomal segments may vary between species,
strains, and individuals, and spontaneous DNA
rearrangements are recognized to be causal in the clonal
evolution of cancers and in the etiology of certain human
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diseases. Ancestral sequence relationships within and
between mammalian genomes indicate a major architec-
tural role for duplication and deletion in shaping
genomes over evolutionary time, but less is known about
how these processes contribute to genetic variation
across more rapid time scales within normal populations
and organisms. We aim to use the laboratory mouse as a
model system to investigate the fundamental properties
of DNA copy-number fluctuation in mammals utilizing
a form of comparative genome hybridization termed
representational oligonucleotide microarray analysis
(ROMA) (Lucito et al., Genome Res. 10: 1726 [2000]).
Internal relationships within sequenced genomes
show that a significant portion (2-5%) of chromoso-
mal DNA in mammals is contained within segmental
duplications (defined as stretches of DNA within a sin-
gle genome >1 kb in length and >90% identical to one
another), and duplicative events underlie the historical
amplification and diversification of many important
gene families. Sequence comparisons are essential to
identify ancient copy-number change but are not well-
suited to detect recent and ongoing genetic events
because a complete genome sequence (1) is usually
derived from a single individual, (2) relies upon assem-
bly methods that are confounded by large identical
repeats, and (3) is still impractical to attain for large
genomes. Traditional molecular techniques are
inevitably limited (and directed) to a small number of
loci, and cytogenetic methods lack sufficient resolution
to detect most changes. ROMA allows for the simulta-
neous detection of DNA copy-number variants (CNVs)
and restriction-fragment-length polymorphisms
(RFLPs) between any two related DNA samples
through comparative hybridization of simplified
genomic representations to high-density oligonu-
cleotide microarrays. This technique assays a large por-
tion of the genome in a relatively unbiased manner and
requires only that a complete genome sequence exists
for the organism in question. A number of recent stud-
ies have cataloged extensive copy-number differences
between humans, indicating that CNVs may account
for a substantial fraction of existing genetic variation.
The apparent evolutionary importance and con-
temporary prevalence of segmental copy-number vari-
ation raises fundamental questions: How often do new
CNVs arise? Do CNVs arise through a random
process? Does copy number generally reflect the
ancestry of a locus? What are the prevalent mecha-
nisms of duplication and deletion? Are different chro-
mosomal regions or classes of DNA sequences more
variable than others? Do distinct cells or cell types of
an organism contain the same genetic material?
The laboratory mouse is an ideal model system for
such investigations in that the human and mouse
genomes appear to have been shaped by similar muta-
tional forces, and the mouse offers the significant
technical advantages of controlled crosses, experimen-
tal manipulation, and a known breeding history.
GENETIC DIVERSITY IN INBRED MICE
During the past century, a large number of phenotypi-
cally diverse inbred strains have been derived from a
small number of founder mice through brother-sister
mating. Because these founders were mixed descen-
dants of Asian and European subspecies, each modern
inbred line contains a unique, recombinant mixture of
chromosomal segments of distinct genetic origin.
These genetic differences are thought to underlie the
many interesting physical and behavioral traits for
which modern strains vary.
To gain an understanding of the current genetic com-
position of the laboratory mouse and to evaluate the util-
ity of ROMA as a tool for mouse genetics, we have pro-
filed the genomes of a number of commonly used inbred
strains. Using a microarray containing about 83,000
probes, we have identified approximately 15,000
ROMA polymorphisms from 12 strains. More than one
third of these markers can be observed in a single strain
comparison, and further investigation with independent
methods indicates that about one fifth of them are CNVs
(the remainder are RFLPs and SNPs). These markers are
distributed throughout the genome in a punctate, highly
nonrandom fashion, and in collaboration with S. Sridhar
(Carnegie Mellon), we have developed a segmentation
algorithm to identify ancestrally divergent haplotypes
and CNVs within our data (this model is based on previ-
ous work by L. Muthuswamy and M. Wigler). We have
compared ROMA polymorphisms to a curated set of 3.8
million single-nucleotide polymorphisms (SNPs) and
found that although the majority of ROMA differences
appear to be ancient in origin and mirror the distribution
of SNPs, significant genomic changes have occurred
since the establishment of inbred lines in the early part
of the 20th century.
GENOME STABILITY AND PLASTICITY
To assess the importance of segmental duplication and
deletion in generating de novo genetic variation, we
are examining genome stability through normal cycles
of somatic development and germ-line transmission in
the laboratory mouse.
A description of the genetic variation normally
present in somatic cells is important for a few major
reasons. Each cancer is thought to begin with a single
cell that has diverged from its relatives, and the accu-
mulation of mutations is thought to be a cause of
aging. DNA rearrangement is also an established reg-
ulatory mechanism. Our own bodies generate a stag-
gering diversity of immunological molecules precisely
through such "mutagenic" processes, and more simple
genetic systems (such as various yeasts and bacteria)
utilize reversible DNA rearrangements to make herita-
ble transcriptional decisions. It is not known how com-
mon such mechanisms are in mammals. In collabora-
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tion with J. Hicks, the Wig ler lab, and K. Eggan
(Harvard University), we are pursuing a survey of
somatic cell diversity in humans and mice. We hope
that these studies result in an estimate of clonal varie-
gation in mammals and help to identify unstable or
hypervariable regions of the genome.
Mutation in the germ line is the basis for the intro-
duction of new alleles to a species and is relevant to our
understanding of evolution, population structure, and
sporadic human disease. Previous estimates of the
germ-line mutation rate have relied upon the observa-
tion of spontaneous loss of function at a small number
of genes and do not adequately distinguish between
classes of mutations. Rates of segmental duplication
and deletion have been examined at just a few loci. Our
analysis of genetic diversity described above utilized
multiple individuals from each strain and thus repre-
sents a test of the purportedly homozygous and uni-
form nature of the inbred mouse genome. We found
that inbred mice are indeed very inbred but are rarely
identical. We did not observe residual heterozygosity
of ancestral genetic variation, but we often encountered
one or more spontaneous CNVs between closely relat-
ed individuals of the same inbred strain. This indicated
that CNVs might arise at a high rate and that it might
be possible to study this process directly.
During the past year, we have examined the process
of spontaneous DNA copy-number changes across the
entire mouse genome. We collected pedigreed mice
from many separate colonies of the C57BL/6 (B6)
inbred strain, each bred independently at different insti-
tutions around the world, and constructed a genealogy
spanning approximately 966 generations of inbreeding.
We then used ROMA to identify 38 de novo CNVs
among B6 colonies. Remarkably, based on the most
parsimonious explanation for the distribution of CNV
genotypes relative to the structure of the genealogy,
almost half of the de novo CNVs arose multiple times
within distinct lineages. Of 38 CNVs, 8 arose once
within B6 colonies but were also variable among other
classical inbred mouse strains, and 10 CNVs arose mul-
tiple times within different B6 colonies. Thus, signifi-
cant changes in DNA copy number occur over relative-
ly short time scales, and new segmental variation is
often the product of recurrent mutation. The recurrent
CNVs that we identified range in size from 4 kb to 4
mb, affect 43 known genes, and fluctuate in copy num-
ber at rates of about 1 x 10-2 to 1 x 10-3/locus/genera-
tion. A preliminary analysis of CNV breakpoints indi-
cates that they recur through a relatively precise mech-
anism. Given that we have significantly underestimated
the prevalence of recurrent CNVs and that many of
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those we identified contain genes for which hypervari-
ability might be beneficial to a population (i.e., factors
involved in immunity, reproduction, and cognition), we
believe that recurrent structural mutation will prove to
be a widespread and phenotypically relevant process for
creating genetic variation in mammals.
Structural and Functional
Studies of the Vertebrate
Taste Bud
L. Henry, M. Siddiqui
We are interested in the molecular biology of taste
receptor cell differentiation. The mammalian taste bud
is a dynamic structure consisting of mitotically active
progenitor cells at its periphery and differentiated taste
receptor cells within its core. The basic goal of our
research is to understand how the daughters of the prog-
enitors select a particular fate. As different receptor
cells are known to respond to different classes of tas-
tants, we hope that understanding this differentiation
process will help to illuminate details of both taste bud
structure and function. Toward this end, we have under-
taken an exhaustive effort to define at the level of tran-
scription the cellular diversity of the murine taste bud.
To do this, single-cell profiling is being used to ana-
lyze the transcriptomes of taste receptor and progenitor
cells. We are currently developing a novel procedure to
produce single-cell profiles that relies on the attachment
of single-cell levels (picogram) of mRNA to magnetic
beads. The immobolization of picogram amounts of
nucleic acid allows manipulations, free from complicat-
ing purification procedures, to be preformed that would
usually require microgram amounts of material. Various
aspects of this procedure have been optimized over the
last year, including the identification of a novel first-
strand cDNA-priming scheme that solves a key back-
ground problem associated with the procedure and the
design and synthesis of a novel cleavable linker that pro-
vides both flexibility for the priming oligonucleotide
and a means to detach cDNA from the magnetic bead
after a series of modification steps.
Finally, we have established a transgenic animal
model that allows expression of green fluorescent
protein (GFP) in cells of both the taste bud and the
surrounding epithelium. Using this animal model, we
are attempting to identify progenitor cells for the
taste bud based on cell cycle criteria for future profil-
ing experiments.
LABEL RETAINING CELLS IN THE
MURINE TASTE BUD
In collaboration with Kristen Brendan and Doug
Melton at Harvard University, we have used a trans-
genic label retention system to identify a population of
slow-cycling cells in the lingual epithelium surround-
ing the anterior fungiform taste bud. The transgenic
model uses a Tet-repressor system to drive expression
of a GFP-histone H2B fusion protein. At anytime dur-
ing prenatal or postnatal development, the transgene is
turned off by withdrawal of the inducing drug from the
animals drinking water. Defined chase periods of no
expression then allow one to track the half-lives of
GFP-labeled cells. In the case of our experiments, the
ubiquitous expressed ROSA26 promoter is used to
drive expression of the transgene from embryonic day
zero (E0) to postnatal day 42 (P42).
Analysis of the tongues of mice chased with no
expression for between 1 and 6 months indicates a num-
ber of interesting points. First, it is widely cited in the lit-
erature that the average lifetime of a cell in the taste bud
is 7-10 days. We however, detect label-retaining cells in
the bud for up to 2 months. The identity of these long-
lived cells is currently under investigation. Of more inter-
est is the identification of a group of label-retaining cells
located around the apical margin of the fungiform taste
bud. These cells retain label for as long as 3 months, and
they form a continuous border around the bud with more
basally located Ki67-positive mitotically active cells.
Both the Ki67 and label-retaining cells express Sox2, a
molecular marker known to be expressed in other types
of stem/progenitor cells. Moreover, in both the skin and
hematopoietic systems, the same transgenic animal
shows label retention in cells known to exhibit a
stem/progenitor function. In the future, we will attempt to
isolate these cells and determine the exact nature of their
transcriptomes via the single-cell amplification tech-
niques that we have developed.
Overview
P. Paddison
Among the emerging themes of cancer research during
the last few decades is the notion that cancer cells hijack
molecular pathways involved not only in promoting cell
proliferation and survival, but also in developmental
decisions such as cell-fate determination. The recent dis-
covery of cancer stem cells, which seem to have vital
roles in tumor progression, maintenance, and recurrence,
further underscores this notion, suggesting that cancers
arise from maligned developmental programs. Because
many of these co-opted developmental pathways (e.g.,
Jak/Stat, epidermal growth factor [EGF], fibroblast
growth factor [FGF], Smad, etc.) are also important for
the self-renewal of embryonic and adult stem cells, it is
vital that we understand how dependencies on these path-
ways for growth, survival, and potency arise during
development and if such functional dependencies are
restructured in cancer cells. Thus, understanding how
molecular pathways promote or constrain "sternness"
may provide critical insight into cancer biology as well as
inroads for novel therapeutic strategies.
General Research Goals
1. Identify genes required for self-renewal and lin-
eage specification in embryonic and adult stem
cells in humans and rodents using in vitro function-
al genetic approaches.
2. Determine if these genes function in stem-cell-dri-
ven cancers.
3. Apply RNAi (RNA interference) technology for
the creation of desirable cell types for cell replace-
ment therapies.
4. Continue to develop RNAi screening technologies.
Currently I have begun to apply RNAi in mouse
embryonic stem cells to functionally dissect self-
renewal and lineage specification using focused gene
sets. We are now expanding our screens for genome-
wide coverage and incorporating human embryonic
stem (ES) cells and neural stem cells.
Current Research
MODIFIERS OF NANOG EXPRESSION IN ESCS
ESCs are cell lines derived from the inner cell mass
(ICM) of blastocyst-stage mammalian embryos (Evans
and Kaufman, Nature 293: 154 [1981]; Martin, Proc.
Natl. Acad. Sci. 78: 7634 [1981]; Thomson et al.,
Science 282: 1145 [1998]). They can grow indefinitely
in culture and give rise to cells of all three embryonic
germ layers as well as germ cells (Keller, Genes Dev.
19: 1129 [2005]). For this reason, ESCs hold great
promise for regenerative medicine, where human ESC
derivatives might be used in cell replacement therapies.
Nanog is an atypical homeobox domain transcrip-
tion factor that is one of several known key regulators
that are required to maintain pluripotency of ESCs
(Chambers et al., Cell 113: 643 [2003]; Mitsui et al.,
Cell 113: 631 [2003]). Current models posit that
187
tUV
,5V
Cr)
= 1 0 0
(1)0
5V
a-
LL
50
82
-100
-150
Oct4_533
Nanog 341
Nanog_870
Oct4_599
EGFP_433
Tcf3_1040
RARa _668
RAIR(1_1 1 58
RARy_1046,,
RARy_952-__LN
FIGURE 1 RNAi screen for modifiers of Nanog expression in mouse ES cells
Nanog, along with factors such as Oct4 and Sox2,
functions in cross-regulatory networks that collective-
ly repress differentiation-inducing genes and activate
those that are required for self-renewal. To find regu-
lators of self-renewal and lineage specification, we
carried out a loss-of-function genetic screen designed
to find modifiers of Nanog expression during the dif-
ferentiation of mouse ESCs (Fig. 1). We used an RNAi
approach in a Nanog-GFP (green fluorescent protein)
ESC line, targeting genes involved in chromatin mod-
ification, signal transduction, and transcription.
We identified 35 that act to repress Nanog expression
during retinoic acid (RA)-induced differentiation (Figs. 2
and 3). These gene products represent at least five distinct
pathways or complexes. In addition, we identied 47 gene
products that act to down-regulate Nanog expression lev-
els. We functionally characterized screen hits using tran-
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FIGURE 2 Clustering of microarray expression profiles of
mouse ES cells transfected with shRNAs and treated with 2 p.m
RA (48 hrs). Each column represents knockdown of indicated
gene (bottom), and rows represent ES cell marker genes (right).
Relative expression levels are shown from low to high.
(Asterisks) Genes known to be required for self-renewal (n = 3;
t-test, p < .05).
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script microarrays, combinatorial short hairpin RNA
(shRNA) experiments, and other differentiation assays
(trophectoderm differentiation). Among the novel find-
ing from this screen were the following:
1. Swi/Snf complex members repress Nanog and
Oct4 expression during ES cell differentiation.
2. Elac2, a novel prostate cancer susceptibility gene,
represses Nanog expression through negative regu-
lation of Rifl, a novel telomere-binding protein
involved in self-renewal.
3. Other Nanog repressors including Hira, Ikbkb, Erkl
,
Tcf3, and Socs3, counteract LIF-Stat3 function dur-
ing differentiation, either directly or indirectly.
4. Mystl/Mof, Myst2/Hbol , Oct4, and Stat3 con-
verge to regulate genes required for pluripotency
and self-renewal.
5. Oct4 involvement in self-renewal is reversibly
dependent on the presence of serum in ESC culture
medium.
Rif 1
FIGURE 3 Model for how various RNAi suppressors function
with respect to self-renewal gene expression during RA-induced
differentiation. Lines and arrows indicate phenotypic outcomes.
While we are gearing up for genome-wide screens,
we are pursuing some of the underlying biology pro-
duced by this initial screen, including Swi/Snf-depen-
dent chromatin remodeling of self-renewal gene pro-
moters and the identity of specificity factors required
for Mystl and Myst2 function. Additionally, we are
exploring in vivo phenotypes using Dox-inducible
shRNA expression cassettes.
Future Work
PATHWAY ADDICTION IN STEM CELLS
The idea of "oncogene addiction," first put forward
by Bernard Weinstein, applies to scenarios where an
oncogene drives a cell toward malignancy through
bypassing molecular constraints imposed on cells
during development for growth, cell division, and/or
survival. Thereby, malignant cells become "addicted"
to an oncogene's activity such that they become more
vulnerable to its loss than normal cells. During devel-
opment, similar scenarios arguably arise in stem
cells. Instead of a rogue gene activity, however, we
find natural "addiction" developing to signaling
pathways that promote stem cell proliferation, sur-
vival, and "potency." Similar to oncogene addiction,
when these pathway activities are withdrawn, cells
either differentiate or die.
Some examples include LIF-Stat3 and BMP-
Smad signaling in mouse ESCs (Chambers, Cell 113:
643 [2003]; Ying et al., Cell 115: 281 [2003]); EGF
and FGF dependency for neural stem/progenitor cells
(Conti et al., PLoS Biol. 3: e283 [2005]); FGF4-ERK
signaling in trophoblast stem cells (Yang et al. 2006);
c-Kit and gp130 signaling in hematopoietic stem
cells (Sui et al., Proc. Natl. Acad. Sci. 92: 2859
[1995]); and the FBS-dependent self-renewal of mes-
enchymal stem cells (Shandadfar et al., Stem Cells
23: 1357 [2005]). In each case, these dependencies
are required for the in vitro derivation and expansion
of these cells. One goal of my research is to build
molecular genetic frameworks to determine how dif-
ferent pathway dependencies arise in stem cell sys-
tems.
Initially, I will focus on RNAi-based screens in
mouse ESCs and neural stem cells (NSCs) to identi-
fy genes required for (1) differentiation and lineage
specification upon withdrawal of a self-renewal fac-
tor or introduction of a differentiation inducer and
(2) self-renewal and potency under normal growth
conditions.
CANCER STEM CELLS
Stem cell tumor models posit that tumors are hierar-
chically organized, such that only a subset of cells,
i.e., the "stem" or initiating cells, are capable of ini-
tiating tumor development. To date, there is evidence
for the existence of subpopulations of tumor initiat-
ing cells in several cancers, including: colon
(O'Brien et al. 2007; Ricci-Vitiani et al. 2007),
prostate (Patrwala et al. 2006), breast (Al-Hajj et al.,
Proc. Natl. Acad. Sci. 100: 3983 [2003]), brain
(glioblastoma and medulloblastoma) (Singh et al.,
Cancer Res. 63: 5821 [2003]; Hemmati et al., Proc.
Natl. Acad. Sci. 100: 15178 [2003]), and certain
leukemias (Lapidot et al., Nature 367: 645 [1994]).
To be considered a stem cell per se, however, cells
must display the ability to self-renew and the poten-
tial for full or partial differentiation. To my knowl-
edge, this criterion has been met for glioblastoma,
medulloblastoma, and leukemias.
For experimentation with cancer stem cells
(CSCs), I will take advantage of a mouse model for
glioblastoma using genetically defined, tumorigenic
mouse NSCs. Ron DePinho's group published that
Ink4a/Arf4- NSCs expressing the activated EGFR
gene (EGFR*) induce tumors resembling high-grade
gliomas (Bachoo et al., Cancer Cell. 1: 269 [2002]).
In human glioblastomas, Ink4a/Arf loss of function
and activation of EGFR are "signature" lesions
(Vogelstein and Kinzler, Nat. Med. 10: 789 [2004];
Wiltshire et al., Neuro-oncol. 2: 164 [2000]). Thus,
these cells may well recapitulate many of the impor-
tant features of glioma cells.
Through performing parallel screens in tumorigenic
and wild-type NSCs I hope to identify self-renewal and
differentiation genes that are required by both wild-type
and tumorigenic NSCs and specifically required by one
or the other but not both. Among these sets of genes, we
should find genetic lesions that induce wild-type NSCs
to become tumorigenic in mice and genetic lesions that
are specifically lethal to tumorigenic NSCs.
SELF-RENEWAL, CELL DIVISION, AND
GROWTH IN ESCS, NSCS, AND CSCS
Mouse ESCs have unusual proliferative properties,
which may be related to their ability to maintain the
undifferentiated state. They devote more than half of
their cell cycle to S phase and have short G1 and G2
phases (Savatier et al., Oncogene 9: 809 [1994]; Stead
et al., Oncogene 21: 8320 [2002]), resulting in short
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doubling times (-12 hours) compared to somatic cells.
They also constitutively express many cell cycle fac-
tors, including cyclin A2, cyclin Bl, cyclin El, Cdc6,
and geminin (Fujii-Yamamoto et al., J Biol. Chem.
280: 12976 [2005]), and Cdk activities, which normal-
ly oscillate, remain robust throughout the cell cycle
with the exception of cyclin B/Cdc2 (Savatier et al.,
Oncogene 12: 309 [1996]; Stead et al., Oncogene 21:
8320 [2002]). Moreover, unlike somatic cells, cyclin
D1 is expressed independently of mitogenic signals
(Burdon et al., Trends Cell. Biol. 12: 432 [2002]), and
cyclin E/Cdk2 activity appears to be leukemia
inhibitory factor (LIF)-dependent (Savatier et al.,
Oncogene 12: 309 [1996]). How factors responsible
for pluripotency also promote ESC proliferation
remains an open question.
Similarly, with NSCs, there are few links known
between potency and cell cycle regulation. NSC differ-
entiation is associated with the lengthening of G1
phase (Lukaszewicz et al., .1 Neurosci. 22: 6610
[2002]) and knocking out retinoblatoma (Rb) family
genes, which inhibit G1 /S progression, in NSCs results
in an enhanced capacity for self-renewal (p107-/--)
(Vanderluit et al., J. Cell Biol. 166: 853 [2004]) or sig-
nificant delay in terminal differentiation (Rb -'- )
(Callaghan et al., Dev. Biol. 15: 257 [1999]). NSCs
require EGF and basic FGF for proliferation, survival,
and potency and have a doubling time of 24-30 hours,
similar to other somatic cell types (Lukaszewicz et al.,
J. Neurosci. 22: 6610 [2002]).
Our initial RNAi studies in mouse ESCs have
revealed potential linkages between genes required
for cell division, growth, and genome integrity and
those promoting the expression of pluripotency
genes (e.g., Stat3). Moreover, we found that nonmi-
togen signaling pathways, e.g., 13-catenin and
Smad4, activate genes rate-limiting for cell cycle
progression, including ribonucleotide reductase and
components of the anaphase-promoting complex.
We also observed that Stat3 uniquely maintains
expression of cyclin El, whereas Oct4 is uniquely
required for cyclin D1 expression, providing possi-
ble explanations for LIF-dependent cyclin E/Cdk2
activity and mitogen-independent cyclin D1 expres-
sion in ESCs.
By the nature of our in vitro screens in stem cells
(especially where outgrowth is the primary pheno-
type), we may uncover some of the fundamental links
between stem cell cycle dynamics and the regulation
of developmental programs.
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RNA! SCREENS IN HUMAN ESCS
One clinical goal of the stem cell research community
is the creation ofdesirable cell types that could one day
be used in cell replacement therapies. The manipula-
tion of human ESCs (hESCs) may represent the best
approach to realize this goal. However, despite the
"hype" surrounding them, hESCs are difficult to cul-
ture and cannot be grown at clonal cell densities.
Moreover, there are therapeutic concerns with the
coculturing hESCs with feeder cells. Thereby, instead
of initially attempting "biological" screens in hESCs, I
have decided first to perform a screen for preventing
their feeder-free, clonal expansion in vitro. This work is
being carried out in collaboration with Jamie
Thomson's lab at University of Wisconsin (Madison).
The hope is that once the pathways are identified that
are rate-limiting for hESC expansion in culture, their
activities can be manipulated by modifying culture
conditions, generating knockout lines, or stably
expressing shRNAs. Once we have the growth parame-
ters down for hESCs, we will move on to more sophis-
ticated biology screens. Part of the goal of my collabo-
ration with Jamie's lab is for members of my lab to gain
training and experience for future work in this system.
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DEAN'S REPORT
Yet another year has flown by here at the Watson School-it is hard to believe that we are now in
our eighth year! "Team Watson" (Alyson Kass-Eisler, Dawn Meehan, Eva Radeck, and Bill Tansey)
continue to ensure that we deliver world-class programs and that we are all taken care of-you are
the best!
The Third Watson School Graduation
April 30 saw the Watson School's third graduation ceremony. The graduating class of 2006 comprised
Santanu Chakraborty, Rebecca Ewald, Charles Kopec, and Marco Mangone, who were awarded the
Ph.D. degree, and Molly Perkins and Izabela Sujka, who were awarded Masters degrees. Both Molly
and Izabela left the program early-Molly relocated to Oxford, England, and Izabela accepted a posi-
tion at OSI Pharmaceuticals as a research assistant in Cancer biology. Both had successfully complet-
ed the first year curriculum and as such received Masters degrees. The graduation was once again a
wonderful occasion where honorary degrees were bestowed on Drs. Susan Hockfield, Tom Maniatis,
and Matt Ridley. Dr. Ridley gave the Commencement address. We were further honored that the par-
ents and family of Rebecca Ewald and Marco Mangone traveled from Germany and Italy, respectively,
to attend the graduation ceremony.
(Left to right) James D. Watson, Lillian Clark, Winship Herr, Charles Kopec, Rebecca Ewald, Marco Mangone, Molly Perkins,
Bruce Stillman
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Student
Santanu Chakraborty
Rebecca Ewald
Charles Kopec
Marco Mangone
Thesis advisor
Carlos D. Brody
Hollis Cline
Roberto Malinow
Winship Herr
Current Postdoctoral Position
With Dr. Michael Wig ler, CSHL
With Dr. Hollis Cline, CSHL
With Dr. Carlos Brody, Princeton University
With Dr. Fabio Piano, New York University
Our First Teaching Award
At this year's graduation ceremony, it was my honor
to present the first annual Winship Herr Faculty
Teaching Award to Dr. David Spector, lead instructor of the Specialized
Disciplines course on Cellular
Structure and Function. This award, named in honor
of our founding dean, recognizes the excellence
and creativity in teaching Watson School courses.
The students chose the recipient of this award and
the following is some of what was said about the recipient:
Though being a Principal Investigator is demanding of time
and energy, the lead instructor of the
Cellular Structure and Function Course showed a level of
dedication, preparation, and enthusi-
asm for the subject and course itself that was most infectious. This level of enthusiasm was also
seen in the guest instructors, due to their respect for
David Spector. The discussions fostered by
this course often continued outside the classroom, usually
around the kitchen table at the Knight
house. The quality of our final presentations was a testament to the outstanding leadership and
instruction of David "Speckles" Spector
(Left to right) Winship Herr, Lilian Clark, David Spector
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THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2000
Rebecca C. Ewald, April 7, 2006
NMDA receptor subtypes and dendritic arbor morphology.
Thesis Examining Committee
Chair:
Research Mentor:
Academic Mentor:
Committee Member:
Committee Member:
External Examiner:
Anthony Zador
Hollis Cline
Bruce Stillman
Linda Van Aelst
Roberto Malinow
Kimberly McAllister,
University of California, Davis
Marco Mangone, March 30, 2006
Analysis of the HCF-1 basic region and its role in sustaining
cell proliferation.
Thesis Examining Committee
Chair: Michael P. Myers
Research Mentor: Winship Herr
Academic Mentor: Linda Van Aelst
Committee Member: David L. Spector
Committee Member: Lincoln Stein
External Examiner: Angus Wilson, New York University
ENTERING CLASS OF 2001
Charles Kopec, April 3, 2006
AMPA receptor trafficking and their effect on spine enlarge-
ment during long-term potentiation.
Thesis Examining Committee
Chair:
Research Mentor:
Academic Mentor:
Committee Member:
Committee Member:
External Examiner:
Linda Van Aelst
Roberto Malinow
Anthony Zador
Hollis Cline
David L. Spector
John Lisman, Brandeis University
Catherine Y. Cormier, November 13, 2006
Alternative apoptotic pathways in cancer cells.
Thesis Examining Committee
Chair: Adrian Krainer
Research Mentor: Yuri Lazebnik
Academic Mentor: David Stewart
Committee Member: Gregory Hannon
Committee Member: William Tansey
External Examiner: Marcus E. Peter,
University of Chicago
Alumni Spotlight
Ji-Joon Song, Ph.D., received a B.S. from Seoul National University and an M.Sc. from Kwangju
Institute of Science and Technology. Dr. Song is conducting postdoctoral research with Dr. Robert E.
Kingston on chromatin modification at Massachusetts General Hospital, Harvard University, in Boston,
Massachusetts. Dr. Song is the recipient of the Jane Coffin Childs Postdoctoral Fellowship.
I remember when I came to Cold Spring Harbor Laboratory for my interview. I immedi-
ately felt the unique and amazing scientific atmosphere, which I did not appreciate
before, beyond its reputation. I was impressed by how much I would be cared about as
an individual by being a student at the Watson School, as opposed to a larger institute.
I became an explorer of science at the Watson School, with endless support and
encouragement from the faculty and colleagues. I also had the opportunity to participate
in many of the CSHL meetings and courses and to interact with many scientists from all
over the world simply by walking along Bungtown Road. My enthusiasm for science
lingers on, as do my memories of the Watson School at Cold Spring Harbor Laboratory.
Ji-Joon Song
Alumni Highlights
We are very proud of the continuing success of our alumni. Three of our graduates were recognized at
the international level in 2006. Ira Hall, from the graduating class of 2004, received a Burroughs
Wellcome Fund Career Award in the Biomedical Sciences. Elena Ezhkova, from the graduating class of
2005, is the recipient of a Life Sciences Research Foundation Postdoctoral Fellowship and is their New
York Stem Cell Foundation Fellow. Masafumi Muratani, also from the graduating class of 2005, was
awarded the Human Frontier of Science Program Long-term Fellowship.
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The Fall Term Curriculum
Our faculty continues to do an outstanding job developing and delivering the
curriculum. As ever, the cur-
riculum development and integration committee
(CDIC), headed by William Tansey, continues to careful-
ly monitor and develop the curriculum. The CDIC
comprises William Tansey (chair), Lilian Clark, Z. Josh
Huang, David Spector, and Nicholas Tonks. For Fall
2006, the Scientific Reasoning and Logic (SRL) core
course has undergone a major re-vamp. Gregory Hannon has taken over
again as lead instructor and
has recruited several other senior faculty as instructors.
The instructors for Fall 2006 are Gregory Hannon,
Leemor Joshua-Tor, David Jackson, Scott Lowe, Robert
Martienssen, and Anthony Zador.
For 2006, the contents of Scientific Exposition and
Ethics (SEE) core course remained essentially the
same, but instructors William Tansey and Yuri Lazebnik stepped down.
They were replaced by Lilian
Clark and Alea Mills with Jan Witkowski as lead instructor.
This course continues to attract outstanding
guest instructors who this year included the following.
Bruce Budowle
Robert Charrow
Mariette Di Christina
Angela Eggleston
Kay Fields
Kathy Hudson
Senior Scientist, FBI
Greenberg Traurig, LLP
Executive Editor, Scientific American
Senior Editor, Nature
Office of Research Integrity, HHS
Director, Genetics and Public Policy Center
Two of the three Specialized Disciplines courses, Genetics
and Cellular Structure and Function, have
largely remained the same. The third course, Systems Neuroscience, has been completely revamped.
Zachary Mainen has taken over from Carlos Brody as lead instructor, but Carlos has stayed on as his
coinstructor.
Recruiting Efforts
Recruitment of the graduate program's entering class of 2007 and of participants for our summer 2007
Undergraduate Research Program (URP) was once again managed by Ms. Dawn Meehan, the School's
admissions, recruitment, and student affairs manager. Throughout 2006, Dawn traveled the length and
breadth of the Country to recruit students to our graduate and undergraduate programs. She has done
an outstanding job at representing Cold Spring Harbor Laboratory and the Watson School and I am
deeply indebted to her efforts. The Recruitment table on page 200 details the different recruitment fairs
and conferences the School has participated in, together with the names of faculty, students, and
administrators who represented the School on these occasions.
Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers to its students. One of the
very special aspects in this regard is its academic mentoring program, led by William Tansey. In this pro-
gram, entering students select by mutual agreement a member of the research or nonresearch faculty
to serve as an academic mentor-a watchful guardian to look over and encourage the student through
the sometimes-trying process of a doctoral education. This program continues to receive much sup-
port from the faculty who volunteer to be academic mentors, and it has rightfully become a vital ingre-
dient in the Watson School's success. This year's new academic mentors for the entering class of 2006
are John Inglis (Claire Biot and Yaniv Erlich), Nicholas Tonks (Eyal Gruntman), Jan A. Witkowski
(Adrienne Jones), David Stewart (Colin Malone), William Tansey (Amy Rappaport), and Gregory Hannon
(Claudio Scuoppo).
Entering Class of 2006
On August 28, 2006, the Watson School opened its doors for the eighth time to welcome yet another
new class. Seven students-Claire Biot, Yaniv Erlich, Eyal Gruntman, Adrienne Jones, Colin Malone,
Amy Rappaport, and Claudio Scuoppo-comprise the Entering Class of 2006. Yaniv Erlich was a par-
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ticipant in our summer Undergraduate Research Program in 2005, and Claire Biot came to us after hav-
ing spent two months in Gregory Hannon's lab in the late summer of 2005.
The School is also deeply indebted to its graduate program's Admissions Committee, who review,
interview, and select candidates for our doctoral program. The Admissions Committee for the 2006
entering class comprised Gregory Hannon (chair), Josh Dubnau, Leemor Joshua-Tor, Adrian R. Krainer,
Robert Lucito, David L. Spector, Nicholas Tonks, Linda Van Aelst, Anthony Zador, and William Tansey
(ex officio). They are a truly remarkable team!
Claire Biot, Ecole Polytechnique, France
George A. and Marjorie H. Anderson Fellow
Yaniv Erlich, Tel Aviv University
Goldberg-Lindsay Fellow
Eyal Gruntman, Tel Aviv University
Elizabeth Sloan Livingston Fellow
ENTERING CLASS OF 2006
Adrienne Jones, University of Toronto
George A. and Marjorie H. Anderson Fellow
Colin Malone, Washington University, St. Louis
Beckman Graduate Student
Amy Rappaport, Cornell University
Barbara McClintock Fellow
Claudio Scuoppo, University of Turin
Engelhorn Scholar
(Standing, left to right) Claudio Scuoppo, Amy Rappaport, Colin Malone, Adrienne Jones. (Sitting, left to right) Claire Biot,
Yaniv Erlich, Eyal Gruntman
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Event
2006 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT
SCHEDULE
WSBS Attendees/Titles
Location
Ronald E. McNair Scholars Conference
Roger Williams University 10th Annual
Career and Graduate School Fair
Stony Brook University Summer Undergraduate
Research Program Information Session
Ronald E. McNair Scholars Conference
Princeton University Summer Undergraduate
Research Program Career Symposium
The Johns Hopkins University Information Session
University of Maryland, Baltimore County,
Meyerhoff Scholarship Program Visit
Massachusetts Institute of Technology Career Fair
Big 10+ Graduate School Expo
Cornell University Information Session and
Graduate and Professional School Day
Washington University, St. Louis
Information Session
Georgetown University Information Session
Massachusetts Institute of Technology
Information Session
University of California, Berkeley, Graduate
School Fair and Information Session
Brandeis University Graduate School Fair
Tufts University Career and Graduate School Fair
Stony Brook University "A Gathering of Science
Scholars: Access for Underrepresented
Students in the Biological, Engineering, and
Applied Sciences" Graduate School Fair
Carnegie Mellon University Information Session
California Institute of Technology Career Fair
Duke University Graduate and Professional
School Day
Dartmouth College Information Session
Five College Graduate and Professional Schools
Information Day (University of Massachusetts,
Amherst, Amherst College; Mt. Holyoke
College; Smith College; Hampshire College)
University of North Carolina, Chapel Hill,
Information Session
Society for Advancement of Chicanos and
Native Americans in Science (SACNAS)
University of California, Irvine, Graduate and
Professional School Day
Notre Dame University Information Session
University of Pennsylvania Information Session
Colgate University Information Session
Annual Biomedical Research Conference for
Minority Students (ABRCMS)
Princeton University Graduate and Professional
School Fair and Information Session
Pomona, Scripps, Harvey Mudd, Pitzer, and
Claremont-McKenna Colleges Information
Session
Emory University Information Session
Wesleyan University Information Session
Yale University Information Session
Northwestern University Information Session
Rice University Information Session
Harvard University Information Session
Swarthmore College Undergraduate
Research Opportunities Presentation
Haverford College Undergraduate Research
Opportunities Presentation
Vassar College Genetics and Bioinformatics
Course Visit and Information Session
University of Maryland, College Park
Roger Williams University
Cold Spring Harbor Laboratory
State University of New York, Buffalo
Princeton University
The Johns Hopkins University
University of Maryland, Baltimore County
Massachusetts Institute of Technology
Purdue University
Cornell University
Washington University, St. Louis
Georgetown University
Massachusetts Institute of Technology
University of California, Berkeley
Brandeis University
Tufts University
Stony Brook University
Carnegie Mellon University
California Institute of Technology
Duke University
Dartmouth College
University of Massachusetts, Amherst
University of North, Carolina, Chapel Hill
Tampa, Florida
University of California, Irvine
Notre Dame University
University of Pennsylvania
Colgate University
Anaheim, California
Princeton University
Pomona College
Emory University
Wesleyan University
Yale University
Northwestern University
Rice University
Harvard University
Swarthmore College
Haverford College
Cold Spring Harbor Laboratory
Date
March 16-18
April 5
July 10
July 13-16
July 20
September 19
September 20
September 21
September 25
September 26-27
October 2
October 3
October 6
October 11-12
October 11
October 11
October 13
October 13
October 18
October 19
October 23
October 25
October 26
October 26-28
October 30
October 31
November 1
November 6
November 8-11
November 9-10
November 13
November 13
November 13
November 14
November 15
November 17
November 29
December 5
December 5
December 11
Dawn Meehan, Admissions, Recruitment,
and Student Affairs Manager
Dawn Meehan
Dr. Lilian Clark, Dean, Dawn Meehan, Dr. William
Tansey, Director of Graduate Studies
Dawn Meehan, Dr. William Tansey
Katherine McJunkin, Graduate Student
Dawn Meehan, Dr. William Tansey
Dawn Meehan, Dr. William Tansey
Dr. Lilian Clark, Dawn Meehan
Galen Collins, Graduate Student
Dawn Meehan, Dr. William Tansey
Dr. Lilian Clark
Jeremy Wilusz, Graduate Student
Beth Chen, Graduate Student
Dawn Meehan, Dr. William Tansey
Fred Rollins, Graduate Student
Fred Rollins
Dr. Alyson Kass-Eisler, Curriculum
Administrator and Postdoctoral
Program Officer
Shraddha Pai, Graduate Student
Dr. Leemor Joshua-Tor, Professor
Dr. David Jackson, Professor, Dawn Meehan
Angelique Girard, Graduate Student
Dawn Meehan
Dr. Vivek Mittal, Assistant Professor
Dawn Meehan
Vicky Zhou, 2006 URP
Oliver Tam, Graduate Student
Amy Leung, Graduate Student
Dr. Alea Mills, Associate Professor
Oliver Fregoso, (Graduate Student), Keisha
John (Graduate Student), Dawn Meehan,
Dr. William Tansey
Galen Collins, Dr. Adrian Krainer, Professor
Dr. Alea Mills
Jeremy Wilusz
Patrick Finigan, Graduate Student
Dr. David Jackson
Dr. Patrick Paddison, CSHL Fellow and
Watson School Alumnus
Dr. Jan Witkowski, Executive Director,
Banbury Center
Dr. James D. Watson, Chancellor, Dawn
Meehan
Information sent for presentation
Information sent for presentation
Dr. Rob Lucito, Assistant Professor, Dawn
Meehan, Dr. Vivek Mittal, Dr. William Tansey
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Student
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 2000
Rebecca C. Ewald
Engelhom Scholar
Thesis Defense: April 2006
Marco Mangone
Charles A. Dana Foundation Fe//ow
Thesis Defense: March 2006
ENTERING CLASS OF 2001
Catherine Y. Cormier
Beckman Graduate Student
NSF Graduate Research Fellow
Thesis Defense: November 2006
Claudia E. Feierstein
George A. and Marjorie H. Anderson Fellow
Tomas Hromadka
Engelhom Scholar
Charles D. Kopec
Goldberg-Lindsay Fellow
NRSA Graduate Research Fellow
Thesis Defense: April 2006
Dougal G.R. (Gowan) Tervo
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute
Predoctoral Fellow
ENTERING CLASS OF 2002
Allison L. Blum
Barbara McClintock Fellow
Darren Burgess
Engelhom Scholar
Beth L. Chen
Beckman Graduate Student
Shu-Ling Chiu
Elisabeth Sloan Livingston Fellow
Jonathan Kui
Alfred Hershey Fellow
Elizabeth Murchison
Engelhom Scholar
ENTERING CLASS OF 2003
Hiroki Asari
Farish-Gerry Fellow
Rebecca Bish
David H. Koch Fellow
Francois Bolduc
William R. Miller Fellow
Monica Dus
Engelhorn Scholar
Angelique Girard
Florence Gould Fellow
Christopher Harvey
David and Fanny Luke Fellow
Wei Wei
George A. and Marjorie H. Anderson Fellow
Bruce Stillman
Linda Van Aelst
David J. Stewart
Linda Van Aelst
William Tansey
Anthony Zador
Carlos D. Brody
Hollis Cline
Nicholas Tonks
Hollis Cline
Winship Herr
Yuri Lazebnik
Zachary Mainen
Anthony Zador
Roberto Malinow
Karel Svoboda
Josh Dubnau
Scott Lowe
Senthil K. Muthuswamy Dmitri Chklovskii
Alea A. Mills
David Jackson
John Inglis
Z. Josh Huang
Linda Van Aelst
Hollis Cline
John Inglis
Jan Witkowski
Adrian Krainer
Jan Witkowski
NMDA receptor subtypes and dendritic arbor
morphology
Analysis of the HCF-1 basic region and its role
in sustaining cell proliferation
Alternative apoptotic pathways in cancer cells
Odor coding and neural correlates of behavioral
choice in the olfactory cortex
Stimulus optimization in the auditory cortex
AMPA receptor trafficking and their effect on
spine enlargement during long-term potentiation
An inducible and reversible lesion of the
corticothalmic projection
Genetic, behavioral, and anatomical
characterization of Radish-dependent memory
Mammalian RNAi genetic screens: Discovery
and characterization of genes mediating the
response to cancer therapy
Neuronal network of C. elegans: From anatomy
to behavior
Hollis Cline The role of insulin receptors in the development
of neuronal structure and function
Tim Tully Identification and characterization of candidate
memory genes in Arleekin, a Drosophila
memory mutant
Gregory Hannon The role of Dicer in mammalian development
Anthony Zador
Michael Myers
Tim Tully
Gregory Hannon
Gregory Hannon
Karel Svoboda
Roberto Malinow
Sparse overcomplete representation as a
principle for computation in the brain
A proteomics approach to the study of ubiquttylation
Role of dFMR1 and the RNAi pathway in
Drosophila learning and memory
Characterization of the biological roles of the
PIWI subfamily
The role of the Piwi family and Piwi-associated
small RNAs in mammalian spermatogenesis
Visualization of MAPK activity in neurons
Activity-dependent modulation of APP processing
and AR production in rat hippocampal neurons
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Student
DOCTORAL THESIS RESEARCH (continued)
Academic Research
Mentor Mentor
ENTERING CLASS OF 2004
Daniel Chitwood
George A. and Marjorie H. Anderson Fellow
Galen Collins
Beckman Graduate Student
Oliver Fregoso
Seraph Foundation Fellow
William Randolph Hearst Scholar
Keisha John
William Randolph Hearst Fellow
Shraddha Pai
Charles A. Dana Fellow
David Simpson
Beckman Graduate Student
ENTERING CLASS OF 2005
Patrick Finigan
Beckman Graduate Student
Amy Leung
Beckman Graduate Student
Sarahjane M. Locke
George A. and Marjorie H. Anderson Fellow
Hiroshi Makino
Elisabeth Sloan Livingston Fellow
Katie McJunkin
Robert and Teresa Lindsay Fellow
Leeds Family Scholar
Frederick D. Rollins
Cashin Fellow
Oliver Tam
Bristol-Myers Squibb Fellow
Jeremy Wilusz
Beckman Graduate Student
Alea A. Mills
Marja Timmermans
Adrian R. Krainer
Josh Dubnau
Anthony Zador
Scott Lowe
Marja Timmermans
William Tansey
Michael P. Myers
Linda Van Aelst
Carlos D. Brody
William Tansey
Senthil K. Muthuswamy Bruce Stillman
David L. Spector
Josh Dubnau
Hollis Cline
Tern Grodzicker
Jan Witkowski
David Jackson
John Inglis
William Tansey
Thesis Research
The contribution of small RNAs to positional
signaling and the establishment of
adaxial-abaxial polarity in leaves
Role of ubiquitin ligases and activator destruction
in transcription
Identifying the mechanism of adeno-associated
virus (MV) integration and gene targeting and
development of a novel molecular biology tool
based on MV
Identification of the molecular determinants
contributing to DOCK7's role in neuronal polarity
Determining the neuroanatomical loci and electrical
correlates of duration discrimination in the rat
Revealing insights into cancer biology with
tumor-derived mutations in c-Myc
ORC1 degradation in the cell cycle
Role of H2B-ubiquitylation in chromatin localization
Robert Martienssen Histone H3 lysine 9 methylation and RNA
processing in RNAi-mediated heterochromatin
formation in Schizosaccharomyces pombe
Roberto Malinow Optical determination of the spatial distribution
of experience-dependent bidirectional
synaptic plasticity
Scott Lowe Using negative-selection RNAi screens to identify
novel treatment strategies for hepatocellular
carcinoma
Gregory Hannon An RNAi screen for modifiers of cellular response
to the targeted therapeutic erlotinib
Gregory Hannon The role of RNAi machinery in oocyte maturation
and embryonic development of the mouse
David L. Spector Identification and functional characterization of
large nuclear retained noncoding RNAs
misregulated in breast cancer
Graduate Student Seminar Series
One of the most important but often overlooked elements of the graduate student experience at Cold
Spring Harbor Laboratory is the weekly Graduate Student Seminar Series. The Laboratory is special in that
it has a diverse multiinstitutional graduate student community, especially mixing Stony Brook University
and Watson School students. The graduate student seminars, which are held each September to May,
enable all graduate students studying at the Laboratory to hear seminars from their colleagues.
Students present their research once a year, with two students presenting each week moderated by
a graduate student chair. In attendance are the graduate students and two members of a core set of
six faculty mentors whose attendance rotates each week. The seminar series, which is open to the
entire Laboratory community, serves three important roles: (1) It provides students with an opportunity
to hone their oral presentation skills; (2) it gives students a chance to defend their research without the
assistance of their research mentors, such that they experience standing on their own two feet as they
will have to throughout their careers; and (3) students in the audience have an opportunity to ask ques-
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tions within their own peer group, thus learning the important roles of audience participation for the
advancement of research. At the end of the evening, two faculty mentors provide each presenting stu-
dent a critique of the seminar. In addition, members of the audience complete (anonymously) seminar
evaluation forms, which are given to the presenting students. Josh Dubnau, Terri Grodzicker, David
Jackson, Patrick Paddison, Arne Stenlund, and myself served as faculty mentors and brought a breadth
of knowledge and experience to the seminar series.
Interinstitutional Academic Interactions
It is important to always bear in mind that many of the graduate students studying at Cold Spring
Harbor Laboratory are not Watson School students. Indeed, the largest percentage of students are
from Stony Brook University, via the programs we have shared with them for some 30 years. The
Watson School provides an on-site "home" for all of these students to ensure that they feel part of the
Laboratory community and to help them as much as possible with the complexitiesof performing doc-
toral research away from the parent institution. This year, the students listed below joined us.
Student
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
CSHL Research Mentor Affiliation
Canan Aksoy
Yen-Yu Tina Chen
Wonchang Choi
Michael Cressy
Yu Fu
Miao He
Mary Kusenda
Wanhe Li
Elena Lum
Nick Navin
Ruei-Ying Tzeng
Yang Yang
Jianping Zhang
Rui Zhao
Leemor Joshua-Tor
Tim Tully
Jonathan Sebat
Josh Dubnau
Josh Huang
Josh Huang
Jonathan Sebat
Josh Dubnau
Robert Lucito
Michael Wig ler
Hollis Cline
Anthony Zador
Scott Powers
David L. Spector
Stony Brook, Molecular and Cellular Biology
Stony Brook, Neuroscience
Stony Brook, Applied Mathematics and Statistics
Stony Brook, Genetics
Stony Brook, Neuroscience
Stony Brook, Genetics
Stony Brook, Genetics
Stony Brook, Molecular and Cellular Biology
Stony Brook, Molecular and Cellular Biology
Stony Brook, Molecular Genetics and Microbiology
Stony Brook, Genetics
Stony Brook, Neuroscience
Stony Brook, Biomedical Engineering
Stony Brook, Molecular and Cellular Biology
Faculty Changes
Three new research faculty members joined the Watson School this year. Raffaella Sordella joined us as
an assistant professor. Raffaella came to the Watson School from
Harvard Medical School and the
Massachusetts General Hospital where she was an instructor in Medicine and assistant in Genetics,
respectively. Raffaella's research will focus on the phenomenon of "oncogene addiction" the process by
which cancer cells become dependent on specific oncogenes. Hiro Furukawa also
joined the School
this year as an assistant professor. Hiro was a postdoctoral fellow at
the Vollum Institute in Oregon
before joining the Laboratory. Hiro's research will use a number of techniques including structural biol-
ogy, biochemistry, and electrophysiology to focus on the signal transduction process of regulated
intramembrane proteolysis. Our third new assistant professor is Glenn Turner. Glenn came to the
Laboratory after completing his postdoctoral studies at the California
Institute of Technology. Glenn will
be focusing on neural coding using smell and taste in the fruit fly,
Drosophila, as model systems. We
are very excited to have them here and look forward to
their participation in Watson School activities.
This year, we also saw the departure of four faculty members: Eli
Hatchwell, who served as a thesis
committee chair and a guest lecturer in a Specialized Disciplines course on
The Genome, moved his
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laboratory to the Pathology Department at Stony Brook University; Andrew
Neuwald, who was a guest
lecturer in Specialized Disciplines courses Fundamentals of Bioinformatics
and The Genome and
served as a member of the admissions committee, moved his laboratory to
The Institute for Genome
Research; Rui-Ming Xu, who served as a thesis committee member and chair and also lectured in the
core Scientific Reasoning and Logic course, moved his laboratory to the Department of Pathology at
New York University; Carlos Brody, who has been an integral part of the Watson School, moved his
laboratory to Princeton University this year. Carlos served on the School's Admissions Committee, was
an instructor in the Scientific Reasoning and Logic core course, the Systems Neuroscience special-
ized disciplines course, and led a Specialized Disciplines course, on Neuroscience: Systems and
Behavior. Carlos served as a laboratory rotation advisor, an academic mentor, and a thesis commit-
tee member and chair. Carlos will continue to be a part of the Watson School family as an adjunct fac-
ulty member.
We are deeply indebted to all for their efforts and wish them well in their new "homes."
Graduate Students and Postdoctoral Fellow Departures
With each year comes not only new arrivals, but also departures. The following graduate students and
postdoctoral fellows departed from the Laboratory during 2006:
Graduate Students
Santanu Chakraborty Cem Kuscu Marco Mangone Aleksander Sobczyk
Rebecca Ewald Michael Kwofie Anagha Matapurkar Kathryn Tworkowski
Teresa Haire (deceased) Pei-Chun Lin Jasmin Roohi Seugtai (Chris) Yoon
Jill Hemish Shi-Chie (Jack) Lin Dustin Schones Min Yu
Helen Hsieh Chris Maher Khalid Siddiqui Chih-Chi Yuan
Postdoctoral Fellows
Eric Allemand Michael Hemann Tianyi Mao Christian Speck
Amy Altick Hao-Chi Hsu Masashi Narita Naoshige Uchida
Jannik Andersen Ying Huang Leopoldo Petreanu Mitsuko Uchida
Michelle Carmell Kanae lijima Tara Phelps-Durr Santosh Vadivelu
Stephanie Chow Koichi lijima Amit Puniyani Robby Weimer
Laurence Denis Vijay lyer Yijun Qi Hans Guido Wendel
Michael Deweese Kendall Jensen Michael Quirk Bin Xiang
Graziella di Cristo Sitharthan Kamalakaran Michael Ronemus Zhong Yao
Ingrid Ehrlich Jidong Liu Simon Rumpel Haining Zhong
Jeffrey Erlich Christian Machens Takashi Sato Jack Zilfou
Michael Golding Alexis Maizel Volker Scheuss Karen Zito
Noah Gray
Executive Committee
A large measure of the Watson School's success can be traced to the sage advice, guidance, and gover-
nance of the School's Executive Committee. In 2006, Hollis Cline, a valuable member of the committee
since 2002, departed the committee as ex officio member, a position she held in her role as Director of
Research. As happens each year, there was also turnover among the student representatives. The Watson
School representative, Hiroki Asari was replaced by David Simpson. Despina Siolas continued as the Stony
Brook University representative. The School is indeed thankful for their frank, honest, and thoughtful advice.
External Advisory Committee
An outstanding External Advisory Committee (EAC) led by Dr. Keith Yamamoto, Professor and
Executive Vice Dean at the School of Medicine, University of California, San Francisco, guides the
Watson School. The members of the Committee are noted for their leadership in graduate education
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in the biological sciences and are recognized leaders in their fields of research. The EAC visited the
School on May 18-19, 2006. As usual, the team met with students, faculty, and administrators, and
the overall feeling was that our "grand experiment" was indeed working. This year, with the help of
EAC members, we will be exploring and putting into practice ways of directly targeting undergradu-
ates at the top Schools and Liberal Arts Colleges. In addition, we have been invited to participate in
the National Research Council Assessment of Research-Doctorate Programs, which is being con-
ducted by the National Academies of Science. This study, which is carried out every 10 years, has
three main purposes:
Help universities improve their doctoral programs through benchmarking.
Expand the talent pool through accessible information, easily available to potential doctoral
students, about doctoral programs.
Benefit the nation's research capacity by improving the quality of doctoral programs and
their students.
The EAC's continued commitment to the success of the Watson School has been a humbling experi-
ence-thank you so much guys!
Site Visits to the School
On May 3, the School was site-visited by Mr. Gerry Gallwas, a trustee of the Arnold and Mabel Beckman
Foundation (the Watson School Graduate Program is now in receipt of its second five-year grant of
$1.75 million from the Beckman Foundation). This was an unexpected visit, but as ever, the students
and faculty rose to the occasion by putting together a series of meetings and a mini-symposium, which
were extremely well received. Mr. Gallwas was also able to visit the other educational divisions of the
Laboratory, including the Dolan DNA Learning Center and the Banbury Conference Center.
The Watson School Graduate program has been in receipt of a training grant from the National
Institutes of Health (NIH) since 2002, which currently supports five American students. In May, the School
submitted a competitive renewal application for this grant. As part of the peer-review process, three
reviewers, Drs. Timothy Formosa, Roger Chalk ley, and Dennis McKearin, a scientific review administrator,
Dr. Carole Latker and the training grant program director, Dr. Marion Zatz, site-visited the School. The pur-
pose of this visit was to gather more information regarding the program. The site-visit team met with the
Laboratory's president, chief financial officer, faculty, and Watson School students. We have received a pri-
ority score in the outstanding range, and the review committee has recommended that we be funded at
the level we requested. Below is some of what the site visit team had to say about the Watson School.
Other strengths include an internationally renowned faculty with well-funded members participat-
ing in training and a very strong pool of graduate students. While this combination alone would
be expected to produce a graduate education experience of high caliber, the real strength of this
program has been the number of innovative features that have been incorporated into the design
of the Watson School curriculum. The faculty of the School has taken full advantage of the oppor-
tunity to design a graduate program from the ground up and as a result have created a very
strong system of graduate education. Innovative features include the use of the teaching profes-
sionals at the CSHL DNA Learning Center to provide instruction and experience in teaching to
the graduate students beginning in their first year of study and an excellent system of mentoring
that provides experience giving presentations with formal feedback at many points during train-
ing. Each student has both a formal research advisor and a dedicated academic mentor. This
gives each of the students at least two faculty mentors, which provides students the opportuni-
ty to get advice on a range of problems quickly and easily. Remarkably, students report that they
feel the advice they get from their advisors is more reliable and informed than the advice they get
from other students. Although true in most places, it is highly unusual for students to have this
perception and indicates how well this system is working at the Watson School.
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Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Cell, who died of cancer in 1991) brings to the Laboratory an eminent
researcher and educator to give the Gavin Borden Lecture, which is
dedicated to the graduate students
at the laboratory. Dr. Michael Levine, Professor of Genetics and
Development at the University of
California, Berkeley, was this year's Gavin Borden Fellow. His lecture
"Gene Networks for Fly
Gastrulation and Heart Formation in Sea Squirts" was thoroughly enjoyed as evidenced by the stand-
ing-room-only audience. In addition, Michael shared his experiences as a scientist at a roundtable dis-
cussion with the students the following day.
Student Awards
The students at the Watson School continue to impress us all with their accomplishments. Our students
continue to publish their research findings in prestigious international journals. Additionally, our students
have received international recognition by obtaining fellowships to pursue their research interests.
Rebecca Bish was awarded a fellowship from the American Foundation for Aging Research. David
Simpson was awarded a fellowship from the U.S. Army Medical Research and Material Command
Breast Cancer Research Program Predoctoral Fellowship. Elizabeth Murchison was awarded an
American Australian Association Education Fund Fellowship, which she will use for her postdoctoral
studies.
The WSBS Family Events
On a lighter note, I am pleased to announce that August saw two marriages in the School. Darren
Burgess of the entering class of 2002 married Fiona Holloway, and David Simpson of the entering class
of 2004 married Erin Dann. Our congratulations and best wishes to all of them.
Lilian Clark
Dean
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Alyson Kass-Eisler and Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting
Lectureship; The Fairchild Martindale Visiting Lectureship; The Lucy and Mark
Ptashne Visiting Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference Center
to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty. These
courses include morning or evening lectures as well as afternoon sessions during which students read
assigned papers. These intensive courses are modeled on the Cold Spring Harbor Laboratory Lecture
Courses held each summer at the Banbury Conference Center. In Spring 2006 there were two such
courses: Immunology and Microbial Pathogenesis.
Immunology
Attended by the entering classes of 2002 and 2005
INSTRUCTOR Hidde Ploegh, Whitehead Institute for Biomedical Research
TEACHING FELLOWS Marianne Boes, Brigham and Women's Hospital, Harvard University
Roberto Bonasio, The CBR Institute for
Biomedical Research
Cristina Costantino, Harvard Medical School
Immunology is a discipline that stretches across a number of distinct
disciplines: genetics, cell biology, microbiology, biochemistry, to
name just a few. The immune system comprises a set of elements
(cells, molecules, tissues/organs) whose function and mode of
action are not only unique, but also essential to a successful defense
against pathogenic microbes (antigens). The cells of the immune
system are readily obtained from experimental animals as well as
humans, and hence, many aspects of their function can be studied
in vitro. Several classes of immunologically important molecules are
serum proteins, and they are likewise available in quantities that
allow their full characterization, in terms of both structure and func-
tion (antibodies, complement). The diversity of antigen-specific
receptors (antibodies, T-cell receptors) is the result of a somatic
recombination process unique to lymphocytes. Because the verte-
brate immune system is not essential for survival, gene ablation and
knock-in approaches have been particularly informative. Especially
questions pertaining to lymphocyte development (fate decisions),
cell survival, and programmed cell death have benefited from this
approach. All of these elements justify detailed study of the immune
system as an evolutionary successful solution to a problem that con-
fronts all metazoans: how to preserve organismal integrity in the face
of microbial aggression. There is a second, more practical element
(Top left to bottom right) Darren Burgess, Shu-Ling Chiu,
Jeremy Wilusz, Allison Blum, Jonathan Kui, Katherine
McJunkin, Hidde Ploegh, Fred Rollins, Oliver Tam, Amy
Leung, Sarahjane Loke, Maria Chen, Suying Sun, Patrick
Finigan, Nicholas Navin, Cristina Costantino, Hiroshi
Makino, and Roberto Bonasio
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that justifies a detailed examination of the immune system. A number of disease states result from inap-
propriate activation of the immune system. Successful therapies can emerge only if the underlying basis
for the disease is fully understood. At the applied level, antibodies (the antigen- specific
receptors on and
secreted by B lymphocytes) are extremely versatile reagents that can be used to detect, isolate, or mod-
ify the function of almost any protein. How does an immune response lead to the
production of anti-
bodies that would be useful for these applications?
This course introduced the elements of the immune system that make it a unique object of biologi-
cal studies, with cross-references to some of the more applied aspects. Its challenge was
to convey a
sense of what the immune system is about. The course ran from Sunday to Saturday, February
26-March 4, and was organized and largely taught by Hidde Ploegh. It integrated lectures by
the
instructors, daily quizzes, directed readings of research papers, and seminars by the instructors. The
students, many of who had little prior awareness of the subject, rated the course very highly.
Microbial Pathogenesis
Attended by the entering classes of 2003 and 2004
INSTRUCTORS Stanley Maloy, Center for Microbial Sciences, San Diego
Ronald K. Taylor, Dartmouth Medical School
GUEST LECTURERS Darren Higgins, Harvard Medical School
Linda Kenney, University of Illinois, Chicago
Paula R. Sundstrom, Dartmouth Medical School
Michele Swanson, University of Michigan
Throughout recorded history microbial pathogens have been a major cause of human disease and mortal-
ity. However, with the advent of effective antibiotics, it seemed like the war on microbes had been won.
Hence, for several decades health-related research shifted to topics such as cancer, heart disease, and
genetic diseases. Although research in microbial pathogenesis slowed, the microbes demonstrated the effi-
cacy of evolution. Microbial resistance to antibiotics developed faster than new antibiotics could be made
available, and the resistance spread throughout the microbial world. The global expansion of food distribu-
tion networks has increased the incidence of common microbial pathogens. Simultaneously, emerging
microbial pathogens filled new ecological niches, such as indwelling medical devices that provide a surface
for biofilms and the growing population of patients who are immunocompromised due to primary infections
such as HIV or due to therapies for chronic diseases. Furthermore, recent discoveries have demonstrated
that some diseases (e.g., ulcers) previously believed to be caused by a genetic predisposition or environ-
mental conditions are actually caused by microbes. This microbial offensive has summoned a renewed
counterattack on microbial pathogens that has intensified during the last several years. Meanwhile, a vari-
ety of new tools have become available that make it possible to dissect the molecular basis of pathogene-
sis from both the microbial and host perspectives. Recently, the complete DNA sequence of bacterial
pathogens has provided valuable insights into how microbial pathogens evolve and the extent of gene
transfer between pathogens. These advances have revealed new ways to control infection, including the
identification of novel targets for antimicrobials and novel approaches for vaccine development.
Nevertheless, many more questions remain unanswered and many pathogens are still poorly understood.
Understanding bacterial pathogenesis demands a detailed knowledge of the host response as well
as the pathogen itself. Both of these perspectives provide potential strategies for solving important clin-
ical problems. To elucidate these distinct aspects of microbial pathogenesis requires an interdisciplinary
approach, integrating the fields of microbiology, eukaryotic cell biology, immunology, and genomics.
This course focused on mechanisms of microbial pathogenesis and the host response, and the scien-
tific approaches that are used to investigate these mechanisms. How do microbes adhere to host cells?
How do environmental cues direct the response of microbial pathogens? How do microbial pathogens
modulate host cells to expedite virulence? How do host cells respond to microbial pathogens? How does
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(Left to right) Francois Bolduc, Monica Dus (and Cupcake), Christopher Harvey, Ronald Taylor, Rebecca Bish, Galen
Collins, Keisha John, Daniel Chitwood, Oliver Fregoso, David Simpson, Shraddha Pai, Stanley Maloy, Angelique
Girard, Hiroki Asari
the host immune system react to microbial pathogens? What does genomics tells us about how micro-
bial pathogens evolve? How do emerging pathogens take advantage of new ecological niches? Although
there are numerous microbial pathogens, the answers to these questions indicate that many pathogens
use similar approaches to solve common problems. The course integrated lectures by the instructors,
directed readings of research papers, and seminars by the instructors plus four invited speakers who spe-
cialize in various aspects of bacterial pathogenesis. The course ran from Monday, April 17 through Sunday,
April 23. As in previous years, the course was highly rated by all of the students.
Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Uwe Hilgert (Lead instructor, high school)
Erin McKechnie (Lead instructor, middle school)
Greg Chin
Jeanette Collette
David Gundaker
Amanda Mc Brien
Bruce Nash
ADMINISTRATOR Carolyn Reid
As science has an increasing role in society, there is also an
increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of
Biological Sciences doctoral program
offers its students unique teaching experiences through the
Laboratory's Dolan DNA Learning Center,
where students teach laboratory courses to high school and
middle school students. From these teach-
ing experiences, they learn how to communicate with nonbiologists
and to inspire and educate creative
young minds. The teaching module entailed pairs of students
teaching one morning or afternoon a week
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for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors
taught the Watson School
students the didactic process-it was not until the fifth week that the
graduate students taught on their
own. At the end of the 12 weeks, the students were very excited
about their teaching experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in
laboratory rotations. These rotations provide students and faculty the opportunity to get to know each
other and to explore possibilities for doctoral thesis research. At the end of each rotation, students
make short presentations of their studies to the other students and their rotation advisors. These talks
give students an opportunity to share their laboratory experiences and to learn how to give a scientific
presentation. With this latter goal in mind, in addition to the research mentors, the instructors of the
Scientific Exposition and Ethics core course and members of the School's Executive Committee attend
the talks and give individual feedback to students on their presentations. This year, 18 faculty members
served as rotation mentors, some mentoring more than one student.
ROTATION MENTORS
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Hollis Cline Alea A. Mills
Gregory Hannon Senthil K. Muthuswamy
David Jackson David L. Spector
Leemor Joshua-Tor Lincoln Stein
Scott Lowe Bruce Stillman
Wolfgang Lukowitz William Tansey
Zachary Mainen Marja Timmermans
Roberto Malinow Nicholas Tonks
Robert Martienssen Michael Wig ler
FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The William Stamps Farish
Lectureship
INSTRUCTORS Gregory Hannon (Lead)
David Jackson
Leemor Joshua-Tor
Scott Lowe
Robert Martienssen
Anthony Zador
GUEST LECTURERS Josh Dubnau
Eric Enemark
Grigori Enikolopov
Alexander A.F. Gann
Adrian R. Krainer
Wolfgang Lukowitz
Patrick Paddison
Scott Powers
Bruce Stillman
William Tansey
VISITING LECTURERS David Allis, The Rockefeller University
Michael Hengartner, University of Zurich
William Merrick, Case Western Reserve University
Daniel la Nicastro, Brandeis University
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the curriculum, students (1) acquired a broad base of knowledge about the
biological sciences, (2) learned the scientific method, and (3) learned how to think critically. This course
consisted of six biweekly modules, each of which had a different theme. Each week, students read an
assigned set of research articles and, at the end of the module, provided written answers to a problem
set that guided them through several of the articles. Twice weekly, students attended lectures related
to the week's topic, which included concepts and fundamental information as well as experimental
methods. During each week, the students met among themselves to discuss the assigned papers not
covered by the problem set. Each week, students spent an evening discussing
the assigned articles
with faculty. The module topics for this course were as follows:
Module 1 Macromolecular Structure Module 4
Signaling in Development
and Function Module 5
Neuroscience and Quantitative
Module 2 Cell Proliferation and Cancer
Reasoning
Module 3 Gene Expression Module 6
NIH Study Section
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The Darrell Core Course on Scientific
Exposition and Ethics
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation;
The John P. and Rita M. Cleary
Visiting Lectureship; The Seraph Foundation Visiting
Lectureship; The Susan
T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS Jan A. Witkowski (Lead)
Lilian Clark
Alea A. Mills
GUEST LECTURERS Walter Goldschmidts
William Tansey
VISITING LECTURERS Bruce Budowle, Federal Bureau of Investigation
Robert P. Charrow, Greenberg Traurig LLP
Mariette Di Christina, Scientific American
Angela Eggleston, Nature
Kay Fields, Office of Research Integrity
Kathy Hudson, Genetics and Public Policy Center
This core course offered instruction in the fundamental elements of scientific exposition-writing skills
and public speaking-and ethics. The ability to communicate effectively and to appreciate the intricacies
of ethical issues are essential skills for biologists; both subjects were taught in a series of example-based
lectures and discussion groups. Writing skills included the fundamentals of modern scientific English and
the organization and preparation of papers, research abstracts, and grant applications. Oral presentation
skills were taught by instructors with different modes of presentation. Together with instructors, students
critiqued formal seminar presentations at the Laboratory. Instruction and discussions about ethics includ-
ed the ethical implications of biological discovery on society as well as the nature and boundaries of eth-
ical behavior of scientists and their rights and responsibilities. A primary objective of the course was that
students consider exposition and ethics an integral part of scientific research.
Research Topics
ORGANIZERS Eva Radeck
Lilian Clark
This core course provided students with an in-depth introduction to the fields of research that
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, at
which faculty members presented their current research topics and methods of investigation each
Wednesday evening over dinner. The students learned how to approach important problems in biolo-
gy. These seminars, together with the annual fall Laboratory In-House symposium, provided students
with a basis for selecting laboratories in which to do rotations. The weekly speakers were:
Hollis Cline
Josh Dubnau
Grigori Enikolopov
Hiro Furukawa
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Gregory Hannon
Z. Josh Huang
David Jackson
Leemor Joshua-Tor
Alexei Koulakov
Adrian R. Krainer
Robert Lucito
Scott Lowe
Wolfgang Lukowitz
Zachary Mainen
Robert Martienssen
W. Richard McCombie
Alea A. Mills
Partha P. Mitra
Vivek Mittal
Senthil K. Muthuswamy
Michael P. Myers
Scott Powers
Jonathan Sebat
Raffaella Sordella
David L. Spector
Lincoln Stein
Arne Stenlund
Bruce Stillman
William Tansey
Marja Timmermans
Nicholas Tonks
Lloyd Trotman
Glenn Turner
Linda Van Aelst
Doreen Ware
Anthony Zador
Michael Q. Zhang
Yi Zhong
SPECIALIZED DISCIPLINES COURSES
Genetics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship; The Pfizer Lectureship;
The George B. Rathmann Lectureship; The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Josh Dubnau (Lead)
Lincoln Stein
Tim Tully
GUEST LECTURER Ira Hall
VISITING LECTURER Bambos Kyriacou, University of Leicester, United Kingdom
In the past, "gene discovery" and association between gene and phenotype were
accomplished in
model organisms. Our understanding of human disease then was advanced by identification of human
orthologs associated with disease and by interventionist experiments using animal models of human
disease. The completion of the human genome sequence and the remarkable advances in molecular
biological techniques have initiated a paradigm shift in genetics. Associations between gene
variants
and disease can now be directly discovered in humans. Gene-to-phenotype
functional associations can
thus be discovered in humans as well as in model organisms. Causal mechanistic
relationships between
gene and phenotype can then be established using interventionist
genetic experiments in animal mod-
els. This permits both a "vertical integration" to understand how
molecular mechanisms influence func-
tional output across various levels of biological organization and a
"horizontal integration" to understand
how genetic pathways have been conserved evolutionarily.
This course placed modern human genetics and genomics into
the context of classical organismal
genetics. History, perspective, and technique were described
around four levels of analysis: naturally
occurring variation, association studies, genome evolution,
and genetic screens. How do gene muta-
tions help to define biological processes? How are more complex
traits genetically dissected into sim-
pler (underlying) components? What concepts and techniques are
used to organize genes into path-
ways and networks? How are genes mapped, cloned, and
engineered to identify functional domains of
proteins? What gene variation exists in natural populations?
What are the functional consequences of
gene variation? How is it detected? How are genomes
organized and coordinately regulated? How can
genomic information be cataloged, organized, and mined?
These questions and concepts were dis-
cussed using examples from the literature.
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Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship; The Sigi Ziering
Lectureship;
The Martha F. Gerry Visiting Lectureship
INSTRUCTORS David L. Spector (Lead)
Linda Van Aelst
VISITING LECTURERS Michael Caplan, Yale University
Gregg Gundersen, Columbia University
Alexy Khodjakov, Wadsworth Center
Marc Symons, The Feinstein Institute for Medical Research
Graham Warren, Yale University
With the complete genome sequence available for many organisms, there is now an
increasing emphasis
on understanding the function of the gene products. This understanding requires an increasing apprecia-
tion of the structure and function of the cell as well as dynamic associations within
the cell. This course
provided a basic overview of the structural and functional organization of cells with
particular emphasis on
cellular compartmentalization and communication. Topics of focus included the
cytoskeleton, cell adhe-
sion and signaling, membrane transport, gene expression, and nuclear
organization. In addition, the
course provided insight into the basic toolbox of the cell biologist of the 21st century.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship; The Klingenstein Lectureship
INSTRUCTORS Zachary Mainen (Lead)
Carlos D. Brody
GUEST INSTRUCTORS Hollis Cline
Alexei Koulakov
Roberto Malinow
VISITING LECTURER Marta Moita, Instituto Gulbenkian de Ciencia, Portugal
This course introduced students to neuroscience, with a focus on learning and plasticity from its cellular
basis, through development, to systems and behavior. Both experimental and theoretical viewpoints
were explored. The course started with the basics of electrical signaling in neurons: ion channels, action
potentials, and synaptic transmission. The cellular basis of learning including Hebb's postulates, LTP
(long-term synaptic potentiation), was discussed. The course explored the consequences of synaptic
learning rules by examining how experience shapes the wiring of the nervous system during develop-
ment and investigated how such building blocks translate into whole-organism behavior. The course then
examined classical conditioning and asked how changes in synaptic transmission could underlie such
behavior. Associative learning computational models, of the learning process, were also discussed.
From behaviors that focus on simple memories, the course turned to behaviors that require making
perceptual decisions. To do this, some basic concepts of perceptual neuroscience were covered, such as
neuronal "receptive fields," and these were used to discuss current results and models of perceptual deci-
sion-making. Finally, the course turned to the learning of behaviors through reward and punishment,
known as reinforcement learning. The course concluded with a discussion at the role of dopamine in
reward and learning, the theory of reinforcement learning, and pathologies of reward-seeking behavior.
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POSTDOCTORAL PROGRAM
Program Director Nicholas Tonks
Program Administrator Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education and has
a deep commitment to the postdoctoral experience. CSHL has long been recognized as a place for
nurturing young scientists, with postdoctoral researchers being an integral part of the discovery
process. The Laboratory currently employs approximately 160 postdoctoral fellows working in the labs
of 40 principal investigators. Current fields of research expertise include genetics; molecular, cellular,
and structural biology; neuroscience; cancer; plant biology; and genomics and bioinformatics. The
postdoctoral community at CSHL is diverse and international, arriving at the Laboratory with many dif-
ferent backgrounds and with needs that change during the course of the postdoctoral years. To
enhance the postdoctoral experience at CSHL, an office for postdoctoral education (the Postdoctoral
Program Office) was established to work closely with the postdoctoral fellows and the administration to
coordinate and organize educational and career development activities.
The Postdoctoral Program Office was established within the Watson School of Biological Sciences
in January 2003, with the appointment of Dr. Alyson Kass-Eisler, to provide support and programmat-
ic elements to postdoctoral training at the Laboratory. The Office provides support for current and arriv-
ing postdoctoral fellows as well as educational and career development programs. CSHL has an active
Postdoctoral Association (PDA) whose purpose is to represent the interests of the CSHL postdoctoral
community. In addition, the Postdoctoral Program Office also maintains a resource center containing
career information, job opportunities, and fellowship opportunities; they organize workshops and career
development seminars, job search forums, and grant-writing workshops and provide networking
opportunities for postdocs.
In 2006, the Watson School was fortunate enough to attract a wonderful array of speakers for its
career development seminar series. John Tooze, Vice President for Scientific and Facility Operations at
The Rockefeller University, described his fascinating career path in "Beyond the Bench." Michael
Stebbins, a former graduate student from the Laboratory and currently Director of Biology Policy at the
Federation of American Scientists, spoke about "Career? What career? Knowing when to seize your
next opportunity." Matt Ridley, an internationally renowned science author and honorary degree recipi-
ent from the Watson School in 2006, spoke about "Nature versus Nurture." Dave Jensen, Managing
Director of CareerTrax Inc. and the host of the Science magazine careers forum, provided his "Insiders'
Secrets to the Job Market." Alex Rai, also a former graduate student and currently an
Attending Staff
member at Memorial Hospital of Memorial Sloan-Kettering, finished the year by talking to postdocs
about a special training program in Clinical Chemistry that he participated in.
The Postdoctoral Program Office also hosted a visit from Dr. Jing Li from the Merck Research
Laboratories (MRL). CSHL has been a member of a special ambassador recruitment program from
MRL since 2005. This program provides the postdocs and students at
CSHL an inside connection to
a scientist working at MRL. In the morning, Dr. Li hosted a
discussion on what it is like to work at Merck
and spent the afternoon holding one-on-one appointments with individuals interested
in working at
Merck. As a result of his visit, three of the Laboratory's trainees had their resumes
submitted to the hir-
ing managers at MRLI
The Dean holds quarterly "Dean's teas" with postdoctoral
trainees newly arrived at CSHL. These
sessions are designed to assist new postdoctoral fellows with making
the most of their postdoctoral
experience at CSHL. During these sessions, postdoctoral
fellows are provided information on the ser-
vices available through the Postdoctoral Program Office and were
given copies of the excellent books
by Kathy Barker, At the Bench: A Laboratory Navigator and At the Helm: A Laboratory
Navigator, pub-
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lished by Cold Spring Harbor Laboratory Press.
In addition, Laboratory President, Bruce Stillman, holds
a "Town Hall" meeting specifically for
postdoctoral fellows in November of each year. At this year's Town
Hall meeting, the postdoctoral fellows were treated
to Dr. Stillman's personal insights into how to pro-
ceed with an academic job search.
In Spring 2003, all postdoctoral fellows and graduate
students at the Laboratory were enrolled in a
new initiative of the New York Academy of Science,
the Science Alliance. The Science Alliance for grad-
uate students and postdoctoral fellows is a consortium
of universities, teaching hospitals, and inde-
pendent research facilities in the New York City metro area that have formed a partnership with the New
York Academy of Sciences. The aim of the Alliance is to provide career and professional development
monitoring for postdoctoral fellows and graduate students in science and engineering, through a series
of live events and a dedicated Web portal. In addition, the Science Alliance gives graduate students and
postdoctoral fellows the opportunity to network with their peers across institutions and with key lead-
ers in academia and industry. In 2006, we were fortunate to cohost a Science Alliance event on our own
campus. Dr. Philip Clifford, Professor of Anesthesiology and Physiology and Associate Dean for
Postdoctoral Education at the Medical College ofWisconsin, came to talk about Individual Development
Plans for postdoctoral fellows. These plans are organizational tools to assist postdoctoral fellows in
planning their future and their career path. Dr. Clifford was also a member of The Federation of American
Societies for Experimental Biology (FASEB) committee that drafted the model Individual Development
Plan for postdoctoral fellows. The talk was well attended, extremely interactive, and highly praised.
Nationally, CSHL continues to help shape the postdoctoral experience. In 2004, CSHL became a
founding institutional member of the National Postdoc Association (NPA). The NPA was founded by a
dynamic group of postdoctoral fellows who attended the 2002 National Postdoc Network meeting. The
2006 National Postdoc Association meeting was held on the National Institutes of Health campus in
Bethesda, Maryland. Alyson Kass-Eisler attended this year's meeting, which highlighted postdoctoral
offices and postdococtoral associations. Lori Conlan, Manager of the Science Alliance, wrote in the
Summer 2006 issue of the NPA newsletter, "As a member of the NPA, I gathered information on post-
doc issues that are now invaluable. I witnessed many institutions change their postdoc policies, and
many of these are now our members. Knowing a bit of history on how Stanford has changed, or the
newly implemented system in California, or the strength of the postdoc office at Cold Spring Harbor
gives me an advantage."
One measure of our postdoctoral program's success is the ability of a postdoc to secure permanent
positions at the end of their training. In 2006, the Laboratory's departing postdocs went on to positions
at the Cambridge Research Institute-Cancer Research UK, Cold Spring Harbor Laboratory Press,
Harvard University, Memorial Sloan-Kettering Cancer Center, Merck Research Laboratory,
Massachusetts Institute of Technology, Medical Research Center Clinical Sciences Centre-Imperial
College London, National Institute of Biological Sciences-Beijing, Radford University, Research Institute
of Molecular Pathology-Vienna, Thomas Jefferson University, University of California, Davis, Universite
de Montreal, to name but a few.
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UNDERGRADUATE RESEARCH PROGRAM
Program Directors
Program Administrator
David Jackson
Lincoln Stein
Dawn Meehan
Each summer, 25 undergraduates from around the world and across the country participate in the
CSHL summer Undergraduate Research Program (URP). More than 700 students have participated in
the URP since the program was founded in 1959.
The fundamental objective of the program is to give students an opportunity to conduct first-rate
research. Participants learn about scientific reasoning, laboratory methods, theoretical principles, and
scientific communication. The specific objectives of the program are to (1) give college undergraduates
a taste of conducting original research at the cutting edge of science, (2) encourage awareness of the
physical and intellectual tools necessary for modern biological research, (3) foster an awarenessof the
major questions currently under investigation in the biomedical and life sciences, and (4) promote inter-
actions with laboratory scientists through an immersion in the research environment.
During the 10-week program, URPs work with senior Laboratory staff members on independent
research projects, specifically in the areas of cancer biology, neuroscience, plant biology, cellular and
molecular biology, genetics, macromolecular structure, and bioinformatics.
URPs work, live, eat, and play among CSHL scientists. They have a very busy academic and social cal-
endar for the summer. They attend lectures in the Goldberg Faculty Lecture Series from CSHL faculty mem-
bers and outside faculty members. The 2006 URPs were fortunate to hear talks by Dr. Keith Yamamoto,
University of California San Francisco, and Dr. James Konopka, Stony Brook University. URPs also attend
a seven-part Bioinformatics Workshop Series and special lectures designed for them, including lectures by
Drs. James Watson (10 Rules for Science), Jan Witkowski (Ethics), and Bill Tansey (How to give a talk).
URPs also are invited to join Dr. and Mrs. Watson for a pizza party and Dr. and Mrs. Stillman for dinner, have
BBQs and pool parties, design an URP tee shirt, run in the annual CSHL plate race and scavenger hunt,
and participate in the ever-famous URP vs. PI volleyball match. The URPs have never won!
_.00.°1
(Top row, left to right) Christopher Quinn, Joseph Calarco, Kathryn Schmidt,
Vicky Zhou,
Kipp Weiskopf, Wenke Li, Ryan Devenyi, Julie Granka,
William Kruesi, Caroline Leeds, Tal
Shamia, Paloma Guzzardo, Oleg Dmytrenko, Lincoln Smith.
(Bottom row, left to right) Katie
Amodeo, Bryan Schmidt, Joshua Siegle, Adam Lowe,
Nandita Garud, Lilian Ho, Brittany
Sternard, Lenore Barhak, Silvia Caballero, Angelica Contero
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At the beginning of the summer, all of the
URPs write an abstract and present a talk on their proposed research for the
summer. At the URP Symposium in August, they
give a 15-minute talk on their results and also prepare a final report. The
following students, selected from 634 applicants, took part
in the 2006 program:
Caroline Leeds, Amherst College
Advisor: Dr. Patrick Paddison
Sponsor: Former URP Fund
Knockdowns and neurons: Using RNAi to specify cell fate in
mouse embryonic stem cells.
Wenke Li, Stevens Institute of Technology
Advisor: Dr. Ravi Sachidanandam
Sponsor: National Science Foundation and Department of Defense
How old are introns?
Adam Lowe, Salisbury University
Advisor: Dr. William Tansey
Sponsor: Steamboat Foundation
Role of the Saccharomyces cerevisiae gene Sc/1 in proteasome-
mediated transcriptional pathways.
Christopher Quinn, Cornell University
Advisor: Dr. Alexei Koulakov
Sponsor: National Science Foundation and Department of Defense
An improved neural spike-clustering approach.
Bryan Schmidt, Indiana University, Bloomington
Advisor: Dr. Gregory J. Hannon
Sponsor: Former URP Fund
Developing a direct biochemical method to identify the targets
of microRNAs.
Katherine Amodeo, Marist College
Advisor: Dr. Vivek Mittal
Sponsor: Jephson Educational Trust
Role of tumor growth factor VEGF in bone-marrow-dependent
angiogenesis-mediated tumor growth.
Lenore Barhak, The Cooper Union
Advisor: Dr. Leemor Joshua-Tor
Sponsor: National Science Foundation and Department of Defense
A molecular view of transcriptional repression.
Silivia Caballero, Hunter College
Advisor: Dr. Alea A. Mills
Sponsor: Hunter College Fund
Gene targeting of a novel tumor suppressor gene chd5 in
mouse embryonic stem cells.
Joseph Calarco, University of Toronto
Advisor: Dr. Senthil K. Muthuswamy
Sponsor: Former URP Fund
The relationship between Erb-B2, the Par polarity complex,
and apoptosis.
Angelica Contero, Swarthmore College
Advisor: Dr. Hollis Cline
Sponsor: William Townsend Porter Foundation
The effect of visual stimulation on GABA expression patterns in
the optic tectum of Xenoplus laevis tadpoles.
Ryan Devenyi, Bowdoin College
Advisor: Dr. Wolfgang Lukowitz
Sponsor: National Science Foundation and Department of Defense
Investigations in the Yoda MAP kinase pathway in Arabidopsis.
Oleg Dmytrenko, International University of Bremen
Advisor: Dr. David P. Jackson
Sponsor: Former URP Fund
Analysis of gat2- mutants with reduced plasmodesmata size-
exclusion limit (Arabidopsis thaliana).
Nandita Garud, Cornell University
Advisor: Dr. Doreen Ware
Sponsor: National Science Foundation and Department of Defense
Weeding for phenotypes and motifs in a weed, in the field, and
within genomes.
Julie Granka, Cornell University
Advisor: Dr. Michael Q. Zhang
Sponsor: National Science Foundation and Department of Defense
Characterizing the binding specificity of CTCF.
Paloma Guzzardo, University of Puerto Rico
Advisor: Dr. Adrian R. Krainer
Sponsor: Former URP Fund
Characterization of a new S6 kinase 1 isoform.
Lilian Ho, Vassar College
Advisor: Dr. Cordula Schultz
Sponsor: National Science Foundation and Department of Defense
Novel protein lucky luke and cellular integrity.
William Kruesi, Carleton College
Advisor: Dr. Marja Timmermans
Sponsor: National Science Foundation and Department of Defense
The AS1/AS2 and ta-siRNA pathways regulate MIR166 gene
expression in Arabidopsis.
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Kathryn Schmidt, Yale University
Advisor: Dr. Linda Van Aelst
Sponsor: Former URP Fund
The role of the X-linked mental retardation protein oligo-
phernin-1 in glutamate receptor signaling.
Tal Shamia, Tel Aviv University
Advisor: Dr. Robert Martienssen
Sponsor: Former URP Fund
RNAi and gene silencing effects on Arabidopsis development.
Joshua Siegle, Brown University
Advisor: Dr. Partha Mitra
Sponsor: National Science Foundation and Department of Defense
Oscillatory brain dynamics of working memory: A simultaneous
MEG and EEG study.
Lincoln Smith, Wabash College
Advisor: Dr. W. Richard McCombie
Sponsor: National Science Foundation and Department of Defense
Bglll fragment selection in the human genome using different
hybridization-based selections.
Britni Sternard, Bethel College
Advisor: Dr. Yi Zhong
Sponsor: Former URP Fund
Construction of RNAi for neurofibromatosis type 1.
Kipp Weiskopf, Amherst College
Advisor: Dr. Bruce Stillman
Sponsor: Former URP Fund
Role of Orc2 in mitotic checkpoint assembly.
Vicky Zhou, University of California, Irvine
Advisor: Dr. Lincoln Stein
Sponsor: National Science Foundation and Department of Defense
Visualization of C. elegans gene expression data in Worm Base.
PARTNERS FOR THE FUTURE
Program Director: Yuri Lazebnik
Program Administrator: Lynn Hardin
The Partners for the Future Program, established by Dr. James Watson in 1990, brings Long Island
high school students into Cold Spring Harbor Laboratory and gives them a taste of the real world of
biomedical research. The competitive program is open to Long Island high school students in their
junior year. Each high school science chairperson may nominate up to three students, and ten to
twelve student semifinalists are then interviewed by CSHL scientists. The selected students spend a
minimum of 10 hours per week, September through March of their senior year, doing original research
under the watchful eye of a scientist mentor. At the conclusion, the students give oral presentations of
their research projects to an enthusiastic audience of the students' scientific mentors, Lab administra-
tors, parents, and teachers. Although the students learn a great deal about modern biology and state-
of-the-art research techniques, the main advantage of the program is in exposing the students to day-
to-day life in a working lab. The students are introduced to a world of relatively young scientists and
their interactive support staff in a relaxed, problem-solving atmosphere. The 2006-2007 Partners for
the Future are
Partner High School CSHL Mentor Laboratory
Leah Libresco The Wheatley School Ken Chang Gregory Hannon
Souvik Paul Syosset High School Anindya Bagchi Alea A. Mills
Hannah Payne Huntington High School James Demas Hollis Cline
Catherine Schlingheyde Oyster Bay High School Fabiola Rivas Gregory Hannon
(Left to right) Catherine Schlingheyde, Souvik Paul, Hannah
Payne, Leah Libresco
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ACADEMIC AFFAIRS
The academic program at the Laboratory serves to
communicate new discoveries, concepts, and
methodologies to an international community of scientists. The program consists of advanced laborato-
ry and lecture courses, short courses at our Woodbury campus,
as well as large meetings and biotech-
nology conferences that are held almost year-round. More than 8000 scientists, ranging from graduate
students and postdoctoral fellows to senior faculty, come from around the world to attend these events.
A growing international program complements the main program of meetings and courses.
In 2006, 27 laboratory and lecture courses were held. These covered a diverse array of topics in mol-
ecular biology, neurobiology, structural studies, and bioinformatics. The primary aim of the courses
remains to teach students the latest advances in technologies and concepts that can be immediately
applied to their own research. Courses are always being evaluated and updated to include the latest
concepts and approaches. For example, the course on microarrays has now evolved into a course on
Integrated Data Analysis for High-throughput Biology, since the majority of investigators are increasing-
ly interested in the experimental design and analysis of the large data sets generated by these kinds of
experiments. New Banbury courses/workshops were started on the biology of brain tumors and the
biology of social cognition.
Instructors, course assistants, and course lecturers come from universities, medical schools, research
institutes, and companies around the world to teach at Cold Spring Harbor. Their excellence and dedi-
cation make the course program work so well. The full program of 2006 courses and instructors are list-
ed below. We would especially like to thank Drs. Judith Bender, Blanche Capel, Lawrence Hobbie,
Thomas Hughes, Michel Labouesse, Hong Ma, Sheila McCormick, Michael Shen, Nelson Spruston, Jeff
Strathern, Jason Swedlow, and Laszlo Tora, who all retired this year after many years of service.
Grants from a variety of sources support the courses. These include multiple awards from the National
Institutes of Health and the National Science Foundation. We also have a valuable large education grant
from the Howard Hughes Medical Institute for the support of neurobiology courses and new courses.
The courses also depend on equipment and reagents that are loaned or donated by a large number of
companies. These are invaluable for making it possible to keep up with the latest technologies.
The Laboratory held 24 meetings this year, which brought together more than 7100 scientists from
around the world to discuss their latest research. A prime feature of the meetings is that there are very
few invited speakers. Meetings organizers select talks from abstracts that are submitted. This format
ensures that the latest findings will be presented and that young scien-
tists will have the chance to describe their work.
As often happens, many meetings were oversubscribed, including The
Biology of Genomes, Retroviruses, Mechanisms and Models of Cancer
and Translational Control, as well as the annual Symposium. Many of the
meetings have become essential for those in the field and are held on a
biannual basis. Partial support for individual meetings is provided by grants
from NIH, NSF, Department of Energy, foundations, and companies. Core
support for the meetings program is provided by the Laboratory's
Corporate Patrons, Benefactors, Sponsors, Affiliates, and Contributors.
The Symposium-now in its 71st year-continues to be the flagship
conference of the meetings program. This year's meeting on Regulatory
RNAs addressed the regulation of cellular processes by RNA-based
mechanisms and featured 70 talks and 209 poster presentations.
Opening night speakers included Susan Gottesman, David Baulcombe,
Gary Ruvkun, and Greg Hannon, and Elizabeth Blackburn presented the
Reginald Harris lecture on "Effects of Telomerase RNP Knockdown."
Ronald Plasterk enlightened a mixed audience of scientists and lay
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D. Baulcombe
friends and neighbors with his Dorcas Cummings lecture on "The Emerging World of Small RNAs" and
Joan Steitz ended the meeting with a masterful and eloquent summary.
The joint Cold Spring Harbor/ Wellcome Trust conference series held at the genome campus south
of Cambridge, England, was expanded to include meetings on Interactome Networks, Genomic
Perspectives to Host-pathogen Interactions, Genome Informatics, and Integrative Approaches to Brain
Complexity. These conferences follow the Cold Spring Harbor model in that the majority of talks are
selected from the abstracts; they attracted a total of 479 participants.
The success of the very large number of meetings and courses is also due to the skilled work of many
Cold Spring Harbor staff and faculty who contribute their expertise, efforts, and good humor to the program.
Terri Grodzicker
Assistant Director for
Academic Affairs
David Stewart
Executive Director,
Meetings and Courses Program
Dining on the terrace overlooking Cold Spring Harbor
at the Symposium on Regulatory RNAs
A leisurely lunch on the lawn at the Structural Biology
meeting
Members of the Integrated Data Analysis for High-throughput course
J. Pomerening and D. Thron at The Cell Cycle
meeting
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PROFESSOR FOR A DAY PROGRAM
Cold Spring Harbor Laboratory's "Professor for a Day" program introduces a
select group of juniors and
seniors drawn from high schools throughout Long Island who show real interest in pursuing a career in
science to experience a day at a Cold Spring Harbor meeting. A small group of students (5-10 maxi-
mum) sit in on platform sessions, listen to the talks, attend one of the meeting's poster sessions, take
a tour of the Laboratory, and meet some of the scientists who congregate at Cold Spring Harbor to
exchange the latest concepts and methods in their field of science.
This first year, students participated in the Channels, Receptors, and Synapse meeting; The Cell
Cycle meeting; and the 71st Symposium on Regulatory RNAs.
J. Williams, Program Mentor; J. Hershowitz, V. Cheng, N. Venkateswaran, J. Nackenson at the 71st Symposium on Regulatory RNAs
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71th COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Regulatory RNAs
May 31-June 5 469 participants
ARRANGED BY Bruce Stillman and David Stewart, Cold Spring Harbor Laboratory
The role of DNA as the primary information carrier and RNA as the interpretative system for that infor-
mation has been the key tenet of modern biology-the central dogma of molecular biology. This was
modified by the discovery of reverse transcription and presented at this Symposium in 1970. The large
majority of enzymatic reactions are carried out by proteins, although the discovery of catalytic RNA and
its emerging centrality in certain highly conserved cellular processes such as protein synthesis and
eukaryotic mRNA splicing have increasingly suggested that RNA has a more
diverse and complex role in the cell than initially proposed.
The discovery of RNA interference (RNAi) and the ubiquity of microRNAs in
diverse systems have clearly established that this polymer regulates gene tran-
scription and translation in hitherto unexpected ways, as well as providing cellu-
lar defense mechanisms against viruses. How many of these regulatory process-
es are relics of an ancient RNA-based world, as has been suggested for the
riboswitches, remains unclear, but their growing importance in both prokaryotic
and eukaryotic biology is fueling research and new ideas in laboratories around
the world. Transcriptional and translational control by RNA, epigenetic phenom-
ena such as RNA-directed DNA methylation and RNAi-directed heterochromatin
formation, meiotic silencing, and cellular defense mechanisms against viruses are
just some of the current areas under intense investigation through a variety of
genetic, genomic, biochemical, cell biological, and structural approaches.
It was therefore deemed timely to focus the annual Symposium broadly on
the theme of regulation of cellular processes by RNA-based mechanisms. It is
increasingly clear that many of these processes may be harnessed to perturb
biological function in a variety of biological systems, work that has reached its
most widespread application with the use of large-scale RNAi screens. The
Symposium explored how the application of these technologies, combined
with a growing understanding of the molecular basis of many of these process-
es, is yielding new insights into the treatment of many human diseases.
In organizing this Symposium with considerable help from Terri Grodzicker,
we relied on the assistance of our colleagues Greg Hannon and Adrian Krainer
for suggestions for speakers while Susan Gottesman provided useful guidance
in the prokaryotic field. We also wish to thank the first evening speakers-Susan
Gottesman, David Baulcombe, Gary Ruvkun, and Greg Hannon-for providing
an overview of the areas to be covered. This year's Reginald Harris Lecture was
delivered by Elizabeth Blackburn on telomere ribonucleoprotein biology. Thanks
to Joan Steitz, with help from Greg Hannon, for delivering a
thoughtful and real-
istic summary of the current state of the field, and to Ronald Plasterk,
who con-
veyed the excitement and surprises of the emerging world
of small RNAs in his
Dorcas Cummings Lecture to the local community and the attending scientists.
We also thank Val Pakaluk and Mary Smith in the Meetings and Courses
Program office for their efficient help in organizing the Symposium.
R. Plasterk, Dorcas Cummings Lecture
J. Steitz giving the Summary
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This Symposium was attended by 469 scientists
from more than 25 countries, and the program
included 70 oral presentations and 209 poster presentations.
Essential funds to run this meeting were obtained from
the National Cancer Institute, a branch of the
National Institutes of Health. In addition, financial help from
the corporate benefactors, sponsors, affiliates,
and contributors of our meetings program is essential to
the continued success of these Symposia and
we are most grateful for their continued support. Corporate Patrons
include Pfizer Inc. Corporate
Benefactors include Amgen Inc.; GlaxoSmithKline;
and Novartis Institutes for BioMedical Research.
Corporate Sponsors include Abbott Laboratories; Applied
Biosystems; BioVentures, Inc.; Bristol-Myers
Squibb Company; Diagnostic Products Corporation; Forest Laboratories, Inc., GE Healthcare Bio-
Sciences; Genentech, Inc.; Hoffmann-La Roche Inc.; Johnson & Johnson Pharmaceutical Reseach and
Development, LLC; Kyowa Hakko Kogyo Co., Ltd.; Merck Research Laboratories; New England BioLabs,
Inc.; OSI Pharmaceuticals, Inc.; Pall Corporation; Sanofi-Aventis; and Schering-Plough Research Institute.
N. Sonenberg, P. Sharp, B. Stillman, T. Cech M. Terns, J. Dahlberg, J. Steitz S. Grewel, D. Moozed
N. Sacchi, J. Watson C. Sharma, R. Giegerich S. Jayesena, J. McSwiggen
R. Jorgensen, D. Baulcombe, M. Timmermans, R. Plasterk
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Plant Corporate Associates include Arbor Gen; Monsanto Company; and Pioneer Hi-Bred International,
Inc. Corporate Affiliates include Abcam and Agilent Technologies. Corporate Contributors include Aviva
Systems Biology; Bethyl Labs; Cell Signaling Technology; Epicentre Biotechnologies; inGenious Targeting
Laboratory Inc.; Illumina; and IRx Therapeutics. Foundations include Albert B. Sabin Vaccine Institute, Inc.
and Hudson Alpha Institute for Biotechnology.
PROGRAM
Introduction
T. Grodzicker, Cold Spring Harbor Laboratory
Mechanism and Biology of RNAi
Chairperson: N. Proudfoot, University of Oxford, United
Kingdom
Genome-Wide Approaches
Chairperson: B. Bass, HHMI/University of Utah School of
Medicine, Salt Lake City
Small RNAs in Development
Chairperson: G. Storz, NICHD/NIH, Bethesda, Maryland
Telomeres and Cancer
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Reginald B. Harris Lecture: Effects of Telomerase RNP
Knockdown
Speaker: E.H. Blackburn, University of California, San
Francisco
End Regulation of Transcripts
Chairperson: T. Nilsen, Case Western Reserve University
Cleveland, Ohio
RNPs and RNA Editing
Chairperson: J. Doudna, University of California, Berkeley
Biology of Short RNAs
Chairperson: C. Greider, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Control of Gene Expression by Noncoding RNAs
Chairperson: D. Spector, Cold Spring Harbor Laboratory
Dorcas Cummings Lecture: The Emerging World of Small
RNAs
Speaker: Ronald Plasterk, Hubrecht Laboratory
Heterochromatin
Chairperson: M. Kuroda, Harvard University Boston,
Massachusetts
Quality Control, mRNA Turnover, and Translational
Control
Chairperson: P. Zamore, University of Massachusetts Medical
School, Worcester
Summary
J. Steitz, Yale University School of Medicine
Viewing the Dorcas Cummings Lecture
227
MEETINGS
Neuronal Circuits: From Structure to Function
March 9-12 164 participants
ARRANGED BY Edward Callaway, Salk Institute for Biological Sciences
Dmitri Chklovskii, Cold Spring Harbor Laboratory
Liquin Luo, Stanford University
In the quest to understand the brain, neuronal circuits represent a
central level of description.
Establishing connectivity in neuronal circuits seems to be as essential for solving the brain as having a
geographic map for planning travel. Although such realization has motivated Cajal to describe a variety
of neuronal circuits using Golgi stains, his contributions were technologically limited. With the recent
appearance of novel molecular genetic, imaging, and computational techniques, a comprehensive
description of the wiring diagram, an old dream of neuroscientists, is about to become a reality.
Because technological advances have been made in different organisms and systems, we wanted
to create a forum that brings together researchers working on different topics, yet focusing on neuronal
circuits. Included at this meeting were six broad slide sessions covering the olfactory system, the visu-
al system, methods, behavior learning and memory, and motor systems and the cortex, as well as a
very interactive poster session.
For a first meeting of this kind, the response of the field was very enthusiastic. The meeting brought
together participants from all over the world, most of whom made either oral or poster presentations.
Invited talks were given by D. Anderson, C. Bargmann, L. Buck, T. Clandinin, W. Denk, B. Dickson, C.
Du lac, M. Goulding, W. Kristan, K. Martin, I. Meinertzhagen, A. Bernard, K. Kindt, P. Somogyi, S. Smith,
P. Sterling, and K. Svoboda. The meeting provided an important clearinghouse for ideas and approach-
es and helped scientists in the field get the most up-to-date information, as well as enabling them to
meet, to network, and to establish collaborations. Based on the uniformly enthusiastic comments of the
participants, the intensity of the oral and poster sessions, and the large crowds that stayed up late every
night at the bar to discuss science, the meeting was a great success.
The meeting program included a Larry Katz memorial, where Liqun Luo, Ed Callaway and Cori
Bargmann shared their reminiscences with the audience.
This meeting was funded in part by The Swartz Foundation.
D. Chklovskii, D. O'Malley
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L. Buck, L. Luo
PROGRAM
Olfactory/Gustatory System
Chairpersons: C. Du lac, HHMI/Harvard University, Cambridge,
Massachusetts; D. Anderson, HHMI /California Institute of
Technology, Pasadena
Visual System I
Chairpersons: P. Sterling, University of Pennsylvania,
Philadelphia; T. Clandinin, Stanford University California
Visual System II
Chairpersons: P. Sterling, University of Pennsylvania,
Philadelphia; T. Clandinin, Stanford University California
Methods
Chairperson: W. Denk, Max-Planck Institute for Medical
Research, Heidelberg, Germany
Behavior, Learning, and Memory I
Chairpersons: C. Bargmann, HHMI/The Rockefeller University
New York; B. Dickson, Institute of Molecular Pathology
Vienna, Austria
Behavior, Learning, and Memory II
Chairpersons: C. Bargmann, HHMI/The Rockefeller University
New York; B. Dickson, Institute of Molecular Pathology
Vienna, Austria
Motor and Oscillations
Chairperson: M. Goulding, Salk Institute, La Jolla, California
Hippocampus
Chairperson: P. Somogyi, Medical Research Council, Oxford,
United Kingdom
Cortex
Chairpersons: K. Svoboda, HHMI/Cold Spring Harbor
Laboratory; K. Martin, Swiss Federal Institute of Technology
Zurich
Y. Jin, K. Brose, J. Simpson
D. Hall, R. Kurtz ler
J. Gray, S. Ashraf
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PTEN Pathways
March 15-19 135 participants
ARRANGED BY Carlos Cordon-Cardo, Memorial Sloan-Kettering Cancer Center
Pier Paolo Pandolfi, Memorial Sloan-Kettering Cancer Center
Ramon Parsons, Columbia University
William Sellers, Dana-Farber Cancer Institute
This first conference was enormously successful. It provided many scientists
in the top of this field-
who are involved in the study of molecular, genetic, and biochemical approaches to
the analysis of the
PTEN pathway in cancer, diabetes, and neurological disorders such as Parkinson's
diseasethe oppor-
tunity to meet with researchers of all levels to get together to discuss their latest
research findings and
technical approaches toward the analysis of the PTEN pathway. Particular emphasis was placed on
human cancer pathogenesis, disease models, and therapy.
A total of 26 investigators presented in the nine scientific sessions, with nearly 55 platform and
poster presentations and 135 registered attendees. The nine platform and two poster sessions were
marked by dynamic and enthusiastic exchanges of new results. In the scientific sessions, many audi-
ence members participated in the question and answer sessions, and the poster sessions were well
attended. Topics at the meeting are listed below under "Program."
Essential funding for the meeting was provided by the National Cancer Institute, a branch of the
National Institutes of Health, and the National Science Foundation.
L. Cant ley, C. Cordon-Cardo
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P. Paolo Pandolfi, E. Holland
PROGRAM
PTEN/PI-3 Kinase Pathway Alterations in Human
Cancer
Chairperson: G. Mills, University of Texas M.D. Anderson
Cancer Center, Houston
PTEN Regulation
Chairperson: M.-M. Georgescu, University of Texas M.D.
Anderson Cancer Center, Houston
PI-3 Kinase, IRS, PDK1, and AKT Signaling
Chairperson: L. Cant ley, Harvard Medical School, Boston,
Massachusetts
AKT & FOXO Signaling
Chairperson: A. Brunet, Stanford University California
TSC and mTOR Signaling
Chairperson: S. Baker, St. Jude Children's Research Hospital,
Memphis, Tennessee
PTEN Pathways, Development, and Metabolic Diseases
Chairperson: D. Accili, Columbia University College of
Physicians & Surgeons, New York
Therapy
Chairperson: S. Lowe, HHMI/Cold Spring Harbor Laboratory
E. Janssen, C. Knobbe
T. Lingraj, J. Thomas, A. Fischl
J. Jackson, J. Kahana
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Systems Biology: Global Regulation of Gene Expression
March 23-26 275 Participants
ARRANGED BY Jack Keene, Duke University Medical Center
Peggy Farnham, University of California, Davis
Nir Friedman, Hebrew University
Gene expression is one of the most important processes determining the functional characteristics of
organisms. Investigating the mechanisms that regulate gene expression is essential to understating all
biological processes and diseases. Most knowledge of the regulation of gene expression in the past has
been derived by investigations of single interactions and outcomes. However, the onset of the genom-
ic revolution has for the first time allowed the ability to investigate many events in gene expression simul-
taneously and in parallel. Much progress has been made in the study of transcriptional regulation, but
the global regulation of gene expression involving posttranscriptional mechanisms as well is especially
challenging. Therefore, the global analysis of gene expression involving both transcription and posttran-
scription was the subject of this fourth meeting on Systems Biology.
It was unique in that it brought together researchers using three major approaches to global gene
expression and systems biology, including transcription, posttranscription (RNA splicing, localization,
stability, and translation), and computational analysis. The sessions were structured with an opening
keynote speaker whose research overlaps all of these three areas and was followed in the first session
by representative presentations form each of the three areas. The subsequent sessions considered first
computational, then transcriptional, then posttranscriptional, and then comparative genomics, followed
on the last day with a session on emerging technologies. Poster sessions that represented these differ-
ent approaches to understanding global gene expression were well attended, allowing direct interac-
tions among with these common interests.
Two changes were made to the format of this 2006 meeting based on discussion with the partici-
pants of the previous 2005 meeting. First, the poster session was split into two parts, allowing presen-
ters to participate in discussion of the posters at the session at which they were not presenting.
Second, two workshops were held prior to the main meeting sessions. The purpose of these work-
shops was to give brief tutorials of bioinformatics-related approaches to bench scientists and to pro-
T. Grodzicker, J. Keene, D. Botstein
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vide to the computational researchers overviews of the experimental approaches that are employed by
the bench scientists. Many participants commented on the quality of the meeting and in a planning ses-
sion; enthusiasm was expressed to continue this meeting series in its current format, including the
incorporation of the workshops.
Partial funding was provided by the National Science
Foundation.
PROGRAM
Keynote Speaker: A Systems Approach to Dissecting
Immunity
A. Aderem, Institute for Systems Biology
Seattle, Washington
Overture
J. Keene, Duke University Durham, North Carolina
Computational Approaches to Identifying cis-Regulatory
Elements
Chairperson: N. Friedman, Hebrew University Jerusalem, Israel
Advances in Detection of Transcription Factor/DNA
Interactions
Chairperson: P. Farnham, University of California, Davis
Transcriptional and Posttranscriptional Network Modeling
Chairperson: P. Benfey, Duke University Durham, North Carolina
Comparative Genomics of Global Gene Regulation
Chairperson: S. Mango, University of Utah, Salt Lake City
Emerging Technologies and Concepts in Systems Biology
Chairperson: P. Silver, Dana-Farber Cancer Institute, Harvard
Medical School, Boston, Massachusett
R. McCord, J. Warner
W. Agnew, N. Clarke
M. Brauer, M. Torkar
A. Sharov, J. Boberg
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Channels, Receptors, and Synapses
April 18-22 190 participants
ARRANGED BY Richard L. Huganir, HHMI/Johns Hopkins University School of Medicine
Lily Jan, HHMI/University of California, San Francisco
Morgan Sheng, HHMI/Massachusetts Institute of Technology
The brain consists of a vast network of excitable cells (neurons) that conduct electrical impulses and com-
municate with each other via specialized junctions (synapses). Information is processed and stored in the
nervous system through patterns of electrical activity and via changes in the strength and structure of
synapses. All aspects of nervous system function, including perception, cognition, and action, depend on
proper information processing by synapses. As master regulators of neuronal excitability and synaptic com-
munication, ion channels and receptors lie at the heart of neurobiology. In
recent years, the molecular and cell biological analyses of neuronal ion chan-
nels and receptors have revolutionized our understanding of the basic mech-
anisms that control electrical signaling and synaptic function in the nervous
systems. The convergence of advances in biochemistry, molecular genetics,
microscopic imaging, and electrophysiology has made synaptic biology one
of the most exciting and rapidly growing fields in neuroscience. Increasingly,
scientists are moving to in vivo systems to investigate the synaptic basis of
behavior in living animals via the genetic engineering of channels, receptors,
and other synaptic proteins in mice and other model organisms.
The entire field is poised for further breakthroughs that will not only illu-
minate basic workings of the brain, but also shed light on neurological and
psychiatric diseases that stem from abnormal neuronal excitability and
synaptic dysfunction. Indeed, genetic association studies already point to
genes for synaptic structure and function as being involved in neuropsychiatric
L. Jan, K. Brose
illnesses. Future
advances will be facilitated by cross-fertilization of ideas and technologies among scientists studying
channels, receptors, and synapses at all levels, in diverse organisms and using different methodologi-
cal approaches. To provide a forum that unites this exciting multidisciplinary area, this meeting was con-
vened for a second time in April 2006 (inaugural meeting was held in April 2004).
R. Huganir, M. Sheng
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The second "Synapses" meeting was extremely successful, bringing together nearly 200 participants
from the United States, Europe, and Asia in an atmosphere of social and scientific exchange. A wide range
of topics were discussed (see Program below). Compared to the first meeting in 2004, the 2006 meeting
had less emphasis on the structure and function of ion channels and more on the cell biology and devel-
opment of synapses and on the in vivo significance of synaptic function and plasticity. More than 50 atten-
dants were selected to give oral presentations of their work, and the majority of the rest presented posters.
Outstanding plenary lectures were given by Tom Sudhof (University of Texas, Southwestern) on presynap-
tic mechanisms and by Rob Malenka (Stanford) on molecular mechanisms of synaptic plasticity.
The overall response to the meeting was extremely positive, cementing the reputation of this Cold
Spring Harbor conference in the field. Attendees enjoyed the breadth of subjects covered and the chance
to interact with investigators in related but distinct fields. The unusual opportunity for junior investigators
(including postdocs and students) to present their own work was welcomed. Based on its continuing
success, this conference will take place again
in one year (April 2007), but under the modi-
fied name "Synapses: From Molecules to
Circuits and Behavior."
Lily Jan and Morgan Sheng have stepped
down as organizers of the meeting. Tom
Sudhof (University of Texas Southwestern)
and Holly Cline (Cold Spring Harbor
Laboratory) will take over and work with
Richard Huganir. We expect that this Cold
Spring Harbor meeting will become a "must-
attend" conference for learning the latest
developments in molecular and cellular
physiology of the brain.
Funding for this meeting was provided by
the National Institutes of Mental Health and
the National Institute of Neurological
Diseases and Stroke.
A. Vincent, S. Waxman
H. Beale, H. Carlisle
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PROGRAM
Presynaptic Function
Chairperson: R DeCamilli, Yale University School of Medicine,
New Haven, Connecticut
Keynote Speaker I: How Ca2+ Triggers Neurotransmitter
Release
Thomas Sudhof, University of Texas Southwestern Medical
Center
Synapse Formation
Chairperson: A.M. Craig, University of British Columbia,
Vancouver, Canada
Neuronal Signaling Mechanisms
Chairperson: M. Greenberg, Harvard Medical School, Boston,
Massachusetts
Modulation of Channel and Receptor Function
Chairperson: I. Levitan, University of Pennsylvania School of
Medicine, Philadelphia
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Synaptic and Nonsynaptic Plasticity
Chairperson: D. Linden, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Keynote Speaker II: Roles of PSD-95 and SAP97 in the
Control of Synaptic Strength
Robert Malenka, Stanford University School of Medicine
Synaptic Plasticity and Development
Chairperson: H. Cline, Cold Spring Harbor Laboratory
Synaptic Plasticity and Behavior
Chairperson: A. Silva, University of California, Los Angeles
Diseases of Channels, Receptors, and Synapses
Chairperson: L. Ptacek, University of California, San Francisco
Professor for a Day Program students and teachers from Elmont, Manhasset, Roslyn, Uniondale, and John F.
Kennedy High Schools
Gene Expression and Signaling in the Immune System
April 26-30 426 participants
ARRANGED BY Doreen Cantrell, University of Dundee, United Kingdom
Richard Flavell, HHMI/Yale University, New Haven, Connecticut
Rudolf Grosscheldl, Max-Planck Institute of Immunobiology, Germany
Stephen Smale, HHMI/University of California School of Medicine, Los Angeles
This year's meeting, the third in the series, continued its focus on rigorous mechanistic studies that suc-
ceed in advancing our understanding of gene regulation and signal transduction circuitry during immune
development and immune responses. A new addition to this year's meeting was a session dedicated
to the regulation of innate immune responses. This session broadened the meeting beyond its previous
focus on adaptive immunity. The innate immunity session attracted major figures in the field, including
Shizuo Akira, Ruslan Medzhitov, Sankar Ghosh, and David Baltimore, and was exceptionally well-
received. One theme of this session was the mechanisms responsible for negative regulation of inflam-
matory gene activation.
A highlight of the meeting was the use of an RNA-interference-
based screen in Drosophila to identify elusive, evolutionarily con-
served regulators of calcium influx, which promotes the activation and
nuclear translocation of NFAT transcription factors. Kinases responsi-
ble for NFAT deactivation were also identified in this screen and a sep-
arate presentation provided a link between one of these kinases and
the genetic abnormalities responsible for Down's syndrome. Another
major focus was the regulatory cascades involved in the maintenance
of hematopoietic stem cells in an undifferentiated state, and in com-
mitment to lymphocyte lineages. Considerable attention was also
directed toward the roles of lymphocyte commitment factors in main-
taining the differentiated state after lymphocyte maturation.
This meeting was supported in part by funds provided by Abbott
Bioresearch; B&D Biosciences; Elan Pharmaceuticals; Genentech,
Inc.; Merck & Co.; Research and Diagnostic Systems, Inc.; Point Therapeutics, Inc.; Cell Signaling
Technology, Inc.; and National Institute of Allergy and Infectious Diseases, a part of the National
Institutes of Health.
S. Tundip, S. Smale
R. Grosschedl, L. Goyal
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PROGRAM
Stem Cells and Early Developmental Decisions
Chairperson: R. Grosschedl, Max-Planck Institute of
lmmunobiology, Freiburg, Germany
Regulation of Immune Cell Development
Chairperson: L. Glimcher, Harvard School of Public Health,
Boston, Massachusetts
Chromatin Structure and Epigenetic Regulation
Chairperson: R. Flavell, Yale University School of Medicine,
New Haven, Connecticut
Antigen Receptor Gene Assembly, Somatic
Hypermutation, and Class Switching
Chairperson: M. Schlissel, University of California, Berkeley
Signal Transduction in Immune Cells
Chairperson: D. Cantrell, University of Dundee, United
Kingdom
Regulation of Lymphocyte Function I
Chairperson: G. Griffiths, University of Oxford, United Kingdom
Regulation of Lymphocyte Function II
Chairperson: D. Mathis, Joslin Diabetes Center, Harvard
Medical School, Boston, Massachusetts
Innate Immunity
Chairperson: S. Smale, HHMI/University of California School of
Medicine, Los Angeles
H. Yoon, J. Boss T. Coche, S. Delhaye
M. Green, R. Schlimgen
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L. Cimmino, A. Spurkland
Molecular Chaperones and Heat Shock Response
May 3-7 279 participants
ARRANGED BY James Bardwell, HHMI/University of Michigan
David Ron, New York University School of Medicine
Jonathan Weissman, HHMI/University of California, San Francisco
This meeting-24 years after the inaugural meeting-featured advances in the areas of structure and mech-
anism of action of molecular chaperones, mechanisms of induction of unfolded protein stress responses in
various compartments, the role of chaperones in protein degradation and in cell signaling, and chaperone
function in disease and aging. In the first area, detailed structural and biophysical studies on well-charac-
terized chaperones, such as GroEUES, the small heat shock factors, Hsp70, 90, and 100 classes, were
presented. Structural data on the relationship between the ribosome and chaperones were
presented here for the first time. New insight into regulation of oxidative protein folding in
the endoplasmic reticulum was provided in a study describing allosteric regulation of the
oxidase ERO1. In a session devoted to regulation of the heat shock response the involve-
ment of a noncoding RNA were described for the first time and data suggesting that it may
be a heat sensor was presented. A novel role for the endoplasmic reticulum stress-activat-
ed kinase/endonuclease IRE1 in mRNA metabolism was described for the first time.
Several talks addressed recent developments in quality control mechanisms and sig-
nals involved in the identification and tagging of misfolded proteins fordegradation.The
session on protein degradation included structural analysis of the protein degradation
and unfolding machines in prokaryotes (CIpB) and eukaryotes (the proteasome). Several
talks described new developments in the application of model organisms to study the
implications of protein misfolded to human diseases. Notable in this regard is the pre-
sentation of experimental tools to correlate the physical state of misfolded proteins with
aging (in worms). Major advances in our understanding of the biophysical basis of prion
diseases were presented, notably studies of prion speciation and fiber growth and fiber
their correlation with phenotypic outcome.
This conference was supported in part by funds provided by National Institutes of Neurological
Diseases and Stroke, a part of the National Institutes of Health.
D. Ron
structure and
J. Heikki la, D. Mosser
R. Morimot, L. Joshua-Tor
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PROGRAM
Chaperone Biochemistry and Protein Folding
Chairperson: E. Craig, University of Wisconsin, Madison
Quality Control and Protein Trafficking
Chairperson: W. Neupert, University of Munich, Germany
Cellular Response to Stress
Chairperson: A. Horwich, Yale University School of Medicine,
New Haven, Connecticut
Chaperone Function in Disease and Development
Chairperson: F.U. Hartl, Max-Planck Institute for Biochemistry
Martinsried, Germany
Regulation of the Stress Response
Chairperson: R. Morimoto, Northwestern University Evanston,
Illinois
Chaperones and Proteolysis
Chairperson: B. Sauer, Massachusetts Institute of Technology
Cambridge
Diseases of Protein Misfolding
Chairperson: J. Kelly, Scripps Research Institute, La Jolla,
California
K. Van Wijk, A. Breiman
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T. Serio, V. Grimminger
D. Smith
Workshop on Chicken Genomics and Development
May 7-10 91 participants
ARRANGED BY David Burt, Roslin Institute
Olivier Pourquie, HHMI/Stowers Institute for Medical Research
This meeting was well attended by researchers representing 15 countries. There were 60 abstracts of
papers presented during the sessions. The workshop began with a keynote presentation by Cliff Tabin
on insights into the development of vertebrate limb and gut. Scientific sessions
are listed below under "Program." Additional discussions centered on ways to
improve the chicken genome, such as new release and annotations, and on the
current sequencing of the zebra finch. Presentations also highlighted some suc-
cessful techniques to make transgenic chicken. A wrap-up session included an
exploration of "what now" and "what next" with plans to hold yearly meetings
alternating between Europe and the United States to allow more people to attend
this meeting and build a strong "chicken community."
This meeting was supported in part by funds provided by a grant from the
Society for Developmental Biology and proceedings from Developmental Biology,
the SDB official journal.
D. Burt
V. Mobegl. S. Lamont
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PROGRAM
Opening Remarks/Plenary Session
0. Pourquie, Stowers Institute for Medical Research, Kansas
City, Missouri
Keynote Speaker: Utilizing the Chick System to Gain
Insights into the Development of the Vertebrate Limb
and Gut
C. Tabin, Harvard Medical School
Emerging Disease and Immunity
Chairperson: D. Burt, Roslin Institute, Edinburgh, United
Kingdom
Development I
Chairperson: C. Tabin, Harvard Medical School, Boston,
Massachusetts
QTL and Population Biology
Chairperson: L. Andersson, Uppsala University Sweden
Avian Genomes and Bioinformatics I
Chairperson: M. Groenen, Wageningen University The
Netherlands
Avian Genomes and Bioinformatics II
Chairperson: M. Groenen, Wageningen University The
Netherlands
Evolution and Biodiversity
Chairperson: J. Dodgson, Michigan State University East
Lansing
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Development II
Chairperson: P. Antin, University of Arizona, Tucson
What's Next?
Summary and Plans for the Future
D. Burt, Roslin Institute
Closing Remarks
0. Pourquie, Stowers Institute for Medical Research
H. Sang, J. Inglis
Hedgehog Signaling
is Required I
but only Partially Regu'lr
.a;"
L. Cogburn, N. Trakooljul
The Biology of Genomes
May 10-14 524 participants
ARRANGED BY Kelly Frazer, Perlegen
Thomas Hudson, McGill University
Svante Paabo, Max-Planck Institute
Richard Wilson, Washington University
This meeting marked the 17th annual gathering of genome scientists in this setting. The past decade
or more has seen remarkable progress in the mapping, sequencing, and annotation of the genomes of
many "model organisms" and publication of finished and draft sequences of the human, mouse, rat,
and dog genomes, in addition to several model organisms and hundreds of bacteria. Just over 500
people from around the world attended the meeting, with more than 300
abstracts presented describing a broad array of topics relating to the analy-
sis of genomes from a number of different organisms.
The session topics included areas such as biological insights from com-
putational genomics, functional genomics, genomics of nonhuman species,
evolutionary genomics, population genomic variation, statistical genomics
and association studies, and high-throughput genomics. The International
Hap Map program announced the completion of the project successfully
genotyping 4 million SNPs in 270 individuals. There was considerable enthu-
siasm and discussion for how the Hap Map data would enable large-scale
association studies to occur over the upcoming year. The ELSI (Ethical,
Legal, and Social Implications) panel chaired by Francis Collins focused on
issues surrounding data release and intellectual property challenges in the
age of large-scale human genotyping and sequencing.
The major themes of the meeting included the analysis of genetic variation across
genome, statistical analysis approaches for understanding whole-genome scans, and several new
imaging and large-scale molecular approaches for understand complex biological processes. The
Saturday afternoon keynote talks were delivered by David Cox, and Nancy Wexler.
Funding for this meeting was provided by National Human Genome Research Institute.
T. Hudson, K. Frazer
the human
F. Collins, D. Cox
R. Waterston, L. Stein, D. Keller
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PROGRAM
Computational Genomics
Chairpersons: T. Hubbard, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; M. Kellis, Broad Institute of MIT
and Harvard, Cambridge, Massachusetts
Functional Genomics
Chairpersons: L. Pennachio, Lawrence Berkeley National
Laboratory California; P. Fraser, Babraham Institute,
Cambridge, United Kingdom
Genomics of Nonhuman Species
Chairpersons: L. Andersson, Uppsala University Sweden; P.
Andolfatto, University of California, San Diego
Evolutionary Genomics
Chairpersons: J. Graves, Australian National University,
Canberra; H. Kaessmann, University of Lausanne,
Switzerland
ELSI Panel Discussion: Data Release and Intellectual
Property Challenges in the Age of Large-scale Human
Genotyping and Sequencing
Moderator: F. Collins, National Human Genome Research
Institute
Panelists: G. Duyk, TPG Ventures; W. Lowrance, Independent
Consultant; R. Cook-Deegan, Duke University
Population Genomic Variation
Chairpersons: J. Pritchard, University of Chicago, Illinois; J.
Sebat, Cold Spring Harbor Laboratory
Statistical Genomics and Association Studies
Chairpersons: K. Roeder, Carnegie Mellon University
Pittsburgh, Pennsylvania; L. Cardon, University of Oxford,
United Kingdom
Guest Speakers
D. Cox, Perlegen Sciences; N. Wexler, Columbia University
High-throughput Genomics
Chairpersons: J. Rogers, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; M. Uhlen, Royal Institute of
Technology, Stockholm, Sweden
A. Baross, S. Sunkin G. Lunter, D.-Q. Nguyen, T. Oh, Z. Lombard, A. Heger, C. Ponting
J. Ng, J. Hudson
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R. Guigo, H. Sussman S. Bhattacharya, S. Chatterjee
The Cell Cycle
May 17-21 382 participants
ARRANGED BY Orna Cohen-Fix, NIDDK/National Institutes of Health
Nicholas Dyson, Massachussetts General Hospital Cancer Center
David Morgan, University of California, San Francisco
The eighth biannual Cell Cycle meeting was held this year at Cold Spring Harbor. This conference is
internationally recognized for its ability to bring together scientists who study cell cycle regulation in
eukaryotes ranging from yeast to humans. As usual, the meeting began with a keynote talk from a
leader in the field, and on this occasion, we were fortunate to have Dr. Marc Kirschner, Chair of the
Department of Systems Biology at Harvard Medical School, tell us about his exciting new studies of
molecular mechanisms controlling the vertebrate cell cycle. The remainder of the meeting was orga-
nized around eight sessions focused on the major stages of the cell division cycle, with an emphasis in
each session on the molecular mechanisms that govern cell cycle progression.
Many of these sessions focused on long-standing problems in cell cycle control, including the tran-
scriptional mechanisms controlling entry in the cell cycle, the mechanisms that initiate chromosome dupli-
cation and limit it to once per cell cycle, the mechanisms that trigger the complex events of chromosome
segregation in mitosis, and the numerous checkpoint systems that ensure that cell cycle events occur in
the correct order. The mechanics of mitosis, and in particular the operation of the mitotic spindle, received
considerably more attention at this meeting than in the past, thanks to a surging interest in the complex
processes that lead to assembly of the spindle and govern the behavior of chromosomes during mitosis.
For the first time, the meeting also included a half-session on the exciting field of cytokinesis, the
process by which the cytoplasm is divided at the end of the cell cycle. Other emerging areas, including
the control of meiosis and the coordination of cell division cell growth, were also represented. As
always, every major model system for cell cycle analysis was represented, and the striking phylogenet-
ic conservation of cell cycle regulatory mechanisms was readily evident. The meeting also served to
demonstrate the impact of whole-genome analysis on basic cell biology, and these achievements will
no doubt continue to drive rapid progress in this field. It was another landmark meeting for the cell cycle
field, and the participants continue to look forward to equally exciting meetings in future years.
Funding for this meeting was provided by the National Cancer Institute.
J. Pomerening, D. Thron
0. Cohen-Fix, D. Morgan, S. El ledge
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Cell Cycle Control Mechanisms
Chairperson: J. Ferrell, Stanford University School of Medicine,
California
Keynote Speaker
M. Kirschner, Harvard Medical School
G1 Control I
Chairpersons: J.W. Harper, Harvard Medical School, Boston,
Massachusetts; S. Van den Heuvel, Utrecht University The
Netherlands
G1 Control II
Chairpersons: B. Edgar, Fred Hutchinson Cancer Research
Center, Seattle, Washington; M. Tyers, Samuel Lunenfeld
Research Institute, Toronto, Canada
S Phase
Chairpersons: S. Bell, HHMI/Massachusetts Institute of
Technology Cambridge; J. Walter, Harvard Medical School,
Boston, Massachusetts
M Phase I: Mitotic Chromosomes and the Spindle
Chairpersons: D. Koshland, HHMI /Carnegie Institute of
Washington, Baltimore, Maryland; C. Walczak, Indiana
University Bloomington
M Phase II: APC and the Spindle Checkpoint
Chairpersons: S. Biggins, Fred Hutchinson Cancer Research
Center, Seattle, Washington; A. Musacchio, European
Institute of Oncology Milan, Italy
M Phase III: Anaphase and Cytokinesis
Chairpersons: M. Glotzer, University of Chicago, Illinois; F.
Uhlmann, Cancer Research UK London Research Institute
DNA Damage Response
Chairpersons: K. Cimprich, Stanford University California; S.J.
El ledge, Harvard Medical School, Boston, Massachusetts
Professor for a Day Program students S. Christedes, K. Bedkowski,
J. Cohen, H. Lewkowitz-Shpuntoff, L. Libresco, M. Indaram
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J. Lahti, K. Kitagawa
R. Scalfani, J. Hamlin
S. Stoynov, Y. Boyarchuk
Retroviruses
May 23-28 459 participants
ARRANGED BY Frederic Bushman, University of Pennsylvania School of Medicine
Jaquelin Dudley, The University of Texas, Austin
This 31st annual meeting devoted to retroviruses was organized into two keynote addresses, ten ses-
sions of short talks on specific topics, and three poster sessions.
Two distinguished scientists delivered the keynote addresses: Michael
Malim described the discovery of the APOBEC antiretroelement system
and the function of HIV Vif, and Marina Cavazzana-Calvo described results
from the first unambiguously successful gene therapy trial in humans, as
well as the first example of insertional activation of oncogenes in humans
by a retrovirus vector. The choice of speakers allowed a wide array of retro-
virus topics to be addressed in basic and applied retrovirology. Both talks
were very well received.
Ten sessions were devoted to short talks on specific topics including
virus entry, assembly, restriction factors, antiviral agents, integration,
accessory genes, pathogenesis, reverse transcription, and RNA synthesis,
processing, and export. Poster sessions were held on Wednesday
evening, Thursday afternoon, and Friday evening and were organized
alphabetically, so that poster presenters were able to see some of the
posters in their fields. Evening poster sessions facilitated interactions by
participants since there were no events immediately following. A multitude of significant new advances
were reported, including new findings on pathogenesis, restriction factors, assembly, and integration.
Because of the intense interest in retroviral restriction factors and assembly, there were two sessions on
each of these subjects. The largest number of abstracts was presented on retroviral assembly, and this
area was highlighted and summarized on the front cover of the abstract book by an excellent graphic
kindly provided by Wes Sundquist.
In other matters, the meeting is increasingly user friendly. Strengths are the improved food, banquet,
and A-V/computer support. Wireless Internet access was appreciated by many participants. Weaknesses
are minor, but include off-site housing for some participants, proximity to Memorial Day, sporadic cell
phone coverage, and small size of the bar. We very much appreciated the help and guidance of David
Stewart, Mark Beavers, and the CSHL audiovisual staff, who greatly facilitated the meeting organization.
Funding for this meeting was provided by the CSHL Corporate Sponsor program.
F. Bushman, M. Malim, J. Dudley
A.M. Skalka, M. Katzman
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Pathogenesis
Chairpersons: J. Stoye, National Institute for Medical Research,
London, United Kingdom; H. Fan, University of California,
Irvine
Assembly I
Chairpersons: P. Cannon, University of Southern California, Los
Angeles; H. Gottlinger, University of Massachusetts Medical
School, Worcester
Restriction Factors I
Chairpersons: T.J. Hope, Northwestern University, Chicago,
Illinois; V.N. KewalRamani, National Cancer Institute,
Frederick, Maryland
Keynote Speaker: Two Decades of Vif Research-An
Illustration of Viral Sophistication?
M. Maim, King's College London
Assembly II
Chairpersons: K. Musier-Forsyth, University of Minnesota,
Minneapolis; E.O. Freed, National Cancer Institute, Frederick,
Maryland
Entry
Chairpersons: L. Pedersen, Aarhus University, Denmark; M.J.
Federspiel, Mayo Clinic College of Medicine, Rochester,
Minnesota
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r
Reverse Transcription/Antivirals
Chairpersons: A. Telesnitsky, University of Michigan, Ann Arbor;
S.H. Hughes, National Cancer Institute, Frederick Maryland
Integration
Chairpersons: P. Cherepanov, Imperial College London, United
Kingdom; J. Grobler, Merck Research Laboratories, West
Point, Pennsylvania
Keynote Speaker: Where Do We Stand Six Years after
Gene Therapy?
M. Cava77ana- Calvo, Hopital Necker-Enfants Malades
Transcription/Processing/Export/Translation/Packaging
Chairpersons: B. Berkout, Academic Medical Center, University
of Amsterdam, The Netherlands; A.M. Lever, University of
Cambridge, United Kingdom
Restriction Factors II
Chairpersons: N.R. Landau, Salk Institute, La Jolla, California;
K. Strebel, NIAID/National Institutes of Health, Bethesda,
Maryland
Accessory Genes
Chairpersons: K. Boris-Lawrie, Ohio State University
Columbus; F. Kirchhoff, University of Ulm, Germany
G. Tachedjian, T. Hatziioannou S. Baenziger, J. DeStefano
C. Haller, B. Wei
New York Structural Biology Summer Forum
July 19 250 participants
ARRANGED BY Hao Wu, Weill Medical College of Cornell University
David Stokes, Skirball Institute, New York University
This conference was the eighth in day-long meetings allowing structural biologists from all over the
region to meet and discuss their latest results. It was open to structural biologists from different disci-
plines, including crystallographers, spectroscopists, computational biologists, and biochemists, with
250 participants from academia and industry from the tri-state area. The program featured 13 talks by
faculty, postdocs and students, as well as a poster session. A beach barbecue concluded the meeting,
allowing a wonderful opportunity for informal interactions. This meeting complements the bimonthly
evening meetings of the group held at The Rockefeller University. No registration was required and par-
ticipants were encouraged to set up posters.
Financial support was provided by Cell Press, FEI Corp., Gatan, GE Healthcare, Hampton Research,
lmclone, JEOL USA, Merck, Rigaku, Roche Pharmaceuticals, and Varian.
Waiting in the auditorium for the meeting to begin
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PROGRAM
Session I
Chairperson: D. Stokes, Skirball Institute, New York University
School of Medicine; R. Ghose, City College of New York; Y.
Huang, Skirball Institute, New York University School of
Medicine; J. Nandakumar, Memorial Sloan-Kettering Cancer
Center; S. Blanchard, Weill Medical College of Cornell
University
Session II
Chairperson: H. Wu, Weill Medical College of Cornell
University; F. Mancia, Columbia University; A. Stewart, SUNY
Stony Brook; J. Fernandez, Columbia University
Session III
Chairperson: W. Hendrickson, Columbia University College of
Physicians & Surgeons, New York; A. McDermott, Columbia
University; M. Vettings, Einstein College of Medicine; G.
Scapin, Merck
Session IV
Chairperson: L. Joshua-Tor, Cold Spring Harbor Laboratory; c
Simmerling, SUNY Stony Brook; E. Enemark, Cold Spring
Harbor Laboratory; D. Patel, Memorial Sloan-Kettering
Cancer Center
The picnic is always a treat
On the beach
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A leisurely lunch on the lawn
Glia in Health and Disease
July 20-24 211 participants
ARRANGED BY Ben Barres, Stanford University School of Medicine
Martin Raff, University College London
Glial cells constitute 90% of cells in the human nervous system, but their roles in the developing, adult,
and diseased brain are still poorly understood. In this new meeting, students and scientists from across
the world gathered to discuss their recent progress. In the first part of the
meeting, sessions focused on understanding the normal roles of glia, includ-
ing sessions on glial development, genetic analysis of glial function, myeli-
nation, axon-glial interactions, and astrocyte function at synapses and blood
vessels. Next, recent progress on understanding the roles of glia in reactive
gliosis, central nervous system regenerative failure, and disease processes
including multiple sclerosis, AIDS, glioma, and neuropathic pain.
The meeting concluded with a session highlighting advances in under-
standing glia that have been made possibly by new techniques, including
time-lapse imaging using two-photon microscopy, laser ablation, mosaic
analysis with double markers in mice, and new transgenic mouse models.
By the end of the meeting, there was a sense of excitement that the func-
tion of glia is finally at long last emerging from the shadows, with glia having
central roles in normal brain development, function, and disease.
Funding for this meeting was provided by the CSHL Corporate Sponsor
program. M. Raff, B. Barres
M. Chheda, H. Higashimori
U. Gaul, M. Freeman
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Glial Development
Chairpersons: S. Temple, Albany Medical College, New York;
C. Stiles, Dana-Farber Cancer Institute, Boston,
Massachusetts
Genetic Analysis of Glial Function
Chairpersons: W. Talbot, Stanford University School of
Medicine, California; S. Shaham, The Rockefeller University,
New York
Myelinating Cells
Chairpersons: D. Colman, McGill University, Montreal, Canada;
J. Griffin, Johns Hopkins Hospital, Baltimore, Maryland
Astrocyte Function at Synapses and Blood Vessels
Chairpersons: U. Gaul, The Rockefeller University, New York; R.
Robitaille, University of Montreal, Canada
Axon-Glial Interactions
Chairpersons: J. Salzer, New York University Medical Center;
E. Peles, Weizmann Institute of Science, Rehovot, Israel; p,
Magistretti, University of Lausanne, Switzerland
Reactive Gliosis and CNS Regenerative Failure
Chairpersons: Z, He, Children's Hospital, Boston, Massachu-
setts; M. Freeman, University of Massachusetts Medical
School, Worcester
Glia and Disease
Chairpersons: L. Watkins, University of Colorado, Boulder; V.H.
Perry, University of Southampton, United Kingdom
New Approaches to Understanding Glia
Chairpersons: W. Gan, New York University Medical Center;
B. Tasic, Stanford University California
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M. Heiman, S. Kucenas A. Mir, L. Dimou
D. Fields
New York Psychiatric Genetics Summer Forum
July 26 70 participants
ARRANGED BY Anil Malhotra, The Zucker Hillside Hospital, Glen Oaks, New York
Sydney Gary, Cold Spring Harbor Laboratory
This first meeting brought together neuroscientists, psychiatrists, and geneticists to
meet and discuss their latest results. This inaugural meeting involved 70 partici-
pants from the tri-state area who welcomed this unique opportunity to interact with
their local colleagues working to understand the genetic basis of psychiatric disor-
ders. The program featured welcoming remarks from Jim Watson, 11 research
talks, and a poster session. Presentations featured faculty, postdocs, and students.
The day concluded with a barbecue on the shore of Cold Spring Harbor, allowing
a wonderful opportunity for continued interactions in an informal setting.
PROGRAM
Welcoming Remarks
James Watson
Session I
Chairpersons: A. Malhotra, The Zucker Hillside Hospital,
Glen Oaks, New York; A. Fyer, Columbia University,
New York; J. Gelernter, Yale University, New Haven,
Connecticut; T. Lencz, The Zucker Hillside Hospital,
Glen Oaks, New York; J. Gordon, Columbia University
New York
Session II
Chairpersons: P. Szezcko, The Zucker Hillside Hospital,
Glen Oaks, New York; K. Burdick, The Zucker Hillside
Hospital, Glen Oaks, New York; J. Chen, Columbia
University, New York; J. Millonig, UMDNJ Robert Wood
Johnson Medical School, Piscataway New Jersey; L.
Delisi, New York University, Piermont; J. Sebat, Cold
Spring Harbor Laboratory
S. Gary, A. Malhotra
Y.S. Machado, B. Stevens
Lunch on the new Blackford deck
Meeting being shown on closed circuit TV in Grace Lobby
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Mechanisms and Models of Cancer
August 16-20
ARRANGED BY
459 participants
Jacqueline Lees, MIT Center for Cancer Research
Scott Lowe, Cold Spring Harbor Laboratory
Charles Sawyers, University of California, Los Angeles
Charles Sherr, HHMI/St. Jude's Children's Research Hospital
The first Mechanisms and Models of Cancer meeting held at the laboratory focused on a variety of topics
related to cancer genetics, biology, and therapy. The meeting evolved from the former Cancer Genetics
and Tumor Suppressor Genes meeting that occurred biannually since 1996 and reflected an increased
emphasis on integrated approaches to studying signaling in nor-
mal and cancer cells, as well as the use of sophisticated in vivo
mouse models to study various aspects of cancer biology.
More than 450 scientists, most of whom presented unpub-
lished research through oral or poster presentations, attended
the conference. The talks were highlighted by two keynote
lectures: Michael Kastan discussed recent advances in DNA
damage response pathways and Robert Eisenman discussed
our increased understanding of the myc oncogene-signaling
network. An international team of established investigators,
whose expertise covered many of the topics highlighted dur-
ing the meeting, chaired the individual sessions and facilitated
discussion and interactions throughout the course of the
meeting. Session topics are listed below under "Program."
This meeting was enthusiastically supported, and the lectures
and poster presentations led to extensive discussions and exchanges of information and ideas.
This conference was funded in part by the National Cancer Institute, a branch of the National
Institutes of Health.
J. Lees, C. Sherr, S. Lowe
K. Vousden, A. Ashworth
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Checkpoints and Cell Cycle Regulation
Chairpersons: C.J. Sherr, HHMI/St. Jude Children's Research
Hospital, Memphis, Tennessee; P.P. Pandolfi, Memorial
Sloan-Kettering Cancer Center, New York
Keynote Speaker: DNA Damage Response Pathways
and Human Disease
M.B. Kastan, St. Jude Children's Research Hospital
Cellular Senescence
Chairpersons: J. Campisi, Lawrence Berkeley National
Laboratory, California; J. Lees, MIT Center for Cancer
Research, Cambridge, Massachusetts
Genomes, Target Identification, and Therapeutics
Chairpersons: S. El ledge, Harvard Medical School, Boston,
Massachusetts; P. Lamb, Exelixis Inc., South San Francisco,
California
p53, ARF, MDM2, p53 Family
Chairpersons: L. Attardi, Stanford University, California; K.
Vousden, Beatson Institute for Cancer Research, Glasgow,
United Kingdom
Cancer Signaling Networks
Chairpersons: G. Evan, University of California Comprehensive
Cancer Center; San Francisco, California; B. Neel, Beth
Israel Deaconess Medical Center; Boston, Massachusetts
Keynote Speaker: Myc Goes Global
R. Eisenman, Fred Hutchinson Cancer Research Center
Signaling Pathways in Mouse Models
Chairpersons: A. Berns, Netherlands Cancer Institute,
Amsterdam; L. Parada, University of Texas Southwestern
Medical Center; Dallas
G. Caprara, P. Martinelli
Tumor Microenvironment
Chairpersons: M. Bissell, Lawrence Berkeley National
Laboratory California; J. Allison, Memorial Sloan-Kettering
Cancer Center, New York
DNA Damage and Repair
Chairpersons: A. Ashworth, Breakthrough Breast Cancer
Research Center; London, United Kingdom; J. Wang,
University of California, San Diego
H. Hermeking, M. Henriksson
S. Muthuswamy, M. Bissell
L. Groth-Pedersen, L. Fang
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Molecular Genetics of Bacteria and Phages
August 22-27 194 participants
ARRANGED BY Tina Henkin, Ohio State University
Gary Dunny, University of Minnesota Medical School
Charles Turnbough, Jr., University of Alabama, Birmingham
This meeting featured 74 talks, arranged in eight oral presentation sessions, and two poster sessions.
Bacteria and phages provide fantastic systems to study the chemistry of biology, and they grow ever
more important in the study of disease, the understanding of our environment, and the development of
new technologies. Topics discussed at the meeting are listed below under "Program."
Although many topics were discussed, a few prominent themes emerged, such as spatial and tem-
poral regulation during cell growth and differentiation. Hubert Lam, the winner of the annual Nat
Sternberg Award for the best thesis in prokaryotic molecular genetics, presented the first talk on this
subject. Dr. Lam, who trained with Christine Jacobs-Wagner at Yale, described key proteins involved in
establishing and perpetuating polarity in Caulobacter crescentus. Other talks described checkpoints,
regulated proteolysis, and subcellular protein localization during sporulation of Bacillus subtilis and also
the dynamics of chromosomal and plasmid partitioning.
Another theme was the application of genomics to study the inner workings of phage and bacteria.
Genomic approaches were used by Roger Hendrix to characterize jumbo phages and by William Navarre
to describe the role of H-NS in silencing horizontally acquired genes. Related approaches were used to
examine the critical role of ppGpp during amino acid starvation, genome-wide binding profiles of
Escherichia coli RNA polymerase, and the contribution of prophages to bacterial pathogenesis.
Gene expression and regulation were, as usual, major topics at the meeting. Richard Ebright described
possible DNA scrunching during the initiation phase of transcription, Rick Gourse described a new recog-
nition element in bacterial promoters, and Smita Shankar presented a model for Q-mediated antitermina-
tion. Another major theme was the connections between environmental signals, integrated signaling cir-
cuitries, and gene expression, and posttranscriptional regulation. Mechanisms for bacterial survival during
stationary phase, heat shock, and other common stress conditions were described. Posttranscriptional
S. Shankar, V. Vimberg
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regulation involving small RNAs was highlighted. For example, Gigi Storz described how the SymE toxin
of E. col/ is neutralized by the small RNA antitoxin SymR. A discussion of signaling would not be complete
without talks on cell structure and surfaces, and there were many of these. Mixed in with these talks was
Albert Siryaporn's use of a most colorful imaging assay to measure the extent of cross-talk between the
many two-component signal transduction systems in live E coif cells. The meeting concluded with a ses-
sion of excellent talks on DNA recombination and repair.
Support for this meeting was provided by the National Science Foundation.
PROGRAM
Cell Division and Development
Chairperson: W. Burkholder, Stanford University California
Bacteriophage and Genomics
Chairperson: R. Hendrix, University of Pittsburgh, Pennsylvania
Mechanism and Regulation of Transcription
Chairperson: R. Gourse, University of Wisconsin, Madison
Cellular Signaling and Stress Responses
Chairperson: E.P. Greenberg, University of Washington, Seattle
Bacterial Pathogenesis
Chairperson: S. Payne, University of Texas, Austin
Posttranscriptional Regulation
Chairperson: G. Storz, NICHD/National Institutes of Health,
Bethesda, Maryland
Prokaryotic Cytology and Surfaces
Chairperson: P. Christie, University of Texas Health Science
Center, Houston
DNA Recombination and Repair
Chairperson: S. Lovett, Brandeis University Waltham,
Massachusetts
S. Jones, M. Laubacher
J. Roberts, S. Gottesman
J. Hu, B. Burton
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Max Delbruck Centennial
August 26-27
ARRANGED BY David Stewart, Cold Spring
Harbor Laboratory
HONORARY COMMITTEE Detlev Ganten, Humboldt
University Berlin/Charite
Peter Star linger, Institute for Genetics, Koln, Germany
James D. Watson, Cold Spring Harbor Laboratory
John Wikswo, Vanderbilt University
The Max DelbrOck Centennial to celebrate the 100th anniversary of his birth
(September 4, 1906) was held immediately following the Molecular Genetics of
Bacteria and Phages meeting, with which DelbrOck was closely associated. The
celebration was attended by all four of Max's children and their families, and other
close friends and collaborators, and included reminiscences and thoughtful pre-
sentations by scientific colleagues and collaborators of Max, as well as current
overviews of scientific questions that intrigued DelbrOck throughout his life and
career. A special exhibition celebrating Max Delbruck's life was assembled by the
Laboratory's Library and Archives Director Mila Pollock and her staff, and it is
now on tour to Vanderbilt University, the California Institute of Technology, and
elsewhere. The celebration, attended by more than 100 people, also included a
classical concert, a special dinner, and various other events. It concluded with a
luncheon at Ballybung hosted by Jim and Liz Watson.
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Beside the lobby display of Max Delbruck's story
Delbruck, Genes, and Phage
In 1906, Wilhelm II was Emperor of the German Empire and King of Prussia; Edward VII had succeed-
ed his mother Queen Victoria and was in the fifth year of his reign as King of Great Britain, and Theodore
Roosevelt was the 26th President of the United States of America. Max DelbrOck was born that year in
Berlin, into an academic family. His father was a professor of history and a noted political controversial-
ist, and his mother's grandfather was the great chemist, Justus von Liebig. DelbrOck early developed a
passion for astronomy and entered the University of TUbingen as an astronomy student in 1924.
Unpromisingly, German astronomy at this time consisted largely of measuring and cataloging the posi-
tions of stars, an enterprise devoid of intellectual rigor or excitement. DelbrOck's interests changed to
theoretical astrophysics, inspired in part by hearing a seminar given by Werner Heisenberg. In 1926, he
moved to Gottingen, then a center of the new physics, with Max Born, Wolfgang Pauli and Heisenberg
working together there. DelbrOck moved intellectually, too, from astronomy to quantum physics, and
completed his Ph.D. with Born in 1928.
DelbrOck's interest in biology was awakened a few years later when he heard Niels Bohr give his
influential lecture "Light and Life," in which he argued that life might not be reducible to atomic physics
and that there was complementarity in biology as there was in physics. As DelbrOck wrote later, he was
inspired to pursue a research program in biology that would eventually "...lead to a paradoxical situa-
tion analogous to that into which classical physics ran in its attempts to analyze atomic phenomena."
DelbrUck was intrigued that the "...stability of the gene and the algebra of genetics suggested some-
thing akin to quantum mechanics," and his first foray into biology was when he teamed up with the
Russian geneticist Nikolai Timofeeff-Ressovsky and the radiobiologist Karl Zimmer to study the effects
of radiation on fruit flies. In the third part of the "Three-man" or "Green Paper," published in 1935,
DelbrOck discusses the nature of the gene from the standpoint of atomic physics. This paper might
have languished in obscurity had not Erwin Schrodinger made it the central argument in his book What
is Life?"(1944). He drew on DelbrUck's analysis to suggest that "a gene-or perhaps the whole chro-
mosome fiber-to be an aperiodic solid." Although it is clear that much of it is wrong (and was wrong
at the time he wrote it), the book had a significant impact, especially on some physicists, notably
Gunther Stent, Seymour Benzer, and Francis Crick.
By 1937, DelbrOck was committed to work on genetics. Stanley had recently crystallized tobacco
mosaic virus, and Delbruck viewed viruses both as crystalline molecules and as living organisms. He
viewed "...replication of viruses as a particular form of primitive replication of genes" and hoped that they
might provide the key to an atomic level analysis of the gene. DelbrOck received a Rockefeller
Foundation Fellowship to work in T.H. Morgan's group at California Institute of Technology but, not sur-
prisingly, found Drosophila genetics uninspiring. He was, however, introduced to bacteriophage by
Emory Ellis, and together they published a classic paper, "The Growth of Bacteriophage," the descrip-
tion and analysis of one-step growth. DelbrOck published three further papers on
phage before his fel-
lowship ended. In a brief reversion to physics, DelbrOck coauthored a short note
with Linus Pau ling
refuting the arguments put forward by Pascual Jordan that identical macromolecules had a special
quantum mechanical attraction for one another.
DelbrOck's second and third significant contribution as a biologist came
from his association with
Salvador Luria. They published a paper with Anderson on the electron
microscopy of bacteriophage,
but their most important collaborative research was their analysis of the appearance
of bacteria resis-
tant to phage infection (1943). The "fluctuation test" showed that mutations leading to resistance were
present in the population of bacteria and were selected for following
addition of phage, rather than resis-
tance arising as an adaptive response to infection. DelbrOck,
Luria, and Alfred Hershey made up the
core of the Phage Group that led to DelbrOck's third contribution,
and arguably the most influential: the
Phage Course at Cold Spring Harbor. DelbrOck and Luria first came
together to Cold Spring Harbor in
the summer of 1941 to do research. Delbruck was now at
Vanderbilt University and during the winter
of 1944-1945, he tentatively introduced a course on phage
biology and genetics to be taught at Cold
Spring Harbor. The first students, a grand total of six, took
the first Phage Course in the summer of
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Benno Muller-Hill, Jeffrey Miller
Karin Moelling, John Inglis
Daniel Wulff, Peter Star linger Bruce Stillman, Jonathan Delbruck Jennifer Rohn, Harry Rubin
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John Wikswo, David Stewart, Jan Witkowski Waclaw Szbalski, Sheng-Tsien Hung, Simanti Datta
Julie Albers, cellist, in concert during the celebration
Elita Delbruck, James Watson, Lina Delbruck
1, i fL,
Lina Delbruck, Yuri Delbruck, Kyuya Tamura Tobi DelbrOck, Christa Mayr Menzel
Klaus Rajewsky, Mila Pollock Nicola Salmon, Liz Watson, Rick Salmon Mathew Meselson, Alex Gann
Detler and Ursula Ganten
Beate Carriere, Giuseppe Bertani
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1945. DelbrOck taught the course
for the first three summers and was
succeeded by Mark Adams. The
influence of the Phage Course is
undeniable. Many of the luminaries of the phage and bacterial genet-
ics underwent initiation in the Course
not only into the biology of phage, but also into the DelbrOck style
of doing research: rigorous, quantitative,
and no toleration of sloppy thinking.
DelbrOck had less and less to do with
phage in the early 1950s as his interest changed from genet-
ics to studying sensory perception and transduction.
He chose to study phototropism in Phycomyces,
"...in the belief that in the field of transducer
physiology, as in genetics, essential progress will require
the use of a suitable microorganism."
DelbrOck, Hershey, and Luria shared the 1969
Nobel Prize for Physiology or Medicine "...for their dis-
coveries concerning the replication mechanism
and the genetic structure of viruses." In his Nobel
Lecture, DelbrOck, returning perhaps to the
philosophical challenges that 30 years earlier he and Bohr
had seen in biology, challenged his audience to
think about truth: "...even if we learn to speak about
consciousness as an emergent property of nerve nets, even
if we learn to understand the processes
that lead to abstraction, reasoning and language, still any
such development presupposes a notion of
truth that is prior to all these efforts and that cannot
be conceived as an emergent property of it, an
emergent property of a biological evolution."
PROGRAM
OPENING REMARKS:
Bruce Stillman, Cold Spring Harbor Laboratory
REMINISCENCES
Chairperson: Mile Pollock, Cold Spring Harbor Laboratory
Jan Drake, National Institute of Environmental Health Sciences
Ernst Peter Fischer, Universitat Konstanz
Detlev Ganten, Humboldt University Berlin/Charite
Rashika Harshey,University of Texas, Austin
Makkuni Jayaram, University of Texas, Austin
Dale Kaiser, Stanford University School of Medicine
Peggy Lieb, University of Southern California
Carol Lipson, Syracuse University
Karl Maramorosch, Rutgers University (Cook College)
Matthew Meselson, Harvard University
Harry Rubin, University of California, Berkeley
Peter Star linger, University of Koln
Gunther Stent, University of California, Berkeley
Waclaw Szybalski, University of Wisconsin, Madison
James D. Watson, Cold Spring Harbor Laboratory
Dan Wulff, SUNY at Albany
After Dinner Speakers
Jonathan DelbrOck, Atlas Pacific TC, Del Mar, California
Lawrence M. Krauss, Case Western Reserve University
ATTENDEES
F. Carter Bancroft, Mount Sinai School of Medicine
Howard Berg, Harvard University
Anni Bergman, Northeastern University
Kostia Bergman, Northeastern University
Giuseppe Bertani, California Institute of Technology
F indicates family, family friends, etc.
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Jan Witkowski
Executive Director; Banbury Center
Current Science
Chairperson: John Wikswo, Vanderbilt University
Howard Berg, Harvard University. Inspired by conversations
with Max DelbrOck at CSHL, Howard began work on bacteri-
al chemotaxis. The field has made substantial progress.
Molecular biology of behavior: Taming bacteria.
Enrique Cercla-Olmedo, University of Seville. Postdoc and col-
laborator of DelbrOck.
Phycomyces under the helm and in the wake of Max DelbrOck.
Tobias DelbrOck, University of Zurich. How Max started
Neuromorphic Engineering, and what is that anyhow?
Karel Svoboda, Cold Spring Harbor Laboratory/HHMI.
European physicist turned neurobiologist working at CSHL
on experience-dependent plasticity in various sensory sys-
tems.
Imaging synaptic plasticity in vivo.
Closing Talk: Max Delbriick and Systems Biology
Lee Hood, Institute for Systems Biology
Pat Burke (F)
Beate Carriere (F)
Enrique Cerda-Olmedo, Universidad de Sevilla, Spain
Clare Clark, Cold Spring Harbor Laboratory
Robert Cohen, University of Florida
Luis Corrochano, Universidad de Sevilla, Spain
Jonathan DelbrOck (F)
Tobi Delbruck (F)
Jan Drake, National Institute of Environmental Health Sci
Gary Dunny, University of Minnesota Medical School
Rada Dyson-Hudson (F)
Jan Eisenman, Cold Spring Harbor Laboratory
Ellen Fanning, Vanderbilt University
Ernst Peter Fischer, Universitat Konstanz, Germany
Naomi Franklin, University of Utah
Paul Gal land, University of Marburg, Germany
Rustem Gamow, University of Colorado (Retired)
Detlev Ganten, Humboldt University Berlin/Charite, Germany
Wally and Celia Gilbert (F)
Sue Harrison (F)
Rashika Harshey, University of Texas, Austin
Kiryn Has linger, Cold Spring Harbor Laboratory
Tina Henkin, The Ohio State University
Leroy Hood, Institute for Systems Biology
John Inglis, Cold Spring Harbor Laboratory
Makkuni Jayaram, University of Texas, Austin
Dale Kaiser, Stanford University School of Medicine
Lawrence Krauss, Case Western Reserve University
Gordon Lark, University of Utah
Margaret Lieb, University of Southern California
Carol Lipson, Syracuse University
Edward Lipson, Syracuse University
Daniel Luria (F)
Zella Luria (F)
Karl Maramorosch, Rutgers University (Cook College)
Marisa Macari, Cold Spring Harbor Laboratory
F indicates family, family friends, etc.
Christa Menzel (F)
Matthew Meselson, Harvard University
Jeffrey Miller, University of California, Los Angeles
Karin Moelling, University of Zurich
Benno Muller-Hill, Universitat zu Koln, Germany
Mila Pollock, Cold Spring Harbor Laboratory
Klaus Rajewsky, CBR Institute for Biomedical Research
Jennifer Rohn, LabLit.com Magazine
Harry Rubin, University of California, Berkeley
Ludina Sal lam (F)
Nicola Salmon (F)
Gorden Sato (F)
Walter and Audrey Shropshire (F)
Robert Sinsheimer, University of California, Santa Barbara
Frank Stahl, University of Oregon
Peter Star linger, University of Koln, Germany
Gunther Stent, University of California, Berkeley
David Stewart, Cold Spring Harbor Laboratory
Bruce Stillman, Cold Spring Harbor Laboratory
Karel Svoboda, Cold Spring Harbor Laboratory
Waclaw Szybalski, University of Wisconsin, Madison
Kyuya Tamura (F)
Charles Turnbough, Jr., University of Alabama at Birmingham
Alexander Ulam (F)
James Watson, Cold Spring Harbor Laboratory
Simone Wenkel, University of Cologne
John Wikswo, Vanderbilt University
Evelyn Witkin, formerly Rutgers University
Jan Witkowski, Cold Spring Harbor Laboratory
Daniel Wulff, SUNY at Albany
Libby Zimmerman, Northeastern University
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Mouse Molecular Genetics
August 30-September 4 243 participants
ARRANGED BY Francois Guillemot,
National Institute for Medical Research,
London, United Kingdom
Janet Rossant, The Hospital for Sick Children,
Toronto, Canada
Hiroyuki Sasaki, National Institute of Genetics,
Japan
Anthony Wynshaw-Boris, University of California,
San Diego
This meeting is held every other year and attracts
researchers from across the globe. Scientists attend-
ing the meeting also come from very diverse areas
of biology and are united by the common use of
mouse mutants in their research. As a result,
the meeting covers very diverse areas of biol-
ogy in which the contribution of mouse genetics
is essential to the progress of knowledge.
The sustained interest of all participants throughout
the meeting is ensured by the common-
ality of techniques, as well as by increasing evidence that basic mechanisms
are conserved
across diverse experimental systems.
The meeting was organized into 11 sessions, and
included the Annual Rosa Beddington
Lecture given by Virginia Papaioannou. Each session was
arranged around two to three
talks of general interests, given by both senior and more
junior invited researchers. Between
these more in-depth talks, five to six speakers per session were
selected from the abstracts
for more concise presentations, and included the presentation
of several hundred posters
in two afternoon sessions. The meeting ended with a farewell to Francois Guillmot
and
Janet Rossant, who stepped down after 4 years as organizers of the meeting.
Some of the sessions have shifted in their emphasis the past 2 years.
The growing empha-
sis on genetics/genomics and on human disease models, already
noted in previous years, has
also continued. Given the increasing importance of the mouse as a
model to investigate dis-
ease mechanisms, and the sophistication with which diseases can now be modeled
and ana-
lyzed in the mouse, the organizing committee has decided to emphasize
the link between
mouse and human genetics. This year, neurogenetic diseases were a
focal point of the session
featuring mouse models of human diseases. Besides a session on genetics/genomics, there
was also a Mouse Genome Bionformatics workshop headed by Deanna Church of NCBI.
This conference was supported in part by funds provided by the National Cancer
Institute, the National Institute of Child Health and Human Development, the National
Institute of Diabetes & Digestive and Kidney Diseases, and the National Institute of
Neurological Diseases and Stroke.
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J. Rossant
A. Naumova, A. Klar
A. Wynshaw-Boris
PROGRAM
Epigenetics
Chairperson: T. Magnuson, University of North Carolina,
Chapel Hill
Genetics and Genomics
Chairperson: D. Hilton, Walter & Eliza Hall Institute of Medical
Research, Parkville, Australia
Stem Cells and Differentiation
Chairperson: E. Fuchs, HHMI/The Rockefeller University, New
York
Neurobiology
Chairperson: L.-H. Tsai, HHMI/Massachusetts Institute of
Technology, Cambridge
Mouse Genome Bioinformatics Workshop
D. Church, National Center for Biotechnology Information,
Bethesda, Maryland
Rosa Beddington Lecture
V. Papaioannou, Columbia University
Signaling
Chairperson: S. Yamanaka, Kyoto University, Japan
Organogenesis
Chairperson: C. Wylie, Children's Hospital Research
Foundation, Cincinnati, Ohio
Human Disease Models: Neurogenetic Diseases
Chairperson: C. Walsh, Beth Israel Deaconess Medical Center,
Boston, Massachusetts
Patterning
Chairperson: K. Anderson, Memorial Sloan-Kettering Cancer
Institute, New York
D. Griffiths, 0. Andersson
C. Ovitt, D. Barlow
R. Arkell, P. Hoodless, T. Rodriguez
A. lulianella, F. Guillemot
265
csHuwencome Trust Conferences
These conferences were held at the Hinxton Hall
Conference Centre, located several miles south of
Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome
Campus, together with
the Sanger Institute, and the European Bioinformatics
Institute. The conferences are managed jointly by Cold
Spring Harbor Laboratory and the Wellcome Trust and
follow the Cold Spring Harbor style in that the major-
ity of talks are chosen from openly submitted abstracts. The
topics of the joint conference series emphasize
genomics and bioinformatics, or topics of particular interest to science
in the United Kingdom or Europe.
Interactome Networks
August 30-September 3 121 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Anne-Claude Gavin, Cellzome Inc.
Marc Vidal, Dana-Farber Cancer Institute
This second meeting brought together senior and junior investigators, postdoctoral, and (post)gradu-
ate researchers in a range of disciplines to share existing research and experience. The conference
addressed topics including ORFeome and other clone resources, Y2H and other binary assay maps;
pull-down mass spectrometry approaches; finishing orthogonal binary assays; assembly/annotation:
integration with phenotypic, transcriptome and localization clustering data; domain-domain networks;
and interaction-defective genetics.
PROGRAM
ORFeome and Other Resources
Chairperson: D. Gerhard, NCl/National Institutes of Health,
Bethesda, Maryland
DNA/Protein and Other Networks
Chairperson: G. Superti-Furga, Austrian Academy of Sciences,
Vienna
Cocomplex Membership Maps
Chairperson: A.-C. Gavin, EMBL, Heidelberg, Germany
Binary Interaction Maps
Chairperson: J. Haas, University of Munich, Germany
Keynote Speaker: The Wall Of Genomics
R. Gibbs, Human Genome Sequencing Center, Baylor
College of Medicine
Assembly, Annotation, Visualization
Chairperson: E. Birney, EMBL-EBI, Hinxton, United
Kingdom
Data Integration, Interactome Modeling I
Chairperson: M. Vidal, Dana-Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts
Data Integration, Interactome Modeling II
Chairperson: D. Scholtens, Northwestern University,
Chicago, Illinois
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Domain-Domain Networks
Chairperson: R. Russell, EMBL, Heidelberg, Germany
Keynote Speaker: Mapping Regulatory Genomes and
Their Evolution
B. Wold, California Institute of Technology
Francis Crick Auditorium
Genomic Perspectives to Host-pathogen Interactions
September 7-10
ARRANGED BY
99 participants
Matthew Berriman, Wellcome Trust Sanger Institute
John Boothroyd, Stanford University
Julian Parkhill, Wellcome Trust Sanger Institute
George Weinstock, Baylor College of Medicine
This second meeting focused on how the rapid expansion in host, pathogen, and vector genome data
and other large data sets is changing the way we think about host-pathogen-(vector) interactions. The
conference brought together leading scientists in this growing field, and we strongly encourage
researchers interested in a variety of different hosts, pathogens, and vectors to attend.
PROGRAM
Session 1
Chairpersons: D.M. Bird, North Carolina State University,
Raleigh; D.F. Smith, University of York, United Kingdom
Session 2
Chairpersons: B. Wren, London School of Hygiene and
Tropical Medicine, United Kingdom; S. Andersson, Uppsala
University, Sweden
Session 3
Chairpersons: J.M. Musser, The Methodist Hospital, Houston,
Texas; P. Keim, Northern Arizona University, Flagstaff
Session 4
Chairpersons: J. Berman, University of Minnesota, Minneapolis;
T. Palzkill, Baylor College of Medicine, Houston, Texas
Session 5: Poster Session
Session 6
Chairpersons: A.A. James, University of California, Irvine; M.J.
Lehane, Liverpool School of Tropical Medicine, United Kingdom
Session 7
Chairpersons: D. Roos, University of Pennsylvania, Philadelphia;
M. Blaxter, University of Edinburgh, United Kingdom
Keynote Speaker: Phenotype and Genotype Evolution of
Influenza A Virus
R.A.M. Fouchier, Erasmus Medical Center
Wellcome Trust Conference Center and Hinxton Hall
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Genome Informatics
September 13-17 207 participants
ARRANGED BY Tim Hubbard, Wellcome Trust Sanger Institute
Suzanna Lewis, University of California, Berkeley
Jason Swedlow, University of Dundee
This sixth conference continued to highlight the latest developments in genome research and, once
again, was a vital and exciting meeting. The explosion of biological data requires a concomitant increase
in the scale and sophistication of information technology. This ranges from the storage of data and their
associated data models, to the design of effective algorithms to uncover nonobvious aspects of these
data sets, to ontologies to concisely describe biological information, and finally to software systems to
support curation, visualization, and exploration. The conference brought together some of the leading
scientists in this growing field, and researchers from other large-scale information handling disciplines
were also invited to attend.
PROGRAM
Keynote Speaker
F. Kafatos, Imperial College London
Populations, Phenotypes, and Disease
Chairpersons: N. Hall, The Institute for Genomic Research,
Rockville, Maryland; 0. White, The Institute for Genomic
Research, Rockville, Maryland
Assembly, Annotation, and Resources I
Chairpersons: R. Durbin, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; A. Valencia, Spanish National
Cancer Research Centre, Madrid
Comparative and Evolutionary Genomics I
Chairpersons: N. Goldman, EMBL-EBI, Hinxton, United
Kingdom; J. Boore, DOE Joint Genome Institute, Walnut
Creek, California
Comparative and Evolutionary Genomics II
Chairpersons: N. Goldman, EMBL-EBI, Hinxton, United
Kingdom; J. Boore, DOE Joint Genome Institute, Walnut
Creek, California
Epigenomics
Chairperson: S. Beck, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Images, Atlases, and Reconstruction
Chairpersons: M. Martone, University of California, San Diego;
R. Baldock, MRC Human Genetics Unit, Edinburgh, United
Kingdom
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Assembly, Annotation, and Resources II
Chairpersons: R. Durbin, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; A. Valencia, Spanish National
Cancer Resarch Centre, Madrid
Regulation, Pathways, and Networks
Chairpersons: S. Teichmann, MRC Laboratory of Molecular
Biology Cambridge, United Kingdom; B.F.F. Ouellette,
University of British Columbia, Vancouver
Grounds of the Wellcome Trust Genome Campus
Integrative Approaches to Brain Complexity
September 28-October 1 65 participants
ARRANGED BY Seth Grant, Wellcome Trust Sanger Institute
Nathaniel Heintz, HHMI/The Rockefeller University
Jeffrey Noebels, Baylor College of Medicine
This second conference explored the structural and functional complexity of the vertebrate nervous sys-
tem. Advances in genomics and proteomics are defining the molecular building blocks that underpin
the structural complexity of the brain and it behavioral output. Combining genetic discoveries with
anatomical, electrophysiological and behavioral findings, it is now feasible to integrate this knowledge
to provide a more integrated understanding of brain function (and dysfunction).
PROGRAM
Human Genome and Genetics
Evolution of Brain Complexity
Keynote Lecture
S. Brenner, Salk Institute of Biological Studies
Brain Gene Expression: Cellular Approaches
Brain Gene Expression: Global Approaches and
Atlases
Neuroscience Datamining Workshop
Electrophysiological Integration
Circuitry Mapping
Behavior and Brain Imaging
Consortium Presentations
Residential Court
Sanger Institute
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Translational Control Meeting
September 6-10 449 participants
ARRANGED BY Alan Hinnebusch, NICHHD/National Institutes of Health
Nahum Sonenberg, McGill University, Canada
Gerhard Wagner, Harvard Medical School
This meeting attracted participants from around the world and included eight invited speakers, eight
platform sessions, and three poster sessions that covered 346 abstracts. There were many novel find-
ings presented concerning the mechanism of translation. It was reported that eIF4G contacts the e sub-
unit of elF3, implicated previously in tumor formation, and the binding site of one domain of elF3j was
mapped near the mRNA entry channel and A site of the 40S subunit. Distinct binding sites for elF5 and
elF3c have been mapped on elF1. There is new evidence that elF1 dissociation from the 40S is a key
step in AUG selection, and the amino and carboxyl termini of elF1A oppositely regulate the transition
from open to closed conformations of the scanning preinitiation complex (PIC). It now appears that
eIF1A participates in subunit joining by stimulating GTP hydrolysis by eIF5B, and a contact point for
eIF5B in 18S rRNA was uncovered by genetic suppressor analysis. Cryoelectron microscopy studies
revealed the structure of human 80S ribosomes trying to melt a pseudoknot structure from a pro-
grammed frameshift site and suggested that bacterial RRF alters its position on terminating ribosomes
to promote ribosome dissociation. The new bacterial elongation factor LepA, homologous to EF-G, was
shown to mediate back-translocation, presumably to correct translocation errors at high ionic strength.
An abortive termination event was described in which peptidyl tRNA is hydrolyzed after translation of a
specific heptapeptide and translation resumes at the next Pro codon.
There were also important new insights into translational control mechanisms. Structural data reveal that
the phosphorylation site in elF2a (Ser51) is buried and that kinase PKR induces a conformational change
that exposes the residue to the catalytic cleft. New data demonstrate the role of elF2a phosphorylation in
synaptic plasticity and memory in mammals. The structure of the domain in tumor suppressor protein
PDCD4 that binds and sequesters RNA helicase eIF4A was found to resemble the eIF4A- binding domain
in its natural partner eIF4G. A small molecule that inhibits eIF4E -eIF4G interaction has pro-apoptotic activ-
ity in Jurkat cells and inhibits proliferation in other cancer cell lines. Drosophila 4E-HP, which competes with
elF4E for mRNA caps but fails to bind eIF4G, was found to interact with the 3' untranslated region (3'UTR)-
binding translational repressors Bicoid and Nanos/Pum/Brat to prevent caudal and hunchback mRNAs
from recruiting elF4F, Cyfip1 emerged as a novel neuronal eIF4E- binding protein (4E-BP) that mediates
repressive association be-
tween the fragile-X mental
retardation protein (FMRP) and
eIF4E. There is now evidence
that 4E-BP promotes cap-
independent translation of sur-
vival-promoting and angiogen-
esis factors in mammalian
cells. It was demonstrated that
the interferon-y-activated in-
hibitor of translation (GAIT)
complex binds the 3'UTR and
silences translation of vascular
endothelial growth factor
(VEGF), ceruloplasmin, and
probably other interferon-in-
duced transcripts to coordi-
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Enjoying the Wine and Cheese Party on Airs lie Lawn
nately regulate inflammatory genes. The GAIT subunit ribosomal protein L1 3a, in a phosphorylation- and
RNA-dependent way, binds eIF4G and blocks recruitment of the 43S PIC, possibly by impeding elF3-
elF4G association. Translation of ASH1 mRNA in yeast is regulated by phosphorylation-dependent bind-
ing of KHD1 to the El element in the open reading frame, and it appears that phospho-KHD1 binds eIF4G
and prevents ribosome recruitment to the mRNA. It was shown that ZBP1 directs actin mRNA localization
to dendrites of expanding neurons and also prevents translation of the mRNA during transport.
Other novel insights concerned meiotic maturation and neuronal differentiation via cytoplasmic
polyadenylation. It was shown that the deadenylase PARN is active in Xenopus oocytes and opposes the
GLD2 cytoplasmic polyadenylase to maintain short poly(A) tails before maturation. A sequential activa-
tion of the cytoplasmic polyadenylation element-binding protein (CPEB) and a protein (C3H-4) that
induces ARE-mediated deadenylation was uncovered that temporally regulates target mRNAs with par-
ticular arrangements of CPE and ARE elements. CPEB and Musashi, a protein controlling cytoplasmic
polyadenylation in maturing eggs, is also activated during neuronal differentiation elicited by NGF in PC12
cells. A novel role for CPEB was discovered in regulating cellular senescence in somatic cells. There is
new evidence that translational repression by a Drosophila microRNA (miRNA) occurs at the level of PIC
assembly, rather than elongation. P bodies store miRNA-repressed mRNAs, and a repressed message
can reenter the translated pool in a manner regulated by ARE-binding protein
HuR. mRNA trafficking between P bodies and ribosomes in yeast involves
DEAD-box helicase UPF1 , which functions in nonsense-mediated mRNA
decay (NMD). Evidence was presented from yeast at odds with the idea that
mRNAs are susceptible to NMD only in the "pioneer" round of translation, and
it was shown that programmed frameshifting can reduce mRNA abundance
by activating NMD. The structure of the exon junction complex, a cis-acting
effector of NMD in mammals, was also described, and new results indicate
that the ARE activates decay from both the 5' and 3' ends of the mRNA.
Support for this meeting was provided by the National Institute of Child
Health and Human Development and Cell Technology, Inc.
PROGRAM
Development, the CNS, and Signaling
Chairperson: N. Standart, University of Cambridge, United
Kingdom
Viruses and Disease
Chairperson: I. Mohr, New York University School ofMedicine
Initiation Factors and Mechanisms
Chairperson: 0. Elroy-Stein, Tel Aviv University Israel
MicroRNAs and Regulation of Factors
Chairperson: R. Kaempfer, Hebrew University Jerusalem, Israel
mRNA Regulatory Elements
Chairperson: P. Fox, Cleveland Clinic Foundation, Ohio
Ribosome Structure and Function
Chairperson: C. Spahn, Charite-Universitatsmedizin, Berlin,
Germany
mRNA Turnover
Chairperson: D. Schoenberg, Ohio State University Columbus
Elongation and Termination
Chairperson: K. Nierhaus, Max-Planck lnstitut fur Molekulare
Genetik, Berlin, Germany
D. Cavener, D. Gietzen
J. Richter, J. Keene
V. Camerini, I. Napoli
271
Axon Guidance, Synaptogenesis, and Neural Plasticity
September 13-17 392 participants
ARRANGED BY Anirvan Ghosh, University of California, San Diego
Christine Holt, University of Cambridge
Mu-Ming Poo, University of California, San Diego
The human brain has billions of nerve cells (neurons) and each neuron is typically connected to hundreds
of other neurons via synapses in a highly precise fashion. This complex neural wiring underlies the ability
of humans, and other animals, to interact with the outside world, to learn and to perform complex behav-
iors. The complexity of the brain, in fact, surpasses that of a computer, and one of the major challenges
for the field of neuroscience is to understand how nerve connections are made accurately and reliably.
Connections between different regions of the brain are first established during embryogenesis and
result in the formation of a stereotyped pattern of axon pathways or fiber tracts. Projection neurons are
often a long distance away from their synaptic targets, and the first step in establishing connectivity is
to extend an axon tipped with a growth cone. The growth cone is the sensory/motile apparatus respon-
sible for steering an accurate course through the early neuroepithelium of the embryonic brain. What
directs the navigation of growth cones along the correct pathway? Once the growth cone reaches its
target area, it must then find the correct region to terminate and begin to make synapses. How do
axons select the correct cells with which to make synapses? Finally, after synapses are initially made,
they can be modified by activity and experience leading to "plastic" changes that are important in impor-
tant processes such as learning and memory. What determines whether a synapse is maintained or
lost? How are these plastic changes controlled? This meeting focused on these key issues in axon guid-
ance, synaptogenesis, and plasticity.
In the past decade, our understanding of the mechanisms that control axon growth and guidance,
synaptogenesis, and the remodeling of neural circuits during development has progressed rapidly from
phenomenology to the identification of specific molecular control mechanisms. Progress has been
assisted by the finding that these mechanisms are highly conserved across evolution, so that both bio-
chemical approaches in vertebrates and genetic approaches in invertebrates (and increasingly, in ver-
tebrates as well) have led to mutually reinforcing discoveries that have helped fuel further advances.
As the pace of discovery has quickened, the field has grown enormously, making it more difficult for
scientists to keep abreast of new developments. To help facilitate communication in the field, a bienni-
al CSH conference series on "Axon Guidance and Developmental Plasticity of the Nervous System" was
initiated in 1998. This year, the fifth of these meetings involved sessions devoted to particular problems
in the assembly of the nervous system, with speakers chosen from among the participants submitting
abstracts by Session chairs who are leaders in the field. Other abstracts were presented as posters.
J. Sanes, C. Mason
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N. -AIN
J. Raper, C. Bargmann
Like the previous four meetings, the response of the field to the 2006 conference was one of over-
whelming enthusiasm. Of the 392 participants, 254 submitted abstracts, and 63 abstracts were select-
ed for talks, in eight sessions. Senior researchers, starting assistant professors, postdoctoral fellows,
and graduate students were well represented as speakers and participants. All of the major areas of
research in the field were covered, as were all of the major approaches (cellular, physiological, anatom-
ical, molecular, dynamic imaging, biochemical, and genetic).
In addition, there were two keynote addresses: Dr. Corey Goodman reviewed the history of the field
of axon guidance and included some of the key contributions made by his own group, and Dr. Joel
Richter focused on the control of polyadendylation-mediated translation and its role in synaptic plastic-
ity. The meeting provided an important forum for ideas and approaches and helped scientists in the field
get the most up-to-date information, as well as enabling them to meet, to network, and to establish col-
laborations. Based on the uniformly enthusiastic comments of the participants, the intensity of the oral
and poster sessions, and the large crowds that stayed up late every night at the bar to discuss science,
the meeting was a great success.
Funding for this meeting was provided by the National Institute of Neurological Diseases and Stroke.
PROGRAM
Axon Guidance I: Guidance Molecules
Chairpersons: A. Kolodkin, HHMI/Johns Hopkins University
School of Medicine, Baltimore, Maryland; L. Zipursky,
HHMI/University of California, Los Angeles
Synapse Formation I
Chairpersons: C. Bargmann, HHMI/The Rockefeller University
New York; P. Scheiffele, Columbia University New York
Special Lecture: The Molecular Biology of Axon
Guidance Revisited
C. Goodman, HHMI/University of California, Berkeley
Neural Circuits and Plasticity I
Chairpersons: D. Feldman, University of California, San Diego;
C. Shatz, Harvard Medical School, Boston, Massachusetts
Axon Guidance II: Guidance Mechanisms
Chairpersons: R. Klein, Max-Planck Institute for Neurobiblogy,
Martinsried, Germany; P Bovolenta, Cajal Institute, Madrid, Spain
Neural Circuits and Plasticity II: Developmental Plasticity
in Sensory Cortex
Chairpersons: D. Feldman, University of California, San Diego;
C. Shatz, Harvard Medical School, Boston, Massachusetts
Axon Guidance Ill: Topographic Maps
Chairpersons: J. Flanagan, Harvard Medical School, Boston,
Massachusetts; C. Mason, Columbia University New York
Synapse Formation II: Targeting
Chairpersons: J. Sanes, Harvard University Cambridge,
Massachusetts; M. Bate, University of Cambridge, United
Kingdom
Special Lecture: Polyadenylation-mediated Translation in
the CNS
J. Richter, University of Massachusetts Medical School
Axon Guidance IV: Novel Mechanisms and Regeneration
Chairpersons: C.-B. Chien, University of Utah, Salt Lake City;
L. Luo, Stanford University California
NIDA Funding Opportunities in Developmental Biology
Chairperson: D.-Y. Wu, NIDA/National Institutes of Health,
Bethesda, Maryland
Neuronal Polarity and Dendritic Patterning
Chairpersons: H. Cline, Cold Spring Harbor Laboratory; Y.-N.
Jan, HHMI/University of California, San Francisco
A. Debant, A. Briacon-Marjollet
A. Nikolaev, A. Jaworski S. Margolis, D. Conon-Ramos
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Dynamic Organization of Nuclear Function
September 27-October 1 310 participants
ARRANGED BY Genevieve Almouzni, Institut Curie,
France
David Spector, Cold Spring Harbor Laboratory
Susan Wente, Vanderbilt University Medical Center
This meeting focused on the relationships between nuclear structure and function. The opening session
highlighted current studies on Chromosome Organization and DNA Replication, the session chair (David
Gilbert) describing his studies using a cell-free replication to dissect com-
ponents that regulate replication timing. Although the nucleus is highly
dynamic, the genome is nonrandomly organized with the mobility of chro-
matin constrained by its proximity to specific anchorage sites whose posi-
tions define the functional organization of the nucleus. This session tack-
led questions of replication and nuclear organization, coordinating chro-
matin assembly with replication, as well as how genomes are organized
in the nucleus for transcription.
The following morning's session on Nuclear Bodies chaired by Greg
Matera illustrated the ongoing and lively debate about the function of these
entities as bona fide sites of macromolecular assembly or merely represent-
ing aggregate byproducts of other nuclear processes. After a lively poster
session and wine and cheese party, the session on RNA Processing and
Export that evening was chaired by Javier Caceres, and served to empha-
size the high degree of connection that exists among different RNA processing events, and many specific
examples were discussed that provided significant insights for experienced observers and newcomers alike.
The Nuclear Structure and Disease session gave multiple direct examples of how the machinery
involved in nuclear organization and function is linked to the underpinnings of several pathophysiologic
states. Robert Goldman gave a broad and lucid introduction of general lamin structure and function, sum-
marized recent discoveries of roles in spindle assembly, and provided clear evidence for defective process-
ing of lamin A being a causative agent of the premature aging disease, progeria. In the Chromosomes and
Cell Cycle session, session chair William Earnshaw described the regulation of mitotic chromosome struc-
D. Spector, G. Almouzni, S. Wente
A.-M. Jacobs, F. Fuller-Pace
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ture by condensin and his group's identification of a novel activity provisionally termed RCA (regulator of
mitotic chromosome architecture). He postulated that that RCA normally drives mitotic chromosome con-
densation, with the role of condensin being to stabilize the condensed chromosomes. The Technologies
to Access Nuclear Organization session was chaired by Jan Ellenberg and provided an exciting overview
of state-of-the-art and emerging technologies to access nuclear organization at different scales of biolog-
ical organization, from whole living cells all the way to single mRNA molecules and nucleosomes.
Although several of the prior sessions pointed to connections to nuclear pore complex proteins
(nucleoporins/Nups) and the nuclear envelope, the Nuclear Periphery session allowed an in-depth
update on these topics, ably chaired by Douglass Forbes who presented provocative work on the role
of the Nup107-160 nucleoporin complex in mitotic spindle assembly. The final session on Transcription
and Genome Function was chaired by Maria Carmo-Fonseca who introduced a very fundamental ques-
tion: How does intranuclear positioning relate to gene function? In particular, she highlighted connec-
tions between pre-mRNA splicing, Pol II transcription and mRNA release. Several laboratories then pre-
sented their most recent progress on mapping multiple genes and regulatory sequences in the nucle-
us, identifying the molecules that mediate genomic confinement relative to different landmarks, and
determining whether positioning is a cause or consequence of gene activity.
The enthusiasm of the meeting participants was overwhelming, and the meeting will be held again
in the fall of 2008.
PROGRAM
Chromosome Organization and DNA Replication
Chairperson: D. Gilbert, Florida State University, Tallahassee
Nuclear Bodies
Chairperson: G. Matera, Case Western Reserve University
Cleveland, Ohio
RNA Processing and Export
Chairperson: J. Caceres, MRC Human Genetics Unit,
Edinburgh, United Kingdom
Nuclear Structure and Disease
Chairperson: R. Goldman, Northwestern University Medical
School, Chicago, Illinois
Chromosomes and the Cell Cycle
Chairperson: W. Earnshaw, University of Edinburgh, United
Kingdom
Technologies to Access Nuclear Organization
Chairperson: J. Ellenberg, European Molecular Biology
Laboratory Heidelbeg, Germany
The Nuclear Periphery
Chairperson: D. Forbes, University of California, San Diego
Transcription and Genome Function
Chairperson: M. Carmo-Fonseca, University of Lisbon,
Portugal
J. Campbell, T. Yoshihisa
M. Engelharolt, T. Pederson
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Molecular Genetics of Aging
October 4-8 338 participants
ARRANGED BY Judith Campisi, Lawrence Berkeley
National Laboratory
Lenny Guarente, Massachusetts Institute of Technology
Gary Ruvkun, Massachusetts General Hospital
Aging is controlled by genetics and the environment, and leads to biological imbalances that increase
the probability of death. Remarkable advances have been made in recent years in understanding how
genes and genetic processes control and influence aging. This meeting focused on these advances and
stimulated lively discussions on the relative contributions of various genetic pathways to the aging
process in simple model organisms and complex organisms such as mice and humans.
Two sessions focused specifically on genetics, highlighting the growing list of mutations that extend
the life span of simple model organisms such as nematodes and fruit flies. A separate session focused
on genetic manipulations that modulate aging and life span in mice. Sessions were also devoted to the
roles that mitochondria and nutrient metabolism play in the aging process. One session concentrated on
the brain and genomic approaches to understand the genes that regulate aging, another explored the
role of stress and cellular processes such as apoptosis and senescence in the aging of tissues and
organisms, and finally, another session focused on the roles of telomeres and genomic instability in both
aging and the development of late-life cancer. The meeting revealed the rapid progress that is being
made in understanding the molecular bases for aging, the many important questions that have yet to be
answered, and the rising hopes that interventions into fundamental aging processes may be possible.
Funding for this meeting was provided by the National Institute on Aging.
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,.Elik.
G. Ruvkun expounding his thoughts to a rapt audience
PROGRAM
Genetics I
Chairpersons: D. Sinclair, Harvard Medical School, Boston,
Massachusetts; M. Driscoll, Rutgers University Piscataway,
New Jersey
Metabolism
Chairpersons: B. Kahn, Beth Israel Deaconess Medical Center,
Boston, Massachusetts; G. Shulman, HHMI/Yale University
School of Medicine, New Haven, Connecticut
Genomics/The Brain
Chairpersons: T. Prolla, University of Wisconsin, Madison; B.
Yankner, Harvard Medical School, Boston, Massachusetts
Mice
Chairpersons: Y.-i. Nabeshima, Kyoto University, Japan; H.
Scrable, University of Virginia, Charlottesville
Senescence/Stress
Chairpersons: D. Bredesen, Buck Institute for Age Research,
Novato, California; W. Wright, University of Texas
Southwestern Medical Center, Dallas
Genetics II
Chairpersons: L. Partridge, University College London, United
Kingdom; C. Kenyon, University of California, San Francisco
Mitochondria
Chairpersons: D. Wallace, University of California, Irvine; S.
Hekimi, McGill University Montreal, Canada
Telomeres/Cancer
Chairperson: M. Blasco, Spanish National Cancer Center,
Madrid
R. Garvin, M. Grabowski
L. Partridge, S. Pletcher
N. Wade
L. Le Cam, B. Yankner
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Germ Cells
October 11-15 229 participants
ARRANGED BY Susan Strome, Indiana University
Azim Surani, Wellcome Trust/CRC Institute
One major advance reported at this meeting was on the mechanism of imprinting in the mouse germ line
and in the Arabidopsis gametophyte. Tim Bestor together with C. David Allis reported the crystallographic
structure of Dnmt3L, which is detected only in germ cells. The structural dimension of Dnmt3L can accom-
modate a nucleosome. The Dnmt3L structure also contains Dnmt3A and Dnmt3B, and this core structure
can "read" histone modification marks and induce DNA methylation of appropriate regions, such as the con-
trol elements of imprinted genes in developing mouse oocytes. Expression of the maternally imprinted SET
domain gene, MEDEA, in the Arabidopsis gametophyte is, however, regulated by a demethylase, DEME-
TER, a protein with a glycosylase domain, which functions to excise 5-methylcytosine. At the same time,
Christof Niehrs has identified a putative DNA demethylase from Xenopus that may have a role in the repro-
gramming of somatic nuclei in the oocyte. This apparently promotes DNA repair to erase DNA methylation
marks. Further studies on the reprogramming of somatic nuclei transferred into mammalian oocytes was
described by Rudolf Jaenisch, who also described the role of transcriptional factors such as Oct4/Sox2 and
epigenetic modifiers such as the polycomb group proteins in regulating pluripotent stem cells. Germ cells
also show expression of pluripotency markers such as Nanog, and Ian Chambers showed that this gene is
essential for the maintenance of the germ-cell lineage in mice. Mitinori Saitou showed how germ-cell spec-
ification in mice is critically dependent on Blimp1 , a transcriptional repressor that represses the somatic pro-
gram that is adopted by neighboring somatic cells. From further analysis, he described that Prdm1 4 is also
critical for formation of the founder population of primordial germ cells in mice.
Two prominent themes in several presentations on germ-line development in invertebrate model
tems were epigenetic regulation and regulation at the level of RNA. A feature shared by the primordial
germ cells of worms and flies is transcriptional repression. Bill Kelly, Akira Nakamura, and Ruth
Lehmann described several levels at which this repression is mediated in worms and flies. Key regula-
tors include PIE-1 in worms, PGC in flies, Nanos, and histone modifiers. Gene expression in the adult
germ line in worms seems to be regulated largely at posttranscriptional levels. Judith Kimble described
a network of translational regulators that operate in different regions of the gonad, and Chris Merritt
demonstrated the importance of genes' coding and/or 3"UTR regions (but not promoters) for achieving
proper protein distributions. Craig Mello discussed his and Andrew Fire's Nobel-winning studies of RNAi
and Argonaute proteins, after which Greg Hannon, Rene Ketting, and Haifan Lin presented advances
on the Piwi subclass of Argonautes, including their association with small (-30 nucleotides) RNAs and
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S. Strome, K. Blackwell R. Martiennsen, A. Surani
with chromatin regulators. Several presentations focused on stem cell biology, including a presentation
by Margaret Fuller demonstrating that during the stem cell divisions in fly testes, the stem cell daugh-
ters retain the mother "Eve" centrosome.
The next Germ Cells meeting will be held in the fall of 2008 and will be organized by Anne Ephrussi,
Renee Reijo Pera, and David Zarkower.
This meeting was supported in part by the March of Dimes Birth Defects Foundation Grant No. 4-
FY05-1255, the National Institute of Child Health and Human Development, and the Lalor Foundation.
PROGRAM
Themes in Germ-cell Biology
Chairpersons: S. Strome, Indiana University Bloomington; A.
Ephrussi, European Molecular Biology Laboratory
Heidelberg, Germany
Epigenetic Regulation
Chairpersons: M. Fuller, Stanford University School of
Medicine, California; T. Bestor, Columbia University College of
Physicians & Surgeons, New York
RNA Regulation
Chairpersons: R. Ketting, Hubrecht Laboratory Utrecht, The
Netherlands; C. Mello, University of Massachusetts Medical
School, Worcester
Germ Line and Reprogramming
Chairpersons: R. Jaenisch, Whitehead Institute, Massachusetts
Institute of Technology Cambridge; C. Niehrs, Deutsches
Krebsforschungzentrum, Heidelberg, Germany
M. Segerstahl, R. Hobbs
Germ-line Stem Cells
Chairpersons: J. Kimble, HHMI/University of Wisconsin,
Madison; N. Geijsen, Massachusetts General Hospital,
Charlestown
Germ-cell Patterning and Specification
Chairpersons: R. Lehmann, HHMI/New York University Medical
Center; G. Seydoux, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Germ-line Programs
Chairpersons: T. Orr-Weaver, Whitehead Institute,
Massachusetts Institute of Technology Cambridge; A.
Villeneuve, Stanford University School of Medicine, California
Gametogenesis and Fertilization
Chairpersons: A. Surani, University of Cambridge, United
Kingdom; D. Page, Whitehead Institute, Massachusetts
Institute of Technology Cambridge
M. McGovern, K. Walstrom
J. Kimble, H. Lin
C. Mello, L. Gann
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Nuclear Receptors: Bench to Bedside
November 1-5 164 participants
ARRANGED BY Ronald Evans, The Salk Institute
Sohaib Khan, University of Cincinnati
Keith Yamamoto, University of California, San Francisco
The discovery of the estrogen receptor 50 years ago spawned the nuclear
receptor superfamily field, now comprising 48 or 49 receptors in mammals
that control diverse developmental and physiological functions in the body
and are implicated in a wide variety of diseases, including cancer and meta-
bolic and neural disorders. At least half of the nuclear receptor superfamily
products are therapeutic targets. The intent of this meeting was to bring
together investigators whose research expertise in nuclear receptors ranged
from basic to clinical, for a detailed appraisal of the current challenges and
opportunities across this field.
Nuclear receptors, which function as transcription factors, modulate tar-
get gene transcription in cooperation with comodulators, overseeing com-
plex transcriptional networks that produce global physiological effects.
Deciphering the molecular mechanisms of nuclear receptor action has
enhanced our basic understanding of gene expression and illuminated
promising avenues for development of therapeutic agents. The diverse bio-
logical functions of the nuclear receptors and their ligands were discussed,
involvement in normal physiology and disease, and their implications for ca
disorders, heart and muscle disease, inflammation, and neurological dis
focused on the prospects for rational drug design based on nuclear receptor
Nuclear Receptor meeting is planned for the fall of 2008.
Partial funding for this meeting was provided by Wyeth.
R. Evans, S. Khan, K. Yamamoto
with an emphasis on their
ncer, metabolic and insulin
orders. Discussions also
crystal structure. The next
280
K. Wallis, Y. Shi
PROGRAM
Keynote Address: Etiology and Treatment of Insulin
Resistance
G. Shulman, HHMI/Yale University School of Medicine
Metabolic and Insulin Resistance Disorders
Chairperson: J. Auwerx, IGBMC, lllkirch, France
Nuclear Receptors in Cancer
Chairperson: J.A. Manson, Brigham & Women's Hospital,
Boston, Massachusetts
Nuclear Receptors in Heart and Muscle Disease
Chairperson: R. Lifton, Yale University School of Medicine, New
Haven, Connecticut
Round Table Discussion
Nuclear Receptors in Inflammation
Chairperson: D. Mangelsdorf, University of Texas Southwestern
Medical Center, Dallas
Nuclear Receptor Architecture and Designer Drugs
Chairperson: W. Chin, Eli Lilly & Co., Indianapolis, Indiana
Where Are We with Estrogen?
Chairperson: E. Jensen, University of Cincinnati College of
Medicine, Ohio
Nuclear Receptors in the Brain
Chairperson: B. Vennstrom, Karolinska Institute, Stockholm,
Sweden
S.-M. Choi, H. Park
D. Kelly, J. Plutzky
P. Ornella, K. Bram lett
C. Royer, J.-P. Renaud, X. Vige
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Pharmacogenomics
November 15-18 215 participants
ARRANGED BY Alan Guttmacher, National Human Genome Research Institute
J. Steven Leeder, Children's Mercy Hospital, Kansas City
Deborah Nickerson, University of Washington
Munir Pirmohamed, University of Liverpool
Richard Weinshilboum, Mayo Medical School, Minnesota
C. Roland Wolf, University of Dundee
This fourth annual meeting was a joint project of Cold Spring Harbor Laboratory and the Wellcome Trust
and funded in part by the National Institute of General Medical Sciences, a branch of the National
Institutes of Health. The primary objective of this series of meetings, held in alternating years on the Cold
Spring Harbor Laboratory and Sanger Center campuses, continues to be the stimulation of interest
from a broadly based constituency representing basic scientists and clinical investigators from both
academic and corporate environments. This goal is accomplished by focusing on diverse issues relat-
ed to the application of genomic approaches to investigations of variability in drug response in humans.
The meeting opened with a session highlighting examples of current research areas within the NIGMS-
led Pharmacogenetics Research Network by Kathy Giacomini, a description of the "Biobank Japan" pro-
ject at RIKEN in Japan by Yusuke Nakamura, and an overview by Francis Collins of current genomic ini-
tiatives at NHGRI relevant to Pharmacogenomics. The second day of the meeting was devoted to an
update of global pharmacogenomic and database initiatives with five continents being represented in the
program. Major subject areas for the remainder of the meeting included functional genomics and model
systems, application of genome-wide approaches to pharmacogenomic studies, and two sessions devot-
ed to "translational pharmacogenomics." The latter two sessions covered several disease-related and
therapeutic areas with a primary emphasis on cancer and cardiovascular pharmacogenomics. A series of
presentations specifically highlighted recent developments in the United States and Germany uncovering
the relationship between CYP2D6 genotype and the response to tamoxifen therapy in breast cancer.
The meeting was attended by 215 registrants from 23 countries, the broadest international represen-
tation to date; 67% of the attendees were from academia and 23% from industry. Women represented
37% of attendees and Ph.D. students and postdoctoral fellows constituted 23%. This year's meeting
I. MacPhee, K. Giacomini, M. Pirmohamed
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was the most extensive integration of the genomics and pharmacogenomics communities to date, and
future efforts will be directed toward further increasing representation at the meeting from the genetics
and genomics community and providing more opportunities for trainees and junior faculty members to
present their work in oral platform sessions. The Pharmacogenomics meeting is the premier meeting of
its type and continues to provide an outstanding forum to explore the impact of genomics on the treat-
ment of human disease and to describe the science underlying pharmacogenomics.
Support for this meeting was provided by the National Institute of General Medical Sciences, a part
of the National Institutes of Health.
PROGRAM
Opening Session
Chairpersons: R.M. Weinshilboum, Mayo Clinic College of
Medicine, Rochester Minnesota; J.S. Leeder, Children's
Mercy Hospital, Kansas City Missouri
Global Pharmacogenomics Research and Database
Initiatives
Chairpersons: K. Giacomini, University of of California, San
Francisco; H.Z. Ring, University of California, San Francisco
Recent Advances in Global Pharmacogenomics
Research
Chairpersons: K. Giacomini, University of of California, San
Francisco; H.Z. Ring, University of California, San Francisco
Functional Genomics and Model Systems
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; C.R. Wolf, University of Dundee, United Kingdom
Translational Pharmacogenomics I
Chairpersons: A. Hattersley, Peninsula Medical School, Exeter
United Kingdom; M. Pirmohamed, University of Liverpool,
United Kingdom
Genome-wide Approaches
Chairpersons: D. Nickerson, University of Washington, Seattle;
J. Hirschhorn, Children's Hospital, Harvard Medical School,
Boston, Massachusetts
Translational Pharmacogenomics II
Chairpersons: D. Flockhart, Indiana University School of
Medicine, Indianapolis; M. Eichelbaum, Dr. Margarete
Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart,
Germany
S. Weiss, R. Weinshilboum
F. Arena, E.A. Ortega, G. Suarez-Kurtz
D.S. Leeder, L. Kaminsky, R. Tyndale
H. Ring, R. Anderson
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Winter Biotechnology Conference: Neurodegenerative Diseases:
Biology and Therapeutics
November 30-December 3 128 participants
ARRANGED BY Sam Gandy, Thomas Jefferson University
Virginia Lee, University of Pennsylvania School of Medicine
Marcy MacDonald, Massachusetts General Hospital
Peter Snyder, University of Connecticut
As many as one half of those aged 85 years or older will develop debilitating degenerative disease of the cen-
tral nervous system, usually characterized by a decade or more of dependent living, accompanied by pro-
gressive failure of cognitive function and/or coordinated movement. Although these illnesses appear most
commonly in the absence of obvious heredibility or identifiable genetic mutations, it has been possible dur-
ing the last 20 years to discover risk-modifying DNA changes in some examples and predictable causative
changes in others. From these findings, transgenic technology has rapidly led to the development of mouse,
fruit fly, and nematode model systems that partially recapitulate the clinical abnormalities of the human dis-
eases, as well as some of the hallmark molecular and morphological pathology of the conditions.
Rational biochemical and cell-based screens have generated lead compounds that show promise in liv-
ing animal models. Most importantly, animal models have enabled the discovery of entirely unanticipated
therapeutic strategies (such as amyloid-f3 immunotherapy). Some of these rationally discovered compounds
and unexpected immunotherapies are now in Phase II and Ill clinical trials. The progress of compounds and
rational strategies from the animal model to the human clinical trial; the design, results, and conclusions of
the trials; and the return to the animal model with questions raised during human trials; are the areas of par-
ticular emphasis for these biannual Winter Biotechnology Conferences instituted in December 2000 with the
explicit goal of facilitating the translation of "breakthrough" science into effective medicines.
For this meeting, seven 3- or 4-hour platform sessions were organized around common technolog-
ical themes. Chairpersons, invited speakers, and speakers selected from submitted abstracts were
drawn from the academic and pharma sectors. Although the discussion of new, unpublished data was
emphasized, the group was tolerant of a wide range of intellectual property conventions. Poster pre-
P. Snyder, M. MacDonald, S. Gandy, V. Lee
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sentations were also encouraged. Posters were displayed for an extended period during the meeting,
and poster viewing was especially encouraged during the cocktail hours before the evening meals.
Topics discussed at this meeting are listed below under "Program." Diseases such as Alzheimer's,
Huntington's, spinocerebellar atrophies, enzymopathies such as Gaucher's disease, ALS, spinal mus-
cular atrophy, prion diseases, Parkinson's, tauopathies, and synucleinopathies, as well as the newly
described TDP-43-related diseases, were also considered.
PROGRAM
Federal and Foundation Perspectives on
Neurodegenerative Disease Drug Discovery
Presymptomatic Evaluation: Imaging Methodology
Development
Amyloid Imaging in Humans and its Applications to
Mouse Models
Pathogenesis of Sporadic Alzheimer's: Synthesizing
Evidence from Imaging, Cell Biology, and Genetics
Presymptomatic Evaluation with Nonimaging
Biomarkers: Genetic, Biochemical, and Physiological
Markers
Innovative Trial Design and an Update on Alzheimer's
Trials
Drug Discovery Strategies in Academic and Pharma
Sectors
Modulation of Disease by Aging, Metabolism,
Excitotoxicity, and Extracellular Matrix
Protein Conformational Considerations: Prion, N3 and
Poly Q Oligomers
Motor Neuron-Frontotemporal Dementia-Parkinson's
Spectrum of Disease(s)
S. Hata, T. Suzuki
D. Royal and his dog Annie
R. Tanzi, J. Talon, J. Rothstein
T. Veldman, M. Agostino P. Seck
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Winter Biotechnology Conference: Engineering Principles in
Biological Systems
December 3-6 101 participants
ARRANGED BY Bud Mishra, New York University School of Medicine
Partha Mitra, Cold Spring Harbor Laboratory
Richard Murray, California Institute of Technology
This year saw the addition of a new meeting to the CSHL repertoire. The first meeting on Engineering
Principles in Biological Systems was held in early December, following on an earlier planning work-
shop at the Banbury conference center in May of the same year. There were two key ideas behind
this meeting: that theoretical principles which have been developed in the context of human engi-
neered systems are useful in understanding biological function and that these principles apply across
scales, from the cellular to the organism level. In keeping with these ideas, we hoped to, and suc-
ceeded in, attracting researchers in a broad range of fields ranging from bacterial systems biology to
neural systems, with shared interest in engineering principles.
Sessions were broken up according to broad areas of engineering, and there was also a session
on evolution. The introductory session set the tone of the meeting: introductory remarks (by Partha
Mitra) about the need of a theoretical canon in biology, was followed on by an experimental talk about
engineering biochemical circuits in cells, design principles in metabolic and gene regulation circuits,
a talk about insect locomotion, and a plenary talk by John Doyle. An innovative aspect of the meet-
ing much appreciated by the attendees was tutorial talks on control theory by Richard Murray and
on machine learning by Partha Niyogi. Attendees also expressed appreciation of the broad spectrum
of the meeting, and it was felt that the meeting was quite unique in its reach and scope. On the basis
of this enthusiasm, the plans are to repeat the meeting in December 2008.
R. Murray, P. Mitra, B. Mishra
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PROGRAM
INTRODUCTION
P. Mitra, Cold Spring Harbor Laboratory
Feedback, Dynamics, and Control I
Chairperson: B. Mishra, New York University School of Medicine
Synthetic Biology, Biomedical Applications
Chairperson: H. EI-Samad, University of California, San
Francisco
Feedback, Dynamics, and Control II
Chairperson: H. Breiter, Massachusetts General Hospital, Boston
Learning, System Identification, Perception
Chairperson: R. Murray, California Institute of Technology
Pasadena
Evolution, Evolvability
Chairperson: L. Carporale, Columbia University New York
Signaling and Communications
Chairperson: P. Niyogi, University of Chicago, Illinois
H. EI-SaMad, C. Smolke, T. Chouard
S. Schiff, D. Pfaff
D. Valente, S. Saar
J. Wang, D. Chklovskii
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The GABAergic System
December 6-10 135 participants
ARRANGED BY Gyorgy Buzsaki, Rutgers University
Joshua Huang, Cold Spring Harbor Laboratory
Henry Markram, Brain & Mind Institute
Roger Nicoll, University of California
GABA is one of the major neurotransmitters and the only known mediator of inhibition in the brain. In
addition to synaptic transmission, homeostatic feedback, oscillations, shaping network patterns, and
assisting in the formation of cell assemblies, this simple molecule has been implicated in a number of
other aspects of neuronal functions, including, e.g., trophic effects, morphogenesis, cell proliferation,
and control of local blood flow. Importantly, GABA dysfunction has been implicated in a range of neu-
rological, neurodevelopmental, and psychiatric disorders. Progress in understanding the genetic design,
construction, and mode of operation of the GABAergic system will significantly advance our knowledge
of brain development and function. Paradoxically, no regular, high-quality scientific conference has been
devoted to the discussion of GABAergic system that would stimulate the interactions between investi-
gators working in different disciplines but with a common interest in GABA function. To facilitate the
interdisciplinary approach to the GABA system, this first meeting brought together scientists using mol-
ecular and genomic approaches, developmental neurobiologists, physiologists, system neuroscientists,
and clinicians, with the explicit goal of fostering future work in this critical domain of research.
The program included a keynote address by Professor Thomas M. Jessell, who has been studying
the assembly of neural circuit in spinal cord. His work has profound implication on the genetic logic
underlying the construction and function of neural circuits in general.
The oral sessions are listed below under "Program." The speakers included mixtures of established
investigators presenting their recent results as well as graduate students and postdoctoral fellows pre-
senting their new findings. These balanced presentations, in the tradition of CSH meetings, are consid-
ered to be major motivation for many participants. They reflect not only some acknowledgment, but also
a wider forum for young researchers. The talks and poster sessions generated lively, interactive discus-
sions. Several presentations described new methods to solve complex problems in GABA signaling and
function. Some of the discussions have already fostered fruitful scientific collaborations.
Describing the specific sessions is not relevant to this short report. Nevertheless, it should be men-
tioned that it became clear for all participants that the field a GABAergic signaling has expanded over
the past decade beyond the niche of specialized areas. In fact, the various subfields, represented at this
meeting emerged semi-independently from the various larger disciplines, and the interactions of the
newly emerged subdivisions allowed for creating a novel forum of discussion under the common
G. Buzsaki, H. Lester
288 J. Huang, A. De Blas
umbrella of this simple molecule (GABA). The importance of this convergence is clearly reflected by the
ever-increasing number of papers and citations beyond the mean average of neuroscience papers.
PROGRAM
From Genomics to Cell Types
Chairpersons: S. Nelson, Brandeis University Waltham,
Massachusetts; R. Yuste, Columbia University, New York
Panel Discussion on Cell Types
Moderator: R. Yuste, HHMI/Columbia University
S. Nelson, Brandeis University
G. Buzsaki, Rutgers University
G. Fishell, New York University
S. Anderson, Cornell University
Development
Chairpersons: J. Rubenstein, University of California, San
Francisco; Y. Ben-Ari, INMED, INSERM, Marseille, France
GABA Transporters
Chairpersons: K. Kai la, University of Helsinki, Finland; H.
Lester, California Institute of Technology Pasadena
GABA Receptors
Chairpersons: S. Moss, University of Pennsylvania,
Philadelphia; I. Mody, University of California, Los Angeles
Keynote Address
T. Jessell, HHMI/Columbia University College of Physicians &
Surgeons
Cellular Physiology
Chairpersons: A. Thomson, University of London School of
Pharmacy United Kingdom; P. Jonas, University of Freiburg,
Germany
Plasticity
Chairpersons: D. Kullman, University College London, United
Kingdom; C. McBain, NICHD/National Institutes of Health,
Bethesda, Maryland
Network, System, Behavior
Chairpersons: T.F. Freund, Hungarian Academy of Sciences,
Budapest; H. Monyer, University of Heidelberg, Germany
C. Wu, A. Thomson
H. Gache, M. Vithlani
B. Chattopadhyaya, C. Avendario
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities do
not adequately treat them. Our aim is to provide intensive study in the most recent developments and
techniques in these subjects and to prepare students to enter directly into research in a particular area.
To ensure up-to-date coverage of current research work, we bring together course faculty from many
laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
March 29-April 11
INSTRUCTORS K. Adelman, National Institutes of Health/NIEHS, Research Triangle Park, North Carolina
R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
ASSISTANTS
S. Duel !man, University of Wisconsin, Madison
N. Fuda, Cornell University, Ithaca, New York
B. Glaser, University of Wisconsin, Madison
H. Hess, Massachusetts Institute of Technology, Cambridge
Y.-C. Lee, M.D. Anderson Cancer Center/University of Texas,
Houston
S. Nechaev, University of California, San Diego, La Jolla
M. Nie, University of California, Los Angeles
M. Marr, University of California, Berkeley
C. Winkler, University of California, Los Angeles
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This course was for scientists who were not familiar with techniques of protein isolation and character-
ization. It was a rigorous program that included laboratory work all day and a lecture with discussion
session every evening. Each student became familiar with each of the major techniques in protein purifi-
cation by actually performing four separate isolations including (1) a regulatory protein from muscle tis-
sue, (2) a sequence-specific, DNA-binding protein, (3) a recombinant protein overexpressed in
Escherichia coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic,
and chromatographic techniques included precipitation by salts, pH, and ionic polymers; ion-
exchange, gel-filtration, hydrophobic interaction, and reverse-phase chromatography; lectin affinity, lig-
and affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel
electrophoresis and electroblotting; and high-performance liquid chromatography.
Procedures were presented for solubilizing proteins from inclusion bodies and refolding them into
active monomeric forms. Methods of protein characterization were utilized to include immunological
and biochemical assays, peptide mapping, amino acid analysis, protein sequencing, and mass spec-
trometry. Emphasis was placed on strategies of protein purification and characterization. Guest lectur-
ers discussed protein structure, modification of proteins, methodologies for protein purification and
characterization, and applications of protein biochemistry to cell molecular and cancer biology.
Speakers included Gerald Hart, Michael Myers, William Tansey, Lemoor Joshua-Tor, Michael Marr,
Richard Burgess, Al Courey, Sue-Hwa Lin, and Andrew Link.
PARTICIPANTS
Capotosti, F., M.S., Universite de Lausanne, Switzerland
Gao, H., Ph.D., Howard Hughes Medical Institute at
Wadsworth Center, Albany, New York
Heusner, C., Ph.D., University of California, Los Angeles
Huang, S., Ph.D., Baylor College of Medicine, Houston, Texas
Laloraya, S., Ph.D., Indian Institute of Science, Bangalore, India
Li, C., B.S., University of California, Los Angeles
Li, Z., Ph.D., New York University School of Medicine, New
York
Link, A., Ph.D., Vanderbilt University School of Medicine,
Nashville, Tennessee
SEMINARS
Burgess, R., University of Wisconsin, Madison: Introduction to
protein purification, immunoaffinity chromatography. RNA
polymerase-sigma factor interactions and use of LRET-
based assays for drug discovery and biochemistry.
Courey, A., University of California, Los Angeles: Spreading the
silence: Groucho, Yan, and polycomb-mediated repression.
Hart, G., Johns Hopkins, Baltimore, Maryland: Protein
glycosylation: The most ubiquitous posttranslational event in
eukaryotes.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Protein
crystallography introduction and demonstration. The crystal
structure of Agronaute: The secret life of slicer.
Luke, B., Ph.D., ISREC, EPFL, Lausanne, Epalinges,
Switzerland
O'Donoghue, P., Ph.D., University of Illinois at Urbana-
Champaign
Oldrini, B., M.D., FIRC Institute of Molecular Oncology, Milan,
Italy
Paden, E., B.S., University of North Carolina, Chapel Hill
. Payne, A., M.S., Georgia Institute of Technology, Atlanta
Payne, C., Ph.D., Harvard University, Cambridge,
Massachusetts
Zamudio, J., B.S., University of California, Los Angeles
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Osteoblasts and prostate cancer metastasis.
Link, A., Vanderbilt University, Nashville, Tennessee: Proteomic
analysis of the yeast translational machinery.
Marr, M., HHMI, University of California, Berkeley:
Characterization of protein-protein and protein-DNA
interactions in vivo.
Myers, M., Cold Spring Harbor Laboratory: Introduction to
mass spectroscopy for analyzying biological samples.
Tansey, W., Cold Spring Harbor Laboratory: Transcriptional
control, cancer, and the ubiquitin proteosome system.
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Cell and Developmental Biology of Xenopus
April 1-11
INSTRUCTORS J. Heasman, Children's Hospital
Medical Center, Cincinnati, Ohio
C. Wylie, Children's Hospital Research Foundation, Cincinnati, Ohio
ASSISTANTS M. Kofron, Children's Hospital Medical
Center, Cincinnati, Ohio
A. Mir, Children's Hospital Medical Center, Cincinnati, Ohio
L. Zacchigna, University of Padua, Italy
Xenopus is the leading vertebrate model for the study of gene function in development. The combina-
tion of lineage analysis, gene-knockout strategies, experimental manipulation of the embryo, and
genomic/bioinformatic techniques makes it ideal for studies on the molecular control of embryo pattern-
292
ing, morphogenesis, and organogenesis. The course combined intensive laboratory training with daily
lectures from recognized experts in the field. Students learned both emerging technologies and classi-
cal techniques to study gene function in Xenopus development. An important element was the infor-
mal interaction between students and course faculty.
Technologies covered included oocyte and embryo culture, lineage analysis and experimental
manipulation of embryos, gain- and loss-of-function analyses using mRNAs and antisense oligos,
whole-mount in situ hybridization, immunocytochemistry, RT-PCR, genomic/bioinformatic tech-
niques, preparation of transgenic embryos, and use of Xenopus tropicalis for genetic analyses. This
course was designed for those new to the Xenopus field, as well as for those wanting a refresher
course in the emerging technologies. The course was open to investigators from all countries.
Additional lecturers included Timothy Grammer, Ray Keller, Mustafa Khokha, Carole La Bonne,
Stefano Piccolo, Jonathan Slack, Janet Weber, and Aaron Zorn.
PARTICIPANTS
Belak, Z., M.S., University of Saskatchewan, Saskatoon,
Canada
Bordalo, P., Ph.D., Harvard Medical School, Boston,
Massachusetts
Delgado, I., M.Sc., Universidad Andres Bello, Santiago, Chile
Gallop, J., M.bioc., Harvard Medical School, Boston,
Massachusetts
Jia, Z., Ph.D., NIH/NCI-Frederick, Maryland
Lacoste, N., Ph.D., Curie Institute, Paris, France
Nerlick, S., B.A., University of Miami, Florida
Pabbidi, M., BVSc., Southern Illinois University,
Springfield
SEMINARS
Grammer, T., University of Berkeley, California: Xenopus
tropicalis genetics.
Heasman, J., Children's Hospital Medical Center, Cincinnati,
Ohio: Maternal control of development.
Keller, R., University of Charlottesville, Virginia: The early
morphogenesis of the Xenopus embryo.
Khoka, M., University of California, San Francisco: Xenopus
tropicalis bioinformatics and genomics.
La Bonne, C., University of Northwestern, Chicago, Illinois:
Neural crest.
Perez, 0., Licen., Pontificia Universidad Catolics del Ecuador,
Quito, Ecuador
Porter, K., Ph.D., U.S. Army Center for Environmental Health
Research, Fort Detrick, Maryland
Sanchez, V.A., B.A., Centro de Investigacion Principe Felipe,
Valencia, Spain
Snedden, D., B.S., University of Notre Dame, Indiana
Taelman, V, Ph.D., Universite Libre de Bruxelles, Gosselies,
Beligum
Wu, M., B.A., Cancer Research U.K., London
Young, J., M.S., Van Andel Research Institute, Grand Rapids,
Michigan
Piccolo, S., University of Padua, Italy: Establishment of the
primary germ layers.
Slack, J., University of Bath, United Kingdom: Tail
regeneration. Tail Development.
Weber, J., National Institutes of Health, Bethesda, Maryland:
NCB' tools and resources.
Wylie, C., Children's Hospital Research Foundation, Cincinnati,
Ohio: Classical experiments in Xenopus.
Zorn, A., Children's Hospital Medical Center, Cincinnati, Ohio:
Organogenesis of the endoderm.
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Genetics of Complex Human Diseases
June 7-13
INSTRUCTORS A. Al-Chalabi, FRCP, Institute of
Psychiatry, Kings College, London, United Kingdom
L. Almasy, Southwest Foundation for Biomedical Research, San Antonio, Texas
Complex diseases are conditions that are influenced by the actions of multiple genes and their inter-
actions with each other and with the environment. This lecture course considered the difficulties in
studying the genetic basis o complex disorders such as diabetes, cardiovascular disease, cancer, and
autism. We discussed genetic-epidemiologic study designs, including family, parent-child trio,
case/control and adoption studies, as well as methods for quantifying the strength of the genetic influ-
ences on a disease. A major focus was the identification of specific gene effects using both linkage
and association analysis and their variants. We discussed the efficiency and robustness of different
designs for such analysis and the appropriate contexts for their use. Study design and methods for
analysis of quantitative risk factors related to complex diseases was covered as well as the latest ideas
in data reduction such as haplotype mapping and SNP tagging. Copy-number variation as an influ-
ence on complex disease risk and Bayesian coalescent models for the fine mapping of disease loci
were also discussed. Illustrations were provided through discussion of results from ongoing studies of
a variety complex diseases and related risk factors.
Speakers included Paul De Bakker (Massachusetts General Hospital), John Gallacher (Cardiff
University, UK), Michael Hauser (Duke University), Toby Johnson (University of Edinburgh, UK), Eden
Martin (Duke University), Cathryn Lewis (Kings College, London), Shaun Purcell (Kings College,
London), Jonathan Sebat (Cold Spring Harbor Laboratory), Pak Sham (University of Hong Kong,
China), and Janet Sinsheimer (University of California, Los Angeles).
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PARTICIPANTS
Agam, A., B.S., University of Oxford, United Kingdom
Burdick, K., Ph.D., Zucker Hillside Hospital-NSLIJHS, Hillside,
New York
Deo, A., B.S., New York University, American Museum of
Natural History, New York
Gallacher, J., Ph.D., Cardiff University, United Kingdom
Gotay, N., Ph.D., National Institute of Mental Health,
Bethesda, Maryland
Hildebrandt, J., Ph.D., Medical University of South Carolina,
Charleston
Houlihan, L., M.S., Indian Institute of Science, Bangalore
Jun, J., M.S., University of Connecticut, Storrs
Kasperaviciute, D., Ph.D., University College, London
Kennerson, M., Ph.D., University of Sydney, Concord, Australia
Lazaridis, K., Ph.D., Mayo Clinic & Foundation/NHGRI-NIH,
Bethesda, Maryland
SEMINARS
Al-Chalabi, A., Kings College, London: Linkage introduction.
Almasy, L., Southwest Foundation for Biomedical Research,
San Antonio, Texas: Welcome and introduction to course.
Methods for analysis of quantitative risk factors.
Almasy, L. and Al-Chalabi, A., Southwest Foundation for
Biomedical Research, San Antonio, Texas: Genetics
programs practical.
De Bakker, P., Massachusetts General Hospital, Boston: SNP
tagging, data integration LD and haplotype blocks, genome-
wide
Gallacher, J., Cardiff University, United Kingdom: Genetic
epidemiology from the epidemiologist's perspective.
Hauser, M., Duke University, Durham, North Carolina: From
locus to gene: Complement factor H in AMD.
Malhotra, D., M.S., Cold Spring Harbor Laboratory
Martina, G., Ph.D., University of Parma, Italy
Mihailov, E., B.S., University of Tartu, Estonia
Pasaniuc, B., B.S., University of Connecticut, Storrs
Rana, N., Ph.D., Cambridge University, United Kingdom
Rocheleau, G., Ph.D., McGill University, Montreal, Canada
Shah, P., B.S., MRC Institute of Neurology, London
Simpson, C., Ph.D., Institute of Psychiatry, London
Sookoian, S., Ph.D., Institute de Investigaciones Medicas,
Buenos Aires, Argentina
Su, H., Ph.D., NIH/NIAID, Bethesda, Maryland
Tinkle, S., Ph.D., National Institutes of Environmental Health
Sciences, Research Triangle, North Carolina
Zia, A., Ph.D., Columbia University, New York
Zipprich, J., B.S., Columbia University, New York
Johnson, T., University of Edinburgh, United Kingdom:
Evolution and population genetics.
Lewis, C., Kings College, London, United Kingdom:
Association studies: An introduction.
Martin, E., Duke University Medical Center, Durham, North
Carolina: Linkage disequilibrium and association studies.
Purcell, S., Kings College, London: Large-scale association
analysis.
Sebat, J., Cold Spring Harbor Laboratory: Analysis of genome
copy-number variation in human disease.
Sham, R, University of Hong Kong, China: Power and multiple
testing issues in association studies.
Sinsheimer, J., David Geffen School of Medicine, University of
California, Los Angeles: Statistics 101.
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Advanced Bacterial Genetics
June 7-27
INSTRUCTORS J. Kirby, Georgia Institute of Technology, Atlanta
S. Lovett, Brandeis University, Waltham, Massachusetts
A. Segall, San Diego State University, California
ASSISTANTS J. Foti, Brandeis University, Waltham, Massachusetts
S. Orchard, University of Wisconsin, Madison
H. Vlamakis, Harvard Medical School, Boston, Massachusetts
The course presented logic and methods used in the genetic dissection of complex biological
processes in eubacteria. Laboratory methods used included classical mutagenesis using transposons,
mutator strains, and chemical and physical mutagens; the mapping of mutations using genetic and
physical techniques; modern approaches to the generation and analysis of targeted gene disruptions
and fusions using PCR and cloning methods; epitope insertion mutagenesis; and site-directed mutage-
nesis. Key components of the course were the use of sophisticated genetic methods in the analysis of
model eubacteria and the use of the wealth of new genomic sequence information to motivate these
methods. Invited lecturers presented various genetic approaches to study eubacterial mechanisms of
metabolism, development, and pathogenesis.
Speakers included Abigail Salyers (University of Illinois at Urbana-Champaign), Ann Hochschild
(Harvard Medical School), Christine Jacobs-Wagner (Yale University), Igor Jou line (University of
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Tennessee), John Roth (University of California), Robert Kolter (Harvard Medical School), Stanley Maloy
(San Diego State University), Susan Golden (Texas A&M University), William Jacobs (Albert Einstein
College of Medicine), and Forest Rohwer (San Diego State University).
PARTICIPANTS
Aldea, M., M.S., Texas A&M University, College Station
Allen, R., Ph.D., University of Edinburgh, United Kingdom
Carr, J., Ph.D., Massachusetts Institute of Technology,
Cambridge
Cohen, D., B.S., University of Minnesota, Minneapolis
Fero, M., Ph.D., Stanford University School of Medicine,
California
Flaherty, P., Ph.D., Massachusetts Institute of Technology,
Cambridge
Forbes, S., B.S., University Albany and Wadsworth Center,
Albany, New York
SEMINARS
Golden, S., Texas A&M University, College Station: Winding up
the cyanobacterial circadian clock.
Hochschild, A., Harvard Medical School, Boston, Massachusetts:
Using a bacterial two-hybird assay to study dynamics at the
sigma/core interface of bacterial RNA polymerise,
Jacobs, W., Albert Einstein College of Medicine/HHMI, Bronx,
New York: Fulfilling Koch's coroliar for mycobacterium
tuberculosis. The five unassailable truths of bacterial
genetics: Elucidating the mechanism of action of isoniazid
mycobacterium tuberculosis.
Jacobs-Wagner, C., Yale University, New Haven, Connecticut:
Cell polarity, cell shape, and the cytoskeleton in Caulobacter
crescentus.
Guzman-Verri, C., Ph.D., Universidad Nacional, Heredia, Costa
Rica
Long, T., B.S., Princeton University, New Jersey
Pereira, C., M.S., Instituto Gulbenkian de Ciencia, Oeiras, Portugal
Pichler, F, Ph.D., The University of Auckland, New Zealand
Roper, M.C., B.S., University of California, Davis
Samoilov, M., Ph.D., HHMI/University of California, Berkeley
Tobin, C., B.Sc., Uppsala University, Sweden
Wagner, S., M.S., Stockholm University, Sweden
Wilson, L., Ph.D., University of British Colombia, Vancouver,
Canada
Jou line (Zhu lin), I., The University of Tennessee, Oakridge:
Comparative genomics of signal transduction.
Kolter, R., Harvard Medical School, Boston, Massachusetts:
B. subtilis multicellular development.
Maloy, S., San Diego State University, California: Deranged
chromosomes in bacteria.
Rohwer, E, San Diego State University, California: The
awesome power of metagenomics.
Roth, J., University of California, Davis: Natural (and unnatural)
selection and their different effects on genetic adaptation.
Salyers, A., University of Illinois at Urbana-Champaign:
Horizontal gene transfer in the human intestine.
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Ion Channel Physiology
June 7-27
INSTRUCTORS M. Farrant, University College London, United Kingdom
M. Hausser, University College London, United Kingdom
N. Spruston, Northwestern University, Evanston, Illinois
COINSTRUCTORS B. Clark, University College London, United Kingdom
J. Diamond, National Institutes of Health, Bethesda, Maryland
I. Soltesz, University of California, Irvine
ASSISTANTS G. Dugue, Ecole Norma le Suprieure, Paris, France
T. Jarsky, Northwestern University, Chicago, Illinois
S. Moore, Northwestern University, Evanston, Illinois
A. Scimemi, National Institutes of Health, Bethesda, Maryland
The primary goal of this course was to investigate, through lectures and laboratory work, the proper-
ties of ion channels that allow neurons to carry out their unique physiological functions in a variety of
neural systems. Areas of particular interest included channels that (1) are activated by neurotransmit-
ter at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites,
(3) respond to neuromodulators with changes in functional properties, or (4) are developmentally
required and regulated. The research interests of guest lecturers reflect these areas of emphasis.
The laboratory component of the course introduced students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises included patch-clamp
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recording of ion-channel activity in neurons in brain slice preparations. Different recording configurations
were used (e.g., whole-cell, cell-free, and nucleated patches) to examine macroscopic or single-chan-
nel activity. The advantages and disadvantages of each method, preparation, and recording techniques
were considered with respect to the specific scientific questions being asked. Admissions priority was
given to students and postdocs with a demonstrated interest, specific plans, and a supportive environ-
ment to apply these techniques to a defined problem.
Guest speakers Bruce Bean (Harvard Medical School), Jeffrey Diamond (National Institutes of
Health), Florian Engert (Harvard University), Daniel Johnston (University of Texas at Austin), Jeffrey
Magee (LSUHSC), Indira Raman (Northwestern University), Massimo Scanziani (University of California,
San Diego), Steve Sigelbaum (Columbia University), Ivan Soltesz (University of California), and Tomoyuki
Takahashi (University of Tokyo Graduate School of Medicine).
PARTICIPANTS
Ahmed, 0., B.Sc., Brown University, Providence, Rhode Island
Domingos, A., Ph.D., The Rockefeller University, New York
Gomez-Ospina, N., B.A., Stanford University, California
Komiyama, T., B.S., Stanford University, California
Kress, G., B.S., Washington University in St. Louis, Missouri
Kwan, K., Ph.D., Harvard Medical School/HHMI, Boston,
Massachusetts
SEMINARS
Bean, B., Harvard Medical School, Boston, Massachusetts:
Pacemaking in central neurons.
Diamond, J., National Institutes of Health, Bethesda,
Maryland: Excitatory synaptic transmission: Glutamate
diffusion, uptake, and receptor activation.
Engert, F., Harvard University, Cambridge, Massachusetts:
Spike-timing-dependent plasticity of synaptic connections:
An overview.
Farrant, M., University College London, United Kingdom:
GABA receptors and synaptic inhibition.
Hausser, M., University College London, United Kingdom:
Synaptic integration.
Johnston, D., University of Texas, Austin: Voltage-dependent
potassium channels.
Ma, G., Ph.D., The Rockefeller University, New York
Schafer, J., B.S., Johns Hopkins University, Baltimore,
Maryland
Stanley, S., Ph.D., The Rockefeller University, New York
Uchida, N., Ph.D., Cold Spring Harbor Laboratory
Vervaeke, K., M.Sc., University of Oslo, Norway
Witt, R., B.S., Harvard Medical School, Boston, Massachusetts
Magee, J., LSUHSC, New Orleans, Louisianna: Dendritic
integration of synaptic input.
Raman, I., Northwestern University, Evanston, Illinois:
Resurgent sodium current and action potential firing in
cerebellar Purkinje neurons.
Scanziani, M., University of California, San Diego, La Jolla:
Short-term synaptic plasticity.
Sigelbaum, S., Columbia University, New York: HCN1
hyperpolarization-activated channels: A gate of learning and
memory.
Soltesz, I., University of California, Irvine: Plasticity of
endocannabinoid regulation of GABA release.
Takahashi, T., University of Tokyo Graduate School of
Medicine, Japan: Voltage-dependent calcium channels.
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Molecular Embryology of the Mouse
June 7-27
INSTRUCTORS B. Capel, Duke University Medical
Center, Durham, North Carolina
M. Shen, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey
COINSTRUCTORS D. Threadgill, University of North Carolina, Chapel Hill
P. Trainor, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS D. Escalante-Alcalde, Institute of Cellular Physiology-UNAM, Mexico
J. Rivera, University of North Carolina, Chapel Hill
K. Yuna, Duke University Medical Center, Durham, North Carolina
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse development. Lectures provided the conceptual basis for contempo-
rary research in mouse embryogenesis and organogenesis, whereas laboratory practicals provided
extensive hands-on introduction to mouse embryo analysis. Experimental techniques covered included
in vitro culture and manipulation of pre- and postimplantation embryos, embryo transfer, culture and
genetic manipulation of embryonic stem cells, production of chimeras by embryo aggregation and by
ES cell injection, and transgenesis by pronuclear microinjection. In addition, this year's practicals fea-
tured increased emphasis on phenotypic analysis of mutants, including techniques of histology, in situ
hybridization, immunohistochemistry, skeletal preparation, organ culture, and tissue recombination.
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Confirmed speakers for this year included Kathryn Anderson, Richard Behringer, Allan Bradley,
Denis Duboule, Kevin Eggan, Kat Hadjantonakis, Greg Hannon, Gerard Karsenty, Robin Lovell-Badge,
Terry Magnuson, Ann McLaren, Andy McMahon, Andras Nagy,Luis Parada, Janet Rossant, Davor
Solter, Oliver Smithies, Colin Stewart, David Threadgill, Patrick Tam, and Paul Trainor.
PARTICIPANTS
Benito-Gutierrez, E., B.Sc., Universitat de Barcelona, Spain
Chaivorapol, C., B.S., University of California, San Francisco
Chen, F., M.D., Boston University School of Medicine,
Massachusetts
Dlugosz, M., B.S., Stony Brook University, Stony Brook, New
York
Eriksson, M., M.S., Karolinska Institutet, Stockholm, Sweden
Girard, A., B.S., Cold Spring Harbor Laboratory
Hofmann, C., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
SEMINARS
Anderson, K., Memorial Sloan-Kettering Institute, New York:
Forward genetic screens.
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenics and insertional mutants.
Bradley, A., Wellcome Trust Sanger Institute, Hinxton, United
Kingdom: Large-scale screens.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Immediate mesoderm.
Duboule, D., University of Geneva, Switzerland: Hox genes/
limb patterning.
Eggan, K., Stowers Medical Institute/Harvard University,
Cambridge, Massachusetts: Nuclear reprogramming.
Escalante, D., Institute of Cellular Physiology-UNAM, Mexico:
Lipid phosphate phosphatase-3 (LPP3) deficiency affects
embryo development due to alterations in several signaling
pathways.
Hadjantonakis, K., Columbia University, New York: Optical
imaging.
Hannon, G., Cold Spring Harbor Laboratory: RNA interference:
Biology and applications.
Karsenty, G., Baylor College of Medicine, Houston, Texas:
Skeletal biology.
Lovell-Badge, R., MRC National Institute for Medical
Research, The Ridgeway, United Kingdom: Sox genes,
neural development, and stem cells in the CNS.
Magnuson, T., University of North Carolina, Chapel Hill:
Liu, Z., Ph.D., Washington University in St. Louis Medical
School, Missouri
Luo, Y., Ph.D., Princeton University, New Jersey
Mekel-Bobrov, N., B.A., University of Chicago, Illinois
Scott, D., Ph.D., Baylor College of Medicine, Houston, Texas
Stafford, D., Ph.D., University of California, Berkeley
Thakar, R., Ph.D., Cold Spring Harbor Laboratory
Vigneau, S., M.S., Pasteur Institute, Paris, France
Epigenetics.
McLaren, A., University of Cambridge, United Kingdom: Germ
line.
McMahon, A., Harvard University, Cambridge, Massachusetts:
Kidney organogenesis.
Nagy, A., Samuel Lunenfeld Research Institute, Mt. Sinai
Hospital, Toronto, Canada: Gene targeting.
Parada, L., University of Texas Southwestern Medical Center,
Dallas: Cancer models.
Rivera-Perez, J., University of North Carolina, Chapel Hill: Axial
development: A viscera C (endoderm) view.
Rossant, J., The Hospital for Sick Children, Toronto, Canada:
Chimera analysis.
Shen, M., UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Nodal signaling and embryo
patterning.
Smithies, 0., University of North Carolina, Chapel Hill: Physiology.
Solter, D., Max-Planck Institut fOr Immunbiology, Freiburg,
Germany: Preimplantation development.
Stewart, C., National Cancer Institute, Frederick, Maryland: ES
cells.
Tam, P., Children's Medical Research Institute, Sydney,
Australia: Introduction to mouse development. Gastrulation
and formation of the body plan.
Threadgill, D., University of North Carolina, Chapel Hill:
Quantitative traits.
Trainor, P., Stowers Institute for Medical Research, Kansas
City, Missouri: Craniofacial development.
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Applications in Next-generation Sequencing
June 8-15
INSTRUCTORS G. Hannon, Cold Spring Harbor Laboratory
G. Irzyk, 454 Life Sciences, Branford, Connecticut
E. Mardis, Washington University School of Medicine, St. Louis, Missouri
R. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Baylor College of Medicine, Houston, Texas
ASSISTANTS V. Balija, Cold Spring Harbor Laboratory
M. Kramer, Cold Spring Harbor Laboratory
V. Magrini, Washington University School of Medicine, St. Louis, Missouri
L. Nascimento, Cold Spring Harbor Laboratory
L. Spiegel, Cold Spring Harbor Laboratory
TECHNICAL FACULTY
J. Lanza, 454 Life Sciences, Branford, Connecticut
C. Perbost, 454 Life Sciences, Branford, Connecticut
During the past decade, large-scale DNA sequencing has markedly changed the landscape of modern
biology. With the introduction of new technologies, time and expenses have been reduced by orders of
magnitude, facilitating investigators to propose and undertake more complex and elaborate experi-
ments and analyses. A combination of the results of de novo sequencing and the vast data already gen-
erated by the genome projects can now be applied to a very diverse set of scientific questions in
prokaryotic and eukaryotic biology. New technologies that facilitate massively parallel sequencing are
available that offer the opportunity to further probe function in genomic data.
This intensive 8-day course explored applications of next-generation sequencing technology, with a par-
ticular focus on currently available methods based on scalable emulsion-based pyrosequencing. Successful
applicants were instructed in the details and pitfalls of (1) emulsion-based sample preparation, (2) pyrose-
quencing, (3) base-calling, (4) quality control, (5) shotgun assembly, and (6) general data handling and analy-
sis. However, the major emphasis of the course was on the experimental design and intepretation of the
resulting data sets in the context of existing sequence information. A diverse range of biological questions
were explored including de novo DNA sequencing of bacterial genomes, DNA (re-)sequencing of genomic
arrangements in cancer, and the use of these technologies in studying small RNAs.
We encouraged applicants from a diversity of scientific backgrounds including molecular evolution,
development, neuroscience, cancer, plant biology, and microbiology.
PARTICIPANTS
Bayes, M., Ph.D., Centre de Regulacio Genomica, Barcelona,
Spain
Briggs, A., B.A., Max-Planck Institute for Evolutionary
Anthropology, Leipzig, Germany
Bhandari, A., B.S., Cold Spring Harbor Laboratory
Domingo, A., B.S., U.S. Department of Homeland Security,
Frederick, Maryland
Fritz, B., Ph.D., Fred Hutchinson Cancer Research Center,
Seattle, Washington
Hnath, J., M.S., U.S. Department of Homeland Security,
Frederick, Maryland
Huisinga, K., Ph.D., Washington University, St. Louis, Missouri
Li, C., M.S., University of Massachusetts Medical School,
Worcester
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Liu, W., Ph.D., Novartis Institute for BioMedical Research, Inc.,
Cambridge, Massachusetts
Persson, H., M.S., Lund University, Sweden
Quinlan, A., B.S., Boston College, Chestnut Hill, Massachusetts
Rosa Amaral, P., B.A., University of Sao Paulo, Brazil
Schroeder, B., Ph.D., Applied Biosystems, Foster City,
California
Terracciano, A., Ph.D., Catholic University, Rome, Italy
Trinh, H., B.S., University of Arizona, Tucson
Verratti, K., B.A., U.S. Department of Homeland Security,
Frederick, Maryland
Wing, R., Ph.D., University of Arizona, Tucson
Young, A., B.A., NISC/NHGRI/NIH, Bethesda, Maryland
Yu, Y., Ph.D., Arizona Genomics Institute, Tucson
SEMINARS
Bentley, D., Solexa Ltd., Cambridge, United Kingdom: The
solexa IGb sequencer.
Chen, F, Joint Genome Institute, Walnut Creek, California:
Sequencing bacterial genomes using the 454 GS-20.
Hannon, G., Cold Spring Harbor Laboratory: microRNA
discovery using the 454 GS-20 sequencer.
Knight, J., 454 Life Sciences, Branford, Connecticut: Signal
processing pipeline and bioinformatics-based analyses using
454 pyrosequencing data.
Mardis, E., Washington University School of Medicine, St. Louis,
Missouri: Sequencing cDNA libraries with the 454 GS-20.
McPherson, J., Baylor College of Medicine, Houston, Texas:
Population genetics using amplicon sequencing on the 454 GS-20.
Methe, B., The Institute of Genome Research, Rockville,
Maryland: Integration of 454 life sciences sequencing
technology in de novo assembly of prokaryotic genomes.
Rohwer, F., San Diego State University, California:
Metagenomics.
Watson, J., Cold Spring Harbor Laboratory: Ethics and the
large-scale sequencing of human DNA.
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Integrated Data Analysis for High-throughput Biology
June 14-27
INSTRUCTORS H. Bussemaker, Columbia University, New York
V. Carey, Harvard University, Boston, Massachusetts
P. Mitra, Cold Spring Harbor Laboratory
M. Reimers, National Cancer Institute, Bethesda, Maryland
A. Sengupta, Rutgers University, Piscataway, New Jersey
ASSISTANTS J. Mar, Harvard University, Boston, Massachusetts
J. Zhang, Dana-Farber Cancer Institute, Boston, Massachusetts
J. Zhang, Cornell Medical College, New York
High-throughput biology, epitomized by the ubiquitous DNA microarray, is rapidly generating enormous
observation sets. Biologists seeking to make sense of this growing body of data needed to have a firm
grasp of statistical methodology. This course was designed to build competence in quantitative meth-
ods for the analysis of high-throughput molecular biology data, from which meaningful inferences about
biological processes were drawn.
Review of multivariate statistics.
R minitutorial.
Expression and other microarrays: Experimental design, scanning and image analysis, quality con-
trol, normalization and probe-level analysis for spotted arrays or prefabricated chips, exploratory
analysis, tests of significance, and multiple testing, using R and Bioconductor.
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Discrimination and classification of samples.
Identifying general regulation themes (e.g., gene ontology categories) in gene lists by statistical
means.
Protein identification and quantification using mass spectrometry.
Promoter analysis in yeast using CHIP and expression data.
Identifying regulatory polymorphism using SNP and expression data.
Characterizing the effect of DNA amplifications and deletions on gene expression in cancer using
CGH and expression data on the same samples.
The first week of the course concentrated on analysis of specific types of microarray data (expres-
sion, Affymetrix, CGH, CHIP-chip, and SNP arrays) and proteomics. The second week explored bio-
logical problems involving the integration of several types of high-throughput data. Data sets were
drawn from yeast, human polymorphisms, and cancer biology.
Confirmed speakers included Rick Young (MIT: yeast and CHIP), Audrey Gasch (Wisconsin: yeast
microarrays), Bruce Futcher (SUNY: microarray techniques), Terry Speed (Berkeley: proteomics), Rafa
Irizarry (Johns Hopkins: Affymetrix arrays), and Keith Bagger ly (Texas; proteomics).
PARTICIPANTS
Chen, S., B.S., University of Chicago, Illinois
Colak, D., Ph.D., King Faisal Specialist Hospital and Research
Center, Riyadh, Saudi Arabia
Cvek, U., Sc.D., Louisiana State University and LSU Health
Sciences Center, Shreveport
de Ridder, J., M.S., Delft University of Technology, The
Netherlands
Engelmann, J., M.S., University of Wurtzburg, Germany
Figueroa, M., M.D., Albert Einstein College of Medicine, Bronx,
New York
Hassane, D., Ph.D., University of Rochester Medical Center,
Rochester, New York
Jackson, S., B.S., U.S. FDA, Laurel, Maryland
Kayak, E., B.S., Bogazici University, Istanbul, Turkey
Kurkin, S., Ph.D., Philips Research, Eindhoven, The Netherlands
Large, T., B.S., Michigan State University, E. Lansing
Lim, L., B.S., Genome Institute of Singapore
SEMINARS
Bagger ly, K., M.D. Anderson Medical Center, Houston, Texas:
Quantitative proteomics I: More mass spec and lysate.
Quantitative proteomics II: More mass spec and lysate.
Cheung, V, University of Pennsylvania, Philadelphia: Genetics
of gene expression.
Futcher, B., SUNY at Stony Brook, New York: The yeast cell
cycle, in shades of green and red.
Gasch, A., University of Wisconsin, Madison: Deciphering
regulatory networks from stress-induced genomic expression
programs in yeast.
Irizzaray, R., Johns Hopkins University, Baltimore, Maryland:
Oligoarrays. Cross-platform.
lyer, V., University of Texas, Austin: Spotted DNA microarrays:
Array and experimental design and quantitation. Analyzing
DNA-protein interactions with chromatin immunopreciptation
(ChIP) and microarrays.
Lyou, Y., B.S., SUNY Upstate Medical University, Syracuse,
New York
Malone, J., M.S., University of Texas, Arlington
Marchand, J., Ph.D., Tufts University School of Medicine,
Boston, Massachusetts
Mathe, E., Ph.D., National Cancer Institute, Bethesda,
Maryland
Pagie, L., Ph.D., Netherlands Cancer Institute, Amsterdam,
The Netherlands
Puniyani, A., Ph.D., Cold Spring Harbor Laboratory
Rabadan, R., Ph.D., Institute for Advanced Study, Princeton,
New Jersey
Riley, T., M.S., Rutgers University, Piscataway, New Jersey
Trutschl, M., Sc.D., Louisiana State University and LSU Health
Sciences Center, Shreveport
Xu, L., Ph.D., University of New Orleans-Research Institute for
Children, New Orleans, Louisiana
Melnick, A., Albert Einstein College of Medicine, Bronx, New
York: Epigenomics.
Speed, T., University of California, Berkeley: SNP arrays.
Peptide identification in MS.
Spielman, R., University of Pennsylvania, Philadelphia:
Genetics of variation in gene expression (jointly with V
Cheung)
Weinstein, J., National Cancer Institute, Bethesda, Maryland:
Integromic analysis of the NCI-60 cancer cell panel:
Biostatistics and bioinformatics.
Wig ler, M., Cold Spring Harbor Laboratory: CGH methods.
Young, R., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge: Regulatory/transcription systems.
Zeit linger, J., Massachusetts Institute of Technology,
Cambridge: ChIP technicalities.
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Computational Neuroscience: Vision
June 16-29
INSTRUCTORS J. Demb, University of Michigan, Ann Arbor
E. Simoncelli, New York University, New York
S. Treue, German Primate Center, Goettingen, Germany
ASSISTANTS G. Field, Salk Institute, La Jolla, California
N. Rust, New York University, New York
Computational approaches to neuroscience will produce important advances in our understanding of
neural processing. Prominent success will come in areas where strong inputs from neurobiological,
behavioral, and computational investigation can interact. The theme of the course was that an under-
standing of the computational problems, the constraints on solutions to these problems, and the
range of possible solutions can help guide research in neuroscience. Through a combination of lec-
tures and hands-on experience in a computer laboratory, this intensive course examined color vision,
spatial pattern analysis, motion analysis, oculomotor function, attention, and decision-making.
Lecturers in this year's course included Larry Abbott, David Brainard, Matteo Carandini, Marisa
Carrasco, Eduardo Chichilnisky, Yang Dan, Jack Gallant, Wilson Geis ler, David Heeger, Nancy
Kainwisher, Michael Lewicki, J. Anthony Movshon, Michael Platt, Pamela Reinagel, Dario Ringach,
and Jonathan Victor.
The course was held at the Laboratory's Banbury Conference Center located on the north shore
of Long Island. All participants stayed within walking distance of the Center, close to the tennis
court, pool, and private beach.
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PARTICIPANTS
Anderson, E., B.S., Salk Institute, La Jolla, California
Benucci, A., Ph.D., Smith Kettelwell Eye Research Institute,
San Francisco, California
Busse, L., B.S., German Primate Center, Goettingen, Germany
Clark, A., B.S., University of Chicago, Illinois
Heckman, G., B.S., University of California, Santa Monica
Hohl, S., B.S., University of California, San Francisco
lshikawa, A., B.S., Osaka University, Toyonaka, Japan
Kalmar, R., B.S., Stanford University, Menlo Park, California
Kiani, R., B.S., University of Washington, Seattle
Majaj, N., B.S., New York University, New York
Marre, 0., B.S., CNRS, Gif sur Yvette, France
Masse, N., B.S., McGill University, Montreal, Canada
SEMINARS
Abbott, L., Columbia University, New York: Population
coding/decoding.
Brainard, D., University of Pennsylvania, Philadelphia: Contrast
adaptation: Psychophysics. Linear algebra/trichromacy.
Color: Constancy/adaptation.
Carandini, M., Smith-Kettelwell Eye Research Institute, San
Francisco, California: Predicting the responses of the early
visual system to complex stimuli.
Carrasco, M., New York University, New York: Psychophysics
of attention.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Linear-nonlinear model. Retina: Luminance adaptation.
Retina: Population coding.
Demb, J., University of Michigan, Ann Arbor: Retina: Contrast
adaptation. Retina: Pathways/linearity. Retina: Nonlinearities/
mechanisms.
Dan, Y., University of California, Berkeley: Adaptation/plasticity.
Field, G., The Salk Institute, La Jolla, California: Transduction.
Gallant, J., University of California at Berkeley: Cortex: Ventral
stream, form vision.
Geis ler, W., University of Texas at Austin: Pattern vision and
natural scenes.
Heeger, D., New York University, New York: Probing human
vision with fMRI.
Merriam, E., Ph.D., New York University, New York
Nauhaus, I., B.S., University of California, Los Angeles
Ng, M., B.S., Salk Institute, La Jolla, California
Pi lz, K., B.S., Max Plank Institute, Tubingen, Germany
Rathbun, D., B.S., University of California, Davis
Rothkopf, C., B.S., University of Rochester, New York
Sher, A., Ph.D., University of California, Santa Cruz
Stocker, A., Ph.D., New York University, New York
Wark, B., B.S., University of Washington, Seattle
Witthoft, N., B.S., Massachusetts Institute of Technology,
Boston
Xio, B., B.S., University of Pennsylvania, Philadelphia
Yeh, C.-I., B.S., SUNY State College of Optometry, New York
Kanwisher, N., Massachusetts Institute of Technology,
Cambridge: fMRI investigations of visual recognition in
humans.
Lewicki, M., Carnegie Mellon University, Pittsburgh,
Pennsylvania: Image statistics and neural representation.
Movshon, J.A., New York University, New York: MT:
Physiology.
Platt, M., Duke University, Durham, North Carolina: Neural
basis of decision-making.
Reinagel, P., University of California at San Diego, La Jolla:
Efficient coding hypothesis: LGN physiology.
Ringach, D., University of California, Los Angeles:
electrophysiology.
Rust, N., Massachusetts Institute of Technology, Cambridge:
Fourier transforms. Spike-triggered covariance analysis in
V-I.
Simoncelli, E., New York University, New York: Visual motion
modeling. Linear systems. Estimation/decision/bayes.
Welcome and introduction.
Treue, S., German Primate Center, Goettingen, Germany: The
role of attention in visual information processing.
Victor, J., Weill Medical College of Cornell, New York: Spikes
and the neural code.
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Proteomics
June 30-July 13
INSTRUCTORS
ASSISTANTS
P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Institute of Proteomics, Cambridge, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
R. Bish, Cold Spring Harbor Laboratory
E. Hainsworth, Harvard Medical School, Boston, Massachusetts
J. Jennings, Vanderbilt University School of Medicine, Nashville, Tennessee
W. Montor, Harvard Institute of Proteomics, Cambridge, Massachusetts
N. Ramachandran, Harvard Institute of Proteomics, Cambridge, Massachusetts
E. Simon, University of Michigan Medical School, Ann Arbor
S. Volk, University of Michigan, Blissfield
This intensive laboratory and lecture course focused on two major themes in proteomics: protein pro-
filing and functional proteomics. In the profiling section of the course, students learned about cutting-
edge protein separation methods, including hands-on experience with two-dimensional gel
electrophoresis, multidimensional liquid chromatography, and affinity purification of protein complexes.
The course covered both MALDI and ESI high-sensitivity mass spectrometry, including peptide mass
mapping and tandem mass spectrometry, quantification, and phosphoproteomics. Students learned to
use several informatics tools available for analyzing the data. In the functional proteomics section of the
course, students learned about recombinational cloning, high-throughput protein isolation, and protein
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microarrays. Students used robots to execute high-throughput methods including expression, purifica-
tion, and characterization of proteins. They also printed and analyzed their own self-assembling protein
microarrays, which was used for protein-protein interaction studies. The overall aim of the course was
to provide each student with a fundamental knowledge and hands-on experience necessary to perform
and analyze proteomics experiments and to learn to identify new opportunities in applying proteomics
approaches to his/her own research.
Speakers included Brian Chait (The Rockefeller University), Pierre Chaurand (Vanderbilt University
School of Medicine), Karl Clauser (Broad Institute), Ileana Critea (The Rockefeller University), Neil
Kelleher (University of Illinois), Akhilesh Pandey (Johns Hopkins University), Michael Snyder (Yale
University), and Forest White (Massachusetts Institute of Technology).
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Borrego, M.-J., Ph.D., Institute Nacional de Sade, Lisboa, Portugal
Carruthers, N., B.S., Wayne State University, Detroit, Michigan
Darling-Reed, S., Ph.D., College of Pharmacy & Pharmaceutical
Sciences, Tallahassee, Florida
Ericson, J., M.S., Goteborg University, Gothenburg, Sweden
Fe licio, A., M.S., Universidade Estadual Pau lista, Araraquara,
Brazil
Fusetti, F., Ph.D., University of Gronigen, The Netherlands
Guha, U., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
La Cour, J., M.S., University of Copenhagen, Denmark
SEMINARS
Chait, B., The Rockefeller University, New York: Purification of
proteins complexes using a magnetic IP.
Chaurand, P., Vanderbilt University School of Medicine,
Nashville, Tennessee: Profiling tissues by mass spectrometry.
Clauser, K., Broad Institute, Cambridge, Massachusetts: De
novo interpretation of tandem mass spectra.
Kelleher, N., University of Illinois, Urbana: Top-down mass
spectrometry analysis of whole proteins.
Lim, J., Ph.D., University of Auckland, Grafton, New Zealand
Marionneau, C., Ph.D., Washington University, St. Louis,
Missouri
Novo, M.T., Ph.D., Universidade Federal de Sao Carlos, Brazil
Oh, S.-H., Ph.D., University of California, Santa Barbara
Sarek, G., M.S., University of Helsinki, Finland
Singh, S., Ph.D., Sandia National Laboratories, Albuquerque,
New Mexico
Sundberg, E., Ph.D., Boston Biomedical Research Institute,
Watertown, Massachusetts
Yang, L., Ph.D., National Center Institute, Rockville, Maryland
Pandey, A., Johns Hopkins University, Baltimore, Maryland:
Proteomics databases.
Pappin, D., Applied Biosystems, Framingham, Massachusetts:
Quantitative mass spectrometry.
Snyder, M., Yale University, New Haven, Connecticut:
Application of protein microarrays.
White, F., Massachusetts Institute of Technology, Cambridge:
Phosphoproteomics.
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Molecular Approaches to Plant Science
June 30-July 20
INSTRUCTORS
ASSISTANTS
J. Bender, Johns Hopkins University School of Public Health,
Baltimore, Maryland
L. Hobbie, Ade 1phi University, Garden City, New York
H. Ma, Pennsylvania State University, University Park
S. McCormick, Plant Gene Expression Center, Albany, California
M. Alandete-Saez, Plant Gene Expression Center, Albany, California
L. Boavida, University of California, Berkeley
L. Quan, Pennsylvania State University, University Park
This course provided an intensive overview of topics in plant physiology and development, focusing on
molecular genetic approaches to understanding plant biology. It emphasized recent results from
Arabidopsis thaliana and other plants and provided an introduction to current methods used in plant
molecular biology. It was designed for scientists with some experience in molecular techniques or in
plant biology who wish to work with Arabidopsis and other plants using the latest technologies in genet-
ics and molecular biology. The course consisted of a vigorous lecture series, a hands-on laboratory, and
informal discussions. Discussions of important topics in plant research were presented by the instruc-
tors and by invited speakers. These seminars included plant morphology and anatomy; plant develop-
ment (such as development of flowers, leaves, male and female gametophytes, and embryos);
perception of light and photomorphogenesis; and synthesis, function, and perception of hormones.
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Lectures describing bioinformatics tools available to the plant community and the resources pro-
vided by plant genome projects were also included. Speakers provided overviews of their fields, fol-
lowed by in-depth discussions of their own work. The laboratory sessions provided an introduction to
important techniques currently used in plant research. These included studies of plant development,
mutant analysis, histochemical staining, transient gene expression, applications of green fluorescent
protein fusions, protein interaction and detection, proteomics approaches, transcription profiling, and
techniques commonly used in genetic and physical mapping. The course also provided several short
workshops on important themes in genetics.
Invited speakers included Jody Banks (Purdue University), Justin Borevitz (University of Chicago),
John Celenza (Boston University), Savithramm Dinesh-Kumar (Yale University), Ueli Grossniklaus
(University of Zurich), Roger Hangarter (Indiana University), Paul Herzmark (University of California, San
Francisco), Vivian Irish (Yale University), Thomas Jack (Dartmouth College), David Jackson (Cold Spring
Harbor Laboratory), Cris Kuhleimeier (Universitat Bern), Wolfgang Lukowitz (Cold Spring Harbor
Laboratory), June Nasrallah (Cornell University), Jennifer Norman ly (University of Massachusetts),
Thomas Nuhse (The Sainsbury Laboratory), Eric Richards (Washington University), John Schiefelbein
(University of Michigan), David Sommers (Ohio State University), Tai-ping Sun (Duke University Medical
Center), and Marja Timmermans (Cold Spring Harbor Laboratory).
PARTICIPANTS
Brandenburg, A., M.S., University of Bern, Switzerland
Crawford, S., B.A., University of York, United Kingdom
Dozier, U., M.Ed., Howard University, Washington, D.C.
Goff, K., B.S., The University of Alabama, Tuscaloosa
Hertel, S., Diplom., Humboldt-University of Berlin, Germany
Jarve, K., M.S., Tallinn University of Technology, Estonia
Johnson, R., B.S., Texas Woman's University, Denton
Jones, K., Ph.D., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Banks, J., Purdue University, W. Lafayette, Indiana:
Gametophytes and evolution.
Bender, J., Johns Hopkins University School of Public Health,
Baltimore, Maryland: Epigenetics II.
Borevitz, J., University of Chicago, Illinois: Adaptation to light.
Celenza, C., Boston University, Cambridge, Massachusetts:
Genetics of secondary metabolism.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophytes.
Hangarter, R., Indiana University, Bloomington: Light responses.
Herzmark, P., University of California, San Francisco:
Microscopy lecture and lab.
Hobbie, L., Ade 1phi University, Garden City, New York: Auxin
signaling.
Irish, V., Yale University, New Haven, Connecticut: Evolution of
flower development.
Jack, T., Dartmouth College, Hanover, New Hampshire: Flower
development.
Kumar-Dinesh, S., Yale University, New Haven, Connecticut:
Plant-pathogen interactions.
Lukowitz, W., Cold Spring Harbor Laboratory: Embryo
development. Genetics II: Double mutants.
Ma, H., Pennsylvania State University, University Park:
Genetics I: Mutagenesis. Genetics II: Double mutants. Plant
Anatomy. Microsporogenesis.
Koniger, M., Ph.D., Wellesley College, Wellesley, Massachusetts
Matveeva, E., M.S., ETH Zentrum, Zurich, Switzerland
Miller, T., B.A., Marquette University, Milwaukee, Wisconsin
Mondragon-Palomino, M., Ph.D., University of Jena, Germany
Muralidharan, M., B.S., Arizona State University, Tempe
Nour-Eldin, H., B.S., The Royal Veterinary and Agricultural
University, Copenhagen, Denmark
Sauer, M.-L., Ph.D., South Dakota State University, Brookings
Veerappan, V., M.S., Texas Tech University, Lubbock
McCormick, S., Plant Gene Expression Center, Albany,
California: Pollen development. Bioinformatics. Scientific
writing workshop.
Nasrallah, J., Cornell University, Ithaca, New York: Self-
incompatibility.
Nelson, T., Yale University, New Haven, Connecticut: Vascular
development.
Norman ly, J., University of Massachusetts, Amherst: Metabol-
omics and auxin homeostasis.
Nuhse, T., John Innes Centre, Norwick, United Kingdom:
Proteomics.
Richards, E., Washington University, St. Louis, Missouri:
Epigenetics I.
Schaller, G.E., Dartmouth College, Hanover, New Hampshire:
Ethylene.
Schiefelbein, J., University of Michigan, Ann Arbor: Root hair
development.
Sommers, D.,, Ohio State University: The circadian clock.
Sun, T.-p., Duke University Medical School, Durham, North
Carolina: GA signaling.
Timmermans, M., Cold Spring Harbor Laboratory: Maize shoot
patterning.
Wildermuth, M., University of California, Berkeley: Metabolomics
and SA function.
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Neurobiology of Drosophila
June 30-July 20
INSTRUCTORS G. Bashaw, University of
Pennsylvania, Philadelphia
S. Waddell, University of Massachusetts Medical School, Worcester
B. Zhang, University of Texas, Austin
ASSISTANTS S. Das Gupta, University of
Massachusetts Medical School, Worcester
D. Garbe, University of Pennsylvania, Philadelphia
J.P. Labrardor, University of Pennsylvania School of Medicine, Philadelphia
R Perrat, University of Massachusetts Medical School, Worcester
C. Spaeth, University of Texas, Austin
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The 3-week course was divided into the study of development,
physiology/function, and behavior. Daily seminars introduced students to a variety of research topics
and developed those topics by including recent experimental contributions and outstanding questions
in the field. Guest lecturers brought original preparations for viewing and discussion and direct labo-
ratory exercises and experiments in their area of interest. The course provided students with hands-
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on experience using a variety of experimental preparations that are used in the investigation of current
neurobiological questions.
The lectures and laboratories focused on both the development of the nervous system and its role in
controlling larval and adult behaviors. In addition to an exposure to the molecular genetic approaches
available in Drosophila, students learned a variety of techniques including embryo in situ hybridization,
labeling of identified neurons, electrophysiological recording from nerves and muscles, and the analysis
of larval and adult behavior. Collectively, the course provided a comprehensive and practical introduction
to modern experimental methods for studying the Drosophila nervous system.
This year's lecturers included), Marcus Allen (University of Kent), Justin Blau (New York University),
Heather Broihier (Case Western Reserve University), Vivian Budnik (University of Massachusetts), Sarah
Certel (Harvard University), Yick-Bun Chan (Harvard Medical School), Josh Dubnau (Cold Spring Harbor
Laboratory), Daniel Eberl (University of Iowa), David Featherstone (University of Illinois at Chicago), Marc
Freeman (University of Massachusetts Medical School), Donald Gailey (California State University,
Hayward), Fen Biao Gao (The Gladstone Institutes at UCSF), Tanja Godenschwege (University of
Massachusetts), Stephen Goodwin (University of Glasgow), Gregory Jefferis (University of Cambridge),
Edward Kravitz (Harvard Medical School), Mary Logan (University of Massachusetts Medical School),
Greg Macleod (University of Arizona), Ben Parrott (University of Georgia), Peng Shen (University of
Georgia), Bryan Stewart (University of Toronto), Glenn Turner (California Institute of Technology), and
Bruno van Swinderen (Neurosciences Institute).
PARTICIPANTS
Cevik, M., Ph.D., Abant Izzet Baysal Universite, Bolu, Turkey
Cho, J.Y., Ph.D., The Johns Hopkins University School of
Medicine, Baltimore, Maryland
Colon-Cesario, W., Ph.D., Stowers Institute for Medical
Research, Kansas City, Missouri
Hill, J., B.A., University of Massachusetts, Amherst
Hoare, D., B.Sc., The University of Manchester, United Kingdom
McKellar, C., Ph.D., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Allen, M., University of Kent, United Kingdom, and Goden-
schwege, T., University of Massachusetts, Amherst: The
giant fiber system.
Bashaw, G., University of Pennsylvania, Philadelphia: Axon
guidance.
Blau, J., New York University, New York: Circadian rhythm and
larvae.
Brohier, H., Case Western Reserve, Cleveland, Ohio: Neuronal
identity.
Budnik, V., University of Masschusetts, Worcester: NMJ
Development. Discussion on the mystery mutant results.
Student activity: Mystery mutants.
Dubnau, J., Cold Spring Harbor Laboratory: Long-term
memory.
Eberl, D., University of Iowa, Iowa City, and Turner, G.,
California Institute of Technology, Pasadena, California:
Hearing and smell.
Featherstone, D., University of Illinois at Chicago: Glutamate
receptors and synaptic plasticity.
Nagaraja, K., Ph.D., University of Michigan, Ann Arbor
Pollarolo, G., M.S., VIB and University of Leuven School of
Medicine, Leuven, Belgium
Repnikova, E., M.S., Texas A&M University, College Station
Smith, R., B.S., University of Alabama, Birmingham
Tabone, C., B.S., University of Nevada, Las Vegas
Weaver, C., Ph.D., University of California, San Diego
Wu, P. -S., M.D., Columbia University, New York
Freeman, M., University of Massachusetts, Worcester: Glial
development and Fn.
Gao, F.B., University of California, San Francisco: Dendrite
morphogenesis.
Jefferis, G., Cambridge University, United Kingdom: Mosaic
genetic techniques. Olfactory system development.
Kravitz, E. and Certel, S., Harvard Medical School, Boston,
Massachusetts: Aggression.
Macleod, G., University of Arizona, Tucson: Imaging neural
activity at the fly NMJ.
Shen, P., University of Georgia, Athens: Feeding behavior.
Stewart, B., University of Toronto, Canada: Electrophysiology 101.
Synaptic release. Student activity: NMJ recording.
van Swinderen, B., Neuroscience Institute, San Diego,
California: Visual learning.
Waddell, S., University of Massachusetts Medical School,
Worcester: Introduction. Olfactory learning and memory.
Zhang, B., University of Texas, Austin: Synaptic vesicle
recycling.
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Mechanisms of Neural Differentiation and Brain Tumors
July 6-12
INSTRUCTORS A. Guha, University of Toronto, Canada
S. Majumuder, M.D. Anderson Cancer Center, Houston, Texas
This 1-week discussion course provided a clinical overview of brain tumors and emphasized molecular
mechanisms involved in the growth and development of brain tumors with special emphasis on neural
differentiation, signaling mechanisms, DNA replication, chromatin modulation, stem cells, mouse mod-
els, genomics, imaging techniques, genetically modified mouse techniques, nanotechnology, mecha-
nism-based therapeutic strategies, and biobanks and ethical concerns. Attendees interacted with
senior investigators on a one-to-one basis in an informal environment.
Topics included Clinical Overview of Brain Tumors, Neuro-oncology/Surgery/Radiology/Pathology,
Nervous System Pre-Disposition Syndromes, Genetic Alterations in Sporadic Brain Tumors, Chromatin
Remodeling, DNA Replication, Extracellular Matrix and Migration, Stem Cells and Cancer Stem Cells,
Neuronal, Glial, and Oligodendrocyte Differentiation, Genetically Engineered Mouse System, Detection
Methods including Nanotechnology, Mechanism-based Therapeutics, Epidemiology, and NCI strategies
and funding mechanisms.
Speakers included Oliver Bog ler (M.D. Anderson Cancer Center), Melissa Bondy (M.D. Anderson Cancer
Center), Melvin DePamphilis (National Institutes of Health), Charles Eberhart (Johns Hopkins University),
Gregory Fuller (M.D. Anderson Cancer Center), Candece Gladson (University of Alabama, Birmingham),
Steve Goldman (University of Rochester), David Gutmann (Washington University School of Medicine), Paul
Knoepfler (Fred Hutchinson Cancer Research Center), Victor Levin (M.D. Anderson Cancer Center),
Guillermina Lozano (M.D. Anderson Cancer Center), Tak Mak (AMDI OCI University Health Network), Gail
Mandel (HHMI/SUNY Stony Brook), Christina Meyers (M.D. Anderson Cancer Center), Judy Mietz (National
Cancer Institute), Andras Nagy (Samuel Lunenfeld Research Institute), Roe land Nusse (HHMI, Stanford
University), Luis Parada (University of Texas Southwestern Medical Center), Mahendra Rao (Invitrogen), Ray
Sawaya (M.D. Anderson Cancer Center), Evan Snyder (Burnham Institute), Charles Stiles (Dana Farber
Cancer Institute), Al Yung (M.D. Anderson Cancer Center), and Miqin Zhang (Washington University)
This course was supported with generous funding provided by the American Brain Tumor Association.
PARTICIPANTS
Aboody, K., Ph.D., Beckman Research Institute, Duarte, California
Agathocleous, M., B.S., University of Cambridge, United
Kingdom
Barish, M., Ph.D., Beckman Research Institute, Duarte,
California
Benitez, J., B.S., CINVESTAV, Mexico City, Mexico
deCarvalho, A., Ph.D., Henry Ford Hospital, Detroit, Michigan
Evans, S., Ph.D., University of Pennsylvania School of
Medicine, Philadelphia
Feng, C., Ph.D., University of Nevada, Reno
Havrda, M., B.S., Dartmouth Medical School, Lebanon, New
Hampshire
Kagalwala, M., B.S., M.D. Anderson Cancer Center, Houston,
Texas
Kamnasaran, D., Ph.D., Hospital for Sick Children, Toronto,
Canada
Kang, N., Ph.D., University of Texas, Houston
Lam, P., Ph.D., National Cancer Center, Singapore
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Ma, J., B.S., University of California, Davis
Maria, B., Ph.D., Medical University of South Carolina, Charleston
Mazumdar, T., B.S., Kent State University, Cleveland, Ohio
Nakashima, H., Ph.D., Ohio State University Medical Center,
Columbus
Narita, Y., Ph.D., National Cancer Center Hospital, Tokyo,
Japan
Onorati, M., Ph.D., University of Pisa, Ghezzano, Italy
Phillips, J., B.S., University of California, San Francisco
Rich, J., Ph.D., Duke University Medical Center, Durham,
North Carolina
Singh, S., Ph.D., M.D. Anderson Cancer Center, Houston,
Texas
Skalli, 0., Ph.D., Louisiana State University, Shreveport
Soroceanu, L., Ph.D., CPMC Research Institute, San
Francisco, California
Uziel, T., Ph.D., St. Jude Children's Research Hospital,
Memphis, Tennessee
SEMINARS
Bog ler, 0., University of Texas, M.D. Anderson Cancer Center,
Houston: Tyrosine kinases in glioma. Proteomics and novel
cytotoxins in glioma.
DePamphilis, M., National Institutes of Health, Bethesda,
Maryland: DNA replication.
Fuller, G., M.D. Anderson Cancer Center, Houston, Texas: The
role of neuropathology in clinical and investigative neuro-
oncology.
Gladson, C., Univerity of Alabama, Birmingham: Extracellular
matrix, migration, angiogenesis.
Guha, A., Hospital for Sick Children, Toronto, Canada: Genetic
mechanisms.
Gutmann, D., Washington University School of Medicine, St.
Louis, Missouri: Using mouse models to dissect the
molecular and cellular pathogenesis of brain tumors.
Levin, V., M.D. Anderson Cancer Center, Houston, Texas:
Understanding treatment strategies for gliomas.
Lozano, G., University of Texas M.D. Anderson Cancer Center,
Houston: Genetic mechanisms.
Mak, T., Princess Margaret Hospital, Toronto, Canada: PTEN
pathways.
Mandel G., Howard Hughes Medical Institute, SUNY Stony
Brook, New York: The rise and fall of REST: Creating the
nervous system.
Meyers, C., M.D. Anderson Cancer Center, Houston, Texas:
Neuropsychology.
Parada, L., University of Texas Southwestern Medical Center,
Dallas: Genetic Mechanisms.
Sawaya, R., M.D. Anderson Cancer Center, Houston, Texas:
New techniques in surgery for brain tumors.
Stiles, C., Dana Farber Cancer Institute, Boston, Massachusetts:
Transcription factors and glial development.
Yung, A., University of Texas M.D. Anderson Cancer Center,
Houston: Mechanism-based therapeutics.
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Advanced Techniques in Molecular Neuroscience
July 6-20
INSTRUCTORS J. Eberwine, University of
Pennsylvania Medical School, Philadelphia
T. Hughes, Montana State University, Bozeman
C. Lai, Scripps Research Institute, La Jolla, California
COINSTRUCTORS K. Becker, National Institutes on
Aging /NIH, Baltimore, Maryland
K. Haas, University of British Columbia, Vancouver, Canada
R. Lansford, California Institute of Technology, Pasadena
ASSISTANTS H. Butler, Montana State University, Bozeman
R. Mealer, Montana State University, Bozeman
T. Peritz, University of Pennsylvania Medical Center, Philadelphia
G. Poynter, California Institute of Technology, Pasadena
J. Tan, Scripps Research Institute, La Jolla, California
W. Wood, Ill, National Institutes on Aging/NIH, Baltimore, Maryland
K. Wu, University of Pennsylvania Medical Center, Philadelphia
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels with
a conceptual and practical understanding of several of the most advanced techniques in molecular neu-
roscience. The course curriculum was divided into three sections: an extensive and up-to-date set of lab-
oratory exercises, daily lectures covering the theoretical and practical aspects of the various methods
used in the laboratory, and a series of evening research seminars. The informal and interactive evening
lectures were given by leading molecular neuroscientists and served to illustrate the ways in which the
various experimental approaches have been used to advance specific areas of neurobiology.
In this year's course, the laboratory portion included topics such as an introduction to the design and
use of animal virus vectors in neurobiology; the use of small interfering RNAs (siRNA) for regulating the
expression of specific genes in neurons; practical exercises in gene-delivery systems including mammalian
cell transfection protocols and single-cell electroporation techniques for targeted gene transfer in vivo; an
introduction to overall strategies, use, and design of BAC transgenic vectors; multiplex and whole-genome
expression analyses using the most recent DNA microarray technologies (including labeled probe prepa-
ration, data analyses, mining, and interpretation); quantitative real-time RT-PCR analyses from small num-
bers of cells (RNA purification, PCR optimization, interpretation of results); single-cell PCR and cDNA
library construction; and methods and application of RNA amplification (aRNA). Each laboratory module
was followed by comprehensive data analyses and interpretation, protocol troubleshooting, and sugges-
tions for ways to improve or modify the existing technique. Finally, course participants were introduced to
bioinformatics and a wide range of Internet resources that were available to molecular neuroscientists.
Speakers included Robert Darnell (HHMITThe Rockefeller University), Philip Haydon (University of
Pennsylvania), Donald Lo (Duke University Medical Center), Ardem Patapoutian (Scripps Research
Institute), Marie Anne Quinn (Montana Molecular LLC), Angeles Riberia (UCDHSC at Fitzsimons), and
Lino Tessarollo (National Cancer Institute).
PARTICIPANTS
Black, M., Ph.D., Georgia State, Atlanta
Chung, K.Y., D.Phil., Columbia University, New York
Delalle, I., Ph.D., Boston University Medical School,
Massachusetts
Gardner, T., Ph.D., Massachusetts Institute of Technology,
Cambridge
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Gkogkas, C., M.Sc., University of Edinburgh, United
Kingdom
Griveau, A., M.S., Universite Paris VI, Paris, France
Kuhn, C., Ph.D., Gothenburg University, Goteborg, Sweden
Ma, C., D.Phil., Harvard Medical School, Charlestown,
Massachusetts
McIver, S., B.A., Washington University, St. Louis, Missouri
Myers, K., Ph.D., Emory University, Atlanta, Georgia
Olveczky, B., Ph.D., Massachusetts Institute of Technology,
Cambridge
Petrinovic, M., M.S., University of Zurich, Switzerland
Pierce, A., M.S., University of Memphis, Tennessee
SEMINARS
Darnell, R., The Rockefeller University, New York: Applying
molecular biology to study the role of RNA-binding proteins
in neurologic disease.
Eberwine, J., University of Pennsylvania, Philadelphia:
Molecular biology of the dendrite.
Haydon, P., University of Pennsylvania, Philadelphia: Glia:
Listening and talking to the synapse.
Patapoutian, A., Scripps Research Institute, La Jolla, California:
Russell, S., M.D., New York University School of Medicine,
New York
Siegert, S., Dipl., Friedrich Miescher Institute, Basel,
Switzerland
Thayer, D., B.S., Scripps Research Institute, La Jolla, California
How do you feel? Molecular basis of temperature sensation.
Ribera, A., Universtity of Colorado Health and Sciences Center
at Fitzsimons, Denver: Molecular neurobiology of the
embryonic zebra fish nervous system.
Tessarollo, L., National Cancer Institute, Frederick, Maryland:
Dissecting neurotrophin functions in vivo: Lessons from
engineered mouse models.
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Biology of Social Cognition
July 14-20
INSTRUCTORS
ASSISTANT
R. Adolphs, California Institute of Technology, Pasadena
D. Skuse, University College London, United Kingdom
D. Newmann, California Institute of Technology, Pasadena
The past few years have seen remarkable advances in our knowledge of the genetic, molecular, and
neural factors that contribute to social behavior. At the same time, sophisticated analytical and theoret-
ical approaches have helped to make sense of the data. This week-long workshop provided a compre-
hensive overview of these topics. Although the emphasis was on social cognition in humans, there were
study days dedicated to state-of-the-art presentations on comparative approaches and evolutionary
models. Finally, all themes were related to the clinical consequences of dysfunctional social cognition
and the role of translational research. The course included introductory seminars on key themes, offered
every morning. Afternoons were devoted largely to practical sessions that provided hands-on experi-
ments in consultation with seminar leaders, rounded off by after-supper keynote lectures by leading sci-
entists that reflected cutting-edge and future views related to our theme for that day. Ample breaks
allowed time for informal interactions between lecturers and students.
This course was supported with funds provided by the Oliver Grace Fund.
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PARTICIPANTS
Bayliss, A., Ph.D., University of Wales, Bangor, United
Kingdom
Belmonte, M., Ph.D., University of Cambridge, United
Kingdom
Bengtsson, S., Ph.D., University College London, United
Kingdom
Bennett, T., Ph.D., McMaster University, Hamilton, Canada
Bishop, S., Ph.D., Cambridge University, United Kingdom
Griffin, A., B.S., University of Texas, Austin
Hagan, C., B.S., University of York, United Kingdom
Halligan, S., Ph.D., University of Reading, United Kingdom
Hassett, J., B.S., Emory University, Atlanta, Georgia
Kipps, C., Ph.D., University of Cambridge, United Kingdom
Krusemark, E., B.S., University of Georgia, Athens
Lee, L., B.S., University of York, United Kingdom
Marco, E., Ph.D., University of California, San Francisco
SEMINARS
Adolphs, R., California Institute of Technology, Pasadena: The
amygdala.
Adolphs, R., California Institute of Technology, Pasadena:
Review and summary.
Adolphs, R., California Institute of Technology, Pasadena: Eye
tracking and psychophysiology.
Newmann, D., California Institute of Technology, Pasadena:
Workshop: Eye tracking and psychophysiology.
Anderson, D., California Institute of Technology, Pasadena:
Model systems for fear and anxiety.
Blakemore, S., University College London, United Kingdom:
Worskhop: Social cognition from adolescence to adulthood.
Cahill, L., University of California, Irvine: Sex differences in
social cognition.
Couzin, I., Oxford University, United Kingdom: Workshop: The
emergence of collective behavior-From locusts and birds to
fish and human crowds.
Crews, D., University of Texas, Austin: Development of social
phenotyes and mating systems.
Crow, T., Oxford University, United Kingdom: Evolution of
language and the origins of psychosis.
Hauser, M., Harvard University, Cambridge, Massachusetts:
The moral mind.
Huhman, K., Georgia State University, Atlanta: Conditioned
defeat in hamsters.
Insel, T., National Institutes of Mental Health, Bethesda,
Maryland: The future of social cognition.
Kidd, K., Yale University, New Haven, Connecticut:
Introduction to complex genetics.
Matheson, A., B.S., Institute of Child Health, London, United
Kingdom
Molnar-Szakacs, I., Ph.D., Ecole Polytechnique Federale de
Lausanne, Switzerland
Moore, H., Ph.D., Columbia University, New York
Norris, C., Ph.D., University of Wisconsin, Madison
Oswald, T., B.S., University of Oregon, Eugene
Overy, K., Ph.D., University of Edinburgh, United Kingdom
Ruz, M., Ph.D., University of Oxford, United Kingdom
Southgate, V, Ph.D., Birkbeck College, London, United
Kingdom
Thompson, S., B.S., University College London, United
Kingdom
Uddin, L., B.S., New York University, New York
Williams, K., Ph.D., University of Edinburgh, United Kingdom
Yang, P., Ph.D., Kaoshiung Medical University, Taiwan
Parr, L., Emory University, Atlanta, Georgia: Emotional
communication in chimpanzees.
Pfaff, D., The Rockefeller University, New York: Molecular
mechanisms for the development of aggression.
Phelps, E., New York University, New York: The interaction of
emotion and cognition.
Raine, A., University of Southern California, Los Angeles:
Psychopathy.
Saxe, R., Massachussets Institute of Technology, Boston:
Imaging how we think about people.
Schultz, R., Yale University, New Haven, Connecticut:
Neuroimaging and neuroanatomy of social cognition.
Sebat, J., Cold Spring Harbor Laboratory: Approaches to
discovering genes that influence social cognitive traits.
Skuse, D., University College London, United Kingdom:
Welcome, introduction, and overview.
Skuse, D., University College London, United Kingdom:
Endophenotypes in social cognitive research.
Skuse, D., University College London, United Kingdom: X-
linked genes and social cognition.
Skuse, D., University College London, United Kingdom: Review
and summary.
Tager-Flusberg, H., Boston University, Massachusetts: Autism
spectrum disorders and Williams syndrome.
Young, L., Emory University, Atlanta, Georgia: Neurobiology of
pair bonding in voles.
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Workshop on Schizophrenia and Related Disorders
July 22-31
INTRUCTORS D. Lewis, University of Pittsburgh
D. Porteous, University of Edinburgh, United Kingdom
D. Weinberger, National Institute of Mental Health
This workshop provided students with the most current understanding of the molecular, cellular, and
neural systems underlying the disturbances in brain function in these devastating illnesses. During the
10-day workshop, students learned about the clinical aspects of schizophrenia, schizoaffective disor-
der, and bipolar disorder, as well as explored in detail the genetic and neurobiological underpinnings of
these complex psychiatric disorders.
The Workshop was divided into four main sessions: Clinical Overview; Genetics and Genomics;
Developmental Neurobiology and Neural Circuits, and Cognitive Systems. In addition to hearing about
the most recent research in these areas, controversial topics and challenges to basic assumptions in
the field were explored and discussed. A diverse faculty brought the most up-to-date results and the-
ories to the students, making this Workshop a valuable resource for young researchers starting out in
this fast-moving and expansive field. Not only did it help them build the foundation for their future
research, it also introduced them to many potential collaborators working to understand schizophrenia
and similar disorders from different perspectives.
This workshop was supported with funds provided by the Oliver Grace Fund.
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PARTICIPANTS
Barnett, J., B.S., University of Cambridge, United Kingdom
Bergman, 0., B.S., Goteborg University, Gothenburg,
Sweden
Bordelon, J., B.S., Emory University, Atlanta, Georgia
Burdick, K., Ph.D., North Shore Long Island Jewish Health
System, Glen Oaks, New York
Den Ouden, H., B.S., University College London, United
Kingdom
Deo, A., B.S., New York University, New York
Duncan, C., B.S., Garvan Institute of Medical Research,
Sydney, Australia
Eyjolfsson, E., B.S., Norwegian University of Science and
Technology, Trondheim, Norway
Gaisler-Salomon, I., Ph.D., Columbia University, New York
Hajos, M., Ph.D., Pfizer Global Research and Development,
Groton, Connecticut
Heimer, H., B.S., Schizophrenia Research Forum, Providence,
Rhode Island
Heinrich, J., Ph.D., Wyeth Research, Monmouth Junction,
SEMINARS
Abi-Dargham, A., Columbia University, New York: Dopamine
system.
Bilder, R., David Geffen School of Medicine at UCLA,
California: Cognition in schizophrenia.
Caron, M., Duke University Medical Center, Durham, North
Carolina: Animal models.
Coyle, J., Harvard University/McLean Hospital, Belmont,
Massachusetts: Glutamate system.
Kane, J., Zucker Hillside Hospital, Glen Oaks, New York:
Diagnosis and clinical phenomenology. Neuropharmacology
and current treatment approaches.
Lawrie, S., Royal Edinburgh Hospital, United Kingdom:
Neuroanatomy and imaging in schizophrenia. Challenges;
new technologies.
Levitt, P., Vanderbilt University, Nashville, Tennessee:
Developmental neurobiology. Development of cortical circuitry
and disorders of processing.
Lewis, D., University of Pittsburgh, Pennsylvania: GABAergic
system. Summary of neurobiology.
Manji, H., National Institutes of Health, Bethesda, Maryland:
Neuronal plasticity cascades: Genes to behavior pathways in
the pathophysiology and treatment of schizophrenia and
mood disorders.
McKay, R., National Institutes of Health, Bethesda, Maryland: Do
stem cells matter? Defining dopamine neuron development
and function.
Murray, R., Institute of Psychiatry, London, United Kingdom:
History and clinical description. Neurodevelopment and
schizophrenia. Summary of session 1.
New Jersey
Horvath, S., B.S., University of Szeged, Hungary
Lin, P -I, Ph.D., Cold Spring Harbor Laboratory
March, D., B.S., Columbia University, New York
McCatthy, S., Ph.D., Cold Spring Harbor Laboratory
Meyer, K., B.S., Northwestern University, Chicago, Illinois
Osumi, N., Ph.D., Tohoku University, Sendai, Japan
Panos, J., B.S., Western Michigan University, Kalamazoo
Rinaldi, T., B.S., Ecole Polytechnique Federale de Lausanne,
Switzerland
Sachs, N., Ph.D., Johns Hopkins University, Baltimore, Maryland
Sosa Machado, Y., B.S., North Dakota State University, Fargo
Stevens, B., Ph.D., University of Florida College of Medicine,
Gainesville
Van Beek, J., Ph.D., H. Lundbeck NS, Valby-Copenhagen,
Denmark
Vogels, T., B.S., Columbia University, New York
Wass, C., B.S., University of Goteborg, Sweden
O'Donnell, P., Albany Medical College, New York: Peri-
adolescent maturation of prefrontal cortical circuits.
O'Donovan, M., University of Wales, Cardiff, United Kingdom:
Schizophrenia genetics: Concepts, methods, current status.
Specific genes 1 (dysbindin/G72, neuregulin 1, the VCFS
region).
Porteous, D., University of Edinburgh, United Kingdom:
Specific genes II: DISC-1. Specific genes III (NPAS, GRIK4).
Summary of genetics.
Robbins, T., University of Cambridge, United Kingdom:
Modeling neural circuits: Cognition. Modeling neural circuits:
Positive symptoms. Preclinical models of schizophrenia and
their utility. Future directions.
Role, L., and Talmage, D., Columbia University, New York:
Neuregulin signaling, smoking, and schizophrenia.
Rutter, M., Institute of Psychiatry, Kings College, London, United
Kingdom: Overview of psychiatric genetics. Gene environment.
Sebat, J., Cold Spring Harbor Laboratory: Genomic
approaches (ROMA, etc.).
Sesack, S., University of Pittsburgh, Pennsylvania: How the
brain is wired: Principles of functional neural circuits.
Susser, E., Columbia University, New York: Epidemiology.
Epidemiology: Part 2.
Tsuang, M., University of California, San Diego: Gene
expression of blood and brain: Toward identifying biomarkers
for schizophrenia.
Weinberger, D., NIMH/St. Elizabeth's Hospital, Bethesda,
Maryland: Introduction: What we've learned so far. Future
Directions.
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Eukaryotic Gene Expression
July 25-August 14
INSTRUCTORS
ASSISTANTS
M. Bulger, University of Rochester School of Medicine, New York
T. Oelgeschlager, Eukaryotic Gene Regulation, United Kingdom
A. Shilatifard, St. Louis University School of Medicine, St. Louis, Missouri
L. Tora, IGBMC, Illkirch, France
G. Fromm, University of Rochester, New York
T. Hilton, IGBMC, Illkirch, France
B. Malecova, Transcription Laboratory, United Kingdom
J. Schneider, St. Louis University School of Medicine, Missouri
M. Steward, St. Louis University School of Medicine, Missouri
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the exciting area of gene regulation. The coursel focused on state-of-the-art strategies and
techniques employed in the field. Emphasis was placed both on in vitro and in vivo protein-DNA inter-
actions and on novel methodologies to study gene regulation. Students made nuclear extracts,
expressed and purified DNA-binding transcriptional activators, performed in vitro transcription reac-
tions, and measured RNA levels using primer extension. Characterizations of the DNA-binding proper-
ties of site-specific transcription factors were carried out using electrophoretic mobility-shift and DNase
I footprinting assays. In addition, students learned techniques for the assembly and analysis of chro-
matin in vitro. This included activator-stimulated histone acetyltransferase assays, chromatin footprint-
ing, and chromatin remodeling assays, as well as histone methyltransferase assays.
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During the past few years, the gene regulation field has developed in vivo approaches to studygene
regulation. Students were exposed to the chromatin immunoprecipitation technique. They also used
RNAi for specific knockdown experiments in mammalian cells. In addition, determining cellular gene
expression profiles has been accelerated tremendously by DNA microarray technology. Students
received hands-on training in performing and interpreting results from DNA microarrays.
Experience with basic recombinant DNA techniques was a prerequisite for admission to this course.
Lectures by the instructors covered the current status of the gene expression field, theoretical aspects
of the methodology, and broader issues regarding strategies for investigating the regulation of gene
expression in eukaryotes. Guest lecturers discussed contemporary problems in eukaryotic gene regu-
lation and technical approaches to their solution.
PARTICIPANTS
Ahlskog, J., M.S., Abo Akademi University, Turku, Finland
Dimitrova, N., Ph.D., Philips Research/CSHL, Briarcliff Manor,
New York
Donaldson, Z., B.S., Emory University, Atlanta, Georgia
Fung, I., B.Sc., University of Toronto, Canada
Gafencu, A., Ph.D., Institute of Cellular Biology and Pathology,
"Nicolae Simionescu," Bucharest, Romania
Goh, A., Ph.D., Institute of Molecular and Cell Biology, Singapore
Helenius, K., M.S., Biomedicum Helsinki, Finland
Hufnagel, L., Ph.D., Kav li Institute for Theoretical Physics,
Santa Barbara, California
SEMINARS
L., Stanford University School of Medicine, California:
Using mouse models to dissect the function of the p53
transactivator in tumor suppression.
Bentley, D., University of Colorado Health Sciences Center,
Denver: Transcription and RNA processing.
Bulger, M., University of Rochester School of Medicine, New
York: Hyperacetylated domains and tissue-specific gene
expression in erythroid cells.
Gasser, S., Friedrich Miescher Institute, Basel, Switzerland:
Chromosomal context and patterns of gene expression.
Hahn, S., Frederick Hutchinson Cancer Center, Seattle,
Washington: Pol II basal transcription factors and gene
expression.
Hannon, G., Cold Spring Harbor Laboratory: RNAi and gene
silencing.
Kraus, L., Cornell University, Ithaca, New York: Chromatin,
nuclear receptors, and transcription.
Levine, M., University of California, Berkeley: Transcription and
development.
Koschubs, T., M.A., University of Munich, Germany
Laybourn, C., M.S., Minnetonka High School, Minnetonka,
Minnesota
Levine, J., Ph.D., California Institute of Technology, Pasadena
Maheshwari, A., M.S., Cornell University, Ithaca, New York
Malone, J., M.S., University of Texas, Arlington
Myburg, H., Ph.D., North Carolina State University, Raleigh
Navratilova, P., M.S., Sars International Centre, Bergen,
Norway
Samten, B., M.S., The University of Texas Health Center, Tyler
Mellor, J., University of Oxford, United Kingdom: Histone
modifications and gene expression.
Oeglgeschlager, T., Marie Curie Research Institute, United
Kingdom: Basal transcription factors/gene expression.
Peterson, C., University of Massachusetts Medical School,
Worcester: Chromatin and nuclear function.
Roeder, R., The Rockefeller University, New York: Transcrip-
tional regulation by RNA polymerase II.
Shilatifard, A., St. Louis University Medical Center, Missouri:
Histone methylation and the regulation of gene expression.
Tora, L., Institut de Genetique et de Biologie Moleculaire et
Cellulaire (IGBMC), France: Variation for a theme, or
regulation of initiation of RNA polymerase II transcripton.
Tyler, J., University of Colorado Health Sciences Center,
Denver: Chromatin, transcription, replication, and repair.
Yamamoto, K., University of California, San Francisco:
Trancriptional control via the intracellular receptors.
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Imaging Structure and Function in the Nervous System
July 25-August 14
INSTRUCTORS F. Engert, Harvard University, Cambridge, Massachusetts
M. Hubener, Max-Planck Institute of Neurobiology, Martinsried, Germany
D. Kleinfeld, University of California, San Diego
J. Waters, Northwestern University, Evanston, Illinois
ASSISTANTS F. Albineau, Harvard University, Cambridge, Massachusetts
D. DiGregorio, University of California School of Medicine, Los Angeles
A. Kampff, Harvard University, E. Aurora, New York
V. Nagerl, Max-Planck Institute of Neurobiology, Munich, Germany
V. Staiger, Volker, Max-Planck Institute of Neurobiology, Bavaria, Germany
A. Trevelyan, Columbia University, New York
P. Tsai, University of California, San Diego
R. Vislay, Harvard University, Cambridge, Massachusetts
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, functional
fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted light
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microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell func-
tion, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") compounds,
and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological methods
were covered. Particular weight was given to multiphoton laser-scanning microscopy and to newly
available biological fluorophores, especially green fluorescent protein (GFP) and its variants. We used a
spectrum of neural and cell biological systems, including living animals, brain slices, and cultured cells.
Applicants had a strong background in the neurosciences or in cell biology.
Lecturers included Wolfhard Almers (Oregon Health & Science University), William Betz (University of
Colorado Medical School), Winfried Denk (Max-Planck Institute for Medical Research), Anna Devor
(MGH/Harvard Medical School), Fred Lanni (Carnegie-Mellon University), Greg Law (Perkin-Elmer), Jeff
Lichtman (Harvard University), Jerome Mertz (Boston University), Venkatesh Murthy (Harvard University),
Mark Schnitzer (Stanford University), Steve Vogel (NIH/NIAAA/DICBR), and Katrin Willig (Max-Planck
Institut for Biophysical Chemistry.
This course was supported with funds provided by the National Institute of Mental Health, National
Institute on Drug Abuse, and the Howard Hughes Medical Institute.
PARTICIPANTS
Anantharam, A., B.A., Cornell University Medical College, New
York
Duguid, I., Ph.D., University College London, United Kingdom
Encalada, S., Ph.D., University of California, San Diego
Gordon, G., B.Sc., University of Calgary, Canada
Kalmbach, A., B.S., University of Pittsburgh, Pennsylvania
Karrow, K., Ph.D., Harvard Medical School, Boston,
Massachusetts
SEMINARS
Almers, W., Oregon Health & Science University, Portland: TIRE.
Betz, W., University of Colorado Medical School, Denver: FM.
David, V, Spectra-Physics, Mountain View, California: Ultrafast
lasers.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: 2-photon and serial EM.
Devor, A., MGH/Harvard Medical School, Charlestown,
Massachusetts: Blood flow imaging.
DiGregorio, D., University of California School of Medicine, Los
Angeles: Uncaging.
Engert, E, Harvard University, Cambridge, Massachusetts:
Basics of 2-photon imaging. Home brew 2-photon overview.
Tadpoles rock.
Griesbeck, 0., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Genetically encoded sensors.
Hubener, M., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Primer on intrinsic optical signals.
Frequent domain methods for intrinsic signals.
Kampff, A., Harvard University, E. Aurora, New York: ImageJ.
Kilborn, K., Intelligent Imaging Innovations, Inc., Santa Monica,
California: Deconvolution.
Kleinfeld, D., University of California, San Diego: Denoising and
Fourier. Ultra-high-resolution blood flow and stroke. Voltage-
sensitive dyes.
Lanni, F, Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Lien, C.-C., Ph.D., University of California, Berkeley
Luo, W., Ph.D., Duke University Medical Center, Durham,
North Carolina
Murphy, G., Ph.D., HHMI/University of Washington, Seattle
Rumpel, S., Ph.D., Cold Spring Harbor Laboratory
Sundberg, K., B.S., The Salk Institute, La Jolla, California
Wu, W., Ph.D., Oregon Health & Science University, Portland
Basic microscopy. Basic microscopy diffraction theory. Light
sources. DIC, dot tube, apotome, demo.
Law, G., Perkin-Elmer: Spinning disk.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Confocal microscopy. Brainbow multilabels.
Mertz, J., Boston University, Massachusetts: Nonlinear
techniques.
Murthy, V, Harvard University, Cambridge, Massachusetts:
Synaptophluorin imaging.
Nagerl, V, Max-Planck Institute of Neurobiology, Munich,
Germany: Bring on da noise.
Schnitzer, M., Stanford University, California: Deep imaging.
Tille, S., Zeiss, Thornwood, New York: Overview of the Zeiss
Meta and Pascal.
Tsai, R, University California, San Diego: Basic optical design.
Basic design scanning.
Vogel, S., NIH/NIAAA/DICBR, Bethesda, Maryland: FRET.
FRET and lifetime imaging in 2-photon microscopy.
Waters, J., Northwestern University, Evanston, Illinois:
Quantitative modeling of organic Ca indicator signals.
Advanced aspects (loading, quantitative modeling) of organic
Ca indicators.
Willig, K., Max-Planck Institute for Biophysical Chemistry,
Germany: Ultramicroscopy.
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Yeast Genetics and Genomics
July 25-August 14
INSTRUCTORS
ASSISTANTS
F. Luca, University of Pennsylvania, Philadelphia
J. Strathern, National Cancer Institute, Frederick, Maryland
M. Whiteway, National Research Council of Canada, Montreal
A. Farley, Vanderbilt University, Nashville, Tennessee
M. Martchenko, Montreal, Quebec, Canada
G. Santoyo, National Cancer Institute, Frederick, Maryland
This course is a modern, state-of-the-art laboratory course designed to teach students the full reper-
toire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cere-
visiae. Combinations of classical genetic approaches were emphasized, including the isolation and
characterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular
genetic techniques, including various types of yeast transformations, gene replacement with plasmids
and PCR prehets, construction and analysis of gene fusions, and generation of mutations in cloned
genes, were also emphasized.
Students used classical and molecular approaches to gain experience in identifying and interpreting
various kinds of genetic interactions including suppression and synthetic lethality. Students were
immersed in yeast genomics and performed and interpreted experiments with DNA arrays. Students
gained first-hand experience in modern cytological approaches such as epitope tagging and imaging
yeast cells using indirect immunofluorescence, GFP-protein fusions, and a variety of fluorescent indica-
tors for various subcellular organelles. Lectures on fundamental aspects of yeast genetics were pre-
sented along with seminars given by outside speakers on topics of current interest.
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This year's speakers included David Amberg (SUNY Upstate Medical University), Linda Breeden
(Fred Hutchinson Cancer Research Center), Dan Burke (University of Virginia), Kara Dolinski (Princeton
University), Beverly Errede (University of North Carolina, Chapel Hill), Daniel Gottschling (Fred
Hutchinson Cancer Research Center), Michael Gustin (Rice University), Alan Hinnebusch (NICHD/NIH),
Chris Kaiser (Massachusetts Institute of Technology), James Konopka (SUNY Stony Brook), Rodney
Rothstein (Columbia University College of Physicians and Surgeons), Pamela Silver (Harvard Medical
School/Dana Farber Cancer Institute), Michael Snyder (Yale University), and George Sprague (University
of Oregon).
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Cheney, C., Ph.D., Pomona College, Claremont, California
Docking, R., B.Sc., McGill University, Montreal, Canada
Geijer, C., M.Sc., Goteborg University, Sweden
Kraft, C., Ph.D., ETH Honggerberg, Zurich, Switzerland
Kuo, D., B.S./M.S., University of California, San Diego
Lopez, A., Ph.D., University of Toronto, Canada
Magnuson, R., Ph.D., University of Alabama in Huntsville
Otero, J.M., M.Eng., BioCentrum-DTU, Denmark
Ranjan, A., Ph.D., National Cancer Institute, Bethesda, Maryland
SEMINARS
Amberg, D., SUNY Upstate Medical University, Syracuse, New
York: Actin cytoskeleton.
Breeden, L., Fred Hutchinson Cancer Research Center,
Seattle, Washington: The transcriptional program that starts
the budding yeast cell cycle.
Burke, D., University of Virginia Medical Center, Charlotteville:
Mitotic regulation.
Dolinski, K., Princeton University, New Jersey: SGD.
Errede, B., University of North Carolina, Chapel Hill: MAP
kinase signaling in yeast.
Gottschling, D., Fred Hutchinson Cancer Research Center,
Seattle, Washington: Yeast as a model for aging.
Gustin, M., Rice University, Houston, Texas: Ups and downs
of osmosensing MAP kinase pathways in yeast.
Rudalska, R., M.S., Euopean Institute of Oncology, Milan, Italy
Samoilov, M., Ph.D., HHMI/University of Berkeley, California.
Sasaki, M., M.S., Cornell University, New York
Siddiqui, K., B.Sc., Cold Spring Harbor Laboratory
Vogelsang, M., B.S., National Institute of Chemistry Slovenia,
Ljubljana, Slovenia
Wurtele, H., B.S., University of Montreal, Canada
Yu, E., B.S., Brandeis University, Madison, Wisconsin
Hinnebusch, A., NICHD/NIH, Bethesda, Maryland: General
amino acid control.
Kasier, C., Massachusetts Institute of Technology, Cambridge:
ER processing and disulfide bond formation.
Konopka, J., SUNY at Stony Brook, New York: Genetic
analysis of the yeast pheromone response.
Rothstein, R., Columbia University College of Physicians and
Surgeons, New York: Yeast recombination.
Silver, P., Harvard Medical School/Dana Farber Cancer
Institute, Boston, Massachusetts: Synthetic biology.
Snyder, M., Yale University, New Haven, Connecticut:
Genomic analysis of regulatory networks in yeast.
Sprague, G., University of Oregon, Eugene: Cell-type
regulation and novel posttranslational modifications.
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C. elegans
July 27-August 14
INSTRUCTORS M. de Bono, MRC/Cambridge, United Kingdom
A. Desai, University of California, San Diego
M. Labouesse, Institut de Genetique et de Biologie MolOculaire et Cellulaire, France
K. Oegema, University of California, San Francisco
ASSISTANTS A. Benedetto, Institut de Genetique
et de Biologie Moleculaire et Cellulaire, France
A. Dammermann, University of California, San Diego
B. Olofsson, MRC/Cambridge, United Kingdom
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis reverse genetic approaches and protein purification. A
major goal was to teach students how to successfully exploit the information generated by the C. ele-
gans genome project. The course was suited both for those who have a current training in molecular
biology and some knowledge of genetics, but have no experience with C. elegans, as well as students
with some prior worm experience who wished to expand their repertoire of expertise.
The following topics were covered both in the laboratory and by lectures from experts in the field:
worm pushing, C. elegans databases and worm bioinformatics, anatomy and development, forward
genetics, chemical and transposon mutagenesis, generation of transgenic animals, expression pattern
analysis, reverse genetics, construction and screening of deletion libraries, RNA interference, antibody
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coimmunoprecipitation, TAP-tag purification, and worm liquid culture. The course was designed to
impart sufficient training to students in the most important attributes of the C. elegans system to enable
them to embark on their own research projects after returning to their home institutions.
Speakers included Raffi Arolan (University of California, San Diego), Kaveh Ashrafi (Washington
University School of Medicine), Joe Culotti (Mount Sinai Hospital Research Institute), Abby Dernburg
(Lawrence Berkeley National Laboratory), Lesilee Rose (University of California, Davis), Hitoshi Sawa
(Center for Developmental Biology, RIKEN), Tim Schedl (Washington University School of Medicine),
Shai Shaham (The Rockefeller University), Frank Slack (Yale University), Ralf Sommer (Max-Planck
Institute for Developmental Biology), and Mei Zhen (Mount Sinai Hospital, University of Toronto).
This course was supported with funds provided by the National Institute of Child Health and Human
Development.
PARTICIPANTS
Au, C., B.S., Vanderbilt University Medical Center, Nashville,
Tennessee
Cowen, L., Ph.D., Whitehead Institute/Massachusetts Institute
of Technology, Cambridge
David, D., Ph.D., University of California, San Francisco
Fensgard, 0., M.Sc., University of Oslo, Norway
Goodchild, R., Ph.D., Columbia University, New York
Husson, S., M.Sc., K.U. Leuven, Belgium
Kaplan, F., Ph.D., University of Florida, Gainesville
Li, W., Ph.D., University of Texas Southwestern Medical
Center, Dallas
SEMINARS
Arolan, R., University of California, San Diego: Nematicidal Bt
crystal proteins: From antiparasitics to innate immunity.
Ashrafi, K., University of California, San Francisco: C. elegans
fat and feeding regulatory circuits.
Cu lotti, J., Samuel Lunenfeld Research Institute, Canada:
Genetic identification of axon guidance and cell migration
signaling pathways: Evidence for the growth cone "setpoint"
hypothesis.
de Bono, M., MRC Laboratory of Molecular Biology, United
Kingdom: Foraging by a blind worm.
Dernburg, A., Lawrence Berkeley National Laboratory,
California: Analysis of meiosis in C. elegans.
Desai, A., University of California, San Diego: Cracking the
kinetochore using the C. elegans embryo.
Labouesse, M., Institut de Genetique et de Biologie
Moleculaire et Cellulaire, France: Using C. elegans to analyze
epithelial morphogenesis.
Pinto, S.M., M.Sc., University of Zurich, Switzerland
Olahova, M., M.Sc., University of Newcastle Upon Tyne,
United Kingdom
Pike, B., Ph.D., Friedrich Miescher Institute, Basel, Switzerland
Pruyne, D., Ph.D., Cornell University, Ithaca, New York
Siedel, H., B.A., Princeton University, New Jersey
van Wolfswinkel, J., M.S., Hubrecht Laboratorium, Utrecht,
The Netherlands
Yin, J., M.S., Queens College at CUNY, Flushing, New York
Williams, C., B.S., University of Alabama, Birmingham
Oegama, K., University of California, San Francisco: Using C.
elegans to dissect cell division mechanisms.
Rose, L., University of California, Davis: Cell polarity and
spindle positioning in the embryo.
Sawa, H., Riken Institute, Japan: Regulation of asymmetric
division by Wnt signaling.
Schedl, T., Washington University, Seattle: Control of C.
elegans germ line development.
Shaham, S., The Rockefeller University, New York: Glia-neuron
interactions in the C. elegans nervous system.
Slack, F., Yale University, New Haven, Connecticut:
Developmental timing of seam cells.
Sommer, R., Max-Planck Institute Tubingen, Germany:
Nematode evolution: Two species is more than one.
Zhen, M., Samuel Lunenfeld Research Institute, Canada:
Channel and active zone formation at the C. elegans
synapse.
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Stem Cells
August 3-16
INSTRUCTORS R. McKay, National Institutes of Health, Bethesda, Maryland
A. McClaren, University of Cambridge, United Kingdom
A. Spradling, Carnegie Institute of Washington, Baltimore, Maryland
A. Surani, Wellcome, CRC Institute, Cambridge, United Kingdom
M. Wicha, University of Michigan, Ann Arbor
ASSISTANTS J. Boyd, National Institutes of Health, Bethesda, Maryland
P. Tesar, National Institutes of Health, Bethesda, Maryland
This 2-week lecture course brought together leading researchers in the stem cell field with a small group
of international students. Stem cells construct organs in development. They sustain tissues in the adult
and restore them after injury. Because of these properties, isolating and manipulating stem cells has
become a major new element in biomedical science. This lecture and discussion course covered a
series of subjects including the cells of the early embryo, the nature of germ cells, the mechanisms that
control the number of stem cells, their stability, and transformation into other cell types. The clinical
potential and political impact of stem cell technology were also presented in depth by invited speakers.
A key feature of the course was the easy access to the instructors and the invited lecturers for informal
discussion. The purpose of the course was to provide participants with an opportunity to achieve an
advanced understanding of the scientific and clinical importance of stem cells.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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PARTICIPANTS
Alexander, M., Ph.D., University of Texas Southwestern
Medical Center, Dallas
Alexandrina, B., Ph.D., Institute of Cellular Biology &
Pathology, Bucharest, Romania
Forde, S., B.S., University of Oxford, United Kingdom
Gakhar, S., Ph.D., Maharshi Dayanand University, Rohtak, India
Hirabayashi, Y., Ph.D., University of Tokyo, Japan
Houbaviy, H., Ph.D., Rutgers University, Piscataway, New
Jersey
Huang, T. -s., Ph.D., University of Bergen, Norway
SEMINARS
Ahn, S., National Institutes of Health, Bethesda, Maryland and
Zervas, M., Brown University, Providence, Rhode Island:
Genetic lineage and stem cells: Linking development,
disease, and physiology of the brain.
Battey, J., National Institutes of Health, Bethesda, Maryland:
Stem cell politics and medicine.
Bernstein, B., Harvard University, Boston, Massachusetts:
Epigenetic mechanisms of pluripotency.
Brickman, J., University of Edinburgh, United Kingdom: What
can a frog teach an ES cell or an ES cell a frog? ES cells as
a model for gastrulation.
Cant ley, L., Harvard Medical School, Boston, Massachusetts:
Biochemical basis of mammalian cell growth.
Civin, C., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Biology of hematopoietic stem cells.
Cooke, H., MRC, Edinburgh, United Kingdom: Germ cells to
stem cells and back again.
Doetsch, F., Columbia University, New York: Natural stem cells
and their role in the adult mammalian brain.
Gotoh, Y., University of Tokyo, Japan: Signaling pathways,
regulation neural precursor cell fate, and apoptosis.
Greiner, E., Evotech AG, Hamburg, Germany: Small-molecule
chemistry and drug screening technologies.
Keller, G., Mount Sinai School of Medicine, New York: Lineage-
specific differentiation of embryonic stem cells.
Krek, W., Friedrich Miescher Institute, Basel, Switzerland: von-
Hippel-Lindau tumor suppressor functions: From oxygen
sensing to ciliary signaling.
Lee, C.-Y., University of Michigan, Ann Arbor: Genetic
regulation of self-renewal and differentiation in Drosophila.
Jonsson, M., B.S., Lund University, Sweden
Lattanzi, A., Ph.D., INBB, Civitanova Marche, Italy
Ma, J., B.S., University of California, Davis
Pepe, A.E., Ph.D., University of Bologna, Italy
Powers, R., B.S., University of Washington, Seattle
Stuelten, C., Ph.D., National Cancer Institute, Bethesda,
Maryland
Wilson, A., Ph.D., Boston University, Massachusetts
Yuan, J., Ph.D., University of California, San Diego
McKay, R., National Institutes of Health, Bethesda, Maryland:
Introduction to stem cells. Stem cells and medicine in the
central nervous system.
McLaren, A., University of Cambridge, United Kingdom: How
mice got where they are today.
Mercola, M., The Burnham Institute, La Jolla, California: Heart
differentiation in vivo and in vitro.
Nakafuku, M., Cincinnati Children's Hospital Research Found-
ation, Ohio: Stem cells and brain repair: Theory and some
practices.
Niederhuber, J., National Cancer Institute, Bethesda,
Maryland: The tissue stem cells as a target for cancer
initiation.
Rafii, S., Cornell University, Ithaca, New York: Interaction
between vascular and organ-specific stem cells.
Segal, R., Harvard Medical School, Boston, Massachusetts:
Neural differentiation and synapse formation.
Shen, M., UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Axis formation in the mouse
embryo.
Spradling, A., Carnegie Institute of Washington, Baltimore,
Maryland: Stem cells and their niches: What are they and
how do you find them? Germ cells and epithelial stem cells
in Drosophila.
Surani, A., Wellcome Trust, Cambridge, United Kingdom:
Imprinting, epigentics, and germ cells.
Wicha, M., University of Michigan, Ann Arbor: Stem cells and
cancer: A fresh look at an old idea.
Wilson, V., Edinburgh University, United Kingdom: The node
and its role in the patterning of the embryo.
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X-Ray Methods in Structural Biology
October 16-31
INSTRUCTORS W. Furey, V.A. Medical Center and
University of Pittsburgh, Pennsylvania
G. Gilliland, Centorcor, Inc., Radnor, Pennsylvania
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT J. Cary, Northern Illinois University, De Kalb
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensified laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It is designed for scientists with a work-
ing knowledge of protein structure and function, but who are new to macromolecular crystallography.
Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids and complexes),
crystal characterization, X-ray sources, and optics, synchrotrons, crystal freezing, data collection, data
reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction, molecular
replacement, solvent flattening, noncrystallographic symmetry averaging, electron density interpreta-
tion, molecular graphics, structure refinement, structure validation, coordinate deposition, and structure
presentation. Participants learned through extensive hands-on experiments. One or more proteins were
crystallized and the structure(s) determined by several methods, in parallel with lectures on the theory
and informal discussions behind the techniques. Applicants were familiar with the creation and editing
of simple text files on Linux workstations using a screen-based editor (either vi or emacs).
332
Speakers included Paul Adams, Martin Caffrey, Serge Cohen, Morten Kjeldgaard, Gerard Kleywegt,
Duncan McRee, Randy Read, David Richardson, Robert Sweet, Thomas Terwilliger, Dale Tronud, David
Waugh, and John Wesbrook.
This course was supported with funds provided by the National Cancer Institute and the Howard
Hughes Medical Institute.
PARTICIPANTS
Barnard, T., Ph.D., NIH/NIDDK, Bethesda, Maryland
Braddock, D., Ph.D., Yale University School of Medicine, New
Haven, Connecticut
Brelidze, T., Ph.D., University of Washington, Seattle
Eriksson, H., M.Sc., Massachusetts Institute of Technology,
Cambridge
Gretes, M., B.Sc., University of British Columbia, Vancouver,
Canada
Guettler, S., M.S., Cancer Research UK London Research
Institute, United Kingdom
SEMINARS
Adams, P, Lawrence Berkeley Laboratory, California:
Introduction to CNS and PHENIX. Structure Refinement.
Caffrey, M., University of Limerick, Castletroy, Ireland:
Introduction to membrane protein crystallization.
Cohen, S., Netherlands Cancer Institute, Amsterdam, The
Netherlands: Automated model building and refinement with
ARP/WARP.
Furey, W., V.A. Medical Center and University of Pittsburgh,
Pennsylvania: Patterson group therapy. Isomorphous
replacement and anomalous scattering. MAD phasing: A
classical approach. Solvent flattening/phase combination.
Solving structures with BnP. Noncrystallographic symmetry
averaging.
Gilliland, G., Centorcor Inc., Radnor, Pennsylvania: Crystalliza-
tion databases and strategies.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Structure
presentation. Argonaute: The secret of slicer.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to 0.
Kleywegt, G., University of Uppsala, Sweden: Just because it's
in Nature, doesn't mean it's true...(macromolecular structure
validation).
McPherson, A., University of California, Irvine: Crystallization of
macromolecules I. Crystallization of macromolecules II.
Waves, vectors, and complex numbers. Symmetry,
periodicity, unit cells, space groups, Miller planes, and
lattices. Fundamental diffraction relationships and Bragg 's
Guo, S., M.S., Eli Lilly, Indianapolis, Indiana
Gupta, D., M.Sc., University of Cambridge, United Kingdom
Harwood, I., B.S., University of California, San Francisco
Hoefer, N., M.S., University of Limerick, Columbus, Ohio
Krajewski, W., B.S., Uppsala University, Sweden
Malojcic, G., M.Sc., ETH Zurich, Switzerland
Mans, J., M.Sc., NIAID/NIH, Bethesda, Maryland
Reddy, R., Ph.D., Metabsis Therapeutics, Inc., La Jolla, California
Stavropoulos, P, B.S., The Rockefeller University, New York
Xue, Y., B.S., Northwestern University, Evanston, Illinois
law. Patterson techniques. Fourier transforms and the
electron density equation. Heavy atoms and anomalous
scatterers. Mechanisms of crystal growth.
McRee, D., Active Sight, San Diego, California:
MlAutoStructure: An industrial strength package for solving,
fitting, and scripting ligand-bound protein structures.
Pflugrath, J., Rigaku Americas Corporation, The Woodlands,
Texas: Data collection: Design and setup I. Scaling and
merging synchrotron data. Away from the edge: Sulfur SAD
with chromium radiation.
Read, R., University of Cambridge, United Kingdom: Molecular
replacement: From Pattersons to likelihood. Likelihood and
experimental phasing.
Richardson, D. and J., Duke University Medical Center,
Durham, North Carolina: Detection and repair of model
errors using MolProbity.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Fundamentals of crystallography. X-ray sources and optics.
Terwilliger, T., Los Alamos National Laboratory, New Mexico:
Automated structure solution and model building.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I. Macromolecular refinement II. Difference
electron density maps.
Waugh, D., National Cancer Institute, Frederick, Maryland:
Protein engineering for X-ray crystallographers.
Westbrook, J., Rutgers University, The State University of New
Jersey, Piscataway: Automating PDB deposition.
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Programming for Biology
October 18-31
INSTRUCTORS S. Lewis, University of California, Berkeley
S. Prochnik, DOE Joint Genome Institute/University of California, Berkeley
L. Stein, Cold Spring Harbor Laboratory
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS J. Babayev, Pioneer Hi -Bred, Johnston, Iowa
D. Curiel, Pioneer HI-Bred, Johnston, Iowa
C. Maher, Cold Spring Harbor Laboratory
T. Marques, Universitat Pompeu Fabra, Barcelona, Spain
D. Messina, Washington University School of Medicine, St. Louis, Missouri
S. Robb, University of Utah, Salt Lake City
C. Schmidt, University of Delaware, Newark
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Today, the computer is an indispensable part of a research biologist's tool kit. The success of the human
and other organism genome projects has created terabytes of data on everything from genetic linkage
mapping, to nucleotide sequences, to protein structures, stashed away in databases around the globe.
Large-scale technologies such as DNA microarrays and high-throughput genotyping have transformed
the nature of laboratory experimentation. Furthermore, even when biologists are not generating large
data sets of their own, they will want to collect and analyze data from myriad sources in the pursuit of
novel candidates or even entire research avenues. A few years ago, it might have been sufficient to use
Excel spreadsheets for managing laboratory data and canned Web interfaces for searching, but as the
volume of data grows and the subtlety of analysis increases, these techniques, even supplemented by
some simple programming skills, have become inadequate. Modern biologists must be adept at jug-
gling disparate data sets in order to pursue their research.
Designed for students and researchers with some prior programming experience, this 2-week pro-
gram gave biologists the expanded bioinformatics skills necessary to construct computational systems
that can exploit this increasingly complex information landscape, with an emphasis on fitting the wide
range of existing analysis tools into extensible bioinformatics systems. The course combined formal lec-
tures with hands-on sessions in which students work to solve a series of problem sets covering com-
mon scenarios in the acquisition, validation, integration, analysis, and visualization of biological data. For
their final projects, students posed problems using their own data and worked with each other and the
faculty to solve them. The prerequisites for the course was basic knowledge of UNIX, procedural Perl
programming, HTML document creation and the database query language, SQL. Lectures and prob-
lem sets covering this background material are available online and students can study this material
before starting the course.
Note that the primary focus of this course was to provide students with practical programming expe-
rience, rather than to present a detailed description of the algorithms used in computational biology. For
the latter, we recommend the Computational Genomics course.
Speakers included Emina Begovic (University of California, Berkeley), Peter Brokstein (DOE Joint
Genome Institute), Roderic Guigo (Institut Municipal d'Investigacio Medica, Spain), Winston
(University Western Cape, South Africa), Gabor Marth (Boston College), Sheldon McKay (Cold Spring
Harbor Laboratory), Chris Mungall (Berkeley Drosophila Genome Project), Lior Pachter (University of
California, Berkeley), William Pearson (University of Virginia), Jason Stajich (Duke University), Paul
Thomas (Applied Biosystems), and Olga Troyanskay (Princeton University).
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Akagi, K., Ph.D., Mouse Cancer Genetics Program/National
Cancer Institute, Frederick, Maryland
Aman, J., B.A., Mount Desert Island Biological Laboratory, Bar
Harbor, Maine
Badhwar, A.P., B.Sc., McGill University, Montreal, Canada
Crosson, S., Ph.D., The University of Chicago, Illinois
Fell, M., M.Sc., Roslin Institute, Edinburgh, United Kingdom
Fernando, 0., M.S., Universitat Pompeu Fabra, Barcelona, Spain
Fritz-Laylin, L., B.A., University of Berkeley, California
Hubbard, E.J., Ph.D., New York University, New York
Jeddeloh, J., Ph.D., Orion Genomics, LLC., St. Louis, Missouri
Kramer, M., B.S., Cold Spring Harbor Laboratory
Lawson, H., B.A., Pennsylvania State University, State College
SEMINARS
Cain, S., Cold Spring Harbor Laboratory: Gbrowse.
Curiel, D., Pioneer Hi-Bred, Johnston, Iowa: Introduction to
Javascript.
Magrini, V., Ph.D., Washington University/Genome Sequencing
Center, St. Louis, Missouri
McGovern, M., B.S., New York University, New York
Pettersson, E., M.Sc., Royal Institute of Technology,
Stockholm, Sweden
Riesenfeld, C., B.S., Desert Research Institute, Reno, Nevada
Ross, E., B.S., HHMI/University of Utah, Salt Lake City
Sandhu, S., M.S., Ohio State University, Wooster
Wang, K., M.S., CBS, Technical University of Denmark,
Lyngby
Zhang, X., Ph.D., Michigan State University, East Lansing
Zhou, Y., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Guigo, R., Center for Genomic Regulation, Barcelona, Spain:
Gene prediction.
Hartzell, G., University of California, Berkeley: Good
programming practices and version control.
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Marth, G., Boston College, Chestnut Hill, Massachusetts:
Sequence variation analysis: SNPs, haplotypes.
McKay, S., Cold Spring Harbor Laboratory: Querying SQL,
databases with DBS.pm. Biological database design.
Pearson, W., University of Virginia, Charlottesville: Aligning
proteins: Local/global alignment algorithms (Smith-Waterman
and blastp, etc.) and substitution matrices.
Prochnik, S., Berkeley Drosophila Genome Project, California:
Designing and running bioinformatics pipelines with Perl: Job
tracking, dependencies.
Rokas, A., The Broad Institute of Massachusetts Institute of
Technology and Harvard, Cambridge, Massachusetts:
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Studying molecular evolution with Perl. Molecular evolution.
Stajich, J., University of California, Berkeley: Introduction to
Bioperl: The organization and the basic classes, Bioperl II:
Using Bioperl: More classes and using them.
Stein, L., Cold Spring Harbor Laboratory: Perl review I. Perl
review II. Perl review III. Perl IV Perl III. Perl review IV (writing
OOP modules).
Thomas, P., Applied Biosystems, Foster City, California:
Functional assignment, protein domain assignment, COGs,
pantherpfam.
Tisdall, J., DuPont Experimental Station, Wilmington,
Delaware: Algorithms in bioinformatics.
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 23-November 5
INSTRUCTORS A. Dernburg, Lawrence Berkeley National Laboratory, Berkeley, California
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANT INSTRUCTORS
W.G. Cox, Invitrogen Molecular Probes Detection Technology, Eugene, Oregon
K. Hu, Indiana University, Bloomington
P. LeBaccon, Institut Curie, Paris, France
J. Peng, University of California, Berkeley
J. Waters, Harvard Medical School, Boston, Massachusetts
ASSISTANTS I. Porter, University of Dundee, United Kingdom
B. Sutton, Invitrogen Molecular Probes Detection Technology, Eugene, Oregon
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This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein
and RNA dynamics in living cells. It emphasized the use of the latest equipment and techniques in flu-
orescence microscopy, including confocal laser-scanning microscopy, deconvolution methods, digital
image processing, and time-lapse imaging of living specimens. The curriculum was designed to present
students with state-of-the-art technology and scientific expertise in the use of light microscopy to
address basic questions in cellular and molecular biology. It was developed for the molecular biologist
who is in need of microscopic approaches and for the cell biologist who is not familiar with the practi-
cal application of the advanced techniques presented in the course.
Among the methods presented were the preparation of tagged nucleic acid probes; fixation meth-
ods; detection of multiple DNA sequences in single nuclei or chromosome spreads; comparative
genomic hybridization; cellular localization of RNA; localization of nucleic acids and proteins in the same
cells; use of a variety of reporter molecules and nonantibody fluorescent tags; indirect antibody label-
ing; detection of multiple proteins in a single cell; and the use of GFP variants to study protein expres-
sion, localization, and dynamics. In each method, several experimental protocols were presented
allowing the students to assess the relative merits of each and to relate them to their own research.
Students were encouraged to bring their own nucleic acid, protein, or antibody probes to the course,
which were used in addition to those provided by the instructors. The laboratory exercises were sup-
plemented with lectures given by invited distinguished scientists, who presented up-to-the-minute
reports on current methods and research using the techniques being presented.
Speakers included W. Gregory Cox, Rich Day, Arshad Desai, Patricia LaBaccon, J. Richard
McIntosh, Tom Ried, David Spector, and Jennifer Waters.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Basu, J., M.Sc., Baylor College of Medicine, Houston, Texas
Boldingh Debernard, K., M.S., University of Oslo, Norway
Buran, B., B.S./B.A., Massachusetts Eye and Ear Infirmary,
Boston
Carter, K., B.S./B.A., Yale University, New Haven, Connecticut
Dudnakova, T., Ph.D., MRC Human Genetics Unit, Edinburgh,
United Kingdom
Dus, M., B.S., Cold Spring Harbor Laboratory/Watson School
of Biological Sciences, Cold Spring Harbor
Garcia, L., Lic., Instituto de Estudios Avanzados, Baruta,
Michigan
Houwing, S., B.S., Hubrecht Laboratory, Utrecht, The Netherlands
SEMINARS
Cox, W.G., Invitrogen Molecular Probes Detection Technology,
Eugene, Oregon: Basics and applications of RNA FISH.
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Dernburg, A., Lawrence Berkeley National Laboratory/University
of California: Basics of DNA FISH.
Desai, A., University of California, San Diego: Studies on
mitosis.
Hu, K., Scripps Research Institute, La Jolla, California, and
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Basic introduction to light and fluorescence
microscopy.
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Hwang, Y.-C., B.S., University of California, Riverside
Janes, K., Ph.D., Harvard Medical School, Boston,
Massachusetts
Jorgensen, S., M.S., University of Copenhagen, Kobenhavn,
Denmark
Kimura, M., Ph.D., Gifu University School of Medicine, Gifu,
Japan
Martins, A., B.S., University of Cambridge, United Kingdom
Tradewell, M., B.Sc., McGill University, Montreal, Canada
Wallace, J., Ph.D., NIH/NIDDK, Bethesda, Maryland
Wu, J., Ph.D., Wellcome Trust Sanger Institute,
Cambridgeshire, United Kingdom
McIntosh, J.R., University of Colorado, Boulder: Current
practice and future prospects for EM.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Immunocytochemistry. How to build a parasite:
Live cell imaging of Toxoplasma
Ried, T., NCl/NIH, Bethesda, Maryland: Mechanisms and
consequences of chromosomal aberrations in cancer cells.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Waters, J., Harvard Medical School, Boston, Massachusetts,
and LeBaccon, P., Institut Curie, Paris, France: Digital
detectors and digital imaging fundamentals.
Phage Display of Proteins and Peptides
November 7-20
INSTRUCTORS C. Barbas, Scripps Research Institute, La. Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, La Jolla
ASSISTANTS S. Kacir, University of Pennsylvania, Philadelphia
K. Noren, New England BioLabs, Beverly, Massachusetts
M. Roman, University of California, San Diego
C. Tuckey, New England BioLabs, Beverly, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and practi-
cal aspects of constructing combinatorial libraries from immune and nonimmune sources, as well as the
construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E. coli were also covered.
Epitopes were selected from peptide libraries and characterized.
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The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglobulin
genes, the biology of filamentous phage, and the utility of surface expression libraries, expression of anti-
bodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies, directed pro-
tein evolution, retroviral and cell display libraries, immunobiology of the antibody response, and recent
results on the use of antibodies in therapy. The theory and practical implications for selection from phage
displayed libraries of random peptides, cDNA products, and semisynthetic proteins were explored.
Seminar speakers included Angela Belcher (Massachusetts Institute of Technology), Marilena Hall
(Stonehill College), Henry Lowman (Genentech, Inc.), Christopher Noren (New England BioLabs),
Sachdev Sidhu (Genentech, Inc), George Smith (University of Missouri), Ian Wilson (Scripps Research
Institute), and K. Dane Wittrup (Massachusetts Institute of Technology).
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Adedoyin, J., M.S., Karolinska Institute, Stockholm, Sweden
Barderas, R., Ph.D., Spanish National Cancer Research,
Madrid, Spain
Cheng, Z., B.Sc., University of Alberta, Edmonton, Canada
Cordier, W., B.S., Egea Biosciences, San Diego, California
Cosic, J., B.S., Dyax Corporation, Cambridge, Massachusetts
Hearty, S., B.Sc., Dublin City University, Republic of Ireland
Mininni, T.L., B.A., Wyeth Research, Pearl River, New York
Nicola, A., M.D., Albert Einstein College of Medicine, Bronx,
New York
SEMINARS
Barbas, C., Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
Belcher, A., Massachusetts Institute of Technology,
Cambridge: Phage as a tool kit for the synthesis and
assembly of materials for electronics and energy.
Hall, M., Stonehill College, Easton, Massachusetts: Target-
unrelated phage.
Lowman, H., Genetech, Inc., San Francisco, California: SAR
of peptides using phage.
Noren, C., New England BioLabs, Beverly, Massachusetts:
Phage peptide libraries: The PhD for peptides.
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O'Rourke, S., Ph.D., University of California, Santa Cruz
Pitaksajjakul, P., M.Sc., Mahidol University, Bangkok, Thailand
Plana, E., M.S., Polytechnic University of Valencia, Spain
Rochette, S., M.S., University of Nottingham, United Kingdom
Rouziere, A.-S., Ph.D., University of Glasgow, United Kingdom
Seiler, T., M.D., The Feinstein Institute for Medical Research,
Manhasset, New York
Shults, M., Ph.D., Illumina, Inc., San Diego, California
Wu, P., Ph.D., HHMI/University of California, Berkeley
Sidhu, S., Genetech, Inc., San Francisco, California: Antibody
phage display and chemical diversity in antigen recognition.
Siegel, D., University of Pennsylvania Medical Center, Philadelphia:
Cell surface selection of combinatorial Fab libraries.
Silverman, G., University of California, San Diego: Repertoire
cloning of SLE autoantibodies.
Smith, G., University of Missouri, Columbia: Phage display of
peptides.
Wilson, I., The Scripps Research Institute, La Jolla, California:
Structural biology of the immune system.
Wittrup, K.D., Massachusetts Institute of Technology,
Cambridge: Yeast display libraries.
Computational and Comparative Genomics
November 8-14
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT B. Cantarel, University of Virginia, Charlottesville
Beyond BLAST and FASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data. The
course focused on approaches for extracting the maximum amount of information from protein and DNA
sequence similarity through sequence database searches, statistical analysis, and multiple sequence
alignment. Additional topics included gene recognition (exon/intron prediction), identifying signals in
unaligned sequences, and integration of genetic and sequence information in biological databases.
The course combined lectures with hands-on exercises; students were encouraged to pose chal-
lenging sequence analysis problems using their own data. The course makes extensive use of local
VVWW pages to present problem sets and the computing tools to solve them. Students used Windows
and Mac workstations attached to a UNIX server; participants were comfortable using the Unix operat-
ing system and a Unix text editor.
The course was designed for biologists seeking advanced training in biological sequence analysis,
computational biology core resource directors and staff, and scientists in other disciplines, such as
computer science, who wish to survey current research problems in biological sequence analysis.
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The primary focus of this course was the theory and practice of algorithms used in
computational
biology, with the goal of using current methods more
effectively and developing new algorithms.
Students more interested in the practical aspects of advanced software development are
encouraged
to apply to the course on Programming for Biology.
Speakers included Stephen Altschul (National Library of Medicine), Judith Blake (The Jackson
Laboratory), Xose Fernandez (EMBL-EBI), Ross Hardison (Pennsylvania State University), Eric Sayers
(National Library of Medicine), and James Taylor (Courant Institute of Mathematics, New York University).
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Anzola, J., B.Sc., Texas A&M University, College Station, Texas
Berglund, L., M.S., Royal Institute of Technology, Stockholm,
Sweden
Brisson, J., Ph.D., Princeton University, New Jersey
Brown, S., Ph.D., Kansas State University, Manhattan
Chandler, E., B.A., VIMS/College of William and Mary,
Gloucester Point, Virginia
Counterman, B., B.S., Duke University, Durham, North Carolina
Dranginis, A., Ph.D., St. John's University, Queens, New York
Ernst, S., Ph.D., Tufts University, Medford, Massachusetts
Gonzalez, M., B.A., University of Maryland Baltimore County,
Baltimore
Hirlyur Nagaraj, S., M.Sc., Macquarie University, Sydney,
Australia
SEMINARS
Altschul, S., National Library of Medicine, Bethesda, Maryland:
Statistics of sequence similiarity scores. Iterated protein
database searches with PSI-BLAST.
Blake, J., The Jackson Laboratory, Bar Harbor, Maine: An
introduction to the gene ontology.
Fernandez, X., EMBL-EBI, Hinxton, United Kingdom: The
ENSEMBL database of genomes. ENSMART and genome
computation.
Hardison, R., Pennsylvania State University, University Park:
Comparative genomics I: Tools for comparative genomics.
Pearson, W., University of Virginia, Charlottesville: Protein
evolution and sequence similarity searching. Algorithms for
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Leonardo, T., Ph.D., Princeton University, New Jersey
Milac, A., Ph.D., National Institutes of Health, Bethesda, Maryland
Molinaro, A., Ph.D., Yale School of Medicine, New Haven,
Connecticut
Oliveira, A., Ph.D., University of Georgia, Athens
Raby, B., M.D., Brigham & Women's Hospital/Harvard Medical
School, Boston, Massachusetts
Sandhu, S., M.S., Ohio State University, Wooster
Skjaeveland, A., M.S., University of Oslo, Norway
Yampolsky, L., Ph.D., East Tennessee State University,
Johnson City, Tennessee
Zhao, Q., B.S., University of Virginia, Charlottesville
Zuccolo, A., Ph.D., Arizona Genomics Institute/University of
Arizona, Tucson
biological sequence comparison. Hidden Markov models
and protein profiles. Finding consensus sites.
Sayers, E., National Library of Medicine, Bethesda, Maryland:
NCBI resources for bioinformatics and computational
biology. NCBI genome resources.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment.
Taylor, J., Pennsylvania State University, University Park:
Genome computation and gene regulation.
The Genome Access Course
April 25-26, August 29-30, November 29-30
TRAINERS T. Fiedler, Cold Spring Harbor Laboratory
G. Howell, The Jackson Laboratory
B. King, The Jackson Laboratory
Initiated in 2002, this course is an intensive 2-day introduction to bioinformatics that was held three
times in 2006, training 63 participants in total. The core of the course was designed to cover the manip-
ulation and analysis of sequence information. The course was broken into modules designed to give a
broad overview of a given topic, with ample time for examples chosen by the instructors. Each module
included three parts, consisting of a discussion of theory and methods, coverage of software and Web
resources, and use of selected tools with examples (including those supplied by the students). The
modular design allowed the instructors to tailor the presentation to the interests of the students.
Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple
Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis.
Applications to the course were open to all on a first-come, first-served basis, subject to basic eligi-
bility requirements. The course was held at the Laboratory's newly opened Genome Research Center
at Woodbury located seven miles south of the main Laboratory campus. Each student was provided
with a PC laptop with wireless modem for the duration of the course. Students were encouraged to
supply problem sets and sequences of interest to the trainers for possible incorporation as examples in
the modules. Materials were made available on the Web, and students continued to ask questionsof
the trainers as they applied what they had learned in their individual endeavors.
In collaboration with the Wellcome Trust Open Door Workshops, this short course was also run in
Sao Paolo, Brazil, and Mexico City, Mexico, in February. The rationale for running these courses for the
regional scientific communities in South and Central America was borne out by significant attendance
in both venues. This effort is featured in the spring issue of the Laboratory's Harbor Transcript.
April 25-26
Dr. M. Aldave, The Jules Stein Eye Institute, University of Los
Angeles
Dr. M. Boccio, The University Hospital of Columbia and
Cornell, New York
Dr. H. Brorson, Natlmmune A/S Copenhagen, Denmark
Dr. J. Brown, Dana-Farber Cancer Institute, Boston
Massachusetts
Dr. J. Diaz, Louisiana State University, Baton Rouge
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Dr. T. Graham, North Carolina State University, Raleigh
Ms. J. Hill, Center for Health and Technology, Deer Park, New
York
Dr. T. Hoy, University of Florida, Gainesville
Dr. M. Lee, Columbia University, New York
Mr. J. Majewski, The Walter and Eliza Hall Institute, Melbourne,
Australia
Dr. S. Nazar, Cancer Institute of New Jersey, New Brunswick
Dr. Z. Otero, Technical University of Denmark, Lyngby
Ms. C. Ponaka, GE Healthcare, Piscataway, New Jersey
Dr. E Singhal, Pacific Northwest National Laboratory, West
Richland, Washington
Dr. B. Stein, Roswell Park Cancer Institute, Buffalo, New York
Dr. I. Stoeckel, United States Geological Survey, Columbus,
Ohio
Dr. A. Sutula, University of Wisconsin, Madison
Mr. B. Symer, National Cancer Institute, Frederick, Maryland
Dr. D. Wang, University of Rochester, New York
August 29-30
Mr. M. Abedi, Roger Williams Hospital, Providence, Rhode Island
Dr. D. Adekoya, University of Tromsoe, Norway
Dr. T. Banck, Mount Sinai School of Medicine, New York
Dr. D. Bandera, Eli Lilly and Co., Indianapolis, Indiana
Dr. C. Beutler, Mount Sinai School of Medicine, New York
Dr. A. Buerckstuemmer, Center for Molecular Medicine, Vienna,
Austria
Ms. S. Dollard, Canadian Food Inspection Agency, Ottawa,
Canada
Dr. M.A. Gaylord, Eli Lilly and Co., Indianapolis, Indiana
Ms. C. Gunturi, Centocor Inc., Raritan, New Jersey
Dr. T. Hao, The Campbell Family Institute for Breast Cancer,
Toronto, Canada
Mr. S. Hsieh, Cleveland Clinic Foundation/Lerner College of
Medicine, Cleveland, Ohio
Mr. F. Abdishakur, Imumorin Spelman College, Atlanta, Georgia
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Ms. J. Knoechel, University of California, San Francisco
Dr. G. Lohr, University of California, San Francisco
Dr. M. Millham, Pfizer Inc., Groton, Connecticut
Mr. B. Mynarcik, SUNY at Stony Brook, New York
Dr. J. Pajaro, Mayo Clinic, Jacksonville, Florida
Mr. I. Piscopo, University of California, San Francisco
Dr. N. Poon, Brigham and Women's Hospital, Boston,
Massachusetts
Dr. A. Meeran Sanders, Brown University/Rhode Island
Hospital, Providence
Dr. D. Tegay, Cold Spring Harbor Laboratory
Mr. J. Tilahun, Amherst College, Massachusetts
Dr. R. Tseng, University of Pennsylvania, Philadelphia
Dr. A. Versalovic, Baylor College of Medicine, Houston, Texas
Ms. M. Yoon, Brigham and Women's Hospital, Boston,
Massachusetts
November 29-30
Dr. M. Bharti, Rutgers, The State University of New Jersey,
Piscataway
Dr. 0. Bonini, University of Pennsylvania, Philadelphia
Ms. S. Butler, DuPont, Wilmington, Delaware
Dr. M. Devare, Cornell University, Ithaca, New York
Ms. L. Fel lay, Duke University, Durham, North Carolina
Dr. A. Greenstein, Multiple Sclerosis Research Institute,
Philadelphia, Pennsylvania
Dr. A. Harris, Helicos Biosciences, Cambridge, Massachusetts
Dr. N. Hastings, Dana-Farber Cancer Institute, Boston,
Massachusetts
Ms. K. He, Temple University, Philadelphia, Pennsylvania
Dr. M. Hong, Tulane University Health Sciences Center, New
Orleans, Lousianna
Dr. J. Koh li, University of Rochester, New York
Dr. T. Noonan, Massachusetts General Hospital for Children,
Boston
Dr. J. Pandelova, Oregon State University, Coravallis
Dr. J. Ramabhadran, United States Environmental Protection
Agency, Research Triangle Park, North Carolina
Dr. T. Taccioli, Ohio State University, Columbus
Ms. J. Vasenkova, Open Biosystems Inc., Huntsville, Alabama
Dr. Q. Welch, Ohio University, Athens
Dr. Y. Yang, Mount Sinai School of Medicine, New York
Dr. G. Zhang, Case Western Reserve University, Cleveland,
Ohio
The Laboratory acknowledges the generosity of the following companies
who loaned equipment and reagents to the various courses:
Agilent Technologies
Ambion Inc.
A.M.R I.
Applied Precision Inc.
Applied Scientific
Instrumentation, Inc.
Astro-Med Inc.
Axon Instruments
Becton Dickinson Labware
Berthold Technologies USA,
LLC
Bioptechs Inc.
Bio-Rad Laboratories
Burleigh Instruments, Inc.
Cambrex Bio Science Rockland
Inc.
Carl Zeiss, Inc.
Charles River Laboratories Inc.
Chroma Technology
Corporation
Dagan Corporation
David Kopf Instruments
Delaware Diamond Knives
Denville Scientific Inc.
Diagnostic Instruments
Drummond Scientific Company
Epicentre Technologies
Eppendorf North America
Fotodyne Inc.
GE Healthcare
Genetix USA Inc.
Hamamatsu Photonic Systems
Hampton Research
Harvard Apparatus, Inc.
Instrutech Corp.
Intelligent Imaging Innovations
Inc.
Invitrogen Corporation
Jackson Immunoresearch
Laboratories
James A. Hill
Kinetic Systems Inc.
Leica Microsystems Inc.
Luigs & Neumann
Lumera
Millipore Corporation
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Probes Inc.
Nalge Nunc International
Narishige International USA, Inc.
Nasco
New England BioLabs, Inc.
Nikon Inc.
Olympus America Inc.
Pel Freez Biologicals
Perkin Elmer Life and Analytical
Sciences
Pierce Chemical Co.
Promega Corp.
QIAGEN Inc.
Q-Imaging Inc
Richard Allan Scientific
Rigaku/MSC
Roche Applied Science
SageN Research
Scigene
Sigma-Aldrich
Siskiyou Corporation
Spectra-Physics Lasers Inc.
Stratagene
Sutter Instruments
Tecan US, Inc.
The Jackson Laboratory
Thermo Finnigan
Thermo Labsystems
The Vibratome Company
TI.L.L. Photonics GmbH
Torrey Pines Scientific
Universal Imaging Corporation
VDS Vosskuhler GmbH
Vector Laboratories
Warner Instruments
Waters Corp
Zeitz-lnstrumente Vertriebs
GmbH
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SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings on a weekly basis. These seminars keep the CSHL staff current on the latest developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in
an informal setting.
January
Dr. Ronald Evans, Department of Gene Expres-
sion, Salk Institute for Biological Studies
Dr. David Cox, Chief Scientific Officer, Perlegen
Sciences, Inc., Mountain View, California
February
Dr. Gail Mandel, Howard Hughes Medical Institute,
Stony Brook University
Dr. Robert Williams, Department of Anatomy and
Neurobiology, University of Tennessee,
Health Science Center
March
Dr. Douglas Hanahan, Department of Biochemistry
and Biophysics, Diabetes Center and
Comprehensive Cancer Center, University
of California, San Francisco
Dr. Anne Brunet, Department of Genetics,
Stanford University School of Medicine
Dr. David Van Vactor, Department of Cell
Biology, Harvard Medical School
Dr. Daniel R. Weinberger, Clinical Brain Disorders
Branch, National Institute of Mental Health
April
Dr. Rebecca Doerge, Department of Statistics,
Purdue University
September
Dr. Michael Hengartner, Institute of Molecular
Biology, University of Zurich
Dr. Yang Shi, Harvard Medical School
October
Dr. Jeff Dangl, University of North Carolina
at Chapel Hill
Dr. Richard Morimoto, Department of Biochem-
istry, Molecular Biology, and Cell Biology,
Northwestern University
Dr. Paolo Sassone-Corsi, Department of
Pharmacology, University of California, Irvine
November
Dr. Aneel Aggarwal, Mount Sinai School
of Medicine
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Title Host
PPARs: Running around obesity. Terri Grodzicker
Common human DNA variation and complex human W. Richard McCombie
traits: Success stories.
The rise and fall of REST: Creating the nervous
system.
A systems genetics approach to study complex
biological systems from the level of gene variants
through to behavior and disease susceptibility.
Holly Cline
Josh Dubnau
Targeting the tumor microenvironment. Vivek Mittal
FOX() transcription factors in the control of longevity. Michael Zhang
Control of synapse morphogenesis by the receptor
tyrosine phosphatase LAR.
Schizophrenia: From genes to pathways.
Senthil Muthuswamy
Holly Cline
Functional genomics of quantitative traits: Expression Holly Cline
level polymorphisms of QTLs affecting disease
resistance pathways in Arabidopsis.
Roads to ruin: Apoptotic pathways in the nematode
C. elegans.
Dynamic regulation of histone methylation by
demethylases.
Mona Spector
Michael Zhang
The molecular logic of the plant immune system. Wolfgang Lukowitz
Stress and protein misfolding in aging and William Tansey
neurodegenerativedisease.
A chromatin remodeling CLOCK. David Spector
Beyond Watson and Crick: Trans lesion DNA syn- Leemor Joshua-Tor
thesis in eukaryotes.
Dr. Robert D. Goldman, Department of Cell and
Molecular Biology, Feinberg School of Medicine,
Northwestern University
Dr. Andrew Chess, Department of Medicine,
Massachusetts General Hospital and
Harvard Medical School
Dr. Freda Miller, The Hospital for Sick Children
Research Institute, University of Toronto
December
Dr. Pamela Silver, Department of Systems
Biology, Harvard Medical School
Dr. Brenda Schulman, St. Jude Children's
Research Hospital, Howard Hughes
Medical Institute
IN-HOUSE SEMINAR PROGRAM
Title
Nuclear lamin functions are being revealed by a
plethora of human diseases.
Unusual mechanisms specifying cell identity.
Neural stem cells: Novel signals and sources.
Discovery and design of biological networks.
Host
David Spector
Holly Cline
Alea Mills
William Tansey
Structural insights into ubiquitin-like protein transfer William Tansey
cascades.
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in organizing, pre-
senting, and defending their research.
January
Dominik Due Ili (Lazebnik Lab)
David Jackson
February
Cordula Schulz
Ivan Ho (Zhong Lab)
Bill Keyes (Mills Lab)
March
Adriana Hemerly (Stillman Lab)
Jannic Boehm (Malinow Lab)
Fabiola Rivas (Hannon Lab)
Rob Lucito
Chris Maher (Stein Lab)
April
Mike Myers
October
Ingrid Bureau (Svoboda Lab)
Rotem Karni (Krainer Lab)
Eric Enemark (Joshua-Tor Lab)
Adam Kepecs (Mainen Lab)
November
Yi-Jun Sheu (Stillman Lab)
Patrick Paddison
Lee Henry
December
Julius Brennecke (Hannon Lab)
Min Yu (McCombie Lab)
Title
Cell fusion, viruses, and oncogenic transformation.
Making sense of the signals in plant development.
Stem cells and their niches: An organismal approach in the male gonad of Drosophila
melanogaster.
Neurofibromatosis type l's involvement in learning and memory.
Investigating the role of p63 in senescence, aging, and cancer.
A novel gene network controlling Gi/S transition in plants.
AMPA-receptor phosphorylation during synaptic plasticity:
All good things come in threes.
RISC proteomics and
microRNA-mediated repression or wag the mRNA: A poly(A) tale.
Characterizing genomic alterations and analyzing their role in cancer.
The expanding microRNA world: Evolution and expression
of plant regulatory RNAs.
Rapid analysis of protein complexes.
Mapping the neuronal circuits of the developing mouse
barrel cortex.
Alternative splicing and cancer.
A coordinated team of escorts with discriminating
fingers promote unzipping.
Uncertainty in decision-making: Why is it
useful and how is it represented in the rat brain?
Protein kinase docking activates the
initiation of DNA replication.
An RNAi screen for modifiers of
Nanog expression in mouse embryonic stem cells.
Label retaining cells in the mouse
gustatory system.
Transposon silencing in the Drosophila germ
line: piRNAs dance flamenco.
3D vs. 2D: Culture influences gene
expression of mammary epithelial cells.
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BANBURY CENTER
EXECUTIVE DIRECTOR'S REPORT
The Banbury Center Annual Report has followed the same format since the first Annual Report in 1976
(although the 1976 report was only 2 pages long compared with the 52-page 2005 report!). This year,
however, the format has changed. Instead of a long introductory director's report describing the meetings,
followed by the individual programs, a short description of each meeting now precedes its program.
Banbury Center continues to have a very full schedule of meetings. Even though 2006 was relative-
ly quiet compared with the record-breaking year 2005, we nevertheless held 17 scientific meetings, a
typical number. Of the 607 scientists who attended the scientific meetings, 82% came from the United
States, a proportion that has remained remarkably constant in recent years. These participants came
from 35 states, with California, Maryland, Massachusetts, and New York providing 45% of the total
number of participants. One hundred fourteen scientists from 19 countries participated in meetings, for
a total of 114. Canada, France, Germany, Sweden, and the United Kingdom provided more than 50%
of these scientists. In addition, the Center was used for 15 other events, including six courses, group
meetings for Laboratory scientists, two week-long courses for the Watson School of Biological
Sciences, and two meetings for local nonprofit groups. Altogether, there were 32 events here in 2006.
The distribution of topics was similar to that previous years, although most of the meetings dealt
with neurological and mental disorders. This reflects the intrinsic importance of these topics and the
Laboratory's increasing research interest in these areas. Two meetings were held on the genetics of
mental disorders (autism and bipolar disorder) and four on degenerative disorders where considerable
progress has been made in understanding their molecular pathogenesis (fragile-X syndrome, spinal
muscular atrophy, Parkinson's disease, and amyotrophic lateral sclerosis). In addition, neuroscience
was the focus of three meetings. One reviewed the experimental analysis of neurogenesis in the adult
brain, a topic of critical importance if therapies to be developed for stroke and other forms of brain
trauma. Another dealth with memory and whether recalled memories are "labile" and subject to modi-
fication before being "reconsolidated." This phenomenon may be important in assessing the validity of
"recovered memories." One meeting reviewed the interactions between physiological and psycholog-
ical correlates of feeding and appetite. This meeting followed up on a Banbury Center meeting in 1998
Banbury Center conference room,
summer
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Banbury Center conference room, winter
on obesity. At that time, leptin had just been identified and that meeting was concerned with what had
been learned of the physiological basis of obesity.
There were two meetings relating to infectious diseases. The meeting on Lyme disease, one of a
long series of Banbury Center meetings on the topic, reviewed the controversial issue of "chronic"
Lyme disease, that is, the persistence of Lyme-disease-like symptoms in the absence of infection. The
second meeting discussed the latest findings on innate, as opposed to acquired, immunity. This, it
seems, is found in all multicellular organisms, and a notable feature of the meeting was that the partic-
ipants worked on plants, invertebrates, and vertebrates.
The meeting on innate immunity included plants, but the Banbury plant meeting itself discussed the
integration of hormonal and genetic regulation of plant development. These have been regarded as
separate fields of research, but it has become clear that the two broad developmental pathways are
closely linked. Participants examined the extent to which hormones regulate known genetic pathways
and vice versa.
There have been repeated attempts to establish a theoretical biology that would provide a firm con-
ceptual framework for experimental research, performing a role analogous to that of theoretical physics.
Theoretical analysis and modeling have, perhaps, played a greater role in neuroscience research than in
other biological disciplines, and we held a meeting that reviewed computational approaches to model-
ing brain function. A second meeting dealt with more general features of biological systems, examining
whether organisms have employed common engineering principles in their evolution. It drew on partici-
pants from a most varied set of disciplines, including mathematics, engineering theory, and biology.
Even during a relatively quiet year, the operation of Banbury Center still requires a major effort by
many people. That our meetings run so smoothly is a tribute to the hard work of Sydney Gary, Bea
To liver, Ellie Sidorenko, and Barbara Polakowski. The Center's grounds crew staff Mike Peluso and Joe
Ellis keep the Banbury environment a beautiful resource for our participants. Our hectic schedule
places a great burden on the Food Services and Housekeeping departments whose staffs must cope
with ever-changing schedules and rapid turnarounds. I thank all of these people and the scientists at
the Laboratory who continue to support the Banbury Center activities.
Jan Witkowski
Executive Director
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MEETINGS
The Evolving Role of the Board-certified Medical Geneticist
February 14-16
FUNDED BY American College of Medical Genetics and individual participants
ARRANGED BY B.R. Korf, University of Alabama, Birmingham
BACKGROUND
As a result of the advances in gene mapping using, for example, single-nucleotide polymorphisms
(SNPs) and genome-wide tools such as microarrays, we now know the genes underlying some 2000
human inherited disorders. However, despite this dramatic increase in our ability to use molecular tech-
niques for diagnosis, applications of this knowledge have been limited. This discussion meeting
focused on defining the role of the medical geneticist in rare and common disorders.
Introduction: J.A Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Setting the Stage
B.R. Korf, University of Alabama, Birmingham
D.H. Ledbetter, Emory University School of Medicine, Atlanta,
Georgia
M.F. Murray, Harvard Medical School, Boston,
Massachusetts: Welcome and overview of meeting.
J. Zonana, University of Oregon Health Science University,
Portland: Roles of medical geneticists outside of the United
States.
G. Feldman, Wayne State University, Detroit, Michigan: Roles
of medical geneticists in the United States.
R. Bachman, Kaiser Permanente Hospital, Oakland,
California: Genetic services: The HMO model.
M. Blitzer, University of Maryland: Genetic workforce study.
SESSION 2: Role of the Medical Geneticist
B.R. Korf, University of Alabama, Birmingham: Pediatrics.
M.F. Murray, Harvard Medical School, Boston,
Massachusetts: Adult medicine.
J.L. Simpson, Baylor College of Medicine, Houston, Texas:
Prenatal diagnosis.
M. Scheuner, RAND Corporation, Santa Monica, California:
Public health.
General Discussion: Action items and planned follow-up
Research on Genetics of Bipolar Disorder: Current
Approaches and Future Directions
February 22
FUNDED BY The Stanley Foundation
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
S. Gary, Banbury Center, Cold Spring Harbor Laboratory
BACKGROUND
This discussion meeting was held to assess the current state of research on bipolar disorder. As with
many psychiatric disorders, research on the genetics of bipolar disorder has been slow to identify
genes underlying the condition. Many factors contribute to this lack of progress, including the hetero-
geneity of the disorder and the absence of a definitive diagnostic classification scheme. The meeting
focused on genetic approaches, and participants reviewed lessons learned from past collaborative
efforts and discussed what is needed to establish a new collaborative project. The meeting concluded
with a discussion on future experiments and the importance of sharing resources and data.
Welcome: J.D. Watson, Cold Spring Harbor Laboratory
J.R. De Paulo and J. Potash, Johns Hopkins University School
of Medicine, Baltimore, Maryland: Overview of clinical
aspects of bipolar disorder.
E.S. Gershon, University of Chicago, Illinois: Current status of
research on genetics of bipolar disorder.
J. Sebat, Cold Spring Harbor Laboratory: ROMA analysis of
autism.
Discussion of Future Research Directions
Questions for discussion
What patient groups are currently represented in the available
DNA collections?
What information is important in collecting future samples?
What are the concerns and suggestions regarding overlap
between bipolar and schizophrenia?
Limit analysis to sib pairs? Other approaches?
Future directions? How best to proceed?
A. Malhotra, T. Marr, E. Gershon
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J. Watson, R. De Paulo
Neurogenesis in the Adult Brain
February 26-March 1
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY F. H. Gage, The Salk Institute for Biological Studies, San Diego, California
G. Enikolopov, Cold Spring Harbor Laboratory
BACKGROUND
Research efforts on neurogenesis in the adult brain have grown substantially in recent years. Improved
methods allow researchers to observe the birth and function of new neurons in the adult, leading to
some exciting reports on the role of neurogenesis not only in the normal adult brain, but also in certain
neurological disorders such as depression and stroke. This meeting examined such questions as What
are the molecular and morphological characteristics of the cells as they transition from stem cells to
mature neurons? What are the key molecular, cellular and electrophysiological mechanisms that regu-
late different aspects of the maturation process? Are changes in neurogenesis responsible for disease-
related changes in behavior?
Introduction: S. Gary, Banbury Center, Cold Spring Harbor Laboratory
F.H. Gage, The Salk Institute for Biological Studies, San Diego, California
SESSION 1: Basic Processes of Adult Neurogenesis
Chairperson: J.D. Mack lis, Harvard Medical Center,
Boston, Massachusetts
D. Van Der Kooy, University of Toronto, Ontario, Canada: The
origin of adult neurons from stem and progenitor cells.
G. Enikolopov, Cold Spring Harbor Laboratory: Differentiation
cascade in the hippocampus.
C. Lie, Institute for Developmental Genetics, Munich, Germany:
Role of Wnt signaling in hippocampal neurogenesis.
A. Schinder, Leloir Institute Foundation, Buenos Aires,
Argentina: Functional convergence of neurons generated in
the developing and adult hippocampus.
SESSION 2: Molecular Mechanisms Regulating
Neurogenesis
Chairperson: R. McKay, National Institute of Neurological
Disorders and Stroke/NIH, Bethesda, Maryland
F. Doetsch, Columbia University, New York: MicroRNA regula-
tion of adult neurogenesis.
H.G. Kuhn, Goteburg University, Sweden: Peripheral growth
factors as stimulants for adult neurogenesis.
J. Bischofberger, Physiologisches Institut der Universitat
Freiburg, Germany: Calcium signaling and synaptic plastici-
ty in newly generated hippocampal granule cells.
H. Song, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Molecular mechanisms regulating
synaptic integration and plasticity of newly generated neu-
rons in the adult brain.
D.A. Steindler, University of Florida Brain Institute, Gainesville:
Tying together cell and molecular interactions that regulate
neurogenesis.
R. Hen, G. Kempermann, J. Macklis
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SESSION 3: Regulation of Adult Neurogenesis
Chairperson: P. Rakic, Yale University School of Medicine, New Haven, Connecticut
G. Kempermann, Max Delbruck Center for Molecular
Medicine, Berlin, Germany: Natural variation and genetic
covariance in adult hippocampal neurogenesis.
H. van Praag, Salk Institute for Biological Studies, San Diego,
California: Regulation of neurogenesis by exercise in
rodents.
H.A. Cameron, National Institute of Mental Health/NIH,
Bethesda, Maryland: Regulation of new neuron survival by
learning.
S.A. Small, Columbia University, New York: MRI correlates of
neurogenesis in mice and humans.
Abrous, Institute Francois Magendie, Bordeaux, France:
Comments and discussion on "environmental regulation of
adult neurogenesis."
SESSION 4: Functional Significance of Adult Neurogenesis
Chairperson: F.H. Gage, The Salk Institute for Biological Studies, San Diego, California
R. Hen, Columbia University, New York: Hippocampal neuro-
genesis contributes to contextual fear learning and antide-
pressant response.
T.J. Shors, Rutgers University, Piscataway, New Jersey:
Learning and neurogenesis: What is it about learning that
rescues new neurons from death?
J.M. Wojtowicz, University of Toronto, Ontario, Canada:
Radiation-induced inhibition of neurogenesis interferes with
hippocampus-dependent memory function.
S. Jessberger, The Salk Institute for Biological Studies, La
Jolla, California: Aberrant neurogenesis contributes to cog-
nitive impairment following seizure activity.
SESSION 5: Role for Neurogenesis in Disease
Chairperson: P. Eriksson, Sahlgrenska Academy Goteburg University, Sweden
R.S. Duman, Yale University School of Medicine, New Haven,
Connecticut: Neurogenic actions of antidepressants.
A. Pieper, University of Texas Southwestern Medical Center,
Dallas: NPAS3 and neurogenesis in schizophrenia.
0. Lindvall, Lund University Hospital, Sweden: Neurogenesis
after ischemic and epileptic insults in adult brain.
S.A. Goldman, The University of Rochester Medical Center,
New York: Hb9 enhancer-based isolation and targeting of
human motor neurons.
G. Kempermann, J. Bischofberger, J. Watson
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S. Jessberger, F. Gage
A Critical Assessment of Autism Genetics
March 12-15
FUNDED BY Autism Speaks; Cure Autism Now; McLaughlin Centre for Molecular Medicine;
Nancy Lurie Marks Family Foundation; National Alliance for Autism Research;
Simons Foundation
ARRANGED BY A.P. Monaco, University of Oxford, United Kingdom
S.W. Scherer, The Hospital for Sick Children, Toronto, Canada
A.J. Bailey, University of Oxford, United Kingdom
BACKGROUND
Autism is known to have a strong genetic etiology, but even after many years of molecular genetic
studies, it has been difficult to identify susceptibility genes for autism that are influencing a large major-
ity of patients. However, there is increasing optimism that this is about to change. The new tools of
genomics that, for example, enable high-density genetic marker studies of individual regions and the
whole genome at reasonable cost, combined with larger families being studied, will hopefully yield new
data. Participants in the meeting critically assessed the current state of research and looked for the
leads that should be followed in the future.
Introduction: S. Gary, Banbury Center, Cold Spring Harbor Laboratory
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SESSION 1: Clinical Aspects
Chairperson: A.P. Monaco, University of Oxford, United Kingdom
P. Szatmari, McMaster University, Ontario, Canada: Historical
and clinical introduction.
A.J. Bailey, University of Oxford, United Kingdom: Utilizing the
whole autism phenotype.
S. Baron-Cohen, University of Cambridge, United Kingdom:
Hypersystemizing, assortative mating, and androgens.
D. Skuse, Institute of Child Health, London, United Kingdom:
Potential X-linked mechanisms influencing susceptibility to
autistic traits.
E. Fombonne, Montreal Children's Hospital, Canada: Recent
trends in the epidemiology of autism and hypotheses about
environmental exposures.
Key Points and Discussion: P. Szatmari, McMaster
University, Ontario, Canada
SESSION 2: Whole-genome Genetic Studies
Chairperson: S.W. Scherer, The Hospital for Sick Children, Toronto, Canada
V.J. Vie land, University of Iowa, Iowa City: The incredible
shrinking LOD: How increasing the sample size can actually
obscure true linkage peaks, and what we can do about this.
D. Geschwind, University of California School of Medicine, Los
Angeles: Approaching heterogeneity in autism:
Endophenotypes and candidate pathway analysis.
I. Jarvela, University of Helsinki, Finland: Molecular genetics of
Asperger syndrome, the under-diagnosed endophenotype
among autism spectrum disorders.
J. Lamb, University of Oxford, United Kingdom: Gender and
SESSION 3: Candidate Genes and Regional Association Studies
Chairperson: A.J. Bailey, University of Oxford, United Kingdom
J. Sutcliffe, Vanderbilt University, Nashville, Tennessee: Autism
susceptibility and dysregulation of serotonin.
J. Lamb, University of Oxford, United Kingdom, and E.
Maestrini, University of Bologna, Italy: A high-density SNP
association study of the autism susceptibility loci on chromo-
somes 2q24-q32 and 7q21-q33.
J. Buxbaum, Mt. Sinai School of Medicine, New York:
Chromosome 2q in autism.
parent of origin affects in linkage data from IMGSAC.
G.D. Schellenberg, Seattle V.A. Medical Center, Washington:
Recently completed genome scan of 225 families.
A. Chakravarti, Johns Hopkins University School of Medicine,
Baltimore, Maryland: A linkage and association scan for
autism genes.
Key Points and Discussion: M.A. Pericak-Vance, Duke
University Medical Center, Durham, North Carolina
A.L. Beaudet, Baylor College of Medicine, Houston, Texas: A
mixed genetic and epigenetic, and mixed de novo and inher-
ited model for autism.
T. Bourgeron, Institut Pasteur, Paris, France: Autism spectrum
disorders and synaptic plasticity.
Key Points and Discussion: M. Gill, St. James' Hospital,
Dublin, Ireland
SESSION 4: Chromosomal Abnormalities/Copy-number Variants
Chairperson: M.A. Pericak-Vance, Duke University Medical Center, Durham, North Carolina
C. Lee, Brigham and Women's Hospital, Boston, Massachu-
setts: Array-based comparative genomic hybridization and
copy-number variation in the human genome.
J. Sebat, Cold Spring Harbor Laboratory: A high-resolution
scan for genome copy-number variation in autism.
E.E. Eichler, University of Washington, Seattle: Structural varia-
tion, mental retardation, and autism.
S.W. Scherer, The Hospital for Sick Children, Toronto,
Canada: Cytogenomic investigations into the molecular etiol-
SESSION 5: Statistical Genetics
Chairperson: V.J. Vie land, University of Iowa, Iowa City
B. Devlin, University of Pittsburgh School of Medicine,
Pennsylvania: Linkage genome scan for the autism genome
project.
R.M. Cantor, University of California School of Medicine, Los
Angeles: Evidence of gene on 17q contributing to autism in
males.
E.M. Wijsman, University of Washington School of Medicine,
Seattle: Multi locus models and analysis of component phe-
notypes.
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ogy of autistic spectrum disorder.
N.C. Schanen, University of Delaware, Wilmington: Autism
spectrum disorders in duplication chromosome 15 syn-
drome.
S. Muthuswamy, Cold Spring Harbor Laboratory: CNP allelic
imbalance in autism.
Key points and discussion: G.D. Schellenberg, Seattle
V.A. Medical Center, Washington
M. Daly, Whitehead Institute for Biomedical Research, Cambridge,
Massachusetts: Genome-wide association prospects in the face
of the great genetic complexity of autism.
Key points and discussion: J.L. Haines, Vanderbilt
University Medical Center, Nashville, Tennessee
Summary: A.P. Monaco, University of Oxford, United
Kingdom
The Phenomenology of Reconsolidation
March 26-29
FUNDED BY Volkswagen Foundation and Marie Robertson Memorial Fund
ARRANGED BY Y. Dudai, Weizmann Institute of Science, Rehovot, Israel
B. Everitt, University of Cambridge, United Kingdom
K. Nader, McGill University, Montreal, Canada
BACKGROUND
We would all like to know more about our memories. How is it that our brains retain just a few mem-
ories out of the myriad events that we experience each moment of the day, and how is it that some of
these memories are kept for decades? It seems that newly formed memory remains in a dynamic or
"labile" form for a short time after which the memory trace is stabilized or "consolidated." During the
past several years, it has emerged that after a memory undergoes consolidation, it may return to a
labile state under certain circumstances, requiring it to be reconsolidated. There are important theoret-
ical and practical implications of these findings, for example, with respect to a variety of mental illness-
es, such as posttraumatic stress disorder, phobia, and drug addiction.
Welcome: S. Gary, Banbury Center, Cold Spring Harbor Laboratory
History of the Phenomenon: S.J. Sara, Universite Pierre & Marie Curie, Paris, France
SESSION 1: The Nature of Amnesia
Chairperson: S.J. Sara, Universite Pierre & Marie Curie,
Paris, France
Topic 1: Why isn't there a resolution to the nature of amnesia?
What are the issues?
D. Riccio, Kent State University, Ohio: Reconsolidation: A bit
of history, a bit of (contrarian?) theory.
P.E. Gold, University of Illinois, Urbana-Champaign: Memories
and amnesias.
Topic 2: New empirical approaches to the issue
L. de Hoz, Medical University Charite, Berlin, Germany:
Memory loss and reminding in the spatial domain.
0. Hardt, University of Arizona, Tucson: A novel approach to
identifying the nature of amnesia.
SESSION 2: Boundary Conditions on Reconsolidation and
Other New Findings
Chairperson: M. Walker, Harvard Medical School, Boston,
Massachusetts
Brief Presentations
Extinction
Strength of Training
Directly Reactivated versus Indirectly Reactivated Memories
Age of Memories
New Findings in Reconsolidation
SESSION 3: Reconsolidation Across Species and Tasks
Chairperson: K.P. Giese, University College of London, United
M. Walker, Harvard Medical School, Boston, Massachusetts: Role
of sleep in memory consolidation and reconsolidation.
S. Davis, CNRS and University Paris Sud, France: Cellular and
molecular mechanisms of consolidation and reconsolidation.
B.W. Balleine, University of California, Los Angeles:
Reconsolidation of appetitive memories.
P. Gold, C. Rankin, S. Sara, K. Lukowiak
Kingdom
K. Lukowiak, University of Calgary, Alberta, Canada:
Reconsolidation and a well-rehearsed memory.
K. Anokhin, Russian Academy of Medical Sciences, Moscow:
Reconsolidation and memory recovery in mice and chicks: A
comparative perspective.
SESSION 4: Molecular and Cellular Mechanisms
Chairperson: B.S. Everitt, University of Cambridge, United Kingdom
R. Fonseca, Julio de Matos Hospital, Lisbon, Portugal:
Neuronal activity determines the protein synthesis depen-
dence of L -LTP.
C. Rankin, University of British Columbia, Vancouver, Canada:
Blocking memory reconsolidation in C. elegans reverses
behavioral expression of memory as well as establishes
changes in glutamate receptor expression.
S. Kida, Tokyo University of Agriculture, Japan: Mechanisms of
interaction between memory reconsolidation and extinction.
K.P. Giese, University College of London, United Kingdom:
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Reconsolidation as partial recapitulation of consolidation.
J.L.C. Lee, University of Cambridge, United Kingdom: The
molecular mechanisms of fear memory consolidation and
reconsolidation are doubly dissociable.
C. Albernini, Mt. Sinai School of Medicine, New York: Why
does memory undergo reconsolidation? A working hypothe-
sis from studies on inhibitory avoidance memory.
K. Nader, McGill University, Quebec, Canada: A neural mani-
festation of the overtraining boundary conditions on recon-
solidation.
SESSION 5: Reconsolidation in Normal and Psychopathological Memories
Chairperson: L. Nadel, University of Arizona, Tucson
S.J. Sara, Universite Pierre and Marie Curie, Paris, France:
Learning-related activation of locus coeruleus during slow
wave sleep: A new player on the reactivation scene?
M. Altemus, Cornell University, New York: Fear conditioning in
healthy humans: Effects of propranolol.
J. Gorman, McLean Hospital, Belmont, Massachusetts: The
significance of reconsolidation of fear memories for the treat-
ment of anxiety disorders.
E. Phelps, New York University: Reconsolidation in humans?
Specific challenges.
R.K. Pitman, Harvard Medical School, Charlestown,
Massachusetts: Translational model of PTSD updated: Role
of reconsolidation and treatment implications.
K. Myers, Emory University, Atlanta, Georgia: Extinction shortly
following fear acquisition may erase conditioned fear.
B.S. Everitt, University of Cambridge, United Kingdom:
Memory reconsolidation as a therapeutic target in drug
addiction.
SESSION 6: Interpretations and New Directions
Chairperson: B.S. Everitt, University of Cambridge, United Kingdom
L. Nadel, University of Arizona, Tucson: Reconsolidation:
Challenging fundamental concepts of memory.
Y. Dudai, The Weizmann Institute of Science, Rehovot, Israel:
Reconsolidation: Taping into trace persistence and use.
Group Discussion
Mediator: Y. Dudai, The Weizmann Institute of Science,
Rehovot, Israel
N. Nader, D. Schiller, Y. Dudai
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Computational Approaches to Cortical Functions
April 2-5
FUNDED BY
ARRANGED BY
BACKGROUND
The Swartz Foundation
L.F. Abbott, Columbia University, New York
H. Cohen, The Swartz Foundation, Scarborough, New York
R.M. Shapley, New York University
The meeting focused on the dynamics of large-scale computational models of the cerebral cortex,
including both theoretical and experimental results concerning large-scale neural systems. Participants
discussed modeling requirements at the synaptic, neuronal, and circuit levels, as well as the effects of
network size and scaling rules. Other topics covered included propagation and gating of signals, self-
sustained oscillations and reverberatory states, spike and local field relationships, chaotic activity, and
other phenomena exhibited by these models and their experimental counterparts.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
X.-J. Wang, Brandeis University, Waltham, Massachusetts:
Neural mechanisms of feature-based attention in a two-net-
work model of sensory processing.
W. Maass, Technical University of Graz, Austria: A model for
computation in cortical microcircuits.
0. White, Massachusetts Institute of Technology, Cambridge:
Signal reconstruction from recurrent neuronal networks.
K. Rajan, College of Physicians & Surgeons, New York:
Controlling neural networks dynamics.
A. Aersten, Albert Ludwigs Universitat, Freiburg, Germany:
Variability and precision in cortical networks.
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SESSION 2
C. Geis ler, Rutgers University, Newark, New Jersey: Behavior-
dependent phase rescaling of hippocampal pyramidal cells.
T. Vogels, Columbia University, New York: Signal propagation
and switching in networks.
M. Diesmann, Albert-Ludwigs University, Freiburg, Germany:
SESSION 3
D. Cai, New York University: Spontaneous cortical activity in V-I.
M.V. Tsodyks, Weizmann Institute of Science, Rehovot, Israel:
Information encoding and processing via spatiotemporal pat-
terns in cortical networks.
C. van Vreeswijk, Rene Descartes University, Paris, France:
Role of dendritic shunting inhibition.
SESSION 4
D. Tranchina, New York University: Try to save computation
time in large-scale neural network modeling with population
density methods, or just fuhgeddaboudit?
R.D. Traub, SUNY Downstate Medical Center, Brooklyn, New
York: Gap junctions and fast oscillations in hippocampus
and neocortex.
SESSION 5
M.J. Shelley, New York University: V1 dynamics and sparsity
and multiple feature maps.
B. Murphy, University of California, San Francisco:
Spontaneous activity and orientation maps in balanced corti-
cal networks with structured -like connectivity.
A. Rangan, New York University: Cortical correlates underlying
X.-Y. Wang, L. Abbot
Spike-timing-dependent plasticity in balanced random networks.
B. Pesaran, New York University: Free choice increases
synaptic interactions between frontal and parietal cortex.
R. Yuste, Columbia University, New York: Internal dynamics
determine the cortical response to thalamic stimulation.
W. Gerstner, Ecole Polytechnique Federale de Lausanne,
Switzerland: Ultra-short-term information buffering in a ran-
dom network of spiking neurons: Macroscopic versus micro-
scopic effects.
B. Knight, The Rockefeller University, New York: Neuron popu-
lation dynamics in a simple canonical form.
R.M. Shapiro, Cape Visions, Inc. New York, New York:
Integrate and fire neural network: VLSI chip design.
A. Henrie, University of California, Los Angeles: Coherence of
activity in primate V1.
D. Plenz, National Institute of Mental Health/NIH, Bethesda,
Maryland: Neuronal avalanches in superficial layers of neocortex.
the line-motion-illusion phenomenon in primary visual cortex.
T. Thiagarajan, National Institute of Mental Health/NIH,
Bethesda, Maryland: Precise propagation of initial neuronal
group activity in neuronal avalanches in cortex.
L. Rajan, W. Maas
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Fragile-X Syndrome: Basic Mechanisms and Treatment Implications
April 9-12
FUNDED BY
ARRANGED BY
BACKGROUND
NIH-National Institute of Mental Health (through a grant to the University of Illinois)
W.T. Greenough, University of Illinois, Urbana
B.A. Oostra, Erasmus Universiteit Rotterdam, The Netherlands
E. Berry-Kravis, Rush University Medical Center, Chicago, Illinois
K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
This meeting was the seventh in a series of annual Banbury Center conferences on fragile X, although
fragile X was discussed at Banbury long before then, in the early days of applying recombinant DNA tech-
niques to mapping and cloning genes involved in inherited disorders. This meeting took a broad perspec-
tive on fragile X, reviewing what is known of FMR1 /RNA interactions, FMRP cellular biology and the pro-
teins that interact with it, synaptic physiology, and how fragile X affects the nervous system in animal mod-
els and humans. A final session discussed progress in the all-important task of developing treatments.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Basic Mechanisms of the FMR1 Gene/RNA Interactions/Cargo RNAs
Chairperson: B.A. Oostra, Erasmus Universiteit Rotterdam, The Netherlands
J.R. Fallon, Brown University, Providence, Rhode Island:
Axonal FMRP in the developing vertebrate brain.
J. Darnell, The Rockefeller University, New York: G-quadruplex
and kissing complex RNA ligands of the fragile-X family of
RNA-binding proteins.
S. Ceman, University of Illinois, Urbana: Identification and
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characterization of the methyl arginines in the fragile-X men-
tal retardation protein.
B. Bardoni, Faculte de Medecine, Nice, France: FMRP and
RNA: Old and novel friends.
Y. Feng, Emory University, Atlanta, Georgia: Translation regula-
tion by FMRP during neuronal development.
SESSION 2: FMRP Interacting Proteins and FMRP Cellular Biology Including Transport, Signal Transduction, and
Mechanisms of Translational Regulation
Chairperson: S.T. Warren, Emory University School of Medicine, Atlanta, Georgia
G.J. Bassell, Emory University, Atlanta, Georgia: The stimulat-
ing travels and function of FMRP.
P.W. Vanderklish, Scripps Research Institute, La Jolla,
California: Novel physiological and proteomic characteriza-
tion of the Fmr1 KO mouse.
M. Hayashi, Massachusetts Institute of Technology,
Cambridge: A physical and functional interaction between
p21-activated kinase and the fragile-X mental retardation
protein.
M.V. Catania, Institute of Neurological Sciences, Catania, Italy:
mG1u5 receptor expression and interaction with Homer pro-
teins in a mouse model of FRAXA syndrome.
I.J. Weiler, University of Illinois, Urbana-Champaign. FMRP:
Some aspects of translational control.
H. Cline, Cold Spring Harbor Laboratory: Control of experi-
ence-dependent structural plasticity by local protein synthe-
sis.
E. Klann, Baylor College of Medicine, Houston, Texas:
Translational and proteasomal regulation of FMRP during
hippocampal mGluR-LTD.
SESSION 3: Synaptic Physiology and Function of FMRP Including Effects on LTP/LTD, Glutamate, and GABA Activity
Chairperson: W.T. Greenough, University of Illinois, Urbana
0. Steward, University of California, Irvine: Translation of
mRNA at synapses in Fmr1 knockout mice.
K.M. Huber, University of Texas Southwestern Medical Center,
Dallas: Role for FMRP in synaptic function and plasticity.
M.F. Bear, Massachusetts Institute of Technology, Cambridge:
Tests of the mGluR theory.
S. Chattarji, National Centre for Biological Sciences,
Bangalore, India: mGluR- and NMDAR-dependent synaptic
plasticity: A contrasting view from the amygdala.
B.A. Oostra, Erasmus Universiteit Rotterdam, The
Netherlands: Cerebellar function and the FMR1 knockout
mouse
C.L. Cox, University of Illinois, Urbana: Altered synaptic plas-
ticity in sensory neocortex associated with FMRP knockout.
J.R. Larson, University of Illinois, Chicago: Age-dependent
impairment of LTP in olfactory cortex of mice lacking FMRP.
SESSION 4: Brain Phenotypes Mediated by FMRP Including Dendritic Morphology, Neural Networks/Seizure
Generation, Learning, and Behavioral Measures in FXS Models
Chairperson: J. Darnell, The Rockefeller University, New York
W.T. Greenough, University of Illinois, Urbana: Spine/synapse
phenotype: Context-dependent expression.
I. Bureau, Cold Spring Harbor Laboratory: Defects of function-
al and anatomical connectivity in the barrel cortex of fmrl
KO mice.
R.K.S. Wong, SUNY-Health Science Center, Brooklyn, New
York: Cellular mechanisms of mGluR-induced epileptogenesis.
M. Zhuo, University of Toronto, Ontario, Canada: Synaptic and
behavioral studies of prefrontal cortical potentiation in a
mouse model for fragile X.
R.E. Paylor, Baylor College of Medicine, Houston, Texas:
Behavior of Fmrl KO mice: Genetic interactions.
C.B. Smith, National Institute of Mental Health/NIH, Bethesda,
Maryland: In vivo studies of regional brain metabolism in the
fragile-X mouse.
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Circadian derangement in Fmrl/Fxr2 knockout mice: A role
for FMR1 in clock control?
SESSION 5: A Look at Progress in Moving toward the Goal of Treatment
in Humans
Chairperson: M.R. Tranfaglia, FRAXA Research Foundation, Newburyport,
Massachusetts
S.T. Warren, Emory University School of Medicine, Atlanta,
Georgia: A 2000-compound drug screen using dFmr1 -defi-
cient Drosophila.
G. Bilbe, Novartis Institutes for BioMedical Research, Basel,
Swtizerland: Exploratory therapeutic approaches to FRX.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
Identification and characterization of PET-imaging ligands for
the mGlu5 receptor.
W. Spooren, Hoffmann-La Roche Ltd., Basel, Switzerland:
Fenobam, a clinically validated non-benzodiazepine anxiolyt-
ic, is a potent, selective, and noncompetitive mG1u5 receptor
antagonist with inverse agonist activity.
E. Berry-Kravis, Rush University Medical Center,
Chicago,
Illinois: Progress in clinical trial design for FXS treatment tri-
als.
S.C. Landis, National Institute of Neurological Disorders and
Stroke/NIH, Bethesda, Maryland: Brief comments about
importance of fragile X from NIH's perspective.
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Appetite and Feeding
April 30-May 3
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J. Friedman, The Rockefeller University, New York
S. O'Rahilly, University of Cambridge, United Kingdom
BACKGROUND
There is a complex interaction between physiology and psychology in determining when and how
much we eat. Biochemical and physiological processes regulate food intake, but this is modified by
psychological stimuli relating to the senses of taste, smell, and sight. These studies involve researchers
in diverse areas of study and one of the goals of the meeting was to bring together these investigators
who may not otherwise meet. The success of the meeting was evident from the range of organisms
and topics discussed. These included studies of round worms, fruit flies, snails, and human beings and
of smell and taste. One talk was titled "Disgust Discussed"!
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Studies in Invertebrates
Chairperson: E.J. Nest ler, University of Texas Southwestern Medical Center, Dallas
C.I. Bargmann, The Rockefeller University, New York: Food
quality and the regulation of food preference.
G. Ruvkun, Massachusetts General Hospital, Boston:
Functional genomic analysis of C. elegans fat control.
L. Vosshall, The Rockefeller University, New York: Genetic
control of olfactory perception in Drosophila.
R. Gillette, University of Illinois, Urbana-Champaign: Neural cir-
cuits integrating appetite, sensation, and experience in for-
aging decisions.
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SESSION 2: Feeding in Vertebrates
Chairperson: G. Barsh, HHMI/Stanford University School of Medicine, California
M.W. Schwartz, Harborview Medical Center, Seattle,
Washington: Integration of homeostatic and satiety signals in
food intake regulation.
J.S. Flier, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Hypothalamic neurogenesis and the regula-
tion of energy balance.
J.K. Elmquist, University of Texas Southwestern Medical
Center, Dallas: CNS pathways underlying coordinated body
weight and glucose homeostasis.
E.J. Nest ler, University of Texas Southwestern Medical Center,
Dallas: Regulation of brain reward regions by feeding pep-
tides in animal models of addiction and depression.
M.A. Cowley, Oregon Health and Science University, Portland:
Cannabinoid antagonists regulate energy balance through
the ventral tegmental area, not the melanocortin circuits.
SESSION 3: Feeding in Vertebrates
Chairperson: J.S. Flier, Beth Israel Deaconess Medical Center, Boston, Massachusetts
R. Cone, Oregon Health Sciences University, Portland, Oregon:
Genetics of energy homeostasis in a vertebrate model system.
G. Barsh, HHMI/Stanford University School of Medicine,
California: Transcriptional regulation of Agrp expression.
E. Maratos-Flier, Beth Israel Deaconess Medical Center,
Boston, Massachusetts: Appetite regulation and drug sensi-
tization: Role of melanin-concentrating hormone in regulating
dopaminergic tone.
H. Grill, University of Pennsylvania, Philadelphia: The neural
control of feeding and energy expenditure is distributed with
nodes in hypothalamus and caudal brainstem.
A.E. Kelley, University of Wisconsin, Madison: Energy, action,
and reward: Neural control of food motivation.
B.E. Levin, V.A. Medical Center, East Orange, New Jersey:
Metabolic sensing neurons and the control of feeding: The
final common pathway to obesity.
SESSION 4: Taste, Smell, and Gut Hormones
Chairperson: S. O'Rahilly, University of Cambridge, United Kingdom
U. Boehm, University Hamburg, Germany: Feedback loops
link odor and pheromone signaling with reproduction.
M. Zoller, Senomyx, Inc., La Jolla, California: Using human
taste receptors to discover novel taste modulators.
SESSION 5: Reward, Addiction, Disgust, and Human Studies
Chairperson: J.M. Friedman, HHMI/The Rockefeller University,
E. Rolls, University of Oxford, United Kingdom: Neurophysiological
and fMRI analyses of the processing of taste and olfactory infor-
mation in cortical areas related to the control of appetite.
A. Calder, MRC Cognition and Brain Science Unit, Cambridge,
United Kingdom: Disgust discussed.
,N11.10.
S.R. Bloom, Imperial College London, United Kingdom:
Mouth, bowel, and brain-Are they connected?
J.M. Friedman, HHMI/The Rockefeller University, New York:
Leptin and the neural circuit regulating appetite.
New York
A. Del Parigi, Pfizer Global R&D, Groton, Connecticut:
Neuroimaging markers of eating behavior in humans.
S. O'Rahilly, University of Cambridge, United Kingdom:
Genetics and human eating behavior.
\th,
A. Calder, E. Rolls
S. O'Rahilly, R. Cone, E. Nest ler
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Design Principles In Biological Systems
May 7-10
FUNDED BY The Dart Foundation
ARRANGED BY P.P. Mitra, Cold Spring Harbor Laboratory
J. Doyle, California Institute of Technology, Pasadena
R.M. Murray, California Institute of Technology, Pasadena
BACKGROUND
Living organisms have been conventionally studied following a reductionist strategy, using the tools of genetics,
biochemistry, and cell biology. However, there are also likely to be more general principles involved, and a new
theoretical biology is currently taking shape with more formal emphasis on design or engineering principles. For
this research program to succeed, biology researchers will need to be trained in the concepts and mathematics
relevant to engineering theories, and engineering theorists and physical scientists need training in biological prob-
lems. This meeting was a bold start to achieving these goals.
Introduction: J.A. Witkowski, Banbury Center, Cold
Spring Harbor Laboratory
SESSION 1: Control Theory
Chairperson: M.E. Csete, Emory Healthcare, Atlanta,
Georgia
R.M. Murray, California Institute of Technology, Pasadena:
Tutorial.
Examples: Cellular Networks
M. Khammash, University of California, Santa Barbara:
Feedback control and heat shock response in bacteria.
M.A. Savageau, University of California, Davis: Feedback con-
trol in cellular metabolism.
Examples: Insect Locomotion
M.H. Dickinson, California Institute of Technology, Pasadena:
Control mechanisms in insect flight.
P. Holmes, Princeton University, New Jersey: Dynamics and
control in insect walking.
SESSION 2: Control Theory
Chairperson: B. Bamieh, University of California, Santa
Barbara
Examples: Motor Control
S. Massaquoi, Massachusetts of Technology, Cambridge:
Cerebellum as feedback controller.
D. Kleinfeld, University of California, San Diego: Active sensa-
tion in the rat vibrissae system.
Examples: Brain Architecture/Evolution
H.J. Karten, University of California, San Diego: Architectural
principles of vertebrate brains and feedback control.
C.C. Hilgetag, International University Bremen, Germany:
Feedback or feedforward? Analysis of visual cortical circuitry.
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H. Samad, M. Kirschner
L. Caporale, H. Karten
SESSION 3: Control Theory-Human Applications
Chairperson: J.E. Spiro, Nature Publishing Group, New York
D. Pre lec, Institute for Advanced Study, Princeton, New
Jersey: Feedback control and economics.
Discussion
Leader: H. EI-Samad, University of California, San Francisco
SESSION 4: Distributed Control and Games
Chairperson: H. Breiter, Massachusetts General Hospital
and Harvard Medical School, Charlestown
M. Kearns, University of Pennsylvania, Philadelphia: Tutorial:
Game theory
B. Bamieh, University of California, Santa Barbara: Tutorial:
Distributed control.
Examples: Evolution of Design
M.W. Kirschner, Harvard Medical School, Boston,
Massachusetts: Facilitated variation.
M. Levine, University of California, Berkeley: Genomic architec-
ture.
SESSION 5: Communication Theory
Chairperson: S.K. Mitter, Massachusetts Institute of
Technology, Cambridge
P. Mitra, Cold Spring Harbor Laboratory: Tutorial.
Examples: Animal Communication Systems
P. Narins, University of California, Los Angeles: Time and fre-
quency division multiplexing in frog communication.
T. Fitch, University of St. Andrews, Fife, Scotland: Animal
source codes: Vocal adaptations in animals.
Examples: Linguistic Communications
P. Niyogi, University of Chicago, Illinois: Human language as a
communication system.
SESSION 6: Communication Theory-Human Applications
Chairperson: L.H. Caporale, Columbia University, New York
J. Doyle, California Institute of Technology, Pasadena:
Comparing human technologies and biological systems.
Discussion
Leader: A. Sengupta, Rutgers, The State University of New
Jersey
SESSION 7: Computation
Chairperson: S. Basu, National Science Foundation,
Arlington, Virginia
Examples: Molecular Circuits
E. Winfree, California Institute of Technology, Pasadena:
Automata and algorithms: Examples from in vitro bio-
chemistry.
B. Mishra, New York University: Tutorial: Theory of computa-
tion.
H.S. Seung, Massachusetts Institute of Technology,
Cambridge: Examples of automata in neural systems.
C.D. Smolke, California Institute of Technology, Pasadena:
Examples from cellular biochemistry.
Recap and future planning
P.P. Mitra, Cold Spring Harbor Laboratory
J. Doyle, California Institute of Technology, Pasadena
R.M. Murray, California Institute of Technology, Pasadena
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Parkinson's Disease: Insights from Genetic and Toxin Models
May 14-17
FUNDED BY
ARRANGED BY
BACKGROUND
The Thomas Hartman Foundation for Parkinson's Research
N. Bonini, University of Pennsylvania, Philadelphia
S.E. Przedborski, Columbia University, New York
Neither the cause nor the mechanism by which neurons degenerate in Parkinson's disease are com-
pletely understood. However, scientists now have experimental models developed through gene
manipulation and the use of toxins in organisms as varied as primates, rodents, roundworms, and
yeast. Cell culture and cell-free systems are also available for investigation of specific aspects of
Parkinson's disease. Unfortunately, none of these models replicate all aspects of the disorder and this
meeting took up the challenge of deciding how to choose the best model for a given question.
Introduction: S. Gary, Banbury Center, Cold Spring
Harbor Laboratory
SESSION 1: Primate Models
Chairperson: P. Aebischer, Swiss Federal Institute of
Technology, Lausanne, Switzerland
E. Bezard, Universite Victor Sega len-Bordeaux, France:
for Parkinson's disease: Call for clinically dri-
ven experimental design in animal models.
J.H. Kordower, Rush University Medical Center, Chicago,
Illinois: Use of aged and MPTP-treated monkeys to study PD
pathogenesis and experimental therapeutics.
D. Gash, University of Kentucky College of Medicine,
Lexington: Toxin-induced and age-associated parkinsonism
in rhesus monkeys.
S. Przedborski, M. Beal
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SESSION 2: Rodent Toxin Model
Chairperson: R. McKay, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, Maryland
R.S. Betarbet, Emory University School of Medicine, Atlanta,
Georgia: The rotenone model and converging mechanisms
in Parkinson's disease.
D.A. Di Monte, The Parkinson's Institute, Sunnyvale, California:
Modeling environmental risk factors for Parkinson's disease.
S.E. Przedborski, Columbia University, New York: The MPTP
mouse model of PD.
M.F. Beal, Cornell University, New York: Testing novel therapies
in the MPTP model of PD.
SESSION 3: Rodent Models: Genetic
Chairperson: M.P. Beal, Cornell University, New York
J. Shen, Harvard Medical School, Boston, Massachusetts:
Insights from multidisciplinary analysis of parkin, DJ-1, and
PINK1 knockout mice.
X.W. Yang, David Geffen School of Medicine at University of
California, Los Angeles: BAC transgenic mouse models of neu-
rodegeneration.
P. Aebischer, Swiss Federal Institute of Technology, Lausanne,
PK. Sonsalla, UMDNJ-RWJMS, Piscataway, New Jersey:
Acute and chronic administration of MPP+: Models of
Parkinson's disease.
M.J. Zigmond, University of Pittsburgh School of Medicine,
Pennsylvania: Endogenous mechanisms of neuroprotection
in cellular and animal models of Parkinson's disease.
Switzerland: Use of viral vectors to create genetic models of
Parkinson's disease.
T.C. Sudhof, University of Texas Southwestern Medical
Center, Dallas: Toward a functional understanding of synu-
cleins.
R.H. Edwards, University of California, San Francisco: The
dynamics of a-synuclein at the nerve terminal.
SESSION 4: Invertebrate Models and Stem Cells
Chairperson: T.C. Sudhof, University of Texas Southwestern Medical Center, Dallas
N. Bonini, University of Pennsylvania, Philadelphia: Insights
from Drosophila models for Parkinson's disease.
R. Nass, Vanderbilt University Medical Center, Nashville,
Tennessee: Pharmacogenetic analysis in a novel model
of Parkinson's disease: Identification of genetic and
chemical modulators of dopamine neuron degeneration
in C. elegans.
P. Muchowski, University of California, San Francisco:
Genetic dissection of a-synuclein toxicity using yeast.
R. McKay, National Institute of Neurological Disorders and
Stroke/NIH, Bethesda, Maryland: Nigro-striatal disease and
the origin of dopamine neurons.
L. Studer, Memorial Sloan-Kettering Cancer Center, New
York: Human embryonic stem cells.
SESSION 5: Cell and Cell-free Systems
Chairperson: D. Di Monte, The Parkinson's Institute, Sunnyvale, California
L.A. Greene, Columbia University, New York: Why neurons die
in PD: Insights from a cellular model of the disease.
D. Sulzer Columbia University, New York: Regulation of
cytosolic dopamine in the SN.
P.T. Lansbury, Brigham and Women's Hospital, Cambridge,
Massachusetts: Discovering new targets for old drugs:
Parkinson's disease therapy in Drosophila.
M. Cookson, National Institutes of Health, Bethesda,
Maryland: Contribution of kinase activity to the cellular phe-
notypes of LRRK2 mutants.
A. Maria Cuervo, Albert Einstein College of Medicine, Bronx,
New York: Selective autophagy in the pathogenesis of PD.
Summary
S. E. Przedborski, Columbia University, New York
N. Bonini, University of Pennsylvania, Philadelphia
M.J. Zigmond, University of Pittsburgh School of Medicine,
Pennsylvania
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Spinal Muscular Atrophy: From RNA To Synapses
September 17-19
FUNDED BY Spinal Muscular Atrophy Foundation
ARRANGED BY T.M. Jessell, Columbia University, New York
C.E. Henderson, Columbia University, New York
C. Joyce, Spinal Muscular Atrophy Foundation, New York
BACKGROUND
Spinal muscular atrophy is another topic that has been covered in several Banbury Center meetings
and it is a further example of how intensive research using the tools of modern experimental biology is
leading to a detailed understanding of the molecular and cellular basis of the disorder. Sessions
reviewed the latest progress made in analysis of the two survival motor neuron genes and the role of
its encoded protein in processing and transport of mRNAs in neurons.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcome and Introductions: C.E. Henderson, Columbia University, New York, and D. Singh, Spinal Muscular
Atrophy Foundation, New York
SMA Overview
D.C. De Vivo, The Neurological Institute, Columbia University Medical Center, New York: SMA clinical features.
K.H. Fischbeck, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, Maryland: SMA research
overview.
lifs71217.17111
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SESSION 1: RNA in Neurons
Chairpersons: K.C. Martin, Semel Institute for Neuroscience and Human Behavior, University of California, Los
Angeles: Local translation at the synapse during synapse formation and neuronal plasticity; S.R. Jaffrey, Weill
Medical College, Cornell University, New York: Intra-axonal mRNA translation and neuronal survival.
G.J. Bassell, Emory University, Atlanta, Georgia: Interactions of
the SMN complex with localized mRNPs in neuronal
processes and growth cones.
G. Dreyfuss, HHMI/University of Pennsylvania School of
Medicine, Philadelphia: The SMN complex: Molecular func-
tions and screening for small molecules that affect its
expression.
C.E. Beattie, The Ohio State University, Columbus: A zebra
fish model of the human motoneuron disease.
A. Krainer, Cold Spring Harbor Laboratory: Strategies for
increasing inclusion of SMN2 exon 7.
Discussants: A. MacKenzie, Children's Hospital of Eastern
Ontario, Canada; C.E. Beattie, The Ohio State University,
Columbus; U.R. Monani, Columbia University Medical
Center, New York
SESSION 2: The Axon and Synapse
Chairpersons: B.A. Barres, Stanford University School of Medicine, California: How are CNS synapses eliminat-
ed?; M.E. Greenberg, Children's Hospital, Boston, Massachusetts: Signaling networks that regulate synaptic
development and cognitive function.
G.S. Battaglia, Neurological Institute, Milano, Italy: The axonal
localization of SMN and the role of a-SMN in stimulating
axon growth.
Z. He, Children's Hospital Boston, Massachusetts: Axon
degeneration and regeneration in SMA.
W. Thompson, University of Texas, Austin: A preliminary exam-
ination of the physiology and innervation of hindlimb muscles
in the mouse model of type II SMA.
C.C.J. Miller, University of London, United Kingdom: Axonal
transport and neurodegeneration.
Discussants: S. Burden, Skirball Institute, New York University
Medical School; J. Pierre Julien, Centre Hospitalier de
l'Universite Laval, Quebec, Canada; T. Gordon, University of
Alberta, Canada
SESSION 3: Survival of Neurons; Gene Therapy
Chairpersons: P. Aebischer, Swiss Federal Institute of Technology, Lausanne, Switzerland: The issue of deliver-
ing therapeutics to motor neurons; M. Sendtner, Universitat Wuerzburg, Germany: Characterization of axonal
alteration in cell culture and mouse models of SMA.
L.L. Rubin, Curis, Inc., Cambridge, Massachusetts: Small-
molecule screens for increased SMN levels in fibroblasts and
motor neurons.
S. Artavanis-Tsakonas, Massachusetts General Hospital and
Harvard Medical School, Charlestown: Genetic modifier
screens for SMN function.
C.T. Sumner National Institute of Neurological Disorders and
Stroke/NIH, Bethesda, Maryland: Histone deacetylase
inhibitors for treatment of SMA.
F. Saudou, Institut Curie, Orsay, France: Huntington's disease:
Understanding and restoring Huntington function in axonal
transport.
Discussants: B. McCabe, Columbia University, New
York; D.K. Gifford, Massachusetts Institute of Technology,
Cambridge
Closing Discussion and Recommendations
C.E. Henderson, Columbia University, New York
T.M. Jessell, HHMI/Columbia University, New York
D. Singh, Spinal Muscular Atrophy Foundation, New York
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The Biology of Neuroendocrine Tumors
September 24-26
FUNDED BY Verto Institute
ARRANGED BY A.J. Levine, Institute of Advanced Studies, Princeton, New Jersey
E. Vosburgh, Verto Institute, Stamford, Connecticut
BACKGROUND
Neuroendocrine tumors are rare tumors with the characteristics of both neural and endocrine cells.
Menin was identified as a tumor suppressor involved in multiple endocrine neoplasia type 1 and has
been the subject of intensive research. It is a histone methyltransferase, and its role in neuroendocrine
cell growth and differentiation and neural crest development was reviewed at this meeting. Data on the
characterization of several new cells lines (essential tools for research) were presented, together with
genomic analysis of tumor samples. Looking toward therapies, recent progress in clinical trials incor-
porating receptor tyrosine kinase, mTOR, and VEGF inhibitors was reviewed.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: A.J. Levine, Institute of Advanced Studies,
Princeton, New Jersey
R.V. Lloyd, Mayo Clinic, Rochester, Minnesota:
Characterization of a new carcinoid cell line (HC-45).
G. Van Buren, M.D. Anderson Cancer Center, University of
Texas, Houston: The development and characterization of a
human midgut carcinoid cell line.
M.L. Meyerson, Dana Farber Cancer Institute, Boston,
Massachusetts: Menin function.
X. Hua, University of Pennsylvania, Philadelphia: Menin regu-
lates hematopoiesis and leukemogenesis.
J.A. Epstein, University of Pennsylvania, Philadelphia: Menin
has a critical role in neural crest development.
S.K. Kim, Stanford University School of Medicine, California:
Calcineurin/NFAT signaling, an essential regulator of neu-
roendocrine cell growth and function.
SESSION 2
Chairperson: A.J. Levine, Institute of Advanced Study, Princeton, New Jersey
S. Karnik, Stanford University Medical Center, California:
Epigenetic regulation of pathologic and facultative neuroen-
docrine cell growth.
F. Leu, Verto Institute, Cancer Institute of New Jersey, New
Brunswick: Stepping the brake on carcinoid/neuroendocrine
tumor by turning on the TGF-P-somatostatin circuitry.
C.J. Barnstable and J. Tombran-Tink, Yale University School
of Medicine, New Haven, Connecticut: PEDF inhibits the
growth of ovarian and breast cancers.
C. Harris, Verto Institute, Cancer Institute of New Jersey, New
Brunswick: CINJ: Ll retrotransposition in neuroendocrine
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tumors.
D. Klimstra and L. Tang, Memorial Sloan-Kettering Cancer
Center, New York: Prognostic classification and gene
expression analysis of well-differentiated pancreatic
endocrine neoplasms.
M.H. Kulke, Dana Farber Cancer Institute, Boston,
Massachusetts: Single-nucleotide polymorphism array analy-
sis of small-bowel carcinoid tumors.
J. Hoh, Yale University School of Medicine, New Haven,
Connecticut: Preliminary report on a collaborative carcinoid
case control study.
SESSION 3
Chairperson: E. Vosburgh, Verto Institute, Stamford, Connecticut
M. Essand, Uppsala University, Sweden: A novel chromo-
granin-a promoter-driven replication-selective oncolytic aden-
ovirus as a therapeutic agent for carcinoid tumors.
K. Oberg, University Hospital, Uppsala, Sweden: 11C-HTP
PET in carcinoid and NET.
L. Kvols, University of South Florida, Tampa: Targeted peptide
receptor radiotherapy and SOM 230.
J. Yao, Gastrointestinal Medical Oncology, Houston, Texas:
Streptizocin-based chemotherapy.
M.H., Kulke, Dana Farber Cancer Institute, Boston,
Massachusetts: VEGF TK inhibitors, temazolamide, thalido-
mide, and lenalinamide therapies.
K. Oberg, University Hospital, Uppsala, Sweden: Biological
therapy of NET.
J. Yao, Gastrointestinal Medical Oncology, Houston, Texas:
Anti-VEGF and mTOR therapy.
L. Kvols, University of South Florida, Tampa: ENETS-NANETS:
What is it and where is it going?
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Chronic Lyme Disease Syndromes: New Avenues for Investigation
October 15-18
FUNDED BY
ARRANGED BY
BACKGROUND
Aetos Technologies, Inc., Centers for Disease Control and Prevention (CDC);
NIH-National Institute of Allergy and Infectious Diseases, National Institute of
Arthritis and Musculoskeletal and Skin Diseases, and National Instituteof
Neurological Diseases and Stroke; U.S. Food and Drug Administration
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
P. Coyle, SUNY Stony Brook, New York
J. Dunn, Brookhaven National Laboratory, Upton, New York
There have been significant advances in the treatment of acute Lyme disease, but many questions remain
about those patients who appear to be pathogen-free but continue to exhibit a variety of symptoms.
These have been ascribed to many different causes. This is a highly controversial subject and one of great
practical importance for individuals who are suffering from these symptoms-How should they be treat-
ed? Participants in this meeting discussed three questions: Does the causative agent of Lyme disease,
the spirochete Borrelia burgdorferi, persist in post-Lyme cases? Might there be other as yet unrecognized
coinfections transmitted by the same tick vector? Might spirochete infection trigger long persisting inflam-
matory symptoms?
Welcoming Remarks, Goals and Objectives: J.A. Witkowski,
Banbury Center, Cold Spring Harbor Laboratory; S.E. Schutzer,
UMDNJ-New Jersey Medical School, Newark
SESSION 1: Can B. burgdorferi Persist? Is There an Autoimmune
Component in Posttreatment Lyme Cases?
Chairpersons: P.J. Baker, National Institute of Allergy and Infectious
Diseases/NIH, Bethesda, Maryland; F.S. Kantor, Yale University, New
Haven, Connecticut
J.L. Benach, SUNY Stony Brook, New York: Discovery of B. burgdorferi
in ticks. Did we miss other organisms and why? P. Baker, S. Schutzer
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A.C. Steere, Harvard Medical School, Massachusetts General
Hospital, Boston: Discovery of Lyme disease in humans and
antibiotic-refractory Lyme arthritis: Persistent infection or
autoimmunity.
J.V. Ravetch, The Rockefeller University, New York:
SESSION 2: Postinfectious Responses
Chairpersons: C.B. Beard, Centers for Disease Control, Fort
New York
S.D. Vernon, Centers for Disease Control and Prevention,
CDC, Salida, Colorado: What the human genome can tell us
once the pathogen's gone: Lessons learned from chronic
fatigue syndrome.
E.S. Raveche, UMDNJ-New Jersey Medical School, Newark:
In vivo studies of Bb infection in autoimmune-prone B-cell
hyperactive NZB mouse strain.
J.L. Benach, SUNY Stony Brook, New York: Joint Babesia
and Borrelia infections in mice.
SESSION 3: Genomics Part 1
Chairperson: E. Fikrig, Yale University School of Medicine,
New Haven, Connecticut
Autoimmune approaches in Lyme disease.
S.W. Barthold, University of California, Davis: Persistent infec-
tion in animal models and collagen-spirochete interaction
and immune evasion.
Collins, Colorado; B.J. Luft, SUNY Stony Brook,
SESSION 4: Insights from Chronic Lyme Disease Therapy Trials
Chairperson: P. Coyle, SUNY Stony Brook, New York
M.S. Klempner, Boston University Medical Campus, Massa-
chusetts: Chronic symptoms following treatment of acute
Lyme disease.
P. Coyle, SUNY Stony Brook, New York: Stony Brook trial.
B. Fallon, College of Physicians & Surgeons, New York:
SESSION 5: Microbes in the Tick
Chairperson: J.L. Benach, SUNY Stony Brook, New York
D. Fish, Yale University, New Haven, Connecticut: Prevalence
and interactions among I. scapularis-borne pathogens.
SESSION 6: Genomics Part 2
Chairperson: E. Fikrig, Yale University School of Medicine,
New Haven, Connecticut
L.K. Bockenstedt, Yale University School of Medicine, New
Haven, Connecticut: Animal models for the study of B.
burgdorferi persistence: What do we know and what can we
learn?
T.H. Rider, Massachusetts Institute of Technology, Lexington:
Novel methods of detecting and inactivating pathogens.
R. Salazar, CytoViva, Aetos Technologies, Inc., Auburn,
Alabama: In situ identification and visualization spirochetal
structures as B. burgdorferi.
D.J. Ecker, Ibis Biosciences, Isis Pharmaceuticals, Carlsbad,
California: Universal biosensing for pathogen discovery.
Placebo ceftriaxone encephalopathy trial.
A.R. Marques, National Institute of Allergy and Infectious
Disease/NIH, Bethesda, Maryland: Framing questions from
the clinical sphere.
K. Clay, Indiana University, Bloomington: Microbial diversity
and interactions in ticks.
B.J. Luft, SUNY Stony Brook, New York: Immunologic and phy-
logenic analysis of OspC: Insights into depth of infection.
SESSION 7: Potential Nonmicrobial Action of Antibiotics
Chairperson: C.B. Beard, Centers for Disease Control, Fort Collins, Colorado
J.N. Adkins, Pacific Northwest National Laboratory, Richland,
Washington: AMT tag proteomics: Application to disease
pathogenesis and diagnosis.
J.D. Rothstein, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Neuroprotective and inflammatory
potential of antibiotics in neurological disease.
D.C. Martz, Rocky Mountain Chronic Disease Specialists,
Colorado Springs, Colorado: Motor neuron disease that is
antibiotic-responsive.
SESSION 8: Rephrasing Questions Amenable to Research
Chairpersons: R Coyle, SUNY Stony Brook, New York; S.E.
Schutzer, UMDNJ-New Jersey Medical School,
Newark
Outline of suggested blueprint for future research.
P.J. Baker, National Institute of Allergy and Infectious
Diseases/NIH, Bethesda, Maryland; M. Nunn, National
Institute of Neurological Disorders and Stroke/NIH,
Bethesda, Maryland: Upcoming federal funding opportunities
in the field.
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New Horizons in Internet Site Development
October 22-25
FUNDED BY The William and Flora Hewlett Foundation
ARRANGED BY D. Mick los and J. Connolly, Dolan DNA Learning Center, Cold Spring Harbor Laboratory
BACKGROUND
The Internet and the Web are revolutionizing the provision and delivery of information of all kinds, and
nowhere more dramatically than in education. However, the design and content presentation of edu-
cation Web sites are almost certainly not optimal for their function. This workshop brought together
workers in a variety of fields, including cognitive science, neuroscience, network theory, knowledge
management, learning theory, and technology convergence. They discussed, for example, how knowl-
edge of concept maps can be harnessed to develop Web sites that are more intuitive to use and
explore.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Insights from Neural and Molecular Science
Chairperson: M. Smith, William and Flora Hewlett Foundation, Menlo Park, California
Opening Remarks: D. Mick los, Dolan DNA Learning Center, Cold Spring Harbor Laboratory: Introducing G2C
Online.
J. Connolly, Dolan DNA Learning Center, Cold Spring Harbor
Laboratory: Bridging genes and behavior.
H.S. Kurtzman, National Institute of Mental Health/NIH, Bethesda,
Maryland: Some current trends in cognitive research.
T. Tully, Cold Spring Harbor Laboratory: Flies R Us revisited:
The case for molecular cognition.
SESSION 2: Cognitive Science and Network Theory
Chairperson: M. Smith, William and Flora Hewlett Foundation, Menlo Park, California
R.M. Shiffrin, Indiana University, Bloomington: Levels of analy-
sis in modeling cognition.
M. Buchanan, La Vignerie, Livarot, France: Evolutionary wis-
dom and anti-intelligent design.
P. McKercher, Knowledge Web, University of California, Santa
SESSION 3: Multimedia Learning and Education
Chairperson: E.F. Rover, Dana Foundation, New York
J.R. Jungck, BioQuest Curriculum Consortium, Beloit College,
Wisconsin: Creative commons: Connecting collaborators,
cooperating communities, crossing chasms, and celebrating
complexity.
J. Bobe, DNA Direct, Inc., San Francisco, California: Citizen
SESSION 4: Knowledge Management
Chairperson: E.F. Rover, Dana Foundation, New York
J. Novak, Institute for Human and Machine Cognition,
University of West Florida, Pensacola: Use of Cmap tools
and a new model for education to facilitate learning about
genes and cognition.
J. Beisty, SAP Knowledge Management, SAP America, Inc.,
Newtown Square, Pennsylvania: The business of knowledge
management.
SESSION 5: Emerging Technologies
Chairperson: K. Borner, Indiana University, Bloomington
W.A. Baer, Annenberg Center for Communication, University of
Southern California, Los Angeles: Internet evolution, techno-
logical opportunities, institutional constraints.
K. Howell, Federation of American Scientists, Washington,
D.C.: Designing games for learning.
H. Heimer, Schizophrenia Research Forum, Providence,
Rhode Island: Research forums: Scientist resources and
K. Borner, J. Connolly
Clara: The Knowledge Web as a dynamic knowledge reposi-
tory.
C. Diet lin, WGBH Interactive West, Greenfield, Massachusetts:
Building an Internet site for the classroom.
science and patient communities on the Web.
J. Kruper, Cardean Learning Group, Chicago, Illinois: What the
"participation culture" offers (science) education.
K. Borner, Indiana University, Bloomington: Mapping the struc-
ture and evolution of science locally and globally.
S. Buckingham, The Open University, Milton Keynes, United
Kingdom: Science portals as hubs for hypermedia dis-
course.
L. Petrides, Institute for the Study of Knowledge Management
in Education, Half Moon Bay, California: Education 2.0: A
knowledge management approach.
communities online.
L. Stark, University of Utah-Eccles Institute of Human
Genetics, Salt Lake City: Exploragraphic: Learning designed
for today's tech-savvy students.
Final Remarks: D. Mick los, Dolan DNA Learning Center,
Cold Spring Harbor Laboratory
C. Sosnowy. H. Bo
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Axonal Dynamics and Synaptic Junctions
October 29-31
FUNDED BY
ARRANGED BY
BACKGROUND
The ALS Association
E. Holzbaur, University of Pennsylvania, Philadelphia
D.W. Cleveland, University of California, San Diego
L. Bruijn, The ALS Association, Palm Harbor, Florida
There is growing interest in the role of axonal dynamics in neurodegenerative diseases including amy-
otrophic lateral sclerosis (ALS). The recent discovery of dynein/dynactin abnormalities linked to motor
neuron degeneration, changes in mitochondrial axonal trafficking in mutant SOD1 -expressing mice,
and studies showing neuromuscular junction abnormalities in ALS have focused more attention on this
area. This workshop reviewed the role of axonal and synaptic junction abnormalities in disease and the
potential of therapeutic interventions for ALS targeting these abnormalities.
Welcome and Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory; L.
Bruijn, The ALS Association, Palm Harbor, Florida
SESSION 1: Axonal Structure and Function
Chairperson: S. Burden, New York University Medical School
D.W. Cleveland, University of California, San Diego: Overview
of axonal dynamics: Motors, fast and slow axonal transport,
and their cargoes.
E. Holzbaur, University of Pennsylvania, Philadelphia:
Dynactin/dynein and ALS.
P.J. Hollenbeck, Purdue University, West Lafayette, Indiana:
The life of mitochondria in the axon.
G. Banker, Oregon Health and Science University, Portland:
Organelle trafficking in hippocampal neurons.
T.L. Schwarz, Children's Hospital, Boston, Massachusetts:
Axonal traffic in Drosophila.
C.C.J. Miller, University of London, United Kingdom: Axonal
transportand neurodegeneration.
SESSION 2: Development and Maintenance of Neural Connectivity
Chairperson: E. Holzbaur, University of Pennsylvania, Philadelphia
J. Lichtman, Harvard University, Cambridge, Massachusetts:
Developmental axonal reorganization: A connectomic
approach.
S. Burden, New York University Medical School: A MuSK-cen-
tric view of neuromuscular synapse formation.
E.S. Levitan, University of Pittsburgh, Pennsylvania: Synaptic
capture of transiting vesicles.
G. Morfini, University of Illinois at Chicago: Mutant SOD-1-
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L. Bruijn, G. Morfini
induced alterations in fast axonal transport.
S. Finkbeiner, University of California, San Francisco:
Molecular mechanisms of Huntington-induced neurodegen-
eration.
L.W. Enquist, Princeton University, New Jersey: Axon-mediat-
ed spread of alpha herpesvirus infections.
SESSION 3: Axonal Abnormalities in Neurodegenerative Diseases
Chairperson: D.W. Cleveland, University of California, San Diego
W. Mobley, Stanford University, California: Tracking signaling
endosomes in axons to decipher neurodegenerative disease
mechanisms.
SESSION 4: Model Systems
Chairperson: L. Bruijn, The ALS Association, Palm Harbor, Florida
M. Sendtner, Universitat Wuerzburg, Germany: Characterization
of axonal alteration in cell culture and mouse models of SMA.
P. Wong, Johns Hopkins University, Baltimore, Maryland:
Mechanism of mutant dynactin-induced motor neuron
degeneration.
B. Zheng, University of California, San Diego: Axon regenera-
tion in the CNS using mouse models of spinal cord injury.
J.D. Glass, Emory Center for Neurodegenerative Disease,
Atlanta, Georgia: Axonal degeneration in neurodegenerative
P. Caroni, Friedrich Miescher Institute for Biomedical Research,
Basal, Switzerland: Selective vulnerability of fast-fatiguable
motoneuron axons.
disease: A rational therapeutic target.
M. Coleman, The Babraham Institute, Cambridge, United
Kingdom: Common mechanisms of axon degeneration
revealed using the slow Wallerian degeneration (Wlds) mouse.
E.P. Pioro, The Cleveland Clinic, Ohio: Axonal degeneration
and protection of Wlds in wobbler motor neuron disease.
L. Reichardt, University of California, San Francisco: Roles of
cadherins and caenins at the synapse.
381
Integration of Hormonal and Genetic Regulation in Plant
Development
November 5-8
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M. Estelle, Indiana University, Bloomington
T. Schmulling, Free University of Berlin, Institute of Biology/Applied Genetics, Germany
W. Lukowitz, Cold Spring Harbor Laboratory
BACKGROUND
The role of plant hormones in growth development has traditionally been considered separately from
the genetic programs that regulate pattern and form. However, with recent advances in our under-
standing of meristem function, organogenesis, and other developmental processes, it is clear that hor-
monal and genetic regulations of development are highly integrated. Participants in this meeting dis-
cussed questions such as What are the different mechanisms of hormone signaling in plants? How do
different hormones act in a synergistic or antagonistic fashion? How do known key genetic players in
shoot and root development regulate plant hormones?
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Pathways and Paradigms
Chairperson: W. Lukowitz, Cold Spring Harbor Laboratory
M. Estelle, Indiana University, Bloomington: Function of the
TIR1/AFB auxin receptors in plant growth and development.
T. Schm011ing, Free University of Berlin, Institute of
Biology/Applied Genetics, Germany: Cytokinin receptor-
mediated developmental pathways.
J. Chory, HHMI/The Salk Institute, La Jolla, California: Using
knowledge gained from the Brassinosteroid signal transduc-
tion pathway to learn how plants grow.
J. Sheen, Massachusetts General Hospital, Boston: MAPK
cascades in hormonal signaling.
G. Juergens, Universitat TObingen, Germany: What role for
auxin in early embryogenesis?
S. Hake, U.S.D.A. Plant Gene Expression Center, Albany,
California: KN1 targets: From maize to Arabidopsis and back
again.
J. Reed, J. Malamy
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SESSION 2: New Players and Cross-talk
Chairperson: M. Estelle, Indiana University, Bloomington
J. Friml, ZMBP, Universitat Tubingen, Germany: A novel path-
way for a nongenomic action of plant hormone auxin.
S. Gilroy, Pennsylvania State University, University Park: C12+
and pH as integrators of plant growth and development.
Z. Yang, University of California, Riverside: ROP GTPases in
hormone signaling.
T. Kakimoto, Osaka University, Japan: Paptide mediators that
regulate epidermal cell patterning.
W. Lukowitz, Cold Spring Harbor Laboratory: A GATA factor
mediating axis and root formation in the early embryo.
J. Long, The Salk Institute for Biological Sciences, La Jolla,
California: A role for TOPLESS in embryonic polarity.
P. Mc Court, University of Toronto, Canada: Using chemical
genetics to map phenotype onto genotype.
SESSION 3: Root and Vascular Development
Chairperson: J. Chory, HHMI/The Salk Institute for Biological Studies, La Jolla, California
D. Weijers, Wageningen University, The Netherlands: Cell
specification and auxin signaling in early embryogenesis.
Y. Helariutta, University of Helsinki, Finland: Integration of hormon-
al and genetic regulation during plant vascular morphogenesis.
J. Malamy, University of Chicago, Illinois: Hormonal regulation
of lateral root formation.
M,J. Bennett, University of Nottingham, Loughborough, United
Kingdom: Dissecting the hormonal control of root growth in
Arabidopsis.
T. Berleth, University of Toronto, Ontario, Canada: Polar sig-
nals and gene regulation in vascular development.
J.M. Alonso, North Carolina State University, Raleigh: Ethylene
and auxin signaling and response pathways: A paradigm for
hormone interaction.
SESSION 4: Shoot Development I: Pathway Integration
Chairperson: T. Schmulling, Free University of Berlin, Institute of Biology/Applied Genetics, Germany
J. Kieber, University of North Carolina, Chapel Hill: Role of
cytokinin signaling in growth and development.
T. Werner, Free University of Berlin, Germany: Cytokinin catab-
olism regulates the activity of plant meristems.
J. Lohmann, Universitat Tubingen, Germany: Regulatory net-
works of meristem development.
D. Weiss, Hebrew University of Jerusalem, Rehovot, Israel:
Role of O- GIcNAc transferase in the interaction between gib-
berelin and cytokinin response.
J.W. Reed, University of North Carolina, Chapel Hill: Functions
of auxin response factors in vegetative and reproductive
development.
SESSION 5: Shoot Development II: Phyllotaxis and Modeling
Chairperson: S. Hake, U.S.D.A. Plant Gene Expression Center, Albany, California
D. Jackson, Cold Spring Harbor Laboratory: Integration of
hormonal signals and phyllotaxy.
C. Kuhlemier, University of Bern, Switzerland: Auxin and phyl-
lotaxis.
M. Heisler, California Institute of Technology, Pasadena: Local
and global control of auxin transport patterns in the shoot
apical meristem.
P. Mc Steen, Pennsylvania State University, University Park:
Genetic and hormonal regulation of axillary meristem initia-
tion during maize inflorescence development.
E. Mjolsness, University of California, Irvine: Integrative mathe-
matical modeling frameworks for plant development.
P. Prusinkiewicz, University of Calgary, Canada: Computational
models of auxin-flow-induced patterning in plants.
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Comparative Biology of Innate Immune Systems
November 27-30
FUNDED BY
ARRANGED BY
BACKGROUND
Cold Spring Harbor Corporate Sponsor Program
J. Dangl, University of North Carolina, Chapel Hill
D.A. Portnoy, University of California, Berkeley
B.J. Staskawicz, University of California, Berkeley
Immunity refers to the ability of an organism to resist attack by pathogens. We usually think of immu-
nity as acquired immunity, the response mediated by the vertebrate immune system. However, organ-
isms without immune systems can mount defenses against pathogens through innate immune sys-
tems, which, after much neglect, are also the subject of intensive research in human beings. This meet-
ing was notable for bringing together scientists working on innate immunity in plants and animals, to
discuss the mechanisms of innate immunity.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Plant Intracellular Receptors
Chairperson: B.J. Staskawicz, University of California, Berkeley
J. Dangl, University of North Carolina, Chapel Hill: Indirect
recognition of pathogen virulence factors by plant NB-LRR
disease resistance proteins.
P. Schulze-Lefert, Max-Planck Institute for Plant Breeding
Research, Koln, Germany: Molecular links between PAMP-
SESSION 2: Mammalian Bacterial Pathogenesis
Chairperson: B.J. Staskawicz, University of California, Berkeley
D.A. Portnoy, University of California, Berkeley: The mam-
malian innate immune system: A bacterial perspective.
R.R. Isberg, Tufts University School of Medicine, Boston,
Massachusetts: Manipulation of host cell death and survival
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and NB-LRR-triggered immune responses.
J. Ellis, CSIRO, Canberra, Australia: Direct receptor-ligand
interaction is the basis of gene-for-gene specificity in the
flax-flax rust resistance avirulence gene interaction.
pathways by LegioneHa pneumophila.
S.I. Miller, University of Washington, Seattle: Salmonella inter-
actions with the innate immune system.
SESSION 3: Signaling Systems in Plant Innate Immunity
Chairperson: J. Dangl, University of North Carolina, Chapel Hill
B.J. Staskawicz, University of California, Berkeley: Host-microbe
interactions shaping the evolution of plant innate immunity.
G.B. Martin, Cornell University, Ithaca, New York: Roles of
Pseudomonas type III effectors AvrPto and AvrPtoB in plant
SESSION 4: TLRs and Host Response
Chairperson: J. Dangl, University of North Carolina, Chapel Hill
K. Fitzgerald, University of Massachusetts Medical School,
Worcester: Regulation and counter-regulation of type I inter-
feron responses.
L. O'Neill, Trinity College, Dublin, Ireland: Toll-like receptor sig-
SESSION 5: Bacterial Type-three Secretion Systems
Chairperson: D.A. Portnoy, University of California, Berkeley
J. Galan, Yale University School of Medicine, New Haven,
Connecticut: The type III secretion system of S. enterica:
Decoding its function.
J.E. Dixon, University of California, San Diego School of
Medicine, La Jolla: Novel type III pathogenic effectors.
M.B. Mudgett, Stanford University, California: The
Xanthomonas XopD protease: A generalist or specialist?
U. Bonas, Martin-Luther University, Halle, Germany: Control of
disease susceptibility.
J. Rathjen, John Innes Centre, Colony Norwich, United
Kingdom: Specific recognition of AvrPto and AvrPtoB by the
Pto/Prf complex in tomato.
nal transduction.
D. Golenbock, University of Massachusetts Medical School,
Worcester: Anatomy of Toll 9 and its relationship to disease.
Xanthomonas type-III secretion and dual activity of the effec-
tor AvrBs3 in the plant.
S. Yang He, Michigan State University, East Lansing:
Suppression of host innate immune responses by the bacte-
rial pathogen P syringae.
J.T. Greenberg, University of Chicago, Illinois: P syringae type-
III effectors: Their functions in host-range determination and
the disease process.
SESSION 6: Intracellular Receptors II
Chairperson: J. Galan, Yale University School of Medicine, New Haven, Connecticut
G. Nunez, University of Michigan Medical School, Ann Arbor:
Function of NLRs in innate immunity.
J. Ting, University of North Carolina, Chapel Hill: CATER-
PILLARs R us: Immune defense genes conserved from
plants to mammals.
F.L.W. Takken, University of Amsterdam, The Netherlands: The
NB-ARC domain: An NTP-hydrolyzing molecular switch.
SESSION 7: Signaling Systems in Plant and Animal Innate
Immunity
Chairperson: J.D.G. Jones, John Innes Centre, Norwich,
United Kingdom
S. Robatzek, Max-Planck Institute for Plant Breeding Research,
Cologne, Germany: Ligand-induced internalization of pattern-
recognition receptors in Arabidopsis innate immunity.
F.M. Ausubel, Massachusetts General Hospital, Boston: The
C. elegans innate immune response.
J. Sheen, Massachusetts General Hospital, Boston: Intracellular
signaling in plant innate immunity.
RW. Michelmore, University of California, Davis: Comparative
analysis of plant-Pseudomonas interactions.
S. Somerville, Carnegie Institution, Stanford, California: The
plant cell wall, the first line of defense.
N. Silverman, University of Massachusetts, Worcester:
Intracellular recognition of pathogens in Drosophila.
R. Innes, Indiana University, Bloomington: Molecular mecha-
nisms underlying the activation of plant NB-LRR proteins.
S. Dinesh-Kumar, Yale University, New Haven, Connecticut: Role
of TIR domain in recognition of pathogen-derived elicitors.
J.D.G. Jones, John Innes Centre, Norwich, United Kingdom:
Novel approaches to understanding coevolution between
plants and filamentous pathogens.
J. Jones, J. Ellis, G. Martin
385
Redox Regulation of Signal Transduction
December 3-6
FUNDED BY
ARRANGED BY
BACKGROUND
Cold Spring Harbor Laboratory Corporate Sponsor Program
T. Finkel, National Heart, Lung, and Blood Institute/NIH, Bethesda, Maryland
S.G. Rhee, National Heart, Lung, and Blood Institute/NH, Bethesda, Maryland
N.K. Tonks, Cold Spring Harbor Laboratory
Cellular production of reactive oxygen species (ROS) has been associated with a number of disease
states as well as the rate of organismal aging. For many years, it was assumed that oxidants functioned
within cells in a random and solely destructive manner. In the last decade, evidence has accumulated
that ROS can also function within the cell as part of normal signal transduction pathways. This meet-
ing reviewed findings on the specific intracellular targets of oxidants, the range of redox-dependent
pathways observed, and the physiological and pathophysiological process specifically regulated by
ROS.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Sensing ROS Levels
Chairpersons: T. Finkel, National Heart, Lung, and Blood Institute/NIH, Bethesda, Maryland; M. Murphy,
University of Cambridge, United Kingdom
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C. Chang, University of California, Berkeley: New chemical
approaches to study peroxide biology.
L.B. Poole, Wake Forest University, Winston-Salem, North
Carolina: Cysteine sulfonic acids in catalysis and regulation.
VN. Gladyshev, University of Nebraska, Lincoln: Thiols,
selenols, and redox signaling networks.
R. Sitia, Universita Vita-Salute San Raffaele, Milan, Italy: Redox
regulation in the endoplasmic reticulum.
J.D. Heimann, Cornell University, Ithaca, New York:
Mechanisms of peroxide sensing in bacteria.
M.B. Toledano, LSOC, CEA-Saclay, Gif-sur-Yvette, France:
H202 sensing and signaling by thiol-based peroxidases.
SESSION 2: ROS Generating/Regulating Systems
Chairpersons: N.K. Tonks, Cold Spring Harbor Laboratory; C.F. Nathan, Weill Medical College of CornellUniversity, New York
A. Holmgren, Karolinska Institute, Stockholm, Sweden:
Thioredoxin and glutaredoxin systems in redox signaling.
P.T. Schumacker, Northwestern University, Chicago, Illinois:
Mitochondrial oxidant generation in response to hypoxia:
Compartmental specificity.
M. Murphy, University of Cambridge, United Kingdom: Role of
SESSION 3: pTyr Signaling
Chairperson: L.B. Poole, Wake Forest University, Winston-Salem,
N.K. Tonks, Cold Spring Harbor Laboratory: Regulation of pro-
tein tyrosine phosphatase function by reversible oxidation.
A. Ostman, Karolinska Institute, Stockholm Sweden:
Regulation of PTPs by hypoxia and ROS.
T. -C. Meng, Institute of Biological Chemistry, Taipei, Taiwan:
Redox regulation of protein tyrosine phosphatases by reac-
tive nitrogen species: From molecular identification to signal-
ing implication.
mitochondria in redox signaling.
U.G. Knaus, Scripps Research Institute, La Jolla, California:
Regulation and function of epithelial NADPH oxidases.
M.R. Williams, University of Maryland School of Medicine,
Baltimore: Expression and function of NADPH oxidases in T
lymphocytes.
North Carolina
P. Downes, University of Dundee, United Kingdom: Redox reg-
ulation of PTEN tumor suppressor amplifies growth-factor-
dependent PI3-kinase signaling.
P. Chiarugi, University of Florence, Italy: Hydrogen peroxide: A
key messenger for ligand-independent rtk activation.
A. Toker, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Protein kinase D signaling in oxidative stress
responses.
SESSION 4: Signaling and Disease
Chairpersons: P.T. Schumacker, Northwestern University, Chicago, Illinois; U.G. Knaus, Scripps Research
Institute, La Jolla, California
G. Gilliland, HHMI/Harvard Medical School, Boston,
Massachusetts: FoxO mediates resistance of hematopoietic
stems cells to physiologic oxidative stress.
E.V. Avvedimento, University of Naples Federico II, Ancona,
Italy: PDGF, ROS, and Ras signals in systemic sclerosis.
K. Griendling, Emory University, Atlanta, Georgia: Regulation of
VSMC migratory signals by reactive oxygen species.
J.F. Engelhardt, University of Iowa, Iowa City: Nox-dependent
signaling by redox-active endosomes.
C. Taylor, University College Dublin, Ireland: Hypoxia, gene
expression, and disease.
C.F. Nathan, Weill Medical College of Cornell University, New
York: Reactive oxygen and nitrogen intermediates signal and
kill specifically.
SESSION 5: Aging and Metabolism
Chairpersons: P. Downes, University of Dundee, United Kingdom; K. Griendling, Emory University, Atlanta,
Georgia
T. Finkel, National Heart, Lung, and Blood Institute/NIH,
Bethesda, Maryland: Longevity genes as regulators of mito-
chondrial metabolism.
BM.T. Burgering, University of Medical Center, Utrecht, The
Netherlands: FoxO transcription factor regulation by oxida-
tive stress: Insights into life span and disease.
M. Giorgio, European Institute of Oncology, Milan, Italy:
Regulation of adipogenesis by p66Shc-generated oxidative
signal.
P. Hwang, National Heart, Lung, and Blood Institute/NIH,
Bethesda, Maryland: p53 as a regulator of aerobic respira-
tion.
F. Mechta-Grigoriou, Institute Curie, Paris, France: AP-1,
oxidative stress, and aging.
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What does it mean to be human? The philosopher, theologian, sociologist, historian, scientist, and every
man or woman on the street have different answers to this question. So, too, does the genome biolo-
gist who determines and compares the complete genetic endowments of living entities.
The human genome is composed of 25 kinds of chromosomes-22 autosomes, the sex chromo-
somes X and Y, and the mitochondrial chromosome. Each chromosome is a package for a single, long,
and unbroken strand of the molecule deoxyribonucleic acid (DNA). The exact sequence of A, T, C, and
G nucleotides compose the DNA molecule running through each chromosome is unique to each
person. Arrayed along the chromosomes are approximately 30,000 genes-stretches of DNA ranging
from several hundred to several million nucleotides-that carry the "genetic code" for making the pro-
tein components of living cells. This code determines physiological and psychological "traits" that we
inherit from our parents, thus setting the parameters of human life, health, and happiness.
The human genome weighs in at about 3 billion nucleotides, and the genomes of any two people
are 99.9% identical. Expressed another way, DNA from two people will on average differ by about one
nucleotide per 1000. This does not seem like much, but taken over the entire genome, it comes
to 3
million differences. The same sort of reasoning applies to our closest living relative,
the chimpanzee,
whose genome is 99% similar to ours. This leaves room for about 30 million DNA
differences between
humans and chimps.
These differences are caused by mutations that
accumulate in DNA over time, so the number of
mutations is roughly proportional to the amount of time since two groups
have diverged from a com-
mon ancestor. The majority of these DNA differences between
humans and chimps are of little or no
consequence. This is because only about 1.5% of the human DNA sequence
actually carries the code
for making proteins. Thus, by chance, most mutations are likely
to occur outside of protein-coding
regions. Even protein-coding regions can tolerate a good deal of mutation,
for two reasons. First, the
genetic code is redundant, such that a number of different nucleotide
sequences can specify the iden-
tical protein. Second, some physical changes in a protein do
not actually alter how it functions.
These gross comparisons can only tell so much. Better to compare
individual genes. As one might
expect, a number of genes have evolved (changed) rapidly
since humans and chimps diverged from a
common ancestor about 6 million years ago, including those
involved in immunity, reproduction, smell,
taste, skin, and hair. Especially intriguing are
changes in a gene called FOXP2, which may have had a
role in language development.
Even so, gene-to-gene comparisons confirm that the
vast majority of human and chimp genes are
functionally identical. This "conservation of function" extends
throughout the evolutionary tree. Beyond
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computer comparisons of gene and protein sequence, functional equivalence is convincingly shown by
gene-transfer experiments, most commonly when a human gene is inserted into a living mouse to
replace its mouse counterpart. In most cases, the human replacement gene functions admirably. This
has led researchers to introduce human disease genes to create mouse models that mimic human dis-
orders such as Alzheimer's disease, Huntington's disease, Parkinson's disease, and breast cancer.
There are even examples of human genes functioning perfectly well in yeast, the simplest form of
advanced cell.
The recent sequencing of the sea urchin genome traced elements of our genealogy even further
back in evolutionary time. Surprisingly, the urchin has the most well-developed immune system yet
encountered in an animal without a backbone. The urchin shares with us prototypes of genes for key
growth factors and receptors that participate in immune and blood system development, including
tumor necrosis factor, interleukins, and vascular endothelial growth factor. Going back further still, we
share a basic set of genes-including those needed to extract energy from food-with the ancient
archaebacteria that inhabit hot springs and deep-ocean vents. These gene comparisons illustrate that
evolution has preserved gene "tool sets" that successfully carry out life processes-layering on new
gene sets as organisms gained complexity.
Organism Genes
Genome Size
(Nucleotides)
Year
Sequenced
Archaebacterium (Methanococcus maripaludis) 1,880 1.7 million 2007
Bacterium (Escherichia coli) 4,400 4.6 million 1997
Baker's Yeast (Saccaromyces cerevisiea) 6,190 12.1 million 1997
Fruit Fly (Drosophila melanogaster) -14,800 180 million 2000
Roundworm (Caenorhabditis elegans) -21,000 100 million 1998
Sea Urchin (Strongylocentrotus purpuratus) -23,300 814 million 2006
House Mouse (Mus muscu/us) -30,000 2.5 billion 2002
Human (Homo sapiens) -30,000 3.2 billion
As shown in the table, adding genes can add only so much complexity to an organism. Bacteria,
single-celled organisms without an organized nucleus, get by with several thousand genes. Yeasts gain
an organized nucleus with only about twice as many genes. The fruit fly gains a complicated body plan
and external skeleton with only about twice as many genes. Mammals gain an internal skeleton and
temperature regulation with only about twice the number of genes as a fruit fly. Here, the gene number
levels off, with essentially no difference in gene number between a mouse and a human.
Clearly, humans share many genes with other organisms-especially other mammals. If this is so,
how can we achieve "humanness" with essentially the same gene set as a mouse or a chimp? Much
of the answer lies in "noncoding" DNA sequences that do not carry the genetic code for making pro-
teins. Much of the noncoding DNA lies in between genes, separating them from one another on the
chromosomes. This "intergenic" DNA contains key regulatory sequences-promoters and enhancers-
that turn genes on and off in specific tissues and at specific times during development from embryo to
adult. Altering the timing and interaction of thousands of genes can produce markedly different mor-
392
411111.-
Model organisms (left to right) E. coli, C. elegans, Drosophila, mouse, human cell, and Arabidopsis.
phological features. For example, the same set of regulatory genes defines the basic body plans of all
animals with twofold (bilateral) symmetry. These "master" genes function in organisms as diverse as fruit
fly to human, controlling the proper placement of body parts, from wings and antenna to arms and ears.
In the mid-1970s, Rich Roberts, at Cold Spring Harbor Laboratory (CSHL), and Phil Sharp, at the
Massachusetts Institute of Technology, discovered that genes themselves are interrupted by noncod-
ing sequences. They shared the Nobel Prize for showing that noncoding sequences-termed
"introns"-separate the genes of higher organisms into modular coding "exons." The average human
gene contains seven exons that can be joined together in different combinations to specify several dif-
ferent proteins. This "differential splicing" further increases the functional complexity of the genome.
Transposons, the so-called jumping genes discovered by CSHL Nobel laureate Barbara McClintock,
are the largest component of noncoding DNA, equal to about half the total mass of the human genome!
It could be worse, transposons account for an estimated 85% of the corn (maize) genome. Biologists
are split about whether jumping genes serve some purpose in genome evolution or are just extremely
effective genetic hitchhikers. Grand scheme or not, the most common human transposon, termed Alu,
provides a sequence that is used in about 5% of differentially spliced exons.
Introns and transposons account for most of the disparity between genome size and gene number as
organisms increase in complexity. Thus, although the fruit fly genome is about 100 times as large as the
archaebacterial genome, it contains only about eight times as many genes. About twice as many human
genes occupy about 18 times as much space as the fruit fly genome. Comparing extremes, human genes
occupy about 100 times the genome space of an equivalent number of archaebacterial genes! Thus,
from a genomicist's point of view, being human is a large endowment of genes shared with many organ-
isms through evolutionary time, retasked by regulatory elements, and reshuffled through differential splic-
ing. Gene sets for a basic bilateral body plan and mammalian way of life are further modified by a rela-
tively small set of genes peculiar to our kind. Inherited gene variations are further shuffled during the gen-
eration of parental sperm and egg. This shared heritage, attenuated by a unique set of mutations, comes
together at the moment of conception to produce a unique individual-one with a brain that is capable
of pondering why so much of his or her genome is given over to jumping genes.
Dynamic Gene
The more than 130 billion nucleotides of DNA sequence residing in Genbank and other databases now
challenge biology students to come to grips with the complex genomes of higher organisms. The
geneticist J.B.S. Haldane once famously said that the universe is not only stranger than we imagine,
but may be stranger than we can imagine. He might as well have been talking about the human
genome, chock full of noncoding introns and transposons, as well as a new class of
RNA genes, that
interact in unexpected and still largely unknown ways to regulate gene expression.
Thus, in 2006, we
continued our work with CSHL researchers to develop interfaces to DNA databases, which open a
win-
dow on the strange and wonderful world of genome science.
The Dynamic Gene Internet site (www.dynamicgene.org) is the educational outreach component
of
Gramene, an online resource for analyzing and comparing genes from plants
in the Gramineae, or
grass, family. This group includes the cereal grains that feed most
of the world's people-rice, wheat,
corn, barley, sorghum, millet, oats, and rye. The site is being
developed in collaboration with CSHL
genomicists Doreen Ware and Lincoln Stein, as well as
three faculty producers: Debra Burhans
(Canisius College, Buffalo, New York), Charlie Gutierrez (John H.
Reagan High School, Austin, Texas),
and Bob Wheeler (Pine Creek High School, Colorado Springs, Colorado).
The site is designed to let students learn about plant genomes
by using bioinformatics to analyze
genes in the newly sequenced rice and maize genomes.
Many of these genes have only been predict-
ed by computers and have never been closely examined
by human beings! The site's name empha-
sizes the gene both as a dynamic structure that changes
through evolutionary time and as a dynamic
concept that changes with our increasing knowledge of genome
organization. The design for Dynamic
Gene recalls the "streamlining movement" that influenced
design during the middle of the 20th century
with ideas borrowed from aviation and automobile design. 393
Animated tutorials in the first three sections-Meaning, Structure, and Evidence-illustrate (1) how
DNA sequences encode biological information, (2) how bioinformatics uncovers sequence patterns that
predict the structural components of genes, and (3) how computer-generated gene "models" are anno-
tated with gene features and evidence from biological experiments. The Annotation section provides
step-by-step instructions on how to analyze a gene model with Apollo, research software that was used
to annotate the Drosophila genome. Once students understand the basics of gene annotation, they go
to the Projects section to download large DNA sequences from cereal chromosomes. They then pit
their logic against the computer that predicted the gene models encountered and upload their new
annotations to share with other researchers.
Bringing Nobel-winning Science to Students
With complete genome sequences accumulating at an accelerating rate, ahead lies the massive task
of determining the physiological function of thousands of newly identified genes for which little is known
beyond their sequences. The 2006 Nobel Prize in Physiology or Medicine recognized the discovery
RNA interference (RNAi), a basic mechanism of gene regulation that also provides an important new
tool for functional genome analysis. American scientists Andrew Fire and Craig Mello shared the Prize
for showing that short, double-stranded RNA (dsRNA) molecules can down-regulate gene expression
of a corresponding target gene. By deliberately introducing defined sequences of dsRNA into living
organisms, biologists can observe the physiological consequences of "silencing" virtually any gene in
Caenorhabditis elegans, as well as other plants and animals. MicroRNAs, which use part of the RNAi
mechanism, have emerged as a powerful force in large-scale gene regulation and genome organiza-
tion. CSHL researchers Greg Hannon, Leemor Joshua-Tor, and Scott Lowe have pioneered work on
the mechanism of RNAi and its adaptation as a tool for genome exploration.
Despite its power, RNAi is amazingly simple to perform in the roundworm C. elegans, an important
model system for eukaryotic gene function. Any gene of choice can be "silenced" merely by feeding
worms bacteria that express the correct dsRNA. In its simplest form, RNAi requires little more than the
ability to grow bacteria and observe C. elegans traits with a dissecting microscope. The vast majority
of high schools and colleges meet these requirements, making RNAi in C. elegans potentially more
accessible than other molecular techniques for which specialized equipment is required, such as poly-
merase chain reaction (PCR) and gel electrophoresis. For these reasons, we have devoted consider-
able effort to developing the RNAVC. elegans system as the vehicle to deliver functional genome analy-
sis into high school and college classes.
Considering the banner year for RNAi in Stockholm, our timing could not have been better as we
completed our National Science Foundation project to develop an integrated experiment- and bioinfor-
matics-based curriculum on RNAi in C. elegans. The curriculum begins with observation of mutant phe-
notypes and basic worm "husbandry," and then progresses to simple methods to induce RNAi and to
use RNAi to rescue (compensate) a mutant phenotype. A more advanced experiment uses "single-
worm PCR" to examine the mechanism of RNAi- comparing the DNA of worms with identical pheno-
types induced by either RNAi or a gene mutation. The curriculum culminates with open-ended meth-
ods that support student projects. Students can perform RNAi "from scratch" using bioinformatics to
develop PCR primers for a target gene, then cloning the amplified product into an RNAi feeding vector,
and finally observing the phenotype of treated worms. Students also have free access to the DNALC's
collection of RNAi feeding strains, which can be used to conduct a miniscreen to identify genes involved
in a particular biological pathway.
An online lab notebook, Silencing Genomes (www.silencinggenomes.org), combines lab methods
with user-friendly features adapted from the DNALC's popular text DNA Science, including flow charts,
reagent recipes, and extensive instructor information. Supporting resources include photos and video
of C. elegans mutants, as well as a simple checkout system to obtain any of 80 C. elegans mutants
and Escherichia coli feeding strains. The Internet site also provides a launch pad for bioinformatics exer-
cises that accompany each experiment. Students use online databases-including Worm Base and
Pubmed-to explore the molecular genetics and physiological functions of the genes targeted by RNAi.
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NCBI's BLAST and the DNALC Sequence Server are used to explore the evolutionary relatedness of
genes in worms and humans.
The experiments were initially tested during a spring workshop of our Advisory Panel of 12 lead high
school and college faculty from around the United States. Building on their feedback, the curriculum was
then field-tested at summer workshops in Oklahoma City, San Francisco, and New York City, which were
attended by 53 high school teachers, 6 junior college faculty, and 9 four-year college faculty. In addition,
the RNAi curriculum was a major focus of the Amgen Leadership Symposium and workshops conduct-
ed for the Singapore Ministry of Education and the Novartis Exploratory Clinical Development Group.
To get a quick picture of early classroom implementation, in December, we administered an online sur-
vey for faculty who participated in testing summer workshops. The majority (71%) of respondents had
already begun to integrate workshop content into their teaching, by using RNAi (51%) or C. elegans (41%)
as examples while teaching about other topics or by teaching entire units of RNAi (37%) or C. elegans
(16%). This teaching impacted 1781 students and 58 other teachers. More than a quarter (27%) had done
one or more labs-basic C. elegans manipulation and mutant analysis (25% each), RNAi by feeding (16%),
analyzing mutants by PCR (12%), and generating a targeting vector (4%). This lab instruction impacted
329 students and 17 teachers. The same proportion (27%) had used bioinformatics to analyze C. elegans
genes or to compare worm to human genes, impacting 410 students and 19 teachers.
Real-time Microscopy Exhibit
The DNALC's museum exhibits are tightly tied to experiments that students
conduct in the teaching
labs. For several years, an Applied Biosystems 307 DNA sequencer
did double duty as exhibit as it
sequenced mitochondrial DNA samples isolated by students
in the teaching labs and submitted from
schools around the United States. As our volume increased to more than
5000 student sequences per
year, we shifted this work to a faster capillary machine at the CSHL
Genome Center. In 2006, this space
was taken over by a new Nikon Eclipse 80i microscope,
with fluorescence and differential interference
contrast (DIC) optics. A high-resolution digital camera output
to a 46-inch LCD display allows us to dis-
play striking, live images taken from the microscope.
Real-time exhibits prepared each day give students a
glimpse of the world as seen through this
research-grade microscope. As a default, live mounts of C. elegans mutants,
including the bizarre "bag
of worms," coordinate with an adjacent exhibit on key model systems used
in biological research. At
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Educator Lauren Weidler focuses in on C. elegans with
the Nikon fluorescence microscope and flat-panel display
newly installed in the exhibit space.
other times, mounts complement a variety of labs
conducted by 5th to 12th grade students. Cells
scraped from an instructor's cheek, or stained chro-
mosomes spreads, show the source of student DNA
for human PCR. Live E coli or C. elegans expressing
green fluorescent protein (GFP) vividly illustrate the
results of student's own efforts to genetically engi-
neer bacteria with the GFP gene. Mounts of plant
and animal cells, as well as C. elegans mutants, rein-
force student observations of differences in cell struc-
ture and variations in phenotype.
DNA Sequencing Service
The DNA Sequencing Service continued to offer students nationwide the opportunity to look at their
own DNA sequence and to use it as the basis for understanding human diversity. Every human cell has
a "second" genome, found in the cell's energy-generating organelle, the mitochondrion. Mutations are
common in part of the mitochondrial chromosome, largely due to exposure to oxygen-free radicals gen-
erated as a by-product of energy production. Because of this mutational variability, the noncoding
region of the mitochondrial chromosome is a mainstay in studies of human variation and evolution.
The DNALC popularized methods to use mitochondrial mutation analysis in education, focusing on
the same region of DNA featured in the National Geographic's Genographic Project and the popular
book The Seven Daughters of Eve. Using DNALC protocols or ready-to-use kits, students isolate a 440
-
nucleotide sequence of their mitochondrial genome, and then send their samples by overnight mail to
the DNALC. At the DNALC, college interns Alina Duvall (Hofstra University) and Jennifer Aiello (Long
Island University) perform dye terminator reactions that label student samples for DNA sequencing. The
reactions are then sent to the CSHL Sequencing Shared Resource Facility in Woodbury, where they are
sequenced on an Applied Biosystems 3730x1 Genetic Analyzer. The finished sequences are uploaded
to a student DNA database at the DNALC's BioServers Internet site (www.bioservers.org).
Using bioinformatics tools at the Internet site, students can compare their own mitochondrial DNA
with their classmates' to see that people have inherited unique patterns of mutations. In comparing
mitochondrial DNA samples from world populations, students can understand the evidence for the
human lineage developing in Africa and recently migrating "out of Africa" to populate the rest of the
world. Students can also compare ancient DNA samples from Neandertals and Otzi "the ice man" to
understand their relationships to modern humans.
In 2006, we sequenced 6400 students' DNA samples submitted from 31 states, Washington, D.C.,
and Canada. On average, results were posted on the Internet site within 12 days of receipt. This unique
educational system-DNA sequencing, student DNA database, and Internet bioinformatics tools-is
provided free of charge to high school and college classes. This is made possible by the donation of
sequencing reagents by Applied Biosystems of Foster City, California.
Genes to Cognition Online
We continued with key formative work on the new Internet site, Genes to Cognition (G2C) Online, which
will explore the molecular basis of human thinking and disorders of thinking. During the first part of the
year, we worked closely with advisory panelist and education pioneer, Joe Novak, to develop methods
to obtain detailed concept maps in three knowledge domains: cognitive disorders, approaches to sci-
ence, and systems-level biology. These concept maps form the backbone of the G2C Online "knowl-
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edge network," which guides content development and defines how different content items are related
to one another. Thirteen experts from neuroscience and education were interviewed:
Eric Kandel (Nobel laureate, Columbia University): Basic memory mechanisms.
Steve Hyman (Harvard University Provost and Harvard University Medical School Professor of
Neurobiology): Reward- and fear-based learning.
Marilyn Albert (Johns Hopkins University): Alzheimer's disease.
Ray De Paulo and Kay Redfield Jamison (Johns Hopkins University): Bipolar disorder.
Adam Kap lin (Johns Hopkins University): Depression.
Alysa Doyle (Harvard University): Attention deficit and hyperactivity disorder.
Daniel Weinberger (National Institutes of Health): Schizophrenia.
Seth Grant (Wellcome Trust Sanger Institute): Genomic neuroscience.
Joy Hirsch (Columbia University): Neuroimaging.
Mary Colvard, Laura Maitland, and Caren Gough (Faculty Fellows): Biology and psychology education.
In conjunction with concept mapping, we developed an Internet-accessible editing system to meta-tag
G2C content. The system uses key words, scales, and classifications to define an item's position in the
knowledge network. A Yahoo! term extractor automatically identifies suggested keywords from any
inputted text field. The item's relevance is then rated according to 20 conceptual domains within biologi-
cal systems, cognitive disorders, and approaches to science. The system also collects a number of basic
data fields that we have developed as a collaborator in BiosciEdNet, a National Digital Science Library
(NSDL) project headed by the American Association for the Advancement of Science. The NSDL meta-
data scheme aligns with the other major projects and includes technical specifications, media type, edu-
cational uses and context, end-user roles, knowledge taxons, creator information, life cycle, and rights.
We chose autism as the topic for which to develop prototype content and interactive student activi-
ties. Of note is an emotion-recognition game that highlights the difficulty many autistic people have in
"reading" facial expressions. This engaging activity is framed within the context of current research on the
neural and genetic basis of the disorder, including interviews with Trevor Robbins (Cambridge University),
Ron McKay (University of Edinburgh), and Dan Geschwind (University of California, Los Angeles). We also
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capitalized on the project's February Advisory Panel meeting at the Wellcome Trust Sanger Institute,
videotaping interviews and lab demonstrations with collaborators on the G2C research team.
In June, we conducted the first evaluation of the prototype site. High school biology and social sci-
ence students reviewed two entirely different G2C Online designs and navigation systems. We were
especially interested in their understanding of the purpose of the site and how to move from topic to
topic. The student reactions and misperceptions prompted important changes that should improve how
they interact with the site and integrate the "big" ideas we hope to get across. This study is the first of
a number of keystone evaluations that will guide the development of G2C Online and, ultimately,
demonstrate its usefulness in modern biology and psychology education.
The project also gained insight from a high-level workshop, New Horizons in Internet Site
Development, held October 22-25 at the CSHL Banbury Center. Cochaired by Ed Rover, President of
the Dana Foundation, and Marshall Smith, Director of Education at the Hewlett Foundation, the 2.5-day
meeting drew together 30 experts and opinion leaders from diverse fields, including cognitive science,
neuroscience, network theory, knowledge management, learning theory, and technology convergence.
A common theme throughout the meeting was the growing ability of the Internet to connect people in
real-time in "communities" of common interest. Among the presenters were Tim Tully (CSHL), Walter
Baer (Annenberg Center for Communication), John Jungck (Beloit College), John Kruper (Cardean
Learning Group), John Beisty (SAP America), and Katy Borner (Indiana University). A working paper on
sights gained from the meeting was developed with the Center for Children and Technology (CCT), with
whom we are collaborating to evaluate site development.
New Horizons in Internet Site Development presenters Simon Buckingham (Open University) and John Kruper
(Cardean Learning Group) network during session break. Conference organizer John Connolly and Katy Bbrner
(Indiana University) discuss her talk on mapping science.
Record Number of Real and Virtual Visitors in 2006
Annual visitation topped 40,000 in 2006. This included 29,657 students who conducted experiments with
DNALC staff (on field trips to the DNALC or at their own schools) and 824 summer campers who spent a
week at the DNALC-both record highs. The DNALC has been the beneficiary of a growing demand for
science enrichment, precipitated by new teaching standards and the specter of the impending national
science achievement test for 6th graders in 2007. More than 60 school systems participated in middle
school programs, and younger students comprised a majority of our clientele for academic year field trips
and summer workshops. A typical middle school field trip includes a mix of hands-on labs (such as DNA
extraction or bacterial transformation), guided tour of The Genes We Share exhibit, and virtual labs (such
as The Mystery of Anastasia and Otzi: The Iceman Cometh). As basic genetics and biotechnology labs
have moved increasingly to the middle schools, we have encouraged high school faculty to upgrade their
instruction. Thus, more than half of high school field trips allowed students to look at their own DNA and
to understand how DNA differences (polymorphisms) are used to understand human evolution.
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Middle-school students participate in a World of Enzymes summer camp.
A grant from the Porter Foundation allowed us to provide field trip scholarships for 1378 middle
school students and 569 high school students from underserved schools from Long Island, Queens,
Brooklyn, and Manhattan. This included 222 students from the Gateway Institute for Pre-College
Education, which provides intensive enrichment to prepare high school students for success in college.
The grant also supported 30 disadvantaged students who attended a five-day workshop on
forensic
biology conducted in cooperation with John Jay College of Criminal Justice, and
four students who
attended DNA camps at the DNALC.
Saturday DNA! Programs offered 375 parents and children fun opportunities
to learn about the lat-
est developments in the biological sciences. The DNALC's education
and scientific divisions presented
lively two-hour programs, such as "When Dinosaurs Roamed the
Earth," "Jellyfish Genes," and
"Mapping Your Way Through DNA." Sessions included hands-on DNA
experiments, computer bioin-
formatics, and microscopic observation.
The DNALC's reach was effectively doubled by the activities
of four institutions that license our
teaching and Internet technology. The DNA Learning Lab at the
Singapore Science Centre led the way
conducting labs with 22,188 students and providing
outreach activities for an additional 14,799 visi-
tors. The DNA Centre at Singapore's National Institute of
Education provided in-depth training for 278
precollege teachers. Vienna Open Lab, located in the new
Campus Vienna Biocenter complex began
operation in the spring, providing labs for 990 students,
training for 13 teachers, and outreach activi-
ties for 425 visitors. The South Carolina DNA Learning
Center at Clemson University got off to a strong
start, reaching 926 students with lab filed trips, 86
students in extended summer camps, and 425
public participants.
Visits to DNALC's family of nine Internet sites rose
14% in 2006 to 7 million. BioServers, tools for
analyzing student DNA differences, registered the largest
increase (43%), followed by DNA Interactive,
commemorating the 50th anniversary of the discovery
of the structure of DNA (31%), and Image Archive
on the American Eugenics Movement, searchable materials
on the misuse of genetics in the early 20th
century (16%). In January, we launched Inside
Cancer, a multimedia resource on the molecular and cel-
lular basis of cancer. During the year, it garnered
considerable recognition, including selection as final-
ist in the Pirelli International Awards (life sciences
category), Science Magazine Netwatch (May 12),
Yahoo "New and Notable Sites" (May 18),
and Adobe Site of the Day (August 4).
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Internet Site
Average Visit Length
(in minutes) Visits in 2006
% Change
Over 2005
Gene Almanac 9:30 2,299,503 8.96
DNA from the Beginning 8:48 1,481,110 9.25
Your Genes, Your Health 8:04 1,115,186 -2.13
DNA Interactive 8:31 1,266,555 31.26
Image Archive on the American 12:52 331,388 15.71
Eugenics Movement
BioServers 17:17 228,464 43.48
Genetic Origins 9:26 150,954 7.58
Inside Cancer 8:39 120,342 n.a.
All Sites 10:23 7,002,140 13.74%
Insights into Internet Site Use
Internet educators are increasingly called on to provide data about who uses their sites and what impact
they have. To answer this call, in November, we administered an e-mail and online survey that provid-
ed a glimpse of how the DNALC's Inside Cancer and the Image Archive on the American Eugenics
Movement sites are used by teachers, students, health professionals, and the general public. Surveys
were completed by 1515 Inside Cancer and 931 Eugenics Archive users. (Inside Cancer response per-
centages are listed first and in italics.)
Consistent with studies by Nielson and the National Center for Education Statistics which show that
the United States is well "wired," the vast majority of respondents accessed the site via a broadband
connection (88%/83%)-with most connecting from home (47%, 47%), school (24%, 28%), or work
(23%, 21%). Respondents were enthusiastic about the sites, with the vast majority giving good or excel-
lent ratings on rating overall content (90%, 90%), content authority (87%, 90%), understandability (87%,
87%), videos (86%), design (84%, 87%), and navigation (81%, 81%). Nearly all (98%, 98%) said that
they likely would visit the sites again and would recommend them to others (95%, 93%), including to
students (69%, 68%), teachers (63%, 65%), professionals (36%, 39%), cancer patients (24%), and
friends and family (42%).
The majority of respondents were educators (55%, 57%), followed by students (20%, 23%) and
medical or science professionals (19%, 12%). Of educators, most reported readily available computer
and Internet resources, including presenter computer with video projector (74%, 74%) and broadband
access (61%, 63%), and student computers with broadband access (71%, 74%). Most educators had
come to the site looking for lesson materials (76%, 74%) or links to assign for student readings (44%,
39%), and nearly all (98%, 95%) said they were likely to continue to use the site in the future to prepare
for class or for student assignments. A number of teachers had already used the sites in their classes
(43%, 56%) impacting the following number of students.
Student Exposures
Classroom Use Inside Cancer Eugenics Archive
Used site for information for preparing a lesson or lecture
Presented site content in lecture or seminar
Students used site in class or computer lab
Assigned students site as homework or independent study
Provided link to site from a community resource
13,383
10,855
8,610
7,288
5,607
13,720
10,666
7,886
8,191
4,078
Most educators had used the sites with secondary (64%, 65%) and college (22%, 25%) classes, with
fewer in middle school or postgraduate classes (7% each, 4% each). Most secondary teachers had
used the sites in general biology (64%, 66%) or Advanced Placement or honors (49%, 45%) classes.
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Although relatively few high school teachers had used Inside Cancer for health education classes (6%),
a majority of college faculty had used the site with health and allied health classes (63%). These results
suggest that there is a strong health context for the site but that we will need to work to develop this
constituency at the high school level. Relatively few high school teachers had used the Eugenics Archive
for nonscience classes (9%). More college faculty had used the site for nonscience classes (32%),
including history, philosophy, or psychology-illustrating the potential for cross-disciplinary instruction.
Most students had visited the sites for a school assignment or project (44%, 67%) or for general
interest (53%, 31%) or for a school assignment. Most also thought it likely that they would return to the
sites as a reference for homework or a project (49%, 65%) or to help them understand course materi-
als (60%, 49%).
We were particularly interested in gauging site accuracy by way of the responses of historians and
medical, legal, and science professionals. Statistical comparisons revealed no significant differences
between professionals' evaluations of the sites compared to other demographic groups. The vast
majority of professionals gave good or excellent ratings for rated overall content (89%, 87%) and con-
tent authority (86%, 89%) and said that they would use the site in the future (95%, 92%). Most profes-
sionals intended to use the Inside Cancer site for background information (68%), to provide a link to a
client or patient (47%), or as a source of content to present at a meeting or seminar (40%). Professionals
thought that they were most likely to use Eugenics Archive materials for academic research (61%), to
prepare for a meeting (59%), or to present at a meeting or seminar (37%).
Cold Spring Harbor Partnership
Since its founding in 1988, the DNALC's interaction with students had been mainly limited to brief expo-
sures during academic year field trips or summer DNA camps. Although we work intensively with
interns, we had for years hoped to implement a "capstone" laboratory course in molecular
and genom-
ic biology in conjunction with neighboring Cold Spring Harbor High School (CSHHS). In the spring, we
realized this long-held desire when we graduated our first class of 21 high school
seniors who partici-
pated in the Cold Spring Harbor Partnership. Then, in the fall, we
welcomed our second class of
Partnership students.
Students observe C. elegans as part of the Cold
Spring Harbor High School course
at the DNALC.
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DNALC staff and biology teacher Scott Renart co-teaches the year-long Partnership course on alter-
nating days at CSHHS and the DNALC. The course uses lab experimentation to explore the genetics
and genomics of four major biological systems: bacteria, plants, roundworms, and humans. In the bac-
terial unit, students learn the basics of gene manipulation by making and analyzing recombinant DNA
molecules in the bacterium E. coli. The plant unit emphasizes concepts in gene structure, including a
detailed analysis of newly sequenced genes in rice and an assay for transgenes in genetically modified
food. In the human unit, students use their own DNA differences to study genetic variation in human
populations and the evolution of sensory receptors. In the final unit, students use the cutting-edge tech-
nique of RNAi to study gene function in the nematode C. elegans.
The first year's course included two miniprojects in the bacterial and human system. The second
year's course places greater emphasis on independent research, providing students opportunities to
design and troubleshoot experiments of their own design. This training in critical thinking will prepare
the Partnership students for success in the business, legal, and social sciences, as well as the biolog-
ical sciences.
Teacher Professional Development
Professional development activities reached a record number of high school and college faculty; 281 edu-
cators attended 13 2- to 5-day workshops on RNAi, plant genomics, bioinformatics, and genetics. Held
in six U.S. states and Singapore, these workshops were sponsored by the National Science Foundation
(NSF), National Institutes of Health (NIH), Amgen Foundation, Aspen Science Center, Wachovia Bank, and
the Singapore Ministry of Education. An additional 220 educators participated in miniworkshops con-
ducted at professional meetings in collaboration with Carolina Biological Supply Company. Topics at mini-
workshops included detecting GM foods by PCR, forensic identification of the Romanov family remains,
molecular genetics of bitter taste, bioinformatics, and the American eugenics movement.
In July, our flagship Leadership Symposium was reinstated with three-year support from the Amgen
Foundation. The program drew 23 high school teachers from 16 American states, Colombia, and
Singapore. Originally established in the early 1990s with support from the National Science Foundation
(NSF), this three-week long program provides super-order training for teachers who have significant
teaching program in genetics or biotechnology. During their stay, Leadership participants were
immersed in science, living on the main CSHL campus, walking in the footsteps of Nobel Prize winners,
and talking informally with high-level participants in the Lab's postgraduate training courses.
The curriculum included experiments in bacteria, plants, roundworms, and humans. Participants had
the opportunity to test the DNALC's latest lab methods, in advance their availability at other institutions
or from commercial suppliers. These experiments included assaying for mutations in olfactory recep-
tors, analyzing newly discovered genes in rice, and using RNAi to "knock down" genes in the round-
worm C. elegans. The final week was dedicated to independent study or group projects that included
screening supermarket foods for genetic modification, expanding computer-based studies on bioinfor-
matics, constructing web pages, and constructing new reagents for RNAi screens.
With support from the National Science Foundation and the Dana Foundation, ten college and high
school faculty took on summer fellowships at Cold Spring Harbor. Six teachers assisted with the devel-
opment of the new Internet sites G2C Online and Dynamic Gene; four split time between the DNALC
and advanced plant genomics on the main CSHL campus.
The DNALC's professional development programs retained widespread popularity among educa-
tors, even while many teacher-training programs experienced difficulty in recruiting faculty participants.
As evidence of educator interest, we received more than 240 qualified applications for a total of 152
spaces in six grant-funded summer workshops. Collaborating with historically Black (HBCU) or Hispanic
(NACU) institutions enabled us to increase the proportionate attendance of underrepresented minori-
ties; 48% of participants were either Black or Hispanic at workshops conducted at Rust College and
North Carolina Agricultural and Technical State University, which compares to 11% at Oklahoma City
Community College, City College San Francisco, and New York Institute of Technology. This observa-
tion prompted us to increase our collaboration with HBCU and HACU institutions in three proposals
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submitted to the NIH and NSF. Ultimately, this initiative will enable
us to tackle the ethnographic dis-
parity between groups pursuing careers in science and the general population.
The DNALC has provided the educational outreach components to four NSF-funded research pro-grams led primarily by CSHL faculty. All four educational programs entail development
and teacher-
training components.
Develop a comparative mapping database for cereals, Lincoln Stein and Doreen Ware (CSHL). We
completed a pilot version of the Dynamic Gene Internet site, developed a Dynamic Gene training cur-
riculum, and disseminated the curriculum in five 1.5-day workshops to 111 high school and college
faculty. Teachers were instructed in the use of the educational segments of the Dynamic Gene
Internet site, as well as in gene annotation using Apollo. Additional workshops will be conducted in
2007 and 2008 for a final total of 16 workshops.
Functional analysis of genes in maize, Marja Timmermans (CSHL) and Mike Scanlon (Cornell
University); and Finishing the sequencing of the rice genome, Dick McCombie (CSHL). These projects
have the objective of expanding the participation of underrepresented minorities in teaching plant
genomic biology. Faculty Fellows are selected from minority institutions and spend time in a CSHL
research lab as well as at the DNALC, giving them the opportunity to update their research and edu-
cational portfolios. In 2006, Dr. Diomede Buzingo (Langston University, Langston, Oklahoma) and Dr.
Gokhan Hacisalihoglu (Florida Agricultural & Mechanical University, Tallahassee, Florida) joined us as
Faculty Fellows on the maize project. After completing training, the Fellows host a DNALC course at
their home institution to introduce local educators to classroom-tailored laboratory and bioinformat-
ics modules. We conducted educator workshops at the home institutions of Dr. Muhammad Mian
(Rust College in Holly Springs, Mississippi) and Dr. Mary Smith (North Carolina Agricultural and
Technical State University in Greensboro, North Carolina), 2005 Fellows on the rice project. Thirty-
eight high school teachers and two-year college faculty participated in these courses. To support
local dissemination, each Fellow's institution receives an equipment package, including a thermocy-
cler, centrifuge, UV-lightbox, camera, pipettes and precast gels. Fellows then establish an equipment
loan program to provide local educators the physical resources to conduct the plant genomics exper-
iments in their classrooms.
Determine the function of protein-coding genes in Arabidopsis thaliana, David Jackson (CSHL).
Although funding for this program expired in 2004, we concluded theeducational component of this
project with a final workshop in August 2006 at the New York Institute of Technology. Seventeen col-
lege educators were introduced to plant genomics laboratory and bioinformatics teaching modules
developed during the program.
Watson School of Biological Sciences
Our collaboration with the Watson School of Biological Sciences provides the CSHL graduate
students
with a unique teaching opportunity. Rather than the traditional training of graduate students as
Teaching
Assistants, Watson school students complete a spring rotation working with middle and
high school
students at the DNALC. Over the course of 12 half-day sessions,
students work in pairs under the tute-
of seasoned DNALC instructors.
During the first phase of the training, students observe a
DNALC instructor deliver a laboratory to a
visiting class. Postobservation, the students begin to organize a lesson plan,
which integrates their own
experience within the context of a specific experiment. The second phase
is co-teaching, during which
each student is responsible for delivering a specific part of the laboratory.
The third phase is indepen-
dent instruction, during which the students work together
to present an entire laboratory-under the
observation of the DNALC instructor. During each phase,
students receive oral and written critiques
aimed at strengthening their presentation and class management skills.
After repeating this learning
process at the middle school and high school levels,
the students are required to independently teach
an additional three lessons of their choice. 403
Some students opt to travel to a local school district to deliver instruction to several middle school
classes. Although the CSHL graduate students are well versed in molecular biology, few have ever
attempted to teach these concepts to young students. We believe that the skills required to deliver a
successful lab experience to precollege students-engagement, organization, and time management-
are the same skills needed to communicate with any audience.
Staff and Interns
At summer's end, we said goodbye to high school instructor Jeanette Collette, who took a position at
Commack High School to teach Regents biology, forensics, and scientific research. During two years
at the DNALC, she proved adept in many areas of biology. She had a key role in developing the
Greenomes plant curriculum, growing specialized Arabidopsis and maize plants, assisting with work-
shop instruction, and working on the companion Internet site. Through thick and thin, she sang her way
through the labs and hallways. We will miss her enthusiasm and sunny personality.
In December, computer programmer Adrian Arva left to pursue a Master's degree in Business
Administration at the prestigious Institute for Management Development (IMD) in Lausanne,
Switzerland. A native of Romania, in 2001, Adrian responded to a job ad on the DNALC Internet,
passed a phone interview with CSHL Professor Lincoln Stein, and was hired site unseen. We could not
have been luckier to find such a brilliant programmer during the height of the Internet bubble. His mas-
terful programming, with added insight from his M.D. background, provided the backbone of the
DNALC's Internet venture during a time of rapid expansion.
So taken were we with Adrian's performance that we immediately hired another Romanian, Cornel
Ghiban, to take his place at year's end. After studying computer science and engineering at Technical
"Gheorghe Asachi" University in Iasi, Cornel designed software for financial clients. He also did contract
work for the DNALC, developing backend registration, database, and Webserver functions for several
of our Internet sites.
During the year, we welcomed Malissa Hewitt back to the instructional staff. Malissa started at the
DNALC as a laboratory instructor in 1994, becoming the first full-time employee devoted to middle
school instruction. In 1997, she stepped up to manage the middle school program and then left in 1998
to become a full-time mom. Her deep understanding of the history of the DNALC, her strong connec-
tions to the local community, and her love of children make Malissa's return especially valuable.
Student interns continued to provide key support for our activities. The sequencing service contin-
ued to grow with the help of college interns Alina Duvall (Hofstra University), Jennifer Aiello (C.W. Post),
and Alexandra Sloane (Loyola College, Maryland). Joining the program in 2006 were Yusuf Anwar
(Syosset), Carissa Maurin (Lynbrook), Seth Schortz (Half Hollow Hills), Andrea Tufano (Syosset), and
Brittany Woods (Cold Spring Harbor High School). The new members joined returning interns Matt
Giambrone (Walt Whitman), Matthew Levy (Kings Park), Tama Mizuno (Northport), Ronnie Morasse
(Plainedge), Nick Wilken (Kings Park), and Janice Yong (Kings Park).
While most interns perform general preparation for lab experiments, Brittany Woods and Carissa
Maurin worked with Bruce Nash to develop and maintain C. elegans stocks used in our NSF program.
Kyle Shybunko, a research student at Ward Melville, worked with Greg Chin to submit a project on
human olfactory receptors to the Siemens competition. Yusuf Anwar's research on tissue development
at Stony Brook University won him a Special Congressional Recognition Award and placed him as a
semifinalist in the Siemens Competition.
Several interns returned from college to assist with summer workshops: Benjamin Blonde (Amherst
College), Bryn Donovan (University of Delaware), Kimberly Izzo (Indiana University), and Marie Mizuno
(SUNY Binghamton). In August, Joseph Hakoopian (Walt Whitman) left for his freshman year at Cornell
University; Margarita Varer (Huntington) left for SUNY Binghamton, and Brittany Woods (Cold Spring
Harbor) left for Boston College.
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2006 Workshops, Meetings, and Collaborations
January 9-11 NSF Gramene Faculty Fellowship:
Robert Wheeler, Pine Creek High School, Colorado
Springs, Colorado
11January Site visit and museum tour for the
incoming class of the Watson School of Biological
Sciences, Cold Spring Harbor Laboratory (CSHL)
21January Saturday DNA!, "When Dinosaurs Roamed the
Earth" and "Teenage Mutant Critters," DNALC
January 30 Site visit by Lisa Blair, Director, Wendi O'Rand, Educator, and Denise Richard,
Administrative Assistant, Abernathy Science Education Center, Girard, Kansas
February 1-2 BiosciEdNet (BEN) Collaborators Meeting, Washington, D.C.
February 6-10 G2C Online Advisory Meeting, Cambridge, United Kingdom
February 11 CSI Workshop for Children Associated with Hermansky Purdlak Syndrome Foundation
Annual Meeting
February 11 Saturday DNA!, "2006: A Science Odyssey" and "One Fish, Two Fish, Green Fish,
Glofish!," DNALC
February 15 Site visit by Norman Kelker, Senior Vice President, Enzo Life Sciences, Farmingdale, New York
February 17 Annual American Association for the Advancement of Science Meeting, St. Louis, Missouri
February 24-25 Aspen Science Center Teacher Training Workshop, Aspen, Colorado
March 1 Site visit by Rogert Mummert, freelance writer, New York Times, New York, New York
March 1 Site visit by Theodore Roosevelt American Inn of Court, St. John's University, School of
Law, Nassau County, New York
March 1 Site visit by Sharon Grosser, Executive Director, Roslyn Savings Foundation, Roslyn, New York
March 1 Site visit by Michio Ichimura, Kyowa Hakko Chemical Co., Ltd., Japan
March 2 Site visit by Patrick Foye, President, and Teri Zielenski, Senior Vice President, United Way
of Long Island
March 8 Site visit by George Harrison, Harrison Family Foundation, John S. Grace, President,
Sterling Grace Capital Management, and Lola N. Grace, Managing Director, Sterling
Grace Capital Management, and Vice Chairman CSHL Board of Trustees
March 11 Saturday DNA! Seminars, "Wanted: Dead or Alive?" and "Little Fly, Why Did You End Up a
Guy?," DNALC
March 15 Site visit by David Skuse, Institute of Child Health, London, United Kingdom
March 19-21 RNAi Advisory Board Meeting, DNALC
March 21 West Side School Lecture, "Why All the Fuss about Bird Flu?," Lee Henry, CSHL
March 22 Site visit to William Randolph Hearst Foundation, New York, New York
March 23 Annual Cancer Biomedical Informatics Grid (caBIG) Meeting, Bethesda, Maryland
April 4 Great Moments in DNA Science Honors Student Seminar, Hollis Cline, CSHL, "Seeing is
Believing: Imaging Brain Development in the Intact Animal," CSHL
April 6-8 National Science Teachers Association National Meeting, Anaheim, California
April 11 Great Moments in DNA Science Honors Student Seminar, Grigori Enikolopov, CSHL,
"Teaching an Old Dog New Tricks? Stem Cells in the Adult Brain," CSHL
April 14 Site visit by Bob Wheeler, Pine Creek High School, Colorado Springs, Colorado; and
Brenda Dempsey, George Washington High School, Denver, Colorado
April 18 Site visit by Lillian DeRosa and family, friends of Leo Guthart, owner of Topspin Partners,
LP, Roslyn Heights, New York
April 19 Site visit by Lynda Parmely, Program Officer, Horace Hagedorn Foundation, Jericho, New York
April 20 Site visit by Joanne Duhl, Goldman Sachs Foundation, New York, New York
April 20 Site visit by Edward Atwood, Vice President Multimedia Services, Cablevision, Bethpage,
New York
April 21 Site visit by Marcia Bishop, Associate Director, and Ronald Sjoerdsma, Fellow, Van Andel
Education Institute, Grand Rapids, Michigan
April 21 Site visit to Davidoff Malito & Hutcher LLP, New York, New York
April 22 Saturday DNA! Seminars, "Jellyfish Genes" and "Mapping Your Way Through DNA," DNALC
April 24 Site visit by Rosemary Nicholls, Senior Vice President, Teachers Federal Credit Union,
Farmingville, New York
April 24 West Side School Lecture, "Why Do We Have Two Copies of Every Gene?," Alea Mills,
CSHL
April 26 Site visit to the Harvard Club of New York City for National Institute of Social Sciences Little
Think Tank Luncheon, New York
May 1 Great Moments in DNA Science Honor Student Seminar, Anthony Leotta, CSHL, "Finding
Cancer Genes Using Microarrays," CSHL
May 1 Site visit to New York Hall of Science for Science Task Force Meeting, Queens, New York
May 5 Site visit to New York City Department of Education with Julia Rankin, Director of Science,
New York, New York
May 7 Dedication Ceremony for the Marc David Chernoff Bioinformatics Laboratory, DNALC
May 10-11 Site visit to Carolina Biological Supply Company, Burlington, North Carolina
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May 11 Site visit by Landon and Lavinia Clay, Directors, and Jim Carlson, President, Clay
Mathematics Institute, Cambridge, Massachusetts
May 13 Site visit by Pamela Omidyar (wife of Pierre Omidyar,Chairman and founder of eBay) and family
May 16 Site visit by Harouna Ba, Senior Research Associate, Center for Children and Technology,
New York, New York
May 16 Site visit to North Shore-Long Island Jewish Health System, Feinstein Institute for Medical
Research, for talk by Lawrence Scherr, Lake Success, New York
May 18 Site visit by Jason Morris, Assistant Professor of Biology, Fordham University, New York,
New York
May 18-19 Site visit to the Life Learning Center, Bologna, Italy
May 20 Saturday DNA! Seminars, "Bug Zappers" and "What's a Stem Cell Supposed to Do'?," DNALC
May 23 Dedication of Vienna Open Lab, Vienna, Austria
June 5-9 NSF Frontiers in Genomics: RNA Interference and Genome Annotation Workshop, with
Charlotte Mulvihill, Oklahoma City Community College, Oklahoma City, Oklahoma
June 6 Cold Spring Harbor Partnership Program Graduation Ceremony: Tom Dolan, Principal,
Scott Renart, science teacher, and 120 students and parents, Cold Spring Harbor High
School, New York
June 8 Site visit by Mahlon Hoagland, author, and Ken Gleason, science museum consultant
June 10 Saturday DNA! Seminars, "Fruit Fly Island" and "Conquering a Genetic Disease," DNALC
June 12-16 NSF Plant Molecular Genetics and Genomics Workshop, with NSF Minority Fellow
Muhammad Mian, Holly Springs, Mississippi
June 13 Site visit by Kidgie Williams, diplomats, and family membersof United Nations representa-
tives, Hospitality Committee for United Nations Delegations, Inc., New York, New York
June 14 Site visit by Robert Diller, Director of Sales and Marketing, and Zock Zamanian, Brinkmann
Instruments, Inc. /Eppendorf AG, Westbury, NY
June 19 Site visit by Arthur Rosoff and Henry Bachman, Long Island Museum of Science &
Technology, Garden City, New York
June 22 Site visit by Kathryn Silva and Ralph Brave, University of California, Sacramento
June 19-23 NSF Plant Molecular Genetics and
Genomics Workshop, with NSF Minority Fellow Mary
Smith, North Carolina Agricultural and Technical State University, Greensboro
June 26-30 Site visit by Florence Francis, Chief Scientific Officer of the Learning
Lab, Singapore
Science Center, Singapore
June 26-30 Fun with DNA Workshop, DNALC
DNA Science Workshop, DNALC
World of Enzymes Workshop, DNALC
Fun with DNA Workshop, DNALC West
June 26-30 NSF Frontiers in Genomics: RNA Interference and Genome
Annotation Workshop, with
Elaine Johnson, Bio-Link, City College, San Francisco,
California
June 26-30 Bioinformatics-In Silico Biology
Workshop, California State University, Dominguez Hills: LA
Biomed, Torrance, California
June 29 New York City Department of Education Advisory
Board on Biotechnology Education,
American Museum of Natural History, New
York, New York
July 3-7 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
July 3-7
Green Genes Workshop, DNALC West
Aspen Science Center Workshops: Fun with
DNA; World of Enzymes; PCR & Genomic
Biology, Aspen, Colorado
July 4
July 8-23
Aspen Science Center Board of Trustees
Meeting, Aspen, Colorado
USDA Gramene Faculty Fellowship:
Charlie Gutierrez, John H. Reagen High School,
Austin, Texas
July 9-21 NSF Minority Faculty
Fellowship: Gokhan Hacisalihoglu, Florida Agricultural
& Mechanical
July 9-30 TeUniversity,
Tallahassee, Florida
Teacher Training at the DNALC:
Lui Shea Nee Shirley, Victoria Junior College; Wee Sock
Chin, Hua Yi Secondary School;
and Petrina Then Yan Ting, Singapore Science Center,
Singapore
July 10 Site visit by Josep Prous, David
Prous, and Miriam Bayes, Prous Science, Barcelona,
Spain
July 10-14 Genetic Horizons
Workshop, DNALC
World of Enzymes Workshop, DNALC
July 10-28
DNA Science Workshop, DNALC
West
July 17-21
Amgen Leadership Symposium,
DNALC
Site visit by Karin Garber
MAS, Vienna Open Lab-Dialog Gentechnik, Vienna,
Austria
July 17-21 Fun with DNA, Workshop,
DNALC
Human Genomics WorkshoP, DN
Fun with DNA, Workshop,
DNALC West
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July 21
July 24-28
July 24-28
July 25-26
July 26-August 5
July 26-August 5
July 31-August 4
July 31-August 4
August 1
August 2
August 2
August 7-11
August 6-19
August 14-18
August 14-18
August 15
August 16
August 21
August 21-25
August 21-25
August 21-25
August 25
August 28-
September 1
September 7
September 8
September 20
September 21
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Site visit by Daryl Ogden, Executive Director, Project GRAD of Long Island, Roosevelt, New
York, and Teresa Kemp Zielenski, Senior Vice President of Community Impact, and
Kristine Donnelly, United Way of Long Island, Deer Park, New York
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Site visit by G2C Online Fellows Caren Gough, Education Consultant, and Laura Maitland,
AP Psychology consultant
Site visit by G2C Online consultant Joe Novack, Institute of Human and Machine Cognition
(IHMC), Pensacola, Florida
NSF Gramene Faculty Fellowship: Debra Burhans, Canisius College, Buffalo, New York,
and Robert Wheeler, Pine Creek High School, Colorado Springs, Colorado
Site visit by Suzanne Leeds, member of Cold Spring Harbor High School Improvement
Team and DNALC Committee
Fun with DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC
World of Enzymes Workshop, DNALC West
Forensics and Human Genomics Workshop, with Lawrence Kobilinsky, John Jay College
of Criminal Justice, Manhattan, New York
Site visit by Dee Rawsthorne, John Innes Centre, Norwich, United Kingdom
Site visit by Lori Bressler, Cold Spring Harbor School Board, Cold Spring Harbor, New York
Site visit by Ida Cole, former Microsoft executive and philanthropist
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
NSF Plant Molecular Biology, Genomics and Bioinformatics Workshop, New York Institute
of Technology, New York, New York
Forensics and Human Genomics Workshop, with Lawrence Kobilinsky, John Jay College
of Criminal Justice, New York, New York
NSF Minority Faculty Fellow Diomede Buzingo, Langston University, Langston, Oklahoma
Fun with DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, DNALC West
NSF Frontiers in Genomics: RNA Interference and Genome Annotation Workshop, New
York Institute of Technology, New York, New York
Site visit by Lisa Mars, Vice President and Director for Digital Schoolhouse Foundation,
Islandia, and Teresa Kemp Zielenski, Senior Vice President of Community Impact, and
Kristine Donnelly, United Way of Long Island, Deer Park, New York
Site visit by Eric Evers ley, Superintendent, Freeport School District, and Teresa Kemp
Zielenski, Senior Vice President of Community Impact, and Kristine Donnelly, United Way
of Long Island, Deer Park, New York
Site visit by Ed Rover, President, Burt Mirsky, Vice President, Finance, and Abigal Slovonic,
Program Officer, Dana Foundation; and James Watson, Chancellor, CSHL
Site visit by Michael Marshall, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Human Genomics Workshop, DNALC West
New York City Department of Education Educator Workshop, DNA Investigations, New
York, New York
Site visit by Fumitaka Akeda, President, and Lee Schuett, Executive Vice President, Nikon
Instruments, Melville, New York
Genetic Horizons Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science, DNALC
Plant Genomics Workshop, DNALC West
Esquire Magazine photo shoot with James Watson, Chancellor, CSHL
Site visit by Richard Quest, CNN's London-based anchor and correspondent, London,
England
Site visit by Susan Berland, Town of Huntington Councilwoman, Huntington, New York
Site visit by Kathy Vandiver, Director of Community Outreach and Education, Center for
Environmental Health Sciences, MIT Museum, Cambridge, Massachusetts
September 21
September 21-25
September 22-25
September 21
September 27
September 28
October 2-4
October 5
October 11-13
October 14
October 16
October 18
October 22-24
October 24
October 25-26
November 2-4
November 6
November 8
November 8
November 8
November 13-23
November 14
November 15
November 18
November 22-23
November 25-
December 9
November 28
November 30
December 7-8
December 8
December 8
December 9
December 11
December 15
December 28
Site visit by Aledandra Manaia, European Molecular Biology Laboratory (EMBL),
Heidelberg, Germany
NSF Gramene Faculty Fellowship: Robert Wheeler, Pine Creek High School, Colorado
Springs, Colorado
NSF Gramene Faculty Fellowship: Debra Burhans, Canisius College, Buffalo, New York
Site visit by Marianne Carolton, Director of Internal Communications, and James Cuniglio,
Communications Coordinator, Arrow Electronics, Melville, New York
Site visit by Edward Atwood, Vice President Multimedia Services, Cablevision, Bethpage,
New York
Site visit to Cold Spring Harbor High School for meeting with Jay Matuk, Principal, and
Andy Clouser, Science Department Chairman, Cold Spring Harbor, New York
Novartis Exploratory Clinical Development Group, RNA and Cancer Biology, Banbury
Center and DNALC
Site visit by Daryl Ogden, Robert Troiano, Executive Director, and Kim Arias, Director of
Programs, Project Grad Long Island, Roosevelt, New York; and Connie Clark,
Superintendent, and Robert Root, Assistant Superintendent for Curriculum Instruction
and Personnel, Westbury School District, Westbury, New York
National Association of Biology Teachers National Meeting, Albuquerque, New Mexico
Saturday DNA! Seminars, "Genes and Generations" and "Spotlight on Cell Division,"
DNALC
Site visit by Eric Krasnoff, President, and Saied Tousi, Senior Vice
President of Global
Infrastructure, Pall Corporation, East Hills, New York
Site visit by Lori Bressler, President, Cold Spring Harbor Board of
Education; and Judith
Wilansky, Cold Spring Harbor Adult Education Program,
Cold Spring Harbor, New York
New Horizons in Internet Site Development Meeting, CSHL
Banbury Center
Site visit by Bob Malito, Garden City, New York, and Arthur
Goldstein, New York, New
York, Law Firm Davidoff, Malito & Hutcher
NY Enhancing Collaborative Leadership for Improved
Performance in Science Education
(ECLIPSE) Leadership Conference, Albany, New York
National Science Teachers Association Regional
Meeting, Baltimore, Maryland
Science Teachers Association of New York State
Conference, Ellenville, New York
Site visit by 30 members of the Princeton Club,
New York, New York
Site visit by Kirk Kordeleski, President and Chief
Executive Officer, and Linda Arymn, Vice
President Business Development, Bethpage
Federal Union, Bethpage, New York
Site visit to York College, Dr. Linda Barley,
Acting Provost, DNA Lab, New York, New York
Singapore Teacher Training, Singapore
Excellence in Science Award Annual
Reception for the American Association of University
Women, Huntington Branch, Huntington,
New York
FIRST (For Inspiration and Recognition of Science and
Technology) Lego Robotics Group,
Long Island, New York
Saturday DNA! Seminars, "The Iceman
Cometh" and "Heart and Sole: Studying Heart
Development in Fish," DNALC
MOE-NIE-STAS International Science Education
Conference, Singapore
Teacher Training at the DNALC:
Rashidah bte Yahya, Marsiling Primary School;
Ginger
Tay Leng See, Telok Kurau Primary
School; Han Tui Kin, Montfort Junior School; and Pok
Sat Yoong, St. Hilda's Primary
School
Site visit by Congressman Bud Cramer,
Alabama's 5th Congressional District, U.S. House
of Representatives, Alabama
Site Visit by Matthias Haury, European
Molecular Biological Laboratory, Heidelberg,
Germany
National Science Teachers Association
Regional Meeting, Salt Lake City, UmtaiMinnetonka,
Site visit and field trip by Minnetonka
High School students and teachers,
Minnesota
Site visit by Manny Arias, High
School Principal, and Darnel Powell,
Middle School
Principal, Westbury School District,
New York
Saturday DNA! Seminars, "As
the Worm Turns" and "Finding
Novel Genes with Degenerate
PCR," DNALC
Site visit by Hans Ullrich, freelance
writer, United Kingdom
Site visit by Bettie Steinberg,
Chief Scientific Officer, and Kirk
Manogue, Director of
Technology Transfer,
Feinstein Institute for Medical
Research, NS-LIJ Health Systems,
Lake Success, New York
Site visit by G2C Online
Fellows Caren Gough, Education
Consultant, and Laura Maitland,
Advanced Placement Psychology
consultant
409
Sites of Major Faculty Workshops 1985-2006
Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa
1987-1990
ALASKA University of Alaska, Fairbanks
1996
ARIZONA Tuba City High School
1988
ARKANSAS Henderson State University, Arkadelphia
1992
CALIFORNIA California State University, Fullerton
2000
Canada College, Redwood City 1997
City College of San Francisco 2006
Contra Costa County Office of Education, Pleasant Hill 2002
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA Biomed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001
San Francisco State University 1991
San Jose State University 2005
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
National Center for Biotechnology Information, Bethesda 2002
MASSACHUSL I I S Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA University of Minnesota St. Paul, St. Paul 2005
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
Rust College, Holly Springs 2006
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MISSOURI
NEW HAMPSHIRE
NEVADA
NEW JERSEY
NEW YORK
Stowers Institute for Medical Research, Kansas City
Washington University, St. Louis
Washington University, St. Louis
New Hampshire Community Technical College, Portsmouth
St. Paul's School, Concord
University of Nevada, Reno
Coriell Institute for Medical Research, Camden
Albany High School
Bronx High School of Science
Columbia University, New York
Cold Spring Harbor High School
Cornell University, Ithaca
DeWitt Middle School, Ithaca
DNA Learning Center
DNA Learning Center
DNA Learning Center
DNA Learning Center West
Fostertown School, Newburgh
Huntington High School
Irvington High School
Junior High School 263, Brooklyn
Lindenhurst Junior High School
Mt. Sinai School of Medicine, New York
New York Institute of Technology, New York
New York Institute of Technology, New York
Orchard Park Junior High School
Plainview-Old Bethpage Middle School
The Rockefeller University, New York
State University of New York, Purchase
State University of New York, Stony Brook
Stuyvesant High School, New York
Titusville Middle School, Poughkeepsie
Trudeau Institute, Lake Saranac
Union College, Schenectady
U.S. Military Academy, West Point
Wheatley School, Old Westbury
NORTH CAROLINA CIIT Center for Health Research, Triangle Park
North Carolina Agricultural & Technical State University, Greensboro
North Carolina School of Science, Durham
OHIO Case Western Reserve University, Cleveland
Cleveland Clinic
North Westerville High School
OKLAHOMA Oklahoma City Community College
Oklahoma City Community College
Oklahoma Medical Research Foundation, Oklahoma City
Oklahoma School of Science and Math, Oklahoma City
OREGON Kaiser Permanente-Center
for Health Research, Portland
PENNSYLVANIA Duquesne University, Pittsburgh
Germantown Academy
SOUTH CAROLINA Clemson University, Clemson
Medical University of South Carolina, Charleston
University of South Carolina, Columbia
TEXAS Austin Community
College-Rio Grande Campus
J.J. Pearce High School, Richardson
Langham Creek High School, Houston
Southwest Foundation for Biomedical Research,
San Antonio
Taft High School, San Antonio
Trinity University, San Antonio
University of Texas, Austin
UTAH University of Utah, Salt
Lake City
University of Utah, Salt Lake City
VERMONT University of Vermont,
Burlington
VIRGINIA Eastern Mennonite
University, Harrisonburg
Jefferson School of Science, Alexandria
Mathematics and Science Center, Richmond
Mills Godwin Specialty Center, Richmond
Virginia Polytechnic Institute and State University,
Blacksburg
2002
1989
1997
1999
1986,1987
1992
2003
1987
1987
1993
1985,1987
2005
1991, 1993
1988-1995,
2001-04,2006
1990,1992,
1995,2000
1990 -1992
2005
1991
1986
1986
1991
1991
1997
2006
2006
1991
1991
2003
1989
1987-1990
1998-1999
1991, 1993
2001
2004
1996
1985
2003
2006
1987
1990
1987
1990
2000
2006
2001
1994
2003
1988
1988
2004
1988
1988
2000
1990
1991
2002
1991
1994
1999,2004
1993
1998,2000
1989
1996
1987
1990
1998
2005
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WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
University of Washington, Seattle 1993, 1998
WASHINGTON, D.0 Howard University 1992, 1996
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999
Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001-2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University, Uppsala 2000
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COLD SPRING HARBOR
LABORATORY PRESS
2006 PUBLICATIONS
SERIALS
Genes and Development, Vol. 20, 1-3532 (www.genesdev.org)
Genome Research, Vol. 16, 1-1624 (www.genome.org)
Learning and Memory, Vol. 13, 1-834 (www.learnmem.org)
Protein Science, Vol. 15, 1-2890 (www.proteinscience.org)
RNA, Vol. 12, 1-2236 (www.rnajournal.org)
Cold Spring Harbor Symposia in Quantitative Biology Vol. 70:
Molecular Approaches to Controlling Cancer, Bruce Stillman
and David Stewart (eds.) (www.cshl-symposium.org)
Cold Spring Harbor Protocols (www.cshprotoocols.org)
LABORATORY MANUALS
The Condensed Protocols from Molecular Cloning:
A Laboratory Manual, Joseph Sambrook and David Russell
Gene Transfer: Delivery and Expression of DNA and RNA:
A Laboratory Manual, Theodore Friedmann and John Rossi (eds.)
HANDBOOKS
Binding and Kinetics for Molecular Biologists, James A.
Goodrich and Jennifer F. Kugel
Experimental Design for Biologists, David J. Glass
Lab Ref, Volume 2: A Handbook of Recipes, Reagents, and
Other Reference Tools the Bench, Albert Mellick
and Linda Rodgers (eds.)
MONOGRAPHS
Genomes, Hillary Sussman and Maria Smit (eds.)
DNA Replication and Human Disease, Melvin DePamphilis (ed.)
Translational Control in Biology and Medicine, Michael
Mathews, Nahum Sonenberg, and John Hershey (eds.)
Epigenetics, Danny Reinberg, C. David Allis, and Thomas
Jenuwein (eds.)
TEXTBOOKS
From a to a: Yeast Mating Type as a Model for Cellular
Differentiation, Hiten Madhani
Recombinant DNA: Genes and Genomes-A Short Course,
Third Edition, James D. Watson, Amy A. Gaudy, Richard M.
Myers, and Jan A. Witkowski (copublished with W.H.
Freeman)
GENERAL INTEREST
The Strongest Boy in the World: How Genetic Information Is
Reshaping Our Lives, Philip R. Reilly
Won for All: How the Drosophila Genome Was Sequenced,
Michael Ashburner
Pandora's Baby: How the First Test Tube Babies Sparked the
Reproductive Revolution, Robin Marantz Henig (paperback
edition)
Times of Triumph, Times of Doubt: Science and the Battle for
Public Trust, Elof Axel Carlson
OTHER
CSHL Annual Report 2005: Yearbook Edition
CSHL Annual Report 2005
Banbury Center Annual Report 2005
Watson School of Biological Sciences Annual Report 2005
WEB SITES
http://www.dnareplication.cshl.org: Web site to accompany
DNA Replication and Human Disease
http://kinetics.cshl.edu: Web site to accompany Binding and
Kinetics for Molecular Biologists
http://rna.cshl.edu: Updated Web site to accompany RNA
World, Third Edition
'MERE Rkcombinanf DNA ...
antrr!' Lakgef
ttgli,`=;. I S!titalitiesi:-
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A selection of recently published books
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The journal publishing program
COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR'S REPORT
Cold Spring Harbor Laboratory Press is the largest of the five educational divisions of the Laboratory,
with offices on the Woodbury campus, marketing operations in San Diego and the United Kingdom, and
distributors in Germany, Japan, China, Korea, India, and South America. The Press furthers and finan-
cially assists Cold Spring Harbor Laboratory's commitment to the advance and spread of scientific
knowledge. Our research journals, books, and manuals provide continuing professional education for
working scientists and graduate students, our textbooks support undergraduate teaching, and our other
books explore the practice, personalities, and history of science and its influence on medicine, business,
and social policy.
In 2006, CSHL Press generated a substantial operating excess, with a preliminary 2006 margin of
$400,000 on income of $9.375 million. Its total contribution to the Laboratory, including support for
institutional overhead and depreciation, was approximately $1 million.
In a challenging market, institutional journal subscription revenue grew by 6.5% compared with
2005 and showed a continued trend toward online-only subscriptions, as institutional libraries became
more comfortable letting go of print copies. All journals increased revenue from regular issues, with
Learning and Memory showing strongest percentage growth. Advertising sales in regular issues
remained steady within our program despite an industry-wide decline. As the commercial momentum
of genome science has slowed, interest in RNA interference has picked up, helping to sustain our
advertising and sponsorship support. BioSupplyNet, our online product and vendor directory, showed
a substantial increase in revenue, and its publication of free laboratory protocols attracted sponsorship
from Sigma-Aldrich. The journal program's value was particularly evident in the extensive use made of
research articles, which increased by 7.5% in 2006 with downloads of 8.1 million articles.
Genome Research, RNA, and most recently Genes & Development publish research papers
imme-
diately and freely online if a fee is paid for this service by the organization that funded the
research. This
"hybrid open access" business model accords with the requirements of The
Wellcome Trust and other
international funding agencies. Currently, a minority of authors choose this option.
Free journal access
within developing nations expanded with the addition of 37 new countries to
the more than 100 lower-
income countries covered by the HINARI and AGORA programs.
According to 2005 journal rankings by impact factor, Genes &
Development was number 2 in devel-
opmental biology and number 3 in genetics, and Genome Research was
number 3 in biotechnology and
number 8 in genetics. With the inclusion of Learning & Memory,
Protein Science, published for The
Protein Society, and RNA, published for The RNA Society, in our program,
all five of our journals are with-
in the top 30% of all journals in their disciplines, and Genes & Development
is ranked among the top 20
of all science journals. Many of the papers published in our journals were
highlighted in the world's major
news media, including The New York Times, The
Wall Street Journal, and the BBC News.
The annual Cold Spring Harbor Symposium volume was
published online for the third time. Readers
within subscribing institutions now have access to
Symposium manuscripts many months ahead of
print publication and to other features such as video
interviews with speakers at the meeting.
Cold Spring Harbor Protocols, an interactive, online source
of new and classic research techniques,
was launched in June 2006. In the first six
months, more than 800 protocols were published.
Subscription interest in this online-only serial has been
extremely strong and downloads of articles from
the database increased by 100% from September
to December. The project has made a most promis-
ing start.
The book program released 15 new titles,
bringing the total number of books in print by the end of
year to more than 200; 15,500 book and multimedia
orders were handled by our customer service
department and over 59,000 units were shipped.
The provision of fulfillment and distribution services
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in the United States for the books of two other publishers generated commission revenue on an
increasing sales income.
The new book titles were a mix of manuals, monographs, reference, and history books. But
Recombinant DNA: Genes and Genomes-A Short Course, the third edition of a successful textbook
originally created by Jim Watson, was also published, a joint project with W.H. Freeman that advanced
our expertise with books for students. The best-selling new book in 2006 was The Strongest Boy in
the World: How Genetic Information Is Reshaping Our Lives, an excellent read by Philip Reilly that was
warmly praised in the scientific press. The best-selling backlist titles were two perennials, At the Bench
by Kathy Barker and Molecular Cloning: A Laboratory Manual, by Joe Sambrook and David Russell,
both long recognized as uniquely valuable contributions to the molecular biology literature.
Fifteen contracts for new books were signed, including agreements for new manuals in RNA sci-
ence, single-molecule biology, and proteomics; several monographs; a biography of Francis Crick; and
the sixth edition of Molecular Biology of the Gene, to be copublished with Benjamin Cummings. Three
agreements were signed with foreign publishers for translations of several of our titles into Chinese and
Japanese. Two contracts were agreed for foreign reprint rights.
During the year, we began to reshape our sales and marketing departments to make them more
responsive to significant financial and technological change in our community. Publications such as
ours are vulnerable to reductions in research funding, and in the current climate, cash-strapped scien-
tists are regretfully choosing to turn down resources they would otherwise have cherished. The
omnipresence of the Internet in our professional lives is driving all forms of information online, and
books are no exception. As the year ended, we embarked on an exploration of the feasibility and eco-
nomics of publishing all of our research-level books online and were encouraged by positive respons-
es from institutional librarians.
As a specialist publisher, our books are to be found some considerable way down the "Long Tail,"
the metaphor for non-best-sellers that caught the popular imagination in 2006. Thanks to the distinc-
tion of the authors, editors, and contributors we can call on, and the expertise of our staff, Cold Spring
Harbor has a strong reputation for the creation of high-quality content that gives our voice some dis-
tinction in the cacophony of the Web. That alone, however, will not be sufficient for prosperity or per-
haps even survival, without a continuation of the hard processes of innovation, adaptation, and change
that characterized much of our work in the past year. I am most grateful to the staff members, partic-
ularly the department heads, whose openness to new thinking made this progress possible.
G. Jaitin, L. Schmidt-Press Customer Service
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M. Mazzullo-Production editor, Books
Staff
In 2006 we welcomed new colleagues Jane Carter, Kaaren Hegquist, Lauren Heller, and Kathleen
MacDonald and Cher Mattes. We said farewell, thanks, and good luck to Debra Banninger, Richard
Cavalieri, Danny deBruin, Katya Gurbeloshvili, and Rita Wallace.
Special thanks are due to the individuals who shouldered supervisory responsibilities within the
Press: Jan Argentine, Alex Gann, Nancy Hodson, Geraldine Jaitin, Bill Keen, Wayne Manos, Marcie
Siconolfi, Linda Sussman, and Denise Weiss. The Press also owes much to the skill and judgment of
the Editors of our successful journals, Tern Grodzicker at Genes & Development and Hillary Sussman
at Genome Research.
A complete listing of staff members of the Press in December 2006 is printed elsewhere in this vol-
ume. The Laboratory is fortunate to have the support of such able and hardworking professionals.
John R. Inglis
Executive Director
J. Argentine, K. Hegquist, R. Stever,
K. Janssen-Press Development and
Production staff
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2006
With comparative financial information as of December 31, 2005
Assets:
2006 2005
Cash and cash equivalents $ 23,563,414 24,580,708
Accounts receivable 2,995,007 5,735,451
Grants receivable 7,859,380 8,352,217
Contributions receivable, net 43,226,518 47,578,065
Publications inventory 3,831,443 2,979,817
Prepaid expenses and other assets 3,720,386 2,015,019
Investments 308,108,275 256,675,871
Investment in employee residences 5,557,353 5,726,739
Restricted use assets 3,598,745 3,226,538
Deposits with trustee 46,014,949
Land, buildings, and equipment, net 130,942,408 115,851,522
Total assets $ 579,417,878 472,721,947
Liabilities and net assets:
Liabilities:
Accounts payable and accrued expenses $ 12,450,777 10,435,051
Deferred revenue 3,585,913 4,237,554
Bonds payable 97,200,000 45,200,000
Total liabilities 113,236,690 59,872,605
Net assets:
Unrestricted 213,562,751 195,431,117
Temporarily restricted 82,791,081 70,289,399
Permanently restricted 169,827,356 147,128,826
Total net assets 466,181,188 412,849,342
Total liabilities and net assets $ 579,417,878 472,721,947
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2006
With summarized financial information for the year ended December 31, 2005
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2006
Total
2005
Total
Revenue and other support:
Public support (contributions and
non-Federal grant awards) $ 21,344,574 23,169,757 14,917,606 59,431,937 83,882,020
Federal grant awards 33,128,165 33,128,165 32,067,800
Indirect cost allowances 20,258,404 20,258,404 19,558,159
Investment return utilized 10,741,551 10,741,551 9,576,065
Program fees 4,192,163 4,192,163 3,583,017
Publications sales 9,319,286 9,319,286
9,751,069
Dining services 3,780,431 3,780,431
3,349,002
Rooms and apartments 3,043,489
3,043,489 2,703,382
Royalty and licensing fees 693,345 -
693,345 2,873,198
Miscellaneous 931,666
931,666 652,207
Net assets released from restrictions 10,668,075 (10,668,075)
Total revenue and other support 118,101,149 12,501,682
14,917,606 145,520,437 167,995,919
Expenses:
Research 62,822,726
62,822,726 57,766,809
Educational programs 13,565,968
13,565,968 13,207,352
Publications 9,351,363
9,351,363 9,432,319
Banbury Center conferences 1,124,415
1,124,415 1,396,425
Dolan DNA Learning Center programs 1,325,479
1,325,479 1,231,059
Watson School of Biological 2,973,896
2,973,896 2,848,109
Sciences programs
General and administrative
Dining services
13,619,460
4,981,661
13,619,460
4,981,661
13,267,025
4,684,031
Total expenses 109,764,968
109,764,968 103,833,129
Excess of revenue and other support
over expenses 8,336,181
12,501,682 14,917,606 35,755,469
64,162,790
Other changes in net assets:
Investment return in excess of 13,165,561
7,780,924 20,946,485 8,264,298
amount utilized
Change in fair value of interest
rate swap
(3,370,108)
(3,370,108)
Increase in net assets
18,131,634 12,501,682
22,698,530 53,331,846 72,427,088
Net assets at beginning of year
195,431,117 70,289,399
147,128,826 412,849,342 340,422,254
Net assets at end of year
$ 213,562,751 82,791,081
169,827,356 466,181,188 412,849,342
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31, 2006
With comparative financial information for the year ended December 31, 2005
2006 2005
Cash flows from operating activities:
Increase in net assets $ 53,331,846 72,427,088
Adjustments to reconcile increase in net assets
to net cash provided by operating activities:
Change in fair value of interest rate swap 3,370,108
Depreciation and amortization 6,032,302 5,852,278
Net appreciation in fair value of investments (24,403,523) (13,009,353)
Contributions restricted for long-term investment (30,918,132) (47,445,268)
Changes in assets and liabilities:
Decrease (increase) in accounts receivable 2,740,444 (3,247,129)
Decrease (increase) in grants receivable 492,837 (1,376,762)
Increase in contributions receivable (31,856) (125,496)
Increase in publications inventory (851,626) (34,718)
Decrease (increase) in prepaid expenses and other assets 535,210 (409,312)
Increase in restricted use assets (372,207) (321,615)
(Decrease) increase in accounts payable and accrued expenses (1,042,172) 900,672
(Decrease) increase in deferred revenue (651,641) 358,816
Net cash provided by operating activities 8,231,590 13,569,201
Cash flows from investing activities:
Capital expenditures (21,123,188) (10,946,777)
97,347,685 134,357,645
Purchases of investments (124,641,857) (162,172,939)
Net change in investment in employee residences 434,677 (678,172)
Net cash used in investing activities (47,982,683) (39,440,243)
Cash flows from financing activities:
Permanently restricted contributions 14,917,606 12,312,801
Contributions restricted for investment in land, buildings,
and equipment 16,000,526 35,132,467
Decrease (increase) in contributions receivable 4,383,403 (34,959,882)
Increase in cash restricted for investment in buildings and equipment (46,014,949)
Cash payments for debt issue costs (2,240,577)
(Decrease) increase in accounts payable relating to capital expenditures (276,659) 2,031,084
Repayment of notes payable (35,551) (34,137)
Redemption of 1993 Suffolk IDA Bond (3,000,000)
Issuance of bonds payable 55,000,000
Net cash provided by financing activities 38,733,799 14 ,482,333
Net decrease in cash and cash equivalents (1,017,294) (11,388,709)
Cash and cash equivalents at beginning of year 24,580,708 35,969,417
Cash and cash equivalents at end of year $ 23,563,414 24,580,708
Supplemental disclosures:
Interest paid $ 2,614,630 1,134,372
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2006.
GRANTS January 1-December 31, 2006
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator
Duration of Grant 2006 Funding'
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Support Dr. Lowe
03/01/06 02/28/07 211,575 *
Dr. Lowe 06/01/06 05/31/07 647,000 *
Program Project Support Drs. Hannon/Krainer/Lazebnik/ 01/01/02
12/31/06 5,223,402
Lowe/S. Muthuswamy/Myers/
D. Spector/Stenlund/Stillman/Tansey
Dr. Stillman-CSHL Cancer Center Core 08/01/05 07/31/10 4,208,052
Drs. Lowe/Hannon/S. Muthuswamy 04/01/04 03/31/09
883,896
Dr. Huang 09/08/06 08/31/11
481,481 *
Pioneer Award Support Dr. Cline
09/30/05 07/31/10 827,584
Merit Award Support Dr. Malinow
05/01/92 04/30/10 658,599
Dr. Tonks 08/01/91
03/31/06 670,834
Contract Support Drs. Sebat/Wigler
01/01/06 12/31/06 447,352
Research Support Dr. Brody
07/01/04 04/30/09 201,760
Dr. Chklovskii 07/08/04
06/30/09 297,930
Dr. Cline 12/01/04
11/30/09 390,584
Dr. Dubnau
09/15/04 06/30/09 357,143
Dr. Hannon
09/01/05 08/31/09 340,021
Dr. Hirano
07/01/05 03/31/07 347,585
Dr. Hirano 05/01/96
03/31/07 397,240
Dr. Huang 07/15/05
04/30/09 382,758
Dr. Joshua-Tor 02/01/06
01/31/10 303,565
Dr. Joshua-Tor
02/15/02 01/31/07 364,724
Dr. Joshua-Tor
07/01/05 06/30/09 309,525
Dr. Krainer
07/01/03 06/30/07 554,951
Dr. Lowe
07/01/04 06/30/09 498,501
Drs. Mainen/Brody 09/23/02
08/31/07 379,876
Dr. Malinow
04/01/95 02/29/08 575,281
Dr. Martienssen
08/01/03 07/31/07 331,034
Dr. Mittal
04/01/04 03/31/09 305,379
Dr. Mitra
03/04/05 02/28/09 510,943
Dr. S. Muthuswamy 03/01/03
02/28/07 368,274
Dr. Neuwald
09/01/06 12/31/06 83,799
Drs. Powers/Lowe 12/01/06
11/30/11 383,210
Dr. Sebat 09/30/05
07/31/10 415,341
`Includes direct and indirect costs
*New and competing renewal grants
awarded in 2006 423
Dr. Skowronski 04/01/98 04/30/08 664,376
Dr. D. Spector 04/01/90 03/31/07 652,851
Dr. D. Spector 09/01/04 08/31/08 315,726
Dr. Stein 09/01/02 11/30/06 400,000 '
Dr. Stein 09/25/06 06/30/09 418,750 *
Drs. Stenlund/Hernandez 07/01/04 06/30/07 240,000
Dr. Stillman 07/01/91 05/31/08 562,712
Dr. Svoboda 12/01/03 11/30/07 244,965
Dr. Svoboda 12/01/02 11/30/07 220,136
Dr. Svoboda 06/01/03 03/31/08 297,482
Dr. Svoboda 03/01/04 02/28/09 335,171
Dr. Tansey 05/01/03 04/30/07 322,758
Dr. Tonks
Dr. Tonks
05/01/97
07/21/06
06/30/07
05/31/10
380,689
297,313 *
Dr. Tully 03/01/03 02/29/08 372,414
Dr. Tully 08/01/03 05/31/07 372,414
Dr. Van Aelst 05/01/03 04/30/08 331,447
Dr. Wig ler 07/15/98 04/30/07 519,388
Dr. Zador 01/23/03 12/31/07 451,725
Dr. Y. Zhong 07/01/03 06/30/08 338,895
Research Subcontracts
NIH/Affymetrix Consortium Dr. Stein 08/01/04 05/31/07 96,124 *
Agreement-Supplement
NIH/Booz Allen Hamilton caBIG Dr. Stein 03/07/06 12/07/06 157,528 *
Consortium Agreement
NIH/Booz Allen Hamilton caBIG Dr. Stein 03/07/06 11/07/06 150,979 *
Consortium Agreement
NIH/Booz Allen Hamilton caBIG Dr. Stein 03/07/06 12/07/06 151,721 *
Consortium Agreement
NIH/Brookhaven National Laboratory Dr. Stillman 09/01/06 08/31/11 35,559 *
NIH/Caltech Consortium Agreement Dr. Stein 09/01/03 08/31/07 757,911
NIH/Caltech Consortium Agreement Dr. Svoboda 04/04/03 02/29/08 147,818
NIH/Columbia University Dr. Lowe 08/18/06 07/31/11 434,305 *
Consortium Agreement
NIH/Columbia University Drs. Wigler/Sebat 09/01/06 05/31/10 286,030 *
Consortium Agreement
NIH/Georgia Institute of Technology Dr. D. Spector 09/30/06 09/29/11 220,000 *
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Mittal 04/01/04 03/31/09 137,480
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Van Aelst 07/10/03 06/30/08 338,271
Consortium Agreement
NIH/Oxford University Dr. Stein 03/01/06 02/28/11 180,874 *
NIH/Rutgers University Dr. Mitra 12/08/04 11/30/08 107,338
Consortium Agreement
NIH/State University at Stony Brook Dr. McCombie 11/01/05 08/31/06 55,000 *
NIH/VVashington University Dr. Stein 09/01/03 08/31/08 56,199
Consortium Agreement
Fellowship Support Dr. Chicas 04/01/06 03/31/09 49,928 *
C. Kopec 03/01/04 09/30/06 4,455
Dr. Gray 03/01/06 12/31/06 29,578 *
Dr. Slotkin 09/16/06 09/14/09 43,996 *
Dr. Weimer 07/01/05 09/08/06 12,192
Dr. Wilbrecht 07/01/05 06/30/08 51,195
Dr. Yang 03/01/06 02/28/09 50,428 *
Career Development Support Dr. He 12/01/06 11/30/08 112,383 *
"New and competing renewal grants awarded in 2006
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Graduate Training Support
Course Support
Dr. Lucito
Dr. Clark
Integrated Data Analysis for
06/01/02
09/01/06
09/30/99
05/31/07
06/30/07
04/30/07
146,156
209,429 *
57,421
High-throughput Biology
Immunocytochemistry, In Situ 07/01/98 08/31/10 99,482
Hybridization, and Live Cell Imaging
Programming for Biology 07/07/00 08/31/09 53,561
C. elegans 08/01/98 08/31/11 80,484
Computational and 06/06/91 08/31/07 48,974
Comparative Genomics
Cell and Developmental 04/01/93 03/31/09 20,624
Biology of Xenopus
Protein Purification and 01/01/83 03/31/11 80,517
Characterization
Molecular Embryology of the Mouse 01/01/83 03/31/11 94,474
Eukaryotic Gene Expression 01/01/83 03/31/11 100,010
Mechanisms and Models of Cancer 07/01/06 06/30/07 4,662 *
Proteomics Course 07/01/03 06/30/11 72,343
Cell Biology Course 07/01/05 06/30/08 62,696
Meeting Support Molecular Chaperones and the 04/01/04 03/31/09 13,001
Heat Shock Response
Pharmacogenomics 08/01/04 07/31/09 39,822
The Biology of Genomes 04/08/05 03/31/08 41,422
Physiological Genomics and Rat Models 09/30/05 08/31/08 15,000
Mouse Molecular Genetics 07/12/02 06/30/07 13,352
Translational Control 07/05/02 06/30/07 6,001
The Cell Cycle 03/01/06 02/28/09 4,000 *
PTEN Pathways 03/01/06 02/28/09 15,000 *
Channels, Receptors, and Synapses 04/01/06 03/31/11 23,265 *
Germ Cells 04/01/06 03/31/07 6,000 *
71st Symposium: Regulatory RNAs 05/01/06 04/30/07 15,000 *
Axon Guidance, Synaptogenesis, and 07/01/06 06/30/07 15,000 *
Neural Plasticity
Molecular Genetics of Aging 07/01/06 06/30/07 20,449 *
Gene Expression and Signaling in the 04/19/02 03/31/07 2,001
Immune System
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Hannon
09/01/06 08/31/09 1,078,000 *
Dr. McCombie 09/01/06 08/31/08
1,891,911 *
Dr. Stein 12/15/03 11/30/07
2,507,500
Dr. Jackson 07/01/05 06/30/10 1,173,258
Research Support Dr. JacksonDr. Lukowitz
03/01/04
04/01/05
02/28/07
03/31/08
145,000
125,970
Dr. Timmermans 09/01/06 08/31/09
130,000 *
Dr. Timmermans 09/01/06 08/31/09 159,532 *
Dr. Van Aelst 08/15/05 07/31/08 133,622
Dr. Ware 09/01/03 08/31/08 211,634
Dr. M. Zhang 09/15/03 08/31/08 104,000
Research Subcontract Support
NSF/Cornell University
Consortium Agreement
NSF/North Carolina State University
Dr. Timmermans
Dr. Martienssen
01/01/06
10/01/04
08/31/07
09/30/09
697,667 *
204,913
Consortium Agreement
NSF/University of Florida
Dr. Martienssen 09/15/05 08/31/07 50,745
Consortium Agreement
NSF/New York University
Drs. McCombie/Martienssen 10/01/04 09/30/09 258,164
Consortium Agreement
*New and competing renewal grants
awarded in 2006
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NSF/Washington Unversity Drs. McCombie/Martienssen/Stein/Ware 11/15/05 10/31/08 1,292,747 "
Consortium Agreement
NSF/University of Arizona Dr. Stein 10/01/03 09/30/07 214,279
Consortium Agreement
NSF/University of Arizona Dr. Stein 10/01/06 09/30/08 152,993 *
Consortium Agreement
NSF/University of Calfornia-Berkeley Dr. Jackson 08/01/06 07/31/11 203,029 *
Consortium Agreement
NSF/University of Wisconsin Drs. Stein/Ware 01/01/04 12/31/08 208,209
NSF/National Center for Genome Dr. Stein 09/01/05 08/31/08 56,132
Research Consortium Agreement
Fellowship Support D. Chitwood 09/01/04 08/31/07 40,500
Undergraduate Training Support Dr. Clark 04/01/05 03/31/08 113,008
Meeting Support Molecular Genetics of Bacteria and Phages 2006 5,000 *
Systems Biology: Global Regulation
of Gene Expression
2006 12,000 *
Course Support Advanced Bacterial Genetics 07/15/04 06/30/09 75,557
Computational Neuroscience: Vision 07/01/06 06/30/07 22,000 *
Molecular Approaches to Plant Science 07/01/03 06/30/07 77,955
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/05 08/31/08 117,669
Dr. McCombie 09/15/04 09/14/09 25,000
Drs. McCombie/Martienssen 02/01/04 01/31/07 198,479
Dr. Stein 09/22/03 09/14/08 210,000
Dr. Timmermans 09/15/06 09/14/09 129,475 *
Research Subcontract Support
USDA/Oregon State University Dr. Martienssen 12/01/04 11/30/07 17,322
Consortium Agreement
Fellowship Support Dr. Whipple 09/15/06 08/14/08 61,819
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 02/01/06 01/31/09 169,500 *
Dr. Hannon 02/15/06 02/14/09 169,500 *
Dr. Lazebnik 12/01/06 11/30/09 209,375 *
Drs. Lucito/Wigler 02/01/05 01/31/07 901,422
Dr. Y. Zhong 12/15/04 12/14/08 338,733
Drs. Wigler/Lucito 04/01/04 08/31/07 1,365,000 *
Fellowship Support D. Khalil 12/01/06 11/30/09 33,300 *
E. Murchison 02/16/05 02/15/08 30,000
S. Nunez 02/27/04 02/28/07 30,000
A. Rosenberg 02/28/05 02/28/08 30,000
D. Simpson 09/01/06 08/31/09 32,400 *
Dr. P. Smith 04/01/04 03/31/07 108,000
Research Subcontract Support
U.S. Army/Johns Hopkins University Dr. Wig ler 12/01/05 12/31/06 294,355 *Consortium Agreement
U.S. Army/New York University Dr. Lucito 09/27/04 09/26/09 147,307Consortium Agreement
"New and competing renewal grants awarded in 2006
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UNITED STATES DEPARTMENT OF ENERGY
DOE/Texas A&M Consortium Agreement Dr. Ware 09/15/06 09/14/08 38,376 *
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
The Berkowitz Family Foundation
F.M. Kirby Foundation, Inc.
Dr. Mittal
Dr. D. Spector
07/01/06
10/01/06
06/30/07
09/30/07
25,000 *
30,000 *
The Seraph Foundation Dr. D. Spector 10/01/06 09/30/07 37,000 *
Program Project Support
DART Neurogenomics Project Drs. Tully/Cline/Dubnau/Henry/ 10/01/04 09/30/07 2,774,046
Mitra/M. Zhang/Y. Zhong
Leukemia and Lymphoma Society Dr. Lowe 10/01/03 09/30/08 1,250,000
Simons Foundation Drs. Wigler/Sebat 06/01/06 05/31/08 3,775,419
Research Support
ALS Association
American Cancer Society
American Cancer Society
American Cancer Society
Anonomous Gift
Anonomous Gift
Berlin Family Foundation
Berlin Family Foundation
Brain Tumor Society
Breast Cancer Research Foundation
Breast Cancer Help Inc.
Clear Channel Worldwide (Walk 97.5 FM)
Breast Cancer Research Walk
CSH Main Street Association
Katheryn Wasserman Davis Gift
De Matteis Family Foundation
The Don Monti Memorial Research
Foundation
ELJI/SUSB Consortium Agreement
Norman and Dorian Feckl Gift
Find A Cure Today (EA.C.T.)
FSMA
GlaxoSmithKline
Glen Cove C.A.R.E.S.
Robert Goldman Foundation
Lita Annenberg Hazen Foundation
Irving Hansen Foundation
Human Frontier of Science Program
Joan's Legacy: The Joan Scarangello
Foundation to Conquer Lung Cancer
Karches Foundation
Karp Foundation
W.M. Keck Foundation
David H. Koch Gift
The Forrest and Francis Lattner
Foundation in Honor of Andrew Harris
Lehman Brothers Foundation, Inc.
L.I.A.B.C.
Long Island 2-Day Walk
Long Island Cruizin' for a Cure
March of Dimes
Carol Marcincuk Ovarian Cancer
Research Fund
Dr. Enikolopov
Dr. Mills
Dr. Wig ler
Dr. Wig ler
Dr. Malinow
Dr. Sebat
Dr. Stillman
Dr. Watson
Dr. Hannon
Dr. Wig ler
Dr. Wig ler
Dr. S. Muthuswamy
Dr. Powers
Dr. Hannon
Dr. Powers
Dr. Lowe
Dr. Huang
Dr. Enikolopov
Dr. S. Muthuswamy
Dr. Hastings
Dr. Powers
Dr. S. Muthuswamy
Dr. Mittal
Dr. Powers
Dr. Tansey
Dr. Dubnau
Dr. Mu
Dr. Wig ler
Dr. Brody
Dr. Mitra
Dr. Powers
Dr. Sebat
Dr. Powers
Dr. Wig ler
Dr. S. Muthuswamy
Dr. Powers
Dr. Huang
Dr. Lucito
09/01/06
07/01/06
01/01/96
01/01/06
09/01/06
01/01/06
04/01/06
04/01/06
11/01/06
10/01/06
2006
04/01/06
07/01/06
04/01/06
10/01/04
06/01/06
01/15/04
03/16/06
07/01/03
01/15/06
09/20/06
02/01/06
12/31/06
11/01/06
08/01/06
10/01/06
11/01/05
07/01/05
01/01/06
07/01/06
07/01/06
12/16/05
11/01/06
2006
08/01/06
2006
06/01/04
2006
08/31/07
06/30/10
12/31/06
12/31/10
08/31/08
12/31/07
03/31/07
03/31/07
10/31/07
09/30/07
03/31/07
06/30/07
03/31/07
09/30/06
05/31/07
01/14/07
03/14/07
07/31/06
01/14/08
08/19/08
01/31/07
12/30/07
10/31/07
07/31/07
09/30/09
10/31/07
06/30/10
12/31/06
06/30/09
06/30/07
12/16/07
10/31/07
07/31/07
05/31/07
118,000 *
240,000 *
10,000 *
60,000 *
130,000 *
244,439 *
20,000 *
5,019 *
100,000 *
250,000 *
1,553 *
4,000 "
4,200 *
400,000 *
450,000 *
250,000 *
70,000
20,000 *
58,167 *
219,674 *
451,524 *
25,000 *
41,000 *
250,000 *
20,000 *
125,000 *
50,000
452,570
40,000 *
500,000 *
50,000 *
504,800
25,000 *
93,831 *
26,000 *
19,426 *
98,270
9,001 *
'Includes direct and indirect costs
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The Mary LaRuffa Gift Dr. Stillman 06/01/06 05/31/07 2,727 '
The Miracle Foundation Dr. Wig ler 01/01/06 12/31/06 100,000
The Elizabeth McFarland Breast Dr. Wig ler 06/01/06 05/31/07 45,050
Cancer Fund
Louis Morin Charitable Trust Drs. Zador/Krainer 12/01/06 11/30/07 75,000
NAAR Dr. Van Aelst 07/01/05 06/30/07 60,000
NARSAD Dr. Enikolopov 09/15/06 09/14/08 50,000
Laura Obadian Smith Initiative Breast Cancer Research 2006 500 *
Omidyar Foundation Drs. Powers/Hannon 10/01/06 09/30/07 500,000 *
Philip Morris USA Dr. Mittal 07/01/05 06/30/06 423,750
Vivian Parisi Gift Dr. Powers 04/01/06 03/31/07 950 *
The Fannie E. Rippel Foundation Drs. Lucito/Tonks 12/01/05 11/30/07 154,000
The Seraph Foundation Dr. Enikolopov 10/01/06 09/30/07 86,000
SMA Foundation Dr. Krainer 06/01/04 05/31/07 59,333
Linda and Henry Spire Gift Dr. Tonks 01/01/06 12/31/06 10,000 *
Topspin/Dr. L. Guthhart Drs. Hannon/Lowe 2006 250,000 *
Town of Islip Breast Cancer Coalition Dr. Powers 06/01/06 05/31/07 10,250 *
Waldbaums Foundation Dr. Powers 10/01/06 09/30/07 50,000 *
Waterbor Foundation Dr. Powers 10/01/06 09/30/07 5,000 *
West Islip Breast Cancer Coalition Dr. Wig ler 11/01/06 10/31/07 10,000 *
Women In Science Dr. Stillman 2006 33,455 "
Women's Insurance Network of Dr. Powers 2006 18,116 "
Long Island
Fellowship Support
American Foundation For Aging Research R. Bish 12/01/06 11/30/07 500 *
Arnold and Mabel Beckman Foundation Dr. Dubnau 09/01/05 08/31/08 88,000
Arnold and Mabel Beckman Foundation Watson School of Biological Sciences 09/01/05 08/31/09 350,000
Burroughs Wellcome Dr. Hall 09/01/06 08/31/08 58,000 *
Burroughs Wellcome Dr. Karpova 09/01/05 08/31/07 58,000
Cashin Family Fund Watson School of Biological Sciences 09/01/04 08/31/07 40,000
Cody Center/State University at Dr. Enikolopov 10/01/06 09/30/07 40,000 *
Stony Brook
C.J. Martin Fellowship Dr. Irvine 04/01/06 03/31/10 45,966 *
CSHL Association Fellowship Dr. Schalch 2006 54,089 *
CSHL Association Fellowship Dr. Jensen 2006 52,102 *
CSHL Association Fellowship Dr. Nawy 2006 53,998 *
CSHL Association Fellowship Dr. Aravin 2006 57,911 *
CSHL Association Fellowship Dr. Thakar 2006 55,062 *
DAAD (German Academic Exchange Service) Dr. Bouyer 09/01/06 08/31/07 14,500 *
DFG German Science Foundation Dr. Bommert 10/01/06 09/30/08 9,810 *
Englehorn Scholarship Program Watson School of Biological Sciences 09/01/00 12/31/07 89,980
European Molecular Biology Organization Dr. Schwab 03/01/06 02/28/06 31,371 *(EMBO) Long-term Fellowship
Francis Goelet Fellowship in Dr. Wig ler 10/01/05 09/30/08 70,707
Biomathematics
Francis Goelet Foundation Dr. Stillman 01/01/06 12/31/06 5,000 *
Ford Foundation Predoctoral Fellowship K. John 09/01/04 08/31/07 22,000
Goldring Fellowship Dr. Stillman 09/01/06 08/31/07 77,550 *
Teresa Haire Memorial Fund Watson School of Biological Sciences 04/01/06 03/31/07 2,640 *
Ira Hazan Dr. Enikolopov 12/22/06 12/21/07 200,000 *
Heat and Stroke Foundation Dr. Boivin 07/01/06 06/30/08 35,928 *
Helen Hay Whitney Foundation Dr. He 04/01/04 11/30/06 31,121
Human Frontier Science Program Dr. Kasri 09/01/06 08/31/09 38,000 *
Organization (HFSPO)
Human Frontier Science Program Dr. Da Silva 01/01/06 12/31/08 38,000 *Organization (HFSPO)
Human Frontier Science Program Dr. Aono 04/01/06 03/31/08 38,000 *Organization (HFSPO)
*New and competing renewal grants awarded in 2006
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Jane Coffin Childs Foundation
Klingenstein Foundation
Lauri Strauss Leukemia Foundation
Leukemia Research Foundation
The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society
The Lymphona Research Foundation
Merck Career Development Award
McKnight Endowment
NARSAD
NARSAD
NARSAD
NARSAD
NYS Department of Health, Health
Research Science Board, Breast Cancer
Research, and Education Program
The Rita Allen Foundation
The Andrew Seligson Memorial Clinical
Fellowship for Cancer Research
The Seraph Cancer Research Scholar Award
The Judi Shesh Memorial Foundation
Swartz Foundation
Swartz Foundation
Swartz Foundation
Swartz Foundation
Swartz Foundation
Swartz Foundation
Michel David-Weill
Training Support
Cornelius N. Bliss Memorial Fund
Hunter College
Jephson Educational Trust
Steamboat Foundation
William Townsend Porter Foundation
Course Support
American Brain Tumor Association
Eppley Foundation
Eli Lilly
Howard Hughes Medical Institute
Medical Research Council
Novartis
New and competing renewal grants
awarded in 2006
Dr. Rivas
Dr. Chklovskii
Dr. Zuber
Dr. Ceparo
Dr. Gangadharan
Dr. Krizhanovsky
Dr. Liu
Dr. Wendel
Dr. Kurland
Watson School of Biological Sciences
Dr. Huang
Dr. Kuhlman
Dr. Real
Dr. Takahashi
Dr. H. Zhong
Dr. S. Chen
Dr. S. Muthuswamy
Dr. Zender
Watson School of Biological Sciences
Dr. Powers
Center for Neural Mechanisms of
Cognition
Dr. Mitra
Drs. Brody/Chow
Drs. Mainen/Felsen
Drs. Chklovskii/Mishchenko
Drs. Mainen/Uchida
CSHL Fellows Program
Undergraduate Research Program
Undergraduate Research Program
Undergraduate Research Program
Undergraduate Research Program
Undergraduate Research Program
Mechanisms of Neural Differentiation
and Brain Tumors
Stem Cells
Nuclear Receptors and Disease
Cell and Developmental Biology
of Xenopus
Ion Channel Physiology
Neurobiology of Drosophila
Advanced Techniques in Molecular
Neuroscience
Yeast Genetics and Genomics
Imaging Structure and Function in
the Nervous System
Crystallography
Phage Display of Proteins and Peptides
Genetics of Complex Human Diseases
Computational Neuroscience: Vision
Biology of Social Cognition Workshop
Novartis Proteomics
07/01/04
07/01/04
05/01/06
07/01/05
07/01/05
07/01/06
07/01/05
07/01/05
07/01/06
01/01/05
07/01/04
07/01/06
07/01/06
07/01/05
07/01/05
01/01/06
06/30/07
06/30/07
04/30/07
11/11/06
06/30/08
06/30/09
06/30/08
12/31/06
06/30/08
12/31/07
06/30/07
06/30/08
06/30/08
06/30/07
08/31/06
12/31/07
08/01/04 07/31/07
11/01/06 10/31/07
10/01/04 09/30/07
12/01/06 11/30/07
01/01/06 12/31/06
01/01/06
01/01/06
01/01/06
01/01/06
01/01/06
09/01/06
12/31/06
12/31/06
12/31/06
12/31/06
12/31/06
08/31/09
2006
2006
2006
05/01/06 04/30/07
04/01/06 03/31/07
2006
2006
2006
09/01/04 08/31/07
2006
2006
45,500
50,000
15,000 "
11,250
55,000
50,000 *
55,000
41,250
50,000 "
20,000
75,000
30,000 *
30,000 "
30,000 *
5,000
60,000 "
58,481
75,000 "
45,000
7,500 *
333,333 "
50,000 *
50,000 *
50,000 *
50,000 *
50,000 *
200,000 *
4,500 *
7,000 *
5,000 *
12,000 *
10,000 *
40,000 *
25,000 *
5,000 *
330,000
17,900 *
141,673 *
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Society for Neuroscience
Meeting Support
Scholarship Support 2006 17,520
Cell Signaling Technologies Translational Control 2006 1,000
Lalor Foundation Germ Cells 2006 5,000 *
March of Dimes Germ Cells 2006 5,000
N.Y. Structural Biology Group Crystallography Workshop 2006 16,000 *
Swartz Foundation Neuronal Circuits: From Structure
to Function
2006 10,000 *
Swartz Foundation Neurobiology Students Journal Clubs 2006 15,000 *
Merck & Co., Inc. Gene Expression and Signaling in the 2006 5,000 *
Immune System
Research and Diagnostic Systems, Inc. Gene Expression and Signaling in the 2006 2,000 "
Immune System
BD Biosciences Gene Expression and Signaling in the 2006 5,000 *
Immune System
Abbott Bioresearch Center Gene Expression and Signaling in the 2006 5,000 *
Immune System
Elan Pharmaceuticals Gene Expression and Signaling in the 2006 4,000 "
Immune System
Genetic Gene Expression and Signaling in the 2006 2,500 *
Immune System
Point Therapeutics, Inc. Gene Expression and Signaling in the 2006 3,500 *
Immune System
Cell Signaling Technology, Inc. Gene Expression and Signaling in the 2006 1,000 *
Immune System
Boehringer Ingelheim Pharmaceuticals, Inc. Gene Expression and Signaling in the 2006 1,000 "
Immune System
Society for Developmental Biology Workshop on Chicken Genomics and 2006 3,000 *
Development
Genesis Faraday Partnership, Ltd. Workshop on Chicken Genomics and 2006 2,515 *
Development
Affymetrix Workshop on Chicken Genomics and 2006 980 *
Development
Roslin Institute Workshop on Chicken Genomics and 2006 5,303 *
Development
Library Support
Josiah Macy, Jr. Foundation 05/01/05 05/31/07 310,857
New York State 07/01/06 06/30/07 4,412 *
Bauman Rare Books Sidney Brenner Collection 10/01/06 09/30/07 40,000 *
Ridley Rare Books 09/01/02 12/31/06 10,000 *
New and competing renewal grants awarded in 2006
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DOLAN DNA LEARNING CENTER GRANTS
Duration
Grantor Program/Principal Investigator of Grant
2006
Funding-
FEDERAL GRANTS
AAAS/NSF BiosciEdNet (BEN) Collaborative Cycle 3 10/05-09/07
Cornell University/NSF Functional Analysis of Genes Involved in Meristem 01/06-08/07
$ 60,958
33,559
Organization and Leaf Initiation
National Science Foundation Developing and Disseminating New Laboratories on 02/05-01/07 37,345
Plant Molecular Genetics and Genomics
National Science Foundation Developing and Disseminating New Laboratories in 06/05-12/06 153,518
RNAi and Functional Genomics
National Science Foundation VCA: Finishing the Rice Genome 09/04-08/07 68,042
National Science Foundation VCA: Gramene: A Platform for Comparative Genomics 12/05-11/07 112,411
U.S.D.A. Systematic Determination of the Gene Set 02/05-01/07 14,611
Virginia Tech/NIH Partnership for Research and Education in Plants 09/04-08/06 7,694
Washington University/NSF Sequencing the Maize Genome 11/05-10/07 17,501
NONFEDERAL GRANTS
Amgen Foundation Amgen Leadership Symposium 04/05-03/08 $ 85,925
Carolina Biological Supply Company Research support 2006 75,000
Clemson University License, training, and development 2006 50,000
Dana Foundation Genes to Cognition (G2C) Online: A Network-driven 10/05-09/07 235,824
Internet Site on Modern Brain Research
Dialog Gentechnik License, training, and development 2006
24,950
Goldman Sachs Foundation Planning grant 2006
50,000
Hewlett Foundation Genes to Cognition (G2C) Online 10/05-10/08 114,451
North Shore-LIJ Health System DNALC West support
2006 50,000
Porter Foundation Underrepresented Communities Program
2006 30,000
The following schools each awarded a grant of $1000 or more for the Curriculum Study Program:
Bellmore-Merrick Central High School District $ 1,250 Locust Valley Central School District
$ 1,250
Bethpage Union Free School District 1,250
Long Beach City School District 2,500
Commack Union Free School District 2,500
Massapequa Union Free School District 2,500
Elwood Union Free School District 1,250
North Shore Hebrew Academy 2,500
Fordham Preparatory School 1,250
Oceanside Union Free School District 1,250
Friends Academy 1,250
Plainedge Union Free School District
Garden City Union Free School District 1,250
Plainview-Old Bethpage Central School District
1,250
1,250
Harborfields Central School District 1,250
Port ledge School 1,250
Herricks Union Free School District 1,250
Port Washington Union Free School District
Huntington Union Free School District 1,750
Roslyn Union Free School District
Island Trees Union Free School District 1,250
Sachem Central School District
Jericho Union Free School District 1,250
South Huntington Union Free School District
Lawrence Union Free School District 1,250
Yeshiva University High School for Girls
1,250
1,250
1,250
2,500
1,250
Levittown Union Free School District 1,250
The following schools each awarded a grant of $1000 or more
for the Genetics as a Model for Whole Learning Program:
$ 5,460 Lawrence Union Free School District $ 7,800
3,400 Locust Valley Central School District 8,187
21,000 Mamaroneck Union Free School District 6,400
1,850 Merrick Union Free School District 1,200
5,100 North Bellmore Union Free School District 1,750
1,975 Old Westbury School of the Holy Child 4,950
5,120 Oyster Bay-East Norwich Central School District 2,267
1,600 Plainview-Old Bethpage Central School District 3,469
5,800 Port Washington Union Free School District 10,400
2,550 Rockville Centre Union Free School District 3,300
10,845 St. Dominic Elementary School 3,900
23,792 St. Edward the Confessor School 1,820
1,587 St. Mary's Elementary School 1,850
6,300 Syosset Union Free School District 30,175
5,800 Three Village Central School District 3,025
9,500 Uniondale Union Free School District 1,200
Bayshore Union Free School District
Bellmore Union Free School District
Bellmore-Merrick Central School District
Brandeis School
Commack Union Free School District
East Meadow Union Free School District
Elwood Union Free School District
Farmingdale Union Free School District
Floral Park-Bellerose Union Free School District
Friends Academy
Garden City Union Free School District
Great Neck Union Free School District
Greenvale School
Half Hollow Hills Central School District
Huntington Union Free School District
Jericho Union Free School District
'Includes direct and indirect costs
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BANBURY CENTER GRANTS
Grantor Program/Principal Investigator Duration of Grant 2006 Funding'
FEDERAL SUPPORT
Centers for Disease Control and
Prevention (CDC)
NIH-National Institute of Allergy and
Infectious Diseases
NIH-National Institute of Arthritis and
Musculoskeletal and Skin Diseases
NIH-National Institute of Mental
Health (through a grant to
University of Illinois)
NIH-National Institute of
Neurological Disorders and Stroke
U.S. Food and Drug Administration
NONFEDERAL SUPPORT
Meeting Support
Aetos Technologies, Inc.
The ALS Association
American College of Medical
Genetics
Autism Speaks
Cure Autism Now
The Dart Foundation
The Thomas Hartman Foundation
for Parkinson's Research
The William and Flora Hewlett
Foundation
Nancy Lurie Marks Family
Foundation
McLaughlin Centre for Molecular
Medicine
National Alliance for Autism
Research
Marie Robertson Memorial Fund
Simons Foundation
Spinal Muscular Atrophy
Foundation
The Stanley Foundation
The Swartz Foundation
Verto Institute
Volkswagen Foundation
'Includes direct and indirect costs
*New grants awarded in 2006
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Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Fragile X Syndrome: Basic Mechanisms
and Treatment Implications
Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Chronic Lyme Disease Syndromes:
New Avenues for Investigation
Axonal Dynamics and Synaptic Junctions
The Evolving Role of the Board-certified
Medical Geneticist
A Critical Assessment of Autism Genetics
A Critical Assessment of Autism Genetics
Design Principles in Biological Systems
Parkinson's Disease: Insights from
Genetics and Toxin Models
New Horizons in Internet Site
Development
A Critical Assessment of Autism Genetics
A Critical Assessment of Autism Genetics
A Critical Assessment of Autism Genetics
The Phenomology of Reconsolidation
A Critical Assessment of Autism Genetics
Spinal Muscular Atrophy: From RNA to
Synapses
Research on Genetics of Bipolar Disorder:
Current Approaches and Future Directions
Computational Approaches to Cortical
Function
The Biology of Neuroendocrine Tumors
The Phenomology of Reconsolidation
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
2006
$ 7,830*
5,000"
5,000*
47,453*
7,000"
7,000*
10,000"
29,311*
10,335*
5,000*
5,000*
50,000*
25,000
30,200
10,000*
5,000*
10,000*
20,000
20,000*
42,267*
7,331"
42,697*
31,490*
19,572*
DEVELOPMENT
The year 2006 was a very exciting one for all of us at Cold Spring Harbor Laboratory. In addition to the many out-
standing research discoveries, the Laboratory officially embarked on a $200 million campaign to raise funds for six new
research buildings, to support recruitment of new faculty in cancer and neurobiology, and to build the endowment. To
date, the Laboratory has already raised $134 million toward this campaign goal.
The inaugural Double Helix Medal Dinner was held on November 9, during which Muhammad Ali, Suzanne and Bob
Wright, and Phil Sharp were honored for their extraordinary achievements in the field of biomedical research. The
evening raised more than $2 million in unrestricted funds for Laboratory research.
This year, as Cold Spring Harbor Laboratory celebrates many successes, we acknowledge all who continue to
believe so strongly in the work that we do.
Cold Spring Harbor Laboratory is a nonprofit research
and educational institution, chartered by the State of
New York. Science Watch, an independent ratings
service, has ranked the Laboratory's molecular biolo-
gy and genetics program number one during the last
decade. Additionally, Charity Navigator, a philanthrop-
ic evaluator, has bestowed their highest 4-star rating
on the laboratory for 5 consecutive years.
Less than half of the Laboratory's annual revenues
are derived from Federal grants and contracts, and
thus, we rely heavily on support from the private sec-
tor: foundations, corporations, and individuals. Foun-
dations, corporations, and individuals can give to Cold
Spring Harbor through a variety of methods:
Capital and Endowment Campaign Support: Cold Spring
Harbor has embarked on a $200 million capital and
endowment campaign to speed the translation of genet-
ic discoveries into diagnostic and therapeutic treatments
and to expand Lab facilities and staff. Endowment gifts
can be directed toward supporting cancer, neuroscience,
or educational programs. Capital gifts can be made to
name laboratories and conference rooms in one of our
six
new research buildings.
Annual Fund and Research Support: Donations
provide
funding for some of the most determined and innovative
young researchers in science today. Your gift is an
invest-
Charles V. Prizzi, Chief Development Officer
Landon and Lavinia Clay
established the Crick-Clay
Endowment for Biomathematics.
A lead gift from Holly and
Henry Wendt will enable the
Lab to construct a building for
neurological disorder research.
ment in some of the world's most innovative research in
cancer, neuroscience, plant biology, and bioinformatics.
Science Education: Donations support programs at the
Dolan DNA Learning Center, where the next generation of
scientists learn about genetics in an exciting and interac-
tive environment.
Planned and Estate Gifts: Individuals who inform us of their
intention to make a gift to Cold Spring Harbor Laboratory
from their estate are invited to become members of The
Harbor Society. Estate gifts help to ensure that CSHL will
continue to pursue its mission for many years to come.
For additional information, please contact the Chief
Development Officer, Cold Spring Harbor Laboratory, One Bungtown Road,
Cold Spring Harbor, New York 11724. Phone number:
516-367-6865.
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President's Council
The Cold Spring Harbor Laboratory President's Council is composed of individuals who gather togeth-
er for stimulating scientific events related to current CSHL research. Their contributions of $25,000 or
more annually support the Cold Spring Harbor Laboratory Fellows, a group of exceptionally talented
young scientists who show the capacity for high-level innovative research. Rather than conducting a
postdoctoral apprenticeship with a senior scientist, as is conventional, Fellows begin independent
research immediately following receipt of their Ph.D.s. This rigorous program promotes outstanding
young scientists to advance their careers at a young age so that they can promptly contribute new
insights to important biomedical science.
In May, President's Council member and cochair Bill Haseltine hosted a spring reception-A Taste
of Cold Spring Harbor Laboratory-for Council members at his home in New York City. At Cold Spring
Harbor's campus in October, the 2006 meeting-Cognition and Its Disorders-featured talks by sci-
entists working throughout the entire spectrum of cognitive neuroscience. From exploring the molecu-
lar and genetic underpinnings of brain function to developing state-of-the-art tools for clinical studies,
these scientists explained how they work to bridge the most promising advances in understanding the
brain. The connections they make, such as the neural circuitry that underlies the workings of the brain,
may elucidate fundamental aspects of emotion, logic, and decision-making, as well as the biological
roots of conditions such as autism, schizophrenia, Alzheimer's, and Parkinson's.
Mr. and Mrs. Abraham Appel
Mr. and Mrs. Donald Everett Axinn
Karen H. Bechtel
Dr. Gerald Chan
Dr. and Mrs. Lan Bo Chen
Richard Baron Cohen
Michel David-Weill
David B. Ford
Mr. and Mrs. John H. Friedman
Jacob Goldfield
Dr. and Mrs. Leo A. Guthart
Mr. and Mrs. Charles E. Harris
Dr. William A. Haseltine
Mr. and Mrs. J. Tomilson Hill
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Bryan H. Lawrence
Mary D. Lindsay
Mr. and
George F. Ohrstrom
Wendy Keys and Donald A. Pels
Mr. and Mrs. John C. Phelan
Roderick N. Reed
Mr. and Mrs. Luis E. Rinaldini
Mr. and Mrs. Alan Seligson
Dr. and Mrs. James H. Simons
Cynthia R. Stebbins
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
Dr. and Mrs. Jerome Swartz
Joan Tilney
Mr. and Mrs. Raymond L.M. Wong
As part of the 2006 President's Council meeting,
Mara Haseltine's sculpture "The Waltz of the Poly-
peptide" was officially donated to the Laboratory
and dedicated to her father, President's Council
cochair Bill Haseltine.
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At the President's Council spring reception "A Taste of Cold Spring Harbor
Laboratory" are (left to right) Jane Friedman, Beverley Gasner, John Friedman,
and Dr. Mark Zoller.
Cold Spring Harbor Laboratory Association (CSHLA)
Members of the Cold Spring Harbor Laboratory Association have supported and encouraged young
scientists for many decades. The Laboratory Association annual fund is an important source of unre-
stricted funding for postdoctoral fellows and new faculty as they set up labs and pursue highly creative
projects that are not eligible for government funding. In 2006, for the third year in a row, members con-
tributed well over $1 million in unrestricted funding for the ground-breaking research projects for which
our scientists are so well known.
Laboratory Association members are invited throughout the year to lectures on timely social science
and health topics ranging from nutrition to bioterrorism. Subscriptions to our popular Saturday evening
Young Concert Artist Series are complimentary to members at the Friend level and above. Our quar-
terly Harbor Transcript newsletter informs Association members about our scientists, students, support
staff, and the volunteers who are integral to the Laboratory's important health discoveries. All members
are invited to social events at the Laboratory and encouraged to get to know our scientists and their
families. They are also encouraged to join our annual Jazz at the Lab benefit committee and to attend
our annual Double Helix Medal benefit in New York City.
We are grateful for the nearly 1000 annual members of the Laboratory Association who partner in
our mission to lead the world in molecular biological discoveries and to raise awareness of the impor-
tance of genetics research to improve the health of people everywhere.
Directors
Joseph T. Donohue,
President
Pien Bosch,
Vice President
Lynn M. Gray,
Vice President
Timothy S. Broadbent,
Treasurer
Lynn McGrath Tone,
Secretary
Joseph V. Amelia
David L. Banker
Joyce Bertoldo
Maria L. Brisbane
Barbara Candee
Suzanne Di Maio
E. Richard Droesch
Nancy Edsparr
Linda Ferrante
Kate Seligson Friedman
Lori Garofalo
Larry E. Gellman, M.D.
John S. Grace
Michael S. O'Brien
Jay C. Plourde
Scott J. Ratner, M.D.
Henry E. Salzhauer
Raymond G. Schuville
Cathy Cyphers Soref
John C. Stevenson, Ph.D.
Bruce Stillman, Ph.D.
Sandy Tytel
James D. Watson, Ph.D.
Honorary Directors
John P. Cleary
George W. Cutting, Jr.
Mary D. Lindsay
Anne R. Meier
2006 CSHLA Directors
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Dolan DNA Learning Center Corporate Advisory Board
The Corporate Advisory Board (CAB), established in 1992, serves the Dolan DNA Learning Center as a
bridge to the corporate community and assists in securing unrestricted funds for annual support.
Composed of influential business leaders from large and small companies on Long Island and
Manhattan, the CAB is a necessary and vital component to the continued success and mission of the
Dolan DNALC.
Edward A. Chernoff, Motors &
Armatures, Inc., Chairman
Laurie J. Landeau, VMD,
CSHL Trustee Liaison
Michael Aboff, Aboff's Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, Commerce Bank
Thomas J. Calabrese, Daniel Gale
Sothebys International Realty
Richard A. Catalano, KPMG, LLP
James Chinitz, Population Diagnostics
Robert Dickstein, Ph.D., Pall Corporation
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis,
Mallet-Prevost, Colt & Mos le LLP
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Mary Jane Helenek, Luitpold
Pharmaceuticals
Arthur D. Herman, Herman Development
Corporation
Neil M. Kaufman, Davidoff, Malito &
Hutcher
Norman Kelker, Enzo Life Sciences
Cary Kravet, Kravet Fabric
Scott Livingston, Axiom Capital,
Livingston Group
John C. Kean III, Kean Development
Corporation
James E. Mattutat, Ingleside Investors, Inc,
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sothebys
Real Estate
Frank Posillico, Rose Racanelli Realty/
Aireco
Christiaan B. Reynolds, Fimat, USA
William D. Roche
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of
New York
Robert Van Nostrand, OSI
Pharmaceuticals, Inc.
Zock Zamaniyan, Eppendorf North
America
Teresa Kemp-Zielenski, United Way of
Long Island
Hans Zobel, Festo Corporation
(osWharinaceutic :
Foundation
Pay to the DiANTNA
LEARNWO Crie
order of
F.,-/ey 777111S a % Dollars
On June 20 at the 13th annual golf fund-raiser, the newly formed OSI
Foundation chose the Dolan DNA Learning Center of Cold Spring Harbor
Laboratory to be the recipient of its first-ever award. (Left to right) Dave Micklos,
Dolan DNA Learning Center; Dr. James Watson, Chancellor of Cold Spring
Harbor Laboratory; Ann McDermott-Kave, Director OSI Pharmaceuticals
Foundation; Dr. Colin Goddard, President and CEO OSI Pharmaceuticals;
Morgan Browne, Chairman of OSI Pharmaceuticals Foundation.
Honor Roll of Donors
Contributions of $5,000,000+ (lifetime)
Anonymous
Anonymous
Mr. and Mrs. Donald Everett Axinn*
Arnold and Mabel Beckman
Foundation
Mr. and Mrs. Landon T. Clay*
The Dart Foundation
Kathryn Wasserman Davis
The Shelby Cullom Davis
Foundation*
The DeMatteis Family Foundation*
Mr. and Mrs. Charles F. Dolan-The
Dolan Family Foundation
The Lita Annenberg Hazen
Foundation
The W.M. Keck Foundation
David H. Koch*
A lead gift from the DeMatteis
Family Foundation will provide fund-
ing to construct one of the
Laboratory's six new research
buildings. Pictured are Nancy
DeMatteis and Jim Watson at the
Cornerstone Dedication Ceremony.
Lucille P. Markey Charitable Trust
Nancy Abeles Marks*
The Quick Family*
The Robertson Family
Mr. and Mrs. Theodore R. Stanley
The Starr Foundation*
Mr. and Mrs. Henry Wendt III*
Contributions of $100,000+ or
$1,000,000+ (lifetime)
Anonymous
Anonymous
Anonymous*
The Breast Cancer Research
Foundation
Bristol-Myers Squibb Company
Edward A. Chernoff-Motors &
Armatures, Inc.*
Mr. and Mrs. John P. Cleary*
The Dana Foundation
Mr. and Mrs. Norris Darrell, Jr."
Michel David-Weill*
Mr. and Mrs. Henry P. Davison II-
The Perkin Fund*
Ira W. DeCamp Foundation
Curt Engelhorn
Mrs. Edward H. Gerry-The William
Stamps Farish Fund*
The Samuel Freeman Charitable
Trust
The Coleman Fung Foundation*
Robert B. Gardner, Jr.
Robert L. Garland
Drs. Joan E. Brooks and James I.
Garrels*
Genentech, Inc."
Kenyon Gillespie
Francis Goelet Trust*
Dr. and Mrs. Philip Goelet*
Florence Gould Foundation
The Grace Family
Dr. and Mrs. Leo A. Guthart
Estate of Louise A. Haberer
The Thomas Hartman Foundation
for Parkinson's Research
Janet Strauss and Jeff Hawkins*
Jo-Ellen and Ira Hazan
William Randolph Hearst
Foundation*
Mr. and Mrs. Martin Gruss-Hope for
Depression Research Foundation,
Inc.
The Karches Foundation
Three generations of the Monte Family attended an
October 30, 2006 dedica-
tion of the Tita Monti Cancer Research Laboratory.
(Left to right) Anna Travaglia,
Arthur Saladino, Caroline Saladino, Richard Monti, and Joseph Monti.
'Gift or pledge to the Hillside Campus Campaign
The inaugural Double Helix Medals
Dinner, held on November 9, 2006,
at the Mandarin Oriental, honored
Muhammad Ali, Bob and Suzanne
Wright, and Dr. Phillip Sharp.
Pictured from left are Double Helix
Medal recipient Muhammad All with
Monsignor Thomas J. Hartman.
Mr. and Mrs. John Klingenstein-The
Esther A. & Joseph Klingenstein
Fund, Inc.
Mr. and Mrs. Townsend J. Knight
The Koshland Foundation*
The Forrest and Frances Lattner
Foundation
Mr. and Mrs. Gerard Leeds*
The Lehrman Institute*
The Lessing Family Foundation*
Mary D. Lindsay*
Mr. and Mrs. Robert D. Lindsay and
Family*
Estate of Elisabeth
Mr. and Mrs. David L. Luke III
Josiah Macy, Jr. Foundation
Dr. Thomas Maniatis*
The G. Harold & Leila Y. Mathers
Charitable Foundation
Gillian and Eduardo Mestre*
Mr. and Mrs. William R. Miller
The Miracle Foundation
The Don Monti Memorial Research
Foundation
New York State Office of Parks,
Recreation and Historic
Preservation"
Pierre and Pamela Omidyar Fund
OSI Pharmaceuticals Foundation*
Pfizer
Mr. and Mrs. John C. Phelan
William and Maude Pritchard
Charitable Trust
Fannie E. Rippel Foundation
The Robertson Foundation*
Mr. and Mrs. David M. Rubenstein
The Seraph Foundation
Dr. and Mrs. Philip A. Sharp*
Herbert J. Siegel
Alfred P. Sloan Foundation
Howard Solomon*
St. Giles Foundation
Swartz Foundation
Dr. Waclaw Szybalski*
Dr. and Mrs. James D. Watson
Dr. Norton D. Zinder*
The Roy J. Zuckerberg Foundation*
Contributions of $50, 000+
Anonymous
Dr. Sydney Brenner*
Cedar Hill Foundation*
Find A Cure Today (F.A.C.T.)
Goldman Sachs Foundation
The Joseph G. Goldring Foundation
Mr. and Mrs. Bryan H. Lawrence
Long Islanders Against Breast
Cancer (L.I.A.B.C.)
Louis Morin Charitable Trust
Manyu Ogale
William Townsend Porter Foundation
Thomas C. Quick
Estate of Mary Vander Poel Russell*
Edith and Alan Seligson-The
Seligson Foundation
Dr. and Mrs. Charles L. Stone,
Jr.-The Stone Foundation*
Waldbaum Foundation
Contributions of $25,000+
Mr. and Mrs. Abraham Appel
Arrow Electronics, Inc.
Karen H. Bechtel
The Louis Berkowitz Family
Foundation
Berlin Family Foundation
Biogen Idec, Inc.
Cashin Family Foundation
Dr. Gerald Chan-The Morningside
Foundation
Dr. and Mrs. Lan Bo Chen
Richard Baron Cohen
Mr. and Mrs. John H. Friedman
David B. Ford
Brandon Fradd
Glen Cove C.A.R.E.S.
Double Helix Medal recipients
Suzanne and Bob Wright with
Meredith Vieira (center).
Jacob Goldfield
Robert I. Goldman Foundation
Mr. and Mrs. Charles E. Harris II
Harrison's Heart Foundation
William A. Haseltine, Ph.D.
Mr. and Mrs. J. Tomilson Hill III
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Cold Spring Harbor Laboratory
President Bruce Stillman (center) with
Bruce Kovner (left) and David Koch
at the Double Helix Medals Dinner.
The Karp Foundation
Eleanora and Michael Kennedy-The
Shana Alexander Foundation
F.M. Kirby Foundation
The Lehman Brothers Foundation
Long Island 2-Day Walk to Fight
Breast Cancer Inc.
The Nancy Lurie Marks Family
Foundation
Marcia Kramer Mayer and Michael
Eisenbud
Breast Cancer Awareness Day in
Memory of Elizabeth McFarland
Mr. and Mrs. Thomas J. McGrath
Monique and Doug Morris
NBC Universal
George F Ohrstrom
Wendy Keys and Donald A. Pets
Leila C. Pile
Mr. and Mrs. Luis E. Rinaldini
Mr. and Mrs. James F Stebbins
Dr. and Mrs. James M. Stone
Joan P. Tilney*
Mr. and Mrs. Raymond Wong
Karen and Mark Zoller
Contributions of $10, 000+
Alnylam Pharmaceuticals, Inc.
Joseph V. Amelia- Accretive
Solutions, Inc.
Autism Speaks
The Bahnik Foundation
Joyce Bertoldo and Michael Griffin
Jamie Nicholls and Fran Biondi
Pien and Hans Bosch
Brownstone Agency, Inc.
Mr. and Mrs. Thomas J. Calabrese, Jr.*
Mr. and Mrs. Michael Carpenter
Centerbrook Architects and
Planners
The Clarkson Family Foundation
Cravath, Swaine & Moore
Creative Artists Agency
Cruizin' for a Cure
Mr. and Mrs. Roderick H. Cushman
Mr. and Mrs. George W. Cutting, Jr.
Daniel Gale Sotheby's International
Realty
Mr. and Mrs. Jack Di Maio
Mr. and Mrs. E. Richard Droesch
Mr. and Mrs. Patrik L. Edsparr
Endeavor
Norman and Dorian Feckl
Fortunato Sons Contracting, Inc.
Stephen and Lori Garofalo
Walter and Celia Gilbert
Dr. and Mrs. Charles B. Goodwin
Mr. and Mrs. John S. Grace
Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. Joseph Gregory
The Irving A. Hansen Memorial
Foundation
Islip Breast Cancer Coalition
JPMorgan Chase & Co.
The Kapp Family Foundation
Ada Howe Kent Foundation
The Kleinknecht Family Foundation
Mr. and Mrs. David M. Knott
The Korein Foundation
Lehman Brothers
The Fay J. Lindner Foundation*
Merck Research Laboratories
North Shore-LIJ Health System
Foundation
Susanne Olin
Pall Corporation
Louise Parent and John Casa ly
Rauch Foundation
Hope and John Reese*
Deborah K. Solbert
Mr. and Mrs. Douglas S. Soref
Nita Soref
On October 16, 2006, the Cornerstone Dedication for Cold Spring Harbors
Hillside Research Campus was held. Pictured along with Jim Watson (left)
are Mardi Matheson, Peter Quick, Tom Quick, Nancy De Matteis, Joan Axinn,
Bruce Stillman, and Jennifer Axinn-Weiss.
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Erwin and Freddie Staller
Steamboat Foundation
Lauri Strauss Leukemia Foundation
Paul J. Taubman
Textor Family Foundation
The Doris M. and Peter S. Tilles
Foundation
Sandy and Howard Tytel
Mrs. Philip R. von Stade
Edwin S. Webster Foundation*
West Islip Breast Cancer Coalition for L.I.
Women's Insurance Network of
Long Island
Contributions of $5, 000+
Mr. and Mrs. Lee S. Ainslie III
All Pro Carpet Co., Inc.
Atkinson Koven Feinberg, LLP
Mr. and Mrs. W. Dillaway Ayres, Jr.
Double Helix Medals Dinner emcee
Phil Dohahue (left) and Medal recipi-
ent Dr. Phillip Sharp.
Geoff and Rene Boisi-The Boisi
Family Foundation
Boston Biochem, Inc.
Brinkmann Instruments/Eppendorf
North America
Lisa and Tim Broadbent
Helen M. Brooks
Drs. Mary Ann Cardile and Gerald A.
Weber
John K. Castle
Leslie Moonves-CBS Corporation
CKx, Inc.
Commerce Bank
The Craigmyle Foundation
Mr. and Mrs. Richard T. Cunniff
The De Vita Family
Mr. and Mrs. Mark DeGennaro
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CORPORATE SPONSOR PROGRAM
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year's meetings nor introduce new and unusual topics. Thank you
to our sponsors!
The members of the Program receive special privileges in acknowledgment of their contributions. We
waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives of the
Corporate Sponsors at our meetings. Six and three scientists, respectively, from Benefactors and
Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by invitation
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Harbor Laboratory Press pub-
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